
<html lang="en"     class="pb-page"  data-request-id="1512d4ca-9546-4e2f-ac65-d6e3955f0414"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/jm7009364;issue:issue:10.1021/jmcmar.2008.51.issue-3;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Multi-target-Directed Ligands To Combat Neurodegenerative Diseases" /></meta><meta name="dc.Creator" content="Andrea  Cavalli" /></meta><meta name="dc.Creator" content="Maria Laura  Bolognesi" /></meta><meta name="dc.Creator" content="Anna  Minarini" /></meta><meta name="dc.Creator" content="Michela  Rosini" /></meta><meta name="dc.Creator" content="Vincenzo  Tumiatti" /></meta><meta name="dc.Creator" content="Maurizio  Recanatini" /></meta><meta name="dc.Creator" content="Carlo  Melchiorre" /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 9, 2008" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm7009364" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm7009364" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm7009364" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm7009364" /></link>
        
    
    

<title>Multi-target-Directed Ligands To Combat Neurodegenerative Diseases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm7009364" /></meta><meta property="og:title" content="Multi-target-Directed Ligands To Combat Neurodegenerative Diseases" /></meta><meta property="og:image" content="https://pubs.acs.org/pb-assets/images/CoverImages_2by1Scaled/jmcmar-1595795902140.png" /></meta><meta property="og:description" content="" /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm7009364"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm7009364">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm7009364&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm7009364&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm7009364&amp;href=/doi/10.1021/jm7009364" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 347-372</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm701385c" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/jm800210c"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Multi-target-Directed Ligands To Combat Neurodegenerative Diseases</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrea++Cavalli">Andrea Cavalli</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria+Laura++Bolognesi">Maria Laura Bolognesi</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anna++Minarini">Anna Minarini</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michela++Rosini">Michela Rosini</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vincenzo++Tumiatti">Vincenzo Tumiatti</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maurizio++Recanatini">Maurizio Recanatini</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carlo++Melchiorre">Carlo Melchiorre</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Department of Pharmaceutical Sciences, Alma Mater Studiorum, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: +39 0512099700 . Fax: +39 0512099734. E-mail: for A.C., <a href="/cdn-cgi/l/email-protection#4d2c23293f282c632e2c3b2c2121240d3823242f22632439"><span class="__cf_email__" data-cfemail="3a5b545e485f5b14595b4c5b5656537a4f5453585514534e">[email protected]</span></a>; for M.L.B., <a href="/cdn-cgi/l/email-protection#ed808c9f848c818c989f8cc38f8281828a83889e84ad9883848f82c38499"><span class="__cf_email__" data-cfemail="f19c908398909d90848390df939e9d9e969f948298b1849f98939edf9885">[email protected]</span></a>; for C.M., <a href="/cdn-cgi/l/email-protection#f39092819f9cdd9e969f909b9a9c818196b3869d9a919cdd9a87"><span class="__cf_email__" data-cfemail="305351425c5f1e5d555c5358595f42425570455e59525f1e5944">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm7009364&amp;href=/doi/10.1021%2Fjm7009364" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 347–372</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 9, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>31 July 2007</li><li><span class="item_label"><b>Published</b> online</span>9 January 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 February 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm7009364" title="DOI URL">https://doi.org/10.1021/jm7009364</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D347%26pageCount%3D26%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAndrea%2BCavalli%252C%2BMaria%2BLaura%2BBolognesi%252C%2BAnna%2BMinarini%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D3%26contentID%3Djm7009364%26title%3DMulti-target-Directed%2BLigands%2BTo%2BCombat%2BNeurodegenerative%2BDiseases%26numPages%3D26%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D372%26publicationDate%3DFebruary%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm7009364"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">8304</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">698</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm7009364" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Multi-target-Directed Ligands To Combat Neurodegenerative Diseases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;Cavalli&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Laura Bolognesi&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Minarini&quot;},{&quot;first_name&quot;:&quot;Michela&quot;,&quot;last_name&quot;:&quot;Rosini&quot;},{&quot;first_name&quot;:&quot;Vincenzo&quot;,&quot;last_name&quot;:&quot;Tumiatti&quot;},{&quot;first_name&quot;:&quot;Maurizio&quot;,&quot;last_name&quot;:&quot;Recanatini&quot;},{&quot;first_name&quot;:&quot;Carlo&quot;,&quot;last_name&quot;:&quot;Melchiorre&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;347-372&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm7009364&quot;},&quot;abstract&quot;:&quot;&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm7009364&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm7009364" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm7009364&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm7009364" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm7009364&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm7009364" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm7009364&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm7009364&amp;href=/doi/10.1021/jm7009364" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm7009364" /></input><a href="/doi/pdf/10.1021/jm7009364" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26pmid%3D18181565%26genre%3Darticle%26aulast%3DCavalli%26date%3D2008%26atitle%3DMulti-target-Directed%2BLigands%2BTo%2BCombat%2BNeurodegenerative%2BDiseases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D3%26spage%3D347%26epage%3D372%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290729" title="Nervous system diseases">Nervous system diseases</a>,</li><li><a href="/action/doSearch?ConceptID=290645" title="Aggregation">Aggregation</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24855" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24855" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our understanding of the pathogenesis of diseases has advanced enormously in recent decades. As a consequence, drug discovery has gradually shifted from an entirely human-phenotype-based endeavor to todayʼs reductionist approach centered on single molecular targets. The focus has shifted from the early animal models to isolated proteins via cellular models. This change has led to a decrease in complexity but also to a decrease in relevance to the human condition.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In this context, drug research has become (and still is) aimed mainly at the discovery of small molecules able to modulate the biological function of a single protein target thought to be fully responsible for a certain disease. Much effort has been devoted to achieving selectivity for that given target, and indeed, nowadays, many ligands endowed with outstanding in vitro selectivity are available. This one-molecule, one-target paradigm has led to the discovery of many successful drugs, and it will probably remain a milestone for years to come. However, it should be noted that a highly selective ligand for a given target does not always result in a clinically efficacious drug. This may be because (a) the ligand does not recognize the target in vivo, (b) the ligand does not reach the site of action, or (c) the interaction with the respective target does not have enough impact on the diseased system to restore it effectively. Reasons for the latter might lie in both the multifactorial nature of many diseases and the fact that cells can often find ways to compensate for a protein whose activity is affected by a drug, by taking advantage of the redundancy of the system, i.e., of the existence of parallel pathways.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> Medicinal chemists are often faced with these frustrating aspects of drug research. Drawbacks a and b can be addressed through the well-established rational ligand modification approaches. But issue c is more problematic and needs to be carefully discussed. This is one of the aims of the present article.</div><div class="NLM_p">Drugs hitting a single target may be inadequate for the treatment of diseases like neurodegenerative syndromes, diabetes, cardiovascular diseases, and cancer, which involve multiple pathogenic factors.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Different pharmacological approaches offer possible ways of overcoming the problems that arise from the use of such drugs.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> When a single medicine is not sufficient to effectively treat a disease, a multiple-medication therapy (MMT)<a class="ref internalNav" href="#fn1" aria-label="a">a</a> (also referred to as a “cocktail” or “combination of drugs”) may be used. Usually, an MMT is composed of two or three different drugs that combine different therapeutic mechanisms. But this approach might be disadvantageous for patients with compliance problems. A second approach might be the use of a multiple-compound medication (MCM) (also referred to as a “single-pill drug combination”), which implies the incorporation of different drugs into the same formulation in order to simplify dosing regimens and improve patient compliance. Finally, a third strategy is now emerging on the basis of the assumption that a single compound may be able to hit multiple targets. Clearly, therapy with a single drug that has multiple biological properties would have inherent advantages over MMT or MCM. It would obviate the challenge of administering multiple single-drug entities, which could have different bioavailability, pharmacokinetics, and metabolism. Indeed, if a single molecular species can show a complex ADMET profile, an MMT/MCM approach might be untenable. Furthermore, in terms of pharmacokinetic and ADMET optimization, the clinical development of a drug able to hit multiple targets should not, in principle, be different from the development of any other single lead molecule. It thus offers a much simpler approach than MMT/MCM. In addition, the risk of possible drug−drug interactions would be avoided and the therapeutic regimen greatly simplified in relation to MMT. All these considerations are of particular relevance, as one of the major contributions to the attrition rate in drug development continues to be the drug candidateʼs pharmacokinetic profiling.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> There is, therefore, a strong indication that the development of compounds able to hit multiple targets might disclose new avenues for the treatment of, for example, major neurodegenerative diseases, for which an effective cure is an urgent need and an unmet goal. <div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: Aβ, amyloid-β; ACh, acetylcholine; AChE, acetylcholinesterase; AChEI, acetylcholinesterase inhibitor; AD, Alzheimerʼs disease; ALS, amyotrophic lateral sclerosis; APP, amyloid precursor protein; BACE, β-secretase; BBB, blood−brain barrier; BuChE, butyrylcholinesterase; cdk5, cyclin-dependent protein kinase 5; COMT, catechol-<i>O</i>-methyltransferase; CoQ, coenzyme Q10; DA, dopamina; ER, endoplasmic reticulum; GSK-3β, glycogen synthase kinase-3β; HD, Huntingtonʼs disease; 5-HT, serotonin; LA, lipoic acid; LBs, Lewy bodies; LPO, lipid peroxidation; MAO, monoamine oxidase; MCM, multiple-compound medication; MMT, multiple-medication therapy; MTDL, multi-target-directed ligand; NFT, neurofibrillary tangle; NQO1, NAD(P)H/quinone oxidoreductase 1; PAS, peripheral anionic site; PD, Parkinsonʼs disease; PHF, paired helical filaments; ROS, reactive oxygen spesies; SAPK, stress-activated protein kinases; SERT, serotonin transporter; SOD, superoxide dismutase; UPS, ubiquitin-proteosomal system; VDCC, voltage-dependent calcium channels.</p></div></div><div class="NLM_p">Morphy and Rankovic elegantly discussed this approach in recent articles,<a onclick="showRef(event, 'ref5 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref7 ref8">(5, 7, 8)</a> which was mostly concerned with non-neurodegenerative diseases. They proposed the term “designed multiple ligands” to describe compounds whose multiple biological profile is rationally designed to address a particular disease. Despite our awareness that the use of different terms to illustrate the same concept may obscure developments in the field, we are convinced that the definition “multi-target-directed ligands” (MTDLs) more completely describes those compounds that are effective in treating complex diseases because of their ability to interact with the multiple targets thought to be responsible for the disease pathogenesis (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><figure id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Pathways leading to the discovery of new medications: (a) Target-driven drug discovery approach, that is, the application of the current one-molecule, one-target paradigm. Although this approach has led to many effective drugs able to hit a single target, it is now well-documented that these drugs may represent the exception rather than the rule. (b) MTDLs approach to drug discovery. A drug could recognize (in principle, with comparable affinities) different targets involved in the cascade of pathological events leading to a given disease. Thus, such a medication would be highly effective for treating multifactorial diseases. The design of such a drug may not be easy because it could also bind targets that are not involved with the disease and could be responsible (although not necessarily) for side effects. With MTDLs, the one-medication, one-disease paradigm finds a practical application.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The excellent perspective by Morphy and Rankovic<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> covers several aspects of the design strategy leading to MTDLs for different areas such as inflammation, dopaminergic D<sub>2</sub>-receptors, histaminergic H<sub>1</sub>-receptors, serotoninergic receptors, angiotensin system, peroxisome proliferators activated receptors, kinases, and nitric oxide releasing conjugates. However, there is a paucity of review literature dealing with complex diseases associated with neurodegeneration. The objective of this Perspective is to review those investigations reported in the past decade that illustrate the ability of medicinal chemists to design MTDLs to confront neurodegenerative diseases. We will briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known molecular bases of the main neurodegenerative pathologies.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">2 Multifactorial Nature of Neurodegenerative Diseases</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16782" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16782" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Neurodegenerative diseases have long been viewed as among the most enigmatic and problematic issues in biomedicine.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> As research on neurodegenerative diseases has moved from descriptive phenomenology to mechanistic analysis, it has become increasingly clear that the major basic processes involved are multifactorial in nature, caused by genetic, environmental, and endogenous factors. The neurodegenerative diseases sharing such multifactorial pathogenic mechanism are, among others, Alzheimerʼs, Parkinsonʼs, and Huntingtonʼs diseases and amyotrophic lateral sclerosis (hereafter referred to as AD, PD, HD, and ALS, respectively). These diseases will be the subject of this article.</div><div class="NLM_p">Although each disease has its own molecular mechanisms and clinical manifestations, some general pathways might be recognized in different pathogenic cascades. They include protein misfolding and aggregation, oxidative stress and free radical formation, metal dyshomeostasis, mitochondrial dysfunction, and phosphorylation impairment, all occurring concurrently (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><figure id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic pathways of the multifactorial events leading to neuronal death. General mechanisms, such as protein misfolding and aggregation, oxidative stress, metal (M) dyshomeostasis, mitochondrial dysfunction, and altered protein phosphorylation, have been identified in several neuronal disorders.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Protein misfolding followed by self-association and subsequent deposition of the aggregated proteins has been observed in the brain tissues of patients affected by these disorders. Monomeric species initially form small oligomers, which then nucleate the growth of fibrillar structures in a stepwise fashion.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> Indeed, soluble proteins of entirely different sequences can fold into stable β-sheet conformations that share conformational epitopes. This finding suggests that assemblies produced by different amyloidogenic proteins might trigger a similar neurotoxic mechanism. Despite presenting widely divergent primary and secondary structures, all proteins, when they form amyloid fibrils, adopt the cross-β-sheet arrangement with the axis of the peptide oriented perpendicularly to the fibril axis.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The final proteinaceous aggregates derived from this pathological event share common structural and histological morphologies. Their biological effects, however, are distinctive and depend on such features as the tissue involved and whether the deposits are intracellular or extracellular.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> The biophysical behavior of these proteins, leading to their misfolding, aggregation, and deposition, has prompted scientists to group these kinds of neurological disorders under the common name of “conformational diseases”.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> It is worth noting that amyloid oligomers such as amyloid-β (Aβ) and α-synuclein have been widely reported to permeabilize both cell and mitochondrial membranes.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> They are therefore probably responsible for calcium dysregulation, membrane depolarization, and impairment of mitochondrial functions, which have been identified as a further common feature of most neurodegenerative disorders (see below).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">The role of reactive oxygen species (ROS) in many neurodegenerative diseases was deemed to be as important as the role of microorganisms in infectious diseases.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> For years, scientists debated whether oxidative stress was a cause or consequence of the neurodegenerative cascade.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> At present, scientists are close to a consensus that imbalance of intracellular oxidation state is an early event of neurodegeneration and is therefore likely to be one of the major factors of neurodegenerative diseases. Neuronal tissue is particularly sensitive to oxidative stress, and imbalance in pro-oxidant vs antioxidant homeostasis in CNS results in the production of several potentially toxic ROS, including both the radical and nonradical species that participate in the initiation and/or propagation of radical chain reactions. In AD, PD, HD, and ALS, oxidative damage is found in every class of biological molecules within neurons, spanning from lipids to DNA and proteins.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> However, the administration of one or a few antioxidants is too simplistic, as demonstrated by the several clinical studies that have shown modest success with antioxidants in the treatment of neurodegeneration.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p">For the above-mentioned neurodegenerative diseases, a direct cause and effect relationship between metal abnormalities and increased oxidative damage has been hypothesized on the basis of various experimental evidence. While transition metals are essential in many biological reactions, alterations in their homeostasis result in increased free radical production, which is catalyzed by iron, copper, or other trace redox active metals.<a onclick="showRef(event, 'ref11 ref24'); return false;" href="javascript:void(0);" class="ref ref11 ref24">(11, 24)</a> Moreover, all the disease-specific proteins bear metal-binding motifs, and metal ions favor fibril generation and deposition.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In all cases, metal-mediated oxidative stress is also linked to mitochondrial dysfunction.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Notably, abnormal mitochondrial function could follow ROS generation rather than being a cause of oxidative stress in neurons.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> There is substantial evidence of morphological, biochemical, and molecular abnormalities in mitochondria in various tissues affected by AD, PD, HD, and ALS.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Moreover, an impressive number of disease-specific proteins that interact with mitochondria have recently been disclosed: (i) amyloid precursor protein (APP), Aβ, presenilin in AD; (ii) α-synuclein, parkin, DJ-1, PINK1, HTRA2 in PD; (iii) superoxide dismutase 1 (SOD1) in ALS; (iv) huntingtin in HD.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Although the chronological hierarchy of events and underlying causes in neurodegenerative diseases with regard to mitochondrial dysfunction and oxidative stress are not yet fully understood, there is overwhelming evidence that either one can lead to the evolution of the other, setting in motion a self-sustaining, amplifying cycle that can ultimately trigger activation of neuronal death processes.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> In addition to mitochondria, the endoplasmic reticulum (ER) also serves as an important apoptotic checkpoint. For instance, it has been shown that, in AD, apoptosis induced by misfolded proteins involves ER impairment.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_p">As recently disclosed in the specialist literature, a further common mechanism shared by neurodegenerative diseases concerns the alteration of the phosphorylation state of some key proteins involved in the pathogenic cascades. Besides the well-recognized hyperphosphorylated state of τ protein in the neurofibrillary tangles observed in AD brain,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> specific altered patterns of kinase and posphatase activities are associated with alteration in the phosphorylation state of disease-specific proteins in PD,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> ALS,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and HD.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_p">The availability of such extensive molecular evidence raises the issue of cell-type specificity in neuronal disorders. Selective neuron degeneration has been shown to be a fundamental characteristic of each disease. The issue of cell-type specificity is therefore an open question for those studying the pathogenesis and treatment of these illnesses.</div><div class="NLM_p">However, none of these general mechanisms alone are sufficient to explain the high number of biochemical and pathological abnormalities of neurodegenerative diseases, which involve a multitude of cross-related cellular and biochemical changes that might not be adequately addressed by following the one-molecule, one-target paradigm. In our opinion, there is therefore a growing interest in and urgent need for MTDLs to provide real disease-modifying drug candidates for such neurodegenerative diseases. Since most of these neurodegenerative mechanisms are shared by many neuronal disorders, MTDLs may also potentially be used as medications for more than one illness. Surprisingly, the pharmaceutical industry is not investing heavily in the development of innovative treatments for neurodegenerative diseases, as one would expect on the basis of both growing scientific evidence and patient populations.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p last">Polypharmacology is not new. What is new is both the understanding of its relevance in drug discovery and the understanding of the molecular events at its basis.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">3 Alzheimerʼs Disease (AD)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67767" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67767" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">AD stands out among the neurodegenerative diseases as the fourth leading cause of death in the Western countries and the most common cause of acquired dementia in the elderly population. Two forms of AD exist: a familial one (multiple family members are affected) and a sporadic one, in which one or a few members of a family develop the disease. In line with an increase in average life expectancy, the number of affected persons is expected to triple by 2050, with immense economic and personal tolls.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In parallel with this increase, the speed of drug research has accelerated noticeably in recent decades. However, the number of therapeutic options on the market remains severely narrow. The currently registered drugs for AD are not able to alter or prevent disease progression. They are, instead, palliative in alleviating disease symptomatology.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_p">One-hundred years after the discovery of AD, the scientific consensus is quite firm that although the pathogenesis of AD is not yet fully understood, it is a multifactorial disease caused by genetic, environmental, and endogenous factors, as with the other neurodegenerative disorders. These factors include excessive protein misfolding and aggregation, often related to the ubiquitin−proteasomal system (UPS), oxidative stress and free radical formation, impaired bioenergetics and mitochondrial abnormalities, and neuroinflammatory processes. These insights, coupled with further ongoing discoveries about AD pathogenesis, have provided the rationale for therapies directly targeting AD molecular causes. New drug candidates with disease-modifying potential are now in the pipeline and have reached testing in clinical trials.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">3.1 Molecular Causes of AD</h3><div class="NLM_p">Since Alois Alzheimerʼs seminal report of November 1906,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> pathologists have considered the defining characteristic hallmarks of the disease to be Aβ deposits in senile plaques and neurofibrillary tangles (NFT), consisting mainly of paired helical filaments of abnormally phosphorylated τ protein. As the disease progresses, neuronal death appears. In particular, cholinergic neurons and synapses of the basal forebrain are selectively lost, accounting for the development of cognitive impairments. These findings constituted the premises for the so-called “cholinergic hypothesis”, which proposed cholinergic enhancement as an approach for improving cognitive function in AD.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> This approach has so far produced the majority of drugs approved for treating AD.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><div class="NLM_p">Nowadays, compelling evidence suggests that Aβ secretion is the triggering event in the pathogenesis of AD and that τ aggregation may be an important secondary event linked to neurodegeneration (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> According to the “amyloid cascade hypothesis”, Aβ would originate from the sequential proteolysis of the APP and it would deposit and aggregate (or aggregate and deposit) in extracellular insoluble plaques. The first cleavage of APP is carried out by β-secretase (also called β-site APP cleaving enzyme or BACE).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The carboxyterminal fragment is then severed by the γ-secretase complex,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> producing Aβ. Alternatively, cleavage of the protein by α-secretase allows for the release of a large fragment, α-APPs, which is not amyloidogenic. Central to this hypothesis is the observation that the amount of fibrillogenic Aβ is increased by the vast majority of mutations causing familial AD and that Aβ impairs neuronal functions in a variety of experimental models.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Soluble Aβ is thought to undergo a conformational change to high β-sheet content, which renders it prone to aggregate into soluble oligomers and larger insoluble fibrils in plaques. In this process, the fibrillogenic Aβ42 isoform triggers the misfolding of other Aβ species. Currently, the nature of the neurotoxic Aβ species is very difficult to define because monomers, soluble oligomers, insoluble oligomers, and insoluble amyloid fibrils are expected to accumulate and exist in dynamic equilibrium in the brain. Initially, only Aβ deposited in plaques was assumed to be neurotoxic, but more recent findings suggest that soluble oligomers (Aβ-derived diffusible ligands or ADDLs) might be the central players. Afterward, Aβ may exert its neurotoxic effects in a variety of ways, including disruption of mitochondrial function via binding of the Aβ-binding alcohol dehydrogenase protein,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> induction of apoptotic genes through inhibition of Wnt<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> and insulin signaling,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> formation of ion channels,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> stimulation of the stress-activated protein kinases (SAPK) pathway<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> or activation of microglia cells leading to the expression of proinflammatory genes, an increase in ROS, and eventual neuronal toxicity and death.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> More recently, it has become clear that, in addition to forming extracellular aggregates, Aβ (or its precursor APP) has complicated intracellular effects involving a variety of subcellular organelles, including mitochondria. Mitochondrial APP has been shown to accumulate in the protein import channels of mitochondria of human AD brains, and this accumulation inhibits the entry of cytochrome <i>c</i> oxidase subunits proteins,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> with decreased activity of respiratory chain enzymes, increased free radical generation, and impaired reducing capacity. These data provide a potential explanation for the well-established observation that mitochondrial function and energy metabolism are impaired early in AD.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><figure id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Possible molecular causes of neuronal death and protective mechanisms in AD. The central event in AD pathogenesis is an imbalance between Aβ production and clearance. The enhanced activity of β- and γ-secretases leads to increased release of amyloidogenic Aβ42, which forms oligomers and then extracellular deposits (senile plaques). One way to confront AD pathogenesis may be to combat the oligomerization by means of small molecules. A role for metal ions and ROS in the Aβ oligomerization has also been advanced. Therefore, metal chelation and antioxidant activity are two general mechanisms to be considered in the search for disease-modifying anti-AD drug candidates. Also, β- and γ-secretase inhibitors may be promising lead compounds because they tackle an early event in AD pathogenesis. Mitochondrial dysfunction plays a fundamental role in the neuronal death associated with AD, as it is likely that intracellular Aβ could compromise the function of this organelle. τ hyperphosphorylation leading to tangle formation is regarded as a downstream event but could contribute to reinforcing neuronal dysfunction and cognitive impairment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">NFTs are composed mainly of paired helical filaments (PHF) that contain an abnormal hyperphosphorylated form of the microtubule-associated protein τ. Phosphorylation within the microtubule binding domain of τ protein results in its reduced ability to stabilize microtubules assembly, leading to the disruption of neuronal transport and eventually to accelerated synaptic loss and cell death. Dephosphorylation of τ protein isolated from NFT restores its ability to bind with neuronal microtubules, indicating that the mechanisms regulating phosphorylation/dephosphorylation kinetics are perturbed in AD. The nature of protein kinases, phosphatases, and τ sites involved in this lesion has recently been elucidated, suggesting that activation of phosphoseryl/phosphothreonyl protein phosphatase-2A (PP-2A) or inhibition of both glycogen synthase kinase-3β (GSK-3β) and cyclin-dependent protein kinase 5 (cdk5) might be required to inhibit AD neurofibrillary degeneration.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p">Several other hypotheses have been proposed to explain the pathogenesis of AD, including oxidative stress, metal ion dyshomeostasis, and inflammation.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> In the context of such a complex disease, it is not trivial to state that these hypotheses are not mutually exclusive. Rather, they complement each other, intersecting at a high level of complexity.</div><div class="NLM_p">Oxidative damage is present within the brain of AD patients and is observed within every class of biological macromolecules, including nucleic acids, proteins, lipids, and carbohydrates.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Oxidative injury may develop secondary to excessive oxidative stress resulting from Aβ-induced free radicals, mitochondrial abnormalities, inadequate energy supply, inflammation, or altered antioxidant defenses. Oxidative stress is thought to have a causative role in the pathogenesis of AD.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Support for this hypothesis has also been provided by the current notion that, while AD is probably associated with multifaceted etiologies and pathogenic phenomena, all these mechanisms seem to share oxidative stress as a unifying factor.</div><div class="NLM_p">Strictly related to the oxidative damage hypothesis, there is general acceptance that redox active metals can contribute to excess production of damaging ROS through Fentonʼs chemistry.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Besides creating oxidative stress, copper, together with other metal ions, influences the protein aggregation processes that are critical in most neurodegenerative diseases. For example, APP and Aβ are able to bind and reduce copper, which forms a high-affinity complex with Aβ, promoting its aggregation, and Aβ neurotoxicity depends on catalytically generated H<sub>2</sub>O<sub>2</sub> by Aβ−copper complexes in vitro. Moreover, copper, together with zinc and iron, is accumulated in the amyloid deposits of AD brains, which are partially disassembled by metal chelators.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p last">Finally, neuroinflammation of CNS cells has been recognized as an invariable feature of all neurodegenerative disorders. In AD, among CNS cells, microglia have received special interest. Microglia are activated by Aβ to produce cytokines, chemokines, and neurotoxins that are potentially toxic and therefore may contribute to neuronal degeneration. However, recent findings suggest that microglia may play a neuroprotective role in AD. This highlights the potential risk of using the inhibition of monocyte/macrophage recruitment as a therapeutic strategy and argues for caution in the pursuit of this approach.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Despite this, modulation of inflammation is one of the most dynamic areas in the search for new therapeutic targets for AD and related neurodegenerative disorders.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">3.2 Current AD Therapies</h3><div class="NLM_p">Of the above-mentioned hypotheses, the cholinergic one is the oldest. It has also had the strongest influence on the development of clinical treatment strategies. In fact, in 1993, it led to the introduction of the acetylcholinesterase inhibitor (AChEI) tacrine (<b>1</b>), the first drug to be approved for the treatment of AD, now rarely used because of its hepatotoxicity. Later, three other AChEIs, donepezil (<b>2</b>), rivastigmine (<b>3</b>), and galantamine (<b>4</b>) reached the market, becoming the standard for AD therapy, only later complemented by memantine (<b>5</b>), a noncompetitive NMDA antagonist (Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).</div><figure id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Chemical structures of the five drugs available for AD treatment (mechanisms of action are indicated in parentheses).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Mechanism of action of ACh at a cholinergic synapse. ACh is released in the synaptic cleft where it activates both postsynaptic and presynaptic cholinergic receptors [nicotinic (N) and muscarinic (M)] leading to an increase of cholinergic transmission, which results in cognition improvement. ACh is removed from the synapse by the action of the enzyme AChE, which is the target of the available AChEIs for AD treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Notwithstanding the diffused clinical practice,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> the debate on whether or not AChEIs are effective medications continues. Although beneficial in improving cognitive, behavioral, and functional impairments, they seem unable to address the molecular mechanisms that underlie the pathogenic processes.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><div class="NLM_p">Current AD drug development programs focus primarily on agents with antiamyloid disease-modifying properties. Many different pharmacological approaches to reducing amyloid pathology and tauopathy are being studied. Classes of therapeutic modalities currently in the advanced stage of clinical trial testing include forms of immunotherapy, a γ-secretase inhibitor, the selective Aβ42-lowering agent <i>R</i>-flurbiprofen, and the antiaggregation agent tramiprosate. Other nontraditional dementia therapies such as the HMG-CoA reductase inhibitors (statins), valproate, and lithium salts are now being evaluated for their clinical benefits as disease-modifying treatments.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></div><div class="NLM_p last">In parallel, the recent discovery of the so-called “nonclassical function”<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> of acetylcholinesterase (AChE) has renewed interest in the search for novel AChEIs, expanding their potential as real disease-modifying agents.<a onclick="showRef(event, 'ref61 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref61 ref62 ref63">(61-63)</a> In particular, it has been reported that AChE might act as a “pathological chaperone” in inducing Aβ aggregation through the direct interaction of its peripheral anionic site (PAS) with fibrils of the peptide.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> This has led scientists to reconsider this enzyme as a target that mediates two important effects in the neurotoxic cascade, that is, Aβ fibrils formation and acetylcholine (ACh) breakdown.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">3.3 MDTLs for the Treatment of AD</h3><div class="NLM_p">The accumulating insights into AD complexity and the multiple etiologies contributing to the disease allow us to be confident that MMT and/or MCM might result in a more effective treatment strategy.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> These medications, which offer the prospect of additional benefits with respect to single-drug treatments, may represent a way of targeting the multiple pathological processes involved in AD. MMT has already proven successful in the treatment of similarly complex diseases such as cancer, HIV, and hypertension, where it achieves maximum efficacy by attacking several targets simultaneously, exploiting synergy, and minimizing individual toxicity. It is worth noting that the number of patented MCM has overtaken that of single-drug entities for the potential treatment of AD.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> In clinics, MMT of memantine (<b>5</b>) and an AChEI appears to produce an additional effect resulting in a well-tolerated, effective treatment strategy.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div><div class="NLM_p">Considering the well-accepted clinical use of MMT as a starting point, the MTDL design strategy might represent a natural evolution, and MTDLs emerge as valuable tools for hitting the multiple targets implicated in AD etiology. Several MTDLs have been developed by academia and industry in recent years. These have been the subject of some interesting review articles.<a onclick="showRef(event, 'ref68 ref69 ref70 ref71 ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref68 ref69 ref70 ref71 ref72 ref73">(68-73)</a></div><div class="NLM_p">To obtain novel MTDLs, a design strategy is usually applied in which distinct pharmacophores of different drugs are combined in the same structure to afford hybrid molecules. In principle, each pharmacophore of these new drugs should retain the ability to interact with its specific site(s) on the target and, consequently, to produce specific pharmacological responses that, taken together, should slow or block the neurodegenerative process. One of the most widely adopted approaches in the field has been to modify the molecular structure of an AChEI in order to provide it with additional biological properties useful for treating AD.</div><div id="sec3_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i7" class="anchor-spacer"></div><h4 class="article-section__title" id="_i7"> Dual Binding Site AChEIs Targeting Aβ Aggregation</h4><div class="NLM_p">In the MTDL design strategy context, major research efforts have been devoted to the development of the so-called “dual binding site” AChEIs. By simultaneously interacting with AChE catalytic and peripheral sites, these AChEIs might alleviate the cognitive deficit in AD by restoring cholinergic activity. More importantly, they might address the disease mechanisms by reducing Aβ aggregation. However, the classification of this highly populated class of compounds as MTDLs deserves comment. The fact that these inhibitors are shown to bind to more than one site along the AChE gorge is not a sufficient condition to label them as MTDLs. Rather, the term “multisite inhibitors” seems more appropriate. However, if it can be proven with experiments that their ability to block PAS allows them to retard Aβ assembly, then they do indeed show concurrent activities deriving from the multiple-binding mode and can therefore be classed as MTDLs.</div><div class="NLM_p">Caproctamine (<b>6</b>) represents one of the first examples of a successfully designed AChEI endowed with additional pharmacological effects beneficial in AD. <b>6</b> was developed using the universal template approach (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> It was argued that ligands having affinity for both AChE catalytic site and PAS and for muscarinic M<sub>2</sub> receptors might be of interest because inhibition of AChE activity would potentiate the remaining cholinergic transmission in affected brain regions while antagonism of muscarinic M<sub>2</sub> autoreceptors would facilitate the release of ACh in the synapse. Furthermore, inhibition of the peripheral binding site would prevent the aggregation of Aβ induced by AChE. The starting point of this study was the observation that the tetraamine disulfide benextramine (<b>7</b>), originally developed as an irreversible α-adrenoreceptor antagonist and then shown to also be a muscarinic M<sub>2</sub> receptor antagonist, turned out to reversibly inhibit AChE activity. Thus, structural manipulations of the tetraamine backbone of <b>7</b> led to <b>6</b>, which emerged as an effective pharmacological tool in AD because of a well-balanced affinity profile as AChEI and competitive muscarinic M<sub>2</sub> receptor antagonist.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Moreover, docking studies aimed at clarifying the binding mode of <b>6</b> at the AChE gorge revealed that it may make contact with both AChE sites, even though this behavior was not experimentally verified.</div><figure id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Design strategy leading to the diamine diamide <b>6</b> and, subsequently, to its two derivatives <b>8</b> and <b>9</b> (selected from among many others) through the modification of the cystamine moiety of the tetraamine <b>7</b> and then the octamethylene spacer of <b>6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The development of <b>10</b> gave direct evidence of the Aβ antiaggregating action of AChEIs purposely designed to bind at both the catalytic site and PAS of the human AChE. Such a dual inhibitor was designed by combining in the same molecule two moieties optimal for the binding at each enzyme site and linked by an appropriate spacer. The two moieties, a benzylamino group and a coumarin (2<i>H</i>-2-chromenone) heterocycle, were selected from previously developed AChEIs (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). With regard to the spacer, the choice of a phenyl ring was dictated by the fact that it could favorably interact with some of the numerous aromatic residues lining the AChE gorge. Besides having an AChE inhibitory activity comparable to that of <b>2</b>, <b>10</b> was shown to counteract Aβ aggregation with a higher potency than other tested AChEIs.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div><figure id="fig7" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Design strategy leading to <b>10</b>, the first AChEI designed to bind both AChE catalytic site and PAS in order to counteract AChE-induced Aβ aggregation as well as increasing ACh content.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">This pioneering work, together with the availability of a detailed experimental protocol for testing the inhibition of AChE-induced Aβ aggregation,<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> opened the way for the development of novel AChEIs that emerged as potential new AD therapeutics because of their ability to increase the level of ACh while simultaneously interfering with amyloid processing.<a onclick="showRef(event, 'ref61 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref61 ref62 ref63">(61-63)</a> In this respect, SAR studies of <b>6</b> were expanded by investigating the role of the octamethylene spacer separating its two amide functions. This was achieved with its replacement by more rigid dipiperidine and dianiline moieties (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Compound <b>9</b> was the most potent AChEI of the series (pIC<sub>50</sub> = 8.48 ± 0.02). It also displayed significant muscarinic M<sub>2</sub> receptor antagonism (p<i>K</i><sub>b</sub> = 6.18 ± 0.20). Moreover, the ability of <b>8</b> and <b>9</b> to inhibit AChE-induced Aβ aggregation was verified in comparison to that of the lead compound <b>6</b>. Although all the derivatives caused a mixed type of AChE inhibition (active site and PAS), only <b>8</b> and <b>9</b>, which bear an inner constrained spacer, were able to inhibit AChE-induced Aβ aggregation to a greater extent than <b>2</b>. Clearly, the ability of an AChEI, based on a linear polyamine backbone, to bind both AChE sites may not be a sufficient condition to inhibit AChE-induced Aβ aggregation too.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Notably, the <b>9</b> concentration that effectively inhibited AChE-induced Aβ aggregation (35% at 100 µM) was much higher than its IC<sub>50</sub> value (36.3 nM) against the AChE catalytic activity. Nevertheless, as previously highlighted,<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> if “normalized” on the basis of the different amounts of enzyme used in the two experiments, the ratio [inhibitor]/[AChE] is the same in both assays. Consequently, it seems plausible that similar amounts of inhibitors can simultaneously carry out both the anticholinesterase and antiaggregating actions.</div><div class="NLM_p">Similarly, the structure of the potent AChEI xanthostigmine (<b>11</b>), which displays only marginal activity against AChE-induced Aβ aggregation, was modified to obtain derivatives able to simultaneously block both AChE catalytic and proaggregatory activities. The design strategy entailed the replacement of the dibenzopyran-4-one moiety of <b>11</b> with groups characterized by greater flexibility and space extension, such as the 2-arylidenebenzofuran-3-one moiety, which provides the ability to bind AChE PAS (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). Indeed, these structural modifications led to <b>12</b>, which was shown to interact with Trp286 of PAS and consequently to effectively prevent AChE-induced Aβ aggregation.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a></div><figure id="fig8" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structural modification of <b>11</b> leading to a series of derivatives, of which <b>12</b>, unlike the prototype, effectively inhibited AChE-induced Aβ aggregation by interacting with both AChE catalytic site and PAS.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of the observation that polyamines inhibit AChE activity and that AChE gorge is lined with several aromatic amino acid side chains capable of forming cation−π interactions with basic counterparts, dual binding site AChEIs were designed by linking the molecular features of well-known AChEIs, which inhibit both AChE catalytic site and PAS, through a polyamine chain. In this case, as postulated by the universal template design strategy,<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> the nature and length of the spacer become critical, since they play an active role in the target recognition process. As proof of principle, the structural motif of propidium (<b>12</b>) was linked to either the tetrahydroaminoacridine system of <b>1</b> or the methoxybenzylamino group of <b>6</b> by way of a triamine backbone, affording novel heterobivalent polyamine ligands (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>). Heterodimerization resulted in a remarkable increase in AChE potency. Compound <b>13</b> was nearly 20000-fold more potent than <b>12</b> and 300-fold more potent than <b>1</b>, consistent with simultaneous binding to both the AChE catalytic site and PAS. In fact, both inhibitors markedly prevented the proaggregating effect of AChE toward Aβ, with IC<sub>50</sub> values comparable to those shown by <b>12</b>, a specific PAS ligand and the most effective inhibitor available at that time.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></div><figure id="fig9" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Design strategy leading to <b>13</b> and <b>14</b> by combining the structural features of <b>12</b> with those of <b>1</b> or <b>6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An improved AChE-induced Aβ aggregation inhibitory profile was shown by a series of heterodimers in which a 1,2,3,4-tetrahydroacridine moiety was linked through a suitable spacer to an indole ring (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>). The indole ring was shown to reach the entrance of the catalytic gorge and interact with the Trp286 by forming a π−π stacking. In particular, compounds <b>15</b> and <b>16</b> emerged as the most potent AChEIs of the series, displaying IC<sub>50</sub> values of 20 and 60 pM, respectively. More importantly, these dual AChEIs inhibit the AChE-induced Aβ aggregation with IC<sub>50</sub> values 1 order of magnitude lower than that of <b>12</b>. They are thus the most potent derivatives so far reported to inhibit the AChE-mediated Aβ aggregation.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a></div><figure id="fig10" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Design strategy leading to dual binding site AChEIs by combining an isosteric group of the indanone moiety of <b>2</b> with the 1,2,3,4-tetrahydroacridine system of <b>1</b> through a spacer of variable chain length.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently, a series of pyridinium-bearing AChEIs were evaluated as inhibitors of self-mediated Aβ aggregation. This was done by means of a thioflavin T fluorescence assay to reveal potential additional pharmacological effects that might reinforce their therapeutic application. <b>17</b> and its dimeric derivative <b>18</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>) inhibited Aβ aggregation by 50% when tested at an equimolar concentration with Aβ40. Although these compounds were not investigated to verify their ability to inhibit AChE-induced Aβ aggregation too, the ability to block both AChE- and self-mediated Aβ aggregation makes <b>17</b> and <b>18</b> valuable tools for developing drugs targeting Aβ pathogenesis in AD.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> However, concern arises about the ability of these quaternary ammonium derivatives to cross the blood−brain barrier (BBB).</div><figure id="fig11" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structures of the AChEIs <b>17</b> and <b>18</b> with the additional property of inhibiting self-mediated Aβ aggregation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8"> AChEIs Targeting Other Neurotransmitter Systems</h4><div class="NLM_p">There is a well-documented link between neurotransmitter changes occurring in the brain of AD patients and clinically observed symptoms, such as cognitive decline and neuropsychiatric abnormalities. It is widely acknowledged that cognitive decline relates most closely to loss of cholinergic and glutamatergic neurons. However, behavioral change relates not only to the severity of cholinergic loss but also to alterations in the serotoninergic and noradrenergic systems. For example, the noradrenergic deficits of AD stem from locus ceruleus atrophy and are linked to depression.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Serotoninergic deficits, in contrast, have their source in raphe atrophy and are linked to depression and psychosis.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div><div class="NLM_p">Opportunities therefore arise for therapeutic intervention with drugs that increase the activity of biogenic amines, either alone or as MMT/MCM with compounds acting on the cholinergic system. Recent clinical trials have combined the monoamine oxidase (MAO) inhibitor selegiline (<b>19</b>) with either <b>1</b> or physostigmine (<b>20</b>). Early data suggest possible synergistic effects<a onclick="showRef(event, 'ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref86 ref87">(86, 87)</a> and point to MAO inhibition as an interesting property to be taken into account when designing MTDLs against AD. In fact, MAO, during its catalytic activity of deamination of neurotransmitters [noradrenalin, dopamine (DA), and serotonin (5-HT)], produces H<sub>2</sub>O<sub>2</sub>, which is a possible source of oxidative stress for vulnerable neurons affected by AD.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></div><div class="NLM_p">The initial design strategy for combined MAO/AChE agents resulted in a series of inhibitors (e.g., <b>21</b>) that, because of the incorporation of the propargylamine pharmacophore of <b>19</b> in <b>20</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>), were still irreversible MAO inhibitors.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Biological testing of imine intermediates of target compounds showed some weak combined activities. More importantly, the compounds appeared to be MAO reversible inhibitors, potentially devoid of the undesirable side effect associated with the old irreversible inhibitors. Therefore, the imino 1,2,3,4-tetrahydrocyclopent[<i>b</i>]indole carbamate scaffold was selected for further SAR studies. Introduction of a bromine atom in a position ortho to the carbamate function afforded <b>22</b>, which showed a dramatic improvement in affinity for both AChE and MAO-A. Unfortunately, following oral administration in animal model, <b>22</b> showed low activity due to poor brain penetration and poor bioavailability and was considered unsuitable for further development.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> However, this work provided researchers with the structural starting point for the design and synthesis of several dual AChE/MAO inhibitors. Thus, some coumarinic derivatives, already characterized as MAO-A and MAO-B inhibitors, were investigated as potential AChEIs.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> All compounds inhibited AChE with IC<sub>50</sub> values in the micromolar range (3–100 µM). In a kinetic study, most of them acted as noncompetitive AChEIs.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> This finding was of particular interest for AD because AChE inhibition, as already pointed out, might also decrease Aβ deposition. Indeed, this program led to the MTDL <b>23</b>, which made it possible to propose an experimental and virtual screening pathway to generate MTDLs as hits for the treatment of AD and other aging-related neurodegenerative disorders.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> The application of this screening pathway to a series of non-alkaloid natural compounds led to the identification of four xanthone derivatives as interesting dual AChE/MAO inhibitors.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a></div><div class="NLM_p">A large series of MAO/AChE inhibitors were rationally designed by assuming that the ability to inhibit AChE activity (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>) might be conferred by the introduction of a carbamate moiety in the structure of either rasagiline (<b>24</b>) or <b>19</b>, both of which are MAO-B inhibitors with neuroprotective activity in vitro and in vivo (see below). These new ligands would hold promise as effective MTDLs because, in addition to reducing oxidative stress, the inhibition of the MAO-A activity could also have a direct effect on cognition and could induce an antidepressant action. Several compounds based on the indane scaffold (<b>25</b>, <b>26</b>) and one phenethylamine (<b>27</b>) were identified as possible leads for further development based on a well-balanced profile of AChE and MAO-B inhibitory activities.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Ladostigil (<b>26</b>) is now finishing phase II clinical studies for the treatment of dementia with PD-like symptoms and depression.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> One major feature of the action mechanism of <b>26</b> is its neuroprotective activity in neuronal cell cultures. In vivo, its molecular basis was clarified by employing an apoptotic model of neuroblastoma cells. In this assay, <b>26</b> significantly decreased apoptosis via inhibition of the cleavage and prevention of caspase-3 activation through a mechanism related to regulation of the Bcl-2 family proteins. This resulted in reduced levels of Bad and Bax and increased levels of Bcl-2. Regarding the regulation of APP processing, <b>26</b> markedly decreased apoptotic-induced levels of APP. It also stimulated the release of the nonamyloidogenic soluble APP via an established protein kinase C-MAP kinase dependent pathway. Thus, <b>26</b> may reasonably be expected to contribute positively to the cognitive benefits of AD patients. The clinical development of such an MTDL, hitting several targets and endowed with diverse pharmacological properties, may conclusively demonstrate the validity of the MTDL approach as a most promising prospective therapy against neurodegeneration.</div><figure id="fig12" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Design strategy leading to selected dual inhibitors of AChE and MAO.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig13" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Design strategy leading to AChE and MAO-B inhibitors by combining the structural features of the MAO-B inhibitors <b>24</b> and <b>19</b> with a carbamate moiety of AChEIs, for example, <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to MAO inhibitors, depression in AD patients has been successfully treated with inhibitors of serotonin transporter (SERT), antidepressants that lack anticholinergic action. Thus, it was reasoned that combining SERT and AChE inhibitory activities could offer greater therapeutic benefits in AD because the antidepressant effect of SERT inhibitors might reduce the disorderʼs related symptoms, such as irritability, anxiety, and depression. Previous efforts had failed to provide any compound able to demonstrate simultaneous activation of both cholinergic and serotonergic nervous systems in vivo probably because of the inappropriate combination of activities.<a onclick="showRef(event, 'ref96 ref97'); return false;" href="javascript:void(0);" class="ref ref96 ref97">(96, 97)</a> A successful design strategy was based on a model, built by means of crystallographic and molecular modeling studies, using <b>4</b> (AChEI) and fluoxetine (<b>28</b>, SERT inhibitor), which were chosen as lead compounds to design AChE/SERT inhibitors (Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>).<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Compounds of the A series were designed by linking the methyleneoxyphenyl moiety of <b>28</b> to the ethylamine function of <b>4</b>,<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> whereas ring-closed compounds of the B series were designed to explore the effect of the conformational restriction.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Of the obtained compounds, (<i>S</i>)-RS-1259 (<b>29</b>) exhibited potent inhibitory activities against AChE and SERT in vitro (IC<sub>50</sub> values of 101 and 42 nM, respectively) and, following oral administration in mice, in the brain as well. Actual simultaneous elevation of extracellular levels of 5-HT and ACh in vivo was confirmed by different rodent models.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a></div><figure id="fig14" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Design strategy leading to dual inhibitors of AChE and SERT by combining the structural features of <b>4</b> and <b>28</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another series of compounds, simultaneously targeting cholinergic and serotoninergic pathways for a synergistic effect against AD, stemmed from the observation that 5-HT<sub>3</sub> receptors mediate the tonic inhibitory control of ACh release in the cortical tissue and do not seem to be significantly impaired in AD.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> In this approach, an optimized 5-HT<sub>3</sub> ligand was used as an anchor for receptor recognition and conjugated (by means of a spacer) to <b>1</b> in order to obtain a 5-HT<sub>3</sub> receptor–ligand (<b>30</b>) endowed with AChE inhibitory properties (Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>). Very interestingly, <b>30</b> displayed a nanomolar affinity (<i>K</i><sub>i</sub> = 5.6 ± 0.02 nM) for the 5-HT<sub>3</sub> receptor. It also displayed a nanomolar potency in inhibiting the human AChE (IC<sub>50</sub> = 4.1 ± 0.6 nM) and a lower potency in inhibiting butyrylcholinesterase (BuChE) (IC<sub>50</sub> = 40 ± 5.0 nM). Molecular modeling studies showed that <b>30</b> may interact with 5-HT<sub>3</sub>, AChE, and BuChE in a comparable fashion, since the two heteroaromatic moieties are accommodated by the three target proteins into suitable pockets located at approximately the same distance (14–17 Å).<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a></div><figure id="fig15" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Design strategy leading to compounds endowed with activity toward 5-HT receptors and AChE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As mentioned above, it seems that several neurotransmitter systems, which probably subserve the various components of memory and cognitive ability, are affected to varying degrees in AD. Blockade of histaminergic H<sub>3</sub> heteroreceptors with selective antagonists can increase the release of the neurotransmitters (such as ACh) that are involved in cognitive processes.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Thus, the possibility that the combined blockade of histaminergic H<sub>3</sub> receptors and AChE might produce added therapeutic benefit in the symptomatic treatment of AD led to the development of a new class of <b>1</b>-based compounds combining histaminergic H<sub>3</sub> receptor antagonism and AChE inhibitory potency. This is exemplified by <b>31</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a>).<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a></div><figure id="fig16" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Structure of <b>31</b>, which was designed to combine, in the same molecule, the pharmacophoric moieties to interact with both histaminergic and cholinergic systems.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> AChEIs with Antioxidant Properties</h4><div class="NLM_p">As already highlighted, oxidative stress is recognized as a central feature of AD pathogenesis. Treatments that specifically target sources of ROS have therefore attracted particular attention. In the search for MTDLs able to act as far upstream as possible in the neurodegenerative cascade, the structure of lipoic acid (LA), an antioxidant exerting different protective effects in neurodegeneration underlying AD,<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> was combined with a pharmacophore endowed with well-established biological properties, namely, the ability to inhibit AChE activity.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> It was also argued that the cyclic moiety of LA could interact with AChE PAS, which is associated with Aβ aggregation. Thus, this strategy allowed the antioxidant properties of LA to be combined into the same molecule with the AChEI <b>1</b> to improve cholinergic transmission, inhibit Aβ aggregation, and control oxidative damage.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> This led to a new class of compounds (Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a>) whose prototype is lipocrine (<b>32</b>). Although all the synthesized analogues showed nanomolar affinities against AChE, <b>32</b> was selected for further development because of its superior AChE inhibition profile. Once kinetic studies verified that <b>32</b> also interacts with the AChE PAS, its ability to inhibit AChE-induced Aβ aggregation was tested. It emerged as significantly more potent than all the other AChEIs investigated at the time. Moreover, cellular assays showed that LA and <b>32</b> did not affect the neuronal viability while <b>32</b> was able to protect neuronal cells against ROS formation evoked by oxidative stress to a higher extent than the parent compound LA.</div><figure id="fig17" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Design strategy leading to <b>32</b> by combining the structural features of <b>1</b> and LA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The same strategy was followed to obtain MTDLs in which the structure of <b>1</b> was linked through a spacer of appropriate length to another high-quality antioxidant moiety, such as melatonin (<b>33</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a>). Furthermore, recent studies have shown that <b>33</b>, an indoleamine secreted by the pineal gland, may play an important preventative role in aging and AD as antioxidant and neuroprotector. The recently documented impact of <b>33</b> on τ and Aβ pathology further enhances its potential in the prevention or treatment of AD.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> The most potent inhibitor of the series (<b>34</b>) exhibited an outstanding potency (IC<sub>50</sub> = 0.008 nM) and selectivity (1000-fold) for AChE inhibition relative to BuChE. It also showed a potency 2.5-fold higher than trolox, a vitamin E analogue universally used as a standard for the assessment of antioxidant properties. In addition, this MTDL was also predicted to cross the BBB without difficulty.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a></div><figure id="fig18" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Design strategy leading to AChEIs with antioxidant properties by combining the structural features of <b>1</b> and <b>33</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> AChEIs and Calcium Channel Blockers</h4><div class="NLM_p">The pivotal role of altered calcium homeostasis in the pathogenesis of AD and other aging-related dementias is well-supported.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Therefore, identification of new compounds that combine both a moderate calcium channel blockade effect and AChE inhibition has been advanced to be useful in the treatment of AD.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a><b>1</b> was shown to inhibit voltage-dependent calcium channels (VDCC) in dorsal root ganglionic cells.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> A series of <b>1</b> derivatives were therefore investigated as AChE/BuChE inhibitors and VDCC modulators as potential neuroprotectants in AD.<a onclick="showRef(event, 'ref114 ref115 ref116 ref117 ref118 ref119'); return false;" href="javascript:void(0);" class="ref ref114 ref115 ref116 ref117 ref118 ref119">(114-119)</a> The structure of <b>1</b> was modified by replacing the benzene ring with different substituted heterocyclic systems and by altering the size of the cyclohexane ring to afford two series of compounds (A and B, Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a>). The compounds of series A are <b>1</b>-dihydropyridine hybrids. Termed “tacripyrines”, they are obtained by combining the tetrahydroaminoquinoline system of <b>1</b> with a 4-substituted dihydropyridine moiety as in nimodipine (<b>35</b>), a well-known calcium channel blocker. Tacripyrine <b>36</b> was the most potent AChEI (IC<sub>50</sub> = 45 nM), being 4-fold more potent than <b>1</b> and displaying high selectivity toward BuChE.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> In addition, it gave a significant Ca<sup>2+</sup> blockade and afforded neuroprotection in a cellular model of calcium overload. Furthermore, in neuroblastoma cells exposed to H<sub>2</sub>O<sub>2</sub>, the protection afforded by <b>36</b> was 1.5-fold higher than that of the prototype <b>35</b>.</div><figure id="fig19" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Design strategy leading to AChEIs with neuroprotective activity, exemplified by tacripyrine (<b>36</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Metal Chelators with Additional Properties</h4><div class="NLM_p">Dyshomeostasis of cerebral metals is another clear-cut factor contributing to the neuropathology of AD. Recent reports have described the development of potential therapeutic agents based on the modulation of metal bioavailability. The metal chelator clioquinol (5-chloro-6-iodo-8-hydroxyquinoline) has been successfully used in vitro, as well as in animal models and small clinical trials, and several metal chelation based therapeutics are currently under development.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></div><div class="NLM_p">However, the poor target specificity and the concurrent safety problems of presently available metal-complexing agents have limited their widespread clinical use. The long-term use of such agents is likely to perturb the homeostasis of many metals as well as the normal physiological functions of essential metal-requiring biomolecules. Within this context, however, the MTDL approach has revealed itself to be particularly successful for developing a new generation of metal-complexing agents.</div><div class="NLM_p">On the basis of a novel “pharmacophore conjugation” concept, the bifunctional molecule XH1 (<b>37</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a>) has been reported as an innovative metal-complexing agent that specifically targets amyloid. <b>37</b> contains in its structure one metal-chelating and two amyloid-binding moieties. These can be envisaged as the pharmacophores of thioflavin T and EDTA-like compounds, respectively, linked by amide bonds. A putative binding geometry between <b>37</b> and Aβ peptide was described by a computational ligand/receptor docking procedure. This showed that the hydrophilic metal-chelating moiety of <b>37</b> may interact preferentially with one of the α-helices in Aβ, while its lipophilic amyloid-binding moieties stretch toward the hydrophobic C-terminal of Aβ. It transpired that <b>37</b> reduced Zn<sup>II</sup>-induced Aβ precipitation and APP expression in vitro and attenuated cerebral Aβ amyloid pathology in PS1/APP transgenic mouse model in a 4-week treatment period. Furthermore, from pilot studies, it appeared that <b>37</b> did not have significant cellular and animal toxicity at the tested doses. These preliminary findings strongly support the potential of <b>37</b> as a candidate metal chelator targeting AD amyloidogenesis.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a></div><figure id="fig20" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Structure of the metal chelator <b>37</b>, which also targets Aβ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A molecule with both a radical scavenger and iron-chelating properties might protect living tissue from oxidative stress to a greater extent than a compound with a single property.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> Therefore, the approach of combining metalsʼ protein-attenuating ability with radical scavenging potential may have relevance for the treatment of neurodegeneration. First, such an MTDL could have the potential to behave synergistically. Second, the antioxidant component (typically lipophilic in nature) of such a molecule would confer more lipophilicity to the iron-chelating component (typically hydrophilic in nature). This would give the resulting compound a greater potential to penetrate and sequester iron from areas susceptible to oxidative damage. This reasoning led to the development of <b>38</b>, in which the structural units of the iron chelator deferiprone (<b>39</b>) and the antioxidant food additive BHT (<b>40</b>) were linked via a simple alkyl chain (Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a>). This pioneering MTDL proved its neuroprotective effect via inhibition of oxidative stress in pharmacological assays. In two models of chemical-induced cell toxicity, it displayed a neuroprotective action superior to that obtained with the separate administration of the two compounds.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a></div><figure id="fig21" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0021.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Design strategy leading to <b>38</b> by combining the structural features of the lipophilic antioxidant <b>40</b> with those of the iron chelator <b>39</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The preliminary successes of both radical scavengers and metal chelators in clinical therapy of AD supported the development of novel MTDLs with this combined profile. Starting from some SOD mimics, which are metal chelators, it was argued that an SOD-mimic ligand with the metal-binding ability would afford the expected MTDL. On the basis of quantum chemically calculated frontier orbital energies, two metal chelators, 1-BYT (<b>41</b>) and 1,4-BYT (<b>42</b>), were considered candidates to fulfill this strategy (Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a>).<a onclick="showRef(event, 'ref71 ref123'); return false;" href="javascript:void(0);" class="ref ref71 ref123">(71, 123)</a></div><figure id="fig22" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0022.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Structures of the metal chelators targeting Aβ <b>41</b> and <b>42</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig23" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0023.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Glucopyranosyl conjugates of the metal chelators <b>39</b> and tetrahydrosalen.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Linking a carbohydrate moiety to drug molecules to form new derivatives and/or prodrugs offers the potential for transporter-facilitated drug delivery for increased brain access of drug molecules. In the case of metal chelators, this strategy appears particularly promising. By use of carbohydrates as both masking and directing substituents, this strategy might solve the potential problem of premature and indiscriminate metal binding. In this respect, a series of <b>39</b> and tetrahydrosalen (<b>43</b>) glucoconjugates (for example, <b>44</b> and <b>45</b>) have been reported (Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a>).<a onclick="showRef(event, 'ref124 ref125'); return false;" href="javascript:void(0);" class="ref ref124 ref125">(124, 125)</a> Once enzymatically deprotected, they can act as selective, tissue-dependent metal binders and ROS scavengers. This is because the hydroxypyridinone group is a well-known metal binder moiety and the free OH, after deprotection, can efficiently trap radicals. It was claimed that a trifunctional approach to AD therapy had been pursued for the first time. The synthesized prodrugs were demonstrated to cross the BBB using an in situ rat brain perfusion technique to lose the pendent carbohydrate by enzymatic cleavage and to passivate excess metal ions in the brain. Moreover, they showed antioxidant properties similar to those of vitamin E and <b>40</b>. Metal-mediated aggregation of Aβ, which occurred following addition of Zn<sup>2+</sup> or Cu<sup>2+</sup>, was significantly attenuated by the subsequent ligand addition. In summary, the experimental results strongly supported the designed mechanism of action and demonstrated the potential of these multifunctional agents in combating AD.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></div></div><div id="sec3_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Development of Memoquin (<b>46</b>)</h4><div class="NLM_p">Most of the previous examples provide a convincing argument for shifting the quest for new and disease-modifying agents for AD from single-target-directed ligands to MTDLs. With this in mind, a new drug candidate (<b>46</b>)<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> has recently been described. <b>46</b> was derived from an academic program<a onclick="showRef(event, 'ref75 ref76 ref81 ref107 ref108'); return false;" href="javascript:void(0);" class="ref ref75 ref76 ref81 ref107 ref108">(75, 76, 81, 107, 108)</a> aimed at exploring the possibility of creating multifunctional molecules that possessed some of the above-mentioned activities relevant to AD, such as the ability to inhibit AChE, Aβ processing and aggregation, and the ability to counteract oxidative stress. <b>46</b> was rationally designed by incorporating a radical scavenger function into the polyamine skeleton of the previously reported series of cholinergic derivatives (see Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Among the possible carriers of radical scavenger activity, attention was focused on the benzoquinone fragment of coenzyme Q10 (CoQ), as this natural antioxidant had offered promise against AD both in vitro<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> and in vivo.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> Moreover, CoQ and different benzoquinone derivatives had been shown to modulate AD molecular targets, directly inhibiting Aβ aggregation.<a onclick="showRef(event, 'ref129 ref130'); return false;" href="javascript:void(0);" class="ref ref129 ref130">(129, 130)</a> Previous SAR and docking studies revealed that in AChE the biophoric space around the octamethylene spacer that separates the two amide functions of <b>6</b> is quite “tolerant” and can accommodate a variety of cyclic moieties.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> We therefore decided to introduce the benzoquinone nucleus to replace the inner polymethylene chain. In the resulting prototypic structure 2,5-bis-diamino-1,4-benzoquinone, the two nitrogen atoms in positions 2 and 5 of the benzoquinone moiety are amide-like in character, precisely mimicking the amide bonds of <b>6</b>. Moreover, because of the resonance effect, a hydrophobic and planar π system is generated, which is able in principle to bind Aβ and to perturb protein–protein interactions in the fibrillogenesis process.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a></div><div class="NLM_p">The biological profile of <b>46</b> was then widely explored by means of both in vitro and in vivo assays to assess its therapeutic potential as an MTDL for combating AD.</div><div class="NLM_p">First, the antioxidant properties of <b>46</b> were verified by testing both its ability to neutralize free radicals<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> and to act as a substrate of the enzyme NAD(P)H/quinone oxidoreductase 1 (NQO1). The results, shown in Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a>, indicate that <b>46</b> is a fairly good antioxidant per se and, more interestingly, that <b>46</b> might be transformed by NQO1 from the quinone to the hydroquinone form. The latter has been shown to be the actual antioxidant species of other 1,4-benzoquinone derivatives, such as CoQ and idebenone.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> This molecular mechanism was also confirmed in cellular assays, using SH-SY5Y cells. It should be noted that NQO1 activity is increased in hippocampal pyramidal neurons of AD patients and colocalizes closely with AD pathology. This supports its role as an antioxidant system up-regulated in response to the oxidative stress of the AD process.<a onclick="showRef(event, 'ref134 ref135'); return false;" href="javascript:void(0);" class="ref ref134 ref135">(134, 135)</a> Second, <b>46</b> maintained a nanomolar inhibitory potency against human AChE. It was also able to inhibit the AChE-induced Aβ aggregation (Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a>). Third, <b>46</b> inhibited self-assembly of Aβ42, which is the most amyloidogenic Aβ fragment found in AD plaques. Finally, the antiamyloidogenic profile of <b>46</b> was also investigated by testing its ability to act as an inhibitor of BACE-1. The compound was found to have an IC<sub>50</sub> value of 108 ± 23 nM. Comment is required on the different concentrations at which <b>46</b> displays its activities. The relevance of these results have to be referred to in vitro systems, where, for instance, the AChE-induced Aβ aggregation is tested. The high inhibitor concentration used in this experiment is derived from the need to use a high concentration of AChE to induce the Aβ aggregation in an experimentally suitable time. Only proof of concept by means of in vivo experiments will shed light on this matter.</div><figure id="fig24" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0024.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Memoquin (<b>46</b>) is able to modulate several mechanisms relevant to AD: the formation of ROS, the aggregation of Aβ peptides, and AChE and BACE-1 activities. It is also a good substrate of the NQO1 enzyme, which in vivo converts it into the corresponding hydroquinone form.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last"><b>46</b> was then tested in vivo by employing the anti-NGF transgenic mouse (AD11 mouse), which has been shown to be a comprehensive animal model for AD.<a onclick="showRef(event, 'ref136 ref137'); return false;" href="javascript:void(0);" class="ref ref136 ref137">(136, 137)</a><b>46</b> prevented the AD-like neurodegeneration at three stages (at 2, 6, and 15 months of age). At all ages, <b>46</b> rescued the cholinergic deficit in the mice basal forebrain. Interestingly, it was also able to prevent or rescue τ hyperphosphorylation in the cortex. Finally, it showed itself capable of rescuing the behavioral deficits linked to attention and memory in different animal models. Remarkably, besides its in vivo effectiveness, <b>46</b> showed other promising properties, such as good oral bioavailability, efficacy in crossing the BBB, and a favorable safety profile, being well-tolerated after prolonged administration. In conclusion, in a scenario where currently available drugs appear to be palliative rather than curative, <b>46</b> emerged as a new chemical entity able to confront AD neurodegeneration at different levels. It can therefore be considered a breakthrough MTDL capable of addressing the biological complexity of AD.</div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">4 Parkinsonʼs disease (PD)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12673" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12673" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In Western countries, PD is the second most common neurodegenerative disorder. Like AD, it is currently an incurable disease. The available pharmacological therapies are unable to arrest or reverse the neurodegeneration associated with PD. The need for a cure for this debilitating condition is therefore urgent. PD is characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta and other subcortical nuclei and by the presence of intraneuronal aggregates known as Lewy bodies (LBs), which are enriched in filamentous α-synuclein and other proteins that are often ubiquitinated. Depletion of DA causes dysregulation of the motor circuits that project throughout the basal ganglia, resulting in the clinical manifestations of PD, which include tremor, bradykinesia, rigidity, and postural instability. However, additional neurotransmitter systems are also involved in PD and, consequently, nonadrenergic, serotoninergic, and cholinergic neurons are also lost. This loss is responsible for nonmotor symptoms such as cognitive decline, sleep abnormalities, and depression. These progressive symptoms dominate the later stages of PD.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">4.1 Molecular Causes of PD</h3><div class="NLM_p">Until recent advances in the identification of some of the genes that underlie rare familial forms of PD, little was known about its molecular pathogenesis.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Although there are differences between some of the clinical and pathological features observed in familial and nonfamilial forms of PD, there are sufficient similarities that could be exploited to characterize some molecular determinants of PD. This could help in understanding the pathogenetic mechanism of a disease that, although not completely clarified yet, implicates mitochondrial dysfunction, protein misfolding, protein phosphorylation, oxidative stress, and impairment of UPS.</div><div class="NLM_p">The crucial molecular step of PD pathogenesis is the formation of LBs whose key constituent is represented by α-synuclein, a 140-amino-acid-long neuronal protein. α-synuclein is a cytoplasmic soluble protein that contains a highly amyloidogenic domain within its mid-region.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> In pathogenic conditions, α-synuclein misfolds and is converted into pathological oligomers and higher-ordered aggregates, which fibrillize and deposit into LBs as β-pleated sheets. Mutations in the α-synuclein gene have been identified in sporadic familial forms of PD, which are responsible for fibrils formation. However, α-synuclein fibrillization could also be enhanced by post-translational modifications, such as C-terminal truncation and phosphorylation, oxidative and nitrative stress, and interaction with metals, such as aluminum, copper, and iron.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> As with AD, some studies propose that small protofibrillar oligomers of α-synuclein, rather than the larger fibrils of LBs, are the toxic species that lead to neuron dysfunction and degeneration by forming structures with porelike morphologies that can disrupt organelle membranes and alter, among others, mitochondrial, ER, and Golgi network functions.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> This molecular mechanism is reminiscent of that of bacterial pore-forming toxins, which can generate vesicles on the membrane.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a></div><div class="NLM_p">Therefore, maintaining α-synuclein in the native and soluble random coil conformation, and consequently preventing α-synuclein-mediated neuron toxicity, emerges as a clear goal of innovative disease-modifying PD therapies. This could be achieved by developing molecules acting at different levels in the cascade of α-synuclein fibril formation (Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a>). First, prevention of protein misfolding might be obtained by enhancing the activity of chaperones, such as DJ-1. In this respect, it has been shown that in α-synuclein-expressing flies model, treatment with geldanamycin might offer a new way to protect neurons against α-synuclein toxicity by augmenting chaperone activity.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> Second, it is possible to counteract the accumulation of intracellular misfolded α-synuclein through proteolytic pathways, such as UPS and authophagic systems.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> Finally, although the role of phoshorylation in fibril formation has yet to be fully clarified, abnormal protein phosphorylation might represent a possible innovative pathway to be addressed for the discovery of innovative anti-PD drug candidates. Indeed, it has been shown that in LBs α-synuclein is extensively phosphorylated at Ser129. As a matter of fact, it has been shown that casein kinase 2 phosphorylates α-synuclein on Ser129 in vitro, but it remains unclear which enzyme phosphorylates α-synuclein in vivo.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> In addition, phosphorylation plays a role in the process of NFT formation because phosphorylation of τ inhibits binding to microtubules and increases the levels of soluble τ in the cytoplasm. Soluble τ is the species that fibrillizes to form NFTs, which might also be implicated in neuronal death in PD.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a></div><figure id="fig25" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0025.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Possible molecular causes of neuronal death and protective mechanisms in PD. Native α-synuclein is a highly soluble protein adopting mainly random coil conformation. Its misfolding leads to oligomers that fibrillize and deposit into LBs. Innovative approaches to the discovery of disease-modifying anti-PD drug candidates might be (i) to prevent α-synuclein misfolding by means of chaperones such as DJ-1, (ii) to enhance UPS activity and in turn to eliminate misfolded proteins, and (iii) to inhibit Ser129 phosphorylation. Oxidative stress and metal-ion-enhanced misfolding are further general mechanisms on which to focus to discover more efficacious anti-PD drug candidates that provide antioxidant and metal-chelating activities. Mitochondrial dysfunction has often been associated with neuronal apoptosis. A straightforward approach to the discovery of small molecules able to recover mitochondrial activity, in terms of (i) respiratory chain modulation, (ii) permeability alteration, and (iii) apoptosis inhibition, has not yet been outlined. Remarkably, mitochondrial dysfunction may be a common pathway in most neurodegenerative diseases by which neuronal death is eventually achieved.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Besides the above-reported strategies, based on the α-synuclein fibril formation pathway, treatment with antioxidants might theoretically be of benefit in preventing neurodegeneration. However, as discussed, whether oxidative stress is causative or symptomatic of neuronal death is still an open question. Systematic treatment of rats with rotenone, a pesticide known to inhibit mitochondrial functions, has been shown to cause selective nigrostriatal dopaminergic degeneration with associated inclusion of α-synuclein fibrils.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> This sheds light on a possible link between mitochondrial dysfunction, oxidative stress, and α-synuclein fibril formation. Therefore, another possible innovative approach would be to target mitochondrial dysfunction. This could be achieved by modulating the respiratory chain, altering mitochondrial permeability, and/or inhibiting mitochondrial-induced apoptosis. The last point should be carefully addressed, since targeting nonspecific cell-death pathways might cause cancerogenesis. Concerning other possible approaches to PD therapy, the evidence that increased levels of iron in the PD brain are responsible for oxidative stress by enhancing the formation of hydroxyl free radicals<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> has prompted scientists to investigate metal chelators as possible drug candidates for the treatment of PD.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">4.2 Current PD Therapies</h3><div class="NLM_p">Despite an increased understanding of the molecular causes of PD, current PD therapies are based mainly on exogenous replacement of DA within the striatum. This improves the symptoms but without halting the progression of the neurodegenerative process or reversing the neuronal degeneration. Furthermore, although PD also involves degeneration of nondopaminergic neurons, the treatment of the resulting predominantly nonmotor features remains a challenge. Depletion of striatal DA from the loss of nigral projections is the main target for the currently available drugs (Figure <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">26</a>). The classes of compound that still hold a prominent position in current anti-PD drug discovery are <span class="smallcaps smallerCapital">l</span>-dopa and dopaminenergic receptor agonists (both used alone or as MMT) and MMT/MCM of <span class="smallcaps smallerCapital">l</span>-dopa with DA modifying drugs, such as (i) peripheral dopa decarboxylase inhibitors, (ii) catecol-<i>O</i>-methyltransferase (COMT) inhibitors, and (iii) selective monoaminooxidase type B (MAO-B) inhibitors.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> The chemical structures and mechanisms of action of the currently available anti-PD drugs are reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. <div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Targets for Classic PD Drug Therapies</div></div></div><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top" class="rowsep1"><td class="rowsep1" align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0026.gif" alt="" id="_i17" /></img></td></tr></tbody></table></div></div><span class="smallcaps smallerCapital">l</span>-Dopa is the key compound in the treatment of PD, acting as a precursor of DA. However, besides offering only symptomatic relief for patients, this drug shows substantial side effects at the high doses required for therapeutic action.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> Certain other available drugs, like MAO-B (<b>19</b> and <b>24</b>)<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> and COMT [entacapone and tolcapone (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>)]<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> inhibitors, are used mainly as MMT with <span class="smallcaps smallerCapital">l</span>-dopa, since they alter the in vivo metabolism of DA by increasing its plasma half-life. Amantadine (an antiviral agent that also bears actions as an ion channels blocker) is believed to release brain DA from nerve endings, making it more available for activating dopaminergic receptors. Anticholinergic compounds (such as biperiden, triexyphenidyl) were among the first drugs used for PD therapy. They were intended to correct the imbalance between DA and ACh brain levels.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> Dopaminergic receptor agonists may be used either alone to delay the need for <span class="smallcaps smallerCapital">l</span>-dopa or as MMT with <span class="smallcaps smallerCapital">l</span>-dopa to increase its effectiveness. More recent therapeutic approaches to PD are represented by nicotine, anti-inflammatory agents, melatonin, selenium, iron chelators, and vitamins A, C, and E.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a></div><figure id="fig26" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0027.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Mechanism of action of DA at a dopaminergic synapse. DA is released in the synaptic cleft where it can interact with dopaminergic receptors at both postsynaptic and presynaptic levels, leading to an improvement in motor symptoms associated with PD. Currently available anti-PD drugs act at points 1–4 as indicated in the picture. <span class="smallcaps smallerCapital">l</span>-Dopa (1), the endogenous precursor of DA, is presently the main drug used for the treatment of PD. The others, MAO (2) and COMT (3) inhibitors as well as dopaminergic receptor agonists (4), are often used either in MMT or in MCM along with <span class="smallcaps smallerCapital">l</span>-dopa (see also Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">None of the currently available pharmacological therapies are able to arrest or reverse the progression of PD. This is probably because these compounds treat only the symptoms of the disease rather than tackling the actual molecular PD causes. Moreover, the currently available drugs have been shown to interact with a single molecular target, instead of confronting the multifactorial nature of PD neurodegeneration. Comment is required, however, for the MAO-B inhibitor <b>24</b>, which, in vitro and in vivo, can protect neurons from a variety of neurotoxic assaults. Unlike <b>19</b>, <b>24</b> is not derived from amphetamine. As with other general neuroprotective mechanisms, <b>24</b> specifically activates enzymes playing a key role in cellular events including mitochondria viability, modulation of apoptotic processes, and neuronal plasticity. In AD (see above), it induces the release of nonamyloidogenic α-secretase-derived soluble amyloid.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> This pharmacological action is also associated with (i) the prevention of both the neurotoxin-induced fall in mitochondrial membrane potential and opening of mitochondria permeability transition pore, (ii) activation of the proteasome−ubiquitin complex, (iii) inhibition of cytochrome <i>c</i> release, and (iv) prevention of caspase 3 activation.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> The molecular mechanism of neuroprotective antiapoptotic activity of <b>24</b> has been attributed to its ability to modulate Bcl-2 protein family, up-regulating the antiapoptotic Bcl-2 and Bcl-xL while down-regulating Bad and Bax.<a onclick="showRef(event, 'ref154 ref155 ref156'); return false;" href="javascript:void(0);" class="ref ref154 ref155 ref156">(154-156)</a> SAR studies on <b>24</b> have demonstrated that its neuroprotective activity is directly dependent on the propargyl moiety, since the enantiomer of <b>24</b> is a very poor MAO inhibitor, but bears similar neuroprotective activity both in vitro and in vivo.<a onclick="showRef(event, 'ref157 ref158 ref159'); return false;" href="javascript:void(0);" class="ref ref157 ref158 ref159">(157-159)</a></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18">4.3 MDTLs for the Treatment of PD</h3><div class="NLM_p">To overcome the major limitations of a single-medication therapy, MMT and MCM are currently adopted for the treatment of PD.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> In particular, the use of <span class="smallcaps smallerCapital">l</span>-dopa plus either an MAO-B or a COMT inhibitor allows patients to decrease the administration of <span class="smallcaps smallerCapital">l</span>-dopa. For instance, an MCM has recently been developed by combining, in a single tablet, <span class="smallcaps smallerCapital">l</span>-dopa, the dopa−decarboxylase inhibitor carbidopa, and the COMT inhibitor entacapone.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> A similar result can also be achieved by coadministering a dopaminergic receptor agonist and <span class="smallcaps smallerCapital">l</span>-dopa. The latter MMT has also been shown to be effective in improving bradykinesia, rigor, and tremor and in ameliorating the abilities of daily living and depressive mood. This has been demonstrated in particular for ropinirole, a modern, nonergot dopaminergic receptor agonist (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a></div><div class="NLM_p">Clearly, in PD too, MTDL design and discovery emerge as a possible alternative strategy to MMT. Such an approach has recently been applied by some research groups to the discovery of new drug candidates for the treatment of PD.<a onclick="showRef(event, 'ref69 ref70 ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref69 ref70 ref72 ref73">(69, 70, 72, 73)</a> A common approach has been the combination, in a single molecule, of the pharmacophoric features responsible for modulating the biological activity of a validated molecular target with the chemical functions able to confer metal-chelating and/or antioxidant properties. In particular, in the first series of derivatives, iron-chelating and antioxidant features were combined with MAO-B inhibitory properties.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> As previously mentioned, the rationale for this design strategy was related to the observation that iron concentrations are significantly elevated at the neurodegenerative neuronal site<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> and iron chelators result in a neuroprotective action in PD animal models.<a onclick="showRef(event, 'ref147 ref164'); return false;" href="javascript:void(0);" class="ref ref147 ref164">(147, 164)</a> The role of MAO enzymes in deaminating (and thus deactivating) DA has been previously mentioned, and MAO-B selective inhibitors are currently in clinics for the treatment of PD. Moreover, a link between high iron concentration and MAO activity, and their involvement in oxidative neuronal stress and ROS production, has also been advanced.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> MAO is considered one of the major enzymes that generate H<sub>2</sub>O<sub>2</sub> as a consequence of its ability to oxidatively deaminate monoamines, especially DA in the substantia nigra pars compacta and striatum. According to Fentonʼs reaction, either Fe<sup>2+</sup> or Fe<sup>3+</sup> free cations can interact with H<sub>2</sub>O<sub>2</sub> to generate hydroxyl radicals. Clearly, an increase in free iron concentration and MAO activity results in an increase in radical production with consequent cell-membrane lipid peroxidation, DNA damage, and neuronal death.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Free iron may also be responsible for α-synuclein aggregation, which in turn contributes to the neurodegenerative process. Therefore, chelating iron and decreasing H<sub>2</sub>O<sub>2</sub> production by means of a MAO inhibitor dramatically reduce Fentonʼs reaction and hydroxyl radical formation.</div><div class="NLM_p">In light of this, the first series of bifunctional derivatives<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a>) was purposely designed to combine, in a single chemical entity, the iron-chelating properties of VK-28 (<b>47</b>)<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> and the propargylamine group of a MAO-B inhibitor, <b>24</b>.<a onclick="showRef(event, 'ref158 ref167'); return false;" href="javascript:void(0);" class="ref ref158 ref167">(158, 167)</a> As previously discussed, the propargyl moiety of <b>24</b> is responsible not only for its MAO-B inhibitory profile but also for a wide neuroprotective profile unrelated to MAO inhibition. These observations highlighted the need to test the new bifunctional derivatives using whole cell assays.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> In PC12 cells, some of these derivatives [(HLA20 (<b>48</b>) and M30 (<b>49</b>)] were also found to be potent lipid peroxidation inhibitors. This is possibly as a consequence of two different mechanisms: (i) strong iron-chelating compounds interfere with Fentonʼs reaction, thus decreasing hydroxyl free radical production; (ii) metal chelators can also directly act as radical scavengers, blocking the formation of free radical species.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> In cell assays, <b>48</b> and <b>49</b> possessed a neuroprotective activity comparable to that of <b>24</b>. It also prevented 6-hydroxydopamine- and iron-induced cell death. Finally, since <b>49</b> and its N-desmethylated derivative M30A (<b>50</b>) were good MAO inhibitors, they were investigated in vivo.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> It turned out that <b>49</b> preferentially inhibits MAO-A and MAO-B in the CNS while it is a weak inhibitor in the liver and small intestine.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> It thus prevents potentiation of tyramine-induced cardiovascular activity, which is a major side effect of other nonselective MAO inhibitors. The exact mechanism underlying the preference of <b>49</b> for CNS MAO enzymes has not yet been definitively clarified. Conversely, in vivo, <b>50</b> inhibited MAO enzymes at concentrations that were 2−3 orders of magnitude higher than those of <b>49</b>. This is in line with the profile of N-desmethylated derivatives of other MAO-B inhibitors such as <b>19</b> and <b>24</b>.<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> Because of its nonselective MAO-inhibiting profile, <b>49</b> was also able to increase 5-HT and adrenaline in the CNS, in addition to DA, providing a probable adjunct profile as an antidepressant. This nonselective profile of <b>49</b> toward MAO enzymes adds value to the compound. In this respect, it should be mentioned that as early as 1983, it was demonstrated that DA is equally well metabolized by both MAO isoforms<a onclick="showRef(event, 'ref169 ref171'); return false;" href="javascript:void(0);" class="ref ref169 ref171">(169, 171)</a> and that when one enzyme form is inhibited, the other can continue to metabolize DA.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> Therefore, a molecule that is able to simultaneously inhibit both MAO-A and MAO-B, without potentiating the tyramine-mediated cardiovascular activity, holds a promising profile for the treatment of PD.</div><figure id="fig27" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0028.jpeg" id="gr27" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Design strategy leading to the bifunctional derivatives <b>48</b>−<b>50</b> by inserting into the same molecule the pharmacophoric groups of <b>47</b>, an iron chelator, and <b>24</b>, a MAO-B inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A second class of potential anti-PD MTDLs was developed by combining MAO inhibition and adenosine A<sub>2A</sub> receptor antagonism. The rationale for the design strategy was based on the observation that caffeine (<b>51</b>) consumption is associated with a reduced risk of developing PD<a onclick="showRef(event, 'ref173 ref174'); return false;" href="javascript:void(0);" class="ref ref173 ref174">(173, 174)</a> and that <b>51</b> can reduce dopaminergic neuron toxicity in a PD mouse model.<a onclick="showRef(event, 'ref175 ref176'); return false;" href="javascript:void(0);" class="ref ref175 ref176">(175, 176)</a> Furthermore, it was observed that such neuroprotective effect could be mimicked by specific adenosine A<sub>2A</sub> receptor antagonists.<a onclick="showRef(event, 'ref175 ref176 ref177'); return false;" href="javascript:void(0);" class="ref ref175 ref176 ref177">(175-177)</a> These antagonists are currently being investigated as possible therapeutic agents for the symptomatic treatment of motor deficit in PD.<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a> One compound is currently undergoing clinical trials for this purpose.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> In addition, it has recently been shown that adenosine A<sub>2A</sub> receptor antagonists can also protect against neuronal degenerative processes.<a onclick="showRef(event, 'ref176 ref177'); return false;" href="javascript:void(0);" class="ref ref176 ref177">(176, 177)</a></div><div class="NLM_p">A selective and potent adenosine A<sub>2A</sub> receptor antagonist, 8-(3-chlorostyryl)caffeine (<b>52</b>)<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">28</a>), was tested in vitro against MAO-B mitochondrial activity to assess a potential bifunctional profile, showing a <i>K</i><sub>i</sub> of about 100 nM.<a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(181)</a> It was then characterized in vivo using the MPTP (1-methyl-4-(1-methylpyrrol-2-yl)-1,2,3,6-tetrahydropyridine) animal model of PD.<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a> To cause neurotoxicity, MPTP requires its oxidation to 1-methyl-4-phenylpyridinium (MPP<sup>+</sup>) by MAO-B. The effects of <b>52</b> on the MPTP metabolism were therefore also investigated in vivo. The inhibition of MPTP metabolism by <b>52</b> suggests that adenosine A<sub>2A</sub> receptor does not regulate MAO-B activity. It also suggests that the two biological profiles, MAO-B inhibition and adenosine A<sub>2A</sub> receptor antagonism, are indeed unrelated, acting on two parallel biochemical pathways.<a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(181)</a> Conversely, the metal-chelating MAO-inhibitor MTDLs discussed above reduced the hydroxyl radical formation synergistically by modulating steps within the same linear biochemical pathway. In the design of MTDLs for complex multifactorial diseases, it is still unclear whether it is more beneficial for an MTDL to act at different points within the same biochemical pathway or to modulate targets belonging to parallel pathways.</div><figure id="fig28" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0029.jpeg" id="gr28" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Design strategy leading to <b>52</b> by combining, into the same structure, caffeine (<b>51</b>), an adenosine A<sub>2A</sub> receptor antagonist, and 1,4-diphenyl-2-butene (<b>53</b>), a reversible MAO-B inhibitor. <b>52</b> is clearly recognizable as a combination of the structural features of both <b>51</b> and <b>53</b>. The caffeine structure is fully incorporated, whereas in the structure of <b>53</b>, one phenyl ring is replaced by the heterocyclic ring of <b>51</b>. The two terminal rings of <b>52</b> are at a comparable distance to that found in <b>53</b>, as shown by molecular modeling calculations (unpublished results).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Following the observation that a bifunctional adenosine A<sub>2A</sub> receptor antagonist and MAO-B inhibitor might bear enhanced therapeutic potential for the treatment of PD,<a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(181)</a> two series of <b>52</b> derivatives (Figure <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">28</a>) were synthesized and biologically evaluated against both molecular targets.<a onclick="showRef(event, 'ref183 ref184'); return false;" href="javascript:void(0);" class="ref ref183 ref184">(183, 184)</a> The main aim was to define the structural requirements of an adenosine A<sub>2A</sub> receptor antagonist to act as inhibitor of the MAO-B enzyme. An initial study showed that structural features relevant to the MAO-B inhibiting profile are the trans configuration of the styryl moiety and the 1,3,7-trimethyl substituents on the xanthinyl ring system of <b>52</b>.<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> A second SAR investigation, carried out on the lead compound <b>52</b>, showed that the C-3 and C-4 substitution of the phenyl ring has a considerable effect on the MAO-B inhibiting profile.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> A possible explanation is that substituents at these positions can interact with the side chains of hydrophobic residues located at the enzyme entrance cavity. SAR and molecular modeling studies indicated that the bulkier is the substituent, the higher is the inhibiting potency against MAO-B enzyme.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> Moreover, electron-withdrawing groups at the C-3 position could cause charge localization on the phenyl ring with possible further interactions with entrance residues. In summary, the two studies explored in depth the SAR of adenosine A<sub>2A</sub> receptor antagonists toward a second validated target (MAO-B) for the treatment of PD.</div><div class="NLM_p">As discussed, current MTDLs for PD have been based on MAO inhibition combined with a second activity, such as iron chelation and antioxidation and adenosine A<sub>2A</sub> receptor antagonism. In addition to these compounds, small molecules derived by conjugating <span class="smallcaps smallerCapital">l</span>-dopa and DA with LA have recently been reported.<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> The rationale for the development of these molecules was derived from the well-recognized observation that ROS play a role in the progressive and selective loss of the nigrostriatal dopaminergic neurons that occur in PD. However, it is noted that low molecular weight free radical scavengers, such as glutathione, vitamin E, carnosine, and ascorbic acid, have limited antioxidant properties because of their marginal efficiency in crossing BBB and/or affecting iron accumulation. Conversely, LA readily crosses BBB, accumulates in neuronal cell types,<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a> and is reduced by mitochondrial dehydrogenases to dihydrolipoic acid (DHLA), which lowers the redox activities of free iron cations.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> Furthermore, LA per se is also a good metal chelator and can therefore contribute to the tackling of the adverse effects of iron accumulation in aging brains. In light of these observations, new derivatives were synthesized combining DA, <span class="smallcaps smallerCapital">l</span>-dopa, and LA (Figure <a data-tab="pane-pcw-Figures" href="#fig29" id="" class=" internalNav">29</a>). The requirements for gastrointestinal absorption were evaluated, showing that all the derivatives could efficiently overcome the gastrointestinal barrier. Further experiments have also shown that compounds <b>54</b>−<b>57</b> pass unhydrolyzed through the stomach and can be absorbed still intact from the intestine. DA, <span class="smallcaps smallerCapital">l</span>-dopa, and LA are then released in human plasma after enzymatic hydrolysis. Compounds <b>54</b>−<b>57</b> were observed to display antioxidant activities when compared to <span class="smallcaps smallerCapital">l</span>-dopa, highlighting their potential in brain diseases where an involvement of DA concentration and free radical damage has been observed. This was demonstrated by comparing the total antioxidant status, the activity of SOD, and glutathione peroxidase in the plasma of rat treated with <span class="smallcaps smallerCapital">l</span>-dopa and with <b>54</b> or <b>55</b>.<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> Earlier, it was shown that SOD and glutathione peroxidase play an important role in the protective mechanisms against oxidative stress. Their activities are therefore very important for protecting against oxidative stress in PD.<a onclick="showRef(event, 'ref188 ref189'); return false;" href="javascript:void(0);" class="ref ref188 ref189">(188, 189)</a> Overall, <b>54</b> and <b>55</b> seem to partially protect against oxidative stress derived from auto-oxidation and MAO-mediated metabolism of DA. This finding, together with the observation that in human plasma they release the parent drugs, suggests that these codrugs are better candidates than <span class="smallcaps smallerCapital">l</span>-dopa alone in the treatment of PD.</div><figure id="fig29" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0030.jpeg" id="gr29" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Design strategy leading to compounds <b>54</b>−<b>57</b> by inserting into the same molecule the structural features of DA or <span class="smallcaps smallerCapital">l</span>-dopa and LA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The concept of a codrug is somewhat different from the original meaning of MTDLs. An MTDL is a single chemical entity able to simultaneously modulate different molecular targets responsible for a multifactorial disease. A codrug, however, is essentially a prodrug made by two parent compounds linked together by a chemical bond. It has to be stable at the gastrointestinal level, but then it has to be hydrolyzed to provide two (or more) different drugs. The final biological effects of an MTDL and a codrug are essentially the same. Conceptually, however, they represent different approaches to the discovery of multifunctional compounds.</div><div class="NLM_p">The last MTDL discovered for the treatment of PD is represented by sarizotan (<b>58</b>), a chromane derivative that exhibits dual serotoninergic 5-HT<sub>1A</sub> receptor agonism and dopaminergic receptor antagonism/partial agonism (Figure <a data-tab="pane-pcw-Figures" href="#fig30" id="" class=" internalNav">30</a>).<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a> The rationale for its discovery is related to the fact that serotoninergic 5-HT<sub>1A</sub> receptor agonists can reduce some relevant side effects of <span class="smallcaps smallerCapital">l</span>-dopa therapy such as wearing-off and <span class="smallcaps smallerCapital">l</span>-dopa-induced dyskinesia.<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a><b>58</b> showed high binding affinity for human dopaminergic D<sub>2</sub>, D<sub>3</sub>, D<sub>4</sub> and serotoninergic 5-HT<sub>1A</sub> receptors, with IC<sub>50</sub> values less than 6 nM. For the latter activity, in vivo characterization demonstrated that <b>58</b> can modulate both presynaptic and postsynaptic 5-HT<sub>1A</sub> receptors. Finally, the new drug candidate was introduced in clinical trials and its promising clinical profile showed that <b>58</b> could improve DA-induced motor complications by reducing striatal serotoninergic nerve impulse activity without altering <span class="smallcaps smallerCapital">l</span>-dopa efficacy. <b>58</b> therefore emerges as an innovative bifunctional drug for the treatment of dyskinesias associated with <span class="smallcaps smallerCapital">l</span>-dopa treatment in PD.<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a></div><figure id="fig30" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0031.jpeg" id="gr30" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Chemical structure of <b>58</b>, displaying both setoninergic 5-HT<sub>1A</sub> receptor agonism and dopaminergic D<sub>2</sub> receptor antagonism/partial agonism.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Despite enormous efforts at academic and industrial levels to discover new anti-PD drug candidates, with some MTDLs designed purposely to combat this neurodegenerative disease, a real disease-modifying small molecule able to confront the multifactorial nature of PD has not yet been discovered.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">5 Other Neurodegenerative Diseases</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75170" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75170" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">5.1 Huntingtonʼs Disease (HD)</h3><div class="NLM_p">HD is a neurodegenerative disorder involving progressive cognitive, psychiatric, and motor symptoms. Cognitive impairment is manifested by difficulties in concentration, decline in language skills with disorganized speech, and perceptive decline. Psychiatric symptoms that usually precede the motor symptoms include depression, anxiety, and sleep disorders. Motor symptoms are characterized by chorea and “dancelike” movements.<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> The brain regions affected in HD are mainly the cerebral cortex and striatum.<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a></div><div class="NLM_p">The molecular causes of HD were elucidated with the discovery that an expansion of a trinucleotide (CAG) was responsible for encoding an abnormally long polyglutamine tract in the huntingtin (htt) protein, which in turn induces dysfunction at molecular and cellular levels. Since CAG codes for glutamine, expanded CAG results in htt protein containing an expanded polyglutamine tract (more than 40 CAG, while the normal number of CAG repeats is less than 36). This induces molecular processes of protein misfolding and protein aggregation. The mechanisms by which the mutated htt induces a cascade of molecular and cellular events leading to cell dysfunction and death have not yet been fully elucidated.<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a> The caspase cleavage of mutant htt, generating toxic polyglutamine-containing N-terminal fragments of the protein, appears to play a role in the pathogenic mechanism.<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a> The truncated htt can interact with other intracellular proteins to form intraneuronal aggregates that the proteosomal machinery is unable to degrade. This is because mutant htt is more resistant to proteolysis than normal htt.<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a> As with AD and PD, it has been suggested that in HD too the small aggregates of mutated htt might be responsible for toxic effects, prior to the formation of larger aggregates.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> Furthermore, oxidative stress and mitochondrial dysfunction again play a role in the pathogenesis of the disease.<a onclick="showRef(event, 'ref196 ref197'); return false;" href="javascript:void(0);" class="ref ref196 ref197">(196, 197)</a> It has been advanced that oxidative stress might be proportional in intensity to the number of CAG repeats in the mutated htt polypeptide.<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a> In addition, experimental observations have shown that mutant htt is physically present on neuronal mitochondrial membranes.<a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a> This probably leads to mitochondrial depolarization, calcium-induced permabilization, and cytochrome <i>c</i> release. Moreover, it has recently been suggested that htt aggregates can be centers of iron-dependent oxidative events, pointing to the metalsʼ possible role in the neuronal death associated with HD.<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a></div><div class="NLM_p">In addition to these general mechanisms, studies with transgenic mice have also disclosed that many changes in neurotransmitter receptors occur in HD. These include alterations in metabotropic glutamate (AMPA, kainate, mGluR<sub>1</sub>, and mGluR<sub>2/3</sub>), NMDA, GABA<sub>A</sub>, adenosine A<sub>2A</sub>, dopaminergic (D<sub>1</sub> and D<sub>2</sub>), and cannabinoid CB<sub>1</sub> receptors.<a onclick="showRef(event, 'ref192 ref194'); return false;" href="javascript:void(0);" class="ref ref192 ref194">(192, 194)</a> In addition, significant reductions in the binding of muscarinic receptors in both the striatum and the cortex have also been observed. These changes frequently precede the onset of disease symptoms in transgenic mouse models, supporting a causative role for selective receptor dysregulation in HD pathogenesis.</div><div class="NLM_p last">Despite an increased understanding of the molecular causes of HD and a plethora of possible molecular targets for potentially efficacious and innovative therapies, there is no effective treatment for HD at present. Additionally, the search for MTDLs is almost absent from the anti-HD drug discovery field.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">5.2 Amyotrophic Lateral Sclerosis (ALS)</h3><div class="NLM_p">ALS, also known as Lou Gehrigʼs disease, is a progressive and lethal neurodegenerative disease characterized by a loss of motor neurons in the brain and spinal cord, leading to progressive muscle loss and paralysis.<a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a> In the U.S., there are approximately 25 000 patients with ALS. It is therefore considered an orphan disease (a condition that affects less than 200 000 people nationwide). The pathological hallmark of ALS is the atrophy of dying motor neurons. Swelling of perikarya and proximal axons is also observed, as is the accumulation of phosphorylated neurofilaments, Bunina bodies (i.e., proteinaceous inclusions in motor neurons), LBs like inclusions, and strands of ubiquitinated material in these axons. The activation and proliferation of astrocytes and microglia, as well as fragmentation of Golgi apparatus in motoneurons, are also observed.<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a></div><div class="NLM_p">Although the molecular causes of ALS are not yet fully disclosed, multiple perturbations of cellular functions have been detected. Protein misfolding and aggregation, alteration of cellular oxidative states, and mitochondrial dysfunction, molecular mechanisms shared by AD, PD, and HD, have been observed in ALS too. Studies with transgenic mouse models have also identified the possible molecular targets involved in ALS pathogenesis.<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a> These studies point to SOD1 as one protein involved in familial ALS. SOD1 is a 153-amino-acid cytosolic protein that functions as a homodimer. Each monomer binds one zinc and one copper cation. Through dismutation of copper, SOD1 converts the superoxide anion, which is a byproduct of oxidative phosphorylation in the mitochondrion, to H<sub>2</sub>O<sub>2</sub>.<a onclick="showRef(event, 'ref203'); return false;" href="javascript:void(0);" class="ref ref203">(203)</a> More than 125 SOD1 mutations have been identified in ALS patients, but it is not yet clear how diverse mutants gain a common toxic property relevant to the disease pathogenesis.<a onclick="showRef(event, 'ref204'); return false;" href="javascript:void(0);" class="ref ref204">(204)</a> Transgenic mice overexpressing human SOD1-G93A mutant are the most widely used model for therapy development. Two hypotheses related to SOD1 malfunctioning have been advanced: oxidative damage and protein misfolding.<a onclick="showRef(event, 'ref203 ref205'); return false;" href="javascript:void(0);" class="ref ref203 ref205">(203, 205)</a> The oxidative damage hypothesis focuses on the impaired SOD1 catalytic activity, which leads to the formation of toxic species such as peroxynitrite, superoxide, and decomposition products of H<sub>2</sub>O<sub>2</sub>. This unbalances the neuron redox state with consequent damage to vital cellular function. The protein misfolding hypothesis states that mutants of SOD1 are prone to misfolding and forming harmful aggregates that may be toxic. Aggregates in ALS transgenic mice are evident at the time of disease onset.<a onclick="showRef(event, 'ref206 ref207'); return false;" href="javascript:void(0);" class="ref ref206 ref207">(206, 207)</a> With disease progression, they increase in abundance.<a onclick="showRef(event, 'ref206 ref207 ref208'); return false;" href="javascript:void(0);" class="ref ref206 ref207 ref208">(206-208)</a> However, the role of such aggregates in the neurodegenerative cascade is still controversial. As with other neuronal disorders, the larger SOD1 aggregates can be protective, while conversion of soluble SOD1 into insoluble aggregates in the mitochondria might be the actual molecular mechanism of SOD1 toxic effects.<a onclick="showRef(event, 'ref204'); return false;" href="javascript:void(0);" class="ref ref204">(204)</a> In this respect, in vitro studies have also shown that mutants of SOD1 form small porelike structures that are similar to some forms of amyloid proteins.<a onclick="showRef(event, 'ref209 ref210'); return false;" href="javascript:void(0);" class="ref ref209 ref210">(209, 210)</a> Interestingly, in addition to other molecular mechanisms, neuronal apoptosis in ALS seems to be related to both an impairment of the association of cytochrome <i>c</i> with the inner membrane of mitochondrion and a gradual reduction of the intramitochondrial cytochrome <i>c</i> concentration that correlates with disease progression.<a onclick="showRef(event, 'ref211'); return false;" href="javascript:void(0);" class="ref ref211">(211)</a> It is not yet clear whether SOD1 participates in increasing mitochondrial permeability to cytochrome <i>c</i> release. It has been suggested that SOD1 accumulates and aggregates in the outer mitochondrial membrane and hinders the protein importation machinery, eventually leading to mitochondrial dysfunction.<a onclick="showRef(event, 'ref212'); return false;" href="javascript:void(0);" class="ref ref212">(212)</a> The observation that both wild-type and mutated SOD1 bind the antiapoptotic Bcl2, trapping it into a detergent resistant aggregate, highlights a second possible toxic effect of SOD1 toward the mitochondrial functions, which probably leads to a mitochondrion-mediated neuronal apoptosis.<a onclick="showRef(event, 'ref213'); return false;" href="javascript:void(0);" class="ref ref213">(213)</a></div><div class="NLM_p">Another component of ALS neuronal degeneration is related to excessive glutamate-induced stimulation of postsynaptic glutamate receptors (mainly, AMPA receptors). The consequent massive calcium influx is potentially harmful because of its ability to activate processes such as proteases, nucleases, and lipases activities. In ALS, a 3-fold increase in CNS glutamate levels has been observed.<a onclick="showRef(event, 'ref214 ref215 ref216'); return false;" href="javascript:void(0);" class="ref ref214 ref215 ref216">(214-216)</a> Glutamate-induced excitotoxicity provides a possible explanation for the selective vulnerability of motor neurons in ALS. Relative to other types of neurons, motor neurons have a diminished capacity to buffer calcium.<a onclick="showRef(event, 'ref217'); return false;" href="javascript:void(0);" class="ref ref217">(217)</a></div><div class="NLM_p">Despite increased knowledge about the molecular mechanisms that underlie ALS, the only drug approved for ALS, riluzole (<b>59</b>), a glutamate receptor antagonist (Figure <a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">31</a>), is not a disease-modifying drug. Indeed, it is able to only slightly prolong patient survival.<a onclick="showRef(event, 'ref218'); return false;" href="javascript:void(0);" class="ref ref218">(218)</a> In this respect, it was reported in 2001 that around 50 different medications had been tested for the treatment of ALS since 1941. Only one, <b>59</b>, had any effect on patient survival.<a onclick="showRef(event, 'ref219'); return false;" href="javascript:void(0);" class="ref ref219">(219)</a> As with other neurodegenerative diseases, there is a growing consensus that new avenues for promising therapeutic approaches to ALS can be derived from MMT treatments.<a onclick="showRef(event, 'ref220'); return false;" href="javascript:void(0);" class="ref ref220">(220)</a> In this respect, a three-drug MMT was recently proposed to delay the onset of the disease, slowing the loss of muscle strength and increasing the average longevity of SOD1-G73R transgenic mice.<a onclick="showRef(event, 'ref221'); return false;" href="javascript:void(0);" class="ref ref221">(221)</a> This MMT is composed of minocycline (<b>60</b>), an antimicrobial agent that inhibits microglial activation, <b>59</b>, and nimodipine (<b>35</b>), a voltage-gated calcium channel blocker (Figure <a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">31</a>). The rationale for this MMT is justified by the molecular (and/or cellular) causes of ALS as described above. However, it is not yet clear whether this MMT is able to definitively confront the molecular causes and progression of ALS.</div><figure id="fig31" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0032.jpeg" id="gr31" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. Chemical structures of compounds <b>35</b> and <b>58</b>−<b>61</b> used or currently under investigation for the treatment of ALS.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Concerning MTDLs for the treatment of ALS, a recent study reports on the neuroprotective effects of (−)-epigallocatechin-3-gallate (<b>61</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig31" id="" class=" internalNav">31</a>) in SOD1-G93A transgenic mice.<a onclick="showRef(event, 'ref222'); return false;" href="javascript:void(0);" class="ref ref222">(222)</a><b>61</b> is the major polyphenolic constituent of green tea. It has been found to possess great chemopreventive potential due to its ability to interact with an array of molecular targets.<a onclick="showRef(event, 'ref223'); return false;" href="javascript:void(0);" class="ref ref223">(223)</a> In particular, <b>61</b> delayed onset of ALS and prolonged survival of SOD1-G93A mice. This is probably a consequence of its preservation of motor neurons in the anterior horns and reduction of microglial activation. At a molecular level, a reduction in both activation NF-κB and caspase-3 activity was observed. While in ALS NF-κB is strongly activated in astrocytes of the spinal cord (probably as a consequence of oxidative stress), the caspase-3 enzyme mediates neuronal apoptosis. The link between microglial and NF-κB activation is probably the inflammation process, which plays an important role in the pathogenesis of ALS. It has been shown that neuroinflammation occurs before there is a clear evidence of motoneurons loss. It has also been suggested that it can act as a defense in the early stages of the disease, whereas in later stages it can become a crucial propagator of damage.<a onclick="showRef(event, 'ref224 ref225'); return false;" href="javascript:void(0);" class="ref ref224 ref225">(224, 225)</a> The results obtained with <b>61</b> suggest that it is a potent inhibitor of neuroinflammatory processes associated with ALS, acting at multiple steps of the neuroinflammatory cascade. It therefore emerges as a potentially effective drug candidate for the treatment (and even prevention) of ALS.<a onclick="showRef(event, 'ref222'); return false;" href="javascript:void(0);" class="ref ref222">(222)</a></div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">6 Perspectives: Designed MTDLs and Systems Biology</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43470" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43470" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In light of recent achievements in the fields of AD, PD, HD, and ALS, neurodegenerative diseases appear to share several common multifactorial degenerative processes that could contribute to neuronal death, leading to functional impairments.<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> From the above evidence, it appears that a bioactive compound, whose efficacy is based on interference with a single target, should no longer be considered a good drug candidate for combating such complex diseases. This is because, as a result of cellular redundancy in many biological pathways, the desired therapeutic effect may not be produced by modulating a single-protein activity.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Indeed, a better candidate might be a molecule able to hit several targets at once (an MTDL). To strengthen this concept, it is worth noting that some of the most interesting compounds under investigation for the treatment of neurodegenerative diseases are those endowed with multifunctional mechanisms. For instance, curcumin and other polyphenols would appear to be useful in AD not only because of their dual function as anti-inflammatory and antioxidant agents but also because they can structurally interfere with Aβ aggregation and metal dyshomeostasis.<a onclick="showRef(event, 'ref226 ref227'); return false;" href="javascript:void(0);" class="ref ref226 ref227">(226, 227)</a> Furthermore, estradiol, besides its classic function as a sexual hormone, has recently been linked to neurodegenerative diseases including AD and PD, where it would exert neuroprotective effects through enhancement of neurotrophin signaling and synaptic activities and protection of neurons against oxidative injuries and Aβ toxicity.<a onclick="showRef(event, 'ref228'); return false;" href="javascript:void(0);" class="ref ref228">(228)</a> A further example is represented by statins, which might be exploited against a variety of CNS illnesses because of their multiple beneficial neuroprotective effects. These effects are linked not only to cholesterol lowering but also to several other mechanisms such as heat-shock proteins and PI-3K/Akt pathways.<a onclick="showRef(event, 'ref229'); return false;" href="javascript:void(0);" class="ref ref229">(229)</a></div><div class="NLM_p">However, such multifunctional profiles have been discovered serendipitously (mainly because of the wide industrial availability of HTS techniques). A systematic strategy to design and optimize MTDLs does not yet constitute an established approach in traditional medicinal chemistry research.<a onclick="showRef(event, 'ref230'); return false;" href="javascript:void(0);" class="ref ref230">(230)</a> The rational design of compounds that simultaneously modulate different protein targets, either positively or negatively, at a comparable concentration for each target remains a challenging task. As shown by the reported examples, the most frequently adopted MTDLs design strategy has been based mainly on linking two properly selected pharmacophores through a spacer. During the subsequent optimization phase, analogues are made to appropriately balance the desired activities for the two targets. Indeed, very similar affinity values should be obtained for an MTDL toward two or more targets. While this might be reasonable for a compound hitting two targets, the tuning of different activities at comparable concentrations might not be so straightforward in the case of a triple ligand. Moreover, designing a triple MTDL by conjugating three distinct pharmacophores might also be disadvantageous from a pharmacokinetic point of view, since it might lead to high molecular weight compounds with an intrinsic lower probability of optimal druglikeness.<a onclick="showRef(event, 'ref33 ref231'); return false;" href="javascript:void(0);" class="ref ref33 ref231">(33, 231)</a> Obviously, the classic meaning of SAR should be revisited in the field of MTDLs. For instance, ameliorating the biological profile of a molecule toward a first target could decrease its activity toward a second one. In this respect, multivariate statistical analyses could be of great usefulness for defining quantitative SARs and for driving the design of new MTDLs.</div><div class="NLM_p">In our opinion, gaining a superior understanding of the cellular mechanisms at which the drug candidate is aimed might represent a step toward rationally designing a balanced MTDL.<a onclick="showRef(event, 'ref232'); return false;" href="javascript:void(0);" class="ref ref232">(232)</a> To tackle this, researchers are turning to the emerging field of systems or network biology. In contrast to the reductionist paradigm, systems biology considers the description of the system, that is, the complex interactions between the molecular constituents of a living cell.<a onclick="showRef(event, 'ref233'); return false;" href="javascript:void(0);" class="ref ref233">(233)</a> A union between systems biology and medicinal chemistry would certainly help overcome the limits of the one-molecule, one-target approach. In target-centric drug discovery strategies, potential leads are identified and optimized for activity against specific molecular targets. In contrast, approaches based on systems biology are aimed at the generation of leads that potentially impact interconnected pathways. In view of such goals, human cell models of diseases can be exploited.<a onclick="showRef(event, 'ref234'); return false;" href="javascript:void(0);" class="ref ref234">(234)</a> Because they allow us to directly measure disease-relevant cellular responses, these models represent a practical means of carrying out drug discovery based on systems biology. In these models, disease complexity is engineered into cell systems by activating multiple pathways simultaneously to elicit network regulation, thus casting a much wider net than target-based approaches.<a onclick="showRef(event, 'ref235'); return false;" href="javascript:void(0);" class="ref ref235">(235)</a> In so doing, one can try to identify those biological functions and processes that are altered in the disease, highlighting the actual molecular effectors of such a malfunctioning. This can help to create new hypotheses about the pathogenesis of complex diseases. It can help to identify new putative drug targets by investigating how these proteins are interlinked to each other and how they are relevant to the disease etiology. Finally, it can help to establish whether it is better to design leads able to modulate multiple points within a linear biochemical pathway or within parallel and independent pathways.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> These innovative strategies represent a departure from current target-centric activities. They offer the promise of opening up an entirely new era in medicinal chemistry, providing compounds able to modulate systems activity rather than a single target. Notably, a systems biology-based approach has already been proposed to facilitate our understanding of the mechanism of action of drug combinations.<a onclick="showRef(event, 'ref236 ref237'); return false;" href="javascript:void(0);" class="ref ref236 ref237">(236, 237)</a></div><div class="NLM_p">From the observations above, it is clear that, analogous to drug combination, MTDLs call for a strategy to properly address their discovery. It must be emphasized, however, that rationally designed MTDLs are conceptually very different from unselective drugs of the past or from the so-called “dirty drugs”, which are found serendipitously and which often exhibit off-target activities irrelevant to the target disease but giving rise to undesired side effects. Conversely, rationally designed MTDLs should only affect their targets partially. This corresponds well with the low-affinity interaction that these compounds usually show against the different targets they modulate. The low affinity of MTDLs may not be a disadvantage. Instead, their weak interactions stabilize the systems, buffering the changes after system perturbation, thus lowering the side effects.<a onclick="showRef(event, 'ref3 ref238'); return false;" href="javascript:void(0);" class="ref ref3 ref238">(3, 238)</a></div><div class="NLM_p last">The use of MTDLs in neurodegeneration has been addressed in this review article, justifying their development on the basis of the multifactorial nature of this group of diseases. However, we mention, in conclusion, that a similar scenario is also present in other fields of CNS disorders such as depression<a onclick="showRef(event, 'ref239'); return false;" href="javascript:void(0);" class="ref ref239">(239)</a> and schizophrenia.<a onclick="showRef(event, 'ref240'); return false;" href="javascript:void(0);" class="ref ref240">(240)</a></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82735" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82735" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea Cavalli</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Sciences, Alma Mater Studiorum, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e988878d9b8c88c78a889f88858580a99c87808b86c7809dc984889b808885889c9b88c78b8685868e878c9a80a99c87808b86c7809dc98a889b8586c7848c858a8180869b9b8ca99c87808b86c7809d"><span class="__cf_email__" data-cfemail="8eefe0eafcebefa0edeff8efe2e2e7cefbe0e7ece1a0e7fa">[email protected]</span> <span class="__cf_email__" data-cfemail="761b17041f171a170304175814191a19111813051f3603181f1419581f02">[email protected]</span> <span class="__cf_email__" data-cfemail="c7a4a6b5aba8e9aaa2aba4afaea8b5b5a287b2a9aea5a8e9aeb3">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Laura Bolognesi</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Sciences, Alma Mater Studiorum, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#fa9b949e889f9bd4999b8c9b969693ba8f94939895d4938eda979b88939b969b8f889bd4989596959d949f8993ba8f94939895d4938eda999b889695d4979f969992939588889fba8f94939895d4938e"><span class="__cf_email__" data-cfemail="0869666c7a6d69266b697e69646461487d66616a6726617c">[email protected]</span> <span class="__cf_email__" data-cfemail="e68b87948f878a87939487c884898a89818883958fa693888f8489c88f92">[email protected]</span> <span class="__cf_email__" data-cfemail="731012011f1c5d1e161f101b1a1c01011633061d1a111c5d1a07">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carlo Melchiorre</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Sciences, Alma Mater Studiorum, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1776797365727639747661767b7b7e5762797e7578397e63377a76657e767b766265763975787b78707972647e5762797e7578397e63377476657b78397a727b747f7e786565725762797e7578397e63"><span class="__cf_email__" data-cfemail="1b7a757f697e7a35787a6d7a7777725b6e7572797435726f">[email protected]</span> <span class="__cf_email__" data-cfemail="8de0ecffe4ece1ecf8ffeca3efe2e1e2eae3e8fee4cdf8e3e4efe2a3e4f9">[email protected]</span> <span class="__cf_email__" data-cfemail="711210031d1e5f1c141d1219181e03031431041f18131e5f1805">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Minarini</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Sciences, Alma Mater Studiorum, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michela Rosini</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Sciences, Alma Mater Studiorum, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincenzo Tumiatti</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Sciences, Alma Mater Studiorum, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maurizio Recanatini</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmaceutical Sciences, Alma Mater Studiorum, University of Bologna, Via Belmeloro 6, 40126 Bologna, Italy</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm7009364" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26432" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26432" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Andrea Cavalli</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p><b>Biographies</b></p><p class="last"><b>Andrea Cavalli</b> received his degree in Medicinal Chemistry in 1996 and his Ph.D. in Pharmaceutical Sciences in 1999 from the University of Bologna (Italy) under the supervision of Maurizio Recanatini. He was then a Postdoctoral Fellow in Biophysics at the International School for Advanced Studies (SISSA/ISAS) of Trieste (Italy), where he worked with Vincent Torre and Paolo Carloni. In 2001−2002, he was Visiting Scientist at the Swiss Federal Institute of Technology (ETH) of Zürich (Switzerland), working with Gerd Folkers and Leonardo Scapozza. At present, he is Researcher at the Department of Pharmaceutical Sciences at the University of Bologna. His research interests are focused on the development and application of computational methods in drug design. In 2003, he was awarded the Farmindustria Prize for Pharmaceutical Research.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Maria Laura Bolognesi</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Maria Laura Bolognesi</b> received her degree in Medicinal Chemistry (with Highest Honors) in 1990 from the University of Bologna. In 1994, she received her Ph.D. in Pharmaceutical Sciences from the same university under the supervision of Prof. Carlo Melchiorre, working on the design, synthesis, and biological evaluation of selective muscarinic antagonists. After enjoying a postdoctoral year in Prof. Philip S. Portogheseʼs research laboratory at the Department of Medicinal Chemistry in Minneapolis, she returned to the University of Bologna where she is now Associate Professor of Medicinal Chemistry. Her current scientific interest lies on the design and synthesis of new chemical entities against neurodegenerative diseases.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Anna Minarini</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Anna Minarini</b> graduated with a degree in Medicinal Chemistry from the University of Bologna in 1987 and received her Ph.D. in Pharmaceutical Sciences in 1992 from the same university. In 1990–1991, she was a Visiting Scientist at the University of Buffalo, New York. In 1998, she was appointed Associate Professor of Medicinal Chemistry at the Department of Pharmaceutical Sciences of the University of Bologna. Her current research interests are devoted to the design and synthesis of new ligands against neurodegenerative diseases.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Michela Rosini</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Michela Rosini</b> obtained her degree in Medicinal Chemistry in 1997, followed by a Ph.D. in Pharmaceutical Sciences in 2001 from the University of Bologna. In 1998 and 2000, she spent some months at The Royal Danish School of Pharmacy of Copenhagen. At present, she is an Assistant Professor in the Department of Pharmaceutical Sciences of the University of Bologna and is focusing her research on the design and synthesis of multitarget-directed ligands for the treatment of Alzheimerʼs disease.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Vincenzo Tumiatti</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Vincenzo Tumiatti</b> obtained his degree in Medicinal Chemistry in 1986. In 1991–1992, he was a Visiting Scientist at the University of Frankfurt/M. In 2005, he was appointed Full Professor of Medicinal Chemistry in the Department of Pharmaceutical Sciences of the University of Bologna. His current scientific activity is focused on the design and synthesis of new chemical entities against neurodegenerative diseases and cancer.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Maurizio Recanatini</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Maurizio Recanatini</b> received his degree in Chemistry from the University of Bologna in 1978. He worked as Postdoctoral Fellow until 1983, when he joined the Faculty of Pharmacy of the same university. In 1984−1985, he was a Visiting Scientist at the Department of Chemistry of the Pomona College, Claremont, CA, in the laboratory of Corwin Hansch. Since 2000, he has been Full Professor of Medicinal Chemistry at the University of Bologna, carrying out his research at the Department of Pharmaceutical Sciences. His research interests are focused on the application of computational methods to drug design and discovery.</p></figure></div><div class="bio" rid="ath7"><figure id="ath7" data-index="37" class="article__inlineFigure"><h2 class="fig-label">Carlo Melchiorre</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Carlo Melchiorre</b> received his degree in Chemistry from Camerino University (1966) where was appointed Full Professor (1980). In 1988, he joined the Faculty of Pharmacy at the University of Bologna where he is presently Professor of Medicinal Chemistry. He has long-standing interests in neurotransmitter receptors. From 1975 to 1979, he joined Professor Bernard Belleauʼs research group at McGill University (Montreal, Canada) where he developed a series of irreversible α-adrenoceptor antagonists, whose prototype, benextramine, has become a valuable tool in α-adrenergic pharmacology. In 1987, his group designed one of the first selective muscarinic M<sub>2</sub> receptor antagonists, methoctramine, which has been widely used in the characterization of muscarinic receptor subtypes. He is currently focusing his research efforts on the identification of MTDLs for the treatment of neurodegenerative disorders.</p></figure></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04055" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04055" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by a grant from MIUR (FIRB RBNE03FH5Y) and the University of Bologna.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37382" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37382" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 240 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Lansbury, P. T.,  Jr</span><span> </span><span class="NLM_article-title">Back to the future: the “old-fashioned” way to new medications for neurodegeneration</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">S51</span><span class="NLM_x">–</span> <span class="NLM_lpage">S57</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=S51-S57&issue=Suppl.&author=P.+T.+Lansbury&title=Back+to+the+future%3A+the+%E2%80%9Cold-fashioned%E2%80%9D+way+to+new+medications+for+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLansbury%26aufirst%3DP.%2BT.%26atitle%3DBack%2520to%2520the%2520future%253A%2520the%2520%25E2%2580%259Cold-fashioned%25E2%2580%259D%2520way%2520to%2520new%2520medications%2520for%2520neurodegeneration%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2004%26volume%3D5%26issue%3DSuppl%26spage%3DS51%26epage%3DS57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Frantz, S.</span><span> </span><span class="NLM_article-title">Drug discovery: playing dirty</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">, 437</span><span class="NLM_x">, </span> <span class="NLM_fpage">942</span><span class="NLM_x">–</span> <span class="NLM_lpage">943</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=%2C+437&publication_year=2005&pages=942-943&author=S.+Frantz&title=Drug+discovery%3A+playing+dirty"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrantz%26aufirst%3DS.%26atitle%3DDrug%2520discovery%253A%2520playing%2520dirty%26jtitle%3DNature%26date%3D2005%26volume%3D437%26spage%3D942%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Mencher, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. G.</span><span> </span><span class="NLM_article-title">Promiscuous drugs compared to selective drugs (promiscuity can be a virtue)</span> <span class="citation_source-journal">BMC Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1186%2F1472-6904-5-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15854222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADC%252BD2M3ktVartA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=3&author=S.+K.+Mencherauthor=L.+G.+Wang&title=Promiscuous+drugs+compared+to+selective+drugs+%28promiscuity+can+be+a+virtue%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Promiscuous drugs compared to selective drugs (promiscuity can be a virtue)</span></div><div class="casAuthors">Mencher Simon K; Wang Long G</div><div class="citationInfo"><span class="NLM_cas:title">BMC clinical pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The word selectivity describes a drug's ability to affect a particular cell population in preference to others.  As part of the current state of art in the search for new therapeutic agents, the property of selectivity is a mode of action thought to have a high degree of desirability.  Consequently there is a growing activity in this area of research.  Selectivity is generally a worthy property in a drug because a drug having high selectivity may have a dramatic effect when there is a single agent that can be targeted against the appropriate molecular-driver involved in the pathogenesis of a disease.  An example is chronic myeloid leukemia (CML).  CML has a specific chromosomal abnormality, the Philadelphia chromosome, that results in a single gene that produces an abnormal protein.  DISCUSSION:  There is a burgeoning understanding of the cellular mechanisms that control the etiology and pathogeneses of diseases.  This understanding both enables and motivates the development of drugs that induce a specific action in a selected cell population; i.e., a targeted treatment.  Consequently, drugs that can target distinct molecular targets involved in pathologic/pathogenetic processes, or signal-transduction pathways, are being developed.  However, in most cases, diseases involve multiple abnormalities.  A disease may be associated with more than one dysfunctional protein and these may be out-of-balance with each other.  Likewise a drug might strongly target a protein that shares a similar active domain with other proteins.  A drug may also target pleiotropic cytokines, or other proteins that have multi-physiological functions.  In this way multiple normal cellular pathways can be simultaneously influenced.  Long term experience with drugs supposedly designed for only a single target, but which unavoidably involve other functional effects, is uncovering the fact that molecular targeting is not medically flawless.  SUMMARY:  We contend that an ideal drug may be one whose efficacy is based not on the inhibition of a single target, but rather on the rebalancing of the several proteins or events, that contribute to the etiology, pathogeneses, and progression of diseases, i.e., in effect a promiscuous drug.  Ideally, if this could be done at minimum drug concentration, side effects could be minimized.  Corollaries to this argument are that the growing fervor for researching truly selective drugs may be imprudent when considering the totality of responses; and that the expensive screening techniques used to discover these, may be both medically and financially inefficient.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQc3Gp004wjH9yzdcP07UmufW6udTcc2ebf_lGS66VPxbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M3ktVartA%253D%253D&md5=bfc2421479ee2f2169efd58bdc0238ec</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1186%2F1472-6904-5-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1472-6904-5-3%26sid%3Dliteratum%253Aachs%26aulast%3DMencher%26aufirst%3DS.%2BK.%26aulast%3DWang%26aufirst%3DL.%2BG.%26atitle%3DPromiscuous%2520drugs%2520compared%2520to%2520selective%2520drugs%2520%2528promiscuity%2520can%2520be%2520a%2520virtue%2529%26jtitle%3DBMC%2520Clin.%2520Pharmacol.%26date%3D2005%26volume%3D5%26spage%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Bishop, T.; Sham, P.</span> <span class="citation_source-book">Analysis of Multifactorial Diseases</span>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">320.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=1-320.&author=T.+Bishop&author=P.+Sham&title=Analysis+of+Multifactorial+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBishop%26aufirst%3DT.%26btitle%3DAnalysis%2520of%2520Multifactorial%2520Diseases%26pub%3DAcademic%2520Press%26date%3D2000%26spage%3D1%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designed multiple ligands. An emerging drug discovery paradigm</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">, 48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6523</span><span class="NLM_x">–</span> <span class="NLM_lpage">6543</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058225d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=%2C+48&publication_year=2005&pages=6523-6543&author=R.+Morphyauthor=Z.+Rankovic&title=Designed+multiple+ligands.+An+emerging+drug+discovery+paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Designed Multiple Ligands.</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6523-6543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review discusses main areas in designed multiple ligands (DMLs) discovery that include 5HT transporter-based DMLs for depression, dopamine D2-receptor based DMLs for schizophrenia, histamine H1 receptor-based DMLs for allergies, DMLs targeting the angiotensin system for hypertension, nonsteroidal anti-inflammatory drugs, and PPAR-based DMLs for metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgouWcjsiKgbVg90H21EOLACvtfcHk0lihqjkOukFwiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL&md5=00e3bf5a521fc91996ce95bb379a0b5c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm058225d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058225d%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigned%2520multiple%2520ligands.%2520An%2520emerging%2520drug%2520discovery%2520paradigm%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6523%26epage%3D6543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Kola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landis, J.</span><span> </span><span class="NLM_article-title">Can the pharmaceutical industry reduce attrition rates?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">715</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=711-715&author=I.+Kolaauthor=J.+Landis&title=Can+the+pharmaceutical+industry+reduce+attrition+rates%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKola%26aufirst%3DI.%26aulast%3DLandis%26aufirst%3DJ.%26atitle%3DCan%2520the%2520pharmaceutical%2520industry%2520reduce%2520attrition%2520rates%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D711%26epage%3D715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Fragments, network biology and designing multiple ligands</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">156</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=156-160&author=R.+Morphyauthor=Z.+Rankovic&title=Fragments%2C+network+biology+and+designing+multiple+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DFragments%252C%2520network%2520biology%2520and%2520designing%2520multiple%2520ligands%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D156%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">From magic bullets to designed multiple ligands</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2FS1359-6446%2804%2903163-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15279847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVSktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=641-651&author=R.+Morphyauthor=C.+Kayauthor=Z.+Rankovic&title=From+magic+bullets+to+designed+multiple+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">From magic bullets to designed multiple ligands</span></div><div class="casAuthors">Morphy, Richard; Kay, Corinne; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">641-651</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  A major trend in medicinal chem. in the coming years will be the rational design of ligands that are capable of modulating multiple disease-relevant targets in a specific manner.  Increasingly, it is being recognized that a balanced modulation of several targets can provide a superior therapeutic effect and side effect profile compared to the action of a selective ligand.  Rational approaches in which structural features from selective ligands are combined have produced designed multiple ligands that span a wide variety of targets and target classes.  A key challenge in the design of multiple ligands is attaining a balanced activity at each target of interest while simultaneously achieving a wider selectivity and a suitable pharmacokinetic profile.  An anal. of literature examples reveals trends and insights that might help medicinal chemists discover the next generation of these types of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcsGpfzZok5rVg90H21EOLACvtfcHk0lgoS77TCy3DeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVSktb8%253D&md5=cd2491baad707043dbee4f59ccad9e1d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903163-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903163-0%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DKay%26aufirst%3DC.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DFrom%2520magic%2520bullets%2520to%2520designed%2520multiple%2520ligands%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D641%26epage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Soluble protein oligomers in neurodegeneration: lessons from the Alzheimerʼs amyloid beta-peptide</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnrm2101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17245412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFKmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=101-112&author=C.+Haassauthor=D.+J.+Selkoe&title=Soluble+protein+oligomers+in+neurodegeneration%3A+lessons+from+the+Alzheimer%CA%BCs+amyloid+beta-peptide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide</span></div><div class="casAuthors">Haass, Christian; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-112</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The distinct protein aggregates that are found in Alzheimer's, Parkinson's, Huntington's and prion diseases seem to cause these disorders.  Small intermediates - sol. oligomers - in the aggregation process can confer synaptic dysfunction, whereas large, insol. deposits might function as reservoirs of the bioactive oligomers.  These emerging concepts are exemplified by Alzheimer's disease, in which amyloid β-protein oligomers adversely affect synaptic structure and plasticity.  Findings in other neurodegenerative diseases indicate that a broadly similar process of neuronal dysfunction is induced by diffusible oligomers of misfolded proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmPK-IDaBZirVg90H21EOLACvtfcHk0lgoS77TCy3DeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFKmtw%253D%253D&md5=e8634ff5c1491580f623c90ded91b4be</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrm2101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2101%26sid%3Dliteratum%253Aachs%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DSoluble%2520protein%2520oligomers%2520in%2520neurodegeneration%253A%2520lessons%2520from%2520the%2520Alzheimer%25CA%25BCs%2520amyloid%2520beta-peptide%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26spage%3D101%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Jellinger, K. A.</span><span> </span><span class="NLM_article-title">General aspects of neurodegeneration</span> <span class="citation_source-journal">J. Neural Transm., Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1007%2F978-3-7091-0643-3_7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=12946052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADC%252BD3svgslSitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=101-144&author=K.+A.+Jellinger&title=General+aspects+of+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">General aspects of neurodegeneration</span></div><div class="casAuthors">Jellinger K A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neural transmission. Supplementum</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">65</span>),
    <span class="NLM_cas:pages">101-44</span>
        ISSN:<span class="NLM_cas:issn">0303-6995</span>.
    </div><div class="casAbstract">Neurodegenerative diseases are morphologically featured by progressive cell loss in specific vulnerable neuronal populations of the central nervous system, often associated with cytoskeletal protein aggregates forming intracytoplasmic and/or intranuclear inclusions in neurons and/or glial cells.  Most neurodegenerative disorders are now classified either according to the hitherto known genetic mechanisms or to the major components of their cellular protein inclusions.  The major basic processes inducing neurodegeneration are considered multifactorial ones caused by genetic, environmental, and endogenous factors.  They include abnormal protein dynamics with defective protein degradation and aggregation, many of them related to the ubiquitin-proteasomal system, oxidative stress and free radical formation, impaired bioenergetics and mitochondrial dysfunctions, and "neuroinflammatory" processes.  These mechanisms that are usually interrelated in complex vitious circles finally leading to programmed cell death cascades are briefly discussed with reference to their pathogenetic role in many, albeit diverse neurodegenerative diseases, like Alzheimer disease, synucleinopathies, tauopathies, and polyglutamine disorders.  The impact of protein inclusions on cell dysfunction, activation or prevention of cell death cascades are discussed, but the molecular basis for the underlying disease mechanisms remains to be elucidated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRa1twIwY8NL8AKB7Fa-xrUfW6udTcc2eaVEGHwAT0jfLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svgslSitA%253D%253D&md5=ba7c72c37d0fc01ee43ed9514adbd819</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2F978-3-7091-0643-3_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-7091-0643-3_7%26sid%3Dliteratum%253Aachs%26aulast%3DJellinger%26aufirst%3DK.%2BA.%26atitle%3DGeneral%2520aspects%2520of%2520neurodegeneration%26jtitle%3DJ.%2520Neural%2520Transm.%252C%2520Suppl.%26date%3D2003%26spage%3D101%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Gaggelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozlowski, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valensin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valensin, G.</span><span> </span><span class="NLM_article-title">Copper homeostasis and neurodegenerative disorders (Alzheimerʼs, prion, and Parkinsonʼs diseases and amyotrophic lateral sclerosis)</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">1995</span><span class="NLM_x">–</span> <span class="NLM_lpage">2044</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr040410w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2006&pages=1995-2044&author=E.+Gaggelliauthor=H.+Kozlowskiauthor=D.+Valensinauthor=G.+Valensin&title=Copper+homeostasis+and+neurodegenerative+disorders+%28Alzheimer%CA%BCs%2C+prion%2C+and+Parkinson%CA%BCs+diseases+and+amyotrophic+lateral+sclerosis%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fcr040410w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr040410w%26sid%3Dliteratum%253Aachs%26aulast%3DGaggelli%26aufirst%3DE.%26aulast%3DKozlowski%26aufirst%3DH.%26aulast%3DValensin%26aufirst%3DD.%26aulast%3DValensin%26aufirst%3DG.%26atitle%3DCopper%2520homeostasis%2520and%2520neurodegenerative%2520disorders%2520%2528Alzheimer%25CA%25BCs%252C%2520prion%252C%2520and%2520Parkinson%25CA%25BCs%2520diseases%2520and%2520amyotrophic%2520lateral%2520sclerosis%2529%26jtitle%3DChem.%2520Rev.%26date%3D2006%26volume%3D106%26spage%3D1995%26epage%3D2044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bucciantini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannoni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formigli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurdo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taddei, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramponi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefani, M.</span><span> </span><span class="NLM_article-title">Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">416</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">511</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2F416507a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=11932737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD38XivVOgtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=416&publication_year=2002&pages=507-511&author=M.+Bucciantiniauthor=E.+Giannoniauthor=F.+Chitiauthor=F.+Baroniauthor=L.+Formigliauthor=J.+Zurdoauthor=N.+Taddeiauthor=G.+Ramponiauthor=C.+M.+Dobsonauthor=M.+Stefani&title=Inherent+toxicity+of+aggregates+implies+a+common+mechanism+for+protein+misfolding+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases</span></div><div class="casAuthors">Bucciantini, Monica; Giannoni, Elisa; Chiti, Fabrizio; Baroni, Fabiana; Formigli, Lucia; Zurdo, Jesus; Taddei, Niccolo; Ramponi, Giampietro; Dobson, Christopher M.; Stefani, Massimo</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">416</span>
        (<span class="NLM_cas:issue">6880</span>),
    <span class="NLM_cas:pages">507-511</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A range of human degenerative conditions, including Alzheimer's disease, light-chain amyloidosis and the spongiform encephalopathies, is assocd. with the deposition in tissue of proteinaceous aggregates known as amyloid fibrils or plaques.  It has been shown previously that fibrillar aggregates that are closely similar to those assocd. with clin. amyloidoses can be formed in vitro from proteins not connected with these diseases, including the SH3 domain from bovine phosphatidylinositol 3'-kinase and the amino-terminal domain of the Escherichia coli HypF protein.  Here we show that species formed early in the aggregation of these non-disease-assocd. proteins can be inherently highly cytotoxic.  This finding provides added evidence that avoidance of protein aggregation is crucial for the preservation of biol. function and suggests common features in the origins of this family of protein deposition diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXeFpX-dgu6bVg90H21EOLACvtfcHk0liCKr2WysWKFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivVOgtbg%253D&md5=51b2c159259afa99b6985a1d2f006ffc</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2F416507a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F416507a%26sid%3Dliteratum%253Aachs%26aulast%3DBucciantini%26aufirst%3DM.%26aulast%3DGiannoni%26aufirst%3DE.%26aulast%3DChiti%26aufirst%3DF.%26aulast%3DBaroni%26aufirst%3DF.%26aulast%3DFormigli%26aufirst%3DL.%26aulast%3DZurdo%26aufirst%3DJ.%26aulast%3DTaddei%26aufirst%3DN.%26aulast%3DRamponi%26aufirst%3DG.%26aulast%3DDobson%26aufirst%3DC.%2BM.%26aulast%3DStefani%26aufirst%3DM.%26atitle%3DInherent%2520toxicity%2520of%2520aggregates%2520implies%2520a%2520common%2520mechanism%2520for%2520protein%2520misfolding%2520diseases%26jtitle%3DNature%26date%3D2002%26volume%3D416%26spage%3D507%26epage%3D511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Kagan, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimova, R.</span><span> </span><span class="NLM_article-title">Amyloid peptide channels</span> <span class="citation_source-journal">J. Membr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1007%2Fs00232-004-0709-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15702375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivFygsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2004&pages=1-10&author=B.+L.+Kaganauthor=R.+Azimovauthor=R.+Azimova&title=Amyloid+peptide+channels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid peptide channels</span></div><div class="casAuthors">Kagan, B. L.; Azimov, R.; Azimova, R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Membrane Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">JMBBBO</span>;
        ISSN:<span class="NLM_cas:issn">0022-2631</span>.
    
            (<span class="NLM_cas:orgname">Springer Science+Business Media, Inc.</span>)
        </div><div class="casAbstract">A review.  At least 16 distinct clin. syndromes including Alzheimer's disease (AD), Parkinson's disease (PD), rheumatoid arthritis, type II diabetes mellitus (DM), and spongiform encephalopathies (prion diseases), are characterized by the deposition of amorphous, Congo red-staining deposits known as amyloid.  These "misfolded" proteins adopt β-sheet structures and aggregate spontaneously into similar extended fibrils despite their widely divergent primary sequences.  Many, if not all, of these peptides are capable of forming ion-permeable channels in vitro and possibly in vivo.  Common channel properties include irreversible, spontaneous insertion into membranes, relatively large, heterogeneous single-channel conductances, inhibition of channel formation by Congo red, and blockade of inserted channels by Zn2+.  Physiol. effects of amyloid, including Ca2+ dysregulation, membrane depolarization, mitochondrial dysfunction, inhibition of long-term potentiation (LTP), and cytotoxicity, suggest that channel formation in plasma and intracellular membranes may play a key role in the pathophysiol. of the amyloidoses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9cqx5JL33HLVg90H21EOLACvtfcHk0lgEoR5bYd2nQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivFygsw%253D%253D&md5=9d97f19b1bea9c648ee1103e72b1ea0f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs00232-004-0709-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00232-004-0709-4%26sid%3Dliteratum%253Aachs%26aulast%3DKagan%26aufirst%3DB.%2BL.%26aulast%3DAzimov%26aufirst%3DR.%26aulast%3DAzimova%26aufirst%3DR.%26atitle%3DAmyloid%2520peptide%2520channels%26jtitle%3DJ.%2520Membr.%2520Biol.%26date%3D2004%26volume%3D202%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Soto, C.</span><span> </span><span class="NLM_article-title">Unfolding the role of protein misfolding in neurodegenerative diseases</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnrn1007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=12511861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=49-60&author=C.+Soto&title=Unfolding+the+role+of+protein+misfolding+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Unfolding the role of protein misfolding in neurodegenerative diseases</span></div><div class="casAuthors">Soto, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-60</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recent evidence indicates that diverse neurodegenerative diseases might have a common cause and pathol. mechanism - the misfolding, aggregation and accumulation of proteins in the brain, resulting in neuronal apoptosis.  Studies from different disciplines strongly support this hypothesis and indicate that a common therapy for these devastating disorders might be possible.  The aim of this article is to review the literature on the mol. mechanism of protein misfolding and aggregation, its role in neurodegeneration and the potential targets for therapeutic intervention in neurodegenerative diseases.  Many questions still need to be answered and future research in this field will result in exciting new discoveries that might impact other areas of biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt-G4N2FMUNbVg90H21EOLACvtfcHk0lgEoR5bYd2nQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlY%253D&md5=08a612ce6947fd846bb0d469fa747bef</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnrn1007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1007%26sid%3Dliteratum%253Aachs%26aulast%3DSoto%26aufirst%3DC.%26atitle%3DUnfolding%2520the%2520role%2520of%2520protein%2520misfolding%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2003%26volume%3D4%26spage%3D49%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Cohen, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, J. W.</span><span> </span><span class="NLM_article-title">Therapeutic approaches to protein-misfolding diseases</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">426</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnature02265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=14685252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVGmur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2003&pages=905-909&author=F.+E.+Cohenauthor=J.+W.+Kelly&title=Therapeutic+approaches+to+protein-misfolding+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic approaches to protein-misfolding diseases</span></div><div class="casAuthors">Cohen, Fred E.; Kelly, Jeffery W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">426</span>
        (<span class="NLM_cas:issue">6968</span>),
    <span class="NLM_cas:pages">905-909</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Several sporadic and genetic diseases are caused by protein misfolding.  These include cystic fibrosis and other devastating diseases of childhood as well as Alzheimer's, Parkinson's and other debilitating maladies of the elderly.  A unified view of the mol. and cellular pathogenesis of these conditions has led to the search for chem. chaperones that can slow, arrest or revert disease progression.  Mols. are now emerging that link our biophys. insights with our therapeutic aspirations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiCHoSl7MD-7Vg90H21EOLACvtfcHk0ljfdBk0NZ1KWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVGmur8%253D&md5=0fbd2350d560f9db117e0f3c666bbcca</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature02265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02265%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DF.%2BE.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26atitle%3DTherapeutic%2520approaches%2520to%2520protein-misfolding%2520diseases%26jtitle%3DNature%26date%3D2003%26volume%3D426%26spage%3D905%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Carrell, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lomas, D. A.</span><span> </span><span class="NLM_article-title">Conformational disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2FS0140-6736%2897%2902073-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=9228977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaK2sXkvFeis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=1997&pages=134-138&author=R.+W.+Carrellauthor=D.+A.+Lomas&title=Conformational+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational disease</span></div><div class="casAuthors">Carrell, Robin W.; Lomas, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">9071</span>),
    <span class="NLM_cas:pages">134-138</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Lancet</span>)
        </div><div class="casAbstract">A review with 40 refs.  Several diverse disorders, including the prevalent dementias and encephalopathies, are now believed to arise from the same general disease mechanism.  In each, there is abnormal unfolding and then aggregation of an underlying protein.  The gradual accumulation of these aggregates and the acceleration of their formation by stress explain the characteristic late or episodic onset of the clin. disease.  The understanding of these processes at the mol. level is opening prospects of more rational approaches to investigation and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh9shwoswSerVg90H21EOLACvtfcHk0ljfdBk0NZ1KWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkvFeis7s%253D&md5=faff5df41f01cb42395ee0b3cb7402e1</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2897%2902073-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252897%252902073-4%26sid%3Dliteratum%253Aachs%26aulast%3DCarrell%26aufirst%3DR.%2BW.%26aulast%3DLomas%26aufirst%3DD.%2BA.%26atitle%3DConformational%2520disease%26jtitle%3DLancet%26date%3D1997%26volume%3D350%26spage%3D134%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Caughey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansbury, P. T.</span><span> </span><span class="NLM_article-title">Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1146%2Fannurev.neuro.26.010302.081142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=12704221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntFSisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2003&pages=267-298&author=B.+Caugheyauthor=P.+T.+Lansbury&title=Protofibrils%2C+pores%2C+fibrils%2C+and+neurodegeneration%3A+separating+the+responsible+protein+aggregates+from+the+innocent+bystanders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders</span></div><div class="casAuthors">Caughey, Byron; Lansbury, Peter T., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">267-298</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Many neurodegenerative diseases, including Alzheimer's and Parkinson's and the transmissible spongiform encephalopathies (prion diseases), are characterized at autopsy by neuronal loss and protein aggregates that are typically fibrillar.  A convergence of evidence strongly suggests that protein aggregation is neurotoxic and not a product of cell death.  However, the identity of the neurotoxic aggregate and the mechanism by which it disables and eventually kills a neuron are unknown.  Both biophys. studies aimed at elucidating the precise mechanism of in vitro aggregation and animal modeling studies support the emerging notion that an ordered prefibrillar oligomer, or protofibril, may be responsible for cell death and that the fibrillar form that is typically obsd. at autopsy may actually be neuroprotective.  A subpopulation of protofibrils may function as pathogenic amyloid pores.  An analogous mechanism may explain the neurotoxicity of the prion protein; recent data demonstrates that the disease-assocd., infectious form of the prion protein differs from the neurotoxic species.  This review focuses on recent exptl. studies aimed at identification and characterization of the neurotoxic protein aggregates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa3a9FOppAYbVg90H21EOLACvtfcHk0li_bt83-rEe2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntFSisL0%253D&md5=d48fc232b660b43c22fabe69854d06f0</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.26.010302.081142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.26.010302.081142%26sid%3Dliteratum%253Aachs%26aulast%3DCaughey%26aufirst%3DB.%26aulast%3DLansbury%26aufirst%3DP.%2BT.%26atitle%3DProtofibrils%252C%2520pores%252C%2520fibrils%252C%2520and%2520neurodegeneration%253A%2520separating%2520the%2520responsible%2520protein%2520aggregates%2520from%2520the%2520innocent%2520bystanders%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D2003%26volume%3D26%26spage%3D267%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Kagan, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimova, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M. C.</span><span> </span><span class="NLM_article-title">The channel hypothesis of Alzheimerʼs disease: current status</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1311</span><span class="NLM_x">–</span> <span class="NLM_lpage">1315</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=1311-1315&author=B.+L.+Kaganauthor=Y.+Hirakuraauthor=R.+Azimovauthor=R.+Azimovaauthor=M.+C.+Lin&title=The+channel+hypothesis+of+Alzheimer%CA%BCs+disease%3A+current+status"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKagan%26aufirst%3DB.%2BL.%26aulast%3DHirakura%26aufirst%3DY.%26aulast%3DAzimov%26aufirst%3DR.%26aulast%3DAzimova%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DM.%2BC.%26atitle%3DThe%2520channel%2520hypothesis%2520of%2520Alzheimer%25CA%25BCs%2520disease%253A%2520current%2520status%26jtitle%3DPeptides%26date%3D2002%26volume%3D23%26spage%3D1311%26epage%3D1315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Lin, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, M. F.</span><span> </span><span class="NLM_article-title">Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">443</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnature05292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17051205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyktbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=443&publication_year=2006&pages=787-795&author=M.+T.+Linauthor=M.+F.+Beal&title=Mitochondrial+dysfunction+and+oxidative+stress+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases</span></div><div class="casAuthors">Lin, Michael T.; Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">443</span>
        (<span class="NLM_cas:issue">7113</span>),
    <span class="NLM_cas:pages">787-795</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Many lines of evidence suggest that mitochondria have a central role in aging-related neurodegenerative diseases.  Mitochondria are crit. regulators of cell death, a key feature of neurodegeneration.  Mutations in mitochondrial DNA and oxidative stress both contribute to aging, which is the greatest risk factor for neurodegenerative diseases.  In all major examples of these diseases there is strong evidence that mitochondrial dysfunction occurs early and acts causally in disease pathogenesis.  Moreover, an impressive no. of disease-specific proteins interact with mitochondria.  Thus, therapies targeting basic mitochondrial processes, such as energy metab. or free-radical generation, or specific interactions of disease-related proteins with mitochondria, hold great promise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ_a_kJVRRZbVg90H21EOLACvtfcHk0li_bt83-rEe2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyktbbO&md5=f1f1e0773f62373232ff10156e630cae</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnature05292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05292%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DM.%2BT.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DMitochondrial%2520dysfunction%2520and%2520oxidative%2520stress%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNature%26date%3D2006%26volume%3D443%26spage%3D787%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Bray, T. M.</span><span> </span><span class="NLM_article-title">Antioxidants and oxidative stress in health and disease: introduction</span> <span class="citation_source-journal">Proc. Soc. Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">222</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1046%2Fj.1525-1373.1999.d01-135.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=10601877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaK1MXnvVSjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=222&publication_year=1999&pages=195&author=T.+M.+Bray&title=Antioxidants+and+oxidative+stress+in+health+and+disease%3A+introduction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidants and oxidative stress in health and disease: introduction</span></div><div class="casAuthors">Bray, Tammy M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Society for Experimental Biology and Medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">222</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">195</span>CODEN:
                <span class="NLM_cas:coden">PSEBAA</span>;
        ISSN:<span class="NLM_cas:issn">0037-9727</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science, Inc.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVQ_gu304CorVg90H21EOLACvtfcHk0li_bt83-rEe2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnvVSjtbs%253D&md5=8d3b1a0c08cc4e2558ccd073796801b6</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1046%2Fj.1525-1373.1999.d01-135.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1525-1373.1999.d01-135.x%26sid%3Dliteratum%253Aachs%26aulast%3DBray%26aufirst%3DT.%2BM.%26atitle%3DAntioxidants%2520and%2520oxidative%2520stress%2520in%2520health%2520and%2520disease%253A%2520introduction%26jtitle%3DProc.%2520Soc.%2520Exp.%2520Biol.%2520Med.%26date%3D1999%26volume%3D222%26spage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Andersen, J. K.</span><span> </span><span class="NLM_article-title">Oxidative stress in neurodegeneration: cause or consequence</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">S18</span><span class="NLM_x">–</span> <span class="NLM_lpage">S25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=S18-S25&issue=Suppl.&author=J.+K.+Andersen&title=Oxidative+stress+in+neurodegeneration%3A+cause+or+consequence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndersen%26aufirst%3DJ.%2BK.%26atitle%3DOxidative%2520stress%2520in%2520neurodegeneration%253A%2520cause%2520or%2520consequence%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26issue%3DSuppl%26spage%3DS18%26epage%3DS25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Contestabile, A.</span><span> </span><span class="NLM_article-title">Oxidative stress in neurodegeneration: mechanisms and therapeutic perspectives</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">568</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.2174%2F1568026013394723" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=11895131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3MXos1ait7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=553-568&author=A.+Contestabile&title=Oxidative+stress+in+neurodegeneration%3A+mechanisms+and+therapeutic+perspectives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress in neurodegeneration: mechanisms and therapeutic perspectives</span></div><div class="casAuthors">Contestabile, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">553-568</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Neural tissue is esp. sensitive to oxidative stress, which is considered a prominent factor in both acute and chronic neurodegenerative diseases and traumatic brain insults.  On this basis, therapeutical strategies centered on antioxidants and on drugs able to scavenge excess free radicals and to re-establish the redox equil., have been proposed for treatment of several brain pathologies.  The present paper shortly summarizes the main sources of free radical prodn. in the brain and reviews some of the recent data on mechanisms of cellular transduction through which free radicals are believed to damage cells and, eventually, to bring them to death.  Some of the most promising therapeutical perspectives for treatment of oxidative stress in neurodegeneration, are then considered.  Their choice is the result of a selection, that is unavoidably due to the enormous amt. of the literature data, based on personal evaluation as well as on the personal exptl. experience of the author.  Four main categories of possible therapeuticals are considered: inhibitors of antioxidant enzymes, endogenous antioxidants and their precursors, vitamins and related compds., other natural antioxidants from fruits and vegetables.  Some theor. and practical issues relevant to the adoption of antioxidant therapies for neurodegeneration are highlighted, with particular ref. to the fact that a basal prodn. of free radicals must be maintained in the brain due to the host of essential cellular functions subserved by them.  In this connection, it seems advisable that future antioxidant strategies for neurodegeneration are based on mixts. of agents able to modulate multiple mechanisms of free radical prodn. and scavenging, without dangerously hampering essential physiol. defense based on free radical cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp67qlqqP46orVg90H21EOLACvtfcHk0liEmS0fnDORig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXos1ait7c%253D&md5=2c612d25cb8b3b34d4c96d24a5c8b473</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F1568026013394723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026013394723%26sid%3Dliteratum%253Aachs%26aulast%3DContestabile%26aufirst%3DA.%26atitle%3DOxidative%2520stress%2520in%2520neurodegeneration%253A%2520mechanisms%2520and%2520therapeutic%2520perspectives%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2001%26volume%3D1%26spage%3D553%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Wang, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ku, M. C.</span><span> </span><span class="NLM_article-title">Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3521</span><span class="NLM_x">–</span> <span class="NLM_lpage">3533</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.2174%2F138161206778343109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17017945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVGlt7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=3521-3533&author=J.+Y.+Wangauthor=L.+L.+Wenauthor=Y.+N.+Huangauthor=Y.+T.+Chenauthor=M.+C.+Ku&title=Dual+effects+of+antioxidants+in+neurodegeneration%3A+direct+neuroprotection+against+oxidative+stress+and+indirect+protection+via+suppression+of+glia-mediated+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of gliamediated inflammation</span></div><div class="casAuthors">Wang, Jia-Yi; Wen, Li- Li; Huang, Ya-Ni; Chen, Yen-Tsun; Ku, Min-Chi</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">3521-3533</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress, in which prodn. of highly reactive oxygen species (ROS) and reactive nitrogen species (RNS) overwhelms antioxidant defenses, is a feature of many neurol. diseases and neurodegeneration.  ROS and RNS generated extracellularly and intracellularly by various processes initiate and promote neurodegeneration in CNS.  ROS and RNS can directly oxidize and damage macromols. such as DNA, proteins, and lipids, culminating in neurodegeneration in the CNS.  Neurons are most susceptible to direct oxidative injury by ROS and RNS.  ROS and RNS can also indirectly contribute to tissue damage by activating a no. of cellular pathways resulting in the expression of stress-sensitive genes and proteins to cause oxidative injury.  Moreover, oxidative stress also activates mechanisms that result in a glia-mediated inflammation that also causes secondary neuronal damage.  Assocd. with neuronal injuries caused by many CNS insults is an activation of glial cells (particularly astrocytes and microglia) at the sites of injury.  Activated glial cells are thus histopathol. hallmarks of neurodegenerative diseases.  Even though direct contact of activated glial with neurons per se may not necessarily be toxic, the immune mediators (e.g. nitric oxide and reactive oxygen species, pro-inflammatory cytokines and chemokines) released by activated glial cells are currently considered to be candidate neurotoxins.  Therefore, study of the protective role of antioxidant compds. on inhibition of the inflammatory response and correcting the fundamental oxidant/antioxidant imbalance in patients suffering from neurodegenerative diseases are important vistas for further research.  The purpose of this review is to summarize the current evidence in support of this crit. role played by oxidative stress of neuronal and glial origin in neurodegenerative diseases.  The mechanistic basis of the neuroprotective activity of antioxidants does not only rely on the general free radical trapping or antioxidant activity per se in neurons, but also the suppression of genes induced by pro-inflammatory cytokines and other mediators released by glial cells.  We propose that combinations of agents which act at sequential steps in the neurodegenerative process can produce additive neuroprotective effects.  A cocktail of multiple antioxidants with anti-inflammatory agents may be more beneficial in the prevention of neurodegenerative disease.  A clearer appreciation of the potential therapeutic utility of antioxidants would emerge only when the complexity of their effects on mechanisms that interact to det. the extent of oxidative damage in vivo are more fully defined and understood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqa4hpnzSYYJbVg90H21EOLACvtfcHk0liEmS0fnDORig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVGlt7zO&md5=2cff0185e16bec5d6a249a77f3f0247a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F138161206778343109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206778343109%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BY.%26aulast%3DWen%26aufirst%3DL.%2BL.%26aulast%3DHuang%26aufirst%3DY.%2BN.%26aulast%3DChen%26aufirst%3DY.%2BT.%26aulast%3DKu%26aufirst%3DM.%2BC.%26atitle%3DDual%2520effects%2520of%2520antioxidants%2520in%2520neurodegeneration%253A%2520direct%2520neuroprotection%2520against%2520oxidative%2520stress%2520and%2520indirect%2520protection%2520via%2520suppression%2520of%2520glia-mediated%2520inflammation%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D3521%26epage%3D3533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Doraiswamy, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finefrock, A. E.</span><span> </span><span class="NLM_article-title">Metals in our minds: therapeutic implications for neurodegenerative disorders</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2FS1474-4422%2804%2900809-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15207800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVOmt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=431-434&author=P.+M.+Doraiswamyauthor=A.+E.+Finefrock&title=Metals+in+our+minds%3A+therapeutic+implications+for+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Metals in our minds: therapeutic implications for neurodegenerative disorders</span></div><div class="casAuthors">Doraiswamy, P. Murali; Finefrock, Anne E.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">431-434</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Lancet Neurology</span>)
        </div><div class="casAbstract">A review.  Abnormal interactions of copper or iron in the brain with metal-binding proteins (such as amyloid-β peptide [Aβ] or neuromelanin) that lead to oxidative stress have emerged as important potential mechanisms in brain ageing and neurodegenerative disorders.  Although a controlled study of desferrioxamine in Alzheimer's disease (AD) had some promising results, concerns about toxicity and brain delivery have limited trials of traditional chelators.  The therapeutic significance of metal dysregulation in neurodegenerative disorders has remained difficult to test.  Clioquinol was identified as a prototype metal-protein-attenuating compd. (MPAC).  In a blinded and controlled 9 wk study of a mouse model of AD, oral clioquinol decreased brain Aβ by 49% without systemic toxicity.  The concns. of copper and zinc in the brain rose by about 15% in mice treated with clioquinol.  Two other studies in mice showed that the raising of brain copper concns. through diet or genetics could lower amyloid load and increase survival.  A recent placebo-controlled trial in 36 patients with AD showed that clioquinol (250-750 mg daily) reduced plasma concns. of Aβ1-42, raised plasma concns. of zinc, and-in a subset with moderate dementia-slowed cognitive decline over 24 wk.  Two recent expts. also showed the neuroprotective effects of iron chelation in a mouse model of Parkinson's disease.  The exptl. and transgenic-animal studies of metal-protein interactions are convincing but do not provide conclusive answers either about causality or whether this strategy will protect against neurodegeneration in human beings.  The finding that clioquinol could modulate plasma concns. of amyloid and cognition in patients with AD needs to be interpreted cautiously, but is an important first step.  Clioquinol was withdrawn because of concerns of its assocn. with subacute myelo-optic neuropathy in Japan; therefore, any addnl. studies with this drug will likely be small and closely monitored proof-of-concept studies.  The development of optimal second-generation MPACs is a desirable goal and may permit greater insights into the significance of metal-protein interactions across several neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4nb8v83ZKXbVg90H21EOLACvtfcHk0liEmS0fnDORig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVOmt7w%253D&md5=fbec7c10a8275304aba421710fbd3d83</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2804%2900809-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252804%252900809-9%26sid%3Dliteratum%253Aachs%26aulast%3DDoraiswamy%26aufirst%3DP.%2BM.%26aulast%3DFinefrock%26aufirst%3DA.%2BE.%26atitle%3DMetals%2520in%2520our%2520minds%253A%2520therapeutic%2520implications%2520for%2520neurodegenerative%2520disorders%26jtitle%3DLancet%2520Neurol.%26date%3D2004%26volume%3D3%26spage%3D431%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Gaeta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hider, R. C.</span><span> </span><span class="NLM_article-title">The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">146</span><span class="NLM_x">, </span> <span class="NLM_fpage">1041</span><span class="NLM_x">–</span> <span class="NLM_lpage">1059</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fsj.bjp.0706416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16205720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht12ltrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2005&pages=1041-1059&author=A.+Gaetaauthor=R.+C.+Hider&title=The+crucial+role+of+metal+ions+in+neurodegeneration%3A+the+basis+for+a+promising+therapeutic+strategy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy</span></div><div class="casAuthors">Gaeta, Alessandra; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1041-1059</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The variety of factors and events involved in neurodegeneration renders the subject a major challenge.  Neurodegenerative disorders include a no. of different pathol. conditions, which share similar crit. metabolic processes, such as protein aggregation and oxidative stress, both of which are assocd. with the involvement of metal ions.  In this review, Alzheimer's disease, Parkinson's disease and prion disease are discussed, with the aim of identifying common trends underlying these devastating neurol. conditions.  Chelation therapy could be a valuable therapeutic approach, since metals are considered to be a pharmacol. target for the rationale design of new therapeutic agents directed towards the treatment of neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAwJWM3yTd87Vg90H21EOLACvtfcHk0lgVuL1wzrY66w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht12ltrvJ&md5=2a2e568a5940601f6a6f6f6aa5f5a1ac</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706416%26sid%3Dliteratum%253Aachs%26aulast%3DGaeta%26aufirst%3DA.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DThe%2520crucial%2520role%2520of%2520metal%2520ions%2520in%2520neurodegeneration%253A%2520the%2520basis%2520for%2520a%2520promising%2520therapeutic%2520strategy%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D146%26spage%3D1041%26epage%3D1059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Zeevalk, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gluck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrhart, J.</span><span> </span><span class="NLM_article-title">Mitochondrial inhibition and oxidative stress: reciprocating players in neurodegeneration</span> <span class="citation_source-journal">Antioxid. Redox Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1089%2Fars.2005.7.1117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16115016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXos1eqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=1117-1139&author=G.+D.+Zeevalkauthor=L.+P.+Bernardauthor=C.+Songauthor=M.+Gluckauthor=J.+Ehrhart&title=Mitochondrial+inhibition+and+oxidative+stress%3A+reciprocating+players+in+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial Inhibition and Oxidative Stress: Reciprocating Players in Neurodegeneration</span></div><div class="casAuthors">Zeevalk, G. D.; Bernard, L. P.; Song, C.; Gluck, M.; Ehrhart, J.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9 & 10</span>),
    <span class="NLM_cas:pages">1117-1139</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Although the etiol. for many neurodegenerative diseases is unknown, the common findings of mitochondrial defects and oxidative damage posit these events as contributing factors.  The temporal conundrum of whether mitochondrial defects lead to enhanced reactive oxygen species generation, or conversely, if oxidative stress is the underlying cause of the mitochondrial defects remains enigmatic.  This review focuses on evidence to show that either event can lead to the evolution of the other with subsequent neuronal cell loss.  Glutathione is a major antioxidant system used by cells and mitochondria for protection and is altered in a no. of neurodegenerative and neuropathol. conditions.  This review also addresses the multiple roles for glutathione during mitochondrial inhibition or oxidative stress.  Protein aggregation and inclusions are hallmarks of a no. of neurodegenerative diseases.  Recent evidence that links protein aggregation to oxidative stress and mitochondrial dysfunction will also be examd.  Lastly, current therapies that target mitochondrial dysfunction or oxidative stress are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnTR7Sks_ifrVg90H21EOLACvtfcHk0lgVuL1wzrY66w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXos1eqsL8%253D&md5=9e2b9466bc8a663620a6fb45fcb17d40</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1089%2Fars.2005.7.1117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2005.7.1117%26sid%3Dliteratum%253Aachs%26aulast%3DZeevalk%26aufirst%3DG.%2BD.%26aulast%3DBernard%26aufirst%3DL.%2BP.%26aulast%3DSong%26aufirst%3DC.%26aulast%3DGluck%26aufirst%3DM.%26aulast%3DEhrhart%26aufirst%3DJ.%26atitle%3DMitochondrial%2520inhibition%2520and%2520oxidative%2520stress%253A%2520reciprocating%2520players%2520in%2520neurodegeneration%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2005%26volume%3D7%26spage%3D1117%26epage%3D1139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Coppede, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancuso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siciliano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliore, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murri, L.</span><span> </span><span class="NLM_article-title">Genes and the environment in neurodegeneration</span> <span class="citation_source-journal">Biosci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1007%2Fs10540-006-9028-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17029001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFyltLnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=341-367&author=F.+Coppedeauthor=M.+Mancusoauthor=G.+Sicilianoauthor=L.+Miglioreauthor=L.+Murri&title=Genes+and+the+environment+in+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Genes and the environment in neurodegeneration</span></div><div class="casAuthors">Coppede, Fabio; Mancuso, Michelangelo; Siciliano, Gabriele; Migliore, Lucia; Murri, Luigi</div><div class="citationInfo"><span class="NLM_cas:title">Bioscience Reports</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">341-367</span>CODEN:
                <span class="NLM_cas:coden">BRPTDT</span>;
        ISSN:<span class="NLM_cas:issn">0144-8463</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative diseases are a heterogeneous group of pathologies which includes complex multifactorial diseases, monogenic disorders and disorders for which inherited, sporadic and transmissible forms are known.  Factors assocd. with predisposition and vulnerability to neurodegenerative disorders may be described usefully within the context of gene-environment interplay.  There are many identified genetic determinants for neurodegeneration, and it is possible to duplicate many elements of recognized human neurodegenerative disorders in animal models of the disease.  However, there are similarly several identifiable environmental influences on outcomes of the genetic defects; and the course of a progressive neurodegenerative disorder can be greatly modified by environmental elements.  In this review we highlight some of the major neurodegenerative disorders (Alzheimer's disease, Parkinson's disease, Amyotrophic lateral sclerosis, Huntington's disease, and prion diseases.) and discuss possible links of gene-environment interplay including, where implicated, mitochondrial genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZBK_hkd2RNrVg90H21EOLACvtfcHk0lgVuL1wzrY66w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFyltLnF&md5=8a67b663438ca4411264bfc5a7e4c971</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs10540-006-9028-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10540-006-9028-6%26sid%3Dliteratum%253Aachs%26aulast%3DCoppede%26aufirst%3DF.%26aulast%3DMancuso%26aufirst%3DM.%26aulast%3DSiciliano%26aufirst%3DG.%26aulast%3DMigliore%26aufirst%3DL.%26aulast%3DMurri%26aufirst%3DL.%26atitle%3DGenes%2520and%2520the%2520environment%2520in%2520neurodegeneration%26jtitle%3DBiosci.%2520Rep.%26date%3D2006%26volume%3D26%26spage%3D341%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Danial, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korsmeyer, S. J.</span><span> </span><span class="NLM_article-title">Cell death: critical control points</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2FS0092-8674%2804%2900046-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=14744432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtValsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2004&pages=205-219&author=N.+N.+Danialauthor=S.+J.+Korsmeyer&title=Cell+death%3A+critical+control+points"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Cell death: Critical control points</span></div><div class="casAuthors">Danial, Nika N.; Korsmeyer, Stanley J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-219</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review and discussion.  Programmed cell death (apoptosis) is a distinct genetic and biochem. pathway essential to metazoans.  An intact death pathway is required for successful embryonic development and the maintenance of normal tissue homeostasis.  Apoptosis has proven to be tightly interwoven with other essential cell pathways.  The identification of crit. control points in the cell death pathway has yielded fundamental insights for basic biol., as well as provided rational targets for new therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfuRt2EjV6WLVg90H21EOLACvtfcHk0lg1k947o3Q7dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtValsrY%253D&md5=de853177ac091305b7f237e58108f579</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2804%2900046-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252804%252900046-7%26sid%3Dliteratum%253Aachs%26aulast%3DDanial%26aufirst%3DN.%2BN.%26aulast%3DKorsmeyer%26aufirst%3DS.%2BJ.%26atitle%3DCell%2520death%253A%2520critical%2520control%2520points%26jtitle%3DCell%26date%3D2004%26volume%3D116%26spage%3D205%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Mi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, G. V.</span><span> </span><span class="NLM_article-title">The role of tau phosphorylation in the pathogenesis of Alzheimerʼs disease</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">449</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.2174%2F156720506779025279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17168644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWksbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=449-463&author=K.+Miauthor=G.+V.+Johnson&title=The+role+of+tau+phosphorylation+in+the+pathogenesis+of+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The role of tau phosphorylation in the pathogenesis of Alzheimer's disease</span></div><div class="casAuthors">Mi, Kaihong; Johnson, Gail V. W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">449-463</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The microtubule-assocd. protein tau, which is abundantly expressed in neurons, is deposited in cells in an abnormally phosphorylated state as fibrillar lesions in numerous neurodegenerative diseases, with the most notable being Alzheimer's disease.  Tau plays a crucial role in the neuron as it binds and stabilizes microtubules, and can regulate axonal transport; functions that are regulated by site-specific phosphorylation events.  In pathol. conditions such as Alzheimer's disease and other tauopathies, tau is abnormally phosphorylated, and that this contributes to its dysfunction.  Given the increasing evidence that a disruption in the normal phosphorylation state of tau followed by conformational changes plays a key role in the pathogenic events that occur in Alzheimer's disease and other tauopathies; it is crit. to elucidate the regulation of tau phosphorylation.  This review focuses on recent literature pertaining to the regulation of tau phosphorylation and function, and the role that a dysregulation of tau phosphorylation may play in the neuronal dysfunction in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_9dvtaMDpfbVg90H21EOLACvtfcHk0lg1k947o3Q7dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWksbrM&md5=1e0ea8f6bceba1b430a44392ceb34181</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2174%2F156720506779025279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720506779025279%26sid%3Dliteratum%253Aachs%26aulast%3DMi%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DG.%2BV.%26atitle%3DThe%2520role%2520of%2520tau%2520phosphorylation%2520in%2520the%2520pathogenesis%2520of%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2006%26volume%3D3%26spage%3D449%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Saito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawashima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruberu, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawabe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanouchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murayama, S.</span><span> </span><span class="NLM_article-title">Accumulation of phosphorylated alpha-synuclein in aging human brain</span> <span class="citation_source-journal">J. Neuropathol. Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">644</span><span class="NLM_x">–</span> <span class="NLM_lpage">654</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=12834109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlt1yqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2003&pages=644-654&author=Y.+Saitoauthor=A.+Kawashimaauthor=N.+N.+Ruberuauthor=H.+Fujiwaraauthor=S.+Koyamaauthor=M.+Sawabeauthor=T.+Araiauthor=H.+Naguraauthor=H.+Yamanouchiauthor=M.+Hasegawaauthor=T.+Iwatsuboauthor=S.+Murayama&title=Accumulation+of+phosphorylated+alpha-synuclein+in+aging+human+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Accumulation of phosphorylated α-synuclein in aging human brain</span></div><div class="casAuthors">Saito, Yuko; Kawashima, Akiko; Ruberu, Nyoka N.; Fujiwara, Hideo; Koyama, Shunichi; Sawabe, Motoji; Arai, Tomio; Nagura, Hiroshi; Yamanouchi, Hiroshi; Hasegawa, Masato; Iwatsubo, Takeshi; Murayama, Shigeo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuropathology and Experimental Neurology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">644-654</span>CODEN:
                <span class="NLM_cas:coden">JNENAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    
            (<span class="NLM_cas:orgname">American Association of Neuropathologists, Inc.</span>)
        </div><div class="casAbstract">α-Synuclein in Lewy bodies (LBs) is phosphorylated at Ser129.  The authors raised monoclonal and polyclonal antibodies to this phosphorylation site (psyn) and examd. 157 serial autopsy brains from a geriatric hospital.  Anti-psyn immunoreactivity was obsd. in 40 of these cases (25.5%).  Immunohistochem. revealed 4 novel types of pathol.: diffuse neuronal cytoplasmic staining (pre-LB); neuropil thread-like structures (Lewy threads); dot-like structures similar to argyrophilic grains (Lewy dots); and axons in the white matter (Lewy axons).  This novel pathol. was abundantly present around LBs and also involved the limbic subcortical white matter, the cerebral cortical mol. layer, and the spongiform changes of the medial temporal lobe assocd. with cases of dementia with LBs (DLB).  The phosphorylated α-synuclein was limited to the temporal lobe in cases of Parkinson disease, spread from the temporal lobe to the frontal lobe in cases of DLB transitional form and further spread to the parietal and occipital lobes in DLB neocortical form.  These findings suggest that LB-related pathol. initially involves the neuronal perikarya, dendrites and axons, causes impairment of axonal transport and synaptic transmission, and later leads to the formation of LBs, a hallmark of functional disturbance long before neuronal cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMmJmRmpThZbVg90H21EOLACvtfcHk0lg1k947o3Q7dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlt1yqu78%253D&md5=54a0ac3adcda371512d36ae45629deec</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DY.%26aulast%3DKawashima%26aufirst%3DA.%26aulast%3DRuberu%26aufirst%3DN.%2BN.%26aulast%3DFujiwara%26aufirst%3DH.%26aulast%3DKoyama%26aufirst%3DS.%26aulast%3DSawabe%26aufirst%3DM.%26aulast%3DArai%26aufirst%3DT.%26aulast%3DNagura%26aufirst%3DH.%26aulast%3DYamanouchi%26aufirst%3DH.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DMurayama%26aufirst%3DS.%26atitle%3DAccumulation%2520of%2520phosphorylated%2520alpha-synuclein%2520in%2520aging%2520human%2520brain%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D2003%26volume%3D62%26spage%3D644%26epage%3D654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Strong, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesavapany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pant, H. C.</span><span> </span><span class="NLM_article-title">The pathobiology of amyotrophic lateral sclerosis: a proteinopathy</span> <span class="citation_source-journal">J. Neuropathol. Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">649</span><span class="NLM_x">–</span> <span class="NLM_lpage">664</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1097%2F01.jnen.0000173889.71434.ea" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16106213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVemsL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2005&pages=649-664&author=M.+J.+Strongauthor=S.+Kesavapanyauthor=H.+C.+Pant&title=The+pathobiology+of+amyotrophic+lateral+sclerosis%3A+a+proteinopathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The pathobiology of amyotrophic lateral sclerosis: a proteinopathy?</span></div><div class="casAuthors">Strong, Michael J.; Kesavapany, Sashi; Pant, Harish C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuropathology & Experimental Neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">649-664</span>CODEN:
                <span class="NLM_cas:coden">JNENAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Amyotrophic lateral sclerosis (ALS) is increasingly considered to be a disorder of multiple etiologies that have in common progressive degeneration of both upper and lower motor neurons, ultimately giving rise to a relentless loss of muscle function.  This progressive degeneration is assocd. with heightened levels of oxidative injury, excitotoxicity, and mitochondrial dysfunction-all occurring concurrently.  In this article, we review the evidence that suggests, in common with other age-dependent neurodegenerative disorders, that ALS can be considered a disorder of protein aggregation.  Morphol., this is evident as Bunina bodies, ubiquitin-immunoreactive fibrils or aggregates, neurofilamentous aggregates, mutant copper/zinc superoxide dismutase (SOD1) aggregates in familial ALS variants harboring mutations in SOD1, peripherin-immunoreactive aggregates within spinal motor neurons and as neuroaxonal spheroids, and in an increasingly greater population of patients with ALS with cognitive impairment, both intra- and extraneuronal tau aggregates.  We review the evidence that somatotopically specific patterns of altered kinase and phosphatase activity are assocd. with alterations in the phosphorylation state of these proteins, altering either soly. or assembly characteristics.  The role of nonneuronal cells in mediating motor neuronal injury is discussed in the context of alterations in tyrosine kinase activity and enhanced protein phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWAmzTh9eWX7Vg90H21EOLACvtfcHk0ljBJp3XZqjA6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVemsL3K&md5=af483a63c7b9cadd240094ad93eea93e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1097%2F01.jnen.0000173889.71434.ea&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.jnen.0000173889.71434.ea%26sid%3Dliteratum%253Aachs%26aulast%3DStrong%26aufirst%3DM.%2BJ.%26aulast%3DKesavapany%26aufirst%3DS.%26aulast%3DPant%26aufirst%3DH.%2BC.%26atitle%3DThe%2520pathobiology%2520of%2520amyotrophic%2520lateral%2520sclerosis%253A%2520a%2520proteinopathy%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D2005%26volume%3D64%26spage%3D649%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Lievens, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, G. P.</span><span> </span><span class="NLM_article-title">Abnormal phosphorylation of synapsin I predicts a neuronal transmission impairment in the R6/2 Huntingtonʼs disease transgenic mice</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">638</span><span class="NLM_x">–</span> <span class="NLM_lpage">648</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1006%2Fmcne.2002.1152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=12213445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsV2lu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2002&pages=638-648&author=J.+C.+Lievensauthor=B.+Woodmanauthor=A.+Mahalauthor=G.+P.+Bates&title=Abnormal+phosphorylation+of+synapsin+I+predicts+a+neuronal+transmission+impairment+in+the+R6%2F2+Huntington%CA%BCs+disease+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Abnormal Phosphorylation of Synapsin I Predicts a Neuronal Transmission Impairment in the R6/2 Huntington's Disease Transgenic Mice</span></div><div class="casAuthors">Lievens, Jean-Charles; Woodman, Benjamin; Mahal, Amarbirpal; Bates, Gillian P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">638-648</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Motor and cognitive deficits in Huntington's disease (HD) are likely caused by progressive neuronal dysfunction preceding neuronal cell death.  Synapsin I is one of the major phosphoproteins regulating neurotransmitter release.  The authors report here an abnormal phosphorylation state of synapsin I in the striatum and the cerebral cortex of R6/2 transgenic mice expressing the HD mutation.  These changes are mostly characterized by an early overphosphorylation at sites 3-5, whereas phosphorylation at site 1 remains unchanged and at site 6 becomes reduced only close to the end stage of the disease.  Such changes do not result from modification in protein expression levels.  However, we show a decreased expression of the calcineurin regulatory subunit-B, which may contribute to an imbalance between kinase and phosphatase activities.  Together the results suggest that an early impairment in synapsin phosphorylation-dephosphorylation may alter synaptic vesicle trafficking and lead to defective neurotransmission in HD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO9WE5VDCzMrVg90H21EOLACvtfcHk0ljBJp3XZqjA6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsV2lu7c%253D&md5=df6d35da491eff4cf40ec8611e3f55eb</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1006%2Fmcne.2002.1152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.2002.1152%26sid%3Dliteratum%253Aachs%26aulast%3DLievens%26aufirst%3DJ.%2BC.%26aulast%3DWoodman%26aufirst%3DB.%26aulast%3DMahal%26aufirst%3DA.%26aulast%3DBates%26aufirst%3DG.%2BP.%26atitle%3DAbnormal%2520phosphorylation%2520of%2520synapsin%2520I%2520predicts%2520a%2520neuronal%2520transmission%2520impairment%2520in%2520the%2520R6%252F2%2520Huntington%25CA%25BCs%2520disease%2520transgenic%2520mice%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2002%26volume%3D20%26spage%3D638%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J. P.</span><span> </span><span class="NLM_article-title">Can we rationally design promiscuous drugs?</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.sbi.2006.01.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16442279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFOjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=127-136&author=A.+L.+Hopkinsauthor=J.+S.+Masonauthor=J.+P.+Overington&title=Can+we+rationally+design+promiscuous+drugs%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Can we rationally design promiscuous drugs?</span></div><div class="casAuthors">Hopkins, Andrew L.; Mason, Jonathan S.; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-136</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Structure-based drug design is now used widely in modern medicinal chem.  The application of structural biol. to medicinal chem. has heralded the 'rational drug design' vision of discovering exquisitely selective ligands.  However, recent advances in post-genomic biol. are indicating that polypharmacol. may be a necessary trait for the efficacy of many drugs, therefore questioning the 'one drug, one target' assumption of current rational drug design.  By combining advances in chemoinformatics and structural biol., it might be possible to rationally design the next generation of promiscuous drugs with polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQWdh60x9AHrVg90H21EOLACvtfcHk0li7jAy1Lk3qJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFOjsrc%253D&md5=8f9e95a41976b8e3ac790f2fff2c406f</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2006.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2006.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DCan%2520we%2520rationally%2520design%2520promiscuous%2520drugs%253F%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2006%26volume%3D16%26spage%3D127%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Mount, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downton, C.</span><span> </span><span class="NLM_article-title">Alzheimer disease: progress or profit</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">780</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnm0706-780" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16829947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1eks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=780-784&author=C.+Mountauthor=C.+Downton&title=Alzheimer+disease%3A+progress+or+profit"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer disease: progress or profit?</span></div><div class="casAuthors">Mount, Claire; Downton, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">780-784</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp458aEz9g7-rVg90H21EOLACvtfcHk0li7jAy1Lk3qJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1eks7s%253D&md5=53e9af938ef93beee99bc9a7feb7eeea</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnm0706-780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0706-780%26sid%3Dliteratum%253Aachs%26aulast%3DMount%26aufirst%3DC.%26aulast%3DDownton%26aufirst%3DC.%26atitle%3DAlzheimer%2520disease%253A%2520progress%2520or%2520profit%26jtitle%3DNat.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D780%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Melnikova, I.</span><span> </span><span class="NLM_article-title">Therapies for Alzheimerʼs disease</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=341-342&author=I.+Melnikova&title=Therapies+for+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMelnikova%26aufirst%3DI.%26atitle%3DTherapies%2520for%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D341%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Alzheimer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stelzmann, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnitzlein, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murtagh, F. R.</span><span> </span><span class="NLM_article-title">An English translation of Alzheimerʼs 1907 paper, “Uber eine eigenartige Erkankung der Hirnrinde”</span> <span class="citation_source-journal">Clin. Anat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fca.980080612" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=8713166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADyaK28zkvVWktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1995&pages=429-431&author=A.+Alzheimerauthor=R.+A.+Stelzmannauthor=H.+N.+Schnitzleinauthor=F.+R.+Murtagh&title=An+English+translation+of+Alzheimer%CA%BCs+1907+paper%2C+%E2%80%9CUber+eine+eigenartige+Erkankung+der+Hirnrinde%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde"</span></div><div class="casAuthors">Alzheimer A; Stelzmann R A; Schnitzlein H N; Murtagh F R</div><div class="citationInfo"><span class="NLM_cas:title">Clinical anatomy (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">429-31</span>
        ISSN:<span class="NLM_cas:issn">0897-3806</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcScU3l9NPx0TrjnyZkbE8yXfW6udTcc2ebzUSxr7O-Phrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28zkvVWktg%253D%253D&md5=0bb8ce0dabc45d35e51a22636756708c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fca.980080612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fca.980080612%26sid%3Dliteratum%253Aachs%26aulast%3DAlzheimer%26aufirst%3DA.%26aulast%3DStelzmann%26aufirst%3DR.%2BA.%26aulast%3DSchnitzlein%26aufirst%3DH.%2BN.%26aulast%3DMurtagh%26aufirst%3DF.%2BR.%26atitle%3DAn%2520English%2520translation%2520of%2520Alzheimer%25CA%25BCs%25201907%2520paper%252C%2520%25E2%2580%259CUber%2520eine%2520eigenartige%2520Erkankung%2520der%2520Hirnrinde%25E2%2580%259D%26jtitle%3DClin.%2520Anat.%26date%3D1995%26volume%3D8%26spage%3D429%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Bartus, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. L.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippa, A. S.</span><span> </span><span class="NLM_article-title">The cholinergic hypothesis of geriatric memory dysfunction</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">217</span><span class="NLM_x">, </span> <span class="NLM_fpage">408</span><span class="NLM_x">–</span> <span class="NLM_lpage">414</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1126%2Fscience.7046051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=7046051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaL38XkslShur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=217&publication_year=1982&pages=408-414&author=R.+T.+Bartusauthor=R.+L.+Deanauthor=B.+Beerauthor=A.+S.+Lippa&title=The+cholinergic+hypothesis+of+geriatric+memory+dysfunction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The cholinergic hypothesis of geriatric memory dysfunction</span></div><div class="casAuthors">Bartus, Raymond T.; Dean, Reginald L., III; Beer, Bernard; Lippa, Arnold S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">217</span>
        (<span class="NLM_cas:issue">4558</span>),
    <span class="NLM_cas:pages">408-17</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 93 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC5hLTTFFYoLVg90H21EOLACvtfcHk0ljqZ8Xz14AdCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XkslShur4%253D&md5=ff0661ed096b9cb45406dd159c88e15e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1126%2Fscience.7046051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.7046051%26sid%3Dliteratum%253Aachs%26aulast%3DBartus%26aufirst%3DR.%2BT.%26aulast%3DDean%26aufirst%3DR.%2BL.%26aulast%3DBeer%26aufirst%3DB.%26aulast%3DLippa%26aufirst%3DA.%2BS.%26atitle%3DThe%2520cholinergic%2520hypothesis%2520of%2520geriatric%2520memory%2520dysfunction%26jtitle%3DScience%26date%3D1982%26volume%3D217%26spage%3D408%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Sivaprakasam, K.</span><span> </span><span class="NLM_article-title">Towards a unifying hypothesis of Alzheimerʼs disease: cholinergic system linked to plaques, tangles and neuroinflammation</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2179</span><span class="NLM_x">–</span> <span class="NLM_lpage">2188</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.2174%2F092986706777935203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16918347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XnslOks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=2179-2188&author=K.+Sivaprakasam&title=Towards+a+unifying+hypothesis+of+Alzheimer%CA%BCs+disease%3A+cholinergic+system+linked+to+plaques%2C+tangles+and+neuroinflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Towards a unifying hypothesis of Alzheimer's disease: cholinergic system linked to plaques, tangles and neuroinflammation</span></div><div class="casAuthors">Sivaprakasam, Kannan</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2179-2188</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The central role of cholinergic system in Alzheimer's disease (AD) pathway is becoming increasingly significant as reports linking the various components of cholinergic neurotransmission with the other pathol. hallmarks emerge.  This review, while addressing the mol. mechanisms assocd. with the pathol. hallmarks of the disease and their close interactions, also makes an attempt to address the crit. question that evades an answer: Given the significant role played by cholinergic system in AD pathway, why do the cholinergic-mechanism-based drugs are not successful in reversing or arresting the disease progress.  Further, as mols. of diverse structural features were shown to inhibit amyloid aggregation, an understanding of the generic pathway of amyloid aggregation slowly emerges.  For the first time, a coherent view of amyloid aggregation is presented in this review.  The possible role of neuroinflammatory response in the events leading to the degeneration of cholinergic neurons is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBXh8g6TaBN7Vg90H21EOLACvtfcHk0lhV6Xqz0xPQXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnslOks7w%253D&md5=b56fac0776c02f3a8aa9c37a974f88dd</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.2174%2F092986706777935203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706777935203%26sid%3Dliteratum%253Aachs%26aulast%3DSivaprakasam%26aufirst%3DK.%26atitle%3DTowards%2520a%2520unifying%2520hypothesis%2520of%2520Alzheimer%25CA%25BCs%2520disease%253A%2520cholinergic%2520system%2520linked%2520to%2520plaques%252C%2520tangles%2520and%2520neuroinflammation%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D2179%26epage%3D2188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Kennedy, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tariot, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, J. L.</span><span> </span><span class="NLM_article-title">Amyloid-based interventions in Alzheimerʼs disease</span> <span class="citation_source-journal">CNS Spectrums</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=1-14&author=G.+J.+Kennedyauthor=T.+E.+Goldeauthor=P.+N.+Tariotauthor=J.+L.+Cummings&title=Amyloid-based+interventions+in+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DG.%2BJ.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DTariot%26aufirst%3DP.%2BN.%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26atitle%3DAmyloid-based%2520interventions%2520in%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DCNS%2520Spectrums%26date%3D2007%26volume%3D12%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Tang, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liou, Y. C.</span><span> </span><span class="NLM_article-title">Novel modulators of amyloid-beta precursor protein processing</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1111%2Fj.1471-4159.2006.04215.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17241154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFaksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2007&pages=314-323&author=B.+L.+Tangauthor=Y.+C.+Liou&title=Novel+modulators+of+amyloid-beta+precursor+protein+processing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Novel modulators of amyloid-β precursor protein processing</span></div><div class="casAuthors">Tang, Bor Luen; Liou, Yih Cherng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">314-323</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Proteolytic processing of the amyloid precursor protein (APP) is modulated by the action of enzymes α-, β- and γ-secretases, with the latter two mediating the amyloidogenic prodn. of amyloid-β (Aβ).  Cellular modulators of APP processing are well known from studies of genetic mutations (such as those found in APP and presenilins) or polymorphisms (such as the apolipoprotein E4 ε-allele) that predisposes an individual to early or late-onset Alzheimer's disease.  In recent years, several classes of mol. with modulating functions in APP processing and Aβ secretion have emerged.  These include the neuronal Munc-18 interacting proteins (Mints)/X11s, members of the reticulon family (RTN-3 and RTN-4/Nogo-B), the Nogo-66 receptor (NgR), the peptidylprolyl isomerase Pin1 and the Rho family GTPases and their effectors.  Mints and NgR bind to APP directly, while RTN3 and Nogo-B interact with the β-secretase BACE1.  Phosphorylated APP is a Pin1 substrate, which binds to its phosphor-Thr668-Pro motif.  These interactions by and large resulted in a redn. of Aβ generation both in vitro and in vivo.  Inhibition of Rho and Rho-kinase (ROCK) activity may underlie the ability of non-steroidal anti-inflammatory drugs and statins to reduce Aβ prodn., a feat which could also be achieved by Rac1 inhibition.  Detailed understanding of the underlying mechanisms of action of these novel modulators of APP processing, as well as insights into the mol. neurol. basis of how Aβ impairs learning and memory, will open up multiple avenues for the therapeutic intervention of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonb01iQcoPn7Vg90H21EOLACvtfcHk0lhV6Xqz0xPQXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFaksrY%253D&md5=ea726b131480814b85cbfc9ddfa86cce</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04215.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04215.x%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DB.%2BL.%26aulast%3DLiou%26aufirst%3DY.%2BC.%26atitle%3DNovel%2520modulators%2520of%2520amyloid-beta%2520precursor%2520protein%2520processing%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D100%26spage%3D314%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Lundkvist, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naslund, J.</span><span> </span><span class="NLM_article-title">Gamma-secretase: a complex target for Alzheimerʼs disease</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.coph.2006.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17169612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntlGisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=112-118&author=J.+Lundkvistauthor=J.+Naslund&title=Gamma-secretase%3A+a+complex+target+for+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase: a complex target for Alzheimer's disease</span></div><div class="casAuthors">Lundkvist, Johan; Naeslund, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-118</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Data accumulated during the past two decades place amyloid β-peptide (Aβ) at center stage as the main perpetrator in initiating the pathol. cascade that eventually leads to Alzheimer's disease.  Consequently, significant resources have been allocated to identify and develop treatment strategies that alter the metab. of Aβ.  The γ-secretase protease has deservedly received attention as an attractive drug target, as it is directly involved in Aβ biogenesis and dets. the pathogenic potential of Aβ by its heterogeneous catalytic action, generating peptides of various lengths.  Despite the complexity of the multi-subunit γ-secretase and the lack of structural information, drug discovery research has identified small-mol. compds. that inhibit or modulate activity of this enzyme and some of these have already entered clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmYpXv1AqDXbVg90H21EOLACvtfcHk0lg8fADeFMOLCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntlGisg%253D%253D&md5=98007a90520f378003e9fa904cd2c5f1</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2006.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2006.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DLundkvist%26aufirst%3DJ.%26aulast%3DNaslund%26aufirst%3DJ.%26atitle%3DGamma-secretase%253A%2520a%2520complex%2520target%2520for%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2007%26volume%3D7%26spage%3D112%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertram, L.</span><span> </span><span class="NLM_article-title">Twenty years of the Alzheimerʼs disease amyloid hypothesis: a genetic perspective</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2005&pages=545-555&author=R.+E.+Tanziauthor=L.+Bertram&title=Twenty+years+of+the+Alzheimer%CA%BCs+disease+amyloid+hypothesis%3A+a+genetic+perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DBertram%26aufirst%3DL.%26atitle%3DTwenty%2520years%2520of%2520the%2520Alzheimer%25CA%25BCs%2520disease%2520amyloid%2520hypothesis%253A%2520a%2520genetic%2520perspective%26jtitle%3DCell%26date%3D2005%26volume%3D120%26spage%3D545%26epage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Lustbader, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirilli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takuma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspersen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinchese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn-Moore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lue, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuppusamy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zewier, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span> </span><span class="NLM_article-title">ABAD directly links Abeta to mitochondrial toxicity in Alzheimerʼs disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">448</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2004&pages=448-452&author=J.+W.+Lustbaderauthor=M.+Cirilliauthor=C.+Linauthor=H.+W.+Xuauthor=K.+Takumaauthor=N.+Wangauthor=C.+Caspersenauthor=X.+Chenauthor=S.+Pollakauthor=M.+Chaneyauthor=F.+Trincheseauthor=S.+Liuauthor=F.+Gunn-Mooreauthor=L.+F.+Lueauthor=D.+G.+Walkerauthor=P.+Kuppusamyauthor=Z.+L.+Zewierauthor=O.+Arancioauthor=D.+Sternauthor=S.+S.+Yanauthor=H.+Wu&title=ABAD+directly+links+Abeta+to+mitochondrial+toxicity+in+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLustbader%26aufirst%3DJ.%2BW.%26aulast%3DCirilli%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DH.%2BW.%26aulast%3DTakuma%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DCaspersen%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DPollak%26aufirst%3DS.%26aulast%3DChaney%26aufirst%3DM.%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DGunn-Moore%26aufirst%3DF.%26aulast%3DLue%26aufirst%3DL.%2BF.%26aulast%3DWalker%26aufirst%3DD.%2BG.%26aulast%3DKuppusamy%26aufirst%3DP.%26aulast%3DZewier%26aufirst%3DZ.%2BL.%26aulast%3DArancio%26aufirst%3DO.%26aulast%3DStern%26aufirst%3DD.%26aulast%3DYan%26aufirst%3DS.%2BS.%26aulast%3DWu%26aufirst%3DH.%26atitle%3DABAD%2520directly%2520links%2520Abeta%2520to%2520mitochondrial%2520toxicity%2520in%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DScience%26date%3D2004%26volume%3D304%26spage%3D448%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Caricasole, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caruso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caraci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iacovelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sortino, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terstappen, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, F.</span><span> </span><span class="NLM_article-title">The Wnt pathway, cell-cycle activation and beta-amyloid: novel therapeutic strategies in Alzheimerʼs disease</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=233-238&author=A.+Caricasoleauthor=A.+Copaniauthor=A.+Carusoauthor=F.+Caraciauthor=L.+Iacovelliauthor=M.+A.+Sortinoauthor=G.+C.+Terstappenauthor=F.+Nicoletti&title=The+Wnt+pathway%2C+cell-cycle+activation+and+beta-amyloid%3A+novel+therapeutic+strategies+in+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaricasole%26aufirst%3DA.%26aulast%3DCopani%26aufirst%3DA.%26aulast%3DCaruso%26aufirst%3DA.%26aulast%3DCaraci%26aufirst%3DF.%26aulast%3DIacovelli%26aufirst%3DL.%26aulast%3DSortino%26aufirst%3DM.%2BA.%26aulast%3DTerstappen%26aufirst%3DG.%2BC.%26aulast%3DNicoletti%26aufirst%3DF.%26atitle%3DThe%2520Wnt%2520pathway%252C%2520cell-cycle%2520activation%2520and%2520beta-amyloid%253A%2520novel%2520therapeutic%2520strategies%2520in%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2003%26volume%3D24%26spage%3D233%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helmerhorst, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taddei, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plewright, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Bronswijk, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, R.</span><span> </span><span class="NLM_article-title">Alzheimerʼs beta-amyloid peptides compete for insulin binding to the insulin receptor</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">RC221</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=RC221&author=L.+Xieauthor=E.+Helmerhorstauthor=K.+Taddeiauthor=B.+Plewrightauthor=W.+Van+Bronswijkauthor=R.+Martins&title=Alzheimer%CA%BCs+beta-amyloid+peptides+compete+for+insulin+binding+to+the+insulin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DL.%26aulast%3DHelmerhorst%26aufirst%3DE.%26aulast%3DTaddei%26aufirst%3DK.%26aulast%3DPlewright%26aufirst%3DB.%26aulast%3DVan%2BBronswijk%26aufirst%3DW.%26aulast%3DMartins%26aufirst%3DR.%26atitle%3DAlzheimer%25CA%25BCs%2520beta-amyloid%2520peptides%2520compete%2520for%2520insulin%2520binding%2520to%2520the%2520insulin%2520receptor%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3DRC221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Tamagno, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parola, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglielmotto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marra, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabaton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danni, O.</span><span> </span><span class="NLM_article-title">Multiple signaling events in amyloid beta-induced, oxidative stress-dependent neuronal apoptosis</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2FS0891-5849%2803%2900244-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=12826255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvVKiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2003&pages=45-58&author=E.+Tamagnoauthor=M.+Parolaauthor=M.+Guglielmottoauthor=G.+Santoroauthor=P.+Bardiniauthor=L.+Marraauthor=M.+Tabatonauthor=O.+Danni&title=Multiple+signaling+events+in+amyloid+beta-induced%2C+oxidative+stress-dependent+neuronal+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple signaling events in amyloid β-induced, oxidative stress-dependent neuronal apoptosis</span></div><div class="casAuthors">Tamagno, Elena; Parola, Maurizio; Guglielmotto, Michela; Santoro, Gianni; Bardini, Paola; Marra, Laura; Tabaton, Massimo; Danni, Oliviero</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-58</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Current evidence suggests that amyloid β peptides (Aβ) may play a major role in the pathogenesis of Alzheimer's disease by eliciting oxidative stress and neuronal apoptosis.  The authors have used differentiated SK-N-BE neurons to investigate mol. mechanisms and regulatory pathways underlying apoptotic neuronal cell death elicited by Aβ1-40 and Aβ1-42 peptides as well as the relationships between apoptosis and oxidative stress.  Aβ peptides, used at concns. able to induce oxidative stress, elicit a classic type of neuronal apoptosis involving mitochondrial regulatory proteins and pathways (i.e. affecting Bax and Bcl-2 protein levels as well as release of cytochrome c in the cytosol), poly-ADP ribose polymerase cleavage and activation of caspase 3.  This pattern of neuronal apoptosis, that is significantly prevented by α-tocopherol and N-acetylcysteine and completely abolished by specific inhibitors of stress-activated protein kinases (SAPK) such as JNKs and p38MAPK, involved early elevation of p53 protein levels.  Pretreatment of neurons with α-pifithrin, a specific p53 inhibitor, resulted in a 50-60% prevention of Aβ induced apoptosis.  These results suggest that oxidative stress - mediated neuronal apoptosis induced by amyloid β operates by eliciting a SAPK-dependent multiple regulation of pro-apoptotic mitochondrial pathways involving both p53 and bcl-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEBIDmfzQuW7Vg90H21EOLACvtfcHk0lg2ZAHZF0hyFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvVKiurY%253D&md5=623197c5ccc38f98dddc6a8761a14050</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2803%2900244-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252803%252900244-2%26sid%3Dliteratum%253Aachs%26aulast%3DTamagno%26aufirst%3DE.%26aulast%3DParola%26aufirst%3DM.%26aulast%3DGuglielmotto%26aufirst%3DM.%26aulast%3DSantoro%26aufirst%3DG.%26aulast%3DBardini%26aufirst%3DP.%26aulast%3DMarra%26aufirst%3DL.%26aulast%3DTabaton%26aufirst%3DM.%26aulast%3DDanni%26aufirst%3DO.%26atitle%3DMultiple%2520signaling%2520events%2520in%2520amyloid%2520beta-induced%252C%2520oxidative%2520stress-dependent%2520neuronal%2520apoptosis%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2003%26volume%3D35%26spage%3D45%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Bamberger, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landreth, G. E.</span><span> </span><span class="NLM_article-title">Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimerʼs disease</span> <span class="citation_source-journal">Microsc. Res. Tech.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fjemt.1121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=11455613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlslGrsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2001&pages=59-70&author=M.+E.+Bambergerauthor=G.+E.+Landreth&title=Microglial+interaction+with+beta-amyloid%3A+implications+for+the+pathogenesis+of+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Microglial interaction with β-amyloid: implications for the pathogenesis of Alzheimer's disease</span></div><div class="casAuthors">Bamberger, Maria E.; Landreth, Gary E.</div><div class="citationInfo"><span class="NLM_cas:title">Microscopy Research and Technique</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">59-70</span>CODEN:
                <span class="NLM_cas:coden">MRTEEO</span>;
        ISSN:<span class="NLM_cas:issn">1059-910X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  The etiol. of Alzheimer's disease (AD) involves a significant inflammatory component as evidenced by the presence of elevated levels of a diverse range of proinflammatory mols. in the AD brain.  These inflammatory mols. are produced principally by activated microglia, which are found to be clustered within and adjacent to the senile plaque.  Moreover, long-term treatment of patients with non-steroidal anti-inflammatory drugs was shown to reduce risk and incidence of AD and delay disease progression.  The microglia respond to beta-amyloid (Aβ) deposition in the brain through the interaction of fibrillar forms of amyloid with cell surface receptors, leading to the activation of intracellular signal transduction cascades.  The activation of multiple independent signaling pathways ultimately leads to the induction of proinflammatory gene expression and prodn. of reactive O and N species.  These microglial inflammatory products act in concert to produce neuronal toxicity and death.  Therapeutic approaches focused on inhibition of the microglial-mediated local inflammatory response in the AD brain offer new opportunities to intervene in the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzNuX6fXLMmrVg90H21EOLACvtfcHk0lg2ZAHZF0hyFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlslGrsr8%253D&md5=2e5dc18d700d23c1602e53204727a198</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fjemt.1121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjemt.1121%26sid%3Dliteratum%253Aachs%26aulast%3DBamberger%26aufirst%3DM.%2BE.%26aulast%3DLandreth%26aufirst%3DG.%2BE.%26atitle%3DMicroglial%2520interaction%2520with%2520beta-amyloid%253A%2520implications%2520for%2520the%2520pathogenesis%2520of%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DMicrosc.%2520Res.%2520Tech.%26date%3D2001%26volume%3D54%26spage%3D59%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Devi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabhu, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galati, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avadhani, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anandatheerthavarada, H. K.</span><span> </span><span class="NLM_article-title">Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimerʼs disease brain is associated with mitochondrial dysfunction</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">9057</span><span class="NLM_x">–</span> <span class="NLM_lpage">9068</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1523%2FJNEUROSCI.1469-06.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16943564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1aqu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=9057-9068&author=L.+Deviauthor=B.+M.+Prabhuauthor=D.+F.+Galatiauthor=N.+G.+Avadhaniauthor=H.+K.+Anandatheerthavarada&title=Accumulation+of+amyloid+precursor+protein+in+the+mitochondrial+import+channels+of+human+Alzheimer%CA%BCs+disease+brain+is+associated+with+mitochondrial+dysfunction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction</span></div><div class="casAuthors">Devi, Latha; Prabhu, Badanavalu M.; Galati, Domenico F.; Avadhani, Narayan G.; Anandatheerthavarada, Hindupur K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">9057-9068</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Mitochondrial dysfunction is one of the major intracellular lesions of Alzheimer's disease (AD).  However, the causative factors involved in the mitochondrial dysfunction in human AD are not well understood.  Here we report that non-glycosylated full-length and C-terminal truncated amyloid precursor protein (APP) accumulates exclusively in the protein import channels of mitochondria of human AD brains but not in age-matched controls.  Furthermore, in AD brains, mitochondrially assocd. APP formed stable ∼480 kDa complexes with the translocase of the outer mitochondrial membrane 40 (TOM40) import channel and a super complex of ∼620 kDa with both mitochondrial TOM40 and the translocase of the inner mitochondrial membrane 23 (TIM23) import channel TIM23 in an "Nin mitochondria-Cout cytoplasm" orientation.  Accumulation of APP across mitochondrial import channels, which varied with the severity of AD, inhibited the entry of nuclear-encoded cytochrome c oxidase subunits IV and Vb proteins, which was assocd. with decreased cytochrome c oxidase activity and increased levels of H2O2.  Regional distribution of mitochondrial APP showed higher levels in AD-vulnerable brain regions, such as the frontal cortex, hippocampus, and amygdala.  Mitochondrial accumulation of APP was also obsd. in the cholinergic, dopaminergic, GABAergic, and glutamatergic neuronal types in the category III AD brains.  The levels of translocationally arrested mitochondrial APP directly correlated with mitochondrial dysfunction.  Moreover, apolipoprotein genotype anal. revealed that AD subjects with the E3/E4 alleles had the highest content of mitochondrial APP.  Collectively, these results suggest that abnormal accumulation of APP across mitochondrial import channels, causing mitochondrial dysfunction, is a hallmark of human AD pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq75HFO53TO0rVg90H21EOLACvtfcHk0ljzCjSd9N9E4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1aqu70%253D&md5=9fd32520cee814fb0b7b89df6176e179</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1469-06.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1469-06.2006%26sid%3Dliteratum%253Aachs%26aulast%3DDevi%26aufirst%3DL.%26aulast%3DPrabhu%26aufirst%3DB.%2BM.%26aulast%3DGalati%26aufirst%3DD.%2BF.%26aulast%3DAvadhani%26aufirst%3DN.%2BG.%26aulast%3DAnandatheerthavarada%26aufirst%3DH.%2BK.%26atitle%3DAccumulation%2520of%2520amyloid%2520precursor%2520protein%2520in%2520the%2520mitochondrial%2520import%2520channels%2520of%2520human%2520Alzheimer%25CA%25BCs%2520disease%2520brain%2520is%2520associated%2520with%2520mitochondrial%2520dysfunction%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D9057%26epage%3D9068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Lin, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, M. F.</span><span> </span><span class="NLM_article-title">Alzheimerʼs APP mangles mitochondria</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1241</span><span class="NLM_x">–</span> <span class="NLM_lpage">1243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnm1106-1241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17088888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKlsLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=1241-1243&author=M.+T.+Linauthor=M.+F.+Beal&title=Alzheimer%CA%BCs+APP+mangles+mitochondria"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's APP mangles mitochondria</span></div><div class="casAuthors">Lin, Michael T.; Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1241-1243</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">New findings in humans examine how mitochondrial function declines during Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX6yOgF6CRHLVg90H21EOLACvtfcHk0ljzCjSd9N9E4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKlsLjI&md5=307d5872ac596a493a6d912ee9ec5e5f</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fnm1106-1241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1106-1241%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DM.%2BT.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DAlzheimer%25CA%25BCs%2520APP%2520mangles%2520mitochondria%26jtitle%3DNat.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D1241%26epage%3D1243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Wang, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundke-Iqbal, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, K.</span><span> </span><span class="NLM_article-title">Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1111%2Fj.1460-9568.2006.05226.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17241267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252Fkt1Sktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=59-68&author=J.+Z.+Wangauthor=I.+Grundke-Iqbalauthor=K.+Iqbal&title=Kinases+and+phosphatases+and+tau+sites+involved+in+Alzheimer+neurofibrillary+degeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration</span></div><div class="casAuthors">Wang Jian-Zhi; Grundke-Iqbal Inge; Iqbal Khalid</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-68</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Microtubule associated protein (MAP) tau is abnormally hyperphosphorylated in Alzheimer's disease (AD) and related tauopathies; in this form it is the major protein subunit of paired helical filaments (PHF)/neurofibrillary tangles.  However, the nature of protein kinases and phosphatases and tau sites involved in this lesion has been elusive.  We investigated self-assembly and microtubule assembly promoting activities of hyperphosphorylated tau isolated from Alzheimer disease brain cytosol, the AD abnormally hyperphosphorylated tau (AD P-tau) before and after dephosphorylation by phosphoseryl/phosphothreonyl protein phosphatase-2A (PP-2A), and then rephosphorylation by cyclic AMP-dependent protein kinase (PKA), calcium, calmodulin-dependent protein kinase II (CaMKII), glycogen synthase kinase-3beta (GSK-3beta) and cyclin-dependent protein kinase 5 (cdk5) in different kinase combinations.  We found that (i) dephosphorylation of AD P-tau by PP-2A inhibits its polymerization into PHF/straight filaments (SF) and restores its binding and ability to promote assembly of tubulin into microtubules; (ii) rephosphorylation of PP-2A-dephosphorylated AD P-tau by sequential phosphorylation by PKA, CaMKII and GSK-3beta or cdk5, and as well as by cdk5 and GSK-3beta, promotes its self-assembly into tangles of PHF similar to those seen in Alzheimer brain, and (iii) phosphorylation of tau sites required for this pathology are Thr231 and Ser262, along with several sites flanking the microtubule binding repeat region.  Phosphorylation of recombinant human brain tau(441) yielded similar results as the PP-2A dephosphorylated AD P-tau, except that mostly SF were formed.  The conditions for the abnormal hyperphosphorylation of tau that promoted its self-assembly also induced the microtubule assembly inhibitory activity.  These findings suggest that activation of PP-2A or inhibition of either both GSK-3beta and cdk5 or one of these two kinases plus PKA or CaMKII might be required to inhibit Alzheimer neurofibrillary degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRI9DB-4K5ZmF1C8OJBvdfbfW6udTcc2eZAnhjdezGxy7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252Fkt1Sktg%253D%253D&md5=b8f8ba0a76085995f6c652cc737c55b2</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.2006.05226.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.2006.05226.x%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BZ.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26aulast%3DIqbal%26aufirst%3DK.%26atitle%3DKinases%2520and%2520phosphatases%2520and%2520tau%2520sites%2520involved%2520in%2520Alzheimer%2520neurofibrillary%2520degeneration%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2007%26volume%3D25%26spage%3D59%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Blennow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Leon, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zetterberg, H.</span><span> </span><span class="NLM_article-title">Alzheimerʼs disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2006&pages=387-403&author=K.+Blennowauthor=M.+J.+de+Leonauthor=H.+Zetterberg&title=Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3Dde%2BLeon%26aufirst%3DM.%2BJ.%26aulast%3DZetterberg%26aufirst%3DH.%26atitle%3DAlzheimer%25CA%25BCs%2520disease%26jtitle%3DLancet%26date%3D2006%26volume%3D368%26spage%3D387%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Sultana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perluigi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butterfield, D. A.</span><span> </span><span class="NLM_article-title">Protein oxidation and lipid peroxidation in brain of subjects with Alzheimerʼs disease: insights into mechanism of neurodegeneration from redox proteomics</span> <span class="citation_source-journal">Antioxid. Redox Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2021</span><span class="NLM_x">–</span> <span class="NLM_lpage">2037</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1089%2Fars.2006.8.2021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17034347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVKntb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=2021-2037&author=R.+Sultanaauthor=M.+Perluigiauthor=D.+A.+Butterfield&title=Protein+oxidation+and+lipid+peroxidation+in+brain+of+subjects+with+Alzheimer%CA%BCs+disease%3A+insights+into+mechanism+of+neurodegeneration+from+redox+proteomics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Oxidation and Lipid Peroxidation in Brain of Subjects with Alzheimer's Disease: Insights into Mechanism of Neurodegeneration from Redox Proteomics</span></div><div class="casAuthors">Sultana, Rukhsana; Perluigi, Marzia; Butterfield, D. Allan</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11 & 12</span>),
    <span class="NLM_cas:pages">2021-2037</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD), the leading cause of dementia, involves regionalized neuronal death, synaptic loss, and an accumulation of intraneuronal, neurofibrillary tangles and extracellular senile plaques.  Although the initiating causes leading to AD are unknown, a no. of previous studies reported the role of oxidative stress in AD brain.  Postmortem anal. of AD brain showed elevated markers of oxidative stress including protein nitrotyrosine, carbonyls in proteins, lipid oxidn. products, and oxidized DNA bases.  In this review, we focus our attention on the role of protein oxidn. and lipid peroxidn. in the pathogenesis of AD.  Particular attention is given to the current knowledge about the redox proteomics identification of oxidatively modified proteins in AD brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6VJc0AQ9nobVg90H21EOLACvtfcHk0lhR894nRHb2Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVKntb%252FO&md5=c8891e5a423e4392cbba68319bde7bd9</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1089%2Fars.2006.8.2021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2006.8.2021%26sid%3Dliteratum%253Aachs%26aulast%3DSultana%26aufirst%3DR.%26aulast%3DPerluigi%26aufirst%3DM.%26aulast%3DButterfield%26aufirst%3DD.%2BA.%26atitle%3DProtein%2520oxidation%2520and%2520lipid%2520peroxidation%2520in%2520brain%2520of%2520subjects%2520with%2520Alzheimer%25CA%25BCs%2520disease%253A%2520insights%2520into%2520mechanism%2520of%2520neurodegeneration%2520from%2520redox%2520proteomics%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2006%26volume%3D8%26spage%3D2021%26epage%3D2037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolston, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreira, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunomura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, G.</span><span> </span><span class="NLM_article-title">Prevention and treatment of Alzheimer disease and aging: antioxidants</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=171-180&author=Q.+Liuauthor=F.+Xieauthor=R.+Rolstonauthor=P.+I.+Moreiraauthor=A.+Nunomuraauthor=X.+Zhuauthor=M.+A.+Smithauthor=G.+Perry&title=Prevention+and+treatment+of+Alzheimer+disease+and+aging%3A+antioxidants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DF.%26aulast%3DRolston%26aufirst%3DR.%26aulast%3DMoreira%26aufirst%3DP.%2BI.%26aulast%3DNunomura%26aufirst%3DA.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26aulast%3DPerry%26aufirst%3DG.%26atitle%3DPrevention%2520and%2520treatment%2520of%2520Alzheimer%2520disease%2520and%2520aging%253A%2520antioxidants%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D171%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Brewer, G. J.</span><span> </span><span class="NLM_article-title">Iron and copper toxicity in diseases of aging, particularly atherosclerosis and Alzheimerʼs disease</span> <span class="citation_source-journal">Exp. Biol. Med. (Maywood)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">232</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17259340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=2007&pages=323-335&author=G.+J.+Brewer&title=Iron+and+copper+toxicity+in+diseases+of+aging%2C+particularly+atherosclerosis+and+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Iron and copper toxicity in diseases of aging, particularly atherosclerosis and Alzheimer's disease</span></div><div class="casAuthors">Brewer, George J.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Biology and Medicine (Maywood, NJ, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">232</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">323-335</span>CODEN:
                <span class="NLM_cas:coden">EBMMBE</span>;
        ISSN:<span class="NLM_cas:issn">1535-3702</span>.
    
            (<span class="NLM_cas:orgname">Society for Experimental Biology and Medicine</span>)
        </div><div class="casAbstract">A review.  In this review, we point out that natural selection does not act to lessen human diseases after the reproductive and caregiving period and that normal levels of iron and copper that may be healthy during the reproductive years appear to be contributing to diseases of aging and possibly the aging process itself.  It is clear that oxidant damage contributes to many of the diseases of aging, such as atherosclerosis, Alzheimer's disease, Parkinson's diseases, diabetes, diseases of inflammation, diseases of fibrosis, diseases of autoimmunity, and so on.  It is equally clear that both iron and copper can contribute to excess prodn. of damaging reactive oxygen species through Fenton chem.  Here, we examine the evidence that "normal" levels of iron and copper contribute to various diseases of aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr43INahQmh17Vg90H21EOLACvtfcHk0lhglX6geNzA8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWjtLg%253D&md5=06225f81609e1f71fcfb0c0366bac19b</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrewer%26aufirst%3DG.%2BJ.%26atitle%3DIron%2520and%2520copper%2520toxicity%2520in%2520diseases%2520of%2520aging%252C%2520particularly%2520atherosclerosis%2520and%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DExp.%2520Biol.%2520Med.%2520%2528Maywood%2529%26date%3D2007%26volume%3D232%26spage%3D323%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">El Khoury, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toft, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Means, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geula, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luster, A. D.</span><span> </span><span class="NLM_article-title">Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">432</span><span class="NLM_x">–</span> <span class="NLM_lpage">438</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnm1555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17351623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvVaqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=432-438&author=J.+El+Khouryauthor=M.+Toftauthor=S.+E.+Hickmanauthor=T.+K.+Meansauthor=K.+Teradaauthor=C.+Geulaauthor=A.+D.+Luster&title=Ccr2+deficiency+impairs+microglial+accumulation+and+accelerates+progression+of+Alzheimer-like+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease</span></div><div class="casAuthors">El Khoury, Joseph; Toft, Michelle; Hickman, Suzanne E.; Means, Terry K.; Terada, Kinya; Geula, Changiz; Luster, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">432-438</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Microglia are the principal immune cells of the brain.  In Alzheimer disease, these brain mononuclear phagocytes are recruited from the blood and accumulate in senile plaques.  However, the role of microglia in Alzheimer disease has not been resolved.  Microglia may be neuroprotective by phagocytosing amyloid-β (Aβ), but their activation and the secretion of neurotoxins may also cause neurodegeneration.  Ccr2 is a chemokine receptor expressed on microglia, which mediates the accumulation of mononuclear phagocytes at sites of inflammation.  Here we show that Ccr2 deficiency accelerates early disease progression and markedly impairs microglial accumulation in a transgenic mouse model of Alzheimer disease (Tg2576).  Alzheimer disease mice deficient in Ccr2 accumulated Aβ earlier and died prematurely, in a manner that correlated with Ccr2 gene dosage, indicating that absence of early microglial accumulation leads to decreased Aβ clearance and increased mortality.  Thus, Ccr2-dependent microglial accumulation plays a protective role in the early stages of Alzheimer disease by promoting Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMCV0o0yiwLbVg90H21EOLACvtfcHk0lhglX6geNzA8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvVaqtbc%253D&md5=4a1f6f506d9573867fbfc12b035ce397</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Fnm1555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1555%26sid%3Dliteratum%253Aachs%26aulast%3DEl%2BKhoury%26aufirst%3DJ.%26aulast%3DToft%26aufirst%3DM.%26aulast%3DHickman%26aufirst%3DS.%2BE.%26aulast%3DMeans%26aufirst%3DT.%2BK.%26aulast%3DTerada%26aufirst%3DK.%26aulast%3DGeula%26aufirst%3DC.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26atitle%3DCcr2%2520deficiency%2520impairs%2520microglial%2520accumulation%2520and%2520accelerates%2520progression%2520of%2520Alzheimer-like%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2007%26volume%3D13%26spage%3D432%26epage%3D438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Piehl, F.</span><span> </span><span class="NLM_article-title">Inflammation and neurodegeneration</span> <span class="citation_source-journal">Future Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.2217%2F14796708.1.1.97" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=95-105&author=F.+Piehl&title=Inflammation+and+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.2217%2F14796708.1.1.97&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252F14796708.1.1.97%26sid%3Dliteratum%253Aachs%26aulast%3DPiehl%26aufirst%3DF.%26atitle%3DInflammation%2520and%2520neurodegeneration%26jtitle%3DFuture%2520Neurol.%26date%3D2006%26volume%3D1%26spage%3D95%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Takeda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loveman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clegg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picot, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, C.</span><span> </span><span class="NLM_article-title">A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimerʼs disease</span> <span class="citation_source-journal">Int. J. Geriatr. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fgps.1402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16323253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADC%252BD2MnovVGmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=17-28&author=A.+Takedaauthor=E.+Lovemanauthor=A.+Cleggauthor=J.+Kirbyauthor=J.+Picotauthor=E.+Payneauthor=C.+Green&title=A+systematic+review+of+the+clinical+effectiveness+of+donepezil%2C+rivastigmine+and+galantamine+on+cognition%2C+quality+of+life+and+adverse+events+in+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease</span></div><div class="casAuthors">Takeda A; Loveman E; Clegg A; Kirby J; Picot J; Payne E; Green C</div><div class="citationInfo"><span class="NLM_cas:title">International journal of geriatric psychiatry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-28</span>
        ISSN:<span class="NLM_cas:issn">0885-6230</span>.
    </div><div class="casAbstract">BACKGROUND:  The use of cholinesterase inhibitors for Alzheimer's disease (AD) is currently being appraised by the National Institute for Clinical Evidence (NICE).  This article provides the latest evidence that NICE will be using as part of this appraisal process.  OBJECTIVE:  To provide a systematic review of the best quality evidence of the effects of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in people with mild to moderately-severe AD.  DESIGN:  Electronic databases were searched, references of all retrieved articles were checked, and experts were contacted for advice, peer review and to identify additional references.  Randomised controlled trials (RCTs) were included if they fulfilled pre-specified criteria.  Data were synthesised through a narrative review.  RESULTS:  Twenty-six RCTs that compared any one of the cholinesterase inhibitors with either a control group or with another cholinesterase inhibitor were included.  The quality of reporting and methodology was varied.  Treatment with donepezil, rivastigmine or galantamine resulted in significantly better cognitive performance using the ADAS-cog scale when compared with placebo.  These findings were generally supported using the MMSE scale.  Results from head to head comparisons were limited by the low number of studies and the study quality; generally showing no robust support for any one drug.  Few studies evaluated quality of life.  Adverse events were generally related to the gastrointestinal system, with a tendency for these to be more common in the treatment arms.  CONCLUSIONS:  The cholinesterase inhibitors donepezil, rivastigmine, and galantamine can delay cognitive impairment in patients with mild to moderately-severe AD for at least 6 months duration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRuEPgp1XJWgr5XHngOXiV_fW6udTcc2eac6Hsuo3u2P7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MnovVGmuw%253D%253D&md5=64dc8b182e5f3c617c2a2a2a3aa24a6f</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1002%2Fgps.1402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fgps.1402%26sid%3Dliteratum%253Aachs%26aulast%3DTakeda%26aufirst%3DA.%26aulast%3DLoveman%26aufirst%3DE.%26aulast%3DClegg%26aufirst%3DA.%26aulast%3DKirby%26aufirst%3DJ.%26aulast%3DPicot%26aufirst%3DJ.%26aulast%3DPayne%26aufirst%3DE.%26aulast%3DGreen%26aufirst%3DC.%26atitle%3DA%2520systematic%2520review%2520of%2520the%2520clinical%2520effectiveness%2520of%2520donepezil%252C%2520rivastigmine%2520and%2520galantamine%2520on%2520cognition%252C%2520quality%2520of%2520life%2520and%2520adverse%2520events%2520in%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DInt.%2520J.%2520Geriatr.%2520Psychiatry%26date%3D2006%26volume%3D21%26spage%3D17%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Birks, J.</span><span> </span><span class="NLM_article-title">Cholinesterase inhibitors for Alzheimerʼs disease</span> <span class="citation_source-journal">Cochrane Database Syst. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">CD005593</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=CD005593&author=J.+Birks&title=Cholinesterase+inhibitors+for+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBirks%26aufirst%3DJ.%26atitle%3DCholinesterase%2520inhibitors%2520for%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2006%26spage%3DCD005593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Christensen, D. D.</span><span> </span><span class="NLM_article-title">Alzheimerʼs disease: progress in the development of anti-amyloid disease-modifying therapies</span> <span class="citation_source-journal">CNS Spectrums</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span><div class="note"><p class="first last">, 119–123</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=113-116&author=D.+D.+Christensen&title=Alzheimer%CA%BCs+disease%3A+progress+in+the+development+of+anti-amyloid+disease-modifying+therapies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DD.%2BD.%26atitle%3DAlzheimer%25CA%25BCs%2520disease%253A%2520progress%2520in%2520the%2520development%2520of%2520anti-amyloid%2520disease-modifying%2520therapies%26jtitle%3DCNS%2520Spectrums%26date%3D2007%26volume%3D12%26spage%3D113%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Silman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase: “classical” and “non-classical” functions and pharmacology</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.coph.2005.01.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15907917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktlejtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=293-302&author=I.+Silmanauthor=J.+L.+Sussman&title=Acetylcholinesterase%3A+%E2%80%9Cclassical%E2%80%9D+and+%E2%80%9Cnon-classical%E2%80%9D+functions+and+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase: "classical" and "non-classical" functions and pharmacology</span></div><div class="casAuthors">Silman, Israel; Sussman, Joel L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">293-302</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The synaptic enzyme acetylcholinesterase (AChE) terminates transmission at cholinergic synapses by rapidly hydrolyzing acetylcholine.  It is anchored within the synaptic cleft by a highly specialized anchoring device in which catalytic subunit tetramers assemble around a polyproline II helix.  AChE is the target of nerve agents, insecticides, and therapeutic drugs, in particular, the first generation of anti-Alzheimer drugs.  Both target-guided synthesis and structure-based drug design have been used effectively to obtain potent anticholinesterase agents.  In addn., AChE is believed to play non-classical roles in addn. to its classical role in terminating synaptic transmission (e.g. as an adhesion protein).  It also accelerates assembly of Aβ into amyloid fibrils.  Both of these actions involve the so-called peripheral anionic site at the entrance to the active-site gorge.  Novel anticholinesterases are targeted against this site, rather than against the active site at the bottom of the gorge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAM8PG1ZkG47Vg90H21EOLACvtfcHk0li2IwogTg3u1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktlejtbg%253D&md5=c7be6648c9f1239a016054f85dba1b44</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2005.01.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2005.01.014%26sid%3Dliteratum%253Aachs%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DAcetylcholinesterase%253A%2520%25E2%2580%259Cclassical%25E2%2580%259D%2520and%2520%25E2%2580%259Cnon-classical%25E2%2580%259D%2520functions%2520and%2520pharmacology%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2005%26volume%3D5%26spage%3D293%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Holzgrabe, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapkova, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alptuzun, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheiber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugelmann, E.</span><span> </span><span class="NLM_article-title">Targeting acetylcholinesterase to treat neurodegeneration</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1517%2F14728222.11.2.161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17227232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt12ruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=161-179&author=U.+Holzgrabeauthor=P.+Kapkovaauthor=V.+Alptuzunauthor=J.+Scheiberauthor=E.+Kugelmann&title=Targeting+acetylcholinesterase+to+treat+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting acetylcholinesterase to treat neurodegeneration</span></div><div class="casAuthors">Holzgrabe, Ulrike; Kapkova, Petra; Alptuezuen, Vildan; Scheiber, Josef; Kugelmann, Eva</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-179</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative disorders, such as Alzheimer's disease, are often characterized by the degeneration of the cholinergic system.  Thus, the aim of many treatment regimens is to support this system either by means of muscarinic agonists or by inhibitors of acetylcholinesterase (AChE), the latter being able to increase the concn. of acetylcholine.  However, both pharmacol. groups of drugs can only help in the beginning of the progressive disease.  The finding that the occupation of the peripheral anionic site of AChE is able to stop the formation of the amyloid plaque led to the development of bivalent ligands that occupy both the active and the peripheral site.  This dual action might be more beneficial for treatment of Alzheimer's disease than simple inhibition of the acetylcholine hydrolysis.  Thus, the new bivalent ligands are the focus of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfJ1Ef8XjB3LVg90H21EOLACvtfcHk0li5zaFEo4VmSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt12ruw%253D%253D&md5=e38fa01804094ae9ed273d68f0e74a50</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1517%2F14728222.11.2.161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.11.2.161%26sid%3Dliteratum%253Aachs%26aulast%3DHolzgrabe%26aufirst%3DU.%26aulast%3DKapkova%26aufirst%3DP.%26aulast%3DAlptuzun%26aufirst%3DV.%26aulast%3DScheiber%26aufirst%3DJ.%26aulast%3DKugelmann%26aufirst%3DE.%26atitle%3DTargeting%2520acetylcholinesterase%2520to%2520treat%2520neurodegeneration%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2007%26volume%3D11%26spage%3D161%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, P.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase inhibitors as a starting point towards improved Alzheimerʼs disease therapeutics</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">3157</span><span class="NLM_x">–</span> <span class="NLM_lpage">3166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.2174%2F1381612043383313" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15544505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnslCktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=3157-3166&author=M.+Recanatiniauthor=P.+Valenti&title=Acetylcholinesterase+inhibitors+as+a+starting+point+towards+improved+Alzheimer%CA%BCs+disease+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase inhibitors as a starting point towards improved Alzheimer's disease therapeutics</span></div><div class="casAuthors">Recanatini, Maurizio; Valenti, Piero</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3157-3166</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The knowledge about the pathogenesis and the development of the neurodegeneration assocd. with Alzheimer's disease (AD) has been organized throughout the years into two theories, namely the cholinergic and the amyloid hypotheses.  The loss of cholinergic neurotransmission and the abnormal aggregation and deposition of the amyloid-β peptide (Aβ) in the brain are retained as the central events by the two theories, resp.  These phenomena and their pathol. consequences are the main targets of the drug discovery strategies based on each hypothesis.  However, the two paradigms share some common aspects as shown by several exptl. evidences, such that they might even fit into a unifying scenario of neuropathol. and neurodegeneration.  In this context, in a perspective of drug discovery, the enzyme acetylcholinesterase (AChE) holds a key position, as it is a main target for cholinomimetic AD drugs being responsible for the breakdown of the neurotransmitter, and it is also involved in the aggregation of Aβ and the formation of the neurotoxic fibrils.  Following this view, in recent years, a drug design strategy has emerged, directed to finding mols. able to inhibit both of these actions exerted by AChE.  In this review, we will briefly introduce the biol. basis of this strategy, and then will account for the early results obtained in this field in our and in other labs.  The main focus will be on potential lead compds. for which some exptl. evidence exists supporting the hypothesis of their dual action, as AChE inhibitors and blockers of the AChE-induced Aβ aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCl-ZXkLB5YrVg90H21EOLACvtfcHk0li5zaFEo4VmSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnslCktrk%253D&md5=d2b80fd0d6598b8cdb9526f24ecea86e</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.2174%2F1381612043383313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612043383313%26sid%3Dliteratum%253Aachs%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DValenti%26aufirst%3DP.%26atitle%3DAcetylcholinesterase%2520inhibitors%2520as%2520a%2520starting%2520point%2520towards%2520improved%2520Alzheimer%25CA%25BCs%2520disease%2520therapeutics%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2004%26volume%3D10%26spage%3D3157%26epage%3D3166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Castro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span> </span><span class="NLM_article-title">Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4377</span><span class="NLM_x">–</span> <span class="NLM_lpage">4387</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.2174%2F138161206778792985" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17105433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1GntrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=4377-4387&author=A.+Castroauthor=A.+Martinez&title=Targeting+beta-amyloid+pathogenesis+through+acetylcholinesterase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors</span></div><div class="casAuthors">Castro, Ana; Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">4377-4387</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Although the hallmarks of neurodegeneration in Alzheimer's brains are well known, one of the current difficulties is related to the lack of solid evidence about the ultimate factors that give rise to the pathogenesis of this disease, creating a great challenge for the definition of efficient treatments for Alzheimer's disease (AD).  Current therapeutic option for AD patients is the use of acetylcholinesterase (AChE) inhibitors, which gives only a symptomatic relief.  However, recent studies show a long-lasting effect in a certain percentage of patients.  In fact, there is accumulating evidence that an AChE has secondary non-cholinergic functions including the processing and deposition of β-amyloid (Aβ).  AChE could play a role in the Aβ metab. and during an early step in the development of the senile plaque, as revealed by the finding that AChE accelerates Aβ deposition.  Considering the non-classical AChE functions, their relationships with AD hallmarks, and the putative role of peripheral anionic site in all these functions, the dual binding site AChE inhibitors may acquire importance for AD treatment.  On the other hand, the interference of AChE inhibitors with Aβ processing is not a general rule for this class of compds. with the involvement of other features such as chem. structure and/or genetic regulation.  This review highlights the collection of several compds. with an outstanding profile against AChE-induced amyloid aggregation and potent AChE inhibitory activity, indicating the possibility of targeting Aβ through the inhibition of AChE and reveals the emergence of a new generation of AChE inhibitors aiming to be excellent candidate drugs for the future cure of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrisn7G_dIHxrVg90H21EOLACvtfcHk0li5zaFEo4VmSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1GntrbI&md5=fd41eca56c6433d9ee6a3989908ff2c5</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.2174%2F138161206778792985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206778792985%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DTargeting%2520beta-amyloid%2520pathogenesis%2520through%2520acetylcholinesterase%2520inhibitors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D4377%26epage%3D4387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Alvarez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronfman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase, a senile plaque component, affects the fibrillogenesis of amyloid-beta-peptides</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">201</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=201&publication_year=1995&pages=49-52&author=A.+Alvarezauthor=F.+Bronfmanauthor=C.+A.+Perezauthor=M.+Vicenteauthor=J.+Garridoauthor=N.+C.+Inestrosa&title=Acetylcholinesterase%2C+a+senile+plaque+component%2C+affects+the+fibrillogenesis+of+amyloid-beta-peptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarez%26aufirst%3DA.%26aulast%3DBronfman%26aufirst%3DF.%26aulast%3DPerez%26aufirst%3DC.%2BA.%26aulast%3DVicente%26aufirst%3DM.%26aulast%3DGarrido%26aufirst%3DJ.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DAcetylcholinesterase%252C%2520a%2520senile%2520plaque%2520component%252C%2520affects%2520the%2520fibrillogenesis%2520of%2520amyloid-beta-peptides%26jtitle%3DNeurosci.%2520Lett.%26date%3D1995%26volume%3D201%26spage%3D49%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Schmitt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernhardt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moeller, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuser, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frolich, L.</span><span> </span><span class="NLM_article-title">Combination therapy in Alzheimerʼs disease: a review of current evidence</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=827-844&author=B.+Schmittauthor=T.+Bernhardtauthor=H.+J.+Moellerauthor=I.+Heuserauthor=L.+Frolich&title=Combination+therapy+in+Alzheimer%CA%BCs+disease%3A+a+review+of+current+evidence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DB.%26aulast%3DBernhardt%26aufirst%3DT.%26aulast%3DMoeller%26aufirst%3DH.%2BJ.%26aulast%3DHeuser%26aufirst%3DI.%26aulast%3DFrolich%26aufirst%3DL.%26atitle%3DCombination%2520therapy%2520in%2520Alzheimer%25CA%25BCs%2520disease%253A%2520a%2520review%2520of%2520current%2520evidence%26jtitle%3DCNS%2520Drugs%26date%3D2004%26volume%3D18%26spage%3D827%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Progress in acetylcholinesterase inhibitors for Alzheimerʼs disease</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">811</span><span class="NLM_x">–</span> <span class="NLM_lpage">823</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1517%2F13543776.16.6.811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XltVOhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=811-823&author=M.+L.+Bolognesiauthor=A.+Minariniauthor=V.+Tumiattiauthor=C.+Melchiorre&title=Progress+in+acetylcholinesterase+inhibitors+for+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in acetylcholinesterase inhibitors for Alzheimer's disease</span></div><div class="casAuthors">Bolognesi, Maria Laura; Minarini, Anna; Tumiatti, Vincenzo; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">811-823</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Current pharmacotherapy of Alzheimer's disease (AD) involves drugs that are known as acetylcholinesterase inhibitors (AChEIs), which increase the acetylcholine concn. in the brain.  Although effective in improving cognitive, behavioral and functional impairments, these drugs are not able to alter disease progression.  In this review, the recent patent literature on AChEIs from 2002 to early 2005 will be discussed, focusing attention on the novel analogs of the approved drugs, as well as on the most important AD therapeutic advances.  The clin. efficacy of AChEIs will probably be enhanced by their combination with other drugs acting through different pharmacol. mechanisms.  As the neuronal loss comprises more than the forebrain cholinergic system, the weak effectiveness of AChEIs is not surprising.  Besides the cholinergic hypothesis' approaches, new treatments are emerging based on multipotent compds. able to target the underlying pathogenic mechanisms of AD; these treatments are summarized herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptSL4AfWXbaLVg90H21EOLACvtfcHk0ljlxe4HZk3apA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltVOhu7g%253D&md5=1094dc53e60353b61a4ac6fe0cbbfee8</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1517%2F13543776.16.6.811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.16.6.811%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DProgress%2520in%2520acetylcholinesterase%2520inhibitors%2520for%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2006%26volume%3D16%26spage%3D811%26epage%3D823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Grossberg, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Q.</span><span> </span><span class="NLM_article-title">Rationale for combination therapy with galantamine and memantine in Alzheimerʼs disease</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">17S</span><span class="NLM_x">–</span> <span class="NLM_lpage">26S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=17S-26S&author=G.+T.+Grossbergauthor=K.+R.+Edwardsauthor=Q.+Zhao&title=Rationale+for+combination+therapy+with+galantamine+and+memantine+in+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrossberg%26aufirst%3DG.%2BT.%26aulast%3DEdwards%26aufirst%3DK.%2BR.%26aulast%3DZhao%26aufirst%3DQ.%26atitle%3DRationale%2520for%2520combination%2520therapy%2520with%2520galantamine%2520and%2520memantine%2520in%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2006%26volume%3D46%26spage%3D17S%26epage%3D26S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Decker, M.</span><span> </span><span class="NLM_article-title">Recent advances in the development of hybrid molecules/designed multiple compounds with antiamnesic properties</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=221-229&author=M.+Decker&title=Recent+advances+in+the+development+of+hybrid+molecules%2Fdesigned+multiple+compounds+with+antiamnesic+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DRecent%2520advances%2520in%2520the%2520development%2520of%2520hybrid%2520molecules%252Fdesigned%2520multiple%2520compounds%2520with%2520antiamnesic%2520properties%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D221%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Van der Schyf, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geldenhuys, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Multifunctional drugs with different CNS targets for neuropsychiatric disorders</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">1033</span><span class="NLM_x">–</span> <span class="NLM_lpage">1048</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1111%2Fj.1471-4159.2006.04141.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17054441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yks7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2006&pages=1033-1048&author=C.+J.+Van+der+Schyfauthor=W.+J.+Geldenhuysauthor=M.+B.+Youdim&title=Multifunctional+drugs+with+different+CNS+targets+for+neuropsychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional drugs with different CNS targets for neuropsychiatric disorders</span></div><div class="casAuthors">Van der Schyf, Cornelis J.; Geldenhuys, Werner J.; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1033-1048</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The multiple disease etiologies that lead to neuropsychiatric disorders, such as Parkinson's and Alzheimer's disease, amyotrophic lateral sclerosis, Huntington disease, schizophrenia, depressive illness and stroke, offer significant challenges to drug discovery efforts aimed at preventing or even reversing the progression of these disorders.  Transcriptomic tools and proteomic profiling have clearly indicated that such diseases are multifactorial in origin.  Further, they are thought to be initiated by a cascade of mol. events that involve several neurotransmitter systems.  In response to this complexity, a new paradigm has recently emerged that challenges the widely held assumption that 'silver bullet' agents are superior to 'dirty drugs' in therapeutic approaches aimed at the prevention or treatment of neuropsychiatric diseases.  A similar pattern of drug development has occurred in strategies for the treatment of cancer, AIDS and cardiovascular diseases.  In this review, we offer an overview of therapeutic strategies and novel investigative drugs discovered or developed in our own and other labs., that address multiple CNS etiol. targets assocd. with an array of neuropsychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC-WgbIJvzwLVg90H21EOLACvtfcHk0lgEqCcKIxHk_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yks7rE&md5=bf77745eb16accd063b0ff8e988dc812</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04141.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04141.x%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26aulast%3DGeldenhuys%26aufirst%3DW.%2BJ.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DMultifunctional%2520drugs%2520with%2520different%2520CNS%2520targets%2520for%2520neuropsychiatric%2520disorders%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D99%26spage%3D1033%26epage%3D1048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J. J.</span><span> </span><span class="NLM_article-title">Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.tips.2004.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15629202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktV2m" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=27-35&author=M.+B.+Youdimauthor=J.+J.+Buccafusco&title=Multi-functional+drugs+for+various+CNS+targets+in+the+treatment+of+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders</span></div><div class="casAuthors">Youdim, Moussa B. H.; Buccafusco, Jerry J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-35</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Individuals with neurodegenerative diseases such as Parkinson's disease or Alzheimer's disease are benefiting from drugs developed to act on a single mol. target.  However, current pharmacol. approaches are limited in their ability to modify significantly the course of the disease, and offer incomplete and transient benefit to patients.  New therapeutic strategies comprise drug candidates designed specifically to act on multiple neural and biochem. targets for the treatment of cognition impairment, motor dysfunction, depression and neurodegeneration.  Examples include the development of single mol. entities that combine 2 or more of the following properties: (i) cholinesterase inhibition; (ii) activation or inhibition of specific subtypes of acetylcholine receptors or α-adrenoceptors; (iii) anti-inflammatory activity; (iv) monoamine oxidase inhibition; (v) catechol-O-Me transferase inhibition; (vi) nitric oxide prodn.; (vii) neuroprotection; (viii) anti-apoptotic activity; and (ix) activation of mitochondrial-dependent cell-survival genes and proteins.  These bi- or multi-functional compds. might provide greater symptomatic efficacy, and better utility as potential neuroprotective disease-modifying drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreBPSKLWPfGLVg90H21EOLACvtfcHk0lgEqCcKIxHk_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktV2m&md5=0f2bd02614627d98b7e17a7a49905d1a</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2004.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2004.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DBuccafusco%26aufirst%3DJ.%2BJ.%26atitle%3DMulti-functional%2520drugs%2520for%2520various%2520CNS%2520targets%2520in%2520the%2520treatment%2520of%2520neurodegenerative%2520disorders%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D27%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Zhang, H. Y.</span><span> </span><span class="NLM_article-title">One-compound-multiple-targets strategy to combat Alzheimerʼs disease</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">579</span><span class="NLM_x">, </span> <span class="NLM_fpage">5260</span><span class="NLM_x">–</span> <span class="NLM_lpage">5264</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=579&publication_year=2005&pages=5260-5264&author=H.+Y.+Zhang&title=One-compound-multiple-targets+strategy+to+combat+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%2BY.%26atitle%3DOne-compound-multiple-targets%2520strategy%2520to%2520combat%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DFEBS%2520Lett.%26date%3D2005%26volume%3D579%26spage%3D5260%26epage%3D5264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">The path from anti Parkinson drug selegiline and rasagiline to multifunctional neuroprotective anti Alzheimer drugs ladostigil and m30</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.2174%2F156720506779025288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17168653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWksbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=541-550&author=M.+B.+Youdim&title=The+path+from+anti+Parkinson+drug+selegiline+and+rasagiline+to+multifunctional+neuroprotective+anti+Alzheimer+drugs+ladostigil+and+m30"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">The path from anti Parkinson drug selegiline and rasagiline to multifunctional neuroprotective anti Alzheimer drugs ladostigil and M30</span></div><div class="casAuthors">Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">541-550</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The therapeutic use of enzyme inhibitors in treatment of neurodegenerative diseases has its origin in the anti Parkinson action of the selective monoamine oxidase (MAO) B inhibitor, 1-deprenyl (selegiline), a failed anti depressant in 1975.  This led to further development of MAO- A and B, catechol-O-methyltansferase and cholinestrerase inhibitors as anti Parkinson and Alzheimer drugs.  One of the main reasons for the cognitive deficit in dementia of the Alzheimer' type (AD) and in dementia with Lewy bodies (DLB) is degeneration of cholinergic cortical neurons and synaptic plasticity.  This led to a correlation that similar to Parkinson's Disease (PD), cholinesterase inhibitors (ChEI) may also have therapeutic activity in AD.  Significant percentage of AD and DLB subjects also nigrostriatal dopaminergic, locus ceruleous noradrenergic and raphe nucleus serotoninergic neurons.  The present ChEI anti AD drugs have limited symptomatic activity and devoid of neuroprotective property that is needed for disease modifying action.  It is becoming clear that there are no magic bullets for neurodegenerative disorders and shut gun approach is needed either as polypharmacol. or drugs with multiple activity at different target sites in the CNS.  The complex pathol. of AD as well as cascade of events that leads to the neurodegenerative process has led us to develop several multifunctional neuroprotective drugs with several CNS targets with possible disease modifying activity.  Employing the pharmacophore of our antiparkinson drug rasagiline (Azilect, Agilect, N-propagrgyl-1R-aminoindan) we have developed a novel multifunctional neuroprotective drug, ladostigil [TV-3326 (N-propargyl-3R-aminoindan-5yl)-Et methylcarbamate], with both cholinesterase-butyrylesterase (Ch-BuE) and brain selective monoamine-oxidase (MAO) AB inhibitory activities possessing the neuroprotective-neurescue propargyl moiety, as potential treatment of AD and DLB and PD with dementias.  Since brain MAO and iron increase in AD, PD and aging, that could lead to iron dependent oxidative stress neurodegeneration, we have developed another series of multifunctional drugs (M30 HLA-20 series) which are brain permeable iron chelators- brain selective MAO inhibitors and possess the propargyl neuroprotective moiety.  These series of drugs have the ability of regulating and processing APP (amyloid precursor protein) and reducing Aβ peptide, since APP is a metaloprotein, with an iron responsive element 5''UTR similar to transferring and ferritin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUf6C6njrCALVg90H21EOLACvtfcHk0lgwWsbyYiTjmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWksbrF&md5=33be9cc15d120660265a0927b176d0dd</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.2174%2F156720506779025288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720506779025288%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DThe%2520path%2520from%2520anti%2520Parkinson%2520drug%2520selegiline%2520and%2520rasagiline%2520to%2520multifunctional%2520neuroprotective%2520anti%2520Alzheimer%2520drugs%2520ladostigil%2520and%2520m30%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2006%26volume%3D3%26spage%3D541%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">van der Schyf, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geldenhuys, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Multifunctional neuroprotective drugs for the treatment of cognitive and movement impairment disorders, including Alzheimerʼs and Parkinsonʼs diseases</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">447</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1358%2Fdof.2006.031.05.985904" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsFyntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=447-460&author=C.+J.+van+der+Schyfauthor=W.+J.+Geldenhuysauthor=M.+B.+Youdim&title=Multifunctional+neuroprotective+drugs+for+the+treatment+of+cognitive+and+movement+impairment+disorders%2C+including+Alzheimer%CA%BCs+and+Parkinson%CA%BCs+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional neuroprotective drugs for the treatment of cognitive and movement impairment disorders, including Alzheimer's and Parkinson's diseases</span></div><div class="casAuthors">Van der Schyf, Cornelis J.; Geldenhuys, Werner J.; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">447-460</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  The concept of targeting multiple disease etiologies that lead to cognitive and movement impairment in neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease and stroke, is challenging the widely held assumption that "silver bullet" agents are superior to "dirty drugs" in the pharmacol. treatment of these diseases.  Accumulating evidence in the literature suggests that a drug with two or more mechanisms of action targeted at multiple etiologies of the same disease may offer greater therapeutic benefit in certain disorders than a drug that targets only one disease etiol.  In addn., the use of a single such multifunctional drug possessing several pharmacol. active moieties may yield a more favorable side effect profile than a combination of several drugs that individually target the same disease etiologies.  In this review, we offer a synopsis of therapeutic strategies and novel investigative drugs developed in our own and other labs. that modulate multiple disease targets assocd. with cognitive and movement impairment disorders, including cognitive decline assocd. with Alzheimer's disease, Parkinson's disease with dementia and movement deficits in Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXfldsPAa7krVg90H21EOLACvtfcHk0lgwWsbyYiTjmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsFyntbk%253D&md5=4899ea8eef04811b55f1c4638898dc42</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1358%2Fdof.2006.031.05.985904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2006.031.05.985904%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26aulast%3DGeldenhuys%26aufirst%3DW.%2BJ.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DMultifunctional%2520neuroprotective%2520drugs%2520for%2520the%2520treatment%2520of%2520cognitive%2520and%2520movement%2520impairment%2520disorders%252C%2520including%2520Alzheimer%25CA%25BCs%2520and%2520Parkinson%25CA%25BCs%2520diseases%26jtitle%3DDrugs%2520Future%26date%3D2006%26volume%3D31%26spage%3D447%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Melchiorre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banzi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span> </span><span class="NLM_article-title">Polymethylene tetraamine backbone as template for the development of biologically active polyamines</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fmed.10029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=12500289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitVyksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=200-233&author=C.+Melchiorreauthor=A.+Antonelloauthor=R.+Banziauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiatti&title=Polymethylene+tetraamine+backbone+as+template+for+the+development+of+biologically+active+polyamines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Polymethylene tetraamine backbone as template for the development of biologically active polyamines</span></div><div class="casAuthors">Melchiorre, Carlo; Antonello, Alessandra; Banzi, Rita; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">200-233</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The concept that polyamines may represent a universal template in the receptor recognition process is embodied in the design of ligands for different biol. targets.  As a matter of fact, the insertion of different pharmacophores onto the polymethylene tetraamine backbone can tune both affinity and selectivity for any given receptor.  The application of this approach provided a prospect of modifying benextramine (1) structure to achieve specific recognition of muscarinic receptors that led to the discovery of methoctramine (2), which is widely used as a pharmacol. tool for muscarinic receptor characterization.  In turn, appropriate structural modifications performed on the structure of methoctramine led to the discovery of new polyamines endowed with high affinity and selectivity for (a) muscarinic receptor subtypes, (b) Gi proteins, and (c) muscle-type nicotinic receptors.  Thus, polyamines tripitramine (9) and spirotramine (33), among others, were designed, which were shown to be highly selective for muscarinic M2 and M1 receptors, resp.  Several polyamines have been discovered, which inhibit noncompetitively a closed state of the nicotinic receptor.  These ligands, such as 66, resulted in important tools for elucidating the mode and site of interaction of polyamines with the ion channel.  It was discovered that reducing the flexibility of the diaminohexane spacer of methoctramine led to polyamines, such as 70, which are endowed with a biol. profile significantly different from that of the prototype.  Most likely, tetraamine (70) is a potent activator of Gi proteins.  Finally, the universal template approach formed the basis for modifying benextramine (1) structure to the design of ligands, which display affinity for acetylcholinesterase and muscarinic M2 receptors.  Thus, these polyamines, such as caproctamine (78), could have potential in the investigation of Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6Nb4xLhb1F7Vg90H21EOLACvtfcHk0lgwWsbyYiTjmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitVyksro%253D&md5=71f7966a0f5ff169106de2d617e340b2</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1002%2Fmed.10029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.10029%26sid%3Dliteratum%253Aachs%26aulast%3DMelchiorre%26aufirst%3DC.%26aulast%3DAntonello%26aufirst%3DA.%26aulast%3DBanzi%26aufirst%3DR.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26atitle%3DPolymethylene%2520tetraamine%2520backbone%2520as%2520template%2520for%2520the%2520development%2520of%2520biologically%2520active%2520polyamines%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2003%26volume%3D23%26spage%3D200%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Melchiorre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budriesi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavrini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimerʼs disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">4186</span><span class="NLM_x">–</span> <span class="NLM_lpage">4189</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9810452" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=4186-4189&author=C.+Melchiorreauthor=V.+Andrisanoauthor=M.+L.+Bolognesiauthor=R.+Budriesiauthor=A.+Cavalliauthor=V.+Cavriniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatini&title=Acetylcholinesterase+noncovalent+inhibitors+based+on+a+polyamine+backbone+for+potential+use+against+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm9810452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9810452%26sid%3Dliteratum%253Aachs%26aulast%3DMelchiorre%26aufirst%3DC.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DBudriesi%26aufirst%3DR.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DCavrini%26aufirst%3DV.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26atitle%3DAcetylcholinesterase%2520noncovalent%2520inhibitors%2520based%2520on%2520a%2520polyamine%2520backbone%2520for%2520potential%2520use%2520against%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D4186%26epage%3D4189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span> </span><span class="NLM_article-title">3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2<i>H</i>-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimerʼs disease therapy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2279</span><span class="NLM_x">–</span> <span class="NLM_lpage">2282</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0340602" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2279-2282&author=L.+Piazziauthor=A.+Rampaauthor=A.+Bisiauthor=S.+Gobbiauthor=F.+Bellutiauthor=A.+Cavalliauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=P.+Valentiauthor=M.+Recanatini&title=3-%284-%5B%5BBenzyl%28methyl%29amino%5Dmethyl%5Dphenyl%29-6%2C7-dimethoxy-2H-2-chromenone+%28AP2238%29+inhibits+both+acetylcholinesterase+and+acetylcholinesterase-induced+beta-amyloid+aggregation%3A+a+dual+function+lead+for+Alzheimer%CA%BCs+disease+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm0340602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0340602%26sid%3Dliteratum%253Aachs%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DValenti%26aufirst%3DP.%26aulast%3DRecanatini%26aufirst%3DM.%26atitle%3D3-%25284-%255B%255BBenzyl%2528methyl%2529amino%255Dmethyl%255Dphenyl%2529-6%252C7-dimethoxy-2H-2-chromenone%2520%2528AP2238%2529%2520inhibits%2520both%2520acetylcholinesterase%2520and%2520acetylcholinesterase-induced%2520beta-amyloid%2520aggregation%253A%2520a%2520dual%2520function%2520lead%2520for%2520Alzheimer%25CA%25BCs%2520disease%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2279%26epage%3D2282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavrini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span> </span><span class="NLM_article-title">beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2FS0006-2952%2802%2901514-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=12527333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivVKitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2003&pages=407-416&author=M.+Bartoliniauthor=C.+Bertucciauthor=V.+Cavriniauthor=V.+Andrisano&title=beta-Amyloid+aggregation+induced+by+human+acetylcholinesterase%3A+inhibition+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">β-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies</span></div><div class="casAuthors">Bartolini, Manuela; Bertucci, Carlo; Cavrini, Vanni; Andrisano, Vincenza</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">407-416</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The aggregation of β-amyloid (1-40) (Aβ) induced by human recombinant acetylcholinesterase (HuAChE) was studied by means of CD (CD) and by thioflavin T fluorescence spectroscopy.  Aβ was incubated alone and with HuAChE.  The kinetic of fibrils formation was followed for 48 h.  The increasing β-conformation content induced by HuAChE, preliminary to the formation of Aβ fibrils, was detd. by CD.  This phenomenon was found to be related to the thioflavin T emission of fluorescence at 490 nm.  Incubation expts. were performed in the presence of known AChE inhibitors (physostigmine, edrophonium, decamethonium, propidium) and drugs used for Alzheimer's disease (AD) (tacrine, donepezil), to test their capability of preventing the HuAChE-induced Aβ aggregation.  The non-competitive or mixed mode of AChE inhibition was confirmed to be an essential feature.  At 100 μM propidium, decamethonium, donepezil and physostigmine were found to inhibit the HuAChE-induced Aβ aggregation by 82, 25, 22 and 30%, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2eDGIBesVCbVg90H21EOLACvtfcHk0li5SBFaSFgc_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivVKitA%253D%253D&md5=51d1021e8be93014f0b15a61db241392</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2802%2901514-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252802%252901514-9%26sid%3Dliteratum%253Aachs%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DBertucci%26aufirst%3DC.%26aulast%3DCavrini%26aufirst%3DV.%26aulast%3DAndrisano%26aufirst%3DV.%26atitle%3Dbeta-Amyloid%2520aggregation%2520induced%2520by%2520human%2520acetylcholinesterase%253A%2520inhibition%2520studies%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2003%26volume%3D65%26spage%3D407%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banzi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Structure−activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 3. Effect of replacing the inner polymethylene chain with cyclic moieties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6490</span><span class="NLM_x">–</span> <span class="NLM_lpage">6498</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0494366" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6490-6498&author=V.+Tumiattiauthor=V.+Andrisanoauthor=R.+Banziauthor=M.+Bartoliniauthor=A.+Minariniauthor=M.+Rosiniauthor=C.+Melchiorre&title=Structure%E2%88%92activity+relationships+of+acetylcholinesterase+noncovalent+inhibitors+based+on+a+polyamine+backbone.+3.+Effect+of+replacing+the+inner+polymethylene+chain+with+cyclic+moieties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjm0494366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0494366%26sid%3Dliteratum%253Aachs%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBanzi%26aufirst%3DR.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520of%2520acetylcholinesterase%2520noncovalent%2520inhibitors%2520based%2520on%2520a%2520polyamine%2520backbone.%25203.%2520Effect%2520of%2520replacing%2520the%2520inner%2520polymethylene%2520chain%2520with%2520cyclic%2520moieties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6490%26epage%3D6498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, P.</span><span> </span><span class="NLM_article-title">Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4444</span><span class="NLM_x">–</span> <span class="NLM_lpage">4456</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049515h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4444-4456&author=F.+Bellutiauthor=A.+Rampaauthor=L.+Piazziauthor=A.+Bisiauthor=S.+Gobbiauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=A.+Cavalliauthor=M.+Recanatiniauthor=P.+Valenti&title=Cholinesterase+inhibitors%3A+xanthostigmine+derivatives+blocking+the+acetylcholinesterase-induced+beta-amyloid+aggregation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fjm049515h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049515h%26sid%3Dliteratum%253Aachs%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DValenti%26aufirst%3DP.%26atitle%3DCholinesterase%2520inhibitors%253A%2520xanthostigmine%2520derivatives%2520blocking%2520the%2520acetylcholinesterase-induced%2520beta-amyloid%2520aggregation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4444%26epage%3D4456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budriesi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacciaguerra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spampinato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">4150</span><span class="NLM_x">–</span> <span class="NLM_lpage">4160</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm981038d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=4150-4160&author=M.+L.+Bolognesiauthor=A.+Minariniauthor=R.+Budriesiauthor=S.+Cacciaguerraauthor=A.+Chiariniauthor=S.+Spampinatoauthor=V.+Tumiattiauthor=C.+Melchiorre&title=Universal+template+approach+to+drug+design%3A+polyamines+as+selective+muscarinic+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjm981038d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm981038d%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DBudriesi%26aufirst%3DR.%26aulast%3DCacciaguerra%26aufirst%3DS.%26aulast%3DChiarini%26aufirst%3DA.%26aulast%3DSpampinato%26aufirst%3DS.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DUniversal%2520template%2520approach%2520to%2520drug%2520design%253A%2520polyamines%2520as%2520selective%2520muscarinic%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D4150%26epage%3D4160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banzi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-beta aggregation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049156q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=24-27&author=M.+L.+Bolognesiauthor=V.+Andrisanoauthor=M.+Bartoliniauthor=R.+Banziauthor=C.+Melchiorre&title=Propidium-based+polyamine+ligands+as+potent+inhibitors+of+acetylcholinesterase+and+acetylcholinesterase-induced+amyloid-beta+aggregation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fjm049156q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049156q%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DBanzi%26aufirst%3DR.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DPropidium-based%2520polyamine%2520ligands%2520as%2520potent%2520inhibitors%2520of%2520acetylcholinesterase%2520and%2520acetylcholinesterase-induced%2520amyloid-beta%2520aggregation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D24%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Munoz-Ruiz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Palomero, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorronsoro, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Monte-Millan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenzuela, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Austria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bidon-Chanal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orozco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimerʼs disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7223</span><span class="NLM_x">–</span> <span class="NLM_lpage">7233</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0503289" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7223-7233&author=P.+Munoz-Ruizauthor=L.+Rubioauthor=E.+Garcia-Palomeroauthor=I.+Dorronsoroauthor=M.+del+Monte-Millanauthor=R.+Valenzuelaauthor=P.+Usanauthor=C.+de+Austriaauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=A.+Bidon-Chanalauthor=M.+Orozcoauthor=F.+J.+Luqueauthor=M.+Medinaauthor=A.+Martinez&title=Design%2C+synthesis%2C+and+biological+evaluation+of+dual+binding+site+acetylcholinesterase+inhibitors%3A+new+disease-modifying+agents+for+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fjm0503289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503289%26sid%3Dliteratum%253Aachs%26aulast%3DMunoz-Ruiz%26aufirst%3DP.%26aulast%3DRubio%26aufirst%3DL.%26aulast%3DGarcia-Palomero%26aufirst%3DE.%26aulast%3DDorronsoro%26aufirst%3DI.%26aulast%3Ddel%2BMonte-Millan%26aufirst%3DM.%26aulast%3DValenzuela%26aufirst%3DR.%26aulast%3DUsan%26aufirst%3DP.%26aulast%3Dde%2BAustria%26aufirst%3DC.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMedina%26aufirst%3DM.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520dual%2520binding%2520site%2520acetylcholinesterase%2520inhibitors%253A%2520new%2520disease-modifying%2520agents%2520for%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7223%26epage%3D7233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Kapkova, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alptuzun, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erciyas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holzgrabe, U.</span><span> </span><span class="NLM_article-title">Search for dual function inhibitors for Alzheimerʼs disease: synthesis and biological activity of acetylcholinesterase inhibitors of pyridinium-type and their Abeta fibril formation inhibition capacity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">472</span><span class="NLM_x">–</span> <span class="NLM_lpage">478</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=472-478&author=P.+Kapkovaauthor=V.+Alptuzunauthor=P.+Freyauthor=E.+Erciyasauthor=U.+Holzgrabe&title=Search+for+dual+function+inhibitors+for+Alzheimer%CA%BCs+disease%3A+synthesis+and+biological+activity+of+acetylcholinesterase+inhibitors+of+pyridinium-type+and+their+Abeta+fibril+formation+inhibition+capacity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKapkova%26aufirst%3DP.%26aulast%3DAlptuzun%26aufirst%3DV.%26aulast%3DFrey%26aufirst%3DP.%26aulast%3DErciyas%26aufirst%3DE.%26aulast%3DHolzgrabe%26aufirst%3DU.%26atitle%3DSearch%2520for%2520dual%2520function%2520inhibitors%2520for%2520Alzheimer%25CA%25BCs%2520disease%253A%2520synthesis%2520and%2520biological%2520activity%2520of%2520acetylcholinesterase%2520inhibitors%2520of%2520pyridinium-type%2520and%2520their%2520Abeta%2520fibril%2520formation%2520inhibition%2520capacity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D472%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Gottfries, C. G.</span><span> </span><span class="NLM_article-title">Neurochemical aspects on aging and diseases with cognitive impairment</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fjnr.490270415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=2079715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaK3MXnvFCjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1990&pages=541-547&author=C.+G.+Gottfries&title=Neurochemical+aspects+on+aging+and+diseases+with+cognitive+impairment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Neurochemical aspects on aging and diseases with cognitive impairment</span></div><div class="casAuthors">Gottfries, C. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-7</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    </div><div class="casAbstract">A review with 61 refs. discussing neurochem. changes in normal aging, in idiopathic dementias, mainly Alzheimer's disease, and in vascular dementias.  Emphasis is placed on neurotransmitter disturbances, disturbed enzyme activities involved in neurotransmitter metab., and disturbed metab. of gangliosides and white matter components.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlFu_AlLpO7Vg90H21EOLACvtfcHk0lhh833a1LA9og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXnvFCjuw%253D%253D&md5=f3744df7ad8b6c0a44ed3587451a3030</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1002%2Fjnr.490270415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.490270415%26sid%3Dliteratum%253Aachs%26aulast%3DGottfries%26aufirst%3DC.%2BG.%26atitle%3DNeurochemical%2520aspects%2520on%2520aging%2520and%2520diseases%2520with%2520cognitive%2520impairment%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D1990%26volume%3D27%26spage%3D541%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Meltzer, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeKosky, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kupfer, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. F.</span><span> </span><span class="NLM_article-title">3rd serotonin in aging, late-life depression, and Alzheimerʼs disease: the emerging role of functional imaging</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1998&pages=407-430&author=C.+C.+Meltzerauthor=G.+Smithauthor=S.+T.+DeKoskyauthor=B.+G.+Pollockauthor=C.+A.+Mathisauthor=R.+Y.+Mooreauthor=D.+J.+Kupferauthor=C.+F.+Reynolds&title=3rd+serotonin+in+aging%2C+late-life+depression%2C+and+Alzheimer%CA%BCs+disease%3A+the+emerging+role+of+functional+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeltzer%26aufirst%3DC.%2BC.%26aulast%3DSmith%26aufirst%3DG.%26aulast%3DDeKosky%26aufirst%3DS.%2BT.%26aulast%3DPollock%26aufirst%3DB.%2BG.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DMoore%26aufirst%3DR.%2BY.%26aulast%3DKupfer%26aufirst%3DD.%2BJ.%26aulast%3DReynolds%26aufirst%3DC.%2BF.%26atitle%3D3rd%2520serotonin%2520in%2520aging%252C%2520late-life%2520depression%252C%2520and%2520Alzheimer%25CA%25BCs%2520disease%253A%2520the%2520emerging%2520role%2520of%2520functional%2520imaging%26jtitle%3DNeuropsychopharmacology%26date%3D1998%26volume%3D18%26spage%3D407%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Schneider, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olin, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawluczyk, S.</span><span> </span><span class="NLM_article-title">A double-blind crossover pilot study of l-deprenyl (selegiline) combined with cholinesterase inhibitor in Alzheimerʼs disease</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">150</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=8422085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADyaK3s7jsFaktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=1993&pages=321-323&author=L.+S.+Schneiderauthor=J.+T.+Olinauthor=S.+Pawluczyk&title=A+double-blind+crossover+pilot+study+of+l-deprenyl+%28selegiline%29+combined+with+cholinesterase+inhibitor+in+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">A double-blind crossover pilot study of l-deprenyl (selegiline) combined with cholinesterase inhibitor in Alzheimer's disease</span></div><div class="casAuthors">Schneider L S; Olin J T; Pawluczyk S</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">321-3</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">The potential efficacy of oral l-deprenyl (5 mg b.i.d.) added to the regimen of 10 patients with Alzheimer's disease receiving either tacrine or physostigmine was assessed in a double-blind, placebo-controlled, 4-week, two-period crossover pilot study. l-Deprenyl was associated with significant improvement in scores on the cognitive subscale of the Alzheimer's Disease Assessment Scale, suggesting possible additive effects of l-deprenyl to the effects of cholinesterase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2cVuWGb1YXiO2kE7krGOBfW6udTcc2eYsc6v1KDOakLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s7jsFaktA%253D%253D&md5=f08c97c512557e001923687acf581e62</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DL.%2BS.%26aulast%3DOlin%26aufirst%3DJ.%2BT.%26aulast%3DPawluczyk%26aufirst%3DS.%26atitle%3DA%2520double-blind%2520crossover%2520pilot%2520study%2520of%2520l-deprenyl%2520%2528selegiline%2529%2520combined%2520with%2520cholinesterase%2520inhibitor%2520in%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D1993%26volume%3D150%26spage%3D321%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Marin, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bierer, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawlor, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmeidler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohs, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, K. L.</span><span> </span><span class="NLM_article-title"><span class="smallcaps smallerCapital">l</span>-Deprenyl and physostigmine for the treatment of Alzheimerʼs disease</span> <span class="citation_source-journal">Psychiatry Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2F0165-1781%2895%2902714-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=8570774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaK28Xhs1ynug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1995&pages=181-189&author=D.+B.+Marinauthor=L.+M.+Biererauthor=B.+A.+Lawlorauthor=T.+M.+Ryanauthor=R.+Jacobsonauthor=J.+Schmeidlerauthor=R.+C.+Mohsauthor=K.+L.+Davis&title=l-Deprenyl+and+physostigmine+for+the+treatment+of+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">L-Deprenyl and physostigmine for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Marin, Deborah B.; Bierer, Linda M.; Lawlor, Brian A.; Ryan, Theresa M.; Jacobson, Rachel; Schmeidler, James; Mohs, Richard C.; Davis, Kenneth L.</div><div class="citationInfo"><span class="NLM_cas:title">Psychiatry Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">181-9</span>CODEN:
                <span class="NLM_cas:coden">PSRSDR</span>;
        ISSN:<span class="NLM_cas:issn">0165-1781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The present study evaluated the safety of and obtained preliminary data on the cognitive effects of L-deprenyl and physostigmine in patients with Alzheimer's Disease.  Seventeen outpatients with Alzheimer's Disease participated in a double-blind crossover study in which they received 4 wk of L-deprenyl at a dose of 10 mg p.o., q.d., and 4 wk of placebo in random order.  During both the L-deprenyl and placebo periods, patients received cognitive assessments during physostigmine (0.5 mg) and placebo infusions sepd. by 2 days.  The cognitive effects of these agents alone and in combination were measured with digit span, verbal fluency, list learning, praxis, delayed recall, and delayed recognition tasks.  Fifteen patients completed the study.  The two drugs, used alone or in combination, were safe and well tolerated.  Analyses of variance demonstrated that neither physostigmine nor L-deprenyl, whether given alone or in combination, significantly improved cognition, when compared with the double placebo condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfpGtkFzVkw7Vg90H21EOLACvtfcHk0ljZVzs0wJx0aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xhs1ynug%253D%253D&md5=ac35b0cee6b80e5f0eef5082cf4ee89f</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2F0165-1781%2895%2902714-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1781%252895%252902714-8%26sid%3Dliteratum%253Aachs%26aulast%3DMarin%26aufirst%3DD.%2BB.%26aulast%3DBierer%26aufirst%3DL.%2BM.%26aulast%3DLawlor%26aufirst%3DB.%2BA.%26aulast%3DRyan%26aufirst%3DT.%2BM.%26aulast%3DJacobson%26aufirst%3DR.%26aulast%3DSchmeidler%26aufirst%3DJ.%26aulast%3DMohs%26aufirst%3DR.%2BC.%26aulast%3DDavis%26aufirst%3DK.%2BL.%26atitle%3Dl-Deprenyl%2520and%2520physostigmine%2520for%2520the%2520treatment%2520of%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DPsychiatry%2520Res.%26date%3D1995%26volume%3D58%26spage%3D181%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Alper, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girgin, F. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozgonul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mentes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ersoz, B.</span><span> </span><span class="NLM_article-title">MAO inhibitors and oxidant stress in aging brain tissue</span> <span class="citation_source-journal">Eur. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2FS0924-977X%2898%2900035-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=10208295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaK1MXhsVWntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=247-252&author=G.+Alperauthor=F.+K.+Girginauthor=M.+Ozgonulauthor=G.+Mentesauthor=B.+Ersoz&title=MAO+inhibitors+and+oxidant+stress+in+aging+brain+tissue"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">MAO inhibitors and oxidant stress in aging brain tissue</span></div><div class="casAuthors">Alper, Gulinnaz; Girgin, Ferhan Kulahcioglu; Ozgonul, Mert; Mentes, Gulriz; Ersoz, Biltan</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">247-252</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">The process of aging presents itself with various alterations in physiol. events.  Among many theories, the free radical (FR) theory of aging which reflects the FR damage to cellular components is accepted as one of the most important theories.  Recently, the increases in catecholamine metab. in aging have also attracted attention, and monoamine oxidase (MAO), a key enzyme in this process has been extensively studied.  The aim of this study was to assess the role of FR species via MAO, a possible source of FRs, in physiol. aging by detg. the lipid peroxidn. products (LPP) (malondialdehyde, diene conjugates) and antioxidant enzyme levels (superoxide dismutase (SOD) and catalase (CAT)) in young (3 mo old, n=10) and aging (16-18 mo old, n=10) rat brain tissues of Swiss male albino rats.  In the second part of the study, the same parameters were detd. after the acute administration of MAO inhibitors (deprenyl and pargyline, 25 mg/kg i.p.) to investigate whether these agents have any beneficial effects in reducing oxidant stress via inhibition of MAO.  In old rat brains, MAO activities showed a significant increase (P=0.000) in addn. to an insignificant increase in LPP, while SOD (P=0.007) and CAT activities showed a decrease with advancing age.  After the acute administration of both deprenyl and pargyline, a significant decrease in the MAO activities of both young (P=0.0002 for each) and aging rats (P=0.0002 for deprenyl and P=0.0001 for pargyline) were obsd.  It was noted that deprenyl causes a significant increase in CAT activity (P<0.05) but a significant decrease in SOD activity (P<0.05) in young rats, while it causes only a significant increase in SOD activity in aging rats (P<0.05).  Both deprenyl and pargyline cause a significant decrease in conjugated diene levels of aging rats (P<0.05).  These results confirm the role of catecholamine oxidn. and MAO activity as one of the causative factors in increased oxidant stress during aging.  By reducing the oxidant stress obsd. in aging brain, MAO inhibitors, esp. deprenyl, may contribute to the control of the aging process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm6M1xBHX5l7Vg90H21EOLACvtfcHk0ljZVzs0wJx0aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhsVWntLc%253D&md5=b575a7571b0de3b6f39e66c1dd2e7088</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2FS0924-977X%2898%2900035-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0924-977X%252898%252900035-2%26sid%3Dliteratum%253Aachs%26aulast%3DAlper%26aufirst%3DG.%26aulast%3DGirgin%26aufirst%3DF.%2BK.%26aulast%3DOzgonul%26aufirst%3DM.%26aulast%3DMentes%26aufirst%3DG.%26aulast%3DErsoz%26aufirst%3DB.%26atitle%3DMAO%2520inhibitors%2520and%2520oxidant%2520stress%2520in%2520aging%2520brain%2520tissue%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D1999%26volume%3D9%26spage%3D247%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Fink, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palermo, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bores, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huger, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurys, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merriman, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petko, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OʼMalley, G. J.</span><span> </span><span class="NLM_article-title">Imino 1,2,3,4-tetrahydrocyclopent[<i>b</i>]indole carbamates as dual inhibitors of acetylcholinesterase and monoamine oxidase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">625</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=625-630&author=D.+M.+Finkauthor=M.+G.+Palermoauthor=G.+M.+Boresauthor=F.+P.+Hugerauthor=B.+E.+Kurysauthor=M.+C.+Merrimanauthor=G.+E.+Olsenauthor=W.+Petkoauthor=G.+J.+O%CA%BCMalley&title=Imino+1%2C2%2C3%2C4-tetrahydrocyclopent%5Bb%5Dindole+carbamates+as+dual+inhibitors+of+acetylcholinesterase+and+monoamine+oxidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFink%26aufirst%3DD.%2BM.%26aulast%3DPalermo%26aufirst%3DM.%2BG.%26aulast%3DBores%26aufirst%3DG.%2BM.%26aulast%3DHuger%26aufirst%3DF.%2BP.%26aulast%3DKurys%26aufirst%3DB.%2BE.%26aulast%3DMerriman%26aufirst%3DM.%2BC.%26aulast%3DOlsen%26aufirst%3DG.%2BE.%26aulast%3DPetko%26aufirst%3DW.%26aulast%3DO%25CA%25BCMalley%26aufirst%3DG.%2BJ.%26atitle%3DImino%25201%252C2%252C3%252C4-tetrahydrocyclopent%255Bb%255Dindole%2520carbamates%2520as%2520dual%2520inhibitors%2520of%2520acetylcholinesterase%2520and%2520monoamine%2520oxidase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1996%26volume%3D6%26spage%3D625%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Gnerre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span> </span><span class="NLM_article-title">Inhibition of monoamine oxidases by functionalized coumarin derivatives: biological activities, QSARs, and 3D-QSARs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4747</span><span class="NLM_x">–</span> <span class="NLM_lpage">4758</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm001028o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4747-4758&author=C.+Gnerreauthor=M.+Cattoauthor=F.+Leonettiauthor=P.+Weberauthor=P.+A.+Carruptauthor=C.+Altomareauthor=A.+Carottiauthor=B.+Testa&title=Inhibition+of+monoamine+oxidases+by+functionalized+coumarin+derivatives%3A+biological+activities%2C+QSARs%2C+and+3D-QSARs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjm001028o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm001028o%26sid%3Dliteratum%253Aachs%26aulast%3DGnerre%26aufirst%3DC.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DWeber%26aufirst%3DP.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DAltomare%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidases%2520by%2520functionalized%2520coumarin%2520derivatives%253A%2520biological%2520activities%252C%2520QSARs%252C%2520and%25203D-QSARs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4747%26epage%3D4758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Bruhlmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ooms, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3195</span><span class="NLM_x">–</span> <span class="NLM_lpage">3198</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010894d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3195-3198&author=C.+Bruhlmannauthor=F.+Oomsauthor=P.+A.+Carruptauthor=B.+Testaauthor=M.+Cattoauthor=F.+Leonettiauthor=C.+Altomareauthor=A.+Carotti&title=Coumarins+derivatives+as+dual+inhibitors+of+acetylcholinesterase+and+monoamine+oxidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fjm010894d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010894d%26sid%3Dliteratum%253Aachs%26aulast%3DBruhlmann%26aufirst%3DC.%26aulast%3DOoms%26aufirst%3DF.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DTesta%26aufirst%3DB.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DAltomare%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DCoumarins%2520derivatives%2520as%2520dual%2520inhibitors%2520of%2520acetylcholinesterase%2520and%2520monoamine%2520oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3195%26epage%3D3198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Novaroli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertolini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Giovanni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reist, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P.-A.</span><span> </span><span class="NLM_article-title">Identification of novel multifunctional compounds for the treatment of some aging related neurodegenerative diseases</span> <span class="citation_source-journal">Chimia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">320</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2005&pages=315-320&author=L.+Novaroliauthor=A.+Dainaauthor=F.+Bertoliniauthor=S.+Di+Giovanniauthor=J.+Bravoauthor=M.+Reistauthor=P.-A.+Carrupt&title=Identification+of+novel+multifunctional+compounds+for+the+treatment+of+some+aging+related+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNovaroli%26aufirst%3DL.%26aulast%3DDaina%26aufirst%3DA.%26aulast%3DBertolini%26aufirst%3DF.%26aulast%3DDi%2BGiovanni%26aufirst%3DS.%26aulast%3DBravo%26aufirst%3DJ.%26aulast%3DReist%26aufirst%3DM.%26aulast%3DCarrupt%26aufirst%3DP.-A.%26atitle%3DIdentification%2520of%2520novel%2520multifunctional%2520compounds%2520for%2520the%2520treatment%2520of%2520some%2520aging%2520related%2520neurodegenerative%2520diseases%26jtitle%3DChimia%26date%3D2005%26volume%3D59%26spage%3D315%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Bruhlmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hostettmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span> </span><span class="NLM_article-title">Screening of non-alkaloidal natural compounds as acetylcholinesterase inhibitors</span> <span class="citation_source-journal">Chem. Biodiversity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">819</span><span class="NLM_x">–</span> <span class="NLM_lpage">829</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fcbdv.200490064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17191882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADC%252BD28jlsV2ltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=819-829&author=C.+Bruhlmannauthor=A.+Marstonauthor=K.+Hostettmannauthor=P.+A.+Carruptauthor=B.+Testa&title=Screening+of+non-alkaloidal+natural+compounds+as+acetylcholinesterase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Screening of non-alkaloidal natural compounds as acetylcholinesterase inhibitors</span></div><div class="casAuthors">Bruhlmann Corinne; Marston Andrew; Hostettmann Kurt; Carrupt Pierre-Alain; Testa Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & biodiversity</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">819-29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Acetylcholinesterase (AChE) inhibitors are currently the only approved therapy for the treatment of Alzheimer's disease, only a limited number of drugs are commercially available.  A library of non-alkaloidal natural compounds was investigated.  To this end, a convenient microtitre plate method for assaying AChE inhibition, which allows a complete kinetic analysis of AChE inhibitors, was developed.  Seven active compounds with Ki values in the micromolar range were identified, six of which were xanthones.  This is the first report that a promising potential for AChE inhibition exists in such non-nitrogenous natural compounds.  Furthermore, four xanthones among these xanthones had already been described as monoamine oxidase (MAO) inhibitors, making then dual AChE/MAO inhibitors of great interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLoMMalrvgaRFwe7cAcrfPfW6udTcc2ebZZNsLUK0Bo7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jlsV2ltw%253D%253D&md5=4fedc3c51f6e5a2ff6b9013b86f3da4e</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.200490064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.200490064%26sid%3Dliteratum%253Aachs%26aulast%3DBruhlmann%26aufirst%3DC.%26aulast%3DMarston%26aufirst%3DA.%26aulast%3DHostettmann%26aufirst%3DK.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DScreening%2520of%2520non-alkaloidal%2520natural%2520compounds%2520as%2520acetylcholinesterase%2520inhibitors%26jtitle%3DChem.%2520Biodiversity%26date%3D2004%26volume%3D1%26spage%3D819%26epage%3D829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Sterling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzig, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkelstein, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miskolczi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molnar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rantal, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagyva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zekany, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavian, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krais, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chorev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstock, M.</span><span> </span><span class="NLM_article-title">Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimerʼs disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5260</span><span class="NLM_x">–</span> <span class="NLM_lpage">5279</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020120c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5260-5279&author=J.+Sterlingauthor=Y.+Herzigauthor=T.+Gorenauthor=N.+Finkelsteinauthor=D.+Lernerauthor=W.+Goldenbergauthor=I.+Miskolcziauthor=S.+Molnarauthor=F.+Rantalauthor=T.+Tamasauthor=G.+Tothauthor=A.+Zagyvaauthor=A.+Zekanyauthor=J.+Finbergauthor=G.+Lavianauthor=A.+Grossauthor=R.+Friedmanauthor=M.+Razinauthor=W.+Huangauthor=B.+Kraisauthor=M.+Chorevauthor=M.+B.+Youdimauthor=M.+Weinstock&title=Novel+dual+inhibitors+of+AChE+and+MAO+derived+from+hydroxy+aminoindan+and+phenethylamine+as+potential+treatment+for+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fjm020120c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020120c%26sid%3Dliteratum%253Aachs%26aulast%3DSterling%26aufirst%3DJ.%26aulast%3DHerzig%26aufirst%3DY.%26aulast%3DGoren%26aufirst%3DT.%26aulast%3DFinkelstein%26aufirst%3DN.%26aulast%3DLerner%26aufirst%3DD.%26aulast%3DGoldenberg%26aufirst%3DW.%26aulast%3DMiskolczi%26aufirst%3DI.%26aulast%3DMolnar%26aufirst%3DS.%26aulast%3DRantal%26aufirst%3DF.%26aulast%3DTamas%26aufirst%3DT.%26aulast%3DToth%26aufirst%3DG.%26aulast%3DZagyva%26aufirst%3DA.%26aulast%3DZekany%26aufirst%3DA.%26aulast%3DFinberg%26aufirst%3DJ.%26aulast%3DLavian%26aufirst%3DG.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DR.%26aulast%3DRazin%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DKrais%26aufirst%3DB.%26aulast%3DChorev%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DWeinstock%26aufirst%3DM.%26atitle%3DNovel%2520dual%2520inhibitors%2520of%2520AChE%2520and%2520MAO%2520derived%2520from%2520hydroxy%2520aminoindan%2520and%2520phenethylamine%2520as%2520potential%2520treatment%2520for%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5260%26epage%3D5279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Am, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yogev-Falach, M.</span><span> </span><span class="NLM_article-title">Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs; ladostigil</span> <span class="citation_source-journal">Neurotoxic. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1007%2FBF03033355" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17197368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsFekt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=181-192&author=M.+B.+Youdimauthor=T.+Amitauthor=O.+Bar-Amauthor=O.+Weinrebauthor=M.+Yogev-Falach&title=Implications+of+co-morbidity+for+etiology+and+treatment+of+neurodegenerative+diseases+with+multifunctional+neuroprotective-neurorescue+drugs%3B+ladostigil"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs; ladostigil</span></div><div class="casAuthors">Youdim, Moussa B. H.; Amit, Tamar; Bar-Am, Orit; Weinreb, Orly; Yogev-Falach, Mara</div><div class="citationInfo"><span class="NLM_cas:title">Neurotoxicity Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3,4</span>),
    <span class="NLM_cas:pages">181-192</span>CODEN:
                <span class="NLM_cas:coden">NURRFI</span>;
        ISSN:<span class="NLM_cas:issn">1029-8428</span>.
    
            (<span class="NLM_cas:orgname">F. P. Graham Publishing Co.</span>)
        </div><div class="casAbstract">A review.  The recent therapeutic approach in which drug candidates are designed to possess diverse pharmacol. properties and act on multiple targets has stimulated the development of several multifunction drugs.  These include ladostigil (TV3326) [(N-propargyl-(3R) aminoindan-5yl)-Et Me carbamate], which combines the pharmacophore-neuroprotective effects of rasagiline, a selective monoamine oxidase (MAO)-B inhibitor, with the cholinesterase (ChE) inhibitory activity of rivastigmine or iron chelating moiety such as M30.  In the case of M30 the pharmacophore of brain permeable iron chelator VK-28 plus the MAO inhibitor-neuroprotective propargylamine moiety of rasagiline are combined in a single mol. as a potential treatment for Alzheimer's disease, Lewy body disease, and Parkinson's disease with dementia.  Here, we discuss the activities of ladostigil in terms of its cholinesterase cognitive enhancing potential, antiParkinson, antidepressant, neuroprotection and APP (amyloid precursor protein) processing potential.  One major attribute of ladostigil is its neuroprotective activity in neuronal cell cultures and in vivo.  Employing an apoptotic model of neuroblastoma SK-N-SH cells, the mol. mechanism of its neuroprotective activity has been detd.  The current studies show that ladostigil significantly decreased apoptosis via inhibition of the cleavage and prevention of caspase-3 activation through a mechanism related to regulation of the Bcl-2 family proteins, resulting in reduced levels of Bad and Bax and induced levels of Bcl-2.  In addn., ladostigil elevated the levels of pPKC(pan).  We have also followed the regulation of APP processing and found that ladostigil markedly decreased apoptotic-induced levels of holo-APP, as well as stimulated the release of the non-amyloidogenic sol. APP (sAPPα) into the conditioned medium via a established protein kinsae c-MAPkinase dependent pathway.  Similar to ladostigil, its S-isomer, TV3279, which is a ChE inhibitor lacking MAO inhibitory activity, exerted similar neuroprotective properties and APP processing, suggesting that the mode of action is independent of MAO inhibition.  These effects were shown to reside in the propargylamine moiety.  These findings indicate that the dual actions of the anti-apoptotic-neuroprotective activity and the ability to modulate APP processing, could make ladostigil a potentially valuable drug for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpywM2IsMu1OLVg90H21EOLACvtfcHk0lh0z4J952jAgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsFekt70%253D&md5=58ba89f08e3eb4afdb5d602265baf060</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1007%2FBF03033355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF03033355%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DBar-Am%26aufirst%3DO.%26aulast%3DWeinreb%26aufirst%3DO.%26aulast%3DYogev-Falach%26aufirst%3DM.%26atitle%3DImplications%2520of%2520co-morbidity%2520for%2520etiology%2520and%2520treatment%2520of%2520neurodegenerative%2520diseases%2520with%2520multifunctional%2520neuroprotective-neurorescue%2520drugs%253B%2520ladostigil%26jtitle%3DNeurotoxic.%2520Res.%26date%3D2006%26volume%3D10%26spage%3D181%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">McKenna, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proctor, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, A. L.</span><span> </span><span class="NLM_article-title">Novel tacrine analogues for potential use against Alzheimerʼs disease: potent and selective acetylcholinesterase inhibitors and 5-HT uptake inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">3516</span><span class="NLM_x">–</span> <span class="NLM_lpage">3523</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970150t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=3516-3523&author=M.+T.+McKennaauthor=G.+R.+Proctorauthor=L.+C.+Youngauthor=A.+L.+Harvey&title=Novel+tacrine+analogues+for+potential+use+against+Alzheimer%CA%BCs+disease%3A+potent+and+selective+acetylcholinesterase+inhibitors+and+5-HT+uptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Fjm970150t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970150t%26sid%3Dliteratum%253Aachs%26aulast%3DMcKenna%26aufirst%3DM.%2BT.%26aulast%3DProctor%26aufirst%3DG.%2BR.%26aulast%3DYoung%26aufirst%3DL.%2BC.%26aulast%3DHarvey%26aufirst%3DA.%2BL.%26atitle%3DNovel%2520tacrine%2520analogues%2520for%2520potential%2520use%2520against%2520Alzheimer%25CA%25BCs%2520disease%253A%2520potent%2520and%2520selective%2520acetylcholinesterase%2520inhibitors%2520and%25205-HT%2520uptake%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D3516%26epage%3D3523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Hirai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayako, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, M.</span><span> </span><span class="NLM_article-title">Neurochemical effects of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1<i>H</i>-1-b enzazepin-8-yl)-1-propanone fumarate (TAK-147), a novel acetylcholinesterase inhibitor, in rats</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=9067312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaK2sXhvF2mtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=1997&pages=1261-1269&author=K.+Hiraiauthor=K.+Katoauthor=T.+Nakayamaauthor=H.+Hayakoauthor=Y.+Ishiharaauthor=G.+Gotoauthor=M.+Miyamoto&title=Neurochemical+effects+of+3-%5B1-%28phenylmethyl%29-4-piperidinyl%5D-1-%282%2C3%2C4%2C5-tetrahydro-1H-1-b+enzazepin-8-yl%29-1-propanone+fumarate+%28TAK-147%29%2C+a+novel+acetylcholinesterase+inhibitor%2C+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Neurochemical effects of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1H-1-benzazepin -8-yl)-1-propanone fumarate (TAK-147), a novel acetylcholinesterase inhibitor, in rats</span></div><div class="casAuthors">Hirai, Keisuke; Kato, Koki; Nakayama, Takahiro; Hayako, Hitomi; Ishihara, Yuji; Goto, Giichi; Miyamoto, Masaomi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1261-1269</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The authors examd. the neurochem. effects of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1H-1-benzazepin-8-yl)-1-propanone fumarate (TAK-147), a novel acetylcholinesterase (AChE) inhibitor in vitro and in vivo.  TAK-147 showed a potent and reversible inhibition of AChE activity in homogenates of the rat cerebral cortex (IC50 = 51.2 nM), and was 3.0- and 2.4-fold more potent than tacrine and physostigmine, resp.  By contrast, TAK-147 was the least potent inhibitor of butyrylcholinesterase activity in rat plasma (IC50 = 23,500 nM).  Tacrine and physostigmine inhibited butyrylcholinesterase activity potently and nonselectively.  TAK-147 showed a moderate inhibition of muscarinic M1 and M2 receptor binding with Ki values of 234 and 340 nM, resp.  TAK-147 showed very weak or no inhibition of high-affinity choline uptake, nicotinic receptor binding and choline acetyltransferase activity.  In ex vivo expts., oral administration of TAK-147 at doses ranging from 1 to 10 mg/kg induced a statistically significant and dose-dependent decrease in AChE activity in the cerebral cortex.  Of the monoaminergic systems, TAK-147 moderately inhibited uptake of noradrenaline and serotonin with IC50 values of 4020 and 1350 nM, resp.  TAK-147 also inhibited ligand binding at alpha-1, alpha-2 and serotonin 2 receptors with Ki values of 324, 2330 and 3510 nM, resp., whereas it showed only weak activities on D1, D2 and serotonin 1A receptor bindings.  Oral administration of TAK-147 (3 mg/kg) significantly accelerated the turnover rates of dopamine, noradrenaline and serotonin in the rat brain.  These results suggest that TAK-147 activates the central cholinergic system by specific inhibition of AChE activity without affecting peripheral butyrylcholinesterase activity, and that TAK-147 also moderately activates the monoaminergic systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4hUQDQN7Cu7Vg90H21EOLACvtfcHk0li4BzONnNFLEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhvF2mtLs%253D&md5=d983c91ca6ea72acfb9322ff93a8a57c</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirai%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DHayako%26aufirst%3DH.%26aulast%3DIshihara%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DG.%26aulast%3DMiyamoto%26aufirst%3DM.%26atitle%3DNeurochemical%2520effects%2520of%25203-%255B1-%2528phenylmethyl%2529-4-piperidinyl%255D-1-%25282%252C3%252C4%252C5-tetrahydro-1H-1-b%2520enzazepin-8-yl%2529-1-propanone%2520fumarate%2520%2528TAK-147%2529%252C%2520a%2520novel%2520acetylcholinesterase%2520inhibitor%252C%2520in%2520rats%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D280%26spage%3D1261%26epage%3D1269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Kogen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naruto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyagi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, T.</span><span> </span><span class="NLM_article-title">Design and synthesis of dual inhibitors of acetylcholinesterase and serotonin transporter targeting potential agents for Alzheimerʼs disease</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">3359</span><span class="NLM_x">–</span> <span class="NLM_lpage">3362</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol026418e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=3359-3362&author=H.+Kogenauthor=N.+Todaauthor=K.+Tagoauthor=S.+Marumotoauthor=K.+Takamiauthor=M.+Oriauthor=N.+Yamadaauthor=K.+Koyamaauthor=S.+Narutoauthor=K.+Abeauthor=R.+Yamazakiauthor=T.+Haraauthor=A.+Aoyagiauthor=Y.+Abeauthor=T.+Kaneko&title=Design+and+synthesis+of+dual+inhibitors+of+acetylcholinesterase+and+serotonin+transporter+targeting+potential+agents+for+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fol026418e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol026418e%26sid%3Dliteratum%253Aachs%26aulast%3DKogen%26aufirst%3DH.%26aulast%3DToda%26aufirst%3DN.%26aulast%3DTago%26aufirst%3DK.%26aulast%3DMarumoto%26aufirst%3DS.%26aulast%3DTakami%26aufirst%3DK.%26aulast%3DOri%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DN.%26aulast%3DKoyama%26aufirst%3DK.%26aulast%3DNaruto%26aufirst%3DS.%26aulast%3DAbe%26aufirst%3DK.%26aulast%3DYamazaki%26aufirst%3DR.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DAoyagi%26aufirst%3DA.%26aulast%3DAbe%26aufirst%3DY.%26aulast%3DKaneko%26aufirst%3DT.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520dual%2520inhibitors%2520of%2520acetylcholinesterase%2520and%2520serotonin%2520transporter%2520targeting%2520potential%2520agents%2520for%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DOrg.%2520Lett.%26date%3D2002%26volume%3D4%26spage%3D3359%26epage%3D3362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Toda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naruto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyagi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogen, H.</span><span> </span><span class="NLM_article-title">Design, synthesis and structure−activity relationships of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimerʼs disease</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1935</span><span class="NLM_x">–</span> <span class="NLM_lpage">1955</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=1935-1955&author=N.+Todaauthor=K.+Tagoauthor=S.+Marumotoauthor=K.+Takamiauthor=M.+Oriauthor=N.+Yamadaauthor=K.+Koyamaauthor=S.+Narutoauthor=K.+Abeauthor=R.+Yamazakiauthor=T.+Haraauthor=A.+Aoyagiauthor=Y.+Abeauthor=T.+Kanekoauthor=H.+Kogen&title=Design%2C+synthesis+and+structure%E2%88%92activity+relationships+of+dual+inhibitors+of+acetylcholinesterase+and+serotonin+transporter+as+potential+agents+for+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToda%26aufirst%3DN.%26aulast%3DTago%26aufirst%3DK.%26aulast%3DMarumoto%26aufirst%3DS.%26aulast%3DTakami%26aufirst%3DK.%26aulast%3DOri%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DN.%26aulast%3DKoyama%26aufirst%3DK.%26aulast%3DNaruto%26aufirst%3DS.%26aulast%3DAbe%26aufirst%3DK.%26aulast%3DYamazaki%26aufirst%3DR.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DAoyagi%26aufirst%3DA.%26aulast%3DAbe%26aufirst%3DY.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DKogen%26aufirst%3DH.%26atitle%3DDesign%252C%2520synthesis%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%2520dual%2520inhibitors%2520of%2520acetylcholinesterase%2520and%2520serotonin%2520transporter%2520as%2520potential%2520agents%2520for%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D1935%26epage%3D1955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Toda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naruto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyagi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogen, H.</span><span> </span><span class="NLM_article-title">A conformational restriction approach to the development of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimerʼs disease</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">4389</span><span class="NLM_x">–</span> <span class="NLM_lpage">4415</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=4389-4415&author=N.+Todaauthor=K.+Tagoauthor=S.+Marumotoauthor=K.+Takamiauthor=M.+Oriauthor=N.+Yamadaauthor=K.+Koyamaauthor=S.+Narutoauthor=K.+Abeauthor=R.+Yamazakiauthor=T.+Haraauthor=A.+Aoyagiauthor=Y.+Abeauthor=T.+Kanekoauthor=H.+Kogen&title=A+conformational+restriction+approach+to+the+development+of+dual+inhibitors+of+acetylcholinesterase+and+serotonin+transporter+as+potential+agents+for+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToda%26aufirst%3DN.%26aulast%3DTago%26aufirst%3DK.%26aulast%3DMarumoto%26aufirst%3DS.%26aulast%3DTakami%26aufirst%3DK.%26aulast%3DOri%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DN.%26aulast%3DKoyama%26aufirst%3DK.%26aulast%3DNaruto%26aufirst%3DS.%26aulast%3DAbe%26aufirst%3DK.%26aulast%3DYamazaki%26aufirst%3DR.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DAoyagi%26aufirst%3DA.%26aulast%3DAbe%26aufirst%3DY.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DKogen%26aufirst%3DH.%26atitle%3DA%2520conformational%2520restriction%2520approach%2520to%2520the%2520development%2520of%2520dual%2520inhibitors%2520of%2520acetylcholinesterase%2520and%2520serotonin%2520transporter%2520as%2520potential%2520agents%2520for%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D4389%26epage%3D4415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Abe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyagi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumagae, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naruto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, T.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of RS-1259, an orally active dual inhibitor of acetylcholinesterase and serotonin transporter, in rodents: possible treatment of Alzheimerʼs disease</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1254%2Fjphs.93.95" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=14501158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvVWntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2003&pages=95-105&author=Y.+Abeauthor=A.+Aoyagiauthor=T.+Haraauthor=K.+Abeauthor=R.+Yamazakiauthor=Y.+Kumagaeauthor=S.+Narutoauthor=K.+Koyamaauthor=S.+Marumotoauthor=K.+Tagoauthor=N.+Todaauthor=K.+Takamiauthor=N.+Yamadaauthor=M.+Oriauthor=H.+Kogenauthor=T.+Kaneko&title=Pharmacological+characterization+of+RS-1259%2C+an+orally+active+dual+inhibitor+of+acetylcholinesterase+and+serotonin+transporter%2C+in+rodents%3A+possible+treatment+of+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of RS-1259, an orally active dual inhibitor of acetylcholinesterase and serotonin transporter, in rodents: Possible treatment of Alzheimer's disease</span></div><div class="casAuthors">Abe, Yasuyuki; Aoyagi, Atsushi; Hara, Takao; Abe, Kazumi; Yamazaki, Reina; Kumagae, Yoshihiro; Naruto, Shunji; Koyama, Kazuo; Marumoto, Shinji; Tago, Keiko; Toda, Narihiro; Takami, Kazuko; Yamada, Naho; Ori, Mayuko; Kogen, Hiroshi; Kaneko, Tsugio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-105</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">A dual inhibitor of acetylcholinesterase (AChE) and serotonin transporter (SERT), RS-1259 , was newly synthesized.  RS-1259 simultaneously inhibited AChE and SERT in the brain following an oral administration in mice and rats.  Actual simultaneous elevation of extra-cellular levels of 5-HT and ACh in the rat hippocampus was confirmed by microdialysis.  The compd. was as effective as SERT inhibitors such as fluoxetine and fluvoxamine in a 5-hydroxytryptophan-enhancing test in mice.  Spatial memory deficits in the two-platform task of a water maze in aged rats were ameliorated by RS-1259 as well as donepezil.  Both RS-1259 and donepezil increased the awake episodes in the daytime EEG of rats.  Although RS-1259 was weaker than donepezil in enhancing central cholinergic transmission, as obsd. by ACh elevation in the hippocampus and memory enhancement in aged rats, the efficacy of RS-1259 on the consciousness level, which reflects the whole activity in the brain, was almost the same as that of donepezil.  These results suggest that both cholinergic and serotonergic systems are involved in maintaining brain arousal and that a dual inhibitor of AChE and SERT may be useful for the treatment of cognitive disorders assocd. with reduced brain activity such as in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBPLc4E5ZapLVg90H21EOLACvtfcHk0lgsU1v6zoAEOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvVWntro%253D&md5=a06b84e5e5f12f2405a05860f10a5515</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1254%2Fjphs.93.95&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.93.95%26sid%3Dliteratum%253Aachs%26aulast%3DAbe%26aufirst%3DY.%26aulast%3DAoyagi%26aufirst%3DA.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DAbe%26aufirst%3DK.%26aulast%3DYamazaki%26aufirst%3DR.%26aulast%3DKumagae%26aufirst%3DY.%26aulast%3DNaruto%26aufirst%3DS.%26aulast%3DKoyama%26aufirst%3DK.%26aulast%3DMarumoto%26aufirst%3DS.%26aulast%3DTago%26aufirst%3DK.%26aulast%3DToda%26aufirst%3DN.%26aulast%3DTakami%26aufirst%3DK.%26aulast%3DYamada%26aufirst%3DN.%26aulast%3DOri%26aufirst%3DM.%26aulast%3DKogen%26aufirst%3DH.%26aulast%3DKaneko%26aufirst%3DT.%26atitle%3DPharmacological%2520characterization%2520of%2520RS-1259%252C%2520an%2520orally%2520active%2520dual%2520inhibitor%2520of%2520acetylcholinesterase%2520and%2520serotonin%2520transporter%252C%2520in%2520rodents%253A%2520possible%2520treatment%2520of%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2003%26volume%3D93%26spage%3D95%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Barnes, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costall, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wischik, C. M.</span><span> </span><span class="NLM_article-title">Normal densities of 5-HT3 receptor recognition sites in Alzheimerʼs disease</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1990&pages=253-254&author=N.+M.+Barnesauthor=B.+Costallauthor=R.+J.+Naylorauthor=T.+J.+Williamsauthor=C.+M.+Wischik&title=Normal+densities+of+5-HT3+receptor+recognition+sites+in+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DN.%2BM.%26aulast%3DCostall%26aufirst%3DB.%26aulast%3DNaylor%26aufirst%3DR.%2BJ.%26aulast%3DWilliams%26aufirst%3DT.%2BJ.%26aulast%3DWischik%26aufirst%3DC.%2BM.%26atitle%3DNormal%2520densities%2520of%25205-HT3%2520receptor%2520recognition%2520sites%2520in%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DNeuroReport%26date%3D1990%26volume%3D1%26spage%3D253%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Cappelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennuni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makovec, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menziani, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortuso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vomero, S.</span><span> </span><span class="NLM_article-title">Further studies on the interaction of the 5-hydroxytryptamine3 (5-HT3) receptor with arylpiperazine ligands. Development of a new 5-HT3 receptor ligand showing potent acetylcholinesterase inhibitory properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3564</span><span class="NLM_x">–</span> <span class="NLM_lpage">3575</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0493461" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3564-3575&author=A.+Cappelliauthor=A.+Gallelliauthor=M.+Maniniauthor=M.+Anziniauthor=L.+Mennuniauthor=F.+Makovecauthor=M.+C.+Menzianiauthor=S.+Alcaroauthor=F.+Ortusoauthor=S.+Vomero&title=Further+studies+on+the+interaction+of+the+5-hydroxytryptamine3+%285-HT3%29+receptor+with+arylpiperazine+ligands.+Development+of+a+new+5-HT3+receptor+ligand+showing+potent+acetylcholinesterase+inhibitory+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1021%2Fjm0493461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0493461%26sid%3Dliteratum%253Aachs%26aulast%3DCappelli%26aufirst%3DA.%26aulast%3DGallelli%26aufirst%3DA.%26aulast%3DManini%26aufirst%3DM.%26aulast%3DAnzini%26aufirst%3DM.%26aulast%3DMennuni%26aufirst%3DL.%26aulast%3DMakovec%26aufirst%3DF.%26aulast%3DMenziani%26aufirst%3DM.%2BC.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DVomero%26aufirst%3DS.%26atitle%3DFurther%2520studies%2520on%2520the%2520interaction%2520of%2520the%25205-hydroxytryptamine3%2520%25285-HT3%2529%2520receptor%2520with%2520arylpiperazine%2520ligands.%2520Development%2520of%2520a%2520new%25205-HT3%2520receptor%2520ligand%2520showing%2520potent%2520acetylcholinesterase%2520inhibitory%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3564%26epage%3D3575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Witkin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span> </span><span class="NLM_article-title">Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.pharmthera.2004.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15251226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsFylu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2004&pages=1-20&author=J.+M.+Witkinauthor=D.+L.+Nelson&title=Selective+histamine+H3+receptor+antagonists+for+treatment+of+cognitive+deficiencies+and+other+disorders+of+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system</span></div><div class="casAuthors">Witkin, J. M.; Nelson, D. L.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-20</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Evidence exists to implicate the monoamine histamine in the control of arousal and cognitive functions.  Antagonists of H3 receptors are postsynaptic and presynaptic modulators of neural transmission in a variety of neuronal circuits relevant to cognition.  Accumulating neuroanatomical, neurochem., pharmacol., and behavioral data support the idea that H3 receptor antagonists may function to improve cognitive performances in disease states (e.g., Alzheimer's disease and mild cognitive impairment states).  Thus, H3 receptor antagonists have been shown to increase performance in attention and memory tests in nonhuman expts. and prevent the degrdn. in performances produced by scopolamine, MK-801, or age.  In contrast, agonists of the H3 receptor generally produce cognitive impairing effects in animal models.  The role of H3 receptors in these behavioral effects is substantiated by data indicating a central origin for their effects, the selectivity of some of the H3 receptor antagonists studied, and the pharmacol. modification of effects of H3 receptor antagonists by selective H3 receptor agonists.  Data and issues that challenge the potential role for H3 receptor antagonists in cognitive processes are also critically reviewed.  H3 receptor antagonists may also have therapeutic value in the management of obesity, pain, sleep disorders, schizophrenia, and attention deficit hyperactivity disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYt2x3LVstu7Vg90H21EOLACvtfcHk0lglfvLLmoO5hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsFylu7c%253D&md5=617ca9544608401f2d0789872e7a8323</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2004.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2004.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DWitkin%26aufirst%3DJ.%2BM.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26atitle%3DSelective%2520histamine%2520H3%2520receptor%2520antagonists%2520for%2520treatment%2520of%2520cognitive%2520deficiencies%2520and%2520other%2520disorders%2520of%2520the%2520central%2520nervous%2520system%26jtitle%3DPharmacol.%2520Ther.%26date%3D2004%26volume%3D103%26spage%3D1%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Petroianu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arafat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasse, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, H.</span><span> </span><span class="NLM_article-title">Multiple enzyme inhibitions by histamine H3 receptor antagonists as potential procognitive agents</span> <span class="citation_source-journal">Pharmazie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2006&pages=179-182&author=G.+Petroianuauthor=K.+Arafatauthor=B.+C.+Sasseauthor=H.+Stark&title=Multiple+enzyme+inhibitions+by+histamine+H3+receptor+antagonists+as+potential+procognitive+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetroianu%26aufirst%3DG.%26aulast%3DArafat%26aufirst%3DK.%26aulast%3DSasse%26aufirst%3DB.%2BC.%26aulast%3DStark%26aufirst%3DH.%26atitle%3DMultiple%2520enzyme%2520inhibitions%2520by%2520histamine%2520H3%2520receptor%2520antagonists%2520as%2520potential%2520procognitive%2520agents%26jtitle%3DPharmazie%26date%3D2006%26volume%3D61%26spage%3D179%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Holmquist, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuchbury, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berbaum, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muscat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hager, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munch, G.</span><span> </span><span class="NLM_article-title">Lipoic acid as a novel treatment for Alzheimerʼs disease and related dementias</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.pharmthera.2006.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16989905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFCkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2007&pages=154-164&author=L.+Holmquistauthor=G.+Stuchburyauthor=K.+Berbaumauthor=S.+Muscatauthor=S.+Youngauthor=K.+Hagerauthor=J.+Engelauthor=G.+Munch&title=Lipoic+acid+as+a+novel+treatment+for+Alzheimer%CA%BCs+disease+and+related+dementias"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Lipoic acid as a novel treatment for Alzheimer's disease and related dementias</span></div><div class="casAuthors">Holmquist, Lina; Stuchbury, Grant; Berbaum, Katrin; Muscat, Sonja; Young, Simon; Hager, Klaus; Engel, Juergen; Muench, Gerald</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">154-164</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a progressive neurodegenerative disorder that destroys patient memory and cognition, communication ability with the social environment and the ability to carry out daily activities.  Despite extensive research into the pathogenesis of AD, a neuroprotective treatment - particularly for the early stages of disease - remains unavailable for clin. use.  In this review, we advance the suggestion that lipoic acid (LA) may fulfil this therapeutic need.  A naturally occurring precursor of an essential cofactor for mitochondrial enzymes, including pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase (KGDH), LA has been shown to have a variety of properties which can interfere with pathogenic principles of AD.  For example, LA increases acetylcholine (ACh) prodn. by activation of choline acetyltransferase and increases glucose uptake, thus supplying more acetyl-CoA for the prodn. of ACh.  LA chelates redox-active transition metals, thus inhibiting the formation of hydroxyl radicals and also scavenges reactive oxygen species (ROS), thereby increasing the levels of reduced glutathione.  Via the same mechanisms, downregulation redox-sensitive inflammatory processes is also achieved.  Furthermore, LA can scavenge lipid peroxidn. products such as hydroxynonenal and acrolein.  The reduced form of LA, dihydrolipoic acid (DHLA), is the active compd. responsible for most of these beneficial effects.  R-α-LA can be applied instead of DHLA, as it is reduced by mitochondrial lipoamide dehydrogenase, a part of the PDH complex.  In this review, the properties of LA are explored with particular emphasis on how this agent, particularly the R-α-enantiomer, may be effective to treat AD and related dementias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcoiEDmF4ru7Vg90H21EOLACvtfcHk0lj3HqdK4jSZqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFCkug%253D%253D&md5=9de980ce1a7f7c2b1c13ed92e36d9b5f</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2006.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2006.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DHolmquist%26aufirst%3DL.%26aulast%3DStuchbury%26aufirst%3DG.%26aulast%3DBerbaum%26aufirst%3DK.%26aulast%3DMuscat%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DS.%26aulast%3DHager%26aufirst%3DK.%26aulast%3DEngel%26aufirst%3DJ.%26aulast%3DMunch%26aufirst%3DG.%26atitle%3DLipoic%2520acid%2520as%2520a%2520novel%2520treatment%2520for%2520Alzheimer%25CA%25BCs%2520disease%2520and%2520related%2520dementias%26jtitle%3DPharmacol.%2520Ther.%26date%3D2007%26volume%3D113%26spage%3D154%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrelia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Rational approach to discover multipotent anti-Alzheimer drugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">360</span><span class="NLM_x">–</span> <span class="NLM_lpage">363</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049112h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslSk" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=360-363&author=M.+Rosiniauthor=V.+Andrisanoauthor=M.+Bartoliniauthor=M.+L.+Bolognesiauthor=P.+Hreliaauthor=A.+Minariniauthor=A.+Tarozziauthor=C.+Melchiorre&title=Rational+approach+to+discover+multipotent+anti-Alzheimer+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Approach To Discover Multipotent Anti-Alzheimer Drugs</span></div><div class="casAuthors">Rosini, Michela; Andrisano, Vincenza; Bartolini, Manuela; Bolognesi, Maria L.; Hrelia, Patrizia; Minarini, Anna; Tarozzi, Andrea; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">360-363</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The coupling of two different pharmacophores, each endowed with different biol. properties, afforded the hybrid compd. lipocrine (7), whose biol. profile was markedly improved relative to those of prototypes tacrine and lipoic acid.  Lipocrine is the first compd. that inhibits the catalytic activity of AChE and AChE-induced amyloid-β aggregation and protects against reactive oxygen species.  Thus, it emerged as a valuable pharmacol. tool to investigate Alzheimer's disease and as a promising lead compd. for new anti-Alzheimer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcNiocyuiJWLVg90H21EOLACvtfcHk0lj3HqdK4jSZqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslSk&md5=e632c934e744d35d5acf7047827fc91f</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1021%2Fjm049112h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049112h%26sid%3Dliteratum%253Aachs%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DHrelia%26aufirst%3DP.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DTarozzi%26aufirst%3DA.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DRational%2520approach%2520to%2520discover%2520multipotent%2520anti-Alzheimer%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D360%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Lipoic acid, a lead structure for multi-target-directed drugs for neurodegeneration</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1269</span><span class="NLM_x">–</span> <span class="NLM_lpage">1274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1269-1274&author=M.+L.+Bolognesiauthor=A.+Minariniauthor=V.+Tumiattiauthor=C.+Melchiorre&title=Lipoic+acid%2C+a+lead+structure+for+multi-target-directed+drugs+for+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DLipoic%2520acid%252C%2520a%2520lead%2520structure%2520for%2520multi-target-directed%2520drugs%2520for%2520neurodegeneration%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1269%26epage%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J. T.</span><span> </span><span class="NLM_article-title">Beneficial effects of melatonin in experimental models of Alzheimer disease</span> <span class="citation_source-journal">Acta Pharmacol. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1111%2Fj.1745-7254.2006.00267.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16412260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Witrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=129-139&author=Y.+Chengauthor=Z.+Fengauthor=Q.+Z.+Zhangauthor=J.+T.+Zhang&title=Beneficial+effects+of+melatonin+in+experimental+models+of+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Beneficial effects of melatonin in experimental models of Alzheimer disease</span></div><div class="casAuthors">Cheng, Yong; Feng, Zheng; Zhang, Qing-zhu; Zhang, Jun-tian</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">129-139</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD), a progressive degenerative disorder, is characterized by the presence of amyloid deposits, neurofibrillary tangles and neuron loss.  Emerging evidence indicates that antioxidants could be useful either for the prevention or treatment of AD.  It has been shown that melatonin is a potent antioxidant and free radical scavenger.  Addnl., melatonin stimulates several antioxidative enzymes and improves mitochondrial energy metab.  These findings led us to study amyloid precursor protein transgenic mice, ovariectomized rats, and pheochromocytoma and astroglioma cell lines, to observe whether melatonin had any effect on Alzheimer's symptoms or pathol. changes.  We found that melatonin had many beneficial effects in exptl. models of AD, including improvement of cognitive function, anti-oxidative injury, anti-apoptosis, inhibition of β-amyloid (Aβ) deposition and Aβ fiber formation.  Several groups have shown that melatonin has an inhibitory effect on tau protein hyperphosphorylation.  These actions may potentially slow down or stop the progression of dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonU5s8mdLRubVg90H21EOLACvtfcHk0ljOSQr7dJPAhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Witrk%253D&md5=8105a133d67224e0fa493f695ee6a00f</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1111%2Fj.1745-7254.2006.00267.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1745-7254.2006.00267.x%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DQ.%2BZ.%26aulast%3DZhang%26aufirst%3DJ.%2BT.%26atitle%3DBeneficial%2520effects%2520of%2520melatonin%2520in%2520experimental%2520models%2520of%2520Alzheimer%2520disease%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2006%26volume%3D27%26spage%3D129%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Rodriguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Bachiller, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez-Ledesma, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolome, B.</span><span> </span><span class="NLM_article-title">Novel tacrine-melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050746d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=459-462&author=M.+I.+Rodriguez-Francoauthor=M.+I.+Fernandez-Bachillerauthor=C.+Perezauthor=B.+Hernandez-Ledesmaauthor=B.+Bartolome&title=Novel+tacrine-melatonin+hybrids+as+dual-acting+drugs+for+Alzheimer+disease%2C+with+improved+acetylcholinesterase+inhibitory+and+antioxidant+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Fjm050746d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050746d%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DFernandez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DHernandez-Ledesma%26aufirst%3DB.%26aulast%3DBartolome%26aufirst%3DB.%26atitle%3DNovel%2520tacrine-melatonin%2520hybrids%2520as%2520dual-acting%2520drugs%2520for%2520Alzheimer%2520disease%252C%2520with%2520improved%2520acetylcholinesterase%2520inhibitory%2520and%2520antioxidant%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D459%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Mattson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, S. L.</span><span> </span><span class="NLM_article-title">Dysregulation of cellular calcium homeostasis in Alzheimerʼs disease: bad genes and bad habits</span> <span class="citation_source-journal">J. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1385%2FJMN%3A17%3A2%3A205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=11816794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosVKit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2001&pages=205-224&author=M.+P.+Mattsonauthor=S.+L.+Chan&title=Dysregulation+of+cellular+calcium+homeostasis+in+Alzheimer%CA%BCs+disease%3A+bad+genes+and+bad+habits"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Dysregulation of cellular calcium homeostasis in Alzheimer's disease. Bad genes and bad habits</span></div><div class="casAuthors">Mattson, Mark P.; Chan, Sic L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-224</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Calcium is one of the most important intracellular messengers in the brain, being essential for neuronal development, synaptic transmission and plasticity, and the regulation of various metabolic pathways.  The findings reviewed in the present article suggest that calcium also plays a prominent role in the pathogenesis of Alzheimer's disease (AD).  Assocns. between the pathol. hallmarks of AD (neurofibrillary tangles [NFT] and amyloid plaques) and perturbed cellular calcium homeostasis have been established in studies of patients, and in animal and cell culture models of AD.  Studies of the effects of mutations in the β-amyloid precursor protein (APP) and presenilins on neuronal plasticity and survival have provided insight into the mol. cascades that result in synaptic dysfunction and neuronal degeneration in AD.  Central to the neurodegenerative process is the inability of neurons to properly regulate intracellular calcium levels.  Increased levels of amyloid β-peptide (Aβ) induce oxidative stress, which impairs cellular ion homeostasis and energy metab. and renders neurons vulnerable to apoptosis and excitotoxicity.  Subtoxic levels of Aβ may induce synaptic dysfunction by impairing multiple signal transduction pathways.  Presenilin mutations perturb calcium homeostasis in the endoplasmic reticulum in a way that sensitizes neurons to apoptosis and excitotoxicity; links between aberrant calcium regulation and altered APP processing are emerging.  Environmental risk factors for AD are being identified and may include high calorie diets, folic acid insufficiency, and a low level of intellectual activity (bad habits); in each case, the environmental factor impacts on neuronal calcium homeostasis.  Low calorie diets and intellectual activity may guard against AD by stimulating prodn. of neurotrophic factors and chaperone proteins.  The emerging picture of the cell and mol. biol. of AD is revealing novel preventative and therapeutic strategies for eradicating this growing epidemic of the elderly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZX54N8EP-37Vg90H21EOLACvtfcHk0ljOSQr7dJPAhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosVKit7g%253D&md5=cca6641a88729abc25b101b0cf03eb30</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1385%2FJMN%3A17%3A2%3A205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FJMN%253A17%253A2%253A205%26sid%3Dliteratum%253Aachs%26aulast%3DMattson%26aufirst%3DM.%2BP.%26aulast%3DChan%26aufirst%3DS.%2BL.%26atitle%3DDysregulation%2520of%2520cellular%2520calcium%2520homeostasis%2520in%2520Alzheimer%25CA%25BCs%2520disease%253A%2520bad%2520genes%2520and%2520bad%2520habits%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2001%26volume%3D17%26spage%3D205%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Villarroya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, J. L.</span><span> </span><span class="NLM_article-title">New classes of AChE inhibitors with additional pharmacological effects of interest for the treatment of Alzheimerʼs disease</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">3177</span><span class="NLM_x">–</span> <span class="NLM_lpage">3184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.2174%2F1381612043383368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15544507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnslCktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=3177-3184&author=M.+Villarroyaauthor=A.+G.+Garciaauthor=J.+L.+Marco&title=New+classes+of+AChE+inhibitors+with+additional+pharmacological+effects+of+interest+for+the+treatment+of+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">New classes of AChE inhibitors with additional pharmacological effects of interest for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Villarroya, M.; Garcia, A. G.; Marco, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3177-3184</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is assocd. to a gradual loss of attention and memory that have been assocd. to impairment of brain cholinergic neurotransmission, particularly a deficit of cholinergic neurons in the nucleus basalis of Meynert.  Thus, it is not surprising that the first therapeutic target that has demonstrated therapeutic efficacy on cognition, behavior and functional daily activities has been the inhibitors of acetylcholinesterase (AChE), i.e. tacrine, donepezil, rivastigmine and galanthamine.  But not all inhibitors of AChE have the same potency to block the enzyme and have a different pharmacol. profile.  For instance, rivastigmine is a dual inhibitor of AChE and butyrylcholinesterase (BuChE), and galanthamine is a mild inhibitor of AChE and an allosteric potentiating ligand of neuronal nicotinic receptors for acetylcholine (nAChRs).  In addn., we have recently found that galanthamine has neuroprotective effects by inducing calcium signals and the induction of the antiapoptotic protein Bcl-2.  In this frame, we have been synthesizing new tacrine derivs. that keep their ability to inhibit AChE but that interfere with neuronal calcium overloading and prevent apoptosis.  Some of these compds. exhibit neuroprotecting properties and thus, could be useful in the treatment of neurodegenerative and ischemic brain diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjQD-w50ztubVg90H21EOLACvtfcHk0ljOSQr7dJPAhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnslCktrc%253D&md5=40b4e7aa0b7fb3c31c85c4058a0e9961</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.2174%2F1381612043383368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612043383368%26sid%3Dliteratum%253Aachs%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DMarco%26aufirst%3DJ.%2BL.%26atitle%3DNew%2520classes%2520of%2520AChE%2520inhibitors%2520with%2520additional%2520pharmacological%2520effects%2520of%2520interest%2520for%2520the%2520treatment%2520of%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2004%26volume%3D10%26spage%3D3177%26epage%3D3184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Kelly, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, R. L.</span><span> </span><span class="NLM_article-title">Tetrahydroaminoacridine (THA) reduces voltage-dependent calcium currents in rat sensory neurons</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=1991&pages=247-250&author=K.+M.+Kellyauthor=R.+A.+Grossauthor=R.+L.+Macdonald&title=Tetrahydroaminoacridine+%28THA%29+reduces+voltage-dependent+calcium+currents+in+rat+sensory+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DK.%2BM.%26aulast%3DGross%26aufirst%3DR.%2BA.%26aulast%3DMacdonald%26aufirst%3DR.%2BL.%26atitle%3DTetrahydroaminoacridine%2520%2528THA%2529%2520reduces%2520voltage-dependent%2520calcium%2520currents%2520in%2520rat%2520sensory%2520neurons%26jtitle%3DNeurosci.%2520Lett.%26date%3D1991%26volume%3D132%26spage%3D247%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">de los Rios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreiras, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinchon, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span> </span><span class="NLM_article-title">Novel tacrine derivatives that block neuronal calcium channels</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2077</span><span class="NLM_x">–</span> <span class="NLM_lpage">2088</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=2077-2088&author=C.+de+los+Riosauthor=J.+L.+Marcoauthor=M.+D.+Carreirasauthor=P.+M.+Chinchonauthor=A.+G.+Garciaauthor=M.+Villarroya&title=Novel+tacrine+derivatives+that+block+neuronal+calcium+channels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2Blos%2BRios%26aufirst%3DC.%26aulast%3DMarco%26aufirst%3DJ.%2BL.%26aulast%3DCarreiras%26aufirst%3DM.%2BD.%26aulast%3DChinchon%26aufirst%3DP.%2BM.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26atitle%3DNovel%2520tacrine%2520derivatives%2520that%2520block%2520neuronal%2520calcium%2520channels%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D2077%26epage%3D2088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Leon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span> </span><span class="NLM_article-title">Synthesis, acetylcholinesterase inhibition and neuroprotective activity of new tacrine analogues</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1167</span><span class="NLM_x">–</span> <span class="NLM_lpage">1175</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=1167-1175&author=R.+Leonauthor=J.+Marco-Contellesauthor=A.+G.+Garciaauthor=M.+Villarroya&title=Synthesis%2C+acetylcholinesterase+inhibition+and+neuroprotective+activity+of+new+tacrine+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeon%26aufirst%3DR.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520acetylcholinesterase%2520inhibition%2520and%2520neuroprotective%2520activity%2520of%2520new%2520tacrine%2520analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D1167%26epage%3D1175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de los Rios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span> </span><span class="NLM_article-title">New multipotent tetracyclic tacrines with neuroprotective activity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">8176</span><span class="NLM_x">–</span> <span class="NLM_lpage">8185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=8176-8185&author=J.+Marco-Contellesauthor=R.+Leonauthor=C.+de+los+Riosauthor=A.+G.+Garciaauthor=M.+G.+Lopezauthor=M.+Villarroya&title=New+multipotent+tetracyclic+tacrines+with+neuroprotective+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DLeon%26aufirst%3DR.%26aulast%3Dde%2Blos%2BRios%26aufirst%3DC.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26atitle%3DNew%2520multipotent%2520tetracyclic%2520tacrines%2520with%2520neuroprotective%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D8176%26epage%3D8185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of new 4<i>H</i>-pyrano[2,3-<i>b</i>]quinoline derivatives that block acetylcholinesterase and cell calcium signals, and cause neuroprotection against calcium overload and free radicals</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1464</span><span class="NLM_x">–</span> <span class="NLM_lpage">1469</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2006&pages=1464-1469&author=J.+Marco-Contellesauthor=R.+Leonauthor=M.+G.+Lopezauthor=A.+G.+Garciaauthor=M.+Villarroya&title=Synthesis+and+biological+evaluation+of+new+4H-pyrano%5B2%2C3-b%5Dquinoline+derivatives+that+block+acetylcholinesterase+and+cell+calcium+signals%2C+and+cause+neuroprotection+against+calcium+overload+and+free+radicals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DLeon%26aufirst%3DR.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520new%25204H-pyrano%255B2%252C3-b%255Dquinoline%2520derivatives%2520that%2520block%2520acetylcholinesterase%2520and%2520cell%2520calcium%2520signals%252C%2520and%2520cause%2520neuroprotection%2520against%2520calcium%2520overload%2520and%2520free%2520radicals%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2006%26volume%3D41%26spage%3D1464%26epage%3D1469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Marco, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de los Rios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreiras, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eleuterio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morreale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orozco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span> </span><span class="NLM_article-title">Synthesis, biological evaluation and molecular modelling of diversely functionalized heterocyclic derivatives as inhibitors of acetylcholinesterase/butyrylcholinesterase and modulators of Ca<sup>2+</sup> channels and nicotinic receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2199</span><span class="NLM_x">–</span> <span class="NLM_lpage">2218</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=2199-2218&author=J.+L.+Marcoauthor=C.+de+los+Riosauthor=A.+G.+Garciaauthor=M.+Villarroyaauthor=M.+C.+Carreirasauthor=C.+Martinsauthor=A.+Eleuterioauthor=A.+Morrealeauthor=M.+Orozcoauthor=F.+J.+Luque&title=Synthesis%2C+biological+evaluation+and+molecular+modelling+of+diversely+functionalized+heterocyclic+derivatives+as+inhibitors+of+acetylcholinesterase%2Fbutyrylcholinesterase+and+modulators+of+Ca2%2B+channels+and+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarco%26aufirst%3DJ.%2BL.%26aulast%3Dde%2Blos%2BRios%26aufirst%3DC.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DCarreiras%26aufirst%3DM.%2BC.%26aulast%3DMartins%26aufirst%3DC.%26aulast%3DEleuterio%26aufirst%3DA.%26aulast%3DMorreale%26aufirst%3DA.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%2520and%2520molecular%2520modelling%2520of%2520diversely%2520functionalized%2520heterocyclic%2520derivatives%2520as%2520inhibitors%2520of%2520acetylcholinesterase%252Fbutyrylcholinesterase%2520and%2520modulators%2520of%2520Ca2%252B%2520channels%2520and%2520nicotinic%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D2199%26epage%3D2218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Los Rios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglietta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terencio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span> </span><span class="NLM_article-title">Novel multipotent tacrine−dihydropyridine hybrids with improved acetylcholinesterase inhibitory and neuroprotective activities as potential drugs for the treatment of Alzheimerʼs disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7607</span><span class="NLM_x">–</span> <span class="NLM_lpage">7610</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061047j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7607-7610&author=J.+Marco-Contellesauthor=R.+Leonauthor=C.+de+Los+Riosauthor=A.+Gugliettaauthor=J.+Terencioauthor=M.+G.+Lopezauthor=A.+G.+Garciaauthor=M.+Villarroya&title=Novel+multipotent+tacrine%E2%88%92dihydropyridine+hybrids+with+improved+acetylcholinesterase+inhibitory+and+neuroprotective+activities+as+potential+drugs+for+the+treatment+of+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Fjm061047j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061047j%26sid%3Dliteratum%253Aachs%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DLeon%26aufirst%3DR.%26aulast%3Dde%2BLos%2BRios%26aufirst%3DC.%26aulast%3DGuglietta%26aufirst%3DA.%26aulast%3DTerencio%26aufirst%3DJ.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26atitle%3DNovel%2520multipotent%2520tacrine%25E2%2588%2592dihydropyridine%2520hybrids%2520with%2520improved%2520acetylcholinesterase%2520inhibitory%2520and%2520neuroprotective%2520activities%2520as%2520potential%2520drugs%2520for%2520the%2520treatment%2520of%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7607%26epage%3D7610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">White, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnham, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, A. I.</span><span> </span><span class="NLM_article-title">Metal homeostasis in Alzheimerʼs disease</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">722</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1586%2F14737175.6.5.711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16734519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtlKntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=711-722&author=A.+R.+Whiteauthor=K.+J.+Barnhamauthor=A.+I.+Bush&title=Metal+homeostasis+in+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Metal homeostasis in Alzheimer's disease</span></div><div class="casAuthors">White, Anthony R.; Barnham, Kevin J.; Bush, Ashley I.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">711-722</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by neuronal dysfunction and the formation of amyloid plaques in the brain.  Although the pathol. processes resulting in the onset and progression of AD are not well understood, there is a growing body of evidence to support a central role for biometals in many crit. aspects of the illness.  Recent reports have described the exciting development of potential therapeutic agents based on the modulation of metal bioavailability.  The metal ligand, clioquinol has demonstrated promising results in animal models and small clin. trials and a new generation of metal ligand-based therapeutics are currently under development.  However, further research is necessary to fully understand the complex and interdependent pathways of biometal homeostasis and amyloid metab. in AD.  This information will be vital for the development of safe and effective metal-based pharmaceuticals for the treatment of AD and, potentially, other neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI6vkJs17_AbVg90H21EOLACvtfcHk0liWHF67QBqeew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtlKntL0%253D&md5=ee25c253448f39464fcf62bc1e49e6e5</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1586%2F14737175.6.5.711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.6.5.711%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DA.%2BR.%26aulast%3DBarnham%26aufirst%3DK.%2BJ.%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DMetal%2520homeostasis%2520in%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2006%26volume%3D6%26spage%3D711%26epage%3D722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Dedeoglu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cormier, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseitlin, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremsky, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowall, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span> </span><span class="NLM_article-title">Preliminary studies of a novel bifunctional metal chelator targeting Alzheimerʼs amyloidogenesis</span> <span class="citation_source-journal">Exp. Gerontol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1641</span><span class="NLM_x">–</span> <span class="NLM_lpage">1649</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.exger.2004.08.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15582280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVCltLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2004&pages=1641-1649&author=A.+Dedeogluauthor=K.+Cormierauthor=S.+Paytonauthor=K.+A.+Tseitlinauthor=J.+N.+Kremskyauthor=L.+Laiauthor=X.+Liauthor=R.+D.+Moirauthor=R.+E.+Tanziauthor=A.+I.+Bushauthor=N.+W.+Kowallauthor=J.+T.+Rogersauthor=X.+Huang&title=Preliminary+studies+of+a+novel+bifunctional+metal+chelator+targeting+Alzheimer%CA%BCs+amyloidogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis</span></div><div class="casAuthors">Dedeoglu, Alpaslan; Cormier, Kerry; Payton, Sandra; Tseitlin, Katya A.; Kremsky, Jonathan N.; Lai, Li; Li, Xiaohua; Moir, Robert D.; Tanzi, Rudolph E.; Bush, Ashley I.; Kowall, Neil W.; Rogers, Jack T.; Huang, Xudong</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Gerontology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">1641-1649</span>CODEN:
                <span class="NLM_cas:coden">EXGEAB</span>;
        ISSN:<span class="NLM_cas:issn">0531-5565</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A growing body of evidence indicates that dysregulation of cerebral biometals (Fe, Cu, Zn) and their interactions with APP and Aβ amyloid may contribute to the Alzheimer's amyloid pathol., and thus metal chelation could be a rational therapeutic approach for interdicting AD pathogenesis.  However, poor target specificity and consequential clin. safety of current metal-complexing agents have limited their widespread clin. use.  To develop the next generation of metal chelators, we have designed and synthesized a new bifunctional mol.-XH1, based on a novel 'pharmacophore conjugation' concept.  This lipophilic mol. has both amyloid-binding and metal-chelating moieties covalently connected by amide bonds.  It achieved a putative binding geometry with Aβ1-40 peptide by the computational chem. modeling and reduced Zn(II)-induced Aβ1-40 aggregation in vitro as detd. by turbidometry.  Moreover, our pilot data indicated that XH1 has no significant neurotoxicity at low micromolar concns. and acute animal toxicity.  XH1 specifically reduced APP protein expression in human SH-SY5Y neuroblastoma cells and attenuated cerebral Aβ amyloid pathol. in PS1/APP transgenic mice without inducing apparent toxicity and behavior disturbances.  Collectively, these preliminary findings carry implication for XH1 being a BBB-permeable lead compd. for AD therapeutics targeting Alzheimer's amyloidogenesis, although further studies are needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ_WW34UJTebVg90H21EOLACvtfcHk0liWHF67QBqeew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVCltLbJ&md5=2811096bf475d1370d099d9e751230c6</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.exger.2004.08.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exger.2004.08.016%26sid%3Dliteratum%253Aachs%26aulast%3DDedeoglu%26aufirst%3DA.%26aulast%3DCormier%26aufirst%3DK.%26aulast%3DPayton%26aufirst%3DS.%26aulast%3DTseitlin%26aufirst%3DK.%2BA.%26aulast%3DKremsky%26aufirst%3DJ.%2BN.%26aulast%3DLai%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DMoir%26aufirst%3DR.%2BD.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DBush%26aufirst%3DA.%2BI.%26aulast%3DKowall%26aufirst%3DN.%2BW.%26aulast%3DRogers%26aufirst%3DJ.%2BT.%26aulast%3DHuang%26aufirst%3DX.%26atitle%3DPreliminary%2520studies%2520of%2520a%2520novel%2520bifunctional%2520metal%2520chelator%2520targeting%2520Alzheimer%25CA%25BCs%2520amyloidogenesis%26jtitle%3DExp.%2520Gerontol.%26date%3D2004%26volume%3D39%26spage%3D1641%26epage%3D1649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Bebbington, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monck, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benwell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, R. H.</span><span> </span><span class="NLM_article-title">3,5-Disubstituted-4-hydroxyphenyls linked to 3-hydroxy-2-methyl-4(1<i>H</i>)-pyridinone: potent inhibitors of lipid peroxidation and cell toxicity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2779</span><span class="NLM_x">–</span> <span class="NLM_lpage">2782</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990945v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2779-2782&author=D.+Bebbingtonauthor=N.+J.+Monckauthor=S.+Gaurauthor=A.+M.+Palmerauthor=K.+Benwellauthor=V.+Harveyauthor=C.+S.+Malcolmauthor=R.+H.+Porter&title=3%2C5-Disubstituted-4-hydroxyphenyls+linked+to+3-hydroxy-2-methyl-4%281H%29-pyridinone%3A+potent+inhibitors+of+lipid+peroxidation+and+cell+toxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1021%2Fjm990945v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990945v%26sid%3Dliteratum%253Aachs%26aulast%3DBebbington%26aufirst%3DD.%26aulast%3DMonck%26aufirst%3DN.%2BJ.%26aulast%3DGaur%26aufirst%3DS.%26aulast%3DPalmer%26aufirst%3DA.%2BM.%26aulast%3DBenwell%26aufirst%3DK.%26aulast%3DHarvey%26aufirst%3DV.%26aulast%3DMalcolm%26aufirst%3DC.%2BS.%26aulast%3DPorter%26aufirst%3DR.%2BH.%26atitle%3D3%252C5-Disubstituted-4-hydroxyphenyls%2520linked%2520to%25203-hydroxy-2-methyl-4%25281H%2529-pyridinone%253A%2520potent%2520inhibitors%2520of%2520lipid%2520peroxidation%2520and%2520cell%2520toxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2779%26epage%3D2782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Ji, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. Y.</span><span> </span><span class="NLM_article-title">A new strategy to combat Alzheimerʼs disease. Combining radical-scavenging potential with metal-protein-attenuating ability in one molecule</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=21-24&author=H.+F.+Jiauthor=H.+Y.+Zhang&title=A+new+strategy+to+combat+Alzheimer%CA%BCs+disease.+Combining+radical-scavenging+potential+with+metal-protein-attenuating+ability+in+one+molecule"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DH.%2BF.%26aulast%3DZhang%26aufirst%3DH.%2BY.%26atitle%3DA%2520new%2520strategy%2520to%2520combat%2520Alzheimer%25CA%25BCs%2520disease.%2520Combining%2520radical-scavenging%2520potential%2520with%2520metal-protein-attenuating%2520ability%2520in%2520one%2520molecule%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D21%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Schugar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storr, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohmerle, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockman, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merkel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orvig, C.</span><span> </span><span class="NLM_article-title">Combating Alzheimerʼs disease with multifunctional molecules designed for metal passivation</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1716</span><span class="NLM_x">–</span> <span class="NLM_lpage">1718</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=1716-1718&author=H.+Schugarauthor=D.+E.+Greenauthor=M.+L.+Bowenauthor=L.+E.+Scottauthor=T.+Storrauthor=K.+Bohmerleauthor=F.+Thomasauthor=D.+D.+Allenauthor=P.+R.+Lockmanauthor=M.+Merkelauthor=K.+H.+Thompsonauthor=C.+Orvig&title=Combating+Alzheimer%CA%BCs+disease+with+multifunctional+molecules+designed+for+metal+passivation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchugar%26aufirst%3DH.%26aulast%3DGreen%26aufirst%3DD.%2BE.%26aulast%3DBowen%26aufirst%3DM.%2BL.%26aulast%3DScott%26aufirst%3DL.%2BE.%26aulast%3DStorr%26aufirst%3DT.%26aulast%3DBohmerle%26aufirst%3DK.%26aulast%3DThomas%26aufirst%3DF.%26aulast%3DAllen%26aufirst%3DD.%2BD.%26aulast%3DLockman%26aufirst%3DP.%2BR.%26aulast%3DMerkel%26aufirst%3DM.%26aulast%3DThompson%26aufirst%3DK.%2BH.%26aulast%3DOrvig%26aufirst%3DC.%26atitle%3DCombating%2520Alzheimer%25CA%25BCs%2520disease%2520with%2520multifunctional%2520molecules%2520designed%2520for%2520metal%2520passivation%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26spage%3D1716%26epage%3D1718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Storr, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merkel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song-Zhao, G. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, B. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schugar, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orvig, C.</span><span> </span><span class="NLM_article-title">Synthesis, Characterization, and Metal Coordinating Ability of Multifunctional Carbohydrate-Containing Compounds for Alzheimerʼs Therapy</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">7453</span><span class="NLM_x">–</span> <span class="NLM_lpage">7463</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja068965r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=7453-7463&author=T.+Storrauthor=M.+Merkelauthor=G.+X.+Song-Zhaoauthor=L.+E.+Scottauthor=D.+E.+Greenauthor=M.+L.+Bowenauthor=K.+H.+Thompsonauthor=B.+O.+Patrickauthor=H.+J.+Schugarauthor=C.+Orvig&title=Synthesis%2C+Characterization%2C+and+Metal+Coordinating+Ability+of+Multifunctional+Carbohydrate-Containing+Compounds+for+Alzheimer%CA%BCs+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fja068965r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja068965r%26sid%3Dliteratum%253Aachs%26aulast%3DStorr%26aufirst%3DT.%26aulast%3DMerkel%26aufirst%3DM.%26aulast%3DSong-Zhao%26aufirst%3DG.%2BX.%26aulast%3DScott%26aufirst%3DL.%2BE.%26aulast%3DGreen%26aufirst%3DD.%2BE.%26aulast%3DBowen%26aufirst%3DM.%2BL.%26aulast%3DThompson%26aufirst%3DK.%2BH.%26aulast%3DPatrick%26aufirst%3DB.%2BO.%26aulast%3DSchugar%26aufirst%3DH.%2BJ.%26aulast%3DOrvig%26aufirst%3DC.%26atitle%3DSynthesis%252C%2520Characterization%252C%2520and%2520Metal%2520Coordinating%2520Ability%2520of%2520Multifunctional%2520Carbohydrate-Containing%2520Compounds%2520for%2520Alzheimer%25CA%25BCs%2520Therapy%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D7453%26epage%3D7463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capsoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margotti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattaneo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">A Small Molecule Targeting the Multifactorial Nature of Alzheimerʼs Disease</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3689</span><span class="NLM_x">–</span> <span class="NLM_lpage">3692</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=3689-3692&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=S.+Capsoniauthor=V.+Andrisanoauthor=M.+Bartoliniauthor=E.+Margottiauthor=A.+Cattaneoauthor=M.+Recanatiniauthor=C.+Melchiorre&title=A+Small+Molecule+Targeting+the+Multifactorial+Nature+of+Alzheimer%CA%BCs+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DCapsoni%26aufirst%3DS.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMargotti%26aufirst%3DE.%26aulast%3DCattaneo%26aufirst%3DA.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DA%2520Small%2520Molecule%2520Targeting%2520the%2520Multifactorial%2520Nature%2520of%2520Alzheimer%25CA%25BCs%2520Disease%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26spage%3D3689%26epage%3D3692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Beal, M. F.</span><span> </span><span class="NLM_article-title">Mitochondrial dysfunction and oxidative damage in Alzheimerʼs and Parkinsonʼs diseases and coenzyme Q10 as a potential treatment</span> <span class="citation_source-journal">J. Bioenerg. Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2004&pages=381-386&author=M.+F.+Beal&title=Mitochondrial+dysfunction+and+oxidative+damage+in+Alzheimer%CA%BCs+and+Parkinson%CA%BCs+diseases+and+coenzyme+Q10+as+a+potential+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DMitochondrial%2520dysfunction%2520and%2520oxidative%2520damage%2520in%2520Alzheimer%25CA%25BCs%2520and%2520Parkinson%25CA%25BCs%2520diseases%2520and%2520coenzyme%2520Q10%2520as%2520a%2520potential%2520treatment%26jtitle%3DJ.%2520Bioenerg.%2520Biomembr.%26date%3D2004%26volume%3D36%26spage%3D381%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Bragin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chemodanova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzhafarova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bragin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czerniawski, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aliev, G.</span><span> </span><span class="NLM_article-title">Integrated treatment approach improves cognitive function in demented and clinically depressed patients</span> <span class="citation_source-journal">Am. J. Alzheimers Dis. Other Dementias</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1177%2F153331750502000103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15751450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADC%252BD2M7itV2ksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2005&pages=21-26&author=V.+Braginauthor=M.+Chemodanovaauthor=N.+Dzhafarovaauthor=I.+Braginauthor=J.+L.+Czerniawskiauthor=G.+Aliev&title=Integrated+treatment+approach+improves+cognitive+function+in+demented+and+clinically+depressed+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated treatment approach improves cognitive function in demented and clinically depressed patients</span></div><div class="casAuthors">Bragin Valentin; Chemodanova Marina; Dzhafarova Narmina; Bragin Ilya; Czerniawski Jennifer L; Aliev Gjumrakch</div><div class="citationInfo"><span class="NLM_cas:title">American journal of Alzheimer's disease and other dementias</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-6</span>
        ISSN:<span class="NLM_cas:issn">1533-3175</span>.
    </div><div class="casAbstract">The purpose of this study was to evaluate the efficacy of an integrative treatment approach on cognitive performance.  The study sample comprised 35 medically ill patients (20 male, 15 female) with an average age of 71.05, who were diagnosed with mild dementia and depression.  These patients were evaluated at baseline and at six, 12, and 24 months of treatment, which included antidepressants (sertraline, citalopram, or venlafaxine XR, alone or in combination with bupropion XR), cholinesterase inhibitors (donepezil, rivastigmine or galantamine), as well as vitamins and supplements (multivitamins, vitamin E, alpha-lipoic acid, omega-3 and coenzyme Q-10).  Patients were encouraged to modify their diet and lifestyle and perform mild physical exercises.  Results show that the integrative treatment not only protracted cognitive decline for 24 months but even improved cognition, especially memory and frontal lobe functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT0vW8RSBBoPWLFM_lbR1VmfW6udTcc2eZ9tRyOevMlSrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7itV2ksw%253D%253D&md5=7eee4011eb7bc5c7ae91312b1c0cd808</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1177%2F153331750502000103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F153331750502000103%26sid%3Dliteratum%253Aachs%26aulast%3DBragin%26aufirst%3DV.%26aulast%3DChemodanova%26aufirst%3DM.%26aulast%3DDzhafarova%26aufirst%3DN.%26aulast%3DBragin%26aufirst%3DI.%26aulast%3DCzerniawski%26aufirst%3DJ.%2BL.%26aulast%3DAliev%26aufirst%3DG.%26atitle%3DIntegrated%2520treatment%2520approach%2520improves%2520cognitive%2520function%2520in%2520demented%2520and%2520clinically%2520depressed%2520patients%26jtitle%3DAm.%2520J.%2520Alzheimers%2520Dis.%2520Other%2520Dementias%26date%3D2005%26volume%3D20%26spage%3D21%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Ono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naiki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, M.</span><span> </span><span class="NLM_article-title">Preformed beta-amyloid fibrils are destabilized by coenzyme Q10 in vitro</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2005&pages=111-116&author=K.+Onoauthor=K.+Hasegawaauthor=H.+Naikiauthor=M.+Yamada&title=Preformed+beta-amyloid+fibrils+are+destabilized+by+coenzyme+Q10+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOno%26aufirst%3DK.%26aulast%3DHasegawa%26aufirst%3DK.%26aulast%3DNaiki%26aufirst%3DH.%26aulast%3DYamada%26aufirst%3DM.%26atitle%3DPreformed%2520beta-amyloid%2520fibrils%2520are%2520destabilized%2520by%2520coenzyme%2520Q10%2520in%2520vitro%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D330%26spage%3D111%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Tomiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoji, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suwa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, N.</span><span> </span><span class="NLM_article-title">Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">6839</span><span class="NLM_x">–</span> <span class="NLM_lpage">6844</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=6839-6844&author=T.+Tomiyamaauthor=A.+Shojiauthor=K.+Kataokaauthor=Y.+Suwaauthor=S.+Asanoauthor=H.+Kanekoauthor=N.+Endo&title=Inhibition+of+amyloid+beta+protein+aggregation+and+neurotoxicity+by+rifampicin.+Its+possible+function+as+a+hydroxyl+radical+scavenger"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTomiyama%26aufirst%3DT.%26aulast%3DShoji%26aufirst%3DA.%26aulast%3DKataoka%26aufirst%3DK.%26aulast%3DSuwa%26aufirst%3DY.%26aulast%3DAsano%26aufirst%3DS.%26aulast%3DKaneko%26aufirst%3DH.%26aulast%3DEndo%26aufirst%3DN.%26atitle%3DInhibition%2520of%2520amyloid%2520beta%2520protein%2520aggregation%2520and%2520neurotoxicity%2520by%2520rifampicin.%2520Its%2520possible%2520function%2520as%2520a%2520hydroxyl%2520radical%2520scavenger%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D6839%26epage%3D6844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Nesterov, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skoch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacskai, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swager, T. M.</span><span> </span><span class="NLM_article-title">In vivo optical imaging of amyloid aggregates in brain: design of fluorescent markers</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">5452</span><span class="NLM_x">–</span> <span class="NLM_lpage">5456</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fanie.200500845" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16059955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvF2ksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=5452-5456&author=E.+E.+Nesterovauthor=J.+Skochauthor=B.+T.+Hymanauthor=W.+E.+Klunkauthor=B.+J.+Bacskaiauthor=T.+M.+Swager&title=In+vivo+optical+imaging+of+amyloid+aggregates+in+brain%3A+design+of+fluorescent+markers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo optical imaging of amyloid aggregates in brain: Design of fluorescent markers</span></div><div class="casAuthors">Nesterov, Evgueni E.; Skoch, Jesse; Hyman, Bradley T.; Klunk, William E.; Bacskai, Brian J.; Swager, Timothy M.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">5452-5456</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Routine diagnostics and studies of Alzheimer's disease might benefit form the noninvasive optical imaging of amyloid-β plaques in the brain.  A rational design strategy for in vivo amyloid-imaging agents that enter the brain and selectively stain amyloid plaques is presented (see picture), and properties of a promising lead biomarker candidate are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5E9TYWs6pyLVg90H21EOLACvtfcHk0ljiCyVatZi3sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvF2ksLs%253D&md5=784428c9422af2b31caf739625afc87a</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1002%2Fanie.200500845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200500845%26sid%3Dliteratum%253Aachs%26aulast%3DNesterov%26aufirst%3DE.%2BE.%26aulast%3DSkoch%26aufirst%3DJ.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DBacskai%26aufirst%3DB.%2BJ.%26aulast%3DSwager%26aufirst%3DT.%2BM.%26atitle%3DIn%2520vivo%2520optical%2520imaging%2520of%2520amyloid%2520aggregates%2520in%2520brain%253A%2520design%2520of%2520fluorescent%2520markers%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2005%26volume%3D44%26spage%3D5452%26epage%3D5456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Rice-Evans, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, N. J.</span><span> </span><span class="NLM_article-title">Total antioxidant status in plasma and body fluids</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">234</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=234&publication_year=1994&pages=279-293&author=C.+Rice-Evansauthor=N.+J.+Miller&title=Total+antioxidant+status+in+plasma+and+body+fluids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRice-Evans%26aufirst%3DC.%26aulast%3DMiller%26aufirst%3DN.%2BJ.%26atitle%3DTotal%2520antioxidant%2520status%2520in%2520plasma%2520and%2520body%2520fluids%26jtitle%3DMethods%2520Enzymol.%26date%3D1994%26volume%3D234%26spage%3D279%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Mordente, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martorana, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minotti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giardina, B.</span><span> </span><span class="NLM_article-title">Antioxidant properties of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone (idebenone)</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx970136j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1998&pages=54-63&author=A.+Mordenteauthor=G.+E.+Martoranaauthor=G.+Minottiauthor=B.+Giardina&title=Antioxidant+properties+of+2%2C3-dimethoxy-5-methyl-6-%2810-hydroxydecyl%29-1%2C4-benzoquinone+%28idebenone%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1021%2Ftx970136j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx970136j%26sid%3Dliteratum%253Aachs%26aulast%3DMordente%26aufirst%3DA.%26aulast%3DMartorana%26aufirst%3DG.%2BE.%26aulast%3DMinotti%26aufirst%3DG.%26aulast%3DGiardina%26aufirst%3DB.%26atitle%3DAntioxidant%2520properties%2520of%25202%252C3-dimethoxy-5-methyl-6-%252810-hydroxydecyl%2529-1%252C4-benzoquinone%2520%2528idebenone%2529%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D1998%26volume%3D11%26spage%3D54%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">SantaCruz, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yazlovitskaya, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCarli, C.</span><span> </span><span class="NLM_article-title">Regional NAD(P)H:quinone oxidoreductase activity in Alzheimerʼs disease</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2FS0197-4580%2803%2900117-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=14675732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVait7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=63-69&author=K.+S.+SantaCruzauthor=E.+Yazlovitskayaauthor=J.+Collinsauthor=J.+Johnsonauthor=C.+DeCarli&title=Regional+NAD%28P%29H%3Aquinone+oxidoreductase+activity+in+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Regional NAD(P)H:quinone oxidoreductase activity in Alzheimer's disease</span></div><div class="casAuthors">SantaCruz, Karen S.; Yazlovitskaya, Eugenia; Collins, Julie; Johnson, Jeff; DeCarli, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-69</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Converging evidence supports the role of oxidative stress in the pathol. of Alzheimer's disease (AD).  This notion is further supported by recent findings of increased NAD(P)H:quinone oxidoreductase (NQO1) activity, a potent antioxidant system, in assocn. with hippocampal AD pathol.  If increased NQO1 activity is truly related to the AD process, however, one would expect to see regional co-localization of NQO1 activity with AD pathol. throughout affected brain regions and the absence of NQO1 activity in regions unaffected by AD.  The authors examd. this hypothesis by measuring NQO1 enzymic activity and NQO1 immunohistochem. staining in regions commonly affected by the AD process such as frontal cortex and compared this to regions generally unaffected by the AD process such as occipital cortex, cerebellum, and substantia nigra for a group of AD patients and controls.  The ratio of frontal to cerebellar NQO1 enzymic activity was significantly increased in patients with AD (2.07±1.90) vs. controls (0.60±0.31; P<0.03).  Moreover, regional immunohistochem. staining revealed specific localization of NQO1 staining to astrocytes and neurites surrounding senile plaques.  The extent of immunohistochem. staining also closely correlated with the extent of local AD pathol. across the various brain regions examd.  Neuronal NQO1 staining seen in frontal cortex of AD patients was absent in frontal cortex of controls, but was found to the same extent in neurons of the substantia nigra of both AD patients and controls.  We conclude that NQO1 activity co-localizes closely with AD pathol. supporting a presumed role as an antioxidant system upregulated in response to the oxidative stress of the AD process.  The antioxidant role for NQO1 is further supported by finding increased neuronal NQO1 activity in substantia nigra neurons of both AD patients and controls as this neuronal population is known to be under const. oxidative stress.  While requiring further study, these findings, in conjunction with previous work, suggest that increased NQO1 activity may be neuroprotective, may offer novel insights into the pathophysiol. of AD and may also provide possible avenues for future treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2fZpmY5FUCrVg90H21EOLACvtfcHk0ljiCyVatZi3sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVait7c%253D&md5=c003379838446fd2a51ab6d6364cf8c4</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2FS0197-4580%2803%2900117-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-4580%252803%252900117-9%26sid%3Dliteratum%253Aachs%26aulast%3DSantaCruz%26aufirst%3DK.%2BS.%26aulast%3DYazlovitskaya%26aufirst%3DE.%26aulast%3DCollins%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DDeCarli%26aufirst%3DC.%26atitle%3DRegional%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520activity%2520in%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2004%26volume%3D25%26spage%3D63%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santa-Cruz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCarli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. A.</span><span> </span><span class="NLM_article-title">NAD(P)H:quinone oxidoreductase activity is increased in hippocampal pyramidal neurons of patients with Aalzheimerʼs disease</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2FS0197-4580%2800%2900114-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=10924765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltlersb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=525-531&author=Y.+Wangauthor=K.+Santa-Cruzauthor=C.+DeCarliauthor=J.+A.+Johnson&title=NAD%28P%29H%3Aquinone+oxidoreductase+activity+is+increased+in+hippocampal+pyramidal+neurons+of+patients+with+Aalzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">NAD(P)H:quinone oxidoreductase activity is increased in hippocampal pyramidal neurons of patients with Alzheimer's disease</span></div><div class="casAuthors">Wang, Y.; Santa-Cruz, K.; DeCarli, C.; Johnson, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">525-531</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">NAD(P)H:quinone oxidoreductase (QR) catalyzes the two-electron redn. of quinones, preventing their participation in redox cycling and subsequent generation of reactive oxygen species.  Pretreatment of neuroblastoma cells with compds., such as tert-butylhydroquinone and di-Me fumarate, that increase QR expression protect cells from oxidative stress-induced cell death by glutamate, H2O2, and dopamine.  The potential neuroprotective role of QR as well as the evidence for oxidative stress-induced neuronal cell death in Alzheimer's disease (AD) led us to examine the expression pattern of QR from AD and control patients.  Histochem. staining of hippocampal sections from AD patients revealed QR activity in pyramidal neurons.  The presence of QR protein in these neurons also was confirmed by immunoreactivity.  In control patients, hippocampal pyramidal neurons were neg. for both QR enzymic activity and QR immunoreactivity.  In addn., the QR pos. neurons of AD patients were selectively located in areas where neuronal populations exhibited tau immunostaining.  Our data demonstrate that QR is up-regulated in hippocampal pyramidal neurons of AD patients.  We hypothesize that this is part of a neuroprotective system up-regulated in response to the AD process.  Understanding this system may lead to further insights into the pathogenesis and potential new avenues of treatment for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoS_EfRfekd7Vg90H21EOLACvtfcHk0ljwHN6Z6NxcZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltlersb8%253D&md5=4b0eb4ff412fc157b063f094627ec126</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2FS0197-4580%2800%2900114-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-4580%252800%252900114-7%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSanta-Cruz%26aufirst%3DK.%26aulast%3DDeCarli%26aufirst%3DC.%26aulast%3DJohnson%26aufirst%3DJ.%2BA.%26atitle%3DNAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520activity%2520is%2520increased%2520in%2520hippocampal%2520pyramidal%2520neurons%2520of%2520patients%2520with%2520Aalzheimer%25CA%25BCs%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2000%26volume%3D21%26spage%3D525%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Capsoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugolini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comparini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruberti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattaneo, A.</span><span> </span><span class="NLM_article-title">Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">6826</span><span class="NLM_x">–</span> <span class="NLM_lpage">6831</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=6826-6831&author=S.+Capsoniauthor=G.+Ugoliniauthor=A.+Compariniauthor=F.+Rubertiauthor=N.+Berardiauthor=A.+Cattaneo&title=Alzheimer-like+neurodegeneration+in+aged+antinerve+growth+factor+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCapsoni%26aufirst%3DS.%26aulast%3DUgolini%26aufirst%3DG.%26aulast%3DComparini%26aufirst%3DA.%26aulast%3DRuberti%26aufirst%3DF.%26aulast%3DBerardi%26aufirst%3DN.%26aulast%3DCattaneo%26aufirst%3DA.%26atitle%3DAlzheimer-like%2520neurodegeneration%2520in%2520aged%2520antinerve%2520growth%2520factor%2520transgenic%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D6826%26epage%3D6831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Capsoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattaneo, A.</span><span> </span><span class="NLM_article-title">On the molecular basis linking nerve growth factor (NGF) to Alzheimerʼs disease</span> <span class="citation_source-journal">Cell. Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">619</span><span class="NLM_x">–</span> <span class="NLM_lpage">633</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1007%2Fs10571-006-9112-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16944323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtleksbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=619-633&author=S.+Capsoniauthor=A.+Cattaneo&title=On+the+molecular+basis+linking+nerve+growth+factor+%28NGF%29+to+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">On the Molecular Basis Linking Nerve Growth Factor (NGF) to Alzheimer's Disease</span></div><div class="casAuthors">Capsoni, Simona; Cattaneo, Antonino</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4-6</span>),
    <span class="NLM_cas:pages">619-633</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  1. Alzheimer's disease (AD) is pathol. defined by the deposition of amyloid peptide and neurofibrillary tangles and is characterized by a progressive loss of cognition and memory function, due to marked cortical cholinergic depletion. 2.  Cholinergic cortical innervation is provided by basal forebrain cholinergic neurons.  The neurotrophin Nerve Growth Factor (NGF) promotes survival and differentiation of basal forebrain cholinergic neurons. 3.  This assertion has been at the basis of the hypothesis developed in the last 20 years, whereby NGF deprivation would be one of the factor involved in the etiol. of sporadic forms of AD. 4.  In this review, we shall summarize data that lead to the prodn. and characterization of a mouse model for AD (AD11 anti-NGF mice), based on the expression of transgenic antibodies neutralizing NGF.  The AD-like phenotype of AD11 mice will be discussed on the basis of recent studies that have posed NGF and its precursor pro-NGF back to the stage of AD-like neurodegeneration, showing the involvement of the precursor pro-NGF in one of the cascades leading to AD neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1JwAZLpPpxbVg90H21EOLACvtfcHk0ljwHN6Z6NxcZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtleksbrL&md5=50ed72a8c0dd983594959edee6e4d787</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1007%2Fs10571-006-9112-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10571-006-9112-2%26sid%3Dliteratum%253Aachs%26aulast%3DCapsoni%26aufirst%3DS.%26aulast%3DCattaneo%26aufirst%3DA.%26atitle%3DOn%2520the%2520molecular%2520basis%2520linking%2520nerve%2520growth%2520factor%2520%2528NGF%2529%2520to%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D2006%26volume%3D26%26spage%3D619%26epage%3D633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Wood-Kaczmar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, N. W.</span><span> </span><span class="NLM_article-title">Understanding the molecular causes of Parkinsonʼs disease</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">521</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=521-528&author=A.+Wood-Kaczmarauthor=S.+Gandhiauthor=N.+W.+Wood&title=Understanding+the+molecular+causes+of+Parkinson%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood-Kaczmar%26aufirst%3DA.%26aulast%3DGandhi%26aufirst%3DS.%26aulast%3DWood%26aufirst%3DN.%2BW.%26atitle%3DUnderstanding%2520the%2520molecular%2520causes%2520of%2520Parkinson%25CA%25BCs%2520disease%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D521%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span> </span><span class="NLM_article-title">Mechanisms of Parkinsonʼs disease linked to pathological alpha-synuclein: new targets for drug discovery</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2006&pages=33-38&author=V.+M.+Leeauthor=J.+Q.+Trojanowski&title=Mechanisms+of+Parkinson%CA%BCs+disease+linked+to+pathological+alpha-synuclein%3A+new+targets+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DMechanisms%2520of%2520Parkinson%25CA%25BCs%2520disease%2520linked%2520to%2520pathological%2520alpha-synuclein%253A%2520new%2520targets%2520for%2520drug%2520discovery%26jtitle%3DNeuron%26date%3D2006%26volume%3D52%26spage%3D33%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Volles, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochet, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shtilerman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansbury, P. T.,  Jr.</span><span> </span><span class="NLM_article-title">Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinsonʼs disease</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">7812</span><span class="NLM_x">–</span> <span class="NLM_lpage">7819</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi0102398" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=7812-7819&author=M.+J.+Vollesauthor=S.+J.+Leeauthor=J.+C.+Rochetauthor=M.+D.+Shtilermanauthor=T.+T.+Dingauthor=J.+C.+Kesslerauthor=P.+T.+Lansbury&title=Vesicle+permeabilization+by+protofibrillar+alpha-synuclein%3A+implications+for+the+pathogenesis+and+treatment+of+Parkinson%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Fbi0102398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0102398%26sid%3Dliteratum%253Aachs%26aulast%3DVolles%26aufirst%3DM.%2BJ.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DRochet%26aufirst%3DJ.%2BC.%26aulast%3DShtilerman%26aufirst%3DM.%2BD.%26aulast%3DDing%26aufirst%3DT.%2BT.%26aulast%3DKessler%26aufirst%3DJ.%2BC.%26aulast%3DLansbury%26aufirst%3DP.%2BT.%26atitle%3DVesicle%2520permeabilization%2520by%2520protofibrillar%2520alpha-synuclein%253A%2520implications%2520for%2520the%2520pathogenesis%2520and%2520treatment%2520of%2520Parkinson%25CA%25BCs%2520disease%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D7812%26epage%3D7819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Bilen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonini, N. M.</span><span> </span><span class="NLM_article-title">Drosophila as a model for human neurodegenerative disease</span> <span class="citation_source-journal">Annu. Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2005&pages=153-171&author=J.+Bilenauthor=N.+M.+Bonini&title=Drosophila+as+a+model+for+human+neurodegenerative+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBilen%26aufirst%3DJ.%26aulast%3DBonini%26aufirst%3DN.%2BM.%26atitle%3DDrosophila%2520as%2520a%2520model%2520for%2520human%2520neurodegenerative%2520disease%26jtitle%3DAnnu.%2520Rev.%2520Genet.%26date%3D2005%26volume%3D39%26spage%3D153%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Cuervo, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredenburg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansbury, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulzer, D.</span><span> </span><span class="NLM_article-title">Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">1292</span><span class="NLM_x">–</span> <span class="NLM_lpage">1295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1126%2Fscience.1101738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15333840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvFCit7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=1292-1295&author=A.+M.+Cuervoauthor=L.+Stefanisauthor=R.+Fredenburgauthor=P.+T.+Lansburyauthor=D.+Sulzer&title=Impaired+degradation+of+mutant+alpha-synuclein+by+chaperone-mediated+autophagy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy</span></div><div class="casAuthors">Cuervo, Ana Maria; Stefanis, Leonidas; Fredenburg, Ross; Lansbury, Peter T.; Sulzer, David</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">5688</span>),
    <span class="NLM_cas:pages">1292-1295</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Aberrant α-synuclein degrdn. is implicated in Parkinson's disease pathogenesis because the protein accumulates in the Lewy inclusion bodies assocd. with the disease.  Little is known, however, about the pathways by which wild-type α-synuclein is normally degraded.  We found that wild-type α-synuclein was selectively translocated into lysosomes for degrdn. by the chaperone-mediated autophagy pathway.  The pathogenic A53T and A30P α-synuclein mutants bound to the receptor for this pathway on the lysosomal membrane, but appeared to act as uptake blockers, inhibiting both their own degrdn. and that of other substrates.  These findings may underlie the toxic gain-of-function by the mutants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCVMt6d-3aVbVg90H21EOLACvtfcHk0ljDlQ6NtRvsBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvFCit7w%253D&md5=9185e1003c9cdd1a63c4ca45e4671614</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1126%2Fscience.1101738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1101738%26sid%3Dliteratum%253Aachs%26aulast%3DCuervo%26aufirst%3DA.%2BM.%26aulast%3DStefanis%26aufirst%3DL.%26aulast%3DFredenburg%26aufirst%3DR.%26aulast%3DLansbury%26aufirst%3DP.%2BT.%26aulast%3DSulzer%26aufirst%3DD.%26atitle%3DImpaired%2520degradation%2520of%2520mutant%2520alpha-synuclein%2520by%2520chaperone-mediated%2520autophagy%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D1292%26epage%3D1295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Okochi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahle, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Constitutive phosphorylation of the Parkinsonʼs disease associated alpha-synuclein</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">390</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=390-397&author=M.+Okochiauthor=J.+Walterauthor=A.+Koyamaauthor=S.+Nakajoauthor=M.+Babaauthor=T.+Iwatsuboauthor=L.+Meijerauthor=P.+J.+Kahleauthor=C.+Haass&title=Constitutive+phosphorylation+of+the+Parkinson%CA%BCs+disease+associated+alpha-synuclein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkochi%26aufirst%3DM.%26aulast%3DWalter%26aufirst%3DJ.%26aulast%3DKoyama%26aufirst%3DA.%26aulast%3DNakajo%26aufirst%3DS.%26aulast%3DBaba%26aufirst%3DM.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DKahle%26aufirst%3DP.%2BJ.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DConstitutive%2520phosphorylation%2520of%2520the%2520Parkinson%25CA%25BCs%2520disease%2520associated%2520alpha-synuclein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D390%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Taylor, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mata, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M. J.</span><span> </span><span class="NLM_article-title">LRRK2: a common pathway for parkinsonism, pathogenesis and prevention</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">76</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=76-82&author=J.+P.+Taylorauthor=I.+F.+Mataauthor=M.+J.+Farrer&title=LRRK2%3A+a+common+pathway+for+parkinsonism%2C+pathogenesis+and+prevention"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DJ.%2BP.%26aulast%3DMata%26aufirst%3DI.%2BF.%26aulast%3DFarrer%26aufirst%3DM.%2BJ.%26atitle%3DLRRK2%253A%2520a%2520common%2520pathway%2520for%2520parkinsonism%252C%2520pathogenesis%2520and%2520prevention%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D76%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Savitt, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span> </span><span class="NLM_article-title">Diagnosis and treatment of Parkinson disease: molecules to medicine</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">1744</span><span class="NLM_x">–</span> <span class="NLM_lpage">1754</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2006&pages=1744-1754&author=J.+M.+Savittauthor=V.+L.+Dawsonauthor=T.+M.+Dawson&title=Diagnosis+and+treatment+of+Parkinson+disease%3A+molecules+to+medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSavitt%26aufirst%3DJ.%2BM.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26atitle%3DDiagnosis%2520and%2520treatment%2520of%2520Parkinson%2520disease%253A%2520molecules%2520to%2520medicine%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2006%26volume%3D116%26spage%3D1744%26epage%3D1754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Zecca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crichton, R. R.</span><span> </span><span class="NLM_article-title">Iron, brain ageing and neurodegenerative disorders</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">863</span><span class="NLM_x">–</span> <span class="NLM_lpage">873</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnrn1537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15496864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXos1Ojtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=863-873&author=L.+Zeccaauthor=M.+B.+Youdimauthor=P.+Riedererauthor=J.+R.+Connorauthor=R.+R.+Crichton&title=Iron%2C+brain+ageing+and+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Iron, brain aging and neurodegenerative disorders</span></div><div class="casAuthors">Zecca, Luigi; Youdim, Moussa B. H.; Riederer, Peter; Connor, James R.; Crichton, Robert R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">863-873</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is increasing evidence that iron is involved in the mechanisms that underlie many neurodegenerative diseases.  Conditions such as neuro-ferritinopathy and Friedreich ataxia are assocd. with mutations in genes that encode proteins that are involved in iron metab., and as the brain ages, iron accumulates in regions that are affected by Alzheimer's disease and Parkinson's disease.  High concns. of reactive iron can increase oxidative-stress induced neuronal vulnerability, and iron accumulation might increase the toxicity of environmental or endogenous toxins.  By studying the accumulation and cellular distribution of iron during aging, we should be able to increase our understanding of these neurodegenerative disorders and develop new therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNNc8epL4ObbVg90H21EOLACvtfcHk0li6Sdf0ym4U0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXos1Ojtrc%253D&md5=e4d3e1b563faffd919138ab1abc0e5b6</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1038%2Fnrn1537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1537%26sid%3Dliteratum%253Aachs%26aulast%3DZecca%26aufirst%3DL.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DConnor%26aufirst%3DJ.%2BR.%26aulast%3DCrichton%26aufirst%3DR.%2BR.%26atitle%3DIron%252C%2520brain%2520ageing%2520and%2520neurodegenerative%2520disorders%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2004%26volume%3D5%26spage%3D863%26epage%3D873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Shachar, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahana, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kampel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warshawsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2004&pages=254-263&author=D.+B.+Shacharauthor=N.+Kahanaauthor=V.+Kampelauthor=A.+Warshawskyauthor=M.+B.+Youdim&title=Neuroprotection+by+a+novel+brain+permeable+iron+chelator%2C+VK-28%2C+against+6-hydroxydopamine+lession+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShachar%26aufirst%3DD.%2BB.%26aulast%3DKahana%26aufirst%3DN.%26aulast%3DKampel%26aufirst%3DV.%26aulast%3DWarshawsky%26aufirst%3DA.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DNeuroprotection%2520by%2520a%2520novel%2520brain%2520permeable%2520iron%2520chelator%252C%2520VK-28%252C%2520against%25206-hydroxydopamine%2520lession%2520in%2520rats%26jtitle%3DNeuropharmacology%26date%3D2004%26volume%3D46%26spage%3D254%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Fernandez, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. J.</span><span> </span><span class="NLM_article-title">Monamine oxidase inhibitors: current and emerging agents for Parkinson disease</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=150-168&author=H.+H.+Fernandezauthor=J.+J.+Chen&title=Monamine+oxidase+inhibitors%3A+current+and+emerging+agents+for+Parkinson+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez%26aufirst%3DH.%2BH.%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26atitle%3DMonamine%2520oxidase%2520inhibitors%253A%2520current%2520and%2520emerging%2520agents%2520for%2520Parkinson%2520disease%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2007%26volume%3D30%26spage%3D150%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Singh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillay, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choonara, Y. E.</span><span> </span><span class="NLM_article-title">Advances in the treatment of Parkinsonʼs disease</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.pneurobio.2006.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17258379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitFOrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=29-44&author=N.+Singhauthor=V.+Pillayauthor=Y.+E.+Choonara&title=Advances+in+the+treatment+of+Parkinson%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the treatment of Parkinson's disease</span></div><div class="casAuthors">Singh, Neha; Pillay, Viness; Choonara, Yahya E.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-44</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) affects one in every 100 persons above the age of 65 years, making it the second most common neurodegenerative disease after Alzheimer's disease.  PD is a disease of the central nervous system that leads to severe difficulties with body motions.  The currently available therapies aim to improve the functional capacity of the patient for as long as possible; however they do not modify the progression of the neurodegenerative process.  The need for newer and more effective agents is consequently receiving a great deal of attention and consequently being subjected to extensive research.  This review concisely compiles the limitations of currently available therapies and the most recent research regarding neuroprotective agents, antioxidants, stem cell research, vaccines and various surgical techniques available and being developed for the management of PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopehFcHUWiALVg90H21EOLACvtfcHk0li6Sdf0ym4U0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitFOrsLg%253D&md5=bfb1aa5f822c802507c43fa1156be14b</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2006.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2006.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DN.%26aulast%3DPillay%26aufirst%3DV.%26aulast%3DChoonara%26aufirst%3DY.%2BE.%26atitle%3DAdvances%2520in%2520the%2520treatment%2520of%2520Parkinson%25CA%25BCs%2520disease%26jtitle%3DProg.%2520Neurobiol.%26date%3D2007%26volume%3D81%26spage%3D29%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Schrag, A.</span><span> </span><span class="NLM_article-title">Entacapone in the treatment of Parkinsonʼs disease</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2FS1474-4422%2805%2970098-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15907741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXls1eis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=366-370&author=A.+Schrag&title=Entacapone+in+the+treatment+of+Parkinson%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Entacapone in the treatment of Parkinson's disease</span></div><div class="casAuthors">Schrag, Anette</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">366-370</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Lancet Neurology</span>)
        </div><div class="casAbstract">A review.  Background: The development of fluctuations in motor response and involuntary movements commonly complicate the treatment of Parkinson's disease (PD).  Catechol-O-methyltransferase (COMT) inhibitors delay the breakdown of levodopa, which leads to an increase in levodopa bioavailability and more stable concns. of plasma levodopa.  The addn. of a COMT inhibitor therefore combines the rapid onset of levodopa with prolonged efficacy, and theor. provides a more continuous stimulation of dopamine receptors with reduced risk of motor complications.  Randomised, controlled trials have shown that in patients with PD who have motor fluctuations, the addn. of the COMT-inhibitor entacapone results in an improvement in motor fluctuations, particularly of the "wearing-off" type, with about 1.0-1.7 h more on-time and less off-time per day, reduced required levodopa dose, modest improvement in motor and disability scores (mean total unified PD rating scale [UPDRS] scores of about 4.5), and in some but not all studies improvement of health-related quality of life [HRQOL] scores.  Recent developments: Patients with stable PD, without motor fluctuations, also have improved HRQOL scores on treatment with entacapone in addn. to levodopa with a dopa-decarboxylase inhibitor.  However, in a recent large multicenter study, UPDRS motor and disability scores were not improved despite significant improvements in HRQOL scores.  The disparity between results on clin. rating scales and HRQOL scores suggests that these scales give different and potentially complementary information on health status changes in PD, and that entacapone provides benefit that may not be captured with std. clin. rating scales.  Whether entacapone combined with levodopa can delay dyskinesia or motor fluctuations in patients with untreated PD is unknown; however, in animal studies, a decrease in motor complications has been reported in drug-naive animals given frequent doses of levodopa combined with entacapone.  Where next: Clin. studies are underway to address the hypothesis that motor complications in PD can be delayed if entacapone is given from the start of treatment.  Until the results of these trials are available, entacapone is indicated as a useful adjunct to levodopa in the symptomatic treatment of patients with PD with and without motor fluctuations.  In addn., future trials should specifically assess the effect of entacapone on HRQOL in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR3O2q8wka4LVg90H21EOLACvtfcHk0li6Sdf0ym4U0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXls1eis7c%253D&md5=f12147171ff96ab71f05c02e4ca83ace</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2805%2970098-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252805%252970098-3%26sid%3Dliteratum%253Aachs%26aulast%3DSchrag%26aufirst%3DA.%26atitle%3DEntacapone%2520in%2520the%2520treatment%2520of%2520Parkinson%25CA%25BCs%2520disease%26jtitle%3DLancet%2520Neurol.%26date%3D2005%26volume%3D4%26spage%3D366%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Schapira, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collingridge, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hengerer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Novere, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obeso, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spampinato, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidai, G.</span><span> </span><span class="NLM_article-title">Novel pharmacological targets for the treatment of Parkinsonʼs disease</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">845</span><span class="NLM_x">–</span> <span class="NLM_lpage">854</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=845-854&author=A.+H.+Schapiraauthor=E.+Bezardauthor=J.+Brotchieauthor=F.+Calonauthor=G.+L.+Collingridgeauthor=B.+Fergerauthor=B.+Hengererauthor=E.+Hirschauthor=P.+Jennerauthor=N.+Le+Novereauthor=J.+A.+Obesoauthor=M.+A.+Schwarzschildauthor=U.+Spampinatoauthor=G.+Davidai&title=Novel+pharmacological+targets+for+the+treatment+of+Parkinson%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchapira%26aufirst%3DA.%2BH.%26aulast%3DBezard%26aufirst%3DE.%26aulast%3DBrotchie%26aufirst%3DJ.%26aulast%3DCalon%26aufirst%3DF.%26aulast%3DCollingridge%26aufirst%3DG.%2BL.%26aulast%3DFerger%26aufirst%3DB.%26aulast%3DHengerer%26aufirst%3DB.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DJenner%26aufirst%3DP.%26aulast%3DLe%2BNovere%26aufirst%3DN.%26aulast%3DObeso%26aufirst%3DJ.%2BA.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26aulast%3DSpampinato%26aufirst%3DU.%26aulast%3DDavidai%26aufirst%3DG.%26atitle%3DNovel%2520pharmacological%2520targets%2520for%2520the%2520treatment%2520of%2520Parkinson%25CA%25BCs%2520disease%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D845%26epage%3D854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Mandel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives</span> <span class="citation_source-journal">Brain Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.brainresrev.2004.12.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15850677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjs1Clsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=379-387&author=S.+Mandelauthor=O.+Weinrebauthor=T.+Amitauthor=M.+B.+Youdim&title=Mechanism+of+neuroprotective+action+of+the+anti-Parkinson+drug+rasagiline+and+its+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives</span></div><div class="casAuthors">Mandel, Silvia; Weinreb, Orly; Amit, Tamar; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">379-387</span>CODEN:
                <span class="NLM_cas:coden">BRERD2</span>;
        ISSN:<span class="NLM_cas:issn">0165-0173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The mitochondria are directly involved in cell survival and death.  Drugs that protect mitochondria viability and prevent apoptotic cascade mechanisms involved in mitochondrial permeability transition pore (MPTp) will be cytoprotective.  Rasagiline (N-propargyl-1R-aminoindan) is a novel, highly potent irreversible monoamine oxidase (MAO) B inhibitor, anti-Parkinson drug.  Unlike selegiline, rasagiline is not derived from amphetamine, is not metabolized to neurotoxic l-methamphetamine deriv., nor does it have sympathomimetic activity.  Rasagiline is effective as monotherapy or adjunct to L-dopa for patients with early and late Parkinson's disease (PD), and adverse events do not occur with greater frequency in subjects receiving rasagiline than those on placebo.  Controlled studies indicate that it might have a disease-modifying effect in PD that may be related to neuroprotection.  Its S-isomer, TVP1022, is a relatively inactive MAO inhibitor.  However, both drugs have similar neuroprotective activities in neuronal cell cultures in response to various neurotoxins and in vivo (global ischemia, neurotrauma, head injury, anoxia, etc.), indicating that MAO inhibition is not a pre-requisite for neuroprotection.  Structure activity studies have shown that the neuroprotective activity is assocd. with the propargyl moiety of rasagiline which protects mitochondrial viability and MPTp by activating Bcl-2 and protein kinase C (PKC), and down regulating pro-apoptotic FAS and Bax.  Rasagiline and its derivs. also process amyloid precursor protein (APP) to the neuroprotective-neurotrophic sol. APP alpha (sAPPα) by PKC and MAP kinase-dependent activation of α-secretase.  The neuroprotective activity of propargylamine has led us to develop novel bifunctional neuroprotective iron-chelating MAO-inhibiting drugs possessing propargyl moiety for the treatment of other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo-jzsUjjFfbVg90H21EOLACvtfcHk0lg81DoJcHfz7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjs1Clsr0%253D&md5=7defa497360ae91d0d8bea6f1e1ee6b0</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresrev.2004.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresrev.2004.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DMandel%26aufirst%3DS.%26aulast%3DWeinreb%26aufirst%3DO.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DMechanism%2520of%2520neuroprotective%2520action%2520of%2520the%2520anti-Parkinson%2520drug%2520rasagiline%2520and%2520its%2520derivatives%26jtitle%3DBrain%2520Res.%2520Rev.%26date%3D2005%26volume%3D48%26spage%3D379%26epage%3D387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falach-Yogev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Am, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naoi, M.</span><span> </span><span class="NLM_article-title">The essentiality of Bcl-2, PKC and proteasome−ubiquitin complex activations in the neuroprotective−antiapoptotic action of the anti-Parkinson drug, rasagiline</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1635</span><span class="NLM_x">–</span> <span class="NLM_lpage">1641</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2003&pages=1635-1641&author=M.+B.+Youdimauthor=T.+Amitauthor=M.+Falach-Yogevauthor=O.+B.+Amauthor=W.+Maruyamaauthor=M.+Naoi&title=The+essentiality+of+Bcl-2%2C+PKC+and+proteasome%E2%88%92ubiquitin+complex+activations+in+the+neuroprotective%E2%88%92antiapoptotic+action+of+the+anti-Parkinson+drug%2C+rasagiline"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DFalach-Yogev%26aufirst%3DM.%26aulast%3DAm%26aufirst%3DO.%2BB.%26aulast%3DMaruyama%26aufirst%3DW.%26aulast%3DNaoi%26aufirst%3DM.%26atitle%3DThe%2520essentiality%2520of%2520Bcl-2%252C%2520PKC%2520and%2520proteasome%25E2%2588%2592ubiquitin%2520complex%2520activations%2520in%2520the%2520neuroprotective%25E2%2588%2592antiapoptotic%2520action%2520of%2520the%2520anti-Parkinson%2520drug%252C%2520rasagiline%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2003%26volume%3D66%26spage%3D1635%26epage%3D1641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Yogev-Falach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Am, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">The importance of propargylamine moiety in the anti-Parkinson drug rasagiline and its derivatives in MAPK-dependent amyloid precursor protein processing</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2325</span><span class="NLM_x">–</span> <span class="NLM_lpage">2327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=2325-2327&author=M.+Yogev-Falachauthor=T.+Amitauthor=O.+Bar-Amauthor=M.+B.+Youdim&title=The+importance+of+propargylamine+moiety+in+the+anti-Parkinson+drug+rasagiline+and+its+derivatives+in+MAPK-dependent+amyloid+precursor+protein+processing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYogev-Falach%26aufirst%3DM.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DBar-Am%26aufirst%3DO.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DThe%2520importance%2520of%2520propargylamine%2520moiety%2520in%2520the%2520anti-Parkinson%2520drug%2520rasagiline%2520and%2520its%2520derivatives%2520in%2520MAPK-dependent%2520amyloid%2520precursor%2520protein%2520processing%26jtitle%3DFASEB%2520J.%26date%3D2003%26volume%3D17%26spage%3D2325%26epage%3D2327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Am, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Contrasting neuroprotective and neurotoxic actions of respective metabolites of anti-Parkinson drugs rasagiline and selegiline</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2004&pages=169-172&author=O.+B.+Amauthor=T.+Amitauthor=M.+B.+Youdim&title=Contrasting+neuroprotective+and+neurotoxic+actions+of+respective+metabolites+of+anti-Parkinson+drugs+rasagiline+and+selegiline"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAm%26aufirst%3DO.%2BB.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DContrasting%2520neuroprotective%2520and%2520neurotoxic%2520actions%2520of%2520respective%2520metabolites%2520of%2520anti-Parkinson%2520drugs%2520rasagiline%2520and%2520selegiline%26jtitle%3DNeurosci.%2520Lett.%26date%3D2004%26volume%3D355%26spage%3D169%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Maruyama, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naoi, M.</span><span> </span><span class="NLM_article-title">Neurotoxins induce apoptosis in dopamine neurons: protection by <i>N</i>-propargylamine-1(<i>R</i>)- and (<i>S</i>)-aminoindan, rasagiline and TV1022</span> <span class="citation_source-journal">J. Neural Transm., Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=11205138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADC%252BD3M3gt1Ojuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=171-186&author=W.+Maruyamaauthor=Y.+Akaoauthor=M.+B.+Youdimauthor=M.+Naoi&title=Neurotoxins+induce+apoptosis+in+dopamine+neurons%3A+protection+by+N-propargylamine-1%28R%29-+and+%28S%29-aminoindan%2C+rasagiline+and+TV1022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotoxins induce apoptosis in dopamine neurons: protection by N-propargylamine-1(R)- and (S)-aminoindan, rasagiline and TV1022</span></div><div class="casAuthors">Maruyama W; Akao Y; Youdim M B; Naoi M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neural transmission. Supplementum</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">60</span>),
    <span class="NLM_cas:pages">171-86</span>
        ISSN:<span class="NLM_cas:issn">0303-6995</span>.
    </div><div class="casAbstract">In Parkinson's disease, apoptosis was proposed to cause cell death in nigral dopamine neurons.  An endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, stereo-selectively induced apoptosis in human neuroblastoma SH-SY5Y cells.  In this paper the intracellular mechanism of apoptosis was studied using N-methyl(R)salsolinol, 6-hydroxydopamine and peroxynitrite as inducers of apoptosis.  Apoptotic cascade was initiated by opening of mitochondrial permeability transition pore, as shown by collapse of mitochondrial membrane potential, deltapsim.  Apoptosis was executed by caspase 3 activation, followed by DNA fragmentation, which was antagonized by overexpressed Bcl-2.  Propargylamines were found to protect the cells from apoptosis, and rasagiline, a selective irreversible inhibitor of type B monoamine oxidase was the most potent to prevent the cell death.  Rasagiline preserved deltapsim, which was proved also in isolated mitochondria, and rasagiline completely suppressed the activation of caspases and DNA fragmentation.  These results suggest that mitochondria regulate apoptotic process, which may be a target of neuroprotection by rasagiline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRj2Aw68nvLXdTiMd2aNQVUfW6udTcc2eaXXvOkMNKd3rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M3gt1Ojuw%253D%253D&md5=92ae001e5921b0d176173c04faf53c88</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaruyama%26aufirst%3DW.%26aulast%3DAkao%26aufirst%3DY.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DNaoi%26aufirst%3DM.%26atitle%3DNeurotoxins%2520induce%2520apoptosis%2520in%2520dopamine%2520neurons%253A%2520protection%2520by%2520N-propargylamine-1%2528R%2529-%2520and%2520%2528S%2529-aminoindan%252C%2520rasagiline%2520and%2520TV1022%26jtitle%3DJ.%2520Neural%2520Transm.%252C%2520Suppl.%26date%3D2000%26spage%3D171%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Petty, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elands, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linnik, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moskowitz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarty, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, B. M.</span><span> </span><span class="NLM_article-title">The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraine</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2FS0014-2999%2897%2901218-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=9384224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaK2sXmsVKmur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=1997&pages=127-136&author=M.+A.+Pettyauthor=J.+Elandsauthor=M.+P.+Johnsonauthor=M.+D.+Linnikauthor=E.+Hamelauthor=M.+A.+Moskowitzauthor=W.+S.+Leeauthor=D.+R.+McCartyauthor=M.+Hibertauthor=B.+M.+Baron&title=The+selectivity+of+MDL+74%2C721+in+models+of+neurogenic+versus+vascular+components+of+migraine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraine</span></div><div class="casAuthors">Petty, Margaret A.; Elands, Jack; Johnson, Michael P.; Linnik, Matthew D.; Hamel, Edith; Moskowitz, Michael A.; Lee, Won Suk; McCarty, Deborah R.; Hibert, Marcel; Baron, Bruce M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">127-136</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">MDL 74,721 (R)-2-(N1,N1-dipropylamino)-8-methylaminosulfonylmethyl-1,2,3,4-tetrahydronaphthalene, a sulfonamidotetralin, has been found to exhibit a 10000-fold greater potency in neurogenic vs. vascular models of migraine.  Sumatriptan, a relatively pure 5-HT1D/5-HT1B receptor agonist, also showed higher potency vs. neurogenic inflammation.  However, for sumatriptan, the potency difference (100-fold) in the two pathophysiol. models was less pronounced than seen for MDL 74,721.  The affinity profile of MDL 74,721 at 5-HT1 receptor subtypes may in part explain its ability to differentiate these two physiol. responses.  MDL 74,721 demonstrated nanomolar affinity for 5-HT1A (12.7 nM) and 5-HT1D (41.3 nM) but considerably lower affinity for 5-HT1B receptors (>1000 nM).  Serotonin-like activity was seen in in vitro functional assays including inhibition of forskolin-stimulated cAMP accumulation in human 5-HT1D receptor-transfected fibroblasts or eliciting vasoconstriction in isolated human pial arteries.  The intrinsic activity (relative to 5-HTEAmax) and affinity (pD2) for the human cerebrovascular 5-HT receptors were: 5-HT (100%, 7.51), sumatriptan (94%, 6.85) and MDL 74,721 (66%, 5.70).  In anesthetized cats, treatment with MDL 74,721 resulted in a dose-related redn. in the percentage of carotid flow going through the arteriovenous anastomoses to the lungs, with an ED50 of 0.3 mg/kg i.v., the same as sumatriptan.  However, in the guinea-pig neurogenic model, MDL 74,721 inhibited plasma protein extravasation with an ED50 of 0.023 μg/kg compared to 2.5 μg/kg for sumatriptan.  MDL 74,721 was also effective in this model (in rats) after oral administration.  In conclusion, MDL 74,721 demonstrates a preclin. profile consistent with anti-migraine efficacy.  Its marked preference for inhibiting neurogenic inflammation makes this compd. a useful tool for assessing the relative contribution of this pathophysiol. mechanism to the human disease state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0OvQvGRQarLVg90H21EOLACvtfcHk0lhO1_R722P9Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmsVKmur8%253D&md5=04ef49479225cf0dea8a4b8e14fbcc35</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2897%2901218-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252897%252901218-1%26sid%3Dliteratum%253Aachs%26aulast%3DPetty%26aufirst%3DM.%2BA.%26aulast%3DElands%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DM.%2BP.%26aulast%3DLinnik%26aufirst%3DM.%2BD.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DMoskowitz%26aufirst%3DM.%2BA.%26aulast%3DLee%26aufirst%3DW.%2BS.%26aulast%3DMcCarty%26aufirst%3DD.%2BR.%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DBaron%26aufirst%3DB.%2BM.%26atitle%3DThe%2520selectivity%2520of%2520MDL%252074%252C721%2520in%2520models%2520of%2520neurogenic%2520versus%2520vascular%2520components%2520of%2520migraine%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D336%26spage%3D127%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatton, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstock, M.</span><span> </span><span class="NLM_article-title">The anti-Parkinson drug rasagiline and its cholinesterase inhibitor derivatives exert neuroprotection unrelated to MAO inhibition in cell culture and in vivo</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">939</span><span class="NLM_x">, </span> <span class="NLM_fpage">450</span><span class="NLM_x">–</span> <span class="NLM_lpage">458</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=939&publication_year=2001&pages=450-458&author=M.+B.+Youdimauthor=A.+Wadiaauthor=W.+Tattonauthor=M.+Weinstock&title=The+anti-Parkinson+drug+rasagiline+and+its+cholinesterase+inhibitor+derivatives+exert+neuroprotection+unrelated+to+MAO+inhibition+in+cell+culture+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DWadia%26aufirst%3DA.%26aulast%3DTatton%26aufirst%3DW.%26aulast%3DWeinstock%26aufirst%3DM.%26atitle%3DThe%2520anti-Parkinson%2520drug%2520rasagiline%2520and%2520its%2520cholinesterase%2520inhibitor%2520derivatives%2520exert%2520neuroprotection%2520unrelated%2520to%2520MAO%2520inhibition%2520in%2520cell%2520culture%2520and%2520in%2520vivo%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2001%26volume%3D939%26spage%3D450%26epage%3D458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">Maruyama, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naoi, M.</span><span> </span><span class="NLM_article-title">Anti-apoptotic action of anti-Alzheimer drug, TV3326 [(<i>N</i>-propargyl)-(3<i>R</i>)-aminoindan-5-yl]-ethyl methyl carbamate, a novel cholinesterase-monoamine oxidase inhibitor</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2003&pages=233-236&author=W.+Maruyamaauthor=M.+Weinstockauthor=M.+B.+Youdimauthor=M.+Nagaiauthor=M.+Naoi&title=Anti-apoptotic+action+of+anti-Alzheimer+drug%2C+TV3326+%5B%28N-propargyl%29-%283R%29-aminoindan-5-yl%5D-ethyl+methyl+carbamate%2C+a+novel+cholinesterase-monoamine+oxidase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaruyama%26aufirst%3DW.%26aulast%3DWeinstock%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DNagai%26aufirst%3DM.%26aulast%3DNaoi%26aufirst%3DM.%26atitle%3DAnti-apoptotic%2520action%2520of%2520anti-Alzheimer%2520drug%252C%2520TV3326%2520%255B%2528N-propargyl%2529-%25283R%2529-aminoindan-5-yl%255D-ethyl%2520methyl%2520carbamate%252C%2520a%2520novel%2520cholinesterase-monoamine%2520oxidase%2520inhibitor%26jtitle%3DNeurosci.%2520Lett.%26date%3D2003%26volume%3D341%26spage%3D233%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">Roach, E. S.</span><span> </span><span class="NLM_article-title">Initial Parkinson disease therapy: levodopa, dopamine agonists, or both</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1972</span><span class="NLM_x">–</span> <span class="NLM_lpage">1973</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1001%2Farchneur.61.12.1972" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15596625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADC%252BD2cnitVyntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2004&pages=1972-1973&author=E.+S.+Roach&title=Initial+Parkinson+disease+therapy%3A+levodopa%2C+dopamine+agonists%2C+or+both"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Initial Parkinson disease therapy: levodopa, dopamine agonists, or both?</span></div><div class="casAuthors">Roach E S</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1972-3</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSDMltEW9VQzPxQvRxYU81tfW6udTcc2eaXXvOkMNKd3rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cnitVyntw%253D%253D&md5=ee996ce0bc9cbf47bb2ad7db0426d5bf</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1001%2Farchneur.61.12.1972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.61.12.1972%26sid%3Dliteratum%253Aachs%26aulast%3DRoach%26aufirst%3DE.%2BS.%26atitle%3DInitial%2520Parkinson%2520disease%2520therapy%253A%2520levodopa%252C%2520dopamine%2520agonists%252C%2520or%2520both%26jtitle%3DArch.%2520Neurol.%26date%3D2004%26volume%3D61%26spage%3D1972%26epage%3D1973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Silver, D. E.</span><span> </span><span class="NLM_article-title">Clinical experience with the novel levodopa formulation entacapone + levodopa + carbidopa (Stalevo)</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1586%2F14737175.4.4.589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15853578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtlSmsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=589-599&author=D.+E.+Silver&title=Clinical+experience+with+the+novel+levodopa+formulation+entacapone+%2B+levodopa+%2B+carbidopa+%28Stalevo%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical experience with the novel levodopa formulation entacapone + levodopa + carbidopa (Stalevo)</span></div><div class="casAuthors">Silver, Dee E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">589-599</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Levodopa is the main pharmacol. treatment for Parkinson's disease.  However, the long-term administration of levodopa is assocd. with the development of motor complications which can seriously compromise patient function.  Increasing evidence indicates that such problems are related to abnormal pulsatile stimulation of striatal dopamine receptors and that treatments providing more continuous stimulation reduce the risk of motor complications.  It is possible that administering levodopa with a reversible catechol-O-Me transferase inhibitor at frequent intervals might reduce the risk of these complications.  Stalevo (Orion) combines levodopa, the dopa-decarboxylase inhibitor carbidopa and the catechol-O-Me transferase inhibitor entacapone in a single tablet.  This review provides an overview of the initial clin. experience gained with Stalevo during clin. trials, including several case studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSrW0p8jctGbVg90H21EOLACvtfcHk0lgSNy5WZ1pwkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtlSmsL4%253D&md5=911ebf6414e5a186f0d2d0ccca5cfac4</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1586%2F14737175.4.4.589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.4.4.589%26sid%3Dliteratum%253Aachs%26aulast%3DSilver%26aufirst%3DD.%2BE.%26atitle%3DClinical%2520experience%2520with%2520the%2520novel%2520levodopa%2520formulation%2520entacapone%2520%252B%2520levodopa%2520%252B%2520carbidopa%2520%2528Stalevo%2529%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2004%26volume%3D4%26spage%3D589%26epage%3D599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group">Jost, W. H.</span><span> </span><span class="NLM_article-title">Ropinirole: current status of the studies</span> <span class="citation_source-journal">J. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">VI/13</span><span class="NLM_x">–</span> <span class="NLM_lpage">VI/18</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=2004&pages=VI%2F13-VI%2F18&issue=6&author=W.+H.+Jost&title=Ropinirole%3A+current+status+of+the+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJost%26aufirst%3DW.%2BH.%26atitle%3DRopinirole%253A%2520current%2520status%2520of%2520the%2520studies%26jtitle%3DJ.%2520Neurol.%26date%3D2004%26volume%3D251%26issue%3D6%26spage%3DVI%252F13%26epage%3DVI%252F18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group">Mattson, M. P.</span><span> </span><span class="NLM_article-title">Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1012</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1012&publication_year=2004&pages=37-50&author=M.+P.+Mattson&title=Metal-catalyzed+disruption+of+membrane+protein+and+lipid+signaling+in+the+pathogenesis+of+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMattson%26aufirst%3DM.%2BP.%26atitle%3DMetal-catalyzed%2520disruption%2520of%2520membrane%2520protein%2520and%2520lipid%2520signaling%2520in%2520the%2520pathogenesis%2520of%2520neurodegenerative%2520disorders%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2004%26volume%3D1012%26spage%3D37%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group">Kaur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yantiri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mo, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boonplueang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viswanath, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMonte, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volitaskis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellerby, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherny, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, J. K.</span><span> </span><span class="NLM_article-title">Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinsonʼs disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2003&pages=899-909&author=D.+Kaurauthor=F.+Yantiriauthor=S.+Rajagopalanauthor=J.+Kumarauthor=J.+Q.+Moauthor=R.+Boonplueangauthor=V.+Viswanathauthor=R.+Jacobsauthor=L.+Yangauthor=M.+F.+Bealauthor=D.+DiMonteauthor=I.+Volitaskisauthor=L.+Ellerbyauthor=R.+A.+Chernyauthor=A.+I.+Bushauthor=J.+K.+Andersen&title=Genetic+or+pharmacological+iron+chelation+prevents+MPTP-induced+neurotoxicity+in+vivo%3A+a+novel+therapy+for+Parkinson%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKaur%26aufirst%3DD.%26aulast%3DYantiri%26aufirst%3DF.%26aulast%3DRajagopalan%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DJ.%26aulast%3DMo%26aufirst%3DJ.%2BQ.%26aulast%3DBoonplueang%26aufirst%3DR.%26aulast%3DViswanath%26aufirst%3DV.%26aulast%3DJacobs%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26aulast%3DDiMonte%26aufirst%3DD.%26aulast%3DVolitaskis%26aufirst%3DI.%26aulast%3DEllerby%26aufirst%3DL.%26aulast%3DCherny%26aufirst%3DR.%2BA.%26aulast%3DBush%26aufirst%3DA.%2BI.%26aulast%3DAndersen%26aufirst%3DJ.%2BK.%26atitle%3DGenetic%2520or%2520pharmacological%2520iron%2520chelation%2520prevents%2520MPTP-induced%2520neurotoxicity%2520in%2520vivo%253A%2520a%2520novel%2520therapy%2520for%2520Parkinson%25CA%25BCs%2520disease%26jtitle%3DNeuron%26date%3D2003%26volume%3D37%26spage%3D899%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group">Shoham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Iron involvement in neural damage and microgliosis in models of neurodegenerative diseases</span> <span class="citation_source-journal">Cell. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">760</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=10875437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkt1agsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2000&pages=743-760&author=S.+Shohamauthor=M.+B.+Youdim&title=Iron+involvement+in+neural+damage+and+microgliosis+in+models+of+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Iron involvement in neural damage and microgliosis in models of neurodegenerative diseases</span></div><div class="casAuthors">Shoham, S.; Youdim, M. B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Biology (Paris)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">743-760</span>CODEN:
                <span class="NLM_cas:coden">CMOBEF</span>;
        ISSN:<span class="NLM_cas:issn">0145-5680</span>.
    
            (<span class="NLM_cas:orgname">C.M.B. Association</span>)
        </div><div class="casAbstract">A review, with 134 refs.  In several neurodegenerative diseases, iron accumulates at sites of brain pathol.  Since post-mortem examn. cannot distinguish whether iron accumulation caused the damage or resulted from damage, it is necessary to manipulate iron in animal and tissue culture models to assess its causal role(s).  However, only in models of Parkinson's disease and of global ischemia, iron deprivation (ID) or iron-chelators have been used to protect from damage.  In these studies, documentation of microgliosis was not performed even though several lines of evidence converge to suggest that activation of microglia is an important source of oxidative stress.  In the kainate model of epilepsy, we found that ID protected the olfactory cortex, thalamus and hippocampus and attenuated microgliosis, whereas iron supplementation to ID rats increased damage and microgliosis in the above regions.  In the hilus of the hippocampal dentate gyrus, even though no cell loss was obsd., ID attenuated microgliosis and iron-supplementation increased it.  Thus there is a tight relationship between iron and microgliosis.  In addn., iron+zinc supplementation dramatically increased damage to hippocampal CA1 whereas zinc supplementation alone had no effect.  This study demonstrates an anatomically unique interaction of iron and zinc, which may lead to new insights to neurodegeneration in epilepsy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIPeEZz1azsLVg90H21EOLACvtfcHk0lgSNy5WZ1pwkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkt1agsLg%253D&md5=4d5e22d9f8f0c95e06e3b132dffce06c</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShoham%26aufirst%3DS.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DIron%2520involvement%2520in%2520neural%2520damage%2520and%2520microgliosis%2520in%2520models%2520of%2520neurodegenerative%2520diseases%26jtitle%3DCell.%2520Mol.%2520Biol.%26date%3D2000%26volume%3D46%26spage%3D743%26epage%3D760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridkin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span> </span><span class="NLM_article-title">Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinsonʼs disease and other neurodegenerative diseases</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">1455</span><span class="NLM_x">–</span> <span class="NLM_lpage">1471</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2004&pages=1455-1471&author=M.+B.+Youdimauthor=M.+Fridkinauthor=H.+Zheng&title=Novel+bifunctional+drugs+targeting+monoamine+oxidase+inhibition+and+iron+chelation+as+an+approach+to+neuroprotection+in+Parkinson%CA%BCs+disease+and+other+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DFridkin%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DH.%26atitle%3DNovel%2520bifunctional%2520drugs%2520targeting%2520monoamine%2520oxidase%2520inhibition%2520and%2520iron%2520chelation%2520as%2520an%2520approach%2520to%2520neuroprotection%2520in%2520Parkinson%25CA%25BCs%2520disease%2520and%2520other%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2004%26volume%3D111%26spage%3D1455%26epage%3D1471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finberg, J. P.</span><span> </span><span class="NLM_article-title">Rasagiline [<i>N</i>-propargyl-1<i>R</i>(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">500</span><span class="NLM_x">–</span> <span class="NLM_lpage">506</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fsj.bjp.0703826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=11159700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3MXht1Sgu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2001&pages=500-506&author=M.+B.+Youdimauthor=A.+Grossauthor=J.+P.+Finberg&title=Rasagiline+%5BN-propargyl-1R%28%2B%29-aminoindan%5D%2C+a+selective+and+potent+inhibitor+of+mitochondrial+monoamine+oxidase+B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B</span></div><div class="casAuthors">Youdim, Moussa B. H.; Gross, Aviva; Finberg, John P. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">500-506</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Rasagiline [N-propargyl-1R(+)-aminoindan], was examd. for its monoamine oxidase (MAO) A and B inhibitor activities in rats together with its S(-)-enantiomer (TVP 1022) and the racemic compd. (AGN-1135) and compared to selegiline (1-deprenyl).  The tissues that were studied for MAO inhibition were the brain, liver and small intestine.  While rasagiline and AGN1135 are highly potent selective irreversible inhibitors of MAO in vitro and in vivo, the S(-) enantiomer is relatively inactive in the tissues examd.  The in vitro IC50 values for inhibition of rat brain MAO activity by rasagiline are 4.43±0.92 nM (type B), and 412±123 nM (type A).  The ED50 values for ex vivo inhibition of MAO in the brain and liver by a single dose of rasagiline are 0.1±0.01, 0.042±0.0045 mg kg-1 resp. for MAO-B, and 6.48±0.81, 2.38±0.35 mg kg-1 resp. for MAO-A.  Selective MAO-B inhibition in the liver and brain was maintained on chronic (21 days) oral dosage with ED50 values of 0.014±0.002 and 0.013±0.001 mg kg-1 resp.  The degree of selectivity of rasagiline for inhibition of MAO-B as opposed to MAO-A was similar to that of selegiline.  Rasagiline was three to 15 times more potent than selegiline for inhibition of MAO-B in rat brain and liver in vivo on acute and chronic administration, but had similar potency in vitro.  These data together with lack of tyramine sympathomimetic potentiation by rasagiline, at selective MAO-B inhibitory dosage, indicate that this inhibitor like selegiline may be a useful agent in the treatment of Parkinson's disease in either symptomatic or L-DOPA adjunct therapy, but lack of amphetamine-like metabolites could present a therapeutic advantage for rasagiline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq020sdG8LiPbVg90H21EOLACvtfcHk0lhtseMGIeNceQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXht1Sgu7o%253D&md5=692cfb1e7f679e073f6cbdb2c8650ba9</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703826%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DFinberg%26aufirst%3DJ.%2BP.%26atitle%3DRasagiline%2520%255BN-propargyl-1R%2528%252B%2529-aminoindan%255D%252C%2520a%2520selective%2520and%2520potent%2520inhibitor%2520of%2520mitochondrial%2520monoamine%2520oxidase%2520B%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D132%26spage%3D500%26epage%3D506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Am, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warshawsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridkin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Novel multifunctional neuroprotective iron chelator−monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1111%2Fj.1471-4159.2005.03340.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16181413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVygs7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2005&pages=68-78&author=H.+Zhengauthor=S.+Galauthor=L.+M.+Weinerauthor=O.+Bar-Amauthor=A.+Warshawskyauthor=M.+Fridkinauthor=M.+B.+Youdim&title=Novel+multifunctional+neuroprotective+iron+chelator%E2%88%92monoamine+oxidase+inhibitor+drugs+for+neurodegenerative+diseases%3A+in+vitro+studies+on+antioxidant+activity%2C+prevention+of+lipid+peroxide+formation+and+monoamine+oxidase+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition</span></div><div class="casAuthors">Zheng, Hailin; Gal, Shunit; Weiner, Lev M.; Bar-Am, Orit; Warshawsky, Abraham; Fridkin, Mati; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">68-78</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Iron-dependent oxidative stress, elevated levels of iron and of monoamine oxidase (MAO)-B activity, and depletion of antioxidants in the brain may be major pathogenic factors in Parkinson's disease, Alzheimer's disease and related neurodegenerative diseases.  Accordingly, iron chelators, antioxidants and MAO-B inhibitors have shown efficacy in a variety of cellular and animal models of CNS injury.  In searching for novel antioxidant iron chelators with potential MAO-B inhibitory activity, a series of new iron chelators has been designed, synthesized and investigated.  In this study, the novel chelators were further examd. for their activity as antioxidants, MAO-B inhibitors and neuroprotective agents in vitro.  Three of the selected chelators (M30, HLA20 and M32) were the most effective in inhibiting iron-dependent lipid peroxidn. in rat brain homogenates with IC50 values (12-16 μM), which is comparable with that of desferal, a prototype iron chelator that is not has orally active.  Their antioxidant activities were further confirmed using ESR spectroscopy.  In PC12 cell culture, the three novel chelators at 0.1 μM were able to attenuate cell death induced by serum deprivation and by 6-hydroxydopamine.  M30 possessing propargyl, the MAO inhibitory moiety of the anti-Parkinson drug rasagiline, displayed greater neuroprotective potency than that of rasagiline.  In addn., in vitro, M30 was a highly potent non-selective MAO-A and MAO-B inhibitor (IC50 < 0.1 μM).  However, HLA20 was more selective for MAO-B but had poor MAO inhibition, with an IC50 value of 64.2 μM.  The data suggest that M30 and HLA20 might serve as leads in developing drugs with multifunctional activities for the treatment of various neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaog8Swg2o4rVg90H21EOLACvtfcHk0lhtseMGIeNceQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVygs7bE&md5=4d75e3046fe79c9f86fc015fa5796529</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2005.03340.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2005.03340.x%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DGal%26aufirst%3DS.%26aulast%3DWeiner%26aufirst%3DL.%2BM.%26aulast%3DBar-Am%26aufirst%3DO.%26aulast%3DWarshawsky%26aufirst%3DA.%26aulast%3DFridkin%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DNovel%2520multifunctional%2520neuroprotective%2520iron%2520chelator%25E2%2588%2592monoamine%2520oxidase%2520inhibitor%2520drugs%2520for%2520neurodegenerative%2520diseases%253A%2520in%2520vitro%2520studies%2520on%2520antioxidant%2520activity%252C%2520prevention%2520of%2520lipid%2520peroxide%2520formation%2520and%2520monoamine%2520oxidase%2520inhibition%26jtitle%3DJ.%2520Neurochem.%26date%3D2005%26volume%3D95%26spage%3D68%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group">Gal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridkin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Novel multifunctional neuroprotective iron chelator−monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1111%2Fj.1471-4159.2005.03341.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16181414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVygs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2005&pages=79-88&author=S.+Galauthor=H.+Zhengauthor=M.+Fridkinauthor=M.+B.+Youdim&title=Novel+multifunctional+neuroprotective+iron+chelator%E2%88%92monoamine+oxidase+inhibitor+drugs+for+neurodegenerative+diseases.+In+vivo+selective+brain+monoamine+oxidase+inhibition+and+prevention+of+MPTP-induced+striatal+dopamine+depletion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion</span></div><div class="casAuthors">Gal, Shunit; Zheng, Hailin; Fridkin, Mati; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-88</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Several multifunctional iron chelators have been synthesized from hydroxyquinoline pharmacophore of the iron chelator, VK-28, possessing the monoamine oxidase (MAO) and neuroprotective N-propargylamine moiety.  They have iron chelating potency similar to desferal.  M30 is a potent irreversible rat brain mitochondrial MAO-A and -B inhibitor in vitro (IC50, MAO-A, 0.037±0.02; MAO-B, 0.057±0.01).  Acute (1-5 mg/kg) and chronic [5-10 mg/kg i.p., or orally (p.o.) once daily for 14 days] in vivo studies have shown M30 to be a potent brain selective (striatum, hippocampus and cerebellum) MAO-A and -B inhibitor.  It has little effects on the enzyme activities of the liver and small intestine.  Its N-des-methylated deriv., M30A is significantly less active.  Acute and chronic treatment with M30 results in increased levels of dopamine (DA), serotonin(5-HT), noradrenaline (NA) and decreases in DOPAC (dihydroxyphenylacetic acid), HVA (homovanillic acid) and 5-HIAA (5-hydroxyindole acetic acid) as detd. in striatum and hypothalamus.  In the mouse MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) model of Parkinson's disease (PD) it attenuates the DA depleting action of the neurotoxin and increases striatal levels of DA, 5-HT and NA, while decreasing their metabolites.  As DA is equally well metabolized by MAO-A and -B, it is expected that M30 would have a greater DA neurotransmission potentiation in PD than selective MAO-B inhibitors, for which it is being developed, as MAO-B inhibitors do not alter brain dopamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphycb87iHT6rVg90H21EOLACvtfcHk0ljkXsbU_GD_YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVygs7bF&md5=2797ec27ec14297aca6733b910ce2aa5</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2005.03341.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2005.03341.x%26sid%3Dliteratum%253Aachs%26aulast%3DGal%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DFridkin%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DNovel%2520multifunctional%2520neuroprotective%2520iron%2520chelator%25E2%2588%2592monoamine%2520oxidase%2520inhibitor%2520drugs%2520for%2520neurodegenerative%2520diseases.%2520In%2520vivo%2520selective%2520brain%2520monoamine%2520oxidase%2520inhibition%2520and%2520prevention%2520of%2520MPTP-induced%2520striatal%2520dopamine%2520depletion%26jtitle%3DJ.%2520Neurochem.%26date%3D2005%26volume%3D95%26spage%3D79%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group">Kalir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabbagh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Selective acetylenic “suicide” and reversible inhibitors of monoamine oxidase types A and B</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=7284698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaL3MXltFSku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1981&pages=55-64&author=A.+Kalirauthor=A.+Sabbaghauthor=M.+B.+Youdim&title=Selective+acetylenic+%E2%80%9Csuicide%E2%80%9D+and+reversible+inhibitors+of+monoamine+oxidase+types+A+and+B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Selective acetylenic 'suicide' and reversible inhibitors of monoamine oxidase types A and B</span></div><div class="casAuthors">Kalir, A.; Sabbagh, A.; Youdim, M. B. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-64</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">Structure-activity studies with arom. N-propargyl (acetylenic) derivs. indicated that brain monoamine oxidase (MAO) inhibitory potency was least dependent on the arom. portion of the compds.  N-Methylated propargyl derivs. were most active; higher alkyl or arom. group replacement of the Me group resulted in a significant redn. of activity.  A triple bond β to the N atom in the propargyl group was essential for irreversible activity; the acetylenic group gave these compds. their irreversible MAO inhibitory properties.  The distance between the arom. ring and N-propargyl terminus of the substrate analogs detd. the specificity for type A or B MAO.  AGN-1133 and AGN-1135 may be useful as antidepressants or in Parkinson's disease treatment as they were specific for MAO type B.  A no. of indoleamine derivs. were found to be reversible selective type A inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsHr_ORRp6z7Vg90H21EOLACvtfcHk0ljkXsbU_GD_YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXltFSku7g%253D&md5=bfc69e02bdb7bffdfbea26aafd9946e3</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKalir%26aufirst%3DA.%26aulast%3DSabbagh%26aufirst%3DA.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DSelective%2520acetylenic%2520%25E2%2580%259Csuicide%25E2%2580%259D%2520and%2520reversible%2520inhibitors%2520of%2520monoamine%2520oxidase%2520types%2520A%2520and%2520B%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1981%26volume%3D73%26spage%3D55%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group">OʼCarrol, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobbia, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipton, K. F.</span><span> </span><span class="NLM_article-title">The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions</span> <span class="citation_source-journal">Naunyn Schmiedebergʼs Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=1983&pages=198-202&author=A.+M.+O%CA%BCCarrolauthor=C.+J.+Fowlerauthor=J.+P.+Phillipsauthor=I.+Tobbiaauthor=K.+F.+Tipton&title=The+deamination+of+dopamine+by+human+brain+monoamine+oxidase.+Specificity+for+the+two+enzyme+forms+in+seven+brain+regions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25CA%25BCCarrol%26aufirst%3DA.%2BM.%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DPhillips%26aufirst%3DJ.%2BP.%26aulast%3DTobbia%26aufirst%3DI.%26aulast%3DTipton%26aufirst%3DK.%2BF.%26atitle%3DThe%2520deamination%2520of%2520dopamine%2520by%2520human%2520brain%2520monoamine%2520oxidase.%2520Specificity%2520for%2520the%2520two%2520enzyme%2520forms%2520in%2520seven%2520brain%2520regions%26jtitle%3DNaunyn%2520Schmiedeberg%25CA%25BCs%2520Arch.%2520Pharmacol.%26date%3D1983%26volume%3D322%26spage%3D198%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group">Green, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tordoff, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1111%2Fj.1476-5381.1977.tb07506.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=890205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaE2sXlslyju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1977&pages=343-349&author=A.+R.+Greenauthor=B.+D.+Mitchellauthor=A.+F.+Tordoffauthor=M.+B.+Youdim&title=Evidence+for+dopamine+deamination+by+both+type+A+and+type+B+monoamine+oxidase+in+rat+brain+in+vivo+and+for+the+degree+of+inhibition+of+enzyme+necessary+for+increased+functional+activity+of+dopamine+and+5-hydroxytryptamine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine</span></div><div class="casAuthors">Green, A. R.; Mitchell, B. D.; Tordoff, Ann F. C.; Youdim, M. B. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">343-9</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">Tranylcypromine (I) (20 mg/kg, i.p.) administration to rats inhibited brain monoamine oxidase (II) [9001-66-5] oxidn. of 5-hydroxytryptamine (III) [50-67-9], phenylethylamine (IV) [64-04-0], and dopamine (V) [51-61-6]; when L-DOPA (50 mg/kg, i.p.) was given 30 min after I, brain V and noradrenaline (VI) [51-41-2] levels increased and the rats displayed hyperactivity syndromes.  Clorgyline (5 mg/kg, i.p.) administration inhibited III and IV oxidn. by 100 and 29% resp. while deprenil (5 mg/kg, i.p.) inhibited III and IV oxidn. by 31 and <100% resp.  Administration of clorgyline + deprenil inhibited oxidn. of III and IV <100%, increased brain V and VI levels and resulted in a behavior pattern similar to that obsd. after I or L-DOPA administration.  Brain III levels were elevated 18 h after I (20 mg/kg, i.p.) and then declined, whereas V and VI increased levels remained steady for 48 h.  Administration of L-tryptophan (50 mg/kg, i.p.) to I-pretreated rats resulted in the hyperactivity syndrome at 12 h but not at 18 h and III levels increased at 12 h.  When L-DOPA (50 mg/kg, i.p.) was given after I a further rise in brain V and VI occurred at 12 h but not at 18 h, and behavioral changes occurred at 12 h.  After I treatment the half-life of II with III, IV, and V as substrates was 4.5, 8.5, and 4.5 days, resp.  Thus V was metabolized by Type A and Type B II in vivo and only when both forms were totally inhibited was III and V functional activity increased.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0gK6LwoWUrbVg90H21EOLACvtfcHk0ljkXsbU_GD_YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXlslyju7g%253D&md5=b9d0533dd87d8e87c32d7581df2b8d8f</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1977.tb07506.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1977.tb07506.x%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DA.%2BR.%26aulast%3DMitchell%26aufirst%3DB.%2BD.%26aulast%3DTordoff%26aufirst%3DA.%2BF.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DEvidence%2520for%2520dopamine%2520deamination%2520by%2520both%2520type%2520A%2520and%2520type%2520B%2520monoamine%2520oxidase%2520in%2520rat%2520brain%2520in%2520vivo%2520and%2520for%2520the%2520degree%2520of%2520inhibition%2520of%2520enzyme%2520necessary%2520for%2520increased%2520functional%2520activity%2520of%2520dopamine%2520and%25205-hydroxytryptamine%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1977%26volume%3D60%26spage%3D343%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group">Ross, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrovitch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morens, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandinetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanner, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masaki, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchette, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curb, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popper, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, L. R.</span><span> </span><span class="NLM_article-title">Association of coffee and caffeine intake with the risk of Parkinson disease</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">2674</span><span class="NLM_x">–</span> <span class="NLM_lpage">2679</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2000&pages=2674-2679&author=G.+W.+Rossauthor=R.+D.+Abbottauthor=H.+Petrovitchauthor=D.+M.+Morensauthor=A.+Grandinettiauthor=K.+H.+Tungauthor=C.+M.+Tannerauthor=K.+H.+Masakiauthor=P.+L.+Blanchetteauthor=J.+D.+Curbauthor=J.+S.+Popperauthor=L.+R.+White&title=Association+of+coffee+and+caffeine+intake+with+the+risk+of+Parkinson+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DG.%2BW.%26aulast%3DAbbott%26aufirst%3DR.%2BD.%26aulast%3DPetrovitch%26aufirst%3DH.%26aulast%3DMorens%26aufirst%3DD.%2BM.%26aulast%3DGrandinetti%26aufirst%3DA.%26aulast%3DTung%26aufirst%3DK.%2BH.%26aulast%3DTanner%26aufirst%3DC.%2BM.%26aulast%3DMasaki%26aufirst%3DK.%2BH.%26aulast%3DBlanchette%26aufirst%3DP.%2BL.%26aulast%3DCurb%26aufirst%3DJ.%2BD.%26aulast%3DPopper%26aufirst%3DJ.%2BS.%26aulast%3DWhite%26aufirst%3DL.%2BR.%26atitle%3DAssociation%2520of%2520coffee%2520and%2520caffeine%2520intake%2520with%2520the%2520risk%2520of%2520Parkinson%2520disease%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2000%26volume%3D283%26spage%3D2674%26epage%3D2679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group">Ascherio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawachi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colditz, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speizer, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, W. C.</span><span> </span><span class="NLM_article-title">Prospective study of caffeine consumption and risk of Parkinsonʼs disease in men and women</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fana.1052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=11456310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlt12gurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2001&pages=56-63&author=A.+Ascherioauthor=S.+M.+Zhangauthor=M.+A.+Hernanauthor=I.+Kawachiauthor=G.+A.+Colditzauthor=F.+E.+Speizerauthor=W.+C.+Willett&title=Prospective+study+of+caffeine+consumption+and+risk+of+Parkinson%CA%BCs+disease+in+men+and+women"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Prospective study of caffeine consumption and risk of Parkinson's disease in men and women</span></div><div class="casAuthors">Ascherio, Alberto; Zhang, Shumin M.; Hernan, Miguel A.; Kawachi, Ichiro; Colditz, Graham A.; Speizer, Frank E.; Willett, Walter C.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-63</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Results of case-control studies and of a prospective investigation in men suggest that consumption of coffee could protect against the risk of Parkinson's disease, but the active constituent is not clear.  To address the hypothesis that caffeine is protective against Parkinson's disease, we examd. the relationship of coffee and caffeine consumption to the risk of this disease among participants in two ongoing cohorts, the Health Professionals' Follow-Up Study (HPFS) and the Nurses' Health Study (NHS).  The study population comprised 47,351 men and 88,565 women who were free of Parkinson's disease, stroke, or cancer at baseline.  A comprehensive life style and dietary questionnaire was completed by the participants at baseline and updated every two to four years.  During the follow-up (10 yr in men, 16 yr in women), we documented a total of 288 incident cases of Parkinson's disease.  Among men, after adjustment for age and smoking, the relative risk of Parkinson's disease was 0.42 (95% CI: 0.23-0.78; p for trend < 0.001) for men in the top one-fifth of caffeine intake compared to those in the bottom one-fifth.  An inverse assocn. was also obsd. with consumption of coffee (p for trend = 0.004), caffeine from non-coffee sources (p for trend < 0.001), and tea (p for trend = 0.02) but not decaffeinated coffee.  Among women, the relationship between caffeine or coffee intake and risk of Parkinson's disease was U-shaped, with the lowest risk obsd. at moderate intakes (1-3 cups of coffee/day, or the third quintile of caffeine consumption).  These results support a possible protective effect of moderate doses of caffeine on risk of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIgS7GGPMwGrVg90H21EOLACvtfcHk0lgjBrDf9pM_4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlt12gurg%253D&md5=6ed856feee3eb746e8149ce9c7c6a5a6</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1002%2Fana.1052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.1052%26sid%3Dliteratum%253Aachs%26aulast%3DAscherio%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DS.%2BM.%26aulast%3DHernan%26aufirst%3DM.%2BA.%26aulast%3DKawachi%26aufirst%3DI.%26aulast%3DColditz%26aufirst%3DG.%2BA.%26aulast%3DSpeizer%26aufirst%3DF.%2BE.%26aulast%3DWillett%26aufirst%3DW.%2BC.%26atitle%3DProspective%2520study%2520of%2520caffeine%2520consumption%2520and%2520risk%2520of%2520Parkinson%25CA%25BCs%2520disease%2520in%2520men%2520and%2520women%26jtitle%3DAnn.%2520Neurol.%26date%3D2001%26volume%3D50%26spage%3D56%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group">Carboni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spielewoy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nosten-Bertrand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giros, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Chiara, G.</span><span> </span><span class="NLM_article-title">Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">RC141:1</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=RC141%3A1-4&author=E.+Carboniauthor=C.+Spielewoyauthor=C.+Vaccaauthor=M.+Nosten-Bertrandauthor=B.+Girosauthor=G.+Di+Chiara&title=Cocaine+and+amphetamine+increase+extracellular+dopamine+in+the+nucleus+accumbens+of+mice+lacking+the+dopamine+transporter+gene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarboni%26aufirst%3DE.%26aulast%3DSpielewoy%26aufirst%3DC.%26aulast%3DVacca%26aufirst%3DC.%26aulast%3DNosten-Bertrand%26aufirst%3DM.%26aulast%3DGiros%26aufirst%3DB.%26aulast%3DDi%2BChiara%26aufirst%3DG.%26atitle%3DCocaine%2520and%2520amphetamine%2520increase%2520extracellular%2520dopamine%2520in%2520the%2520nucleus%2520accumbens%2520of%2520mice%2520lacking%2520the%2520dopamine%2520transporter%2520gene%26jtitle%3DJ.%2520Neurosci.%26date%3D2001%26volume%3D21%26spage%3DRC141%253A1%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group">Chen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzer, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beilstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonsalla, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, N.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span> </span><span class="NLM_article-title">Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinsonʼs disease</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">RC143</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=RC143&author=J.+F.+Chenauthor=K.+Xuauthor=J.+P.+Petzerauthor=R.+Staalauthor=Y.+H.+Xuauthor=M.+Beilsteinauthor=P.+K.+Sonsallaauthor=K.+Castagnoliauthor=N.+Castagnoliauthor=M.+A.+Schwarzschild&title=Neuroprotection+by+caffeine+and+A%282A%29+adenosine+receptor+inactivation+in+a+model+of+Parkinson%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BF.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26aulast%3DStaal%26aufirst%3DR.%26aulast%3DXu%26aufirst%3DY.%2BH.%26aulast%3DBeilstein%26aufirst%3DM.%26aulast%3DSonsalla%26aufirst%3DP.%2BK.%26aulast%3DCastagnoli%26aufirst%3DK.%26aulast%3DCastagnoli%26aufirst%3DN.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26atitle%3DNeuroprotection%2520by%2520caffeine%2520and%2520A%25282A%2529%2520adenosine%2520receptor%2520inactivation%2520in%2520a%2520model%2520of%2520Parkinson%25CA%25BCs%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D2001%26volume%3D21%26spage%3DRC143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group">Ikeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurokawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwana, Y.</span><span> </span><span class="NLM_article-title">Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinsonʼs disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1046%2Fj.0022-3042.2001.00694.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=11902116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD38XptV2jsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2002&pages=262-270&author=K.+Ikedaauthor=M.+Kurokawaauthor=S.+Aoyamaauthor=Y.+Kuwana&title=Neuroprotection+by+adenosine+A2A+receptor+blockade+in+experimental+models+of+Parkinson%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease</span></div><div class="casAuthors">Ikeda, Ken; Kurokawa, Masako; Aoyama, Shiro; Kuwana, Yoshihisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">262-270</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Adenosine A2A receptors are abundant in the caudate-putamen and involved in the motor control in several species.  In MPTP-treated monkeys, A2A receptor-blockade with an antagonist alleviates parkinsonian symptoms without provoking dyskinesia, suggesting this receptor may offer a new target for the antisymptomatic therapy of Parkinson's disease.  In the present study, a significant neuroprotective effect of A2A receptor antagonists is shown in exptl. models of Parkinson's disease.  Oral administration of A2A receptor antagonists protected against the loss of nigral dopaminergic neuronal cells induced by 6-hydroxydopamine in rats.  A2A antagonists also prevented the functional loss of dopaminergic nerve terminals in the striatum and the ensuing gliosis caused by MPTP in mice.  The neuroprotective property of A2A receptor antagonists may be exerted by altering the packaging of these neurotoxins into vesicles, thus reducing their effective intracellular concn.  We therefore conclude that the adenosine A2A receptor may provide a novel target for the long-term medication of Parkinson's disease, because blockade of this receptor exerts both acutely antisymptomatic and chronically neuroprotective activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb8toXJpqCzLVg90H21EOLACvtfcHk0lgjBrDf9pM_4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptV2jsQ%253D%253D&md5=68ddb10b0be184393df31567d2acc7ca</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1046%2Fj.0022-3042.2001.00694.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0022-3042.2001.00694.x%26sid%3Dliteratum%253Aachs%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DKurokawa%26aufirst%3DM.%26aulast%3DAoyama%26aufirst%3DS.%26aulast%3DKuwana%26aufirst%3DY.%26atitle%3DNeuroprotection%2520by%2520adenosine%2520A2A%2520receptor%2520blockade%2520in%2520experimental%2520models%2520of%2520Parkinson%25CA%25BCs%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D80%26spage%3D262%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group">Xu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzschild, M.</span><span> </span><span class="NLM_article-title">Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinsonʼs disease</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.pharmthera.2004.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15737407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvVCjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=267-310&author=K.+Xuauthor=E.+Bastiaauthor=M.+Schwarzschild&title=Therapeutic+potential+of+adenosine+A%282A%29+receptor+antagonists+in+Parkinson%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease</span></div><div class="casAuthors">Xu, Kui; Bastia, Elena; Schwarzschild, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">267-310</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In the pursuit of improved treatments for Parkinson's disease (PD), the adenosine A2A receptor has emerged as an attractive nondopaminergic target.  Based on the compelling behavioral pharmacol. and selective basal ganglia expression of this G-protein-coupled receptor, its antagonists are now crossing the threshold of clin. development as adjunctive symptomatic treatment for relatively advanced PD.  The antiparkinsonian potential of A2A antagonism has been boosted further by recent preclin. evidence that A2A antagonists might favorably alter the course as well as the symptoms of the disease.  Convergent epidemiol. and lab. data have suggested that A2A blockade may confer neuroprotection against the underlying dopaminergic neuron degeneration.  In addn., rodent and nonhuman primate studies have raised the possibility that A2A receptor activation contributes to the pathophysiol. of dyskinesias-problematic motor complications of std. PD therapy-and that A2A antagonism might help prevent them.  Realistically, despite being targeted to basal ganglia pathophysiol., A2A antagonists may be expected to have other beneficial and adverse effects elsewhere in the central nervous system (e.g., on mood and sleep) and in the periphery (e.g., on immune and inflammatory processes).  The thoughtful design of new clin. trials of A2A antagonists should take into consideration these counterbalancing hopes and concerns and may do well to shift toward a broader set of disease-modifying as well as symptomatic indications in early PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3HbF9ZxHP3bVg90H21EOLACvtfcHk0lhASSm6I2TCjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvVCjt7s%253D&md5=ca493d29bdda09382108c0566a3a0877</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2004.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2004.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DK.%26aulast%3DBastia%26aufirst%3DE.%26aulast%3DSchwarzschild%26aufirst%3DM.%26atitle%3DTherapeutic%2520potential%2520of%2520adenosine%2520A%25282A%2529%2520receptor%2520antagonists%2520in%2520Parkinson%25CA%25BCs%2520disease%26jtitle%3DPharmacol.%2520Ther.%26date%3D2005%26volume%3D105%26spage%3D267%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group">Bara-Jimenez, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherzai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitrova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibbiani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouradian, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, T. N.</span><span> </span><span class="NLM_article-title">Adenosine A(2A) receptor antagonist treatment of Parkinsonʼs disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2003&pages=293-296&author=W.+Bara-Jimenezauthor=A.+Sherzaiauthor=T.+Dimitrovaauthor=A.+Favitauthor=F.+Bibbianiauthor=M.+Gillespieauthor=M.+J.+Morrisauthor=M.+M.+Mouradianauthor=T.+N.+Chase&title=Adenosine+A%282A%29+receptor+antagonist+treatment+of+Parkinson%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBara-Jimenez%26aufirst%3DW.%26aulast%3DSherzai%26aufirst%3DA.%26aulast%3DDimitrova%26aufirst%3DT.%26aulast%3DFavit%26aufirst%3DA.%26aulast%3DBibbiani%26aufirst%3DF.%26aulast%3DGillespie%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DM.%2BJ.%26aulast%3DMouradian%26aufirst%3DM.%2BM.%26aulast%3DChase%26aufirst%3DT.%2BN.%26atitle%3DAdenosine%2520A%25282A%2529%2520receptor%2520antagonist%2520treatment%2520of%2520Parkinson%25CA%25BCs%2520disease%26jtitle%3DNeurology%26date%3D2003%26volume%3D61%26spage%3D293%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikodijevic, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padgett, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo-Rodriguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maillard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, J. W.</span><span> </span><span class="NLM_article-title">8-(3-Chlorostyryl)caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">323</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=1993&pages=141-144&author=K.+A.+Jacobsonauthor=O.+Nikodijevicauthor=W.+L.+Padgettauthor=C.+Gallo-Rodriguezauthor=M.+Maillardauthor=J.+W.+Daly&title=8-%283-Chlorostyryl%29caffeine+%28CSC%29+is+a+selective+A2-adenosine+antagonist+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DNikodijevic%26aufirst%3DO.%26aulast%3DPadgett%26aufirst%3DW.%2BL.%26aulast%3DGallo-Rodriguez%26aufirst%3DC.%26aulast%3DMaillard%26aufirst%3DM.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3D8-%25283-Chlorostyryl%2529caffeine%2520%2528CSC%2529%2520is%2520a%2520selective%2520A2-adenosine%2520antagonist%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DFEBS%2520Lett.%26date%3D1993%26volume%3D323%26spage%3D141%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group">Chen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzer, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Der Schyf, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonsalla, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, N.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span> </span><span class="NLM_article-title">8-(3-Chlorostyryl)caffeine may attenuate MPTP neurotoxicity through dual actions of monoamine oxidase inhibition and A2A receptor antagonism</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">36040</span><span class="NLM_x">–</span> <span class="NLM_lpage">36044</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=36040-36044&author=J.+F.+Chenauthor=S.+Steynauthor=R.+Staalauthor=J.+P.+Petzerauthor=K.+Xuauthor=C.+J.+Van+Der+Schyfauthor=K.+Castagnoliauthor=P.+K.+Sonsallaauthor=N.+Castagnoliauthor=M.+A.+Schwarzschild&title=8-%283-Chlorostyryl%29caffeine+may+attenuate+MPTP+neurotoxicity+through+dual+actions+of+monoamine+oxidase+inhibition+and+A2A+receptor+antagonism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BF.%26aulast%3DSteyn%26aufirst%3DS.%26aulast%3DStaal%26aufirst%3DR.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DVan%2BDer%2BSchyf%26aufirst%3DC.%2BJ.%26aulast%3DCastagnoli%26aufirst%3DK.%26aulast%3DSonsalla%26aufirst%3DP.%2BK.%26aulast%3DCastagnoli%26aufirst%3DN.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26atitle%3D8-%25283-Chlorostyryl%2529caffeine%2520may%2520attenuate%2520MPTP%2520neurotoxicity%2520through%2520dual%2520actions%2520of%2520monoamine%2520oxidase%2520inhibition%2520and%2520A2A%2520receptor%2520antagonism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D36040%26epage%3D36044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group">Gerlach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, P.</span><span> </span><span class="NLM_article-title">Animal models of Parkinsonʼs disease: an empirical comparison with the phenomenology of the disease in man</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">1041</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1996&pages=987-1041&author=M.+Gerlachauthor=P.+Riederer&title=Animal+models+of+Parkinson%CA%BCs+disease%3A+an+empirical+comparison+with+the+phenomenology+of+the+disease+in+man"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGerlach%26aufirst%3DM.%26aulast%3DRiederer%26aufirst%3DP.%26atitle%3DAnimal%2520models%2520of%2520Parkinson%25CA%25BCs%2520disease%253A%2520an%2520empirical%2520comparison%2520with%2520the%2520phenomenology%2520of%2520the%2520disease%2520in%2520man%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D1996%26volume%3D103%26spage%3D987%26epage%3D1041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group">Petzer, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Schyf, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, N.</span><span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase B by selective adenosine A2A receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1299</span><span class="NLM_x">–</span> <span class="NLM_lpage">1310</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=1299-1310&author=J.+P.+Petzerauthor=S.+Steynauthor=K.+P.+Castagnoliauthor=J.+F.+Chenauthor=M.+A.+Schwarzschildauthor=C.+J.+Van+der+Schyfauthor=N.+Castagnoli&title=Inhibition+of+monoamine+oxidase+B+by+selective+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26aulast%3DSteyn%26aufirst%3DS.%26aulast%3DCastagnoli%26aufirst%3DK.%2BP.%26aulast%3DChen%26aufirst%3DJ.%2BF.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26aulast%3DCastagnoli%26aufirst%3DN.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520B%2520by%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D1299%26epage%3D1310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group">Vlok, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malan, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, N.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzer, J. P.</span><span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase B by analogues of the adenosine A2A receptor antagonist (<i>E</i>)-8-(3-chlorostyryl)caffeine (CSC)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3512</span><span class="NLM_x">–</span> <span class="NLM_lpage">3521</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=3512-3521&author=N.+Vlokauthor=S.+F.+Malanauthor=N.+Castagnoliauthor=J.+J.+Berghauthor=J.+P.+Petzer&title=Inhibition+of+monoamine+oxidase+B+by+analogues+of+the+adenosine+A2A+receptor+antagonist+%28E%29-8-%283-chlorostyryl%29caffeine+%28CSC%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVlok%26aufirst%3DN.%26aulast%3DMalan%26aufirst%3DS.%2BF.%26aulast%3DCastagnoli%26aufirst%3DN.%26aulast%3DBergh%26aufirst%3DJ.%2BJ.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520B%2520by%2520analogues%2520of%2520the%2520adenosine%2520A2A%2520receptor%2520antagonist%2520%2528E%2529-8-%25283-chlorostyryl%2529caffeine%2520%2528CSC%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D3512%26epage%3D3521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group">Di Stefano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sozio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iannitelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santucci, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasuti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantalamessa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinnen, F.</span><span> </span><span class="NLM_article-title"><span class="smallcaps smallerCapital">l</span>-dopa- and dopamine-(<i>R</i>)-alpha-lipoic acid conjugates as multifunctional codrugs with antioxidant properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1486</span><span class="NLM_x">–</span> <span class="NLM_lpage">1493</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051145p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1486-1493&author=A.+Di+Stefanoauthor=P.+Sozioauthor=A.+Coccoauthor=A.+Iannitelliauthor=E.+Santucciauthor=M.+Costaauthor=L.+Pecciauthor=C.+Nasutiauthor=F.+Cantalamessaauthor=F.+Pinnen&title=l-dopa-+and+dopamine-%28R%29-alpha-lipoic+acid+conjugates+as+multifunctional+codrugs+with+antioxidant+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1021%2Fjm051145p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051145p%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BStefano%26aufirst%3DA.%26aulast%3DSozio%26aufirst%3DP.%26aulast%3DCocco%26aufirst%3DA.%26aulast%3DIannitelli%26aufirst%3DA.%26aulast%3DSantucci%26aufirst%3DE.%26aulast%3DCosta%26aufirst%3DM.%26aulast%3DPecci%26aufirst%3DL.%26aulast%3DNasuti%26aufirst%3DC.%26aulast%3DCantalamessa%26aufirst%3DF.%26aulast%3DPinnen%26aufirst%3DF.%26atitle%3Dl-dopa-%2520and%2520dopamine-%2528R%2529-alpha-lipoic%2520acid%2520conjugates%2520as%2520multifunctional%2520codrugs%2520with%2520antioxidant%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1486%26epage%3D1493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group">Packer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tritschler, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wessel, K.</span><span> </span><span class="NLM_article-title">Neuroprotection by the metabolic antioxidant alpha-lipoic acid</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">378</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2FS0891-5849%2896%2900269-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=8958163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaK28XnsVGisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1997&pages=359-378&author=L.+Packerauthor=H.+J.+Tritschlerauthor=K.+Wessel&title=Neuroprotection+by+the+metabolic+antioxidant+alpha-lipoic+acid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection by the metabolic antioxidant α-lipoic acid</span></div><div class="casAuthors">Packer, Lester; Tritschler, Hans J.; Wessel, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">359-378</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Reactive oxygen species are thought to be involved in a no. of types of acute and chronic pathol. conditions in the brain and neural tissue.  The metabolic antioxidant α-lipoate (thioctic acid, 1, 2-dithiolane-3-pentanoic acid; 1, 2-dithiolane-3 valeric acid; and 6,8-dithiooctanoic acid) is a low mol. wt. substance that is absorbed from the diet and crosses the blood-brain barrier.  α-Lipoate is taken up and reduced in cells and tissues to dihydrolipoate, which is also exported to the extracellular medium; hence, protection is afforded to both intracellular and extracellular environments.  Both α-lipoate and esp. dihydrolipoate have been shown to be potent antioxidants, to regenerate through redox cycling other antioxidants like vitamin C and vitamin E, and to raise intracellular glutathione levels.  Thus, it would seem an ideal substance in the treatment of oxidative brain and neural disorders involving free radical processes.  Examn. of current research reveals protective effects of these compds. in cerebral ischemia-reperfusion, excitotoxic amino acid brain injury, mitochondrial dysfunction, diabetes and diabetic neuropathy, inborn errors of metab., and other causes of acute or chronic damage to brain or neural tissue.  Very few neuropharmacol. intervention strategies are currently available for the treatment of stroke and numerous other brain disorders involving free radical injury.  We propose that the various metabolic antioxidant properties of α-lipoate relate to its possible therapeutic roles in a variety of brain and neuronal tissue pathologies: thiols are central to antioxidant defense in brain and other tissues.  The most important thiol antioxidant, glutathione, cannot be directly administered, whereas α-lipoic acid can.  In vitro, animal, and preliminary human studies indicate that α-lipoate may be effective in numerous neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ_kYauAICg7Vg90H21EOLACvtfcHk0lj_L4eirrAFkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XnsVGisr0%253D&md5=57e70add85f7f074e28936031085be69</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2896%2900269-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252896%252900269-9%26sid%3Dliteratum%253Aachs%26aulast%3DPacker%26aufirst%3DL.%26aulast%3DTritschler%26aufirst%3DH.%2BJ.%26aulast%3DWessel%26aufirst%3DK.%26atitle%3DNeuroprotection%2520by%2520the%2520metabolic%2520antioxidant%2520alpha-lipoic%2520acid%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D1997%26volume%3D22%26spage%3D359%26epage%3D378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group">Suh, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">deSzoeke, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frei, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagen, T. M.</span><span> </span><span class="NLM_article-title">Dihydrolipoic acid lowers the redox activity of transition metal ions but does not remove them from the active site of enzymes</span> <span class="citation_source-journal">Redox Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1179%2F135100004225003923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15035828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtlajs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=57-61&author=J.+H.+Suhauthor=B.+Z.+Zhuauthor=E.+deSzoekeauthor=B.+Freiauthor=T.+M.+Hagen&title=Dihydrolipoic+acid+lowers+the+redox+activity+of+transition+metal+ions+but+does+not+remove+them+from+the+active+site+of+enzymes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydrolipoic acid lowers the redox activity of transition metal ions but does not remove them from the active site of enzymes</span></div><div class="casAuthors">Suh, Jung H.; Zhu, Ben-Zhan; DeSzoeke, Evan; Frei, Balz; Hagen, Tory M.</div><div class="citationInfo"><span class="NLM_cas:title">Redox Report</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-61</span>CODEN:
                <span class="NLM_cas:coden">RDRPE4</span>;
        ISSN:<span class="NLM_cas:issn">1351-0002</span>.
    
            (<span class="NLM_cas:orgname">Maney Publishing</span>)
        </div><div class="casAbstract">α-Lipoic acid (LA) and its reduced form, dihydrolipoic acid (DHLA), have been suggested to chelate transition metal ions and, hence, mitigate iron- and copper-mediated oxidative stress in biol. systems.  However, it remains unclear whether LA and DHLA chelate transition metal ions in a redox-inactive form, and whether they remove metal ions from the active site of enzymes.  Therefore, we investigated the effects of LA and DHLA on iron- or copper-catalyzed oxidn. of ascorbate, a sensitive assay for the redox activity of these metal ions.  We found that DHLA, but not LA, significantly inhibited ascorbate oxidn. mediated by Fe(III)-citrate, suggesting that reduced thiols are required for iron binding.  DHLA also strongly inhibited Cu(II)(histidine)2-mediated ascorbate oxidn. in a concn.-dependent manner, with complete inhibition at a DHLA:Cu(II) molar ratio of 3:1.  In contrast, no inhibition of copper-catalyzed ascorbate oxidn. was obsd. with LA.  To investigate whether LA and DHLA remove copper or iron from the active site of enzymes, Cu,Zn superoxide dismutase and the iron-contg. enzyme aconitase were used.  We found that neither LA nor DHLA, even at high, millimolar concns., altered the activity of these enzymes.  Our results suggest that DHLA chelates and inactivates redox-active transition metal ions in small-mol., biol. complexes without affecting iron- or copper-dependent enzyme activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxxfH-XQwivLVg90H21EOLACvtfcHk0lj_L4eirrAFkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtlajs70%253D&md5=1aabfe4bb0be8ff80f82fbfc487c9ae5</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1179%2F135100004225003923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1179%252F135100004225003923%26sid%3Dliteratum%253Aachs%26aulast%3DSuh%26aufirst%3DJ.%2BH.%26aulast%3DZhu%26aufirst%3DB.%2BZ.%26aulast%3DdeSzoeke%26aufirst%3DE.%26aulast%3DFrei%26aufirst%3DB.%26aulast%3DHagen%26aufirst%3DT.%2BM.%26atitle%3DDihydrolipoic%2520acid%2520lowers%2520the%2520redox%2520activity%2520of%2520transition%2520metal%2520ions%2520but%2520does%2520not%2520remove%2520them%2520from%2520the%2520active%2520site%2520of%2520enzymes%26jtitle%3DRedox%2520Rep.%26date%3D2004%26volume%3D9%26spage%3D57%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group">Michiels, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toussaint, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remacle, J.</span><span> </span><span class="NLM_article-title">Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2F0891-5849%2894%2990079-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=7982629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaK2cXmslOitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1994&pages=235-248&author=C.+Michielsauthor=M.+Raesauthor=O.+Toussaintauthor=J.+Remacle&title=Importance+of+Se-glutathione+peroxidase%2C+catalase%2C+and+Cu%2FZn-SOD+for+cell+survival+against+oxidative+stress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress</span></div><div class="casAuthors">Michiels, Carine; Raes, Martine; Toussaint, Olivier; Remacle, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-48</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    </div><div class="casAbstract">A review, with 110 refs., on: O-derived free radicals; antioxidant systems; protecting effects of the antioxidant enzymes; threshold of free radical attacks and modulation by antioxidant enzymes; effects of inhibition of the different antioxidant enzymes; and transfection of antioxidant enzyme cDNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7pT0pnOa9b7Vg90H21EOLACvtfcHk0lj_L4eirrAFkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmslOitLg%253D&md5=ae2b9a2e754a6618ac7932e62ee84457</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1016%2F0891-5849%2894%2990079-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0891-5849%252894%252990079-5%26sid%3Dliteratum%253Aachs%26aulast%3DMichiels%26aufirst%3DC.%26aulast%3DRaes%26aufirst%3DM.%26aulast%3DToussaint%26aufirst%3DO.%26aulast%3DRemacle%26aufirst%3DJ.%26atitle%3DImportance%2520of%2520Se-glutathione%2520peroxidase%252C%2520catalase%252C%2520and%2520Cu%252FZn-SOD%2520for%2520cell%2520survival%2520against%2520oxidative%2520stress%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D1994%26volume%3D17%26spage%3D235%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group">Nappi, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vass, E.</span><span> </span><span class="NLM_article-title">Comparative studies of enhanced iron-mediated production of hydroxyl radical by glutathione, cysteine, ascorbic acid, and selected catechols</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">1336</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1336&publication_year=1997&pages=295-302&author=A.+J.+Nappiauthor=E.+Vass&title=Comparative+studies+of+enhanced+iron-mediated+production+of+hydroxyl+radical+by+glutathione%2C+cysteine%2C+ascorbic+acid%2C+and+selected+catechols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNappi%26aufirst%3DA.%2BJ.%26aulast%3DVass%26aufirst%3DE.%26atitle%3DComparative%2520studies%2520of%2520enhanced%2520iron-mediated%2520production%2520of%2520hydroxyl%2520radical%2520by%2520glutathione%252C%2520cysteine%252C%2520ascorbic%2520acid%252C%2520and%2520selected%2520catechols%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1997%26volume%3D1336%26spage%3D295%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group">McIntyre, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayes, M.</span><span> </span><span class="NLM_article-title">Sarizotan hydrochloride</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1358%2Fdof.2006.031.04.982108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVylsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=314-319&author=J.+A.+McIntyreauthor=J.+Castanerauthor=M.+Bayes&title=Sarizotan+hydrochloride"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Sarizotan hydrochloride: antidyskinetic drug 5-HT1A receptor agonist dopamine D2 receptor ligand</span></div><div class="casAuthors">McIntyre, J. A.; Castaner, J.; Bayes, M.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">314-319</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  The treatment of Parkinson's disease with levodopa is assocd. with the development of dyskinesias, or involuntary movements.  The risk increases with increasing duration of treatment.  Sarizotan exhibits dual 5-HT1A receptor agonism and dopamine D2 receptor ligand activity and is in development for the treatment of dyskinesia assocd. with Parkinson's disease.  In an animal model of Parkinson's disease, sarizotan reduced levodopa-induced choreiform dyskinesias in monkeys by up to 90% without diminishing the antiparkinsonian efficacy of levodopa.  In hemiparkinsonian rats, sarizotan effectively reduced the abnormal involuntary movements, dystonia and contralateral rotations assocd. with chronic levodopa therapy.  In an initial proof-of-concept study in patients with moderate to advanced Parkinson's disease, sarizotan significantly reduced levodopa-induced dyskinesias in a within-patient comparison.  The efficacy of sarizotan was further demonstrated in an open-label study in which there was a significant increase between baseline and the final treatment visit in the percent "on" time without dyskinesia.  This benefit was maintained in a 1-yr follow-up.  Sarizotan has been well tolerated in clin. studies to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr21CO_hP5UnrVg90H21EOLACvtfcHk0lhzvqMWTuFIIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVylsbo%253D&md5=fad99882b586e823c0da83b02af56340</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1358%2Fdof.2006.031.04.982108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2006.031.04.982108%26sid%3Dliteratum%253Aachs%26aulast%3DMcIntyre%26aufirst%3DJ.%2BA.%26aulast%3DCastaner%26aufirst%3DJ.%26aulast%3DBayes%26aufirst%3DM.%26atitle%3DSarizotan%2520hydrochloride%26jtitle%3DDrugs%2520Future%26date%3D2006%26volume%3D31%26spage%3D314%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group">Nicholson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchie, J. M.</span><span> </span><span class="NLM_article-title">5-Hydroxytryptamine (5-HT, serotonin) and Parkinsonʼs disease. Opportunities for novel therapeutics to reduce the problems of levodopa therapy</span> <span class="citation_source-journal">Eur. J. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1046%2Fj.1468-1331.9.s3.1.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=12464115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADC%252BD38jgt1yktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=1-6&issue=Suppl.+3&author=S.+L.+Nicholsonauthor=J.+M.+Brotchie&title=5-Hydroxytryptamine+%285-HT%2C+serotonin%29+and+Parkinson%CA%BCs+disease.+Opportunities+for+novel+therapeutics+to+reduce+the+problems+of+levodopa+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">5-hydroxytryptamine (5-HT, serotonin) and Parkinson's disease - opportunities for novel therapeutics to reduce the problems of levodopa therapy</span></div><div class="casAuthors">Nicholson S L; Brotchie J M</div><div class="citationInfo"><span class="NLM_cas:title">European journal of neurology : the official journal of the European Federation of Neurological Societies</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9 Suppl 3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-6</span>
        ISSN:<span class="NLM_cas:issn">1351-5101</span>.
    </div><div class="casAbstract">While Parkinson's disease is undoubtedly a disorder with a primary pathology of dopamine neuronal loss, that loss of dopamine and subsequent dopamine replacement therapy leads to imbalances in many non-dopaminergic transmitter systems, including 5-hydroxytryptamine (5-HT).  Recent advances in understanding the role of 5-HT in parkinsonism and the generation of side-effects of dopamine replacement therapy (e.g. wearing-off and levodopa-induced dyskinesia) have identified 5-HT1A, 5-HT1B and 5-HT2C receptors as potential therapeutic targets in Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDFVC73stjdnWEEzDrymxmfW6udTcc2eaury2XxuPJ4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38jgt1yktQ%253D%253D&md5=190f721c9c5e3a5cdd645a323ff3131a</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1046%2Fj.1468-1331.9.s3.1.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1468-1331.9.s3.1.x%26sid%3Dliteratum%253Aachs%26aulast%3DNicholson%26aufirst%3DS.%2BL.%26aulast%3DBrotchie%26aufirst%3DJ.%2BM.%26atitle%3D5-Hydroxytryptamine%2520%25285-HT%252C%2520serotonin%2529%2520and%2520Parkinson%25CA%25BCs%2520disease.%2520Opportunities%2520for%2520novel%2520therapeutics%2520to%2520reduce%2520the%2520problems%2520of%2520levodopa%2520therapy%26jtitle%3DEur.%2520J.%2520Neurol.%26date%3D2002%26volume%3D9%26issue%3DSuppl.%25203%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group">Spires, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannan, A. J.</span><span> </span><span class="NLM_article-title">Molecular mechanisms mediating pathological plasticity in Huntingtonʼs disease and Alzheimerʼs disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">874</span><span class="NLM_x">–</span> <span class="NLM_lpage">882</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1111%2Fj.1471-4159.2006.04275.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17217424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisFGnurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2007&pages=874-882&author=T.+L.+Spiresauthor=A.+J.+Hannan&title=Molecular+mechanisms+mediating+pathological+plasticity+in+Huntington%CA%BCs+disease+and+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms mediating pathological plasticity in Huntington's disease and Alzheimer's disease</span></div><div class="casAuthors">Spires, Tara L.; Hannan, Anthony J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">874-882</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative diseases such as Huntington's disease and Alzheimer's disease, although very different in etiol., share common degenerative processes.  These include neuronal dysfunction, decreased neural connectivity, and disruption of cellular plasticity.  Understanding the mol. mechanisms underlying the neural plasticity deficits in these devastating conditions may lead the way toward new therapeutic targets, both disease-specific and more generalized, which can ameliorate degenerative cognitive deficits.  Furthermore, investigations of 'pathol. plasticity' in these diseases lend insight into normal brain function.  This review will present evidence for altered plasticity in Huntington's and Alzheimer's diseases, relate these findings to symptomatol., and review possible causes and commonalities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXDMEh_U7kELVg90H21EOLACvtfcHk0lhzvqMWTuFIIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisFGnurw%253D&md5=7a34d44e348aeb29be06e15070343cf3</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04275.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04275.x%26sid%3Dliteratum%253Aachs%26aulast%3DSpires%26aufirst%3DT.%2BL.%26aulast%3DHannan%26aufirst%3DA.%2BJ.%26atitle%3DMolecular%2520mechanisms%2520mediating%2520pathological%2520plasticity%2520in%2520Huntington%25CA%25BCs%2520disease%2520and%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D100%26spage%3D874%26epage%3D882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group">Bates, G.; Harper, P.; Jones, L.</span> <span class="citation_source-book">Huntingtonʼs Disease</span>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_publisher-name">Oxford University Press</span>: <span class="NLM_publisher-loc">Oxford, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=G.+Bates&author=P.+Harper&author=L.+Jones&title=Huntington%CA%BCs+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBates%26aufirst%3DG.%26btitle%3DHuntington%25CA%25BCs%2520Disease%26pub%3DOxford%2520University%2520Press%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group">van Dellen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grote, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannan, A. J.</span><span> </span><span class="NLM_article-title">Gene−environment interactions, neuronal dysfunction and pathological plasticity in Huntingtonʼs disease</span> <span class="citation_source-journal">Clin. Exp. Pharmacol. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1019</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1111%2Fj.1440-1681.2005.04313.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16445565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtFaitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2005&pages=1007-1019&author=A.+van+Dellenauthor=H.+E.+Groteauthor=A.+J.+Hannan&title=Gene%E2%88%92environment+interactions%2C+neuronal+dysfunction+and+pathological+plasticity+in+Huntington%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Gene-environment interactions, neuronal dysfunction and pathological plasticity in Huntington's disease</span></div><div class="casAuthors">van Dellen, Anton; Grote, Helen E.; Hannan, Anthony J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Pharmacology and Physiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1007-1019</span>CODEN:
                <span class="NLM_cas:coden">CEXPB9</span>;
        ISSN:<span class="NLM_cas:issn">0305-1870</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">A review.  Huntington's disease (HD) is a fatal autosomal dominant disorder in which there is progressive neurodegeneration producing motor, cognitive and psychiatric symptoms.  The dynamic mutation that causes the disease is common to numerous other brain disorders, which may share similar pathogenic mechanisms.  Much progress has been made in the past decade in understanding how a trinucleotide (CAG) repeat expansion, encoding an expanded polyglutamine tract in the huntingtin protein, induces dysfunction at mol. and cellular levels.  The present review integrates various lines of exptl. evidence in an attempt to move towards a unifying mechanistic framework, which may explain the pathogenesis of HD, from mol. through to neuronal network and behavioral levels.  Recent evidence, using transgenic mouse models, also suggests that environmental factors can modify the onset and progression of HD.  The effects of specific environmental manipulations are discussed in the context of gene-environment interactions and experience-dependent plasticity in the healthy and diseased brain, particularly the cerebral cortex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpadwVYKG-KYbVg90H21EOLACvtfcHk0ljZswQ7Zxj25w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtFaitw%253D%253D&md5=4c5229e1d1698b630d5766cd1abdf68f</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1111%2Fj.1440-1681.2005.04313.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1440-1681.2005.04313.x%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BDellen%26aufirst%3DA.%26aulast%3DGrote%26aufirst%3DH.%2BE.%26aulast%3DHannan%26aufirst%3DA.%2BJ.%26atitle%3DGene%25E2%2588%2592environment%2520interactions%252C%2520neuronal%2520dysfunction%2520and%2520pathological%2520plasticity%2520in%2520Huntington%25CA%25BCs%2520disease%26jtitle%3DClin.%2520Exp.%2520Pharmacol.%2520Physiol.%26date%3D2005%26volume%3D32%26spage%3D1007%26epage%3D1019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group">Tarlac, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storey, E.</span><span> </span><span class="NLM_article-title">Role of proteolysis in polyglutamine disorders</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">406</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fjnr.10746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=14598317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptFWnt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2003&pages=406-416&author=V.+Tarlacauthor=E.+Storey&title=Role+of+proteolysis+in+polyglutamine+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Role of proteolysis in polyglutamine disorders</span></div><div class="casAuthors">Tarlac, V.; Storey, E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">406-416</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  To date, nine polyglutamine disorders have been characterized, including Huntington's disease (HD), spinobulbar muscular atrophy (SBMA), dentatorubralpallidoluysian atrophy (DRPLA), and spinocerebellar ataxias 1, 2, 3, 6, 7 and 17 (SCAs).  Although knockout and transgenic mouse expts. suggest that a toxic gain of function is central to neuronal death in these diseases (with the probable exception of SCA6), the exact mechanisms of neurotoxicity remain contentious.  A further conundrum is the characteristic distribution of neuronal damage in each disease, despite ubiquitous expression of the abnormal proteins.  One mechanism that could possibly underlie the specific distribution of neuronal toxicity is proteolytic cleavage of the full-length expanded polyglutamine tract-contg. proteins.  There is evidence found in vitro or in vivo (or both) of proteolytic cleavage in HD, SBMA, DRPLA, and SCAs 2, 3, and 7.  In HD, cleavage has been demonstrated to be regionally specific, occurring as a result of caspase activation.  These diseases are also characterized by development of intra-neuronal aggregates of the abnormal protein that co-localize with components of the ubiquitin-proteasome pathway.  It remains unclear whether these aggregates are pathogenic or merely disease markers; however, at least in the case of ataxin-3, cleavage promotes aggregation.  Inhibition of specific proteases constitutes a potential therapeutic approach in these diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkz1EUfPsR3LVg90H21EOLACvtfcHk0ljZswQ7Zxj25w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptFWnt74%253D&md5=891e0cb99c1b6cf056478668508b5089</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1002%2Fjnr.10746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.10746%26sid%3Dliteratum%253Aachs%26aulast%3DTarlac%26aufirst%3DV.%26aulast%3DStorey%26aufirst%3DE.%26atitle%3DRole%2520of%2520proteolysis%2520in%2520polyglutamine%2520disorders%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2003%26volume%3D74%26spage%3D406%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group">Arrasate, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweitzer, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segal, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkbeiner, S.</span><span> </span><span class="NLM_article-title">Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">431</span><span class="NLM_x">, </span> <span class="NLM_fpage">805</span><span class="NLM_x">–</span> <span class="NLM_lpage">810</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnature02998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15483602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotl2ktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=431&publication_year=2004&pages=805-810&author=M.+Arrasateauthor=S.+Mitraauthor=E.+S.+Schweitzerauthor=M.+R.+Segalauthor=S.+Finkbeiner&title=Inclusion+body+formation+reduces+levels+of+mutant+huntingtin+and+the+risk+of+neuronal+death"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death</span></div><div class="casAuthors">Arrasate, Montserrat; Mitra, Siddhartha; Schweitzer, Erik S.; Segal, Mark R.; Finkbeiner, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">431</span>
        (<span class="NLM_cas:issue">7010</span>),
    <span class="NLM_cas:pages">805-810</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Huntington's disease is caused by an abnormal poly-glutamine expansion within the protein huntingtin and is characterized by microscopic inclusion bodies of aggregated huntingtin and by the death of selected types of neuron.  Whether inclusion bodies are pathogenic, incidental or a beneficial coping response is controversial.  To resolve this issue we have developed an automated microscope that returns to precisely the same neuron after arbitrary intervals, even after cells have been removed from the microscope stage.  Here we show, by survival anal., that neurons die in a time-independent fashion but one that is dependent on mutant huntingtin dose and poly-glutamine expansion; many neurons die without forming an inclusion body.  Rather, the amt. of diffuse intracellular huntingtin predicts whether and when inclusion body formation or death will occur.  Surprisingly, inclusion body formation predicts improved survival and leads to decreased levels of mutant huntingtin elsewhere in a neuron.  Thus, inclusion body formation can function as a coping response to toxic mutant huntingtin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4cEVA-oqxdLVg90H21EOLACvtfcHk0lhJsY8RTCYAbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotl2ktrc%253D&md5=6c5f5ffc582e0015fa0a3c3ca0051e64</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1038%2Fnature02998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02998%26sid%3Dliteratum%253Aachs%26aulast%3DArrasate%26aufirst%3DM.%26aulast%3DMitra%26aufirst%3DS.%26aulast%3DSchweitzer%26aufirst%3DE.%2BS.%26aulast%3DSegal%26aufirst%3DM.%2BR.%26aulast%3DFinkbeiner%26aufirst%3DS.%26atitle%3DInclusion%2520body%2520formation%2520reduces%2520levels%2520of%2520mutant%2520huntingtin%2520and%2520the%2520risk%2520of%2520neuronal%2520death%26jtitle%3DNature%26date%3D2004%26volume%3D431%26spage%3D805%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group">Panov, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutekunst, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leavitt, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayden, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strittmatter, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenamyre, J. T.</span><span> </span><span class="NLM_article-title">Early mitochondrial calcium defects in Huntingtonʼs disease are a direct effect of polyglutamines</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">731</span><span class="NLM_x">–</span> <span class="NLM_lpage">736</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=12089530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFaqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2002&pages=731-736&author=A.+V.+Panovauthor=C.+A.+Gutekunstauthor=B.+R.+Leavittauthor=M.+R.+Haydenauthor=J.+R.+Burkeauthor=W.+J.+Strittmatterauthor=J.+T.+Greenamyre&title=Early+mitochondrial+calcium+defects+in+Huntington%CA%BCs+disease+are+a+direct+effect+of+polyglutamines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines</span></div><div class="casAuthors">Panov, Alexander V.; Gutekunst, Claire-Anne; Leavitt, Blair R.; Hayden, Michael R.; Burke, James R.; Strittmatter, Warren J.; Greenamyre, J. Timothy</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">731-736</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Huntington's disease (HD) is caused by an expansion of exonic CAG triplet repeats in the gene encoding huntingtin protein (Htt), but the mechanisms by which this mutant protein causes neurodegeneration remain unknown.  Here we show that lymphoblast mitochondria from patients with HD have a lower membrane potential and depolarize at lower calcium loads than do mitochondria from controls.  We found a similar defect in brain mitochondria from transgenic mice expressing full-length mutant huntingtin, and this defect preceded the onset of pathol. or behavioral abnormalities by months.  By electron microscopy, we identified N-terminal mutant huntingtin on neuronal mitochondrial membranes, and by incubating normal mitochondria with a fusion protein contg. an abnormally long polyglutamine repeat, we reproduced the mitochondrial calcium defect seen in human patients and transgenic animals.  Thus, mitochondrial calcium abnormalities occur early in HD pathogenesis and may be a direct effect of mutant huntingtin on the organelle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqpe87fhbCK7Vg90H21EOLACvtfcHk0lhJsY8RTCYAbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFaqu7g%253D&md5=59fd63b141c8f7205c791fa36ad9d33d</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPanov%26aufirst%3DA.%2BV.%26aulast%3DGutekunst%26aufirst%3DC.%2BA.%26aulast%3DLeavitt%26aufirst%3DB.%2BR.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26aulast%3DBurke%26aufirst%3DJ.%2BR.%26aulast%3DStrittmatter%26aufirst%3DW.%2BJ.%26aulast%3DGreenamyre%26aufirst%3DJ.%2BT.%26atitle%3DEarly%2520mitochondrial%2520calcium%2520defects%2520in%2520Huntington%25CA%25BCs%2520disease%2520are%2520a%2520direct%2520effect%2520of%2520polyglutamines%26jtitle%3DNat.%2520Neurosci.%26date%3D2002%26volume%3D5%26spage%3D731%26epage%3D736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group">Firdaus, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyttenbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Latoud, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currie, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrigo, A. P.</span><span> </span><span class="NLM_article-title">Analysis of oxidative events induced by expanded polyglutamine huntingtin exon 1 that are differentially restored by expression of heat shock proteins or treatment with an antioxidant</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">3076</span><span class="NLM_x">–</span> <span class="NLM_lpage">3093</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=2006&pages=3076-3093&author=W.+J.+Firdausauthor=A.+Wyttenbachauthor=C.+Diaz-Latoudauthor=R.+W.+Currieauthor=A.+P.+Arrigo&title=Analysis+of+oxidative+events+induced+by+expanded+polyglutamine+huntingtin+exon+1+that+are+differentially+restored+by+expression+of+heat+shock+proteins+or+treatment+with+an+antioxidant"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFirdaus%26aufirst%3DW.%2BJ.%26aulast%3DWyttenbach%26aufirst%3DA.%26aulast%3DDiaz-Latoud%26aufirst%3DC.%26aulast%3DCurrie%26aufirst%3DR.%2BW.%26aulast%3DArrigo%26aufirst%3DA.%2BP.%26atitle%3DAnalysis%2520of%2520oxidative%2520events%2520induced%2520by%2520expanded%2520polyglutamine%2520huntingtin%2520exon%25201%2520that%2520are%2520differentially%2520restored%2520by%2520expression%2520of%2520heat%2520shock%2520proteins%2520or%2520treatment%2520with%2520an%2520antioxidant%26jtitle%3DFEBS%2520J.%26date%3D2006%26volume%3D273%26spage%3D3076%26epage%3D3093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group">Firdaus, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyttenbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kretz-Remy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currie, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrigo, A. P.</span><span> </span><span class="NLM_article-title">Huntingtin inclusion bodies are iron-dependent centers of oxidative events</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">5428</span><span class="NLM_x">–</span> <span class="NLM_lpage">5441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=2006&pages=5428-5441&author=W.+J.+Firdausauthor=A.+Wyttenbachauthor=P.+Giulianoauthor=C.+Kretz-Remyauthor=R.+W.+Currieauthor=A.+P.+Arrigo&title=Huntingtin+inclusion+bodies+are+iron-dependent+centers+of+oxidative+events"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFirdaus%26aufirst%3DW.%2BJ.%26aulast%3DWyttenbach%26aufirst%3DA.%26aulast%3DGiuliano%26aufirst%3DP.%26aulast%3DKretz-Remy%26aufirst%3DC.%26aulast%3DCurrie%26aufirst%3DR.%2BW.%26aulast%3DArrigo%26aufirst%3DA.%2BP.%26atitle%3DHuntingtin%2520inclusion%2520bodies%2520are%2520iron-dependent%2520centers%2520of%2520oxidative%2520events%26jtitle%3DFEBS%2520J.%26date%3D2006%26volume%3D273%26spage%3D5428%26epage%3D5441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group">Mulder, D. W.</span><span> </span><span class="NLM_article-title">Clinical limits of amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Adv. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=7180681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADyaL3s%252Fps1yqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1982&pages=15-22&author=D.+W.+Mulder&title=Clinical+limits+of+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical limits of amyotrophic lateral sclerosis</span></div><div class="casAuthors">Mulder D W</div><div class="citationInfo"><span class="NLM_cas:title">Advances in neurology</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15-22</span>
        ISSN:<span class="NLM_cas:issn">0091-3952</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAAieAWmRWDEBuFdjgVNKSfW6udTcc2ea4xhsHLZVa4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3s%252Fps1yqsA%253D%253D&md5=845d754b50ccadc1e9c00d71658947b5</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMulder%26aufirst%3DD.%2BW.%26atitle%3DClinical%2520limits%2520of%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DAdv.%2520Neurol.%26date%3D1982%26volume%3D36%26spage%3D15%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group">Ince, P. G.</span> In  <span class="citation_source-book">Amyotrophic Lateral Sclerosis</span>; <span class="NLM_contrib-group">Brown, R. H.,  Jr.; Meininger, V.; Swash, M.</span>, Eds.; <span class="NLM_publisher-name">Martin Dunitz</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=83-112&author=P.+G.+Ince&title=Amyotrophic+Lateral+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DInce%26aufirst%3DP.%2BG.%26btitle%3DAmyotrophic%2520Lateral%2520Sclerosis%26aulast%3DBrown%26aufirst%3DR.%2BH.%26pub%3DMartin%2520Dunitz%26date%3D2000%26spage%3D83%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group">Gurney, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Canto, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polchow, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliendo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hentati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, H. X.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">264</span><span class="NLM_x">, </span> <span class="NLM_fpage">1772</span><span class="NLM_x">–</span> <span class="NLM_lpage">1775</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1994&pages=1772-1775&author=M.+E.+Gurneyauthor=H.+Puauthor=A.+Y.+Chiuauthor=M.+C.+Dal+Cantoauthor=C.+Y.+Polchowauthor=D.+D.+Alexanderauthor=J.+Caliendoauthor=A.+Hentatiauthor=Y.+W.+Kwonauthor=H.+X.+Deng&title=Motor+neuron+degeneration+in+mice+that+express+a+human+Cu%2CZn+superoxide+dismutase+mutation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGurney%26aufirst%3DM.%2BE.%26aulast%3DPu%26aufirst%3DH.%26aulast%3DChiu%26aufirst%3DA.%2BY.%26aulast%3DDal%2BCanto%26aufirst%3DM.%2BC.%26aulast%3DPolchow%26aufirst%3DC.%2BY.%26aulast%3DAlexander%26aufirst%3DD.%2BD.%26aulast%3DCaliendo%26aufirst%3DJ.%26aulast%3DHentati%26aufirst%3DA.%26aulast%3DKwon%26aufirst%3DY.%2BW.%26aulast%3DDeng%26aufirst%3DH.%2BX.%26atitle%3DMotor%2520neuron%2520degeneration%2520in%2520mice%2520that%2520express%2520a%2520human%2520Cu%252CZn%2520superoxide%2520dismutase%2520mutation%26jtitle%3DScience%26date%3D1994%26volume%3D264%26spage%3D1772%26epage%3D1775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group">Rakhit, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabartty, A.</span><span> </span><span class="NLM_article-title">Structure, folding, and misfolding of Cu,Zn superoxide dismutase in amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1762</span><span class="NLM_x">, </span> <span class="NLM_fpage">1025</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1762&publication_year=2006&pages=1025-1037&author=R.+Rakhitauthor=A.+Chakrabartty&title=Structure%2C+folding%2C+and+misfolding+of+Cu%2CZn+superoxide+dismutase+in+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRakhit%26aufirst%3DR.%26aulast%3DChakrabartty%26aufirst%3DA.%26atitle%3DStructure%252C%2520folding%252C%2520and%2520misfolding%2520of%2520Cu%252CZn%2520superoxide%2520dismutase%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2006%26volume%3D1762%26spage%3D1025%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group">Deng, H. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrie, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigio, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Canto, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OʼHalloran, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddique, T.</span><span> </span><span class="NLM_article-title">Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria</span> <span class="citation_source-journal">Proc. Natl. Acad. Sc.i U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">7142</span><span class="NLM_x">–</span> <span class="NLM_lpage">7147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1073%2Fpnas.0602046103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16636275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslCktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=7142-7147&author=H.+X.+Dengauthor=Y.+Shiauthor=Y.+Furukawaauthor=H.+Zhaiauthor=R.+Fuauthor=E.+Liuauthor=G.+H.+Gorrieauthor=M.+S.+Khanauthor=W.+Y.+Hungauthor=E.+H.+Bigioauthor=T.+Lukasauthor=M.+C.+Dal+Cantoauthor=T.+V.+O%CA%BCHalloranauthor=T.+Siddique&title=Conversion+to+the+amyotrophic+lateral+sclerosis+phenotype+is+associated+with+intermolecular+linked+insoluble+aggregates+of+SOD1+in+mitochondria"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria</span></div><div class="casAuthors">Deng, Han-Xiang; Shi, Yong; Furukawa, Yoshiaki; Zhai, Hong; Fu, Ronggen; Liu, Erdong; Gorrie, George H.; Khan, Mohammad S.; Hung, Wu-Yen; Bigio, Eileen H.; Lukas, Thomas; Dal Canto, Mauro C.; O'Halloran, Thomas V.; Siddique, Teepu</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7142-7147</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Twenty percent of the familial form of amyotrophic lateral sclerosis (ALS) is caused by mutations in the Cu, Zn-superoxide dismutase gene (SOD1) through the gain of a toxic function.  The nature of this toxic function of mutant SOD1 has remained largely unknown.  Here we show that WT SOD1 not only hastens onset of the ALS phenotype but can also convert an unaffected phenotype to an ALS phenotype in mutant SOD1 transgenic mouse models.  Further analyses of the single- and double-transgenic mice revealed that conversion of mutant SOD1 from a sol. form to an aggregated and detergent-insol. form was assocd. with development of the ALS phenotype in transgenic mice.  Conversion of WT SOD1 from a sol. form to an aggregated and insol. form also correlates with exacerbation of the disease or conversion to a disease phenotype in double-transgenic mice.  This conversion, obsd. in the mitochondrial fraction of the spinal cord, involved formation of insol. SOD1 dimers and multimers that are crosslinked through intermol. disulfide bonds via oxidn. of cysteine residues in SOD1.  Our data thus show a mol. mechanism by which SOD1, an important protein in cellular defense against free radicals, is converted to aggregated and apparently ALS-assocd. toxic dimers and multimers by redox processes.  These findings provide evidence of direct links among oxidn., protein aggregation, mitochondrial damage, and SOD1-mediated ALS, with possible applications to the aging process and other late-onset neurodegenerative disorders.  Importantly, rational therapy based on these observations can now be developed and tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7JwV_hQLzRrVg90H21EOLACvtfcHk0lgsRiYLDmgn7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslCktLg%253D&md5=c3a2c3ef835a417ab5072963db77ccfd</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0602046103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0602046103%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DH.%2BX.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DFurukawa%26aufirst%3DY.%26aulast%3DZhai%26aufirst%3DH.%26aulast%3DFu%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DE.%26aulast%3DGorrie%26aufirst%3DG.%2BH.%26aulast%3DKhan%26aufirst%3DM.%2BS.%26aulast%3DHung%26aufirst%3DW.%2BY.%26aulast%3DBigio%26aufirst%3DE.%2BH.%26aulast%3DLukas%26aufirst%3DT.%26aulast%3DDal%2BCanto%26aufirst%3DM.%2BC.%26aulast%3DO%25CA%25BCHalloran%26aufirst%3DT.%2BV.%26aulast%3DSiddique%26aufirst%3DT.%26atitle%3DConversion%2520to%2520the%2520amyotrophic%2520lateral%2520sclerosis%2520phenotype%2520is%2520associated%2520with%2520intermolecular%2520linked%2520insoluble%2520aggregates%2520of%2520SOD1%2520in%2520mitochondria%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sc.i%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D7142%26epage%3D7147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group">Pasinelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. H.</span><span> </span><span class="NLM_article-title">Molecular biology of amyotrophic lateral sclerosis: insights from genetics</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnrn1971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16924260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlCgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=710-723&author=P.+Pasinelliauthor=R.+H.+Brown&title=Molecular+biology+of+amyotrophic+lateral+sclerosis%3A+insights+from+genetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular biology of amyotrophic lateral sclerosis: insights from genetics</span></div><div class="casAuthors">Pasinelli, Piera; Brown, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">710-723</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Amyotrophic lateral sclerosis (ALS) is a paralytic disorder caused by motor neuron degeneration.  Mutations in more than 50 human genes cause diverse types of motor neuron pathol.  Moreover, defects in five Mendelian genes lead to motor neuron disease, with two mutations reproducing the ALS phenotype.  Analyses of these genetic effects have generated new insights into the diverse mol. pathways involved in ALS pathogenesis.  Here, we present an overview of the mechanisms for motor neuron death and of the role of non-neuronal cells in ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGeL8ButRoa7Vg90H21EOLACvtfcHk0lgsRiYLDmgn7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlCgtro%253D&md5=0c023f607f81378751f0b2c3cd8310f7</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1038%2Fnrn1971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1971%26sid%3Dliteratum%253Aachs%26aulast%3DPasinelli%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DR.%2BH.%26atitle%3DMolecular%2520biology%2520of%2520amyotrophic%2520lateral%2520sclerosis%253A%2520insights%2520from%2520genetics%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2006%26volume%3D7%26spage%3D710%26epage%3D723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borchelt, D. R.</span><span> </span><span class="NLM_article-title">High molecular weight complexes of mutant superoxide dismutase 1: age-dependent and tissue-specific accumulation</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1006%2Fnbdi.2001.0471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=11895367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvVSksrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=139-148&author=J.+Wangauthor=G.+Xuauthor=D.+R.+Borchelt&title=High+molecular+weight+complexes+of+mutant+superoxide+dismutase+1%3A+age-dependent+and+tissue-specific+accumulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">High Molecular Weight Complexes of Mutant Superoxide Dismutase 1: Age-Dependent and Tissue-Specific Accumulation</span></div><div class="casAuthors">Wang, Jiou; Xu, Guilian; Borchelt, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-148</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Mutations in the cytosolic enzyme, superoxide dismutase 1, have been identified as the cause of motor neuron disease in a subset of cases of familial amyotrophic lateral sclerosis.  It has been postulated that the injurious property of mutant enzyme resides in its propensity to aggregate or its propensity to catalyze deleterious, copper-mediated, chemistries.  Aggregates of SOD1 have been identified, histol., in neurons and astroglia of the spinal cords of SOD1-linked FALS patients and in transgenic mice that express these mutant proteins.  In the present study, we have employed a technique used in detecting and quantifying aggregates of mutant huntingtin (cellulose acetate filtration) to examine the mol. characteristics of mutant SOD1 in three previously characterized transgenic mouse models of FALS.  The brains and spinal cords of these mice accumulate mutant SOD1 complexes that can be trapped by cellulose acetate filtration.  The relative abundance of these structures increases dramatically with age.  Although expressed to the same level in nonnervous tissues, mutant SOD1 was not found in high mol. wt. structures.  We conclude that some aspect of the biol. of neural tissues (in a setting of declining motor neuron function) predisposes to the accumulation of high mol. wt. complexes of mutant SOD1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1LrTI2-qYQrVg90H21EOLACvtfcHk0lgsRiYLDmgn7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvVSksrw%253D&md5=effd7d4c1cd5c379b8fd68429313586f</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1006%2Fnbdi.2001.0471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fnbdi.2001.0471%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DBorchelt%26aufirst%3DD.%2BR.%26atitle%3DHigh%2520molecular%2520weight%2520complexes%2520of%2520mutant%2520superoxide%2520dismutase%25201%253A%2520age-dependent%2520and%2520tissue-specific%2520accumulation%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2002%26volume%3D9%26spage%3D139%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group">Johnston, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalton, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurney, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopito, R. R.</span><span> </span><span class="NLM_article-title">Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">12571</span><span class="NLM_x">–</span> <span class="NLM_lpage">12576</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1073%2Fpnas.220417997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=11050163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotFygt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=12571-12576&author=J.+A.+Johnstonauthor=M.+J.+Daltonauthor=M.+E.+Gurneyauthor=R.+R.+Kopito&title=Formation+of+high+molecular+weight+complexes+of+mutant+Cu%2C+Zn-superoxide+dismutase+in+a+mouse+model+for+familial+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Formation of high molecular weight complexes of mutant Cu,Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis</span></div><div class="casAuthors">Johnston, Jennifer A.; Dalton, Muffie J.; Gurney, Mark E.; Kopito, Ron R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">12571-12576</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Deposition of aggregated protein into neurofilament-rich cytoplasmic inclusion bodies is a common cytopathol. feature of neurodegenerative disease.  How-or indeed whether-protein aggregation and inclusion body formation cause neurotoxicity are presently unknown.  Here, we show that the capacity of superoxide dismutase (SOD) to aggregate into biochem. distinct, high mol. wt., insol. protein complexes (IPCs) is a gain of function assocd. with mutations linked to autosomal dominant familial amyotrophic lateral sclerosis.  SOD IPCs are detectable in spinal cord exts. from transgenic mice expressing mutant SOD several months before inclusion bodies and motor neuron pathol. are apparent.  Sequestration of mutant SOD into cytoplasmic inclusion bodies resembling aggresomes requires retrograde transport on microtubules.  These data indicate that aggregation and inclusion body formation are mechanistically and temporally distinct processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-ZLh_Cnv-67Vg90H21EOLACvtfcHk0lhz-ZKJpv7cnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotFygt7c%253D&md5=85abbf2d15a35bc59273345093f58f87</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1073%2Fpnas.220417997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.220417997%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DJ.%2BA.%26aulast%3DDalton%26aufirst%3DM.%2BJ.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26aulast%3DKopito%26aufirst%3DR.%2BR.%26atitle%3DFormation%2520of%2520high%2520molecular%2520weight%2520complexes%2520of%2520mutant%2520Cu%252C%2520Zn-superoxide%2520dismutase%2520in%2520a%2520mouse%2520model%2520for%2520familial%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D12571%26epage%3D12576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref208"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref208'); return false;" data-citation="" class="refNumLink">208</a></strong><div class="NLM_citation" id="cit208"><span><span class="NLM_contrib-group">Bruijn, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houseweart, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohama, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reaume, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleveland, D. W.</span><span> </span><span class="NLM_article-title">Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">1851</span><span class="NLM_x">–</span> <span class="NLM_lpage">1854</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=1998&pages=1851-1854&author=L.+I.+Bruijnauthor=M.+K.+Houseweartauthor=S.+Katoauthor=K.+L.+Andersonauthor=S.+D.+Andersonauthor=E.+Ohamaauthor=A.+G.+Reaumeauthor=R.+W.+Scottauthor=D.+W.+Cleveland&title=Aggregation+and+motor+neuron+toxicity+of+an+ALS-linked+SOD1+mutant+independent+from+wild-type+SOD1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBruijn%26aufirst%3DL.%2BI.%26aulast%3DHouseweart%26aufirst%3DM.%2BK.%26aulast%3DKato%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DK.%2BL.%26aulast%3DAnderson%26aufirst%3DS.%2BD.%26aulast%3DOhama%26aufirst%3DE.%26aulast%3DReaume%26aufirst%3DA.%2BG.%26aulast%3DScott%26aufirst%3DR.%2BW.%26aulast%3DCleveland%26aufirst%3DD.%2BW.%26atitle%3DAggregation%2520and%2520motor%2520neuron%2520toxicity%2520of%2520an%2520ALS-linked%2520SOD1%2520mutant%2520independent%2520from%2520wild-type%2520SOD1%26jtitle%3DScience%26date%3D1998%26volume%3D281%26spage%3D1851%26epage%3D1854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref209"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref209'); return false;" data-citation="" class="refNumLink">209</a></strong><div class="NLM_citation" id="cit209"><span><span class="NLM_contrib-group">Ray, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strokovich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. H.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansbury, P. T.,  Jr</span><span> </span><span class="NLM_article-title">An intersubunit disulfide bond prevents in vitro aggregation of a superoxide dismutase-1 mutant linked to familial amytrophic lateral sclerosis</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4899</span><span class="NLM_x">–</span> <span class="NLM_lpage">4905</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi030246r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=4899-4905&author=S.+S.+Rayauthor=R.+J.+Nowakauthor=K.+Strokovichauthor=R.+H.+Brownauthor=T.+Walzauthor=P.+T.+Lansbury&title=An+intersubunit+disulfide+bond+prevents+in+vitro+aggregation+of+a+superoxide+dismutase-1+mutant+linked+to+familial+amytrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1021%2Fbi030246r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi030246r%26sid%3Dliteratum%253Aachs%26aulast%3DRay%26aufirst%3DS.%2BS.%26aulast%3DNowak%26aufirst%3DR.%2BJ.%26aulast%3DStrokovich%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DR.%2BH.%26aulast%3DWalz%26aufirst%3DT.%26aulast%3DLansbury%26aufirst%3DP.%2BT.%26atitle%3DAn%2520intersubunit%2520disulfide%2520bond%2520prevents%2520in%2520vitro%2520aggregation%2520of%2520a%2520superoxide%2520dismutase-1%2520mutant%2520linked%2520to%2520familial%2520amytrophic%2520lateral%2520sclerosis%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D4899%26epage%3D4905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref210"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref210'); return false;" data-citation="" class="refNumLink">210</a></strong><div class="NLM_citation" id="cit210"><span><span class="NLM_contrib-group">Matsumoto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morimoto, R. I.</span><span> </span><span class="NLM_article-title">Huntingtin and mutant SOD1 form aggregate structures with distinct molecular properties in human cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">4477</span><span class="NLM_x">–</span> <span class="NLM_lpage">4485</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=4477-4485&author=G.+Matsumotoauthor=S.+Kimauthor=R.+I.+Morimoto&title=Huntingtin+and+mutant+SOD1+form+aggregate+structures+with+distinct+molecular+properties+in+human+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DG.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DMorimoto%26aufirst%3DR.%2BI.%26atitle%3DHuntingtin%2520and%2520mutant%2520SOD1%2520form%2520aggregate%2520structures%2520with%2520distinct%2520molecular%2520properties%2520in%2520human%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D4477%26epage%3D4485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref211"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref211'); return false;" data-citation="" class="refNumLink">211</a></strong><div class="NLM_citation" id="cit211"><span><span class="NLM_contrib-group">Bacman, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraes, C. T.</span><span> </span><span class="NLM_article-title">Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target</span> <span class="citation_source-journal">Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1385%2FMN%3A33%3A2%3A113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16603792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFOmtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=113-131&author=S.+R.+Bacmanauthor=W.+G.+Bradleyauthor=C.+T.+Moraes&title=Mitochondrial+involvement+in+amyotrophic+lateral+sclerosis%3A+trigger+or+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial involvement in amyotrophic lateral sclerosis. Trigger or target?</span></div><div class="casAuthors">Bacman, Sandra R.; Bradley, Walter G.; Moraes, Carlos T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-131</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Despite numerous reports demonstrating mitochondrial abnormalities assocd. with amyotrophic lateral sclerosis (ALS), the role of mitochondrial dysfunction in the disease onset and progression remains unknown.  The intrinsic mitochondrial apoptotic program is activated in the central nervous system of mouse models of ALS harboring mutant superoxide dismutase 1 protein.  This is assocd. with the release of cytochrome-c from the mitochondrial intermembrane space and mitochondrial swelling.  However, it is unclear if the obsd. mitochondrial changes are caused by the decreasing cellular viability or if these changes precede and actually trigger apoptosis.  This article discusses the current evidence for mitochondrial involvement in familial and sporadic ALS and concludes that mitochondria is likely to be both a trigger and a target in ALS and that their demise is a crit. step in the motor neuron death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_zr-rp7GijbVg90H21EOLACvtfcHk0lhz-ZKJpv7cnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFOmtbo%253D&md5=614f8c9b4330ea7f12c46c72f924aaa1</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1385%2FMN%3A33%3A2%3A113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FMN%253A33%253A2%253A113%26sid%3Dliteratum%253Aachs%26aulast%3DBacman%26aufirst%3DS.%2BR.%26aulast%3DBradley%26aufirst%3DW.%2BG.%26aulast%3DMoraes%26aufirst%3DC.%2BT.%26atitle%3DMitochondrial%2520involvement%2520in%2520amyotrophic%2520lateral%2520sclerosis%253A%2520trigger%2520or%2520target%26jtitle%3DMol.%2520Neurobiol.%26date%3D2006%26volume%3D33%26spage%3D113%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref212"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref212'); return false;" data-citation="" class="refNumLink">212</a></strong><div class="NLM_citation" id="cit212"><span><span class="NLM_contrib-group">Okado-Matsumoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridovich, I.</span><span> </span><span class="NLM_article-title">Amyotrophic lateral sclerosis: a proposed mechanism</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">9010</span><span class="NLM_x">–</span> <span class="NLM_lpage">9014</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=9010-9014&author=A.+Okado-Matsumotoauthor=I.+Fridovich&title=Amyotrophic+lateral+sclerosis%3A+a+proposed+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkado-Matsumoto%26aufirst%3DA.%26aulast%3DFridovich%26aufirst%3DI.%26atitle%3DAmyotrophic%2520lateral%2520sclerosis%253A%2520a%2520proposed%2520mechanism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D9010%26epage%3D9014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref213"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref213'); return false;" data-citation="" class="refNumLink">213</a></strong><div class="NLM_citation" id="cit213"><span><span class="NLM_contrib-group">Pasinelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belford, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lennon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacskai, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trotti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. H.,  Jr</span><span> </span><span class="NLM_article-title">Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=19-30&author=P.+Pasinelliauthor=M.+E.+Belfordauthor=N.+Lennonauthor=B.+J.+Bacskaiauthor=B.+T.+Hymanauthor=D.+Trottiauthor=R.+H.+Brown&title=Amyotrophic+lateral+sclerosis-associated+SOD1+mutant+proteins+bind+and+aggregate+with+Bcl-2+in+spinal+cord+mitochondria"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPasinelli%26aufirst%3DP.%26aulast%3DBelford%26aufirst%3DM.%2BE.%26aulast%3DLennon%26aufirst%3DN.%26aulast%3DBacskai%26aufirst%3DB.%2BJ.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DTrotti%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DR.%2BH.%26atitle%3DAmyotrophic%2520lateral%2520sclerosis-associated%2520SOD1%2520mutant%2520proteins%2520bind%2520and%2520aggregate%2520with%2520Bcl-2%2520in%2520spinal%2520cord%2520mitochondria%26jtitle%3DNeuron%26date%3D2004%26volume%3D43%26spage%3D19%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref214"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref214'); return false;" data-citation="" class="refNumLink">214</a></strong><div class="NLM_citation" id="cit214"><span><span class="NLM_contrib-group">Rothstein, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuncl, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clawson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornblath, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drachman, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pestronk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauch, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyle, J. T.</span><span> </span><span class="NLM_article-title">Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fana.410280106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=2375630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaK3MXksVOitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1990&pages=18-25&author=J.+D.+Rothsteinauthor=G.+Tsaiauthor=R.+W.+Kunclauthor=L.+Clawsonauthor=D.+R.+Cornblathauthor=D.+B.+Drachmanauthor=A.+Pestronkauthor=B.+L.+Stauchauthor=J.+T.+Coyle&title=Abnormal+excitatory+amino+acid+metabolism+in+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis</span></div><div class="casAuthors">Rothstein, Jeffrey D.; Tsai, Guochuan; Kuncl, Ralph W.; Clawson, Lora; Cornblath, David R.; Drachman, Daniel B.; Pestronk, Alan; Stauch, Barbara L.; Coyle, Joseph T.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-25</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">Recently, the excitatory amino acid neurotransmitter glutamate was implicated in the pathogenesis of a variety of chronic degenerative neurol. diseases in humans and animals.  This report described abnormalities in excitatory amino acids in the central nervous system of 18 patients with amyotrophic lateral sclerosis (ALS).  The concn. of the excitatory amino acids glutamate and aspartate in the cerebrospinal fluid were increased by 100-200% in patients with ALS.  Similarly, the concns. of the excitatory neuropeptide N-acetyl-aspartyl glutamate and its metabolite, N-acetyl-aspartate, were elevated 2-3-fold in the cerebrospinal fluid from the patients.  There was no relationship between amino acid concns. and duration of disease, clin. impairment, or patient age.  In the ventral horns of the cervical region of the spinal cord, levels of N-acetyl-aspartyl glutamate and N-acetyl-aspartate were decreased by 60% and 40%, resp., in 8 patients with ALS.  Choline acetyltransferase activity was also diminished by 35% in the ventral horn consistent with motor neuron loss.  It is concluded that excitatory amino acid metab. is altered in patients with ALS.  Based on neurodegenerative disease models, these changes may play a role in motor neuron loss in ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRX8VxT6HRubVg90H21EOLACvtfcHk0lhQoKtP_QOYIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXksVOitL8%253D&md5=b4e78be9359965fbf623e86df98248bd</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1002%2Fana.410280106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410280106%26sid%3Dliteratum%253Aachs%26aulast%3DRothstein%26aufirst%3DJ.%2BD.%26aulast%3DTsai%26aufirst%3DG.%26aulast%3DKuncl%26aufirst%3DR.%2BW.%26aulast%3DClawson%26aufirst%3DL.%26aulast%3DCornblath%26aufirst%3DD.%2BR.%26aulast%3DDrachman%26aufirst%3DD.%2BB.%26aulast%3DPestronk%26aufirst%3DA.%26aulast%3DStauch%26aufirst%3DB.%2BL.%26aulast%3DCoyle%26aufirst%3DJ.%2BT.%26atitle%3DAbnormal%2520excitatory%2520amino%2520acid%2520metabolism%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DAnn.%2520Neurol.%26date%3D1990%26volume%3D28%26spage%3D18%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref215"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref215'); return false;" data-citation="" class="refNumLink">215</a></strong><div class="NLM_citation" id="cit215"><span><span class="NLM_contrib-group">Rothstein, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Kammen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levey, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuncl, R. W.</span><span> </span><span class="NLM_article-title">Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fana.410380114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=7611729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaK2MXnt12lsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=73-84&author=J.+D.+Rothsteinauthor=M.+Van+Kammenauthor=A.+I.+Leveyauthor=L.+J.+Martinauthor=R.+W.+Kuncl&title=Selective+loss+of+glial+glutamate+transporter+GLT-1+in+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis</span></div><div class="casAuthors">Rothstein, Jeffrey D.; Van Kammen, Marleen; Levey, Allan I.; Martin, Lee J.; Kuncl, Ralph W.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-84</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Little, Brown</span>)
        </div><div class="casAbstract">The pathogenesis of sporadic amyotrophic lateral sclerosis (ALS) is unknown, but defects in synaptosomal high-affinity glutamate transport have been obsd.  In exptl. models, chronic loss of glutamate transport can produce a loss of motor neurons and, therefore, could contribute to the disease.  With the recent cloning of three glutamate transporters, i.e., EAAC1, GLT-1, and GLAST, it has become possible to det. if the loss of glutamate transport in ALS is subtype specific.  We developed C-terminal, antioligopeptide antibodies that were specific for each glutamate transporter.  EAAC1 is selective for neurons, while GLT-1 and GLAST are selective for astroglia.  Tissue from various brain regions of ALS patients and controls were examd. by immunoblot or immunocytochem. methods for each transporter subtype.  All tissue was matched for age and postmortem delay.  GLT-1 immunoreactive protein was severely decreased in ALS, both in motor cortex (71% decrease compared with control) and in spinal cord.  In approx. a quarter of the ALS motor cortex specimens, the loss of GLT-1 protein (90% decrease from control) was dramatic.  By contrast, there was only a modest loss (20% decrease from control) of immunoreactive protein EAAC1 in ALS motor cortex, and there was no appreciable change in GLAST.  The minor loss of EAAC1 could be secondary to loss of cortical motor neurons.  As a comparison, glial fibrillary acidic protein, which is selectively localized to astroglia, was not changed in ALS motor cortex.  Because there is no loss of astroglia in ALS, the dramatic abnormalities in GLT-1 could reflect a primary defect in GLT-1 protein, a secondary loss due to down regulation, or other toxic processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8oaNq-rMF6rVg90H21EOLACvtfcHk0lh4IsPhr4oU-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnt12lsbw%253D&md5=f3d58fa817c3adb6e9204b68419d29d5</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1002%2Fana.410380114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410380114%26sid%3Dliteratum%253Aachs%26aulast%3DRothstein%26aufirst%3DJ.%2BD.%26aulast%3DVan%2BKammen%26aufirst%3DM.%26aulast%3DLevey%26aufirst%3DA.%2BI.%26aulast%3DMartin%26aufirst%3DL.%2BJ.%26aulast%3DKuncl%26aufirst%3DR.%2BW.%26atitle%3DSelective%2520loss%2520of%2520glial%2520glutamate%2520transporter%2520GLT-1%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DAnn.%2520Neurol.%26date%3D1995%26volume%3D38%26spage%3D73%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref216"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref216'); return false;" data-citation="" class="refNumLink">216</a></strong><div class="NLM_citation" id="cit216"><span><span class="NLM_contrib-group">Rothstein, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuncl, R. W.</span><span> </span><span class="NLM_article-title">Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">1464</span><span class="NLM_x">–</span> <span class="NLM_lpage">1468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1056%2FNEJM199205283262204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=1349424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADyaK383ksVejug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=1992&pages=1464-1468&author=J.+D.+Rothsteinauthor=L.+J.+Martinauthor=R.+W.+Kuncl&title=Decreased+glutamate+transport+by+the+brain+and+spinal+cord+in+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis</span></div><div class="casAuthors">Rothstein J D; Martin L J; Kuncl R W</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1464-8</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND:  Amyotrophic lateral sclerosis (ALS) is a chronic degenerative neurologic disorder characterized by the death of motor neurons in the cerebral cortex and spinal cord.  Recent studies have suggested that the metabolism of glutamate, a potentially neurotoxic amino acid, is abnormal in patients with ALS.  We hypothesized that the high-affinity glutamate transporter is the site of the defect.  METHODS:  We measured high-affinity, sodium-dependent glutamate transport in synaptosomes from neural tissue obtained from 13 patients with ALS, 17 patients with no neurologic disease, and 27 patients with other neuro-degenerative diseases (Alzheimer's disease in 15 patients and Huntington's disease in 12 patients).  The groups were comparable with respect to age and the interval between death and autopsy.  Synaptosomes were prepared from spinal cord, motor cortex, sensory cortex, visual cortex, striatum, and hippocampus.  We also measured sodium-dependent transport of gamma-aminobutyric acid and phenylalanine in the synaptosomal preparations.  RESULTS:  In patients with ALS, there was a marked decrease in the maximal velocity of transport for high-affinity glutamate uptake in synaptosomes from spinal cord (-59 percent, P less than 0.001), motor cortex (-70 percent, P less than 0.001), and somatosensory cortex (-39 percent, P less than 0.05), but not in those from visual cortex, striatum, or hippocampus.  The affinity of the transporter for glutamate was not altered.  No abnormalities in glutamate transport were found in synaptosomes from patients with other chronic neurodegenerative disorders.  The transport of gamma-aminobutyric acid and phenylalanine was normal in patients with ALS.  CONCLUSIONS:  ALS is associated with a defect in high-affinity glutamate transport that has disease, region, and chemical specificity.  Defects in the clearance of extracellular glutamate because of a faulty transporter could lead to neurotoxic levels of extracellular glutamate and thus be pathogenic in ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSb-TqizNGf3TQLBVDQn4bCfW6udTcc2eblDnp4gDHFWrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK383ksVejug%253D%253D&md5=ef942d464aa496ae655355af27de2e3a</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1056%2FNEJM199205283262204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199205283262204%26sid%3Dliteratum%253Aachs%26aulast%3DRothstein%26aufirst%3DJ.%2BD.%26aulast%3DMartin%26aufirst%3DL.%2BJ.%26aulast%3DKuncl%26aufirst%3DR.%2BW.%26atitle%3DDecreased%2520glutamate%2520transport%2520by%2520the%2520brain%2520and%2520spinal%2520cord%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1992%26volume%3D326%26spage%3D1464%26epage%3D1468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref217"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref217'); return false;" data-citation="" class="refNumLink">217</a></strong><div class="NLM_citation" id="cit217"><span><span class="NLM_contrib-group">Alexianu, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohamed, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Bella, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appel, S. H.</span><span> </span><span class="NLM_article-title">The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">846</span><span class="NLM_x">–</span> <span class="NLM_lpage">858</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fana.410360608" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=7998770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaK2MXjsVehsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1994&pages=846-858&author=M.+E.+Alexianuauthor=B.+K.+Hoauthor=A.+H.+Mohamedauthor=V.+La+Bellaauthor=R.+G.+Smithauthor=S.+H.+Appel&title=The+role+of+calcium-binding+proteins+in+selective+motoneuron+vulnerability+in+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit217R"><div class="casContent"><span class="casTitleNuber">217</span><div class="casTitle"><span class="NLM_cas:atitle">The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis</span></div><div class="casAuthors">Alexianu, Maria E.; Ho, Bao-Kuang; Mohamed, A. Habib; La Bella, Vincenzo; Smith, R. Glenn; Appel, Stanley H.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">846-58</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">The factors contributing to selective motoneuron loss in amyotrophic lateral sclerosis (ALS) remain undefined.  To investigate whether calcium-binding proteins contribute to selective motoneuron vulnerability in ALS, the authors compared calbindin-D28K and parvalbumin immunoreactivity in motoneuron populations in human ALS, and in a ventral spinal cord hybrid cell line selectively vulnerable to the cytotoxic effects of ALS IgG.  In human autopsy specimens, immunoreactive calbindin-D28K and parvalbumin were absent in motoneuron populations lost early in ALS (i.e., cortical and spinal motoneurons, lower cranial nerve motoneurons), while motoneurons damaged late or infrequently in the disease (i.e., Onuf's nucleus motoneurons, oculomotor, trochlear, and abducens nerve neurons) expressed markedly higher levels of immunoreactive calbindin-D28K and/or parvalbumin.  Motoneuron-neuroblastoma VSC 4.1 hybrid cells lost immunoreactive calbindin-D28K and parvalbumin following dibutyryl-cAMP-induced differentiation and were killed by IgG from ALS patients.  Undifferentiated calbindin/parvalbumin-reactive VSC 4.1 cells were not killed, nor were other cell lines expressing high levels of calbindin-D28K and parvalbumin immunoreactivity (substantia nigra-neuroblastoma hybrid cells and N18TG2 neuroblastoma parent cells).  These studies suggest that decreased calbindin-D28K and parvalbumin immunoreactivity may help explain the selective vulnerability of motoneurons in ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5FDzYpk22RrVg90H21EOLACvtfcHk0lhUDMJ0_mSZAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjsVehsrw%253D&md5=d89e6445c9c145a75151772471eb2796</span></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1002%2Fana.410360608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410360608%26sid%3Dliteratum%253Aachs%26aulast%3DAlexianu%26aufirst%3DM.%2BE.%26aulast%3DHo%26aufirst%3DB.%2BK.%26aulast%3DMohamed%26aufirst%3DA.%2BH.%26aulast%3DLa%2BBella%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DAppel%26aufirst%3DS.%2BH.%26atitle%3DThe%2520role%2520of%2520calcium-binding%2520proteins%2520in%2520selective%2520motoneuron%2520vulnerability%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DAnn.%2520Neurol.%26date%3D1994%26volume%3D36%26spage%3D846%26epage%3D858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref218"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref218'); return false;" data-citation="" class="refNumLink">218</a></strong><div class="NLM_citation" id="cit218"><span><span class="NLM_contrib-group">Bruijn, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cudkowicz, M.</span><span> </span><span class="NLM_article-title">Therapeutic targets for amyotrophic lateral sclerosis: current treatments and prospects for more effective therapies</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1586%2F14737175.6.3.417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16533145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjs1yjt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=417-428&author=L.+I.+Bruijnauthor=M.+Cudkowicz&title=Therapeutic+targets+for+amyotrophic+lateral+sclerosis%3A+current+treatments+and+prospects+for+more+effective+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targets for amyotrophic lateral sclerosis: current treatments and prospects for more effective therapies</span></div><div class="casAuthors">Bruijn, Lucie I.; Cudkowicz, Merit</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">417-428</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Although amyotrophic lateral sclerosis (ALS) was described more than 130 years ago, the cause(s) of most cases of this adult motor neuron disease remains a mystery.  With the discovery of mutations in one gene (Cu/Zn superoxide dismutase) as a primary cause of some forms of ALS, model systems have been developed that have helped us begin to understand mechanisms involved in motor neuron death and enabled testing of potential new therapies.  Several other genes have been implicated as risk factors in motor neuron diseases, including neurofilaments, cytoplasmic dynein and dynactin, vascular endothelial growth factor, and angiogenin.  With advances in the basic research of the disease, many hypotheses accounting for motor neuron death are being explored, including loss of trophic support, protein mishandling, mitochondrial dysfunction, excitotoxicity, axonal abnormalities and inflammation.  Many of these mechanisms are the focus of research in other neurodegenerative disorders, such as Parkinson's, Alzheimer's and Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1He-j3O0w1LVg90H21EOLACvtfcHk0lhUDMJ0_mSZAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjs1yjt7o%253D&md5=916d3cef60e529d8da7a5bc4c3bebaff</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.1586%2F14737175.6.3.417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.6.3.417%26sid%3Dliteratum%253Aachs%26aulast%3DBruijn%26aufirst%3DL.%2BI.%26aulast%3DCudkowicz%26aufirst%3DM.%26atitle%3DTherapeutic%2520targets%2520for%2520amyotrophic%2520lateral%2520sclerosis%253A%2520current%2520treatments%2520and%2520prospects%2520for%2520more%2520effective%2520therapies%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2006%26volume%3D6%26spage%3D417%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref219"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref219'); return false;" data-citation="" class="refNumLink">219</a></strong><div class="NLM_citation" id="cit219"><span><span class="NLM_contrib-group">Turner, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parton, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leigh, P. N.</span><span> </span><span class="NLM_article-title">Clinical trials in ALS: an overview</span> <span class="citation_source-journal">Semin. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1055%2Fs-2001-15262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=11442325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADC%252BD38%252FhvVymtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=167-175&author=M.+R.+Turnerauthor=M.+J.+Partonauthor=P.+N.+Leigh&title=Clinical+trials+in+ALS%3A+an+overview"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit219R"><div class="casContent"><span class="casTitleNuber">219</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical trials in ALS: an overview</span></div><div class="casAuthors">Turner M R; Parton M J; Leigh P N</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in neurology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-75</span>
        ISSN:<span class="NLM_cas:issn">0271-8235</span>.
    </div><div class="casAbstract">Clinical trials in amyotrophic lateral sclerosis (ALS) have been conducted for over half a century now and have incorporated a wide variety of drugs.  Most of these trials have had negative results and a cure remains elusive.  The explosion in our understanding of molecular biology and parallel developments in clinical epidemiology have opened up a vast number of novel therapeutic strategies.  However, advances in statistical analysis, computing, and global communications have also put greater pressure on scientific investigators to improve the design and implementation of clinical trials so that they permit rigorous testing of hypotheses within a solid ethical framework.  This article documents the first published trial for all drugs tried clinically in the treatment of ALS, focusing in more detail on the large, multicenter trials of recent years, namely those involving riluzole, ciliary neurotrophic factor, insulin-like growth factor-I, brain-derived neurotrophic factor, and SR57746A.  The problems in the design of trials in ALS are discussed, including the selection of end points and surrogate markers of disease progression, and the major parameters in ALS assessment are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSrRzVfxY9I0DdblLE_E9PWfW6udTcc2easaFm69Y5oK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38%252FhvVymtQ%253D%253D&md5=48b77e678bcbdc0179a38d8047d001fa</span></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.1055%2Fs-2001-15262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2001-15262%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DM.%2BR.%26aulast%3DParton%26aufirst%3DM.%2BJ.%26aulast%3DLeigh%26aufirst%3DP.%2BN.%26atitle%3DClinical%2520trials%2520in%2520ALS%253A%2520an%2520overview%26jtitle%3DSemin.%2520Neurol.%26date%3D2001%26volume%3D21%26spage%3D167%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref220"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref220'); return false;" data-citation="" class="refNumLink">220</a></strong><div class="NLM_citation" id="cit220"><span><span class="NLM_contrib-group">Carri, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grignaschi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bendotti, C.</span><span> </span><span class="NLM_article-title">Targets in ALS: designing multidrug therapies</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=267-273&author=M.+T.+Carriauthor=G.+Grignaschiauthor=C.+Bendotti&title=Targets+in+ALS%3A+designing+multidrug+therapies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarri%26aufirst%3DM.%2BT.%26aulast%3DGrignaschi%26aufirst%3DG.%26aulast%3DBendotti%26aufirst%3DC.%26atitle%3DTargets%2520in%2520ALS%253A%2520designing%2520multidrug%2520therapies%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2006%26volume%3D27%26spage%3D267%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref221"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref221'); return false;" data-citation="" class="refNumLink">221</a></strong><div class="NLM_citation" id="cit221"><span><span class="NLM_contrib-group">Kriz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowing, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julien, J. P.</span><span> </span><span class="NLM_article-title">Efficient three-drug cocktail for disease induced by mutant superoxide dismutase</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">436</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fana.10500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=12666110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtFGitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2003&pages=429-436&author=J.+Krizauthor=G.+Gowingauthor=J.+P.+Julien&title=Efficient+three-drug+cocktail+for+disease+induced+by+mutant+superoxide+dismutase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit221R"><div class="casContent"><span class="casTitleNuber">221</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient three-drug cocktail for disease induced by mutant superoxide dismutase</span></div><div class="casAuthors">Kriz, Jasna; Gowing, Genevieve; Julien, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">429-436</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">There is currently no effective pharmacol. treatment for amyotrophic lateral sclerosis (ALS).  Because evidence suggests that multiple pathways may contribute to ALS pathogenesis, we tested in a mouse model of ALS (SOD1G37R mice) a combination approach consisting of three drugs for distinct targets in the complex pathway to neuronal death: minocycline, an antimicrobial agent that inhibits microglial activation, riluzole, a glutamate antagonist, and nimodipine, a voltage-gated calcium channel blocker.  The efficacy of this three-drug cocktail was remarkable when administered in the diet from late presymptomatic stage (8-9 mo).  It delayed the onset of disease, slowed the loss of muscle strength, and increased the av. longevity of SOD1G37R mice by 6 wk.  The protective effect of the treatment was corroborated by the reduced immunodetection signals for markers of gliosis and neurodegeneration in the spinal cord of SOD1G37R mice.  These results indicate that such three-drug combination may represent an effective strategy for ALS treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0XMOUSREXlbVg90H21EOLACvtfcHk0lhUDMJ0_mSZAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtFGitbg%253D&md5=9ee13296465b5f87a8c3024c10fa787b</span></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=10.1002%2Fana.10500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.10500%26sid%3Dliteratum%253Aachs%26aulast%3DKriz%26aufirst%3DJ.%26aulast%3DGowing%26aufirst%3DG.%26aulast%3DJulien%26aufirst%3DJ.%2BP.%26atitle%3DEfficient%2520three-drug%2520cocktail%2520for%2520disease%2520induced%2520by%2520mutant%2520superoxide%2520dismutase%26jtitle%3DAnn.%2520Neurol.%26date%3D2003%26volume%3D53%26spage%3D429%26epage%3D436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref222"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref222'); return false;" data-citation="" class="refNumLink">222</a></strong><div class="NLM_citation" id="cit222"><span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, W.</span><span> </span><span class="NLM_article-title">Neuroprotective effects of (−)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1263</span><span class="NLM_x">–</span> <span class="NLM_lpage">1269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1007%2Fs11064-006-9166-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17021948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKmtr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=1263-1269&author=Z.+Xuauthor=S.+Chenauthor=X.+Liauthor=G.+Luoauthor=L.+Liauthor=W.+Le&title=Neuroprotective+effects+of+%28%E2%88%92%29-epigallocatechin-3-gallate+in+a+transgenic+mouse+model+of+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit222R"><div class="casContent"><span class="casTitleNuber">222</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective Effects of (-)-Epigallocatechin-3-gallate in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis</span></div><div class="casAuthors">Xu, Zhihao; Chen, Sheng; Li, Xuping; Luo, Guangrui; Li, Liang; Le, Weidong</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1263-1269</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The purpose of this study is to evaluate neuroprotective effects of (-)-Epigallocatechin-3-gallate (EGCG) in a transgenic mouse model of Amyotrophic lateral sclerosis (ALS).  SOD1-G93A transgenic mice and wild-type mice were randomly divided into EGCG-treated groups (10 mg/kg, p.o) and vehicle-treated control groups.  Rotarod measurement was performed to assess the motor function of mice starting at the age of 70 days.  Nissl staining to examine the no. of motor neurons and CD11b immunohistochem. staining to evaluate activation of microglia in the lumbar spinal cords were conducted at the age of 120 days.  In addn., for further observation of regulation of cell signaling pathways by EGCG, we used immunohistochem. anal. for nuclear factor kappa B (NF-κB) and cleaved caspase-3 as well as western blot anal. to det. the expression of nitric oxide synthase (iNOS) and NF-κB in the spinal cord.  This study demonstrated that oral administration of EGCG beginning from a pre-symptomatic stage significantly delayed the onset of disease, and extended life span.  Furthermore, EGCG-treated transgenic mice showed increased no. of motor neurons, diminished microglial activation, reduced immunohistochem. reaction of NF-κB and cleaved caspase-3 as well as reduced protein level of iNOS and NF-κB in the spinal cords.  In conclusion, this study provides further evidences that EGCG has multifunctional therapeutic effects in the mouse model of ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhxjL14Q6Bo7Vg90H21EOLACvtfcHk0liOEpu99lVwDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKmtr7L&md5=4fba17c226be1fdda5f22d02b227daa3</span></div><a href="/servlet/linkout?suffix=cit222&amp;dbid=16384&amp;doi=10.1007%2Fs11064-006-9166-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-006-9166-z%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLe%26aufirst%3DW.%26atitle%3DNeuroprotective%2520effects%2520of%2520%2528%25E2%2588%2592%2529-epigallocatechin-3-gallate%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DNeurochem.%2520Res.%26date%3D2006%26volume%3D31%26spage%3D1263%26epage%3D1269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref223"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref223'); return false;" data-citation="" class="refNumLink">223</a></strong><div class="NLM_citation" id="cit223"><span><span class="NLM_contrib-group">Nagle, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y. D.</span><span> </span><span class="NLM_article-title">Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives</span> <span class="citation_source-journal">Phytochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1849</span><span class="NLM_x">–</span> <span class="NLM_lpage">1855</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.phytochem.2006.06.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16876833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XovVSisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=1849-1855&author=D.+G.+Nagleauthor=D.+Ferreiraauthor=Y.+D.+Zhou&title=Epigallocatechin-3-gallate+%28EGCG%29%3A+chemical+and+biomedical+perspectives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit223R"><div class="casContent"><span class="casTitleNuber">223</span><div class="casTitle"><span class="NLM_cas:atitle">Epigallocatechin-3-gallate (EGCG): Chemical and biomedical perspectives</span></div><div class="casAuthors">Nagle, Dale G.; Ferreira, Daneel; Zhou, Yu-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry (Elsevier)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1849-1855</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The compd. (-)-epigallocatechin-3-gallate (EGCG) is the major catechin found in green tea [Camellia sinensis L. Ktze. (Theaceae)].  This polyphenolic compd. and several related catechins are believed to be responsible for the health benefits assocd. with the consumption of green tea.  The potential health benefits ascribed to green tea and EGCG include antioxidant effects, cancer chemoprevention, improving cardiovascular health, enhancing wt. loss, protecting the skin from the damage caused by ionizing radiation, and others.  The compd. EGCG has been shown to regulate dozens of disease-specific mol. targets.  Many of these mol. targets are only affected by concns. of EGCG that are far above the levels achieved by either drinking green tea or consuming moderate doses of green tea ext.-based dietary supplements.  In spite of this, well-designed double-blinded controlled clin. studies have recently demonstrated the efficacy of green tea exts. and purified EGCG products in patients.  Therefore, this review highlights results from what the authors believe to be some of the most clin. significant recent studies and describes current developments in the stereoselective total synthesis of EGCG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoURj2mtMid77Vg90H21EOLACvtfcHk0liOEpu99lVwDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovVSisL4%253D&md5=88777ac2cfe6a65f09a74db2cffe0386</span></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=10.1016%2Fj.phytochem.2006.06.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytochem.2006.06.020%26sid%3Dliteratum%253Aachs%26aulast%3DNagle%26aufirst%3DD.%2BG.%26aulast%3DFerreira%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DY.%2BD.%26atitle%3DEpigallocatechin-3-gallate%2520%2528EGCG%2529%253A%2520chemical%2520and%2520biomedical%2520perspectives%26jtitle%3DPhytochemistry%26date%3D2006%26volume%3D67%26spage%3D1849%26epage%3D1855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref224"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref224'); return false;" data-citation="" class="refNumLink">224</a></strong><div class="NLM_citation" id="cit224"><span><span class="NLM_contrib-group">Streit, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conde, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fendrick, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flanary, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariani, C. L.</span><span> </span><span class="NLM_article-title">Role of microglia in the central nervous systemʼs immune response</span> <span class="citation_source-journal">Neurol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16197805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Wkt7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2005&pages=685-691&author=W.+J.+Streitauthor=J.+R.+Condeauthor=S.+E.+Fendrickauthor=B.+E.+Flanaryauthor=C.+L.+Mariani&title=Role+of+microglia+in+the+central+nervous+system%CA%BCs+immune+response"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit224R"><div class="casContent"><span class="casTitleNuber">224</span><div class="casTitle"><span class="NLM_cas:atitle">Role of microglia in the central nervous system's immune response</span></div><div class="casAuthors">Streit, Wolfgang J.; Conde, Jessica R.; Fendrick, Sarah E.; Flanary, Barry E.; Mariani, Christopher L.</div><div class="citationInfo"><span class="NLM_cas:title">Neurological Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">685-691</span>CODEN:
                <span class="NLM_cas:coden">NRESDZ</span>;
        ISSN:<span class="NLM_cas:issn">0161-6412</span>.
    
            (<span class="NLM_cas:orgname">Maney Publishing</span>)
        </div><div class="casAbstract">Microglial cells comprise a network of endogenous immunocompetent cells that pervade the brain and spinal cord.  The primary function of this system is to provide continuous surveillance of the parenchyma and protect the central nervous system (CNS) during injury and disease.  Here we discuss the involvement of microglia during brain aging and aging-related neurodegenerative disease, i.e. Alzheimer's disease, and briefly summarize their possible roles in amyotrophic lateral sclerosis (ALS).  In addn., we provide an overview of the neuroinflammation assocd. with primary brain tumors and how microglial tumor cytotoxicity could be targeted for immunotherapeutic approaches designed to treat these lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5CYtfyJhGhLVg90H21EOLACvtfcHk0liOEpu99lVwDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Wkt7bI&md5=e168e449e1fe19229ef3f19c89ec8cea</span></div><a href="/servlet/linkout?suffix=cit224&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStreit%26aufirst%3DW.%2BJ.%26aulast%3DConde%26aufirst%3DJ.%2BR.%26aulast%3DFendrick%26aufirst%3DS.%2BE.%26aulast%3DFlanary%26aufirst%3DB.%2BE.%26aulast%3DMariani%26aufirst%3DC.%2BL.%26atitle%3DRole%2520of%2520microglia%2520in%2520the%2520central%2520nervous%2520system%25CA%25BCs%2520immune%2520response%26jtitle%3DNeurol.%2520Res.%26date%3D2005%26volume%3D27%26spage%3D685%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref225"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref225'); return false;" data-citation="" class="refNumLink">225</a></strong><div class="NLM_citation" id="cit225"><span><span class="NLM_contrib-group">Weydt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, T.</span><span> </span><span class="NLM_article-title">Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosis</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=527-531&author=P.+Weydtauthor=T.+Moller&title=Neuroinflammation+in+the+pathogenesis+of+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit225&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeydt%26aufirst%3DP.%26aulast%3DMoller%26aufirst%3DT.%26atitle%3DNeuroinflammation%2520in%2520the%2520pathogenesis%2520of%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DNeuroReport%26date%3D2005%26volume%3D16%26spage%3D527%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref226"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref226'); return false;" data-citation="" class="refNumLink">226</a></strong><div class="NLM_citation" id="cit226"><span><span class="NLM_contrib-group">Ji, H.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-Y.</span><span> </span><span class="NLM_article-title">Theoretical evaluation of flavonoids as multipotent agents to combat Alzheimerʼs disease</span> <span class="citation_source-journal">J. Mol. Struct.: THEOCHEM</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">767</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.theochem.2006.04.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVGnt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=767&publication_year=2006&pages=3-9&author=H.-F.+Jiauthor=H.-Y.+Zhang&title=Theoretical+evaluation+of+flavonoids+as+multipotent+agents+to+combat+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit226R"><div class="casContent"><span class="casTitleNuber">226</span><div class="casTitle"><span class="NLM_cas:atitle">Theoretical evaluation of flavonoids as multipotent agents to combat Alzheimer's disease</span></div><div class="casAuthors">Ji, Hong-Fang; Zhang, Hong-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Structure: THEOCHEM</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">767</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-9</span>CODEN:
                <span class="NLM_cas:coden">THEODJ</span>;
        ISSN:<span class="NLM_cas:issn">0166-1280</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">As multiple pathogenetic factors, including aggregated amyloid-β peptide and tau protein, excessive transition metals, oxidative stress and reduced acetylcholine level, have been implicated in Alzheimer's disease (AD), multipotent agents aiming at diverse targets are expected to act better than the single-target-aiming counterparts in the fight against AD.  Among the potential multipotent agents, natural products, esp. flavonoids (including xanthones), have been given much attention.  To explore to what extent the desired multiple pharmacol. effects can be combined into one flavonoid mol., we examd. the structural requirements of flavonoids (including xanthones) as inhibitors of monoamine oxidase (including isoenzymes A and B), acetylcholinesterase and/or butyrylcholinesterase.  In combination with the known structure-activity relationships of flavonoids as reactive oxygen species scavengers and metal chelators, we provide a theor. evaluation of flavonoids (including xanthones) as multipotent agents to combat AD, which is of great significance to directing the screening of novel AD-modifying drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqLJDStXLf27Vg90H21EOLACvtfcHk0lgyRt7sXMqB8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVGnt74%253D&md5=9c2f716c5b94ad2e307c95ffa0c11ffa</span></div><a href="/servlet/linkout?suffix=cit226&amp;dbid=16384&amp;doi=10.1016%2Fj.theochem.2006.04.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.theochem.2006.04.041%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DH.-F.%26aulast%3DZhang%26aufirst%3DH.-Y.%26atitle%3DTheoretical%2520evaluation%2520of%2520flavonoids%2520as%2520multipotent%2520agents%2520to%2520combat%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DJ.%2520Mol.%2520Struct.%253A%2520THEOCHEM%26date%3D2006%26volume%3D767%26spage%3D3%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref227"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref227'); return false;" data-citation="" class="refNumLink">227</a></strong><div class="NLM_citation" id="cit227"><span><span class="NLM_contrib-group">Mandel, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avramovich-Tirosh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reznichenko, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway</span> <span class="citation_source-journal">Neurosignals</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1159%2F000085385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15956814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlt1Smsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=46-60&author=S.+A.+Mandelauthor=Y.+Avramovich-Tiroshauthor=L.+Reznichenkoauthor=H.+Zhengauthor=O.+Weinrebauthor=T.+Amitauthor=M.+B.+Youdim&title=Multifunctional+activities+of+green+tea+catechins+in+neuroprotection.+Modulation+of+cell+survival+genes%2C+iron-dependent+oxidative+stress+and+PKC+signaling+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit227R"><div class="casContent"><span class="casTitleNuber">227</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional Activities of Green Tea Catechins in Neuroprotection</span></div><div class="casAuthors">Mandel, Silvia A.; Avramovich-Tirosh, Yael; Reznichenko, Lydia; Zheng, Hailin; Weinreb, Orly; Amit, Tamar; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Neurosignals</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">46-60</span>CODEN:
                <span class="NLM_cas:coden">NEURIQ</span>;
        ISSN:<span class="NLM_cas:issn">1424-862X</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  Many lines of evidence suggest that oxidative stress resulting in reactive oxygen species (ROS) generation and inflammation play a pivotal role in the age-assocd. cognitive decline and neuronal loss in neurodegenerative diseases including Alzheimer's (AD), Parkinson's (PD) and Huntington's diseases.  One cardinal chem. pathol. obsd. in these disorders is the accumulation of iron at sites where the neurons die.  The buildup of an iron gradient in conjunction with ROS (superoxide, hydroxyl radical and nitric oxide) are thought to constitute a major trigger in neuronal toxicity and demise in all these diseases.  Thus, promising future treatment of neurodegenerative diseases and aging depends on availability of effective brain permeable, iron-chelatable/radical scavenger neuroprotective drugs that would prevent the progression of neurodegeneration.  Tea flavonoids (catechins) have been reported to possess potent iron-chelating, radical-scavenging and anti-inflammatory activities and to protect neuronal death in a wide array of cellular and animal models of neurol. diseases.  Recent studies have indicated that in addn. to the known antioxidant activity of catechins, other mechanisms such as modulation of signal transduction pathways, cell survival/death genes and mitochondrial function, contribute significantly to the induction of cell viability.  This review will focus on the multifunctional properties of green tea and its major component (-)-epigallocatechin-3-gallate (EGCG) and their ability to induce neuroprotection and neurorescue in vitro and in vivo.  In particular, their transitional metal (iron and copper) chelating property and inhibition of oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPpE1q4N9CerVg90H21EOLACvtfcHk0lgyRt7sXMqB8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlt1Smsr0%253D&md5=98fc92ac5ece333afa15e5197364b2df</span></div><a href="/servlet/linkout?suffix=cit227&amp;dbid=16384&amp;doi=10.1159%2F000085385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000085385%26sid%3Dliteratum%253Aachs%26aulast%3DMandel%26aufirst%3DS.%2BA.%26aulast%3DAvramovich-Tirosh%26aufirst%3DY.%26aulast%3DReznichenko%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DWeinreb%26aufirst%3DO.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DMultifunctional%2520activities%2520of%2520green%2520tea%2520catechins%2520in%2520neuroprotection.%2520Modulation%2520of%2520cell%2520survival%2520genes%252C%2520iron-dependent%2520oxidative%2520stress%2520and%2520PKC%2520signaling%2520pathway%26jtitle%3DNeurosignals%26date%3D2005%26volume%3D14%26spage%3D46%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref228"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref228'); return false;" data-citation="" class="refNumLink">228</a></strong><div class="NLM_citation" id="cit228"><span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span> </span><span class="NLM_article-title">Estrogen, beta-amyloid metabolism/trafficking, and Alzheimerʼs disease</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1089</span><span class="NLM_x">, </span> <span class="NLM_fpage">324</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1089&publication_year=2006&pages=324-342&author=H.+Xuauthor=R.+Wangauthor=Y.+W.+Zhangauthor=X.+Zhang&title=Estrogen%2C+beta-amyloid+metabolism%2Ftrafficking%2C+and+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit228&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DY.%2BW.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DEstrogen%252C%2520beta-amyloid%2520metabolism%252Ftrafficking%252C%2520and%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2006%26volume%3D1089%26spage%3D324%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref229"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref229'); return false;" data-citation="" class="refNumLink">229</a></strong><div class="NLM_citation" id="cit229"><span><span class="NLM_contrib-group">Schmeer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kretz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isenmann, S.</span><span> </span><span class="NLM_article-title">Statin-mediated protective effects in the central nervous system: general mechanisms and putative role of stress proteins</span> <span class="citation_source-journal">Restor. Neurol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16720944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28Xks1Cgtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=79-95&author=C.+Schmeerauthor=A.+Kretzauthor=S.+Isenmann&title=Statin-mediated+protective+effects+in+the+central+nervous+system%3A+general+mechanisms+and+putative+role+of+stress+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit229R"><div class="casContent"><span class="casTitleNuber">229</span><div class="casTitle"><span class="NLM_cas:atitle">Statin-mediated protective effects in the central nervous system: General mechanisms and putative role of stress proteins</span></div><div class="casAuthors">Schmeer, Christian; Kretz, Alexandra; Isenmann, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Restorative Neurology and Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">79-95</span>CODEN:
                <span class="NLM_cas:coden">RNNEEL</span>;
        ISSN:<span class="NLM_cas:issn">0922-6028</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Purpose: The 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase inhibitors, or "statins", are used as cholesterol-lowering agents worldwide.  This review, focused on recent exptl. and clin. data, summarizes general mechanisms of statin actions underlying neuroprotective effects in the central nervous system (CNS) and presents evidence for putative mechanisms involving heat shock proteins and the survival-related PI-3K/Akt pathway that may be beneficial for the treatment of neurol. disorders.  Methods: We carried out a med-line search on statin actions, with respect to biochem. pathways and signal transduction on the one hand, and clin. studies in neurol. and retinal diseases on the other hand.  Novel exptl. data obtained in a rat model of axonal CNS injury were also included.  Results: Statins exert multiple effects on endothelial function, cell proliferation, inflammatory response, immunol. reactions, platelet function, and lipid oxidn.  These "pleiotropic actions" are independent of cholesterol lowering and appear to be beneficial in the context of brain injury.  Several mechanisms of statin actions underlying neuroprotective effects may also involve heat shock proteins and the survival-related PI-3K/Akt pathway.  Conclusions: Available data suggest that statins may be of potential therapeutic use in a variety of diseases of the CNS including ischemic stroke, Alzheimer's disease, multiple sclerosis and some forms of retinal and eye diseases.  Before general recommendations can be made and specific therapeutic approaches can be developed, more reliable clin. data and studies are required, and possible side effects must be carefully evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6Jk3l14yr2rVg90H21EOLACvtfcHk0lhNTvLKfKg4HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xks1Cgtb8%253D&md5=92827c63de07d1c12025f9329e86aabe</span></div><a href="/servlet/linkout?suffix=cit229&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchmeer%26aufirst%3DC.%26aulast%3DKretz%26aufirst%3DA.%26aulast%3DIsenmann%26aufirst%3DS.%26atitle%3DStatin-mediated%2520protective%2520effects%2520in%2520the%2520central%2520nervous%2520system%253A%2520general%2520mechanisms%2520and%2520putative%2520role%2520of%2520stress%2520proteins%26jtitle%3DRestor.%2520Neurol.%2520Neurosci.%26date%3D2006%26volume%3D24%26spage%3D79%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref230"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref230'); return false;" data-citation="" class="refNumLink">230</a></strong><div class="NLM_citation" id="cit230"><span><span class="NLM_contrib-group">Barger, S. W.</span><span> </span><span class="NLM_article-title">Cooperative ideas about cooperative strategies</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1035</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1035&publication_year=2004&pages=350-353&author=S.+W.+Barger&title=Cooperative+ideas+about+cooperative+strategies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit230&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarger%26aufirst%3DS.%2BW.%26atitle%3DCooperative%2520ideas%2520about%2520cooperative%2520strategies%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2004%26volume%3D1035%26spage%3D350%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref231"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref231'); return false;" data-citation="" class="refNumLink">231</a></strong><div class="NLM_citation" id="cit231"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">The physicochemical challenges of designing multiple ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4961</span><span class="NLM_x">–</span> <span class="NLM_lpage">4970</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFejtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4961-4970&author=R.+Morphyauthor=Z.+Rankovic&title=The+physicochemical+challenges+of+designing+multiple+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit231R"><div class="casContent"><span class="casTitleNuber">231</span><div class="casTitle"><span class="NLM_cas:atitle">The Physicochemical Challenges of Designing Multiple Ligands</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4961-4970</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compds. designed to bind more than one target can provide a therapeutic benefit relative to highly target-selective ligands.  The physicochem. properties of designed multiple ligands were found to be less druglike than those for preclin. compds. in general.  These properties are controlled by the superfamily to which the targets belong and the lead discovery strategy that was followed.  The properties for peptide G-protein-coupled receptor (GPCR) ligands were the least favorable for oral delivery, whereas transporter, monoamine GPCR, and oxidase ligands were the most druglike.  The lead discovery strategy, framework combination or screening, exerts a profound influence on the property values.  Combining the frameworks from two selective ligands often results in large, complex dual ligands, but druglike ligands can be achieved if the degree of framework overlap is maximized and the size of the selective ligands minimized.  For some target combinations, a screening approach may provide a route to smaller, less complex leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonGHbXyxgv4LVg90H21EOLACvtfcHk0lhNTvLKfKg4HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFejtL4%253D&md5=c7a227848516d0aa58ed037a582943fe</span></div><a href="/servlet/linkout?suffix=cit231&amp;dbid=16384&amp;doi=10.1021%2Fjm0603015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603015%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DThe%2520physicochemical%2520challenges%2520of%2520designing%2520multiple%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4961%26epage%3D4970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref232"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref232'); return false;" data-citation="" class="refNumLink">232</a></strong><div class="NLM_citation" id="cit232"><span><span class="NLM_contrib-group">Stark, H.</span><span> </span><span class="NLM_article-title">Turning from monogamy to strategic promiscuity</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">736</span><span class="NLM_x">–</span> <span class="NLM_lpage">737</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=736-737&author=H.+Stark&title=Turning+from+monogamy+to+strategic+promiscuity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit232&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStark%26aufirst%3DH.%26atitle%3DTurning%2520from%2520monogamy%2520to%2520strategic%2520promiscuity%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D736%26epage%3D737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref233"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref233'); return false;" data-citation="" class="refNumLink">233</a></strong><div class="NLM_citation" id="cit233"><span><span class="NLM_contrib-group">Barabasi, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oltvai, Z. N.</span><span> </span><span class="NLM_article-title">Network biology: understanding the cellʼs functional organization</span> <span class="citation_source-journal">Nat. Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnrg1272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=14735121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovV2mtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=101-113&author=A.+L.+Barabasiauthor=Z.+N.+Oltvai&title=Network+biology%3A+understanding+the+cell%CA%BCs+functional+organization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit233R"><div class="casContent"><span class="casTitleNuber">233</span><div class="casTitle"><span class="NLM_cas:atitle">Network biology: Understanding the cell's functional organization</span></div><div class="casAuthors">Barabasi, Albert-Laszlo; Oltvai, Zoltan N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-113</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A key aim of postgenomic biomedical research is to systematically catalog all mols. and their interactions within a living cell.  There is a clear need to understand how these mols. and the interactions between them det. the function of this enormously complex machinery, both in isolation and when surrounded by other cells.  Rapid advances in network biol. indicate that cellular networks are governed by universal laws and offer a new conceptual framework that could potentially revolutionize our view of biol. and disease pathologies in the twenty-first century.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov1DuovBZth7Vg90H21EOLACvtfcHk0lhJULNZIg4SvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovV2mtg%253D%253D&md5=2ac9082dfaf88d56da1fdd75b9edddb4</span></div><a href="/servlet/linkout?suffix=cit233&amp;dbid=16384&amp;doi=10.1038%2Fnrg1272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg1272%26sid%3Dliteratum%253Aachs%26aulast%3DBarabasi%26aufirst%3DA.%2BL.%26aulast%3DOltvai%26aufirst%3DZ.%2BN.%26atitle%3DNetwork%2520biology%253A%2520understanding%2520the%2520cell%25CA%25BCs%2520functional%2520organization%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2004%26volume%3D5%26spage%3D101%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref234"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref234'); return false;" data-citation="" class="refNumLink">234</a></strong><div class="NLM_citation" id="cit234"><span><span class="NLM_contrib-group">van der Greef, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBurney, R. N.</span><span> </span><span class="NLM_article-title">Innovation: rescuing drug discovery: in vivo systems pathology and systems pharmacology</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">961</span><span class="NLM_x">–</span> <span class="NLM_lpage">967</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=961-967&author=J.+van+der+Greefauthor=R.+N.+McBurney&title=Innovation%3A+rescuing+drug+discovery%3A+in+vivo+systems+pathology+and+systems+pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit234&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BGreef%26aufirst%3DJ.%26aulast%3DMcBurney%26aufirst%3DR.%2BN.%26atitle%3DInnovation%253A%2520rescuing%2520drug%2520discovery%253A%2520in%2520vivo%2520systems%2520pathology%2520and%2520systems%2520pharmacology%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D961%26epage%3D967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref235"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref235'); return false;" data-citation="" class="refNumLink">235</a></strong><div class="NLM_citation" id="cit235"><span><span class="NLM_contrib-group">Butcher, E. C.</span><span> </span><span class="NLM_article-title">Can cell systems biology rescue drug discovery?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=461-467&author=E.+C.+Butcher&title=Can+cell+systems+biology+rescue+drug+discovery%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit235&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DButcher%26aufirst%3DE.%2BC.%26atitle%3DCan%2520cell%2520systems%2520biology%2520rescue%2520drug%2520discovery%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D461%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref236"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref236'); return false;" data-citation="" class="refNumLink">236</a></strong><div class="NLM_citation" id="cit236"><span><span class="NLM_contrib-group">Keith, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borisy, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockwell, B. R.</span><span> </span><span class="NLM_article-title">Multicomponent therapeutics for networked systems</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=71-78&author=C.+T.+Keithauthor=A.+A.+Borisyauthor=B.+R.+Stockwell&title=Multicomponent+therapeutics+for+networked+systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit236&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeith%26aufirst%3DC.%2BT.%26aulast%3DBorisy%26aufirst%3DA.%2BA.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DMulticomponent%2520therapeutics%2520for%2520networked%2520systems%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D71%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref237"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref237'); return false;" data-citation="" class="refNumLink">237</a></strong><div class="NLM_citation" id="cit237"><span><span class="NLM_contrib-group">Fitzgerald, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoeberl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, U. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorger, P. K.</span><span> </span><span class="NLM_article-title">Systems biology and combination therapy in the quest for clinical efficacy</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnchembio817" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16921358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1Gns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=458-466&author=J.+B.+Fitzgeraldauthor=B.+Schoeberlauthor=U.+B.+Nielsenauthor=P.+K.+Sorger&title=Systems+biology+and+combination+therapy+in+the+quest+for+clinical+efficacy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit237R"><div class="casContent"><span class="casTitleNuber">237</span><div class="casTitle"><span class="NLM_cas:atitle">Systems biology and combination therapy in the quest for clinical efficacy</span></div><div class="casAuthors">Fitzgerald, Jonathan B.; Schoeberl, Birgit; Nielsen, Ulrik B.; Sorger, Peter K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">458-466</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Combinatorial control of biol. processes, in which redundancy and multifunctionality are the norm, fundamentally limits the therapeutic index that can be achieved by even the most potent and highly selective drugs.  Thus, it will almost certainly be necessary to use new 'targeted' pharmaceuticals in combinations.  Multicomponent drugs are std. in cytotoxic chemotherapy, but their development has required arduous empirical testing.  However, exptl. validated numerical models should greatly aid in the formulation of new combination therapies, particularly those tailored to the needs of specific patients.  This perspective focuses on opportunities and challenges inherent in the application of math. modeling and systems approached to pharmacol., specifically with respect to the idea of achieving combinatorial selectivity through use of multicomponent drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8p9-4JKdU17Vg90H21EOLACvtfcHk0lhJULNZIg4SvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1Gns7k%253D&md5=223e075af6f4df42ea1be560accfaf31</span></div><a href="/servlet/linkout?suffix=cit237&amp;dbid=16384&amp;doi=10.1038%2Fnchembio817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio817%26sid%3Dliteratum%253Aachs%26aulast%3DFitzgerald%26aufirst%3DJ.%2BB.%26aulast%3DSchoeberl%26aufirst%3DB.%26aulast%3DNielsen%26aufirst%3DU.%2BB.%26aulast%3DSorger%26aufirst%3DP.%2BK.%26atitle%3DSystems%2520biology%2520and%2520combination%2520therapy%2520in%2520the%2520quest%2520for%2520clinical%2520efficacy%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D458%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref238"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref238'); return false;" data-citation="" class="refNumLink">238</a></strong><div class="NLM_citation" id="cit238"><span><span class="NLM_contrib-group">Csermely, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agoston, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pongor, S.</span><span> </span><span class="NLM_article-title">The efficiency of multi-target drugs: the network approach might help drug design</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">178</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.tips.2005.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15808341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivV2ht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=178-182&author=P.+Csermelyauthor=V.+Agostonauthor=S.+Pongor&title=The+efficiency+of+multi-target+drugs%3A+the+network+approach+might+help+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit238R"><div class="casContent"><span class="casTitleNuber">238</span><div class="casTitle"><span class="NLM_cas:atitle">The efficiency of multi-target drugs: the network approach might help drug design</span></div><div class="casAuthors">Csermely, Peter; Agoston, Vilmos; Pongor, Sandor</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">178-182</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Despite considerable progress in genome- and proteome-based high-throughput screening methods and rational drug design, the no. of successful single-target drugs did not increase appreciably during the past decade.  Network models suggest that partial inhibition of a surprisingly small no. of targets can be more efficient than the complete inhibition of a single target.  This and the success stories of multi-target drugs and combinatorial therapies led us to suggest that systematic drug-design strategies should be directed against multiple targets.  The authors propose that the final effect of partial, but multiple, drug actions might often surpass that of complete drug action at a single target.  The future success of this novel drug-design paradigm will depend not only on a new generation of computer models to identify the correct multiple targets and their multi-fitting, low-affinity drug candidates but also on more-efficient in vivo testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQRoFMVKb5m7Vg90H21EOLACvtfcHk0lhJULNZIg4SvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivV2ht70%253D&md5=4f1383f4699221ef99041dffafe03e8c</span></div><a href="/servlet/linkout?suffix=cit238&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2005.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2005.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DCsermely%26aufirst%3DP.%26aulast%3DAgoston%26aufirst%3DV.%26aulast%3DPongor%26aufirst%3DS.%26atitle%3DThe%2520efficiency%2520of%2520multi-target%2520drugs%253A%2520the%2520network%2520approach%2520might%2520help%2520drug%2520design%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D178%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref239"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref239'); return false;" data-citation="" class="refNumLink">239</a></strong><div class="NLM_citation" id="cit239"><span><span class="NLM_contrib-group">Millan, M. J.</span><span> </span><span class="NLM_article-title">Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.pharmthera.2005.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16522330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtFCqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2006&pages=135-370&author=M.+J.+Millan&title=Multi-target+strategies+for+the+improved+treatment+of+depressive+states%3A+conceptual+foundations+and+neuronal+substrates%2C+drug+discovery+and+therapeutic+application"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit239R"><div class="casContent"><span class="casTitleNuber">239</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application</span></div><div class="casAuthors">Millan, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-370</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Major depression is a debilitating and recurrent disorder with a substantial lifetime risk and a high social cost.  Depressed patients generally display co-morbid symptoms, and depression frequently accompanies other serious disorders.  Currently available drugs display limited efficacy and a pronounced delay to onset of action, and all provoke distressing side effects.  Cloning of the human genome has fuelled expectations that symptomatic treatment may soon become more rapid and effective, and that depressive states may ultimately be "prevented" or "cured".  In pursuing these objectives, in particular for genome-derived, non-monoaminergic targets, "specificity" of drug actions is often emphasized.  That is, priority is afforded to agents that interact exclusively with a single site hypothesized as critically involved in the pathogenesis and/or control of depression.  Certain highly selective drugs may prove effective, and they remain indispensable in the exptl. (and clin.) evaluation of the significance of novel mechanisms.  However, by analogy to other multifactorial disorders, "multi-target" agents may be better adapted to the improved treatment of depressive states.  Support for this contention is garnered from a broad palette of observations, ranging from mechanisms of action of adjunctive drug combinations and electroconvulsive therapy to "network theory" anal. of the etiol. and management of depressive states.  The review also outlines opportunities to be exploited, and challenges to be addressed, in the discovery and characterization of drugs recognizing multiple targets.  Finally, a diversity of multi-target strategies is proposed for the more efficacious and rapid control of core and co-morbid symptoms of depression, together with improved tolerance relative to currently available agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxf3nCB4E-O7Vg90H21EOLACvtfcHk0ljzydXQFMbAig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtFCqtr4%253D&md5=dbca7f1b7bba52c69d9c6b95eea01d69</span></div><a href="/servlet/linkout?suffix=cit239&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2005.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2005.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26atitle%3DMulti-target%2520strategies%2520for%2520the%2520improved%2520treatment%2520of%2520depressive%2520states%253A%2520conceptual%2520foundations%2520and%2520neuronal%2520substrates%252C%2520drug%2520discovery%2520and%2520therapeutic%2520application%26jtitle%3DPharmacol.%2520Ther.%26date%3D2006%26volume%3D110%26spage%3D135%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref240"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref240'); return false;" data-citation="" class="refNumLink">240</a></strong><div class="NLM_citation" id="cit240"><span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroeze, W. K.</span><span> </span><span class="NLM_article-title">Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnrd1346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15060530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1Gkt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=353-359&author=B.+L.+Rothauthor=D.+J.+Shefflerauthor=W.+K.+Kroeze&title=Magic+shotguns+versus+magic+bullets%3A+selectively+non-selective+drugs+for+mood+disorders+and+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit240R"><div class="casContent"><span class="casTitleNuber">240</span><div class="casTitle"><span class="NLM_cas:atitle">Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia</span></div><div class="casAuthors">Roth, Bryan L.; Sheffler, Douglas J.; Kroeze, Wesley K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">353-359</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Most common central nervous system disorders - such as depression, bipolar disorder, and schizophrenia - seem to be polygenic in origin, and the most effective medications have exceedingly complex pharmacologies.  Attempts to develop more effective treatments for diseases such as schizophrenia and depression by discovering drugs selective for single mol. targets (i.e., 'magic bullets') have, not surprisingly, been largely unsuccessful.  Here the authors propose that designing selectively non-selective drugs (i.e., 'magic shotguns') that interact with several mol. targets will lead to new and more effective medications for a variety of central nervous system disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnSsuUXzmbirVg90H21EOLACvtfcHk0ljzydXQFMbAig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1Gkt78%253D&md5=77196583acccca65457fec7a67218463</span></div><a href="/servlet/linkout?suffix=cit240&amp;dbid=16384&amp;doi=10.1038%2Fnrd1346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1346%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26atitle%3DMagic%2520shotguns%2520versus%2520magic%2520bullets%253A%2520selectively%2520non-selective%2520drugs%2520for%2520mood%2520disorders%2520and%2520schizophrenia%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D353%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207'],'ref208':['cit208'],'ref209':['cit209'],'ref210':['cit210'],'ref211':['cit211'],'ref212':['cit212'],'ref213':['cit213'],'ref214':['cit214'],'ref215':['cit215'],'ref216':['cit216'],'ref217':['cit217'],'ref218':['cit218'],'ref219':['cit219'],'ref220':['cit220'],'ref221':['cit221'],'ref222':['cit222'],'ref223':['cit223'],'ref224':['cit224'],'ref225':['cit225'],'ref226':['cit226'],'ref227':['cit227'],'ref228':['cit228'],'ref229':['cit229'],'ref230':['cit230'],'ref231':['cit231'],'ref232':['cit232'],'ref233':['cit233'],'ref234':['cit234'],'ref235':['cit235'],'ref236':['cit236'],'ref237':['cit237'],'ref238':['cit238'],'ref239':['cit239'],'ref240':['cit240']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 698 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Alessandra G. Ritacca, Ida Ritacco, Eslam Dabbish, Nino Russo, Gloria Mazzone, <span class="NLM_string-name hlFld-ContribAuthor">Emilia Sicilia</span>. </span><span class="cited-content_cbyCitation_article-title">A Boron-Containing Compound Acting on Multiple Targets Against Alzheimer’s Disease. Insights from Ab Initio and Molecular Dynamics Simulations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2021,</strong> <em>61 </em>
                                    (7)
                                     , 3397-3410. <a href="https://doi.org/10.1021/acs.jcim.1c00262" title="DOI URL">https://doi.org/10.1021/acs.jcim.1c00262</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.1c00262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.1c00262%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DA%252BBoron-Containing%252BCompound%252BActing%252Bon%252BMultiple%252BTargets%252BAgainst%252BAlzheimer%2525E2%252580%252599s%252BDisease.%252BInsights%252Bfrom%252BAb%252BInitio%252Band%252BMolecular%252BDynamics%252BSimulations%26aulast%3DRitacca%26aufirst%3DAlessandra%2BG.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D05032021%26date%3D13072021%26volume%3D61%26issue%3D7%26spage%3D3397%26epage%3D3410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wen Shuai, Guan Wang, Yiwen Zhang, Faqian Bu, Sicheng Zhang, Duane D. Miller, Wei Li, Liang Ouyang, <span class="NLM_string-name hlFld-ContribAuthor">Yuxi Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress on Tubulin Inhibitors with Dual Targeting Capabilities for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 7963-7990. <a href="https://doi.org/10.1021/acs.jmedchem.1c00100" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00100%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BProgress%252Bon%252BTubulin%252BInhibitors%252Bwith%252BDual%252BTargeting%252BCapabilities%252Bfor%252BCancer%252BTherapy%26aulast%3DShuai%26aufirst%3DWen%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D19012021%26date%3D08062021%26volume%3D64%26issue%3D12%26spage%3D7963%26epage%3D7990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hong Yao, Giuseppe Uras, Pengfei Zhang, Shengtao Xu, Ying Yin, Jie Liu, Shuai Qin, Xinuo Li, Stephanie Allen, Renren Bai, Qi Gong, Haiyan Zhang, Zheying Zhu, <span class="NLM_string-name hlFld-ContribAuthor">Jinyi Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Tacrine–Pyrimidone Hybrids as Potent Dual AChE/GSK-3 Inhibitors for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (11)
                                     , 7483-7506. <a href="https://doi.org/10.1021/acs.jmedchem.1c00160" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00160</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00160%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BTacrine%2525E2%252580%252593Pyrimidone%252BHybrids%252Bas%252BPotent%252BDual%252BAChE%25252FGSK-3%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DYao%26aufirst%3DHong%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D28012021%26date%3D24052021%26volume%3D64%26issue%3D11%26spage%3D7483%26epage%3D7506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lukas Gorecki, Elisa Uliassi, Manuela Bartolini, Jana Janockova, Martina Hrabinova, Vendula Hepnarova, Lukas Prchal, Lubica Muckova, Jaroslav Pejchal, Jana Z. Karasova, Eva Mezeiova, Marketa Benkova, Tereza Kobrlova, Ondrej Soukup, Sabrina Petralla, Barbara Monti, Jan Korabecny, <span class="NLM_string-name hlFld-ContribAuthor">Maria Laura Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (9)
                                     , 1698-1715. <a href="https://doi.org/10.1021/acschemneuro.1c00184" title="DOI URL">https://doi.org/10.1021/acschemneuro.1c00184</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.1c00184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.1c00184%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DPhenothiazine-Tacrine%252BHeterodimers%25253A%252BPursuing%252BMultitarget%252BDirected%252BApproach%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DGorecki%26aufirst%3DLukas%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D26032021%26date%3D07042021%26date%3D14042021%26volume%3D12%26issue%3D9%26spage%3D1698%26epage%3D1715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michele Rossi, Michela Freschi, Luciana de Camargo Nascente, Alessandra Salerno, Sarah de Melo Viana Teixeira, Florian Nachon, Fabien Chantegreil, Ondrej Soukup, Lukáš Prchal, Marco Malaguti, Christian Bergamini, Manuela Bartolini, Cristina Angeloni, Silvana Hrelia, Luiz Antonio Soares Romeiro, <span class="NLM_string-name hlFld-ContribAuthor">Maria Laura Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 4972-4990. <a href="https://doi.org/10.1021/acs.jmedchem.1c00048" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00048%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSustainable%252BDrug%252BDiscovery%252Bof%252BMulti-Target-Directed%252BLigands%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DRossi%26aufirst%3DMichele%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D11012021%26date%3D08042021%26volume%3D64%26issue%3D8%26spage%3D4972%26epage%3D4990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hafiza Rabia Afzal, Najm ul Hassan Khan, Kishwar Sultana, Aisha Mobashar, Aqsa Lareb, Ayesha Khan, Abrashim Gull, Hasan Afzaal, Muhammad Tariq Khan, Muhammad Rizwan, <span class="NLM_string-name hlFld-ContribAuthor">Muhammad Imran</span>. </span><span class="cited-content_cbyCitation_article-title">Schiff Bases of Pioglitazone Provide Better Antidiabetic and Potent Antioxidant Effect in a Streptozotocin–Nicotinamide-Induced Diabetic Rodent Model. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2021,</strong> <em>6 </em>
                                    (6)
                                     , 4470-4479. <a href="https://doi.org/10.1021/acsomega.0c06064" title="DOI URL">https://doi.org/10.1021/acsomega.0c06064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c06064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c06064%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DSchiff%252BBases%252Bof%252BPioglitazone%252BProvide%252BBetter%252BAntidiabetic%252Band%252BPotent%252BAntioxidant%252BEffect%252Bin%252Ba%252BStreptozotocin%2525E2%252580%252593Nicotinamide-Induced%252BDiabetic%252BRodent%252BModel%26aulast%3DAfzal%26aufirst%3DHafiza%2BRabia%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D13122020%26date%3D25012021%26date%3D03022021%26volume%3D6%26issue%3D6%26spage%3D4470%26epage%3D4479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Angela De Simone, Vincenzo Tumiatti, Vincenza Andrisano, <span class="NLM_string-name hlFld-ContribAuthor">Andrea Milelli</span>. </span><span class="cited-content_cbyCitation_article-title">Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 26-41. <a href="https://doi.org/10.1021/acs.jmedchem.0c00931" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00931</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00931%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGlycogen%252BSynthase%252BKinase%252B3%2525CE%2525B2%25253A%252BA%252BNew%252BGold%252BRush%252Bin%252BAnti-Alzheimer%2525E2%252580%252599s%252BDisease%252BMultitarget%252BDrug%252BDiscovery%25253F%26aulast%3DDe%2BSimone%26aufirst%3DAngela%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D01062020%26date%3D21122020%26volume%3D64%26issue%3D1%26spage%3D26%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Elisabet Viayna, Nicolas Coquelle, Monika Cieslikiewicz-Bouet, Pedro Cisternas, Carolina A. Oliva, Elena Sánchez-López, Miren Ettcheto, Manuela Bartolini, Angela De Simone, Mattia Ricchini, Marisa Rendina, Mégane Pons, Omidreza Firuzi, Belén Pérez, Luciano Saso, Vincenza Andrisano, Florian Nachon, Xavier Brazzolotto, Maria Luisa García, Antoni Camins, Israel Silman, Ludovic Jean, Nibaldo C. Inestrosa, Jacques-Philippe Colletier, Pierre-Yves Renard, <span class="NLM_string-name hlFld-ContribAuthor">Diego Muñoz-Torrero</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 812-839. <a href="https://doi.org/10.1021/acs.jmedchem.0c01775" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01775</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01775%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252BDual%252BInhibitor%252Bof%252BAcetylcholinesterase%252Band%252BButyrylcholinesterase%252Bwith%252BAntioxidant%252BActivity%252Bthat%252BAlleviates%252BAlzheimer-like%252BPathology%252Bin%252BOld%252BAPP%25252FPS1%252BMice%26aulast%3DViayna%26aufirst%3DElisabet%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D09102020%26date%3D28122020%26volume%3D64%26issue%3D1%26spage%3D812%26epage%3D839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kai Li, Yu Jiang, Guoliang Li, Tianjun Liu, <span class="NLM_string-name hlFld-ContribAuthor">Zhuo Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Multitarget Directed Tacrine Hybrids as Anti-Alzheimer’s Compounds Improved Synaptic Plasticity and Cognitive Impairment in APP/PS1 Transgenic Mice. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (24)
                                     , 4316-4328. <a href="https://doi.org/10.1021/acschemneuro.0c00574" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00574</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00574%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DNovel%252BMultitarget%252BDirected%252BTacrine%252BHybrids%252Bas%252BAnti-Alzheimer%2525E2%252580%252599s%252BCompounds%252BImproved%252BSynaptic%252BPlasticity%252Band%252BCognitive%252BImpairment%252Bin%252BAPP%25252FPS1%252BTransgenic%252BMice%26aulast%3DLi%26aufirst%3DKai%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D01092020%26date%3D09112020%26date%3D20112020%26volume%3D11%26issue%3D24%26spage%3D4316%26epage%3D4328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michele Rossi, Sabrina Petralla, Michele Protti, Monica Baiula, Tereza Kobrlova, Ondrej Soukup, Santi Mario Spampinato, Laura Mercolini, Barbara Monti, <span class="NLM_string-name hlFld-ContribAuthor">Maria Laura Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">α-Linolenic Acid–Valproic Acid Conjugates: Toward Single-Molecule Polypharmacology for Multiple Sclerosis. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (12)
                                     , 2406-2413. <a href="https://doi.org/10.1021/acsmedchemlett.0c00375" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00375</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00375%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D%2525CE%2525B1-Linolenic%252BAcid%2525E2%252580%252593Valproic%252BAcid%252BConjugates%25253A%252BToward%252BSingle-Molecule%252BPolypharmacology%252Bfor%252BMultiple%252BSclerosis%26aulast%3DRossi%26aufirst%3DMichele%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07072020%26date%3D23102020%26date%3D27102020%26volume%3D11%26issue%3D12%26spage%3D2406%26epage%3D2413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Anna Więckowska, Natalia Szałaj, Izabella Góral, Adam Bucki, Gniewomir Latacz, Katarzyna Kiec-Kononowicz, Òscar. M. Bautista-Aguilera, Alejandro Romero, Eva Ramos, Javier Egea, Victor Farré Alíns, Águeda González-Rodríguez, Francisco López-Muñoz, Mourad Chioua, <span class="NLM_string-name hlFld-ContribAuthor">José Marco-Contelles</span>. </span><span class="cited-content_cbyCitation_article-title">In Vitro and In Silico ADME-Tox Profiling and Safety Significance of Multifunctional Monoamine Oxidase Inhibitors Targeting Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (22)
                                     , 3793-3801. <a href="https://doi.org/10.1021/acschemneuro.0c00489" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00489</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00489%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DIn%252BVitro%252Band%252BIn%252BSilico%252BADME-Tox%252BProfiling%252Band%252BSafety%252BSignificance%252Bof%252BMultifunctional%252BMonoamine%252BOxidase%252BInhibitors%252BTargeting%252BNeurodegenerative%252BDiseases%26aulast%3DWi%25C4%2599ckowska%26aufirst%3DAnna%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29072020%26date%3D21102020%26date%3D03112020%26volume%3D11%26issue%3D22%26spage%3D3793%26epage%3D3801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">F. Javier Pérez-Areales, María Garrido, Ester Aso, Manuela Bartolini, Angela De Simone, Alba Espargaró, Tiziana Ginex, Raimon Sabate, Belén Pérez, Vincenza Andrisano, Dolors Puigoriol-Illamola, Mercè Pallàs, F. Javier Luque, María Isabel Loza, José Brea, Isidro Ferrer, Francisco Ciruela, Angel Messeguer, <span class="NLM_string-name hlFld-ContribAuthor">Diego Muñoz-Torrero</span>. </span><span class="cited-content_cbyCitation_article-title">Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9360-9390. <a href="https://doi.org/10.1021/acs.jmedchem.0c00528" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00528</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00528%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCentrally%252BActive%252BMultitarget%252BAnti-Alzheimer%252BAgents%252BDerived%252Bfrom%252Bthe%252BAntioxidant%252BLead%252BCR-6%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJavier%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D31032020%26date%3D11082020%26date%3D24072020%26volume%3D63%26issue%3D17%26spage%3D9360%26epage%3D9390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Maurizio Recanatini, <span class="NLM_string-name hlFld-ContribAuthor">Chiara Cabrelle</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Research Meets Network Science: Where Are We?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (16)
                                     , 8653-8666. <a href="https://doi.org/10.1021/acs.jmedchem.9b01989" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01989</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01989%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDrug%252BResearch%252BMeets%252BNetwork%252BScience%25253A%252BWhere%252BAre%252BWe%25253F%26aulast%3DRecanatini%26aufirst%3DMaurizio%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D29112019%26date%3D08052020%26date%3D27042020%26volume%3D63%26issue%3D16%26spage%3D8653%26epage%3D8666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hyejin Park, Aarti N. Urs, Joseph Zimmerman, Chuan Liu, Qiu Wang, <span class="NLM_string-name hlFld-ContribAuthor">Nikhil M. Urs</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Functional–Selectivity Relationship Studies of Novel Apomorphine Analogs to Develop D1R/D2R Biased Ligands. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (3)
                                     , 385-392. <a href="https://doi.org/10.1021/acsmedchemlett.9b00575" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00575</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00575%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%2525E2%252580%252593Functional%2525E2%252580%252593Selectivity%252BRelationship%252BStudies%252Bof%252BNovel%252BApomorphine%252BAnalogs%252Bto%252BDevelop%252BD1R%25252FD2R%252BBiased%252BLigands%26aulast%3DPark%26aufirst%3DHyejin%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D07122019%26date%3D06012020%26date%3D13012020%26date%3D06012020%26volume%3D11%26issue%3D3%26spage%3D385%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rim Malek, Raquel L. Arribas, Alejandra Palomino-Antolin, Perle Totoson, Celine Demougeot, Tereza Kobrlova, Ondrej Soukup, Isabel Iriepa, Ignacio Moraleda, Daniel Diez-Iriepa, Justyna Godyń, Dawid Panek, Barbara Malawska, Monika Głuch-Lutwin, Barbara Mordyl, Agata Siwek, Fakher Chabchoub, José Marco-Contelles, Katarzyna Kiec-Kononowicz, Javier Egea, Cristóbal de los Ríos, <span class="NLM_string-name hlFld-ContribAuthor">Lhassane Ismaili</span>. </span><span class="cited-content_cbyCitation_article-title">New Dual Small Molecules for Alzheimer’s Disease Therapy Combining Histamine H3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (24)
                                     , 11416-11422. <a href="https://doi.org/10.1021/acs.jmedchem.9b00937" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00937</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00937%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252BDual%252BSmall%252BMolecules%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BTherapy%252BCombining%252BHistamine%252BH3%252BReceptor%252B%252528H3R%252529%252BAntagonism%252Band%252BCalcium%252BChannels%252BBlockade%252Bwith%252BAdditional%252BCholinesterase%252BInhibition%26aulast%3DMalek%26aufirst%3DRim%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D12062019%26date%3D05122019%26date%3D14112019%26volume%3D62%26issue%3D24%26spage%3D11416%26epage%3D11422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhiren Wang, Mengru Cao, Hongling Xiang, Wei Wang, Xing Feng, <span class="NLM_string-name hlFld-ContribAuthor">Xiaoping Yang</span>. </span><span class="cited-content_cbyCitation_article-title">WBQ5187, a Multitarget Directed Agent, Ameliorates Cognitive Impairment in a Transgenic Mouse Model of Alzheimer’s Disease and Modulates Cerebral β-Amyloid, Gliosis, cAMP Levels, and Neurodegeneration. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (12)
                                     , 4787-4799. <a href="https://doi.org/10.1021/acschemneuro.9b00409" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00409%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DWBQ5187%25252C%252Ba%252BMultitarget%252BDirected%252BAgent%25252C%252BAmeliorates%252BCognitive%252BImpairment%252Bin%252Ba%252BTransgenic%252BMouse%252BModel%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%252Band%252BModulates%252BCerebral%252B%2525CE%2525B2-Amyloid%25252C%252BGliosis%25252C%252BcAMP%252BLevels%25252C%252Band%252BNeurodegeneration%26aulast%3DWang%26aufirst%3DZhiren%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D20072019%26date%3D07112019%26date%3D20112019%26date%3D07112019%26volume%3D10%26issue%3D12%26spage%3D4787%26epage%3D4799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Junting Zhou, Xueyang Jiang, Siyu He, Hongli Jiang, Feng Feng, Wenyuan Liu, Wei Qu, <span class="NLM_string-name hlFld-ContribAuthor">Haopeng Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (20)
                                     , 8881-8914. <a href="https://doi.org/10.1021/acs.jmedchem.9b00017" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00017%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252BDesign%252Bof%252BMultitarget-Directed%252BLigands%25253A%252BStrategies%252Band%252BEmerging%252BParadigms%26aulast%3DZhou%26aufirst%3DJunting%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D04012019%26date%3D28052019%26date%3D13052019%26volume%3D62%26issue%3D20%26spage%3D8881%26epage%3D8914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dushyant
V. Patel, Nirav R. Patel, Ashish M. Kanhed, Sagar P. Patel, Anshuman Sinha, Deep D. Kansara, Annie R. Mecwan, Sarvangee B. Patel, Pragnesh N. Upadhyay, Kishan B. Patel, Dharti B. Shah, Navnit K. Prajapati, Prashant R. Murumkar, Kirti V. Patel, <span class="NLM_string-name hlFld-ContribAuthor">Mange Ram Yadav</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Multitarget Directed Triazinoindole Derivatives as Anti-Alzheimer Agents. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (8)
                                     , 3635-3661. <a href="https://doi.org/10.1021/acschemneuro.9b00226" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00226</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00226%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DNovel%252BMultitarget%252BDirected%252BTriazinoindole%252BDerivatives%252Bas%252BAnti-Alzheimer%252BAgents%26aulast%3DPatel%26aufirst%3DDushyant%2BV.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D13042019%26date%3D16072019%26date%3D29072019%26date%3D16072019%26volume%3D10%26issue%3D8%26spage%3D3635%26epage%3D3661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Da Shi, Feroz Khan, <span class="NLM_string-name hlFld-ContribAuthor">Ruben Abagyan</span>. </span><span class="cited-content_cbyCitation_article-title">Extended Multitarget Pharmacology of Anticancer Drugs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (6)
                                     , 3006-3017. <a href="https://doi.org/10.1021/acs.jcim.9b00031" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b00031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b00031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b00031%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DExtended%252BMultitarget%252BPharmacology%252Bof%252BAnticancer%252BDrugs%26aulast%3DShi%26aufirst%3DDa%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D07012019%26date%3D03052019%26date%3D26042019%26volume%3D59%26issue%3D6%26spage%3D3006%26epage%3D3017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Virendra
Kumar Meena, Shubhra Chaturvedi, Rakesh Kumar Sharma, Anil Kumar Mishra, <span class="NLM_string-name hlFld-ContribAuthor">Puja Panwar Hazari</span>. </span><span class="cited-content_cbyCitation_article-title">Potent Acetylcholinesterase Selective and Reversible Homodimeric Agent Based on Tacrine for Theranostics. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2019,</strong> <em>16 </em>
                                    (6)
                                     , 2296-2308. <a href="https://doi.org/10.1021/acs.molpharmaceut.8b01058" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.8b01058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.8b01058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.8b01058%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DPotent%252BAcetylcholinesterase%252BSelective%252Band%252BReversible%252BHomodimeric%252BAgent%252BBased%252Bon%252BTacrine%252Bfor%252BTheranostics%26aulast%3DMeena%26aufirst%3DVirendra%2BKumar%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D2019%26date%3D12102018%26date%3D06052019%26date%3D09042019%26date%3D15052019%26date%3D06052019%26volume%3D16%26issue%3D6%26spage%3D2296%26epage%3D2308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fabio Del Bello, Dario Ambrosini, Alessandro Bonifazi, Amy H. Newman, Thomas M. Keck, Mario Giannella, Gianfabio Giorgioni, Alessandro Piergentili, Loredana Cappellacci, Antonio Cilia, Silvia Franchini, <span class="NLM_string-name hlFld-ContribAuthor">Wilma Quaglia</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson’s Disease or Schizophrenia. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (5)
                                     , 2222-2228. <a href="https://doi.org/10.1021/acschemneuro.8b00677" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00677</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00677%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DMultitarget%252B1%25252C4-Dioxane%252BCompounds%252BCombining%252BFavorable%252BD2-like%252Band%252B5-HT1A%252BReceptor%252BInteractions%252Bwith%252BPotential%252Bfor%252Bthe%252BTreatment%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease%252Bor%252BSchizophrenia%26aulast%3DDel%2BBello%26aufirst%3DFabio%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D06122018%26date%3D04012019%26date%3D09012019%26date%3D04012019%26volume%3D10%26issue%3D5%26spage%3D2222%26epage%3D2228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Maria Laura Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">Harnessing Polypharmacology with Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (3)
                                     , 273-275. <a href="https://doi.org/10.1021/acsmedchemlett.9b00039" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00039%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DHarnessing%252BPolypharmacology%252Bwith%252BMedicinal%252BChemistry%26aulast%3DBolognesi%26aufirst%3DMaria%2BLaura%26date%3D2019%26date%3D2019%26date%3D15022019%26volume%3D10%26issue%3D3%26spage%3D273%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Huan Wang, <span class="NLM_string-name hlFld-ContribAuthor">Haiyan Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Reconsideration of Anticholinesterase Therapeutic Strategies against Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (2)
                                     , 852-862. <a href="https://doi.org/10.1021/acschemneuro.8b00391" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00391</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00391%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DReconsideration%252Bof%252BAnticholinesterase%252BTherapeutic%252BStrategies%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DWang%26aufirst%3DHuan%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D31072018%26date%3D20112018%26date%3D06122018%26volume%3D10%26issue%3D2%26spage%3D852%26epage%3D862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ewgenij Proschak, Holger Stark, <span class="NLM_string-name hlFld-ContribAuthor">Daniel Merk</span>. </span><span class="cited-content_cbyCitation_article-title">Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (2)
                                     , 420-444. <a href="https://doi.org/10.1021/acs.jmedchem.8b00760" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00760</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00760%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPolypharmacology%252Bby%252BDesign%25253A%252BA%252BMedicinal%252BChemist%2525E2%252580%252599s%252BPerspective%252Bon%252BMultitargeting%252BCompounds%26aulast%3DProschak%26aufirst%3DEwgenij%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D11052018%26date%3D03082018%26date%3D23072018%26volume%3D62%26issue%3D2%26spage%3D420%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Masha
G. Savelieff, Geewoo Nam, Juhye Kang, Hyuck Jin Lee, Misun Lee, <span class="NLM_string-name hlFld-ContribAuthor">Mi Hee Lim</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2019,</strong> <em>119 </em>
                                    (2)
                                     , 1221-1322. <a href="https://doi.org/10.1021/acs.chemrev.8b00138" title="DOI URL">https://doi.org/10.1021/acs.chemrev.8b00138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.8b00138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.8b00138%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DDevelopment%252Bof%252BMultifunctional%252BMolecules%252Bas%252BPotential%252BTherapeutic%252BCandidates%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%25252C%252BParkinson%2525E2%252580%252599s%252BDisease%25252C%252Band%252BAmyotrophic%252BLateral%252BSclerosis%252Bin%252Bthe%252BLast%252BDecade%26aulast%3DSavelieff%26aufirst%3DMasha%2BG.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D02032018%26date%3D10082018%26volume%3D119%26issue%3D2%26spage%3D1221%26epage%3D1322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Asma Elmabruk, Banibrata Das, Deepthi Yedlapudi, Liping Xu, Tamara Antonio, Maarten E. A. Reith, <span class="NLM_string-name hlFld-ContribAuthor">Aloke K. Dutta</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Pharmacological Characterization of Carbazole Based Dopamine Agonists as Potential Symptomatic and Neuroprotective Therapeutic Agents for Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     , 396-411. <a href="https://doi.org/10.1021/acschemneuro.8b00291" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00291</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00291%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BPharmacological%252BCharacterization%252Bof%252BCarbazole%252BBased%252BDopamine%252BAgonists%252Bas%252BPotential%252BSymptomatic%252Band%252BNeuroprotective%252BTherapeutic%252BAgents%252Bfor%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DElmabruk%26aufirst%3DAsma%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D18062018%26date%3D09102018%26date%3D24102018%26date%3D09102018%26volume%3D10%26issue%3D1%26spage%3D396%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yixiang Xu, Jian Zhang, Huan Wang, Fei Mao, Keting Bao, Wenwen Liu, Jin Zhu, Xiaokang Li, Haiyan Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Jian Li</span>. </span><span class="cited-content_cbyCitation_article-title">Rational Design of Novel Selective Dual-Target Inhibitors of Acetylcholinesterase and Monoamine Oxidase B as Potential Anti-Alzheimer’s Disease Agents. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     , 482-496. <a href="https://doi.org/10.1021/acschemneuro.8b00357" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00357</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00357%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DRational%252BDesign%252Bof%252BNovel%252BSelective%252BDual-Target%252BInhibitors%252Bof%252BAcetylcholinesterase%252Band%252BMonoamine%252BOxidase%252BB%252Bas%252BPotential%252BAnti-Alzheimer%2525E2%252580%252599s%252BDisease%252BAgents%26aulast%3DXu%26aufirst%3DYixiang%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D15072018%26date%3D15082018%26date%3D29082018%26date%3D15082018%26volume%3D10%26issue%3D1%26spage%3D482%26epage%3D496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nguyen
Quoc Thai, Zuzana Bednarikova, Miroslav Gancar, Huynh Quang Linh, Chin-Kun Hu, Mai Suan Li, <span class="NLM_string-name hlFld-ContribAuthor">Zuzana Gazova</span>. </span><span class="cited-content_cbyCitation_article-title">Compound CID 9998128 Is a Potential Multitarget Drug for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2018,</strong> <em>9 </em>
                                    (11)
                                     , 2588-2598. <a href="https://doi.org/10.1021/acschemneuro.8b00091" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00091%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DCompound%252BCID%252B9998128%252BIs%252Ba%252BPotential%252BMultitarget%252BDrug%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DThai%26aufirst%3DNguyen%2BQuoc%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27022018%26date%3D18052018%26date%3D07062018%26date%3D18052018%26volume%3D9%26issue%3D11%26spage%3D2588%26epage%3D2598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Annachiara Gandini, Manuela Bartolini, Daniele Tedesco, Loreto Martinez-Gonzalez, Carlos Roca, Nuria E. Campillo, Josefa Zaldivar-Diez, Concepción Perez, Giampaolo Zuccheri, Andrea Miti, Alessandra Feoli, Sabrina Castellano, Sabrina Petralla, Barbara Monti, Martina Rossi, Fabio Moda, Giuseppe Legname, Ana Martinez, <span class="NLM_string-name hlFld-ContribAuthor">Maria Laura Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (17)
                                     , 7640-7656. <a href="https://doi.org/10.1021/acs.jmedchem.8b00610" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00610</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00610%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTau-Centric%252BMultitarget%252BApproach%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BDevelopment%252Bof%252BFirst-in-Class%252BDual%252BGlycogen%252BSynthase%252BKinase%252B3%2525CE%2525B2%252Band%252BTau-Aggregation%252BInhibitors%26aulast%3DGandini%26aufirst%3DAnnachiara%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D17042018%26date%3D24082018%26date%3D04082018%26volume%3D61%26issue%3D17%26spage%3D7640%26epage%3D7656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mariama Jaiteh, Alexey Zeifman, Marcus Saarinen, Per Svenningsson, Jose Bréa, Maria Isabel Loza, <span class="NLM_string-name hlFld-ContribAuthor">Jens Carlsson</span>. </span><span class="cited-content_cbyCitation_article-title">Docking Screens for Dual Inhibitors of Disparate Drug Targets for Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (12)
                                     , 5269-5278. <a href="https://doi.org/10.1021/acs.jmedchem.8b00204" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00204</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00204%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDocking%252BScreens%252Bfor%252BDual%252BInhibitors%252Bof%252BDisparate%252BDrug%252BTargets%252Bfor%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DJaiteh%26aufirst%3DMariama%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D06022018%26date%3D15062018%26date%3D24052018%26volume%3D61%26issue%3D12%26spage%3D5269%26epage%3D5278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Anna Więckowska, Tomasz Wichur, Justyna Godyń, Adam Bucki, Monika Marcinkowska, Agata Siwek, Krzysztof Więckowski, Paula Zaręba, Damijan Knez, Monika Głuch-Lutwin, Grzegorz Kazek, Gniewomir Latacz, Kamil Mika, Marcin Kołaczkowski, Jan Korabecny, Ondrej Soukup, Marketa Benkova, Katarzyna Kieć-Kononowicz, Stanislav Gobec, <span class="NLM_string-name hlFld-ContribAuthor">Barbara Malawska</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2018,</strong> <em>9 </em>
                                    (5)
                                     , 1195-1214. <a href="https://doi.org/10.1021/acschemneuro.8b00024" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00024%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DNovel%252BMultitarget-Directed%252BLigands%252BAiming%252Bat%252BSymptoms%252Band%252BCauses%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DWi%25C4%2599ckowska%26aufirst%3DAnna%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D18012018%26date%3D31012018%26date%3D13022018%26date%3D31012018%26volume%3D9%26issue%3D5%26spage%3D1195%26epage%3D1214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">María
Jesús Oset-Gasque, <span class="NLM_string-name hlFld-ContribAuthor">José Marco-Contelles</span>. </span><span class="cited-content_cbyCitation_article-title">Alzheimer’s Disease, the “One-Molecule, One-Target” Paradigm, and the Multitarget Directed Ligand Approach. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2018,</strong> <em>9 </em>
                                    (3)
                                     , 401-403. <a href="https://doi.org/10.1021/acschemneuro.8b00069" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00069%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DAlzheimer%2525E2%252580%252599s%252BDisease%25252C%252Bthe%252B%2525E2%252580%25259COne-Molecule%25252C%252BOne-Target%2525E2%252580%25259D%252BParadigm%25252C%252Band%252Bthe%252BMultitarget%252BDirected%252BLigand%252BApproach%26aulast%3DOset-Gasque%26aufirst%3DMar%25C3%25ADa%2BJes%25C3%25BAs%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D13022018%26date%3D14022018%26date%3D21022018%26volume%3D9%26issue%3D3%26spage%3D401%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Prati</span>, <span class="hlFld-ContribAuthor ">Giovanni  Bottegoni</span>, <span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>, and <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>  . </span><span class="cited-content_cbyCitation_article-title">BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 619-637. <a href="https://doi.org/10.1021/acs.jmedchem.7b00393" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00393</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00393%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBACE-1%252BInhibitors%25253A%252BFrom%252BRecent%252BSingle-Target%252BMolecules%252Bto%252BMultitarget%252BCompounds%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DPrati%26aufirst%3DFederica%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D13032017%26date%3D08082017%26date%3D08022018%26date%3D27072017%26volume%3D61%26issue%3D3%26spage%3D619%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liu  He</span>, <span class="hlFld-ContribAuthor ">Yuqi  Jiang</span>, <span class="hlFld-ContribAuthor ">Kai  Liu</span>, <span class="hlFld-ContribAuthor ">Victoria  Gomez-Murcia</span>, <span class="hlFld-ContribAuthor ">Xiaopin  Ma</span>, <span class="hlFld-ContribAuthor ">Alejandro  Torrecillas</span>, <span class="hlFld-ContribAuthor ">Qun  Chen</span>, <span class="hlFld-ContribAuthor ">Xiongwei  Zhu</span>, <span class="hlFld-ContribAuthor ">Edward  Lesnefsky</span>, <span class="hlFld-ContribAuthor ">Juan C.  Gomez-Fernandez</span>, <span class="hlFld-ContribAuthor ">Bin  Xu</span>, and <span class="hlFld-ContribAuthor ">Shijun  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Insights into the Impact of a Membrane-Anchoring Moiety on the Biological Activities of Bivalent Compounds As Potential Neuroprotectants for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 777-790. <a href="https://doi.org/10.1021/acs.jmedchem.7b01284" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01284</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01284%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInsights%252Binto%252Bthe%252BImpact%252Bof%252Ba%252BMembrane-Anchoring%252BMoiety%252Bon%252Bthe%252BBiological%252BActivities%252Bof%252BBivalent%252BCompounds%252BAs%252BPotential%252BNeuroprotectants%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DHe%26aufirst%3DLiu%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D05092017%26date%3D05012018%26date%3D08022018%26date%3D22122017%26volume%3D61%26issue%3D3%26spage%3D777%26epage%3D790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pei  Cai</span>, <span class="hlFld-ContribAuthor ">Si-Qiang  Fang</span>, <span class="hlFld-ContribAuthor ">Xue-Lian  Yang</span>, <span class="hlFld-ContribAuthor ">Jia-Jia  Wu</span>, <span class="hlFld-ContribAuthor ">Qiao-Hong  Liu</span>, <span class="hlFld-ContribAuthor ">Hao  Hong</span>, <span class="hlFld-ContribAuthor ">Xiao-Bing  Wang</span>, and <span class="hlFld-ContribAuthor ">Ling-Yi  Kong</span>  . </span><span class="cited-content_cbyCitation_article-title">Rational Design and Multibiological Profiling of Novel Donepezil–Trolox Hybrids against Alzheimer’s Disease, with Cholinergic, Antioxidant, Neuroprotective, and Cognition Enhancing Properties. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (11)
                                     , 2496-2511. <a href="https://doi.org/10.1021/acschemneuro.7b00257" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00257</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00257%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DRational%252BDesign%252Band%252BMultibiological%252BProfiling%252Bof%252BNovel%252BDonepezil%2525E2%252580%252593Trolox%252BHybrids%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%25252C%252Bwith%252BCholinergic%25252C%252BAntioxidant%25252C%252BNeuroprotective%25252C%252Band%252BCognition%252BEnhancing%252BProperties%26aulast%3DCai%26aufirst%3DPei%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D10072017%26date%3D14082017%26date%3D25082017%26date%3D15112017%26date%3D14082017%26volume%3D8%26issue%3D11%26spage%3D2496%26epage%3D2511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ludovic  Peauger</span>, <span class="hlFld-ContribAuthor ">Rabah  Azzouz</span>, <span class="hlFld-ContribAuthor ">Vincent  Gembus</span>, <span class="hlFld-ContribAuthor ">Mihaela-Liliana  Ţînţaş</span>, <span class="hlFld-ContribAuthor ">Jana  Sopková-de Oliveira Santos</span>, <span class="hlFld-ContribAuthor ">Pierre  Bohn</span>, <span class="hlFld-ContribAuthor ">Cyril  Papamicaël</span>, and <span class="hlFld-ContribAuthor ">Vincent  Levacher</span>  . </span><span class="cited-content_cbyCitation_article-title">Donepezil-Based Central Acetylcholinesterase Inhibitors by Means of a “Bio-Oxidizable” Prodrug Strategy: Design, Synthesis, and in Vitro Biological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (13)
                                     , 5909-5926. <a href="https://doi.org/10.1021/acs.jmedchem.7b00702" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00702</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00702%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDonepezil-Based%252BCentral%252BAcetylcholinesterase%252BInhibitors%252Bby%252BMeans%252Bof%252Ba%252B%2525E2%252580%25259CBio-Oxidizable%2525E2%252580%25259D%252BProdrug%252BStrategy%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252Bin%252BVitro%252BBiological%252BEvaluation%26aulast%3DPeauger%26aufirst%3DLudovic%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D12052017%26date%3D29062017%26date%3D13072017%26date%3D14062017%26volume%3D60%26issue%3D13%26spage%3D5909%26epage%3D5926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anne-Sophie  Cornec</span>, <span class="hlFld-ContribAuthor ">Ludovica  Monti</span>, <span class="hlFld-ContribAuthor ">Jane  Kovalevich</span>, <span class="hlFld-ContribAuthor ">Vishruti  Makani</span>, <span class="hlFld-ContribAuthor ">Michael J.  James</span>, <span class="hlFld-ContribAuthor ">Krishna G.  Vijayendran</span>, <span class="hlFld-ContribAuthor ">Killian  Oukoloff</span>, <span class="hlFld-ContribAuthor ">Yuemang  Yao</span>, <span class="hlFld-ContribAuthor ">Virginia M.-Y.  Lee</span>, <span class="hlFld-ContribAuthor ">John Q.  Trojanowski</span>, <span class="hlFld-ContribAuthor ">Amos B.  Smith, III</span>, <span class="hlFld-ContribAuthor ">Kurt R.  Brunden</span>, and <span class="hlFld-ContribAuthor ">Carlo  Ballatore</span>  . </span><span class="cited-content_cbyCitation_article-title">Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer’s and Other Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (12)
                                     , 5120-5145. <a href="https://doi.org/10.1021/acs.jmedchem.7b00475" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00475</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00475%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMultitargeted%252BImidazoles%25253A%252BPotential%252BTherapeutic%252BLeads%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Band%252BOther%252BNeurodegenerative%252BDiseases%26aulast%3DCornec%26aufirst%3DAnne-Sophie%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D27032017%26date%3D08062017%26date%3D22062017%26date%3D22052017%26volume%3D60%26issue%3D12%26spage%3D5120%26epage%3D5145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weilin  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianfeng  Pei</span>, and <span class="hlFld-ContribAuthor ">Luhua  Lai</span>  . </span><span class="cited-content_cbyCitation_article-title">Computational Multitarget Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (3)
                                     , 403-412. <a href="https://doi.org/10.1021/acs.jcim.6b00491" title="DOI URL">https://doi.org/10.1021/acs.jcim.6b00491</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.6b00491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.6b00491%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DComputational%252BMultitarget%252BDrug%252BDesign%26aulast%3DZhang%26aufirst%3DWeilin%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D19082016%26date%3D23022017%26date%3D27032017%26date%3D06022017%26volume%3D57%26issue%3D3%26spage%3D403%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaokang  Li</span>, <span class="hlFld-ContribAuthor ">Huan  Wang</span>, <span class="hlFld-ContribAuthor ">Zhengyu  Lu</span>, <span class="hlFld-ContribAuthor ">Xinyu  Zheng</span>, <span class="hlFld-ContribAuthor ">Wei  Ni</span>, <span class="hlFld-ContribAuthor ">Jin  Zhu</span>, <span class="hlFld-ContribAuthor ">Yan  Fu</span>, <span class="hlFld-ContribAuthor ">Fulin  Lian</span>, <span class="hlFld-ContribAuthor ">Naixia  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>, <span class="hlFld-ContribAuthor ">Haiyan  Zhang</span>, and <span class="hlFld-ContribAuthor ">Fei  Mao</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of Multifunctional Pyrimidinylthiourea Derivatives as Potential Anti-Alzheimer Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (18)
                                     , 8326-8344. <a href="https://doi.org/10.1021/acs.jmedchem.6b00636" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00636</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00636%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BMultifunctional%252BPyrimidinylthiourea%252BDerivatives%252Bas%252BPotential%252BAnti-Alzheimer%252BAgents%26aulast%3DLi%26aufirst%3DXiaokang%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D25042016%26date%3D06092016%26date%3D22092016%26date%3D23082016%26volume%3D59%26issue%3D18%26spage%3D8326%26epage%3D8344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Serena  Montanari</span>, <span class="hlFld-ContribAuthor ">Laura  Scalvini</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Federica  Belluti</span>, <span class="hlFld-ContribAuthor ">Silvia  Gobbi</span>, <span class="hlFld-ContribAuthor ">Vincenza  Andrisano</span>, <span class="hlFld-ContribAuthor ">Alessia  Ligresti</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Di Marzo</span>, <span class="hlFld-ContribAuthor ">Silvia  Rivara</span>, <span class="hlFld-ContribAuthor ">Marco  Mor</span>, <span class="hlFld-ContribAuthor ">Alessandra  Bisi</span>, and <span class="hlFld-ContribAuthor ">Angela  Rampa</span>  . </span><span class="cited-content_cbyCitation_article-title">Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer’s Disease Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (13)
                                     , 6387-6406. <a href="https://doi.org/10.1021/acs.jmedchem.6b00609" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00609</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00609%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFatty%252BAcid%252BAmide%252BHydrolase%252B%252528FAAH%252529%25252C%252BAcetylcholinesterase%252B%252528AChE%252529%25252C%252Band%252BButyrylcholinesterase%252B%252528BuChE%252529%25253A%252BNetworked%252BTargets%252Bfor%252Bthe%252BDevelopment%252Bof%252BCarbamates%252Bas%252BPotential%252BAnti-Alzheimer%2525E2%252580%252599s%252BDisease%252BAgents%26aulast%3DMontanari%26aufirst%3DSerena%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D20042016%26date%3D28062016%26date%3D14072016%26date%3D16062016%26volume%3D59%26issue%3D13%26spage%3D6387%26epage%3D6406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahesh  Shidore</span>, <span class="hlFld-ContribAuthor ">Jatin  Machhi</span>, <span class="hlFld-ContribAuthor ">Kaushik  Shingala</span>, <span class="hlFld-ContribAuthor ">Prashant  Murumkar</span>, <span class="hlFld-ContribAuthor ">Mayank Kumar  Sharma</span>, <span class="hlFld-ContribAuthor ">Neetesh  Agrawal</span>, <span class="hlFld-ContribAuthor ">Ashutosh  Tripathi</span>, <span class="hlFld-ContribAuthor ">Zalak  Parikh</span>, <span class="hlFld-ContribAuthor ">Prakash  Pillai</span>, and <span class="hlFld-ContribAuthor ">Mange Ram  Yadav</span>  . </span><span class="cited-content_cbyCitation_article-title">Benzylpiperidine-Linked Diarylthiazoles as Potential Anti-Alzheimer’s Agents: Synthesis and Biological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (12)
                                     , 5823-5846. <a href="https://doi.org/10.1021/acs.jmedchem.6b00426" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00426</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00426%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBenzylpiperidine-Linked%252BDiarylthiazoles%252Bas%252BPotential%252BAnti-Alzheimer%2525E2%252580%252599s%252BAgents%25253A%252BSynthesis%252Band%252BBiological%252BEvaluation%26aulast%3DShidore%26aufirst%3DMahesh%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D21032016%26date%3D13062016%26date%3D23062016%26date%3D02062016%26volume%3D59%26issue%3D12%26spage%3D5823%26epage%3D5846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajiv K.  Kar</span>, <span class="hlFld-ContribAuthor ">Zuzana  Gazova</span>, <span class="hlFld-ContribAuthor ">Zuzana  Bednarikova</span>, <span class="hlFld-ContribAuthor ">Kamal H.  Mroue</span>, <span class="hlFld-ContribAuthor ">Anirban  Ghosh</span>, <span class="hlFld-ContribAuthor ">Ruiyan  Zhang</span>, <span class="hlFld-ContribAuthor ">Katarina  Ulicna</span>, <span class="hlFld-ContribAuthor ">Hans-Christian  Siebert</span>, <span class="hlFld-ContribAuthor ">Nikolay E.  Nifantiev</span>, and <span class="hlFld-ContribAuthor ">Anirban  Bhunia</span>  . </span><span class="cited-content_cbyCitation_article-title">Evidence for Inhibition of Lysozyme Amyloid Fibrillization by Peptide Fragments from Human Lysozyme: A Combined Spectroscopy, Microscopy, and Docking Study. </span><span class="cited-content_cbyCitation_journal-name">Biomacromolecules</span><span> <strong>2016,</strong> <em>17 </em>
                                    (6)
                                     , 1998-2009. <a href="https://doi.org/10.1021/acs.biomac.6b00165" title="DOI URL">https://doi.org/10.1021/acs.biomac.6b00165</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biomac.6b00165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biomac.6b00165%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomacromolecules%26atitle%3DEvidence%252Bfor%252BInhibition%252Bof%252BLysozyme%252BAmyloid%252BFibrillization%252Bby%252BPeptide%252BFragments%252Bfrom%252BHuman%252BLysozyme%25253A%252BA%252BCombined%252BSpectroscopy%25252C%252BMicroscopy%25252C%252Band%252BDocking%252BStudy%26aulast%3DKar%26aufirst%3DRajiv%2BK.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D01022016%26date%3D25042016%26date%3D03052016%26date%3D13062016%26date%3D26042016%26volume%3D17%26issue%3D6%26spage%3D1998%26epage%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aubrie A.  Harland</span>, <span class="hlFld-ContribAuthor ">Aaron M.  Bender</span>, <span class="hlFld-ContribAuthor ">Nicholas W.  Griggs</span>, <span class="hlFld-ContribAuthor ">Chao  Gao</span>, <span class="hlFld-ContribAuthor ">Jessica P.  Anand</span>, <span class="hlFld-ContribAuthor ">Irina D.  Pogozheva</span>, <span class="hlFld-ContribAuthor ">John R.  Traynor</span>, <span class="hlFld-ContribAuthor ">Emily M.  Jutkiewicz</span>, and <span class="hlFld-ContribAuthor ">Henry I.  Mosberg</span>  . </span><span class="cited-content_cbyCitation_article-title">Effects of N-Substitutions on the Tetrahydroquinoline (THQ) Core of Mixed-Efficacy μ-Opioid Receptor (MOR)/δ-Opioid Receptor (DOR) Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (10)
                                     , 4985-4998. <a href="https://doi.org/10.1021/acs.jmedchem.6b00308" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00308</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00308%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DEffects%252Bof%252BN-Substitutions%252Bon%252Bthe%252BTetrahydroquinoline%252B%252528THQ%252529%252BCore%252Bof%252BMixed-Efficacy%252B%2525CE%2525BC-Opioid%252BReceptor%252B%252528MOR%252529%25252F%2525CE%2525B4-Opioid%252BReceptor%252B%252528DOR%252529%252BLigands%26aulast%3DHarland%26aufirst%3DAubrie%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D02032016%26date%3D16052016%26date%3D26052016%26date%3D05052016%26volume%3D59%26issue%3D10%26spage%3D4985%26epage%3D4998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rita Maria Concetta  Di Martino</span>, <span class="hlFld-ContribAuthor ">Angela  De Simone</span>, <span class="hlFld-ContribAuthor ">Vincenza  Andrisano</span>, <span class="hlFld-ContribAuthor ">Paola  Bisignano</span>, <span class="hlFld-ContribAuthor ">Alessandra  Bisi</span>, <span class="hlFld-ContribAuthor ">Silvia  Gobbi</span>, <span class="hlFld-ContribAuthor ">Angela  Rampa</span>, <span class="hlFld-ContribAuthor ">Romana  Fato</span>, <span class="hlFld-ContribAuthor ">Christian  Bergamini</span>, <span class="hlFld-ContribAuthor ">Daniel I.  Perez</span>, <span class="hlFld-ContribAuthor ">Ana  Martinez</span>, <span class="hlFld-ContribAuthor ">Giovanni  Bottegoni</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>, and <span class="hlFld-ContribAuthor ">Federica  Belluti</span>  . </span><span class="cited-content_cbyCitation_article-title">Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (2)
                                     , 531-544. <a href="https://doi.org/10.1021/acs.jmedchem.5b00894" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00894</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00894%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DVersatility%252Bof%252Bthe%252BCurcumin%252BScaffold%25253A%252BDiscovery%252Bof%252BPotent%252Band%252BBalanced%252BDual%252BBACE-1%252Band%252BGSK-3%2525CE%2525B2%252BInhibitors%26aulast%3DDi%2BMartino%26aufirst%3DRita%2BMaria%2BConcetta%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D10062015%26date%3D07012016%26date%3D28012016%26date%3D22122015%26volume%3D59%26issue%3D2%26spage%3D531%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Banibrata  Das</span>, <span class="hlFld-ContribAuthor ">Seenuvasan  Vedachalam</span>, <span class="hlFld-ContribAuthor ">Dan  Luo</span>, <span class="hlFld-ContribAuthor ">Tamara  Antonio</span>, <span class="hlFld-ContribAuthor ">Maarten E. A.  Reith</span>, and <span class="hlFld-ContribAuthor ">Aloke K.  Dutta</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of a Highly Potent D2/D3 Agonist and a Partial Agonist from Structure–Activity Relationship Study of N6-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine Analogues: Implication in the Treatment of Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (23)
                                     , 9179-9195. <a href="https://doi.org/10.1021/acs.jmedchem.5b01031" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01031%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Ba%252BHighly%252BPotent%252BD2%25252FD3%252BAgonist%252Band%252Ba%252BPartial%252BAgonist%252Bfrom%252BStructure%2525E2%252580%252593Activity%252BRelationship%252BStudy%252Bof%252BN6-%2525282-%2525284-%2525281H-Indol-5-yl%252529piperazin-1-yl%252529ethyl%252529-N6-propyl-4%25252C5%25252C6%25252C7-tetrahydrobenzo%25255Bd%25255Dthiazole-2%25252C6-diamine%252BAnalogues%25253A%252BImplication%252Bin%252Bthe%252BTreatment%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DDas%26aufirst%3DBanibrata%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D01072015%26date%3D30112015%26date%3D10122015%26date%3D10112015%26volume%3D58%26issue%3D23%26spage%3D9179%26epage%3D9195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aubrie A.  Harland</span>, <span class="hlFld-ContribAuthor ">Larisa  Yeomans</span>, <span class="hlFld-ContribAuthor ">Nicholas W.  Griggs</span>, <span class="hlFld-ContribAuthor ">Jessica P.  Anand</span>, <span class="hlFld-ContribAuthor ">Irina D.  Pogozheva</span>, <span class="hlFld-ContribAuthor ">Emily M.  Jutkiewicz</span>, <span class="hlFld-ContribAuthor ">John R.  Traynor</span>, and <span class="hlFld-ContribAuthor ">Henry I.  Mosberg</span>  . </span><span class="cited-content_cbyCitation_article-title">Further Optimization and Evaluation of Bioavailable, Mixed-Efficacy μ-Opioid Receptor (MOR) Agonists/δ-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (22)
                                     , 8952-8969. <a href="https://doi.org/10.1021/acs.jmedchem.5b01270" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01270</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01270%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFurther%252BOptimization%252Band%252BEvaluation%252Bof%252BBioavailable%25252C%252BMixed-Efficacy%252B%2525CE%2525BC-Opioid%252BReceptor%252B%252528MOR%252529%252BAgonists%25252F%2525CE%2525B4-Opioid%252BReceptor%252B%252528DOR%252529%252BAntagonists%25253A%252BBalancing%252BMOR%252Band%252BDOR%252BAffinities%26aulast%3DHarland%26aufirst%3DAubrie%2BA.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D12082015%26date%3D13112015%26date%3D25112015%26date%3D02112015%26volume%3D58%26issue%3D22%26spage%3D8952%26epage%3D8969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eugenie  Nepovimova</span>, <span class="hlFld-ContribAuthor ">Jan  Korabecny</span>, <span class="hlFld-ContribAuthor ">Rafael  Dolezal</span>, <span class="hlFld-ContribAuthor ">Katerina  Babkova</span>, <span class="hlFld-ContribAuthor ">Ales  Ondrejicek</span>, <span class="hlFld-ContribAuthor ">Daniel  Jun</span>, <span class="hlFld-ContribAuthor ">Vendula  Sepsova</span>, <span class="hlFld-ContribAuthor ">Anna  Horova</span>, <span class="hlFld-ContribAuthor ">Martina  Hrabinova</span>, <span class="hlFld-ContribAuthor ">Ondrej  Soukup</span>, <span class="hlFld-ContribAuthor ">Neslihan  Bukum</span>, <span class="hlFld-ContribAuthor ">Petr  Jost</span>, <span class="hlFld-ContribAuthor ">Lubica  Muckova</span>, <span class="hlFld-ContribAuthor ">Jiri  Kassa</span>, <span class="hlFld-ContribAuthor ">David  Malinak</span>, <span class="hlFld-ContribAuthor ">Martin  Andrs</span>, and <span class="hlFld-ContribAuthor ">Kamil  Kuca</span>  . </span><span class="cited-content_cbyCitation_article-title">Tacrine–Trolox Hybrids: A Novel Class of Centrally Active, Nonhepatotoxic Multi-Target-Directed Ligands Exerting Anticholinesterase and Antioxidant Activities with Low In Vivo Toxicity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (22)
                                     , 8985-9003. <a href="https://doi.org/10.1021/acs.jmedchem.5b01325" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01325</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01325%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTacrine%2525E2%252580%252593Trolox%252BHybrids%25253A%252BA%252BNovel%252BClass%252Bof%252BCentrally%252BActive%25252C%252BNonhepatotoxic%252BMulti-Target-Directed%252BLigands%252BExerting%252BAnticholinesterase%252Band%252BAntioxidant%252BActivities%252Bwith%252BLow%252BIn%252BVivo%252BToxicity%26aulast%3DNepovimova%26aufirst%3DEugenie%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D27082015%26date%3D10112015%26date%3D25112015%26date%3D27102015%26volume%3D58%26issue%3D22%26spage%3D8985%26epage%3D9003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Prati</span>, <span class="hlFld-ContribAuthor ">Angela  De Simone</span>, <span class="hlFld-ContribAuthor ">Andrea  Armirotti</span>, <span class="hlFld-ContribAuthor ">Maria  Summa</span>, <span class="hlFld-ContribAuthor ">Daniela  Pizzirani</span>, <span class="hlFld-ContribAuthor ">Rita  Scarpelli</span>, <span class="hlFld-ContribAuthor ">Sine Mandrup  Bertozzi</span>, <span class="hlFld-ContribAuthor ">Daniel I.  Perez</span>, <span class="hlFld-ContribAuthor ">Vincenza  Andrisano</span>, <span class="hlFld-ContribAuthor ">Ana  Perez-Castillo</span>, <span class="hlFld-ContribAuthor ">Barbara  Monti</span>, <span class="hlFld-ContribAuthor ">Francesca  Massenzio</span>, <span class="hlFld-ContribAuthor ">Letizia  Polito</span>, <span class="hlFld-ContribAuthor ">Marco  Racchi</span>, <span class="hlFld-ContribAuthor ">Piera  Sabatino</span>, <span class="hlFld-ContribAuthor ">Giovanni  Bottegoni</span>, <span class="hlFld-ContribAuthor ">Ana  Martinez</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>, and <span class="hlFld-ContribAuthor ">Maria L.  Bolognesi</span>  . </span><span class="cited-content_cbyCitation_article-title">3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2015,</strong> <em>6 </em>
                                    (10)
                                     , 1665-1682. <a href="https://doi.org/10.1021/acschemneuro.5b00121" title="DOI URL">https://doi.org/10.1021/acschemneuro.5b00121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.5b00121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.5b00121%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3D3%25252C4-Dihydro-1%25252C3%25252C5-triazin-2%2525281H%252529-ones%252Bas%252Bthe%252BFirst%252BDual%252BBACE-1%25252FGSK-3%2525CE%2525B2%252BFragment%252BHits%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DPrati%26aufirst%3DFederica%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D21042015%26date%3D14072015%26date%3D03082015%26date%3D21102015%26date%3D14072015%26volume%3D6%26issue%3D10%26spage%3D1665%26epage%3D1682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irene  Sola</span>, <span class="hlFld-ContribAuthor ">Ester  Aso</span>, <span class="hlFld-ContribAuthor ">Daniela  Frattini</span>, <span class="hlFld-ContribAuthor ">Irene  López-González</span>, <span class="hlFld-ContribAuthor ">Alba  Espargaró</span>, <span class="hlFld-ContribAuthor ">Raimon  Sabaté</span>, <span class="hlFld-ContribAuthor ">Ornella  Di Pietro</span>, <span class="hlFld-ContribAuthor ">F. Javier  Luque</span>, <span class="hlFld-ContribAuthor ">M. Victòria  Clos</span>, <span class="hlFld-ContribAuthor ">Isidro  Ferrer</span>, and <span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Levetiracetam Derivatives That Are Effective against the Alzheimer-like Phenotype in Mice: Synthesis, in Vitro, ex Vivo, and in Vivo Efficacy Studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (15)
                                     , 6018-6032. <a href="https://doi.org/10.1021/acs.jmedchem.5b00624" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00624</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00624%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BLevetiracetam%252BDerivatives%252BThat%252BAre%252BEffective%252Bagainst%252Bthe%252BAlzheimer-like%252BPhenotype%252Bin%252BMice%25253A%252BSynthesis%25252C%252Bin%252BVitro%25252C%252Bex%252BVivo%25252C%252Band%252Bin%252BVivo%252BEfficacy%252BStudies%26aulast%3DSola%26aufirst%3DIrene%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D23042015%26date%3D27072015%26date%3D13082015%26date%3D16072015%26volume%3D58%26issue%3D15%26spage%3D6018%26epage%3D6032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christophe  Rochais</span>, <span class="hlFld-ContribAuthor ">Cédric  Lecoutey</span>, <span class="hlFld-ContribAuthor ">Florence  Gaven</span>, <span class="hlFld-ContribAuthor ">Patrizia  Giannoni</span>, <span class="hlFld-ContribAuthor ">Katia  Hamidouche</span>, <span class="hlFld-ContribAuthor ">Damien  Hedou</span>, <span class="hlFld-ContribAuthor ">Emmanuelle  Dubost</span>, <span class="hlFld-ContribAuthor ">David  Genest</span>, <span class="hlFld-ContribAuthor ">Samir  Yahiaoui</span>, <span class="hlFld-ContribAuthor ">Thomas  Freret</span>, <span class="hlFld-ContribAuthor ">Valentine  Bouet</span>, <span class="hlFld-ContribAuthor ">François  Dauphin</span>, <span class="hlFld-ContribAuthor ">Jana  Sopkova de Oliveira Santos</span>, <span class="hlFld-ContribAuthor ">Céline  Ballandonne</span>, <span class="hlFld-ContribAuthor ">Sophie  Corvaisier</span>, <span class="hlFld-ContribAuthor ">Aurélie  Malzert-Fréon</span>, <span class="hlFld-ContribAuthor ">Remi  Legay</span>, <span class="hlFld-ContribAuthor ">Michel  Boulouard</span>, <span class="hlFld-ContribAuthor ">Sylvie  Claeysen</span>, and <span class="hlFld-ContribAuthor ">Patrick  Dallemagne</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT4R) Agonist Activities As Potential Agents against Alzheimer’s Disease: The Design of Donecopride. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (7)
                                     , 3172-3187. <a href="https://doi.org/10.1021/acs.jmedchem.5b00115" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00115%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BMultitarget-Directed%252BLigands%252B%252528MTDLs%252529%252Bwith%252BAcetylcholinesterase%252B%252528AChE%252529%252BInhibitory%252Band%252BSerotonergic%252BSubtype%252B4%252BReceptor%252B%2525285-HT4R%252529%252BAgonist%252BActivities%252BAs%252BPotential%252BAgents%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BThe%252BDesign%252Bof%252BDonecopride%26aulast%3DRochais%26aufirst%3DChristophe%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D21012015%26date%3D31032015%26date%3D09042015%26date%3D20032015%26volume%3D58%26issue%3D7%26spage%3D3172%26epage%3D3187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valentina  Oliveri</span>, <span class="hlFld-ContribAuthor ">Giuseppa I.  Grasso</span>, <span class="hlFld-ContribAuthor ">Francesco  Bellia</span>, <span class="hlFld-ContribAuthor ">Francesco  Attanasio</span>, <span class="hlFld-ContribAuthor ">Maurizio  Viale</span>, and <span class="hlFld-ContribAuthor ">Graziella  Vecchio</span>  . </span><span class="cited-content_cbyCitation_article-title">Soluble Sugar-Based Quinoline Derivatives as New Antioxidant Modulators of Metal-Induced Amyloid Aggregation. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2015,</strong> <em>54 </em>
                                    (6)
                                     , 2591-2602. <a href="https://doi.org/10.1021/ic502713f" title="DOI URL">https://doi.org/10.1021/ic502713f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ic502713f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fic502713f%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3DSoluble%252BSugar-Based%252BQuinoline%252BDerivatives%252Bas%252BNew%252BAntioxidant%252BModulators%252Bof%252BMetal-Induced%252BAmyloid%252BAggregation%26aulast%3DOliveri%26aufirst%3DValentina%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D13112014%26date%3D02032015%26date%3D16032015%26volume%3D54%26issue%3D6%26spage%3D2591%26epage%3D2602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiansong  Fang</span>, <span class="hlFld-ContribAuthor ">Yongjie  Li</span>, <span class="hlFld-ContribAuthor ">Rui  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaocong  Pang</span>, <span class="hlFld-ContribAuthor ">Chao  Li</span>, <span class="hlFld-ContribAuthor ">Ranyao  Yang</span>, <span class="hlFld-ContribAuthor ">Yangyang  He</span>, <span class="hlFld-ContribAuthor ">Wenwen  Lian</span>, <span class="hlFld-ContribAuthor ">Ai-Lin  Liu</span>, and <span class="hlFld-ContribAuthor ">Guan-Hua  Du</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Multitarget-Directed Ligands against Alzheimer’s Disease through Systematic Prediction of Chemical–Protein Interactions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2015,</strong> <em>55 </em>
                                    (1)
                                     , 149-164. <a href="https://doi.org/10.1021/ci500574n" title="DOI URL">https://doi.org/10.1021/ci500574n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci500574n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci500574n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DDiscovery%252Bof%252BMultitarget-Directed%252BLigands%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%252Bthrough%252BSystematic%252BPrediction%252Bof%252BChemical%2525E2%252580%252593Protein%252BInteractions%26aulast%3DFang%26aufirst%3DJiansong%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D21092014%26date%3D13012015%26date%3D26012015%26date%3D22122014%26volume%3D55%26issue%3D1%26spage%3D149%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oscar M.  Bautista-Aguilera</span>, <span class="hlFld-ContribAuthor ">Abdelouahid  Samadi</span>, <span class="hlFld-ContribAuthor ">Mourad  Chioua</span>, <span class="hlFld-ContribAuthor ">Katarina  Nikolic</span>, <span class="hlFld-ContribAuthor ">Slavica  Filipic</span>, <span class="hlFld-ContribAuthor ">Danica  Agbaba</span>, <span class="hlFld-ContribAuthor ">Elena  Soriano</span>, <span class="hlFld-ContribAuthor ">Lucía  de Andrés</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>, <span class="hlFld-ContribAuthor ">Stefano  Alcaro</span>, <span class="hlFld-ContribAuthor ">Rona R.  Ramsay</span>, <span class="hlFld-ContribAuthor ">Francesco  Ortuso</span>, <span class="hlFld-ContribAuthor ">Matilde  Yañez</span>, and <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>  . </span><span class="cited-content_cbyCitation_article-title">N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a New Cholinesterase and Monoamine Oxidase Dual Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (24)
                                     , 10455-10463. <a href="https://doi.org/10.1021/jm501501a" title="DOI URL">https://doi.org/10.1021/jm501501a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501501a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501501a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DN-Methyl-N-%252528%2525281-methyl-5-%2525283-%2525281-%2525282-methylbenzyl%252529piperidin-4-yl%252529propoxy%252529-1H-indol-2-yl%252529methyl%252529prop-2-yn-1-amine%25252C%252Ba%252BNew%252BCholinesterase%252Band%252BMonoamine%252BOxidase%252BDual%252BInhibitor%26aulast%3DBautista-Aguilera%26aufirst%3DOscar%2BM.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D18092014%26date%3D08122014%26date%3D26122014%26date%3D24112014%26volume%3D57%26issue%3D24%26spage%3D10455%26epage%3D10463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eugenie  Nepovimova</span>, <span class="hlFld-ContribAuthor ">Elisa  Uliassi</span>, <span class="hlFld-ContribAuthor ">Jan  Korabecny</span>, <span class="hlFld-ContribAuthor ">Luis Emiliano  Peña-Altamira</span>, <span class="hlFld-ContribAuthor ">Sarah  Samez</span>, <span class="hlFld-ContribAuthor ">Alessandro  Pesaresi</span>, <span class="hlFld-ContribAuthor ">Gregory E.  Garcia</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Vincenza  Andrisano</span>, <span class="hlFld-ContribAuthor ">Christian  Bergamini</span>, <span class="hlFld-ContribAuthor ">Romana  Fato</span>, <span class="hlFld-ContribAuthor ">Doriano  Lamba</span>, <span class="hlFld-ContribAuthor ">Marinella  Roberti</span>, <span class="hlFld-ContribAuthor ">Kamil  Kuca</span>, <span class="hlFld-ContribAuthor ">Barbara  Monti</span>, and <span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>  . </span><span class="cited-content_cbyCitation_article-title">Multitarget Drug Design Strategy: Quinone–Tacrine Hybrids Designed To Block Amyloid-β Aggregation and To Exert Anticholinesterase and Antioxidant Effects. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (20)
                                     , 8576-8589. <a href="https://doi.org/10.1021/jm5010804" title="DOI URL">https://doi.org/10.1021/jm5010804</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5010804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5010804%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMultitarget%252BDrug%252BDesign%252BStrategy%25253A%252BQuinone%2525E2%252580%252593Tacrine%252BHybrids%252BDesigned%252BTo%252BBlock%252BAmyloid-%2525CE%2525B2%252BAggregation%252Band%252BTo%252BExert%252BAnticholinesterase%252Band%252BAntioxidant%252BEffects%26aulast%3DNepovimova%26aufirst%3DEugenie%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D17072014%26date%3D10102014%26date%3D23102014%26date%3D26092014%26volume%3D57%26issue%3D20%26spage%3D8576%26epage%3D8589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koneni V.  Sashidhara</span>, <span class="hlFld-ContribAuthor ">Ram K.  Modukuri</span>, <span class="hlFld-ContribAuthor ">Pooja  Jadiya</span>, <span class="hlFld-ContribAuthor ">K. Bhaskara  Rao</span>, <span class="hlFld-ContribAuthor ">Tanuj  Sharma</span>, <span class="hlFld-ContribAuthor ">Rizwanul  Haque</span>, <span class="hlFld-ContribAuthor ">Deependra Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Dibyendu  Banerjee</span>, <span class="hlFld-ContribAuthor ">Mohammad Imran  Siddiqi</span>, and <span class="hlFld-ContribAuthor ">Aamir  Nazir</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-Arylcoumarin-tetracyclic Tacrine Hybrids as Multifunctional Agents against Parkinson’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (10)
                                     , 1099-1103. <a href="https://doi.org/10.1021/ml500222g" title="DOI URL">https://doi.org/10.1021/ml500222g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml500222g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml500222g%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B3-Arylcoumarin-tetracyclic%252BTacrine%252BHybrids%252Bas%252BMultifunctional%252BAgents%252Bagainst%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DSashidhara%26aufirst%3DKoneni%2BV.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D28052014%26date%3D20082014%26date%3D25082014%26date%3D09102014%26date%3D20082014%26volume%3D5%26issue%3D10%26spage%3D1099%26epage%3D1103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alejandro  Romero</span>, <span class="hlFld-ContribAuthor ">Javier  Egea</span>, <span class="hlFld-ContribAuthor ">Gema C.  González-Muñoz</span>, <span class="hlFld-ContribAuthor ">M<sup>a</sup> Dolores  Martı́n de Saavedra</span>, <span class="hlFld-ContribAuthor ">Laura  del Barrio</span>, <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>, <span class="hlFld-ContribAuthor ">Santiago  Conde</span>, <span class="hlFld-ContribAuthor ">Manuela G.  López</span>, <span class="hlFld-ContribAuthor ">Mercedes  Villarroya</span>, and <span class="hlFld-ContribAuthor ">Cristóbal  de los Ríos</span>  . </span><span class="cited-content_cbyCitation_article-title">ITH12410/SC058: A New Neuroprotective Compound with Potential in the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2014,</strong> <em>5 </em>
                                    (9)
                                     , 770-775. <a href="https://doi.org/10.1021/cn500131t" title="DOI URL">https://doi.org/10.1021/cn500131t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn500131t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn500131t%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DITH12410%25252FSC058%25253A%252BA%252BNew%252BNeuroprotective%252BCompound%252Bwith%252BPotential%252Bin%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DRomero%26aufirst%3DAlejandro%26date%3D2014%26date%3D2014%26date%3D10072014%26date%3D15072014%26date%3D17092014%26date%3D10072014%26volume%3D5%26issue%3D9%26spage%3D770%26epage%3D775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gyan  Modi</span>, <span class="hlFld-ContribAuthor ">Chandrashekhar  Voshavar</span>, <span class="hlFld-ContribAuthor ">Sanjib  Gogoi</span>, <span class="hlFld-ContribAuthor ">Mrudang  Shah</span>, <span class="hlFld-ContribAuthor ">Tamara  Antonio</span>, <span class="hlFld-ContribAuthor ">Maarten E. A.  Reith</span>, and <span class="hlFld-ContribAuthor ">Aloke K.  Dutta</span>  . </span><span class="cited-content_cbyCitation_article-title">Multifunctional D2/D3 Agonist D-520 with High in Vivo Efficacy: Modulator of Toxicity of Alpha-Synuclein Aggregates. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2014,</strong> <em>5 </em>
                                    (8)
                                     , 700-717. <a href="https://doi.org/10.1021/cn500084x" title="DOI URL">https://doi.org/10.1021/cn500084x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn500084x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn500084x%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DMultifunctional%252BD2%25252FD3%252BAgonist%252BD-520%252Bwith%252BHigh%252Bin%252BVivo%252BEfficacy%25253A%252BModulator%252Bof%252BToxicity%252Bof%252BAlpha-Synuclein%252BAggregates%26aulast%3DModi%26aufirst%3DGyan%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D17042014%26date%3D24062014%26date%3D09072014%26date%3D20082014%26date%3D24062014%26volume%3D5%26issue%3D8%26spage%3D700%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianfeng  Pei</span>, <span class="hlFld-ContribAuthor ">Ning  Yin</span>, <span class="hlFld-ContribAuthor ">Xiaomin  Ma</span>, and <span class="hlFld-ContribAuthor ">Luhua  Lai</span>  . </span><span class="cited-content_cbyCitation_article-title">Systems Biology Brings New Dimensions for Structure-Based Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2014,</strong> <em>136 </em>
                                    (33)
                                     , 11556-11565. <a href="https://doi.org/10.1021/ja504810z" title="DOI URL">https://doi.org/10.1021/ja504810z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja504810z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja504810z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DSystems%252BBiology%252BBrings%252BNew%252BDimensions%252Bfor%252BStructure-Based%252BDrug%252BDesign%26aulast%3DPei%26aufirst%3DJianfeng%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D14052014%26date%3D06082014%26date%3D20082014%26date%3D25072014%26volume%3D136%26issue%3D33%26spage%3D11556%26epage%3D11565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alban  Lepailleur</span>, <span class="hlFld-ContribAuthor ">Thomas  Freret</span>, <span class="hlFld-ContribAuthor ">Stéphane  Lemaître</span>, <span class="hlFld-ContribAuthor ">Michel  Boulouard</span>, <span class="hlFld-ContribAuthor ">François  Dauphin</span>, <span class="hlFld-ContribAuthor ">Antoine  Hinschberger</span>, <span class="hlFld-ContribAuthor ">Fabienne  Dulin</span>, <span class="hlFld-ContribAuthor ">Aurélien  Lesnard</span>, <span class="hlFld-ContribAuthor ">Ronan  Bureau</span>, and <span class="hlFld-ContribAuthor ">Sylvain  Rault</span>  . </span><span class="cited-content_cbyCitation_article-title">Dual Histamine H3R/Serotonin 5-HT4R Ligands with Antiamnesic Properties: Pharmacophore-Based Virtual Screening and Polypharmacology. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2014,</strong> <em>54 </em>
                                    (6)
                                     , 1773-1784. <a href="https://doi.org/10.1021/ci500157n" title="DOI URL">https://doi.org/10.1021/ci500157n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci500157n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci500157n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DDual%252BHistamine%252BH3R%25252FSerotonin%252B5-HT4R%252BLigands%252Bwith%252BAntiamnesic%252BProperties%25253A%252BPharmacophore-Based%252BVirtual%252BScreening%252Band%252BPolypharmacology%26aulast%3DLepailleur%26aufirst%3DAlban%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D12032014%26date%3D10062014%26date%3D23062014%26date%3D23052014%26volume%3D54%26issue%3D6%26spage%3D1773%26epage%3D1784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Beatriz  López-Iglesias</span>, <span class="hlFld-ContribAuthor ">Concepción  Pérez</span>, <span class="hlFld-ContribAuthor ">José A.  Morales-García</span>, <span class="hlFld-ContribAuthor ">Sandra  Alonso-Gil</span>, <span class="hlFld-ContribAuthor ">Ana  Pérez-Castillo</span>, <span class="hlFld-ContribAuthor ">Alejandro  Romero</span>, <span class="hlFld-ContribAuthor ">Manuela G.  López</span>, <span class="hlFld-ContribAuthor ">Mercedes  Villarroya</span>, <span class="hlFld-ContribAuthor ">Santiago  Conde</span>, and <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>  . </span><span class="cited-content_cbyCitation_article-title">New Melatonin–N,N-Dibenzyl(N-methyl)amine Hybrids: Potent Neurogenic Agents with Antioxidant, Cholinergic, and Neuroprotective Properties as Innovative Drugs for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (9)
                                     , 3773-3785. <a href="https://doi.org/10.1021/jm5000613" title="DOI URL">https://doi.org/10.1021/jm5000613</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5000613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5000613%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252BMelatonin%2525E2%252580%252593N%25252CN-Dibenzyl%252528N-methyl%252529amine%252BHybrids%25253A%252BPotent%252BNeurogenic%252BAgents%252Bwith%252BAntioxidant%25252C%252BCholinergic%25252C%252Band%252BNeuroprotective%252BProperties%252Bas%252BInnovative%252BDrugs%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DL%25C3%25B3pez-Iglesias%26aufirst%3DBeatriz%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D13012014%26date%3D28042014%26date%3D08052014%26date%3D16042014%26volume%3D57%26issue%3D9%26spage%3D3773%26epage%3D3785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erchang  Shang</span>, <span class="hlFld-ContribAuthor ">Yaxia  Yuan</span>, <span class="hlFld-ContribAuthor ">Xinyi  Chen</span>, <span class="hlFld-ContribAuthor ">Ying  Liu</span>, <span class="hlFld-ContribAuthor ">Jianfeng  Pei</span>, and <span class="hlFld-ContribAuthor ">Luhua  Lai</span>  . </span><span class="cited-content_cbyCitation_article-title">De Novo Design of Multitarget Ligands with an Iterative Fragment-Growing Strategy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2014,</strong> <em>54 </em>
                                    (4)
                                     , 1235-1241. <a href="https://doi.org/10.1021/ci500021v" title="DOI URL">https://doi.org/10.1021/ci500021v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci500021v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci500021v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DDe%252BNovo%252BDesign%252Bof%252BMultitarget%252BLigands%252Bwith%252Ban%252BIterative%252BFragment-Growing%252BStrategy%26aulast%3DShang%26aufirst%3DErchang%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D11012014%26date%3D18032014%26date%3D28042014%26date%3D10032014%26volume%3D54%26issue%3D4%26spage%3D1235%26epage%3D1241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dingxin  Jiang</span>, <span class="hlFld-ContribAuthor ">Xiaohua  Zheng</span>, <span class="hlFld-ContribAuthor ">Guang  Shao</span>, <span class="hlFld-ContribAuthor ">Zhang  Ling</span>, and <span class="hlFld-ContribAuthor ">Hanhong  Xu</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Novel Series of Phenyl Pyrazole Inner Salts Based on Fipronil as Potential Dual-Target Insecticides. </span><span class="cited-content_cbyCitation_journal-name">Journal of Agricultural and Food Chemistry</span><span> <strong>2014,</strong> <em>62 </em>
                                    (16)
                                     , 3577-3583. <a href="https://doi.org/10.1021/jf405512e" title="DOI URL">https://doi.org/10.1021/jf405512e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jf405512e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjf405512e%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Agricultural%2520and%2520Food%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BNovel%252BSeries%252Bof%252BPhenyl%252BPyrazole%252BInner%252BSalts%252BBased%252Bon%252BFipronil%252Bas%252BPotential%252BDual-Target%252BInsecticides%26aulast%3DJiang%26aufirst%3DDingxin%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D2014%26date%3D26122013%26date%3D01042014%26date%3D01042014%26date%3D08042014%26date%3D23042014%26date%3D01042014%26volume%3D62%26issue%3D16%26spage%3D3577%26epage%3D3583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michela  Rosini</span>, <span class="hlFld-ContribAuthor ">Elena  Simoni</span>, <span class="hlFld-ContribAuthor ">Andrea  Milelli</span>, <span class="hlFld-ContribAuthor ">Anna  Minarini</span>, and <span class="hlFld-ContribAuthor ">Carlo  Melchiorre</span>  . </span><span class="cited-content_cbyCitation_article-title">Oxidative Stress in Alzheimer’s Disease: Are We Connecting the Dots?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (7)
                                     , 2821-2831. <a href="https://doi.org/10.1021/jm400970m" title="DOI URL">https://doi.org/10.1021/jm400970m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400970m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400970m%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOxidative%252BStress%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BAre%252BWe%252BConnecting%252Bthe%252BDots%25253F%26aulast%3DRosini%26aufirst%3DMichela%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D27062013%26date%3D05112013%26date%3D10042014%26date%3D16102013%26volume%3D57%26issue%3D7%26spage%3D2821%26epage%3D2831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elisabet  Viayna</span>, <span class="hlFld-ContribAuthor ">Irene  Sola</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Angela  De Simone</span>, <span class="hlFld-ContribAuthor ">Cheril  Tapia-Rojas</span>, <span class="hlFld-ContribAuthor ">Felipe G.  Serrano</span>, <span class="hlFld-ContribAuthor ">Raimon  Sabaté</span>, <span class="hlFld-ContribAuthor ">Jordi  Juárez-Jiménez</span>, <span class="hlFld-ContribAuthor ">Belén  Pérez</span>, <span class="hlFld-ContribAuthor ">F. Javier  Luque</span>, <span class="hlFld-ContribAuthor ">Vincenza  Andrisano</span>, <span class="hlFld-ContribAuthor ">M. Victòria  Clos</span>, <span class="hlFld-ContribAuthor ">Nibaldo C.  Inestrosa</span>, and <span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Multitarget Biological Profiling of a Novel Family of Rhein Derivatives As Disease-Modifying Anti-Alzheimer Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (6)
                                     , 2549-2567. <a href="https://doi.org/10.1021/jm401824w" title="DOI URL">https://doi.org/10.1021/jm401824w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401824w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401824w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BMultitarget%252BBiological%252BProfiling%252Bof%252Ba%252BNovel%252BFamily%252Bof%252BRhein%252BDerivatives%252BAs%252BDisease-Modifying%252BAnti-Alzheimer%252BAgents%26aulast%3DViayna%26aufirst%3DElisabet%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D26112013%26date%3D10032014%26date%3D27032014%26date%3D25022014%26volume%3D57%26issue%3D6%26spage%3D2549%26epage%3D2567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gyan  Modi</span>, <span class="hlFld-ContribAuthor ">Tamara  Antonio</span>, <span class="hlFld-ContribAuthor ">Maarten  Reith</span>, and <span class="hlFld-ContribAuthor ">Aloke  Dutta</span>  . </span><span class="cited-content_cbyCitation_article-title">Structural Modifications of Neuroprotective Anti-Parkinsonian (−)-N6-(2-(4-(Biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264): An Effort toward the Improvement of in Vivo Efficacy of the Parent Molecule. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (4)
                                     , 1557-1572. <a href="https://doi.org/10.1021/jm401883v" title="DOI URL">https://doi.org/10.1021/jm401883v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401883v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401883v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252BModifications%252Bof%252BNeuroprotective%252BAnti-Parkinsonian%252B%252528%2525E2%252588%252592%252529-N6-%2525282-%2525284-%252528Biphenyl-4-yl%252529piperazin-1-yl%252529-ethyl%252529-N6-propyl-4%25252C5%25252C6%25252C7-tetrahydrobenzo%25255Bd%25255Dthiazole-2%25252C6-diamine%252B%252528D-264%252529%25253A%252BAn%252BEffort%252Btoward%252Bthe%252BImprovement%252Bof%252Bin%252BVivo%252BEfficacy%252Bof%252Bthe%252BParent%252BMolecule%26aulast%3DModi%26aufirst%3DGyan%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D08122013%26date%3D12022014%26date%3D27022014%26date%3D28012014%26volume%3D57%26issue%3D4%26spage%3D1557%26epage%3D1572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tarek  Mohamed</span>, <span class="hlFld-ContribAuthor ">Tuan  Hoang</span>, <span class="hlFld-ContribAuthor ">Masoud  Jelokhani-Niaraki</span>, and <span class="hlFld-ContribAuthor ">Praveen P. N.  Rao</span>  . </span><span class="cited-content_cbyCitation_article-title">Tau-Derived-Hexapeptide 306VQIVYK311 Aggregation Inhibitors: Nitrocatechol Moiety as A Pharmacophore In Drug Design. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2013,</strong> <em>4 </em>
                                    (12)
                                     , 1559-1570. <a href="https://doi.org/10.1021/cn400151a" title="DOI URL">https://doi.org/10.1021/cn400151a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn400151a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn400151a%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DTau-Derived-Hexapeptide%252B306VQIVYK311%252BAggregation%252BInhibitors%25253A%252BNitrocatechol%252BMoiety%252Bas%252BA%252BPharmacophore%252BIn%252BDrug%252BDesign%26aulast%3DMohamed%26aufirst%3DTarek%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D06082013%26date%3D03092013%26date%3D19092013%26date%3D18122013%26date%3D05092013%26volume%3D4%26issue%3D12%26spage%3D1559%26epage%3D1570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jens-Uwe  Peters</span>  . </span><span class="cited-content_cbyCitation_article-title">Polypharmacology – Foe or Friend?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (22)
                                     , 8955-8971. <a href="https://doi.org/10.1021/jm400856t" title="DOI URL">https://doi.org/10.1021/jm400856t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400856t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400856t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPolypharmacology%252B%2525E2%252580%252593%252BFoe%252Bor%252BFriend%25253F%26aulast%3DPeters%26aufirst%3DJens-Uwe%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D11062013%26date%3D22082013%26date%3D27112013%26date%3D06082013%26volume%3D56%26issue%3D22%26spage%3D8955%26epage%3D8971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zonghua  Luo</span>, <span class="hlFld-ContribAuthor ">Jianfei  Sheng</span>, <span class="hlFld-ContribAuthor ">Yang  Sun</span>, <span class="hlFld-ContribAuthor ">Chuanjun  Lu</span>, <span class="hlFld-ContribAuthor ">Jun  Yan</span>, <span class="hlFld-ContribAuthor ">Anqiu  Liu</span>, <span class="hlFld-ContribAuthor ">Hai-bin  Luo</span>, <span class="hlFld-ContribAuthor ">Ling  Huang</span>, and <span class="hlFld-ContribAuthor ">Xingshu  Li</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of Multi-Target-Directed Ligands against Alzheimer’s Disease Based on the Fusion of Donepezil and Ebselen. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (22)
                                     , 9089-9099. <a href="https://doi.org/10.1021/jm401047q" title="DOI URL">https://doi.org/10.1021/jm401047q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401047q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401047q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252BMulti-Target-Directed%252BLigands%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BBased%252Bon%252Bthe%252BFusion%252Bof%252BDonepezil%252Band%252BEbselen%26aulast%3DLuo%26aufirst%3DZonghua%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D11072013%26date%3D12112013%26date%3D27112013%26date%3D25102013%26volume%3D56%26issue%3D22%26spage%3D9089%26epage%3D9099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Soumava  Santra</span>, <span class="hlFld-ContribAuthor ">Liping  Xu</span>, <span class="hlFld-ContribAuthor ">Mrudang  Shah</span>, <span class="hlFld-ContribAuthor ">Mark  Johnson</span>, and <span class="hlFld-ContribAuthor ">Aloke  Dutta</span>  . </span><span class="cited-content_cbyCitation_article-title">D-512 and D-440 as Novel Multifunctional Dopamine Agonists: Characterization of Neuroprotection Properties and Evaluation of In Vivo Efficacy in a Parkinson’s Disease Animal Model. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2013,</strong> <em>4 </em>
                                    (10)
                                     , 1382-1392. <a href="https://doi.org/10.1021/cn400106n" title="DOI URL">https://doi.org/10.1021/cn400106n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn400106n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn400106n%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DD-512%252Band%252BD-440%252Bas%252BNovel%252BMultifunctional%252BDopamine%252BAgonists%25253A%252BCharacterization%252Bof%252BNeuroprotection%252BProperties%252Band%252BEvaluation%252Bof%252BIn%252BVivo%252BEfficacy%252Bin%252Ba%252BParkinson%2525E2%252580%252599s%252BDisease%252BAnimal%252BModel%26aulast%3DSantra%26aufirst%3DSoumava%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D14052013%26date%3D01082013%26date%3D20082013%26date%3D16102013%26date%3D01082013%26volume%3D4%26issue%3D10%26spage%3D1382%26epage%3D1392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony J.  Veloso</span>, <span class="hlFld-ContribAuthor ">Ari M.  Chow</span>, <span class="hlFld-ContribAuthor ">Devjani  Dhar</span>, <span class="hlFld-ContribAuthor ">Derek W. F.  Tang</span>, <span class="hlFld-ContribAuthor ">Hashwin V.S.  Ganesh</span>, <span class="hlFld-ContribAuthor ">Svetlana  Mikhaylichenko</span>, <span class="hlFld-ContribAuthor ">Ian R.  Brown</span>, and <span class="hlFld-ContribAuthor ">Kagan  Kerman</span>  . </span><span class="cited-content_cbyCitation_article-title">Biological Activity of sym-Triazines with Acetylcholine-like Substitutions as Multitarget Modulators of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2013,</strong> <em>4 </em>
                                    (6)
                                     , 924-929. <a href="https://doi.org/10.1021/cn400028w" title="DOI URL">https://doi.org/10.1021/cn400028w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn400028w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn400028w%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DBiological%252BActivity%252Bof%252Bsym-Triazines%252Bwith%252BAcetylcholine-like%252BSubstitutions%252Bas%252BMultitarget%252BModulators%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DVeloso%26aufirst%3DAnthony%2BJ.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D24012013%26date%3D10032013%26date%3D21032013%26date%3D19062013%26date%3D11032013%26volume%3D4%26issue%3D6%26spage%3D924%26epage%3D929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eleni  Ladopoulou</span>, <span class="hlFld-ContribAuthor ">Alexios N.  Matralis</span>, and <span class="hlFld-ContribAuthor ">Angeliki P.  Kourounakis</span>  . </span><span class="cited-content_cbyCitation_article-title">New Multifunctional Di-tert-butylphenoloctahydro(pyrido/benz)oxazine Derivatives with Antioxidant, Antihyperlipidemic, and Antidiabetic Action. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (8)
                                     , 3330-3338. <a href="https://doi.org/10.1021/jm400101e" title="DOI URL">https://doi.org/10.1021/jm400101e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400101e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400101e%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252BMultifunctional%252BDi-tert-butylphenoloctahydro%252528pyrido%25252Fbenz%252529oxazine%252BDerivatives%252Bwith%252BAntioxidant%25252C%252BAntihyperlipidemic%25252C%252Band%252BAntidiabetic%252BAction%26aulast%3DLadopoulou%26aufirst%3DEleni%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D22012013%26date%3D12042013%26date%3D25042013%26date%3D27032013%26volume%3D56%26issue%3D8%26spage%3D3330%26epage%3D3338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony J.  Veloso</span>, <span class="hlFld-ContribAuthor ">Devjani  Dhar</span>, <span class="hlFld-ContribAuthor ">Ari M.  Chow</span>, <span class="hlFld-ContribAuthor ">Biao  Zhang</span>, <span class="hlFld-ContribAuthor ">Derek W. F.  Tang</span>, <span class="hlFld-ContribAuthor ">Hashwin V. S.  Ganesh</span>, <span class="hlFld-ContribAuthor ">Svetlana  Mikhaylichenko</span>, <span class="hlFld-ContribAuthor ">Ian R.  Brown</span>, and <span class="hlFld-ContribAuthor ">Kagan  Kerman</span>  . </span><span class="cited-content_cbyCitation_article-title">sym-Triazines for Directed Multitarget Modulation of Cholinesterases and Amyloid-β in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2013,</strong> <em>4 </em>
                                    (2)
                                     , 339-349. <a href="https://doi.org/10.1021/cn300171c" title="DOI URL">https://doi.org/10.1021/cn300171c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn300171c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn300171c%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3Dsym-Triazines%252Bfor%252BDirected%252BMultitarget%252BModulation%252Bof%252BCholinesterases%252Band%252BAmyloid-%2525CE%2525B2%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DVeloso%26aufirst%3DAnthony%2BJ.%26date%3D2013%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D02102012%26date%3D30102012%26date%3D20112012%26date%3D20022013%26date%3D30102012%26volume%3D4%26issue%3D2%26spage%3D339%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Béla  Török</span>, <span class="hlFld-ContribAuthor ">Abha  Sood</span>, <span class="hlFld-ContribAuthor ">Seema  Bag</span>, <span class="hlFld-ContribAuthor ">Rekha  Tulsan</span>, <span class="hlFld-ContribAuthor ">Sanjukta  Ghosh</span>, <span class="hlFld-ContribAuthor ">Dmitry  Borkin</span>, <span class="hlFld-ContribAuthor ">Arleen R.  Kennedy</span>, <span class="hlFld-ContribAuthor ">Michelle  Melanson</span>, <span class="hlFld-ContribAuthor ">Richard  Madden</span>, <span class="hlFld-ContribAuthor ">Weihong  Zhou</span>, <span class="hlFld-ContribAuthor ">Harry  LeVine, III</span>, and <span class="hlFld-ContribAuthor ">Marianna  Török</span>  . </span><span class="cited-content_cbyCitation_article-title">Diaryl Hydrazones as Multifunctional Inhibitors of Amyloid Self-Assembly. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2013,</strong> <em>52 </em>
                                    (7)
                                     , 1137-1148. <a href="https://doi.org/10.1021/bi3012059" title="DOI URL">https://doi.org/10.1021/bi3012059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bi3012059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbi3012059%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DDiaryl%252BHydrazones%252Bas%252BMultifunctional%252BInhibitors%252Bof%252BAmyloid%252BSelf-Assembly%26aulast%3DT%25C3%25B6r%25C3%25B6k%26aufirst%3DB%25C3%25A9la%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D2012%26date%3D04092012%26date%3D01122012%26date%3D06022013%26date%3D19022013%26date%3D24012013%26volume%3D52%26issue%3D7%26spage%3D1137%26epage%3D1148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lina  Yin</span>, <span class="hlFld-ContribAuthor ">Qingzhong  Hu</span>, and <span class="hlFld-ContribAuthor ">Rolf W.  Hartmann</span>  . </span><span class="cited-content_cbyCitation_article-title">Tetrahydropyrroloquinolinone Type Dual Inhibitors of Aromatase/Aldosterone Synthase as a Novel Strategy for Breast Cancer Patients with Elevated Cardiovascular Risks. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (2)
                                     , 460-470. <a href="https://doi.org/10.1021/jm301408t" title="DOI URL">https://doi.org/10.1021/jm301408t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301408t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301408t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTetrahydropyrroloquinolinone%252BType%252BDual%252BInhibitors%252Bof%252BAromatase%25252FAldosterone%252BSynthase%252Bas%252Ba%252BNovel%252BStrategy%252Bfor%252BBreast%252BCancer%252BPatients%252Bwith%252BElevated%252BCardiovascular%252BRisks%26aulast%3DYin%26aufirst%3DLina%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D27092012%26date%3D03012013%26date%3D24012013%26volume%3D56%26issue%3D2%26spage%3D460%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena  Simoni</span>, <span class="hlFld-ContribAuthor ">Simona  Daniele</span>, <span class="hlFld-ContribAuthor ">Giovanni  Bottegoni</span>, <span class="hlFld-ContribAuthor ">Daniela  Pizzirani</span>, <span class="hlFld-ContribAuthor ">Maria L.  Trincavelli</span>, <span class="hlFld-ContribAuthor ">Luca  Goldoni</span>, <span class="hlFld-ContribAuthor ">Glauco  Tarozzo</span>, <span class="hlFld-ContribAuthor ">Angelo  Reggiani</span>, <span class="hlFld-ContribAuthor ">Claudia  Martini</span>, <span class="hlFld-ContribAuthor ">Daniele  Piomelli</span>, <span class="hlFld-ContribAuthor ">Carlo  Melchiorre</span>, <span class="hlFld-ContribAuthor ">Michela  Rosini</span>, and <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>  . </span><span class="cited-content_cbyCitation_article-title">Combining Galantamine and Memantine in Multitargeted, New Chemical Entities Potentially Useful in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (22)
                                     , 9708-9721. <a href="https://doi.org/10.1021/jm3009458" title="DOI URL">https://doi.org/10.1021/jm3009458</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3009458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3009458%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCombining%252BGalantamine%252Band%252BMemantine%252Bin%252BMultitargeted%25252C%252BNew%252BChemical%252BEntities%252BPotentially%252BUseful%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DSimoni%26aufirst%3DElena%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D04072012%26date%3D17102012%26date%3D26112012%26date%3D04102012%26volume%3D55%26issue%3D22%26spage%3D9708%26epage%3D9721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angelo D.  Favia</span>, <span class="hlFld-ContribAuthor ">Damien  Habrant</span>, <span class="hlFld-ContribAuthor ">Rita  Scarpelli</span>, <span class="hlFld-ContribAuthor ">Marco  Migliore</span>, <span class="hlFld-ContribAuthor ">Clara  Albani</span>, <span class="hlFld-ContribAuthor ">Sine Mandrup  Bertozzi</span>, <span class="hlFld-ContribAuthor ">Mauro  Dionisi</span>, <span class="hlFld-ContribAuthor ">Glauco  Tarozzo</span>, <span class="hlFld-ContribAuthor ">Daniele  Piomelli</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>, and <span class="hlFld-ContribAuthor ">Marco  De Vivo</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification and Characterization of Carprofen as a Multitarget Fatty Acid Amide Hydrolase/Cyclooxygenase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (20)
                                     , 8807-8826. <a href="https://doi.org/10.1021/jm3011146" title="DOI URL">https://doi.org/10.1021/jm3011146</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3011146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3011146%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Band%252BCharacterization%252Bof%252BCarprofen%252Bas%252Ba%252BMultitarget%252BFatty%252BAcid%252BAmide%252BHydrolase%25252FCyclooxygenase%252BInhibitor%26aulast%3DFavia%26aufirst%3DAngelo%2BD.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D30072012%26date%3D08102012%26date%3D25102012%26volume%3D55%26issue%3D20%26spage%3D8807%26epage%3D8826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Johnson</span>, <span class="hlFld-ContribAuthor ">Tamara  Antonio</span>, <span class="hlFld-ContribAuthor ">Maarten E. A.  Reith</span>, and <span class="hlFld-ContribAuthor ">Aloke K.  Dutta</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationship Study of N6-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine Analogues: Development of Highly Selective D3 Dopamine Receptor Agonists along with a Highly Potent D2/D3 Agonist and Their Pharmacological Characterization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (12)
                                     , 5826-5840. <a href="https://doi.org/10.1021/jm300268s" title="DOI URL">https://doi.org/10.1021/jm300268s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300268s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300268s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationship%252BStudy%252Bof%252BN6-%2525282-%2525284-%2525281H-Indol-5-yl%252529piperazin-1-yl%252529ethyl%252529-N6-propyl-4%25252C5%25252C6%25252C7-tetrahydrobenzo%25255Bd%25255Dthiazole-2%25252C6-diamine%252BAnalogues%25253A%252BDevelopment%252Bof%252BHighly%252BSelective%252BD3%252BDopamine%252BReceptor%252BAgonists%252Balong%252Bwith%252Ba%252BHighly%252BPotent%252BD2%25252FD3%252BAgonist%252Band%252BTheir%252BPharmacological%252BCharacterization%26aulast%3DJohnson%26aufirst%3DMark%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D26022012%26date%3D13062012%26date%3D28062012%26date%3D29052012%26volume%3D55%26issue%3D12%26spage%3D5826%26epage%3D5840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yue  Wang</span>, <span class="hlFld-ContribAuthor ">Xin-Lei  Guan</span>, <span class="hlFld-ContribAuthor ">Peng-Fei  Wu</span>, <span class="hlFld-ContribAuthor ">Can-Ming  Wang</span>, <span class="hlFld-ContribAuthor ">Hui  Cao</span>, <span class="hlFld-ContribAuthor ">Lei  Li</span>, <span class="hlFld-ContribAuthor ">Xiao-Juan  Guo</span>, <span class="hlFld-ContribAuthor ">Fang  Wang</span>, <span class="hlFld-ContribAuthor ">Na  Xie</span>, <span class="hlFld-ContribAuthor ">Feng-Chao  Jiang</span>, and <span class="hlFld-ContribAuthor ">Jian-Guo  Chen</span>  . </span><span class="cited-content_cbyCitation_article-title">Multifunctional Mercapto-tacrine Derivatives for Treatment of Age-Related Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (7)
                                     , 3588-3592. <a href="https://doi.org/10.1021/jm300124p" title="DOI URL">https://doi.org/10.1021/jm300124p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300124p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300124p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMultifunctional%252BMercapto-tacrine%252BDerivatives%252Bfor%252BTreatment%252Bof%252BAge-Related%252BNeurodegenerative%252BDiseases%26aulast%3DWang%26aufirst%3DYue%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D03022012%26date%3D28032012%26date%3D12042012%26date%3D15032012%26volume%3D55%26issue%3D7%26spage%3D3588%26epage%3D3592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angela  Rampa</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Alessandra  Bisi</span>, <span class="hlFld-ContribAuthor ">Federica  Belluti</span>, <span class="hlFld-ContribAuthor ">Silvia  Gobbi</span>, <span class="hlFld-ContribAuthor ">Vincenza  Andrisano</span>, <span class="hlFld-ContribAuthor ">Alessia  Ligresti</span>, and <span class="hlFld-ContribAuthor ">Vincenzo  Di Marzo</span>  . </span><span class="cited-content_cbyCitation_article-title">The First Dual ChE/FAAH Inhibitors: New Perspectives for Alzheimer's Disease?. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>3 </em>
                                    (3)
                                     , 182-186. <a href="https://doi.org/10.1021/ml200313p" title="DOI URL">https://doi.org/10.1021/ml200313p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml200313p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml200313p%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252BFirst%252BDual%252BChE%25252FFAAH%252BInhibitors%25253A%252BNew%252BPerspectives%252Bfor%252BAlzheimer%252527s%252BDisease%25253F%26aulast%3DRampa%26aufirst%3DAngela%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D28072011%26date%3D21012012%26date%3D26012012%26date%3D08032012%26date%3D21012012%26volume%3D3%26issue%3D3%26spage%3D182%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María Isabel  Fernández-Bachiller</span>, <span class="hlFld-ContribAuthor ">Concepción  Pérez</span>, <span class="hlFld-ContribAuthor ">Leticia  Monjas</span>, <span class="hlFld-ContribAuthor ">Jörg  Rademann</span>, and <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>  . </span><span class="cited-content_cbyCitation_article-title">New Tacrine–4-Oxo-4H-chromene Hybrids as Multifunctional Agents for the Treatment of Alzheimer’s Disease, with Cholinergic, Antioxidant, and β-Amyloid-Reducing Properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (3)
                                     , 1303-1317. <a href="https://doi.org/10.1021/jm201460y" title="DOI URL">https://doi.org/10.1021/jm201460y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201460y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201460y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNew%252BTacrine%2525E2%252580%2525934-Oxo-4H-chromene%252BHybrids%252Bas%252BMultifunctional%252BAgents%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%25252C%252Bwith%252BCholinergic%25252C%252BAntioxidant%25252C%252Band%252B%2525CE%2525B2-Amyloid-Reducing%252BProperties%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DMar%25C3%25ADa%2BIsabel%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D28102011%26date%3D27012012%26date%3D09022012%26date%3D13012012%26volume%3D55%26issue%3D3%26spage%3D1303%26epage%3D1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>, <span class="hlFld-ContribAuthor ">GianPaolo  Chiriano</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Francesca  Mancini</span>, <span class="hlFld-ContribAuthor ">Giovanni  Bottegoni</span>, <span class="hlFld-ContribAuthor ">Valentina  Maestri</span>, <span class="hlFld-ContribAuthor ">Stefan  Czvitkovich</span>, <span class="hlFld-ContribAuthor ">Manfred  Windisch</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>, <span class="hlFld-ContribAuthor ">Anna  Minarini</span>, <span class="hlFld-ContribAuthor ">Michela  Rosini</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Tumiatti</span>, <span class="hlFld-ContribAuthor ">Vincenza  Andrisano</span>, and <span class="hlFld-ContribAuthor ">Carlo  Melchiorre</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of Monomeric Derivatives To Probe Memoquin’s Bivalent Interactions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (24)
                                     , 8299-8304. <a href="https://doi.org/10.1021/jm200691d" title="DOI URL">https://doi.org/10.1021/jm200691d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200691d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200691d%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252BMonomeric%252BDerivatives%252BTo%252BProbe%252BMemoquin%2525E2%252580%252599s%252BBivalent%252BInteractions%26aulast%3DBolognesi%26aufirst%3DMaria%2BLaura%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D31052011%26date%3D23112011%26date%3D22122011%26date%3D07112011%26volume%3D54%26issue%3D24%26spage%3D8299%26epage%3D8304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irene  Bolea</span>, <span class="hlFld-ContribAuthor ">Jordi  Juárez-Jiménez</span>, <span class="hlFld-ContribAuthor ">Cristóbal  de los Rı́os</span>, <span class="hlFld-ContribAuthor ">Mourad  Chioua</span>, <span class="hlFld-ContribAuthor ">Ramón  Pouplana</span>, <span class="hlFld-ContribAuthor ">F. Javier  Luque</span>, <span class="hlFld-ContribAuthor ">Mercedes  Unzeta</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>, and <span class="hlFld-ContribAuthor ">Abdelouahid  Samadi</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis, Biological Evaluation, and Molecular Modeling of Donepezil and N-[(5-(Benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine Hybrids as New Multipotent Cholinesterase/Monoamine Oxidase Inhibitors for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (24)
                                     , 8251-8270. <a href="https://doi.org/10.1021/jm200853t" title="DOI URL">https://doi.org/10.1021/jm200853t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200853t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200853t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252BBiological%252BEvaluation%25252C%252Band%252BMolecular%252BModeling%252Bof%252BDonepezil%252Band%252BN-%25255B%2525285-%252528Benzyloxy%252529-1-methyl-1H-indol-2-yl%252529methyl%25255D-N-methylprop-2-yn-1-amine%252BHybrids%252Bas%252BNew%252BMultipotent%252BCholinesterase%25252FMonoamine%252BOxidase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DBolea%26aufirst%3DIrene%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D25022011%26date%3D15112011%26date%3D22122011%26date%3D24102011%26volume%3D54%26issue%3D24%26spage%3D8251%26epage%3D8270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexios N.  Matralis</span>, <span class="hlFld-ContribAuthor ">Maria G.  Katselou</span>, <span class="hlFld-ContribAuthor ">Anastasios  Nikitakis</span>, and <span class="hlFld-ContribAuthor ">Angeliki P.  Kourounakis</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Benzoxazine and Benzothiazine Derivatives as Multifunctional Antihyperlipidemic Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (15)
                                     , 5583-5591. <a href="https://doi.org/10.1021/jm200763k" title="DOI URL">https://doi.org/10.1021/jm200763k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200763k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200763k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BBenzoxazine%252Band%252BBenzothiazine%252BDerivatives%252Bas%252BMultifunctional%252BAntihyperlipidemic%252BAgents%26aulast%3DMatralis%26aufirst%3DAlexios%2BN.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D14062011%26date%3D07072011%26date%3D11082011%26date%3D27062011%26volume%3D54%26issue%3D15%26spage%3D5583%26epage%3D5591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ki Duk  Park</span>, <span class="hlFld-ContribAuthor ">Dongwook  Kim</span>, <span class="hlFld-ContribAuthor ">Onrapak  Reamtong</span>, <span class="hlFld-ContribAuthor ">Claire  Eyers</span>, <span class="hlFld-ContribAuthor ">Simon J.  Gaskell</span>, <span class="hlFld-ContribAuthor ">Rihe  Liu</span>, and <span class="hlFld-ContribAuthor ">Harold  Kohn</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of a Lacosamide Binding Protein Using an Affinity Bait and Chemical Reporter Strategy: 14-3-3 ζ. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2011,</strong> <em>133 </em>
                                    (29)
                                     , 11320-11330. <a href="https://doi.org/10.1021/ja2034156" title="DOI URL">https://doi.org/10.1021/ja2034156</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja2034156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja2034156%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DIdentification%252Bof%252Ba%252BLacosamide%252BBinding%252BProtein%252BUsing%252Ban%252BAffinity%252BBait%252Band%252BChemical%252BReporter%252BStrategy%25253A%252B14-3-3%252B%2525CE%2525B6%26aulast%3DPark%26aufirst%3DKi%2BDuk%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D13042011%26date%3D06072011%26date%3D27072011%26date%3D21062011%26volume%3D133%26issue%3D29%26spage%3D11320%26epage%3D11330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luciana  Méndez</span>, <span class="hlFld-ContribAuthor ">Mario O.  Salazar</span>, <span class="hlFld-ContribAuthor ">I. Ayelen  Ramallo</span>, and <span class="hlFld-ContribAuthor ">Ricardo L. E.  Furlan</span>  . </span><span class="cited-content_cbyCitation_article-title">Brominated Extracts As Source of Bioactive Compounds. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2011,</strong> <em>13 </em>
                                    (2)
                                     , 200-204. <a href="https://doi.org/10.1021/co100073k" title="DOI URL">https://doi.org/10.1021/co100073k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/co100073k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fco100073k%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DBrominated%252BExtracts%252BAs%252BSource%252Bof%252BBioactive%252BCompounds%26aulast%3DM%25C3%25A9ndez%26aufirst%3DLuciana%26date%3D2011%26date%3D2010%26date%3D2010%26date%3D25112010%26date%3D17122010%26date%3D14032011%26volume%3D13%26issue%3D2%26spage%3D200%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shailendra S.  Chaudhaery</span>, <span class="hlFld-ContribAuthor ">Kuldeep K.  Roy</span>, <span class="hlFld-ContribAuthor ">Neeraj  Shakya</span>, <span class="hlFld-ContribAuthor ">Gunjan  Saxena</span>, <span class="hlFld-ContribAuthor ">Shreesh Raj  Sammi</span>, <span class="hlFld-ContribAuthor ">Aamir  Nazir</span>, <span class="hlFld-ContribAuthor ">Chandishwar  Nath</span> and <span class="hlFld-ContribAuthor ">Anil K.  Saxena</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Carbamates as Orally Active Acetylcholinesterase Inhibitors Found to Improve Scopolamine-Induced Cognition Impairment: Pharmacophore-Based Virtual Screening, Synthesis, and Pharmacology. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (17)
                                     , 6490-6505. <a href="https://doi.org/10.1021/jm100573q" title="DOI URL">https://doi.org/10.1021/jm100573q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100573q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100573q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BCarbamates%252Bas%252BOrally%252BActive%252BAcetylcholinesterase%252BInhibitors%252BFound%252Bto%252BImprove%252BScopolamine-Induced%252BCognition%252BImpairment%25253A%252BPharmacophore-Based%252BVirtual%252BScreening%25252C%252BSynthesis%25252C%252Band%252BPharmacology%26aulast%3DChaudhaery%26aufirst%3DShailendra%2BS.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D11052010%26date%3D04082010%26date%3D09092010%26volume%3D53%26issue%3D17%26spage%3D6490%26epage%3D6505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carlo  Melchiorre</span>, <span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>, <span class="hlFld-ContribAuthor ">Anna  Minarini</span>, <span class="hlFld-ContribAuthor ">Michela  Rosini</span> and <span class="hlFld-ContribAuthor ">Vincenzo  Tumiatti</span>. </span><span class="cited-content_cbyCitation_article-title">Polyamines in Drug Discovery: From the Universal Template Approach to the Multitarget-Directed Ligand Design Strategy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (16)
                                     , 5906-5914. <a href="https://doi.org/10.1021/jm100293f" title="DOI URL">https://doi.org/10.1021/jm100293f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100293f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100293f%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPolyamines%252Bin%252BDrug%252BDiscovery%25253A%252BFrom%252Bthe%252BUniversal%252BTemplate%252BApproach%252Bto%252Bthe%252BMultitarget-Directed%252BLigand%252BDesign%252BStrategy%26aulast%3DMelchiorre%26aufirst%3DCarlo%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D05032010%26date%3D26042010%26date%3D26082010%26volume%3D53%26issue%3D16%26spage%3D5906%26epage%3D5914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James A.  Lenhart</span>, <span class="hlFld-ContribAuthor ">Xiao  Ling</span>, <span class="hlFld-ContribAuthor ">Ronak  Gandhi</span>, <span class="hlFld-ContribAuthor ">Tai L.  Guo</span>, <span class="hlFld-ContribAuthor ">Phillip M.  Gerk</span>, <span class="hlFld-ContribAuthor ">Darlene H.  Brunzell</span> and <span class="hlFld-ContribAuthor ">Shijun  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">“Clicked” Bivalent Ligands Containing Curcumin and Cholesterol As Multifunctional Aβ Oligomerization Inhibitors: Design, Synthesis, and Biological Characterization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (16)
                                     , 6198-6209. <a href="https://doi.org/10.1021/jm100601q" title="DOI URL">https://doi.org/10.1021/jm100601q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100601q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100601q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D%2525E2%252580%25259CClicked%2525E2%252580%25259D%252BBivalent%252BLigands%252BContaining%252BCurcumin%252Band%252BCholesterol%252BAs%252BMultifunctional%252BA%2525CE%2525B2%252BOligomerization%252BInhibitors%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BCharacterization%26aulast%3DLenhart%26aufirst%3DJames%2BA.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D17052010%26date%3D28072010%26date%3D26082010%26volume%3D53%26issue%3D16%26spage%3D6198%26epage%3D6209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristóbal  de los Ríos</span>, <span class="hlFld-ContribAuthor ">Javier  Egea</span>, <span class="hlFld-ContribAuthor ">José  Marco-Contelles</span>, <span class="hlFld-ContribAuthor ">Rafael  León</span>, <span class="hlFld-ContribAuthor ">Abdelouahid  Samadi</span>, <span class="hlFld-ContribAuthor ">Isabel  Iriepa</span>, <span class="hlFld-ContribAuthor ">Ignacio  Moraleda</span>, <span class="hlFld-ContribAuthor ">Enrique  Gálvez</span>, <span class="hlFld-ContribAuthor ">Antonio G.  García</span>, <span class="hlFld-ContribAuthor ">Manuela G.  López</span>, <span class="hlFld-ContribAuthor ">Mercedes  Villarroya</span> and <span class="hlFld-ContribAuthor ">Alejandro  Romero</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis, Inhibitory Activity of Cholinesterases, and Neuroprotective Profile of Novel 1,8-Naphthyridine Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (14)
                                     , 5129-5143. <a href="https://doi.org/10.1021/jm901902w" title="DOI URL">https://doi.org/10.1021/jm901902w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901902w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901902w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252BInhibitory%252BActivity%252Bof%252BCholinesterases%25252C%252Band%252BNeuroprotective%252BProfile%252Bof%252BNovel%252B1%25252C8-Naphthyridine%252BDerivatives%26aulast%3Dde%2Blos%2BR%25C3%25ADos%26aufirst%3DCrist%25C3%25B3bal%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D23122009%26date%3D24062010%26date%3D22072010%26volume%3D53%26issue%3D14%26spage%3D5129%26epage%3D5143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María Isabel  Fernández-Bachiller</span>, <span class="hlFld-ContribAuthor ">Concepción  Pérez</span>, <span class="hlFld-ContribAuthor ">Gema C.  González-Muñoz</span>, <span class="hlFld-ContribAuthor ">Santiago  Conde</span>, <span class="hlFld-ContribAuthor ">Manuela G.  López</span>, <span class="hlFld-ContribAuthor ">Mercedes  Villarroya</span>, <span class="hlFld-ContribAuthor ">Antonio G.  García</span> and <span class="hlFld-ContribAuthor ">María Isabel  Rodríguez-Franco</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Tacrine−8-Hydroxyquinoline Hybrids as Multifunctional Agents for the Treatment of Alzheimer’s Disease, with Neuroprotective, Cholinergic, Antioxidant, and Copper-Complexing Properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (13)
                                     , 4927-4937. <a href="https://doi.org/10.1021/jm100329q" title="DOI URL">https://doi.org/10.1021/jm100329q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100329q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100329q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BTacrine%2525E2%252588%2525928-Hydroxyquinoline%252BHybrids%252Bas%252BMultifunctional%252BAgents%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%25252C%252Bwith%252BNeuroprotective%25252C%252BCholinergic%25252C%252BAntioxidant%25252C%252Band%252BCopper-Complexing%252BProperties%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DMar%25C3%25ADa%2BIsabel%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D11032010%26date%3D14062010%26date%3D08072010%26volume%3D53%26issue%3D13%26spage%3D4927%26epage%3D4937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hailin  Zheng</span>, <span class="hlFld-ContribAuthor ">Moussa B. H.  Youdim</span> and <span class="hlFld-ContribAuthor ">Mati  Fridkin</span>  . </span><span class="cited-content_cbyCitation_article-title">Site-Activated Chelators Targeting Acetylcholinesterase and Monoamine Oxidase for Alzheimer’s Therapy. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2010,</strong> <em>5 </em>
                                    (6)
                                     , 603-610. <a href="https://doi.org/10.1021/cb900264w" title="DOI URL">https://doi.org/10.1021/cb900264w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb900264w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb900264w%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DSite-Activated%252BChelators%252BTargeting%252BAcetylcholinesterase%252Band%252BMonoamine%252BOxidase%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BTherapy%26aulast%3DZheng%26aufirst%3DHailin%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D27%252011%25202009%26date%3D07%252005%25202010%26date%3D19052010%26date%3D18062010%26date%3D10052010%26volume%3D5%26issue%3D6%26spage%3D603%26epage%3D610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christophe  Salomé</span>, <span class="hlFld-ContribAuthor ">Elise  Salomé-Grosjean</span>, <span class="hlFld-ContribAuthor ">James P.  Stables</span> and <span class="hlFld-ContribAuthor ">Harold  Kohn</span>  . </span><span class="cited-content_cbyCitation_article-title">Merging the Structural Motifs of Functionalized Amino Acids and α-Aminoamides: Compounds with Significant Anticonvulsant Activities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (9)
                                     , 3756-3771. <a href="https://doi.org/10.1021/jm100185c" title="DOI URL">https://doi.org/10.1021/jm100185c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100185c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100185c%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMerging%252Bthe%252BStructural%252BMotifs%252Bof%252BFunctionalized%252BAmino%252BAcids%252Band%252B%2525CE%2525B1-Aminoamides%25253A%252BCompounds%252Bwith%252BSignificant%252BAnticonvulsant%252BActivities%26aulast%3DSalom%25C3%25A9%26aufirst%3DChristophe%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D11022010%26date%3D15042010%26date%3D13052010%26volume%3D53%26issue%3D9%26spage%3D3756%26epage%3D3771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Fang</span>, <span class="hlFld-ContribAuthor ">Sabine  Jumpertz</span>, <span class="hlFld-ContribAuthor ">Yihua  Zhang</span>, <span class="hlFld-ContribAuthor ">Dorothea  Appenroth</span>, <span class="hlFld-ContribAuthor ">Christian  Fleck</span>, <span class="hlFld-ContribAuthor ">Klaus  Mohr</span>, <span class="hlFld-ContribAuthor ">Christian  Tränkle</span> and <span class="hlFld-ContribAuthor ">Michael  Decker</span>  . </span><span class="cited-content_cbyCitation_article-title">Hybrid Molecules from Xanomeline and Tacrine: Enhanced Tacrine Actions on Cholinesterases and Muscarinic M1 Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (5)
                                     , 2094-2103. <a href="https://doi.org/10.1021/jm901616h" title="DOI URL">https://doi.org/10.1021/jm901616h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901616h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901616h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHybrid%252BMolecules%252Bfrom%252BXanomeline%252Band%252BTacrine%25253A%252BEnhanced%252BTacrine%252BActions%252Bon%252BCholinesterases%252Band%252BMuscarinic%252BM1%252BReceptors%26aulast%3DFang%26aufirst%3DLei%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D09112009%26date%3D16022010%26date%3D11032010%26volume%3D53%26issue%3D5%26spage%3D2094%26epage%3D2103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan Z.  Long</span>, <span class="hlFld-ContribAuthor ">Xin  Jin</span>, <span class="hlFld-ContribAuthor ">Alexander  Adibekian</span>, <span class="hlFld-ContribAuthor ">Weiwei  Li</span> and <span class="hlFld-ContribAuthor ">Benjamin F.  Cravatt</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of Tunable Piperidine and Piperazine Carbamates as Inhibitors of Endocannabinoid Hydrolases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (4)
                                     , 1830-1842. <a href="https://doi.org/10.1021/jm9016976" title="DOI URL">https://doi.org/10.1021/jm9016976</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm9016976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm9016976%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCharacterization%252Bof%252BTunable%252BPiperidine%252Band%252BPiperazine%252BCarbamates%252Bas%252BInhibitors%252Bof%252BEndocannabinoid%252BHydrolases%26aulast%3DLong%26aufirst%3DJonathan%2BZ.%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D16112009%26date%3D25012010%26date%3D25022010%26volume%3D53%26issue%3D4%26spage%3D1830%26epage%3D1842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Balaram  Ghosh</span>, <span class="hlFld-ContribAuthor ">Tamara  Antonio</span>, <span class="hlFld-ContribAuthor ">Juan  Zhen</span>, <span class="hlFld-ContribAuthor ">Prashant  Kharkar</span>, <span class="hlFld-ContribAuthor ">Maarten E. A.  Reith</span> and <span class="hlFld-ContribAuthor ">Aloke K.  Dutta</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of (S)-N6-(2-(4-(Isoquinolin-1-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]-thiazole-2,6-diamine and Its Analogue as a D3 Receptor Preferring Agonist: Potent in Vivo Activity in Parkinson’s Disease Animal Models. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (3)
                                     , 1023-1037. <a href="https://doi.org/10.1021/jm901184n" title="DOI URL">https://doi.org/10.1021/jm901184n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901184n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901184n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252B%252528S%252529-N6-%2525282-%2525284-%252528Isoquinolin-1-yl%252529piperazin-1-yl%252529ethyl%252529-N6-propyl-4%25252C5%25252C6%25252C7-tetrahydrobenzo%25255Bd%25255D-thiazole-2%25252C6-diamine%252Band%252BIts%252BAnalogue%252Bas%252Ba%252BD3%252BReceptor%252BPreferring%252BAgonist%25253A%252BPotent%252Bin%252BVivo%252BActivity%252Bin%252BParkinson%2525E2%252580%252599s%252BDisease%252BAnimal%252BModels%26aulast%3DGhosh%26aufirst%3DBalaram%26date%3D2010%26date%3D2009%26date%3D2009%26date%3D09082009%26date%3D28122009%26date%3D11022010%26volume%3D53%26issue%3D3%26spage%3D1023%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jos H. M.  Lange</span>, <span class="hlFld-ContribAuthor ">Hein K. A. C.  Coolen</span>, <span class="hlFld-ContribAuthor ">Martina A. W.  van der Neut</span>, <span class="hlFld-ContribAuthor ">Alice J. M.  Borst</span>, <span class="hlFld-ContribAuthor ">Bob  Stork</span>, <span class="hlFld-ContribAuthor ">Peter C.  Verveer</span> and <span class="hlFld-ContribAuthor ">Chris G.  Kruse</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, Biological Properties, and Molecular Modeling Investigations of Novel Tacrine Derivatives with a Combination of Acetylcholinesterase Inhibition and Cannabinoid CB1 Receptor Antagonism. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (3)
                                     , 1338-1346. <a href="https://doi.org/10.1021/jm901614b" title="DOI URL">https://doi.org/10.1021/jm901614b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901614b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901614b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252BBiological%252BProperties%25252C%252Band%252BMolecular%252BModeling%252BInvestigations%252Bof%252BNovel%252BTacrine%252BDerivatives%252Bwith%252Ba%252BCombination%252Bof%252BAcetylcholinesterase%252BInhibition%252Band%252BCannabinoid%252BCB1%252BReceptor%252BAntagonism%26aulast%3DLange%26aufirst%3DJos%2BH.%2BM.%26date%3D2010%26date%3D2010%26date%3D2009%26date%3D03112009%26date%3D04012010%26date%3D11022010%26volume%3D53%26issue%3D3%26spage%3D1338%26epage%3D1346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Cavalli</span> and <span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>  . </span><span class="cited-content_cbyCitation_article-title">Neglected Tropical Diseases: Multi-Target-Directed Ligands in the Search for Novel Lead Candidates against Trypanosoma and Leishmania. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (23)
                                     , 7339-7359. <a href="https://doi.org/10.1021/jm9004835" title="DOI URL">https://doi.org/10.1021/jm9004835</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm9004835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm9004835%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNeglected%252BTropical%252BDiseases%25253A%252BMulti-Target-Directed%252BLigands%252Bin%252Bthe%252BSearch%252Bfor%252BNovel%252BLead%252BCandidates%252Bagainst%252BTrypanosoma%252Band%252BLeishmania%26aulast%3DCavalli%26aufirst%3DAndrea%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D15042009%26date%3D16072009%26date%3D10122009%26volume%3D52%26issue%3D23%26spage%3D7339%26epage%3D7359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>, <span class="hlFld-ContribAuthor ">Christian  Bergamini</span>, <span class="hlFld-ContribAuthor ">Romana  Fato</span>, <span class="hlFld-ContribAuthor ">Giorgio  Lenaz</span>, <span class="hlFld-ContribAuthor ">Michela  Rosini</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Vincenza  Andrisano</span> and <span class="hlFld-ContribAuthor ">Carlo  Melchiorre</span>  . </span><span class="cited-content_cbyCitation_article-title">Toward a Rational Design of Multitarget-Directed Antioxidants: Merging Memoquin and Lipoic Acid Molecular Frameworks. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (23)
                                     , 7883-7886. <a href="https://doi.org/10.1021/jm901123n" title="DOI URL">https://doi.org/10.1021/jm901123n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm901123n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm901123n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DToward%252Ba%252BRational%252BDesign%252Bof%252BMultitarget-Directed%252BAntioxidants%25253A%252BMerging%252BMemoquin%252Band%252BLipoic%252BAcid%252BMolecular%252BFrameworks%26aulast%3DBolognesi%26aufirst%3DMaria%2BLaura%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D31052009%26date%3D08102009%26date%3D10122009%26volume%3D52%26issue%3D23%26spage%3D7883%26epage%3D7886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ki Duk  Park</span>, <span class="hlFld-ContribAuthor ">Pierre  Morieux</span>, <span class="hlFld-ContribAuthor ">Christophe  Salomé</span>, <span class="hlFld-ContribAuthor ">Steven W.  Cotten</span>, <span class="hlFld-ContribAuthor ">Onrapak  Reamtong</span>, <span class="hlFld-ContribAuthor ">Claire  Eyers</span>, <span class="hlFld-ContribAuthor ">Simon J.  Gaskell</span>, <span class="hlFld-ContribAuthor ">James P.  Stables</span>, <span class="hlFld-ContribAuthor ">Rihe  Liu</span> and <span class="hlFld-ContribAuthor ">Harold  Kohn</span>  . </span><span class="cited-content_cbyCitation_article-title">Lacosamide Isothiocyanate-Based Agents: Novel Agents To Target and Identify Lacosamide Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (21)
                                     , 6897-6911. <a href="https://doi.org/10.1021/jm9012054" title="DOI URL">https://doi.org/10.1021/jm9012054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm9012054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm9012054%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLacosamide%252BIsothiocyanate-Based%252BAgents%25253A%252BNovel%252BAgents%252BTo%252BTarget%252Band%252BIdentify%252BLacosamide%252BReceptors%26aulast%3DPark%26aufirst%3DKi%2BDuk%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D12082009%26date%3D01102009%26date%3D12112009%26volume%3D52%26issue%3D21%26spage%3D6897%26epage%3D6911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pelayo  Camps</span>, <span class="hlFld-ContribAuthor ">Xavier  Formosa</span>, <span class="hlFld-ContribAuthor ">Carles  Galdeano</span>, <span class="hlFld-ContribAuthor ">Diego  Muñoz-Torrero</span>, <span class="hlFld-ContribAuthor ">Lorena  Ramírez</span>, <span class="hlFld-ContribAuthor ">Elena  Gómez</span>, <span class="hlFld-ContribAuthor ">Nicolás  Isambert</span>, <span class="hlFld-ContribAuthor ">Rodolfo  Lavilla</span>, <span class="hlFld-ContribAuthor ">Albert  Badia</span>, <span class="hlFld-ContribAuthor ">M. Victòria  Clos</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Francesca  Mancini</span>, <span class="hlFld-ContribAuthor ">Vincenza  Andrisano</span>, <span class="hlFld-ContribAuthor ">Mariana P.  Arce</span>, <span class="hlFld-ContribAuthor ">M. Isabel  Rodríguez-Franco</span>, <span class="hlFld-ContribAuthor ">Óscar  Huertas</span>, <span class="hlFld-ContribAuthor ">Thomai  Dafni</span> and <span class="hlFld-ContribAuthor ">F. Javier  Luque</span>  . </span><span class="cited-content_cbyCitation_article-title">Pyrano[3,2-c]quinoline−6-Chlorotacrine Hybrids as a Novel Family of Acetylcholinesterase- and β-Amyloid-Directed Anti-Alzheimer Compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (17)
                                     , 5365-5379. <a href="https://doi.org/10.1021/jm900859q" title="DOI URL">https://doi.org/10.1021/jm900859q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm900859q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm900859q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyrano%25255B3%25252C2-c%25255Dquinoline%2525E2%252588%2525926-Chlorotacrine%252BHybrids%252Bas%252Ba%252BNovel%252BFamily%252Bof%252BAcetylcholinesterase-%252Band%252B%2525CE%2525B2-Amyloid-Directed%252BAnti-Alzheimer%252BCompounds%26aulast%3DCamps%26aufirst%3DPelayo%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D16032009%26date%3D07082009%26date%3D10092009%26volume%3D52%26issue%3D17%26spage%3D5365%26epage%3D5379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm7009364&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Fjm7009364%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-3%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=698&amp;pagesCount=6&amp;pageNumber=2" title="Load more citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load more citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Pathways leading to the discovery of new medications: (a) Target-driven drug discovery approach, that is, the application of the current one-molecule, one-target paradigm. Although this approach has led to many effective drugs able to hit a single target, it is now well-documented that these drugs may represent the exception rather than the rule. (b) MTDLs approach to drug discovery. A drug could recognize (in principle, with comparable affinities) different targets involved in the cascade of pathological events leading to a given disease. Thus, such a medication would be highly effective for treating multifactorial diseases. The design of such a drug may not be easy because it could also bind targets that are not involved with the disease and could be responsible (although not necessarily) for side effects. With MTDLs, the one-medication, one-disease paradigm finds a practical application.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic pathways of the multifactorial events leading to neuronal death. General mechanisms, such as protein misfolding and aggregation, oxidative stress, metal (M) dyshomeostasis, mitochondrial dysfunction, and altered protein phosphorylation, have been identified in several neuronal disorders.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Possible molecular causes of neuronal death and protective mechanisms in AD. The central event in AD pathogenesis is an imbalance between Aβ production and clearance. The enhanced activity of β- and γ-secretases leads to increased release of amyloidogenic Aβ42, which forms oligomers and then extracellular deposits (senile plaques). One way to confront AD pathogenesis may be to combat the oligomerization by means of small molecules. A role for metal ions and ROS in the Aβ oligomerization has also been advanced. Therefore, metal chelation and antioxidant activity are two general mechanisms to be considered in the search for disease-modifying anti-AD drug candidates. Also, β- and γ-secretase inhibitors may be promising lead compounds because they tackle an early event in AD pathogenesis. Mitochondrial dysfunction plays a fundamental role in the neuronal death associated with AD, as it is likely that intracellular Aβ could compromise the function of this organelle. τ hyperphosphorylation leading to tangle formation is regarded as a downstream event but could contribute to reinforcing neuronal dysfunction and cognitive impairment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Chemical structures of the five drugs available for AD treatment (mechanisms of action are indicated in parentheses).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Mechanism of action of ACh at a cholinergic synapse. ACh is released in the synaptic cleft where it activates both postsynaptic and presynaptic cholinergic receptors [nicotinic (N) and muscarinic (M)] leading to an increase of cholinergic transmission, which results in cognition improvement. ACh is removed from the synapse by the action of the enzyme AChE, which is the target of the available AChEIs for AD treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Design strategy leading to the diamine diamide <b>6</b> and, subsequently, to its two derivatives <b>8</b> and <b>9</b> (selected from among many others) through the modification of the cystamine moiety of the tetraamine <b>7</b> and then the octamethylene spacer of <b>6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Design strategy leading to <b>10</b>, the first AChEI designed to bind both AChE catalytic site and PAS in order to counteract AChE-induced Aβ aggregation as well as increasing ACh content.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structural modification of <b>11</b> leading to a series of derivatives, of which <b>12</b>, unlike the prototype, effectively inhibited AChE-induced Aβ aggregation by interacting with both AChE catalytic site and PAS.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Design strategy leading to <b>13</b> and <b>14</b> by combining the structural features of <b>12</b> with those of <b>1</b> or <b>6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Design strategy leading to dual binding site AChEIs by combining an isosteric group of the indanone moiety of <b>2</b> with the 1,2,3,4-tetrahydroacridine system of <b>1</b> through a spacer of variable chain length.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Structures of the AChEIs <b>17</b> and <b>18</b> with the additional property of inhibiting self-mediated Aβ aggregation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Design strategy leading to selected dual inhibitors of AChE and MAO.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Design strategy leading to AChE and MAO-B inhibitors by combining the structural features of the MAO-B inhibitors <b>24</b> and <b>19</b> with a carbamate moiety of AChEIs, for example, <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Design strategy leading to dual inhibitors of AChE and SERT by combining the structural features of <b>4</b> and <b>28</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Design strategy leading to compounds endowed with activity toward 5-HT receptors and AChE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Structure of <b>31</b>, which was designed to combine, in the same molecule, the pharmacophoric moieties to interact with both histaminergic and cholinergic systems.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Design strategy leading to <b>32</b> by combining the structural features of <b>1</b> and LA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Design strategy leading to AChEIs with antioxidant properties by combining the structural features of <b>1</b> and <b>33</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Design strategy leading to AChEIs with neuroprotective activity, exemplified by tacripyrine (<b>36</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Structure of the metal chelator <b>37</b>, which also targets Aβ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0021.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Design strategy leading to <b>38</b> by combining the structural features of the lipophilic antioxidant <b>40</b> with those of the iron chelator <b>39</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0022.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Structures of the metal chelators targeting Aβ <b>41</b> and <b>42</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0023.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Glucopyranosyl conjugates of the metal chelators <b>39</b> and tetrahydrosalen.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0024.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Memoquin (<b>46</b>) is able to modulate several mechanisms relevant to AD: the formation of ROS, the aggregation of Aβ peptides, and AChE and BACE-1 activities. It is also a good substrate of the NQO1 enzyme, which in vivo converts it into the corresponding hydroquinone form.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig25" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0025.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Possible molecular causes of neuronal death and protective mechanisms in PD. Native α-synuclein is a highly soluble protein adopting mainly random coil conformation. Its misfolding leads to oligomers that fibrillize and deposit into LBs. Innovative approaches to the discovery of disease-modifying anti-PD drug candidates might be (i) to prevent α-synuclein misfolding by means of chaperones such as DJ-1, (ii) to enhance UPS activity and in turn to eliminate misfolded proteins, and (iii) to inhibit Ser129 phosphorylation. Oxidative stress and metal-ion-enhanced misfolding are further general mechanisms on which to focus to discover more efficacious anti-PD drug candidates that provide antioxidant and metal-chelating activities. Mitochondrial dysfunction has often been associated with neuronal apoptosis. A straightforward approach to the discovery of small molecules able to recover mitochondrial activity, in terms of (i) respiratory chain modulation, (ii) permeability alteration, and (iii) apoptosis inhibition, has not yet been outlined. Remarkably, mitochondrial dysfunction may be a common pathway in most neurodegenerative diseases by which neuronal death is eventually achieved.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig26" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0027.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Mechanism of action of DA at a dopaminergic synapse. DA is released in the synaptic cleft where it can interact with dopaminergic receptors at both postsynaptic and presynaptic levels, leading to an improvement in motor symptoms associated with PD. Currently available anti-PD drugs act at points 1–4 as indicated in the picture. <span class="smallcaps smallerCapital">l</span>-Dopa (1), the endogenous precursor of DA, is presently the main drug used for the treatment of PD. The others, MAO (2) and COMT (3) inhibitors as well as dopaminergic receptor agonists (4), are often used either in MMT or in MCM along with <span class="smallcaps smallerCapital">l</span>-dopa (see also Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig27" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0028.jpeg" id="rightTab-gr27" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Design strategy leading to the bifunctional derivatives <b>48</b>−<b>50</b> by inserting into the same molecule the pharmacophoric groups of <b>47</b>, an iron chelator, and <b>24</b>, a MAO-B inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig28" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0029.jpeg" id="rightTab-gr28" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Design strategy leading to <b>52</b> by combining, into the same structure, caffeine (<b>51</b>), an adenosine A<sub>2A</sub> receptor antagonist, and 1,4-diphenyl-2-butene (<b>53</b>), a reversible MAO-B inhibitor. <b>52</b> is clearly recognizable as a combination of the structural features of both <b>51</b> and <b>53</b>. The caffeine structure is fully incorporated, whereas in the structure of <b>53</b>, one phenyl ring is replaced by the heterocyclic ring of <b>51</b>. The two terminal rings of <b>52</b> are at a comparable distance to that found in <b>53</b>, as shown by molecular modeling calculations (unpublished results).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig29" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0030.jpeg" id="rightTab-gr29" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 29. Design strategy leading to compounds <b>54</b>−<b>57</b> by inserting into the same molecule the structural features of DA or <span class="smallcaps smallerCapital">l</span>-dopa and LA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig30" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Figure 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0031.jpeg" id="rightTab-gr30" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 30. Chemical structure of <b>58</b>, displaying both setoninergic 5-HT<sub>1A</sub> receptor agonism and dopaminergic D<sub>2</sub> receptor antagonism/partial agonism.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig31" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Figure 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/medium/jm-2007-009364_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0032.jpeg" id="rightTab-gr31" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 31. Chemical structures of compounds <b>35</b> and <b>58</b>−<b>61</b> used or currently under investigation for the treatment of ALS.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-3/jm7009364/production/images/large/jm-2007-009364_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7009364&amp;id=fig31"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i31">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50225" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50225" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 240 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Lansbury, P. T.,  Jr</span><span> </span><span class="NLM_article-title">Back to the future: the “old-fashioned” way to new medications for neurodegeneration</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">S51</span><span class="NLM_x">–</span> <span class="NLM_lpage">S57</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=S51-S57&issue=Suppl.&author=P.+T.+Lansbury&title=Back+to+the+future%3A+the+%E2%80%9Cold-fashioned%E2%80%9D+way+to+new+medications+for+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLansbury%26aufirst%3DP.%2BT.%26atitle%3DBack%2520to%2520the%2520future%253A%2520the%2520%25E2%2580%259Cold-fashioned%25E2%2580%259D%2520way%2520to%2520new%2520medications%2520for%2520neurodegeneration%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2004%26volume%3D5%26issue%3DSuppl%26spage%3DS51%26epage%3DS57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Frantz, S.</span><span> </span><span class="NLM_article-title">Drug discovery: playing dirty</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">, 437</span><span class="NLM_x">, </span> <span class="NLM_fpage">942</span><span class="NLM_x">–</span> <span class="NLM_lpage">943</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=%2C+437&publication_year=2005&pages=942-943&author=S.+Frantz&title=Drug+discovery%3A+playing+dirty"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrantz%26aufirst%3DS.%26atitle%3DDrug%2520discovery%253A%2520playing%2520dirty%26jtitle%3DNature%26date%3D2005%26volume%3D437%26spage%3D942%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Mencher, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. G.</span><span> </span><span class="NLM_article-title">Promiscuous drugs compared to selective drugs (promiscuity can be a virtue)</span> <span class="citation_source-journal">BMC Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1186%2F1472-6904-5-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15854222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADC%252BD2M3ktVartA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=3&author=S.+K.+Mencherauthor=L.+G.+Wang&title=Promiscuous+drugs+compared+to+selective+drugs+%28promiscuity+can+be+a+virtue%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Promiscuous drugs compared to selective drugs (promiscuity can be a virtue)</span></div><div class="casAuthors">Mencher Simon K; Wang Long G</div><div class="citationInfo"><span class="NLM_cas:title">BMC clinical pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The word selectivity describes a drug's ability to affect a particular cell population in preference to others.  As part of the current state of art in the search for new therapeutic agents, the property of selectivity is a mode of action thought to have a high degree of desirability.  Consequently there is a growing activity in this area of research.  Selectivity is generally a worthy property in a drug because a drug having high selectivity may have a dramatic effect when there is a single agent that can be targeted against the appropriate molecular-driver involved in the pathogenesis of a disease.  An example is chronic myeloid leukemia (CML).  CML has a specific chromosomal abnormality, the Philadelphia chromosome, that results in a single gene that produces an abnormal protein.  DISCUSSION:  There is a burgeoning understanding of the cellular mechanisms that control the etiology and pathogeneses of diseases.  This understanding both enables and motivates the development of drugs that induce a specific action in a selected cell population; i.e., a targeted treatment.  Consequently, drugs that can target distinct molecular targets involved in pathologic/pathogenetic processes, or signal-transduction pathways, are being developed.  However, in most cases, diseases involve multiple abnormalities.  A disease may be associated with more than one dysfunctional protein and these may be out-of-balance with each other.  Likewise a drug might strongly target a protein that shares a similar active domain with other proteins.  A drug may also target pleiotropic cytokines, or other proteins that have multi-physiological functions.  In this way multiple normal cellular pathways can be simultaneously influenced.  Long term experience with drugs supposedly designed for only a single target, but which unavoidably involve other functional effects, is uncovering the fact that molecular targeting is not medically flawless.  SUMMARY:  We contend that an ideal drug may be one whose efficacy is based not on the inhibition of a single target, but rather on the rebalancing of the several proteins or events, that contribute to the etiology, pathogeneses, and progression of diseases, i.e., in effect a promiscuous drug.  Ideally, if this could be done at minimum drug concentration, side effects could be minimized.  Corollaries to this argument are that the growing fervor for researching truly selective drugs may be imprudent when considering the totality of responses; and that the expensive screening techniques used to discover these, may be both medically and financially inefficient.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQc3Gp004wjH9yzdcP07UmufW6udTcc2eakOcMGZB1-aLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M3ktVartA%253D%253D&md5=bfc2421479ee2f2169efd58bdc0238ec</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1186%2F1472-6904-5-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1472-6904-5-3%26sid%3Dliteratum%253Aachs%26aulast%3DMencher%26aufirst%3DS.%2BK.%26aulast%3DWang%26aufirst%3DL.%2BG.%26atitle%3DPromiscuous%2520drugs%2520compared%2520to%2520selective%2520drugs%2520%2528promiscuity%2520can%2520be%2520a%2520virtue%2529%26jtitle%3DBMC%2520Clin.%2520Pharmacol.%26date%3D2005%26volume%3D5%26spage%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Bishop, T.; Sham, P.</span> <span class="citation_source-book">Analysis of Multifactorial Diseases</span>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">320.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=1-320.&author=T.+Bishop&author=P.+Sham&title=Analysis+of+Multifactorial+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBishop%26aufirst%3DT.%26btitle%3DAnalysis%2520of%2520Multifactorial%2520Diseases%26pub%3DAcademic%2520Press%26date%3D2000%26spage%3D1%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designed multiple ligands. An emerging drug discovery paradigm</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">, 48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6523</span><span class="NLM_x">–</span> <span class="NLM_lpage">6543</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058225d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=%2C+48&publication_year=2005&pages=6523-6543&author=R.+Morphyauthor=Z.+Rankovic&title=Designed+multiple+ligands.+An+emerging+drug+discovery+paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Designed Multiple Ligands.</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6523-6543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review discusses main areas in designed multiple ligands (DMLs) discovery that include 5HT transporter-based DMLs for depression, dopamine D2-receptor based DMLs for schizophrenia, histamine H1 receptor-based DMLs for allergies, DMLs targeting the angiotensin system for hypertension, nonsteroidal anti-inflammatory drugs, and PPAR-based DMLs for metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgouWcjsiKgbVg90H21EOLACvtfcHk0lhAdzxXuaVW5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL&md5=00e3bf5a521fc91996ce95bb379a0b5c</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm058225d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058225d%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigned%2520multiple%2520ligands.%2520An%2520emerging%2520drug%2520discovery%2520paradigm%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6523%26epage%3D6543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Kola, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landis, J.</span><span> </span><span class="NLM_article-title">Can the pharmaceutical industry reduce attrition rates?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">715</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=711-715&author=I.+Kolaauthor=J.+Landis&title=Can+the+pharmaceutical+industry+reduce+attrition+rates%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKola%26aufirst%3DI.%26aulast%3DLandis%26aufirst%3DJ.%26atitle%3DCan%2520the%2520pharmaceutical%2520industry%2520reduce%2520attrition%2520rates%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D711%26epage%3D715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Fragments, network biology and designing multiple ligands</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">156</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=156-160&author=R.+Morphyauthor=Z.+Rankovic&title=Fragments%2C+network+biology+and+designing+multiple+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DFragments%252C%2520network%2520biology%2520and%2520designing%2520multiple%2520ligands%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D156%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">From magic bullets to designed multiple ligands</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">651</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2FS1359-6446%2804%2903163-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15279847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVSktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=641-651&author=R.+Morphyauthor=C.+Kayauthor=Z.+Rankovic&title=From+magic+bullets+to+designed+multiple+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">From magic bullets to designed multiple ligands</span></div><div class="casAuthors">Morphy, Richard; Kay, Corinne; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">641-651</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  A major trend in medicinal chem. in the coming years will be the rational design of ligands that are capable of modulating multiple disease-relevant targets in a specific manner.  Increasingly, it is being recognized that a balanced modulation of several targets can provide a superior therapeutic effect and side effect profile compared to the action of a selective ligand.  Rational approaches in which structural features from selective ligands are combined have produced designed multiple ligands that span a wide variety of targets and target classes.  A key challenge in the design of multiple ligands is attaining a balanced activity at each target of interest while simultaneously achieving a wider selectivity and a suitable pharmacokinetic profile.  An anal. of literature examples reveals trends and insights that might help medicinal chemists discover the next generation of these types of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcsGpfzZok5rVg90H21EOLACvtfcHk0ljII-lXIjwpsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVSktb8%253D&md5=cd2491baad707043dbee4f59ccad9e1d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903163-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903163-0%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DKay%26aufirst%3DC.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DFrom%2520magic%2520bullets%2520to%2520designed%2520multiple%2520ligands%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D641%26epage%3D651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Soluble protein oligomers in neurodegeneration: lessons from the Alzheimerʼs amyloid beta-peptide</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnrm2101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17245412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFKmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=101-112&author=C.+Haassauthor=D.+J.+Selkoe&title=Soluble+protein+oligomers+in+neurodegeneration%3A+lessons+from+the+Alzheimer%CA%BCs+amyloid+beta-peptide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide</span></div><div class="casAuthors">Haass, Christian; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-112</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The distinct protein aggregates that are found in Alzheimer's, Parkinson's, Huntington's and prion diseases seem to cause these disorders.  Small intermediates - sol. oligomers - in the aggregation process can confer synaptic dysfunction, whereas large, insol. deposits might function as reservoirs of the bioactive oligomers.  These emerging concepts are exemplified by Alzheimer's disease, in which amyloid β-protein oligomers adversely affect synaptic structure and plasticity.  Findings in other neurodegenerative diseases indicate that a broadly similar process of neuronal dysfunction is induced by diffusible oligomers of misfolded proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmPK-IDaBZirVg90H21EOLACvtfcHk0ljII-lXIjwpsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFKmtw%253D%253D&md5=e8634ff5c1491580f623c90ded91b4be</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrm2101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2101%26sid%3Dliteratum%253Aachs%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DSoluble%2520protein%2520oligomers%2520in%2520neurodegeneration%253A%2520lessons%2520from%2520the%2520Alzheimer%25CA%25BCs%2520amyloid%2520beta-peptide%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26spage%3D101%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Jellinger, K. A.</span><span> </span><span class="NLM_article-title">General aspects of neurodegeneration</span> <span class="citation_source-journal">J. Neural Transm., Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1007%2F978-3-7091-0643-3_7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=12946052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADC%252BD3svgslSitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=101-144&author=K.+A.+Jellinger&title=General+aspects+of+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">General aspects of neurodegeneration</span></div><div class="casAuthors">Jellinger K A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neural transmission. Supplementum</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">65</span>),
    <span class="NLM_cas:pages">101-44</span>
        ISSN:<span class="NLM_cas:issn">0303-6995</span>.
    </div><div class="casAbstract">Neurodegenerative diseases are morphologically featured by progressive cell loss in specific vulnerable neuronal populations of the central nervous system, often associated with cytoskeletal protein aggregates forming intracytoplasmic and/or intranuclear inclusions in neurons and/or glial cells.  Most neurodegenerative disorders are now classified either according to the hitherto known genetic mechanisms or to the major components of their cellular protein inclusions.  The major basic processes inducing neurodegeneration are considered multifactorial ones caused by genetic, environmental, and endogenous factors.  They include abnormal protein dynamics with defective protein degradation and aggregation, many of them related to the ubiquitin-proteasomal system, oxidative stress and free radical formation, impaired bioenergetics and mitochondrial dysfunctions, and "neuroinflammatory" processes.  These mechanisms that are usually interrelated in complex vitious circles finally leading to programmed cell death cascades are briefly discussed with reference to their pathogenetic role in many, albeit diverse neurodegenerative diseases, like Alzheimer disease, synucleinopathies, tauopathies, and polyglutamine disorders.  The impact of protein inclusions on cell dysfunction, activation or prevention of cell death cascades are discussed, but the molecular basis for the underlying disease mechanisms remains to be elucidated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRa1twIwY8NL8AKB7Fa-xrUfW6udTcc2eYQGtI77ic39Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svgslSitA%253D%253D&md5=ba7c72c37d0fc01ee43ed9514adbd819</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2F978-3-7091-0643-3_7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-7091-0643-3_7%26sid%3Dliteratum%253Aachs%26aulast%3DJellinger%26aufirst%3DK.%2BA.%26atitle%3DGeneral%2520aspects%2520of%2520neurodegeneration%26jtitle%3DJ.%2520Neural%2520Transm.%252C%2520Suppl.%26date%3D2003%26spage%3D101%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Gaggelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozlowski, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valensin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valensin, G.</span><span> </span><span class="NLM_article-title">Copper homeostasis and neurodegenerative disorders (Alzheimerʼs, prion, and Parkinsonʼs diseases and amyotrophic lateral sclerosis)</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">1995</span><span class="NLM_x">–</span> <span class="NLM_lpage">2044</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr040410w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2006&pages=1995-2044&author=E.+Gaggelliauthor=H.+Kozlowskiauthor=D.+Valensinauthor=G.+Valensin&title=Copper+homeostasis+and+neurodegenerative+disorders+%28Alzheimer%CA%BCs%2C+prion%2C+and+Parkinson%CA%BCs+diseases+and+amyotrophic+lateral+sclerosis%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fcr040410w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr040410w%26sid%3Dliteratum%253Aachs%26aulast%3DGaggelli%26aufirst%3DE.%26aulast%3DKozlowski%26aufirst%3DH.%26aulast%3DValensin%26aufirst%3DD.%26aulast%3DValensin%26aufirst%3DG.%26atitle%3DCopper%2520homeostasis%2520and%2520neurodegenerative%2520disorders%2520%2528Alzheimer%25CA%25BCs%252C%2520prion%252C%2520and%2520Parkinson%25CA%25BCs%2520diseases%2520and%2520amyotrophic%2520lateral%2520sclerosis%2529%26jtitle%3DChem.%2520Rev.%26date%3D2006%26volume%3D106%26spage%3D1995%26epage%3D2044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bucciantini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannoni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Formigli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zurdo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taddei, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramponi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefani, M.</span><span> </span><span class="NLM_article-title">Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">416</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">511</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2F416507a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=11932737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD38XivVOgtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=416&publication_year=2002&pages=507-511&author=M.+Bucciantiniauthor=E.+Giannoniauthor=F.+Chitiauthor=F.+Baroniauthor=L.+Formigliauthor=J.+Zurdoauthor=N.+Taddeiauthor=G.+Ramponiauthor=C.+M.+Dobsonauthor=M.+Stefani&title=Inherent+toxicity+of+aggregates+implies+a+common+mechanism+for+protein+misfolding+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases</span></div><div class="casAuthors">Bucciantini, Monica; Giannoni, Elisa; Chiti, Fabrizio; Baroni, Fabiana; Formigli, Lucia; Zurdo, Jesus; Taddei, Niccolo; Ramponi, Giampietro; Dobson, Christopher M.; Stefani, Massimo</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">416</span>
        (<span class="NLM_cas:issue">6880</span>),
    <span class="NLM_cas:pages">507-511</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A range of human degenerative conditions, including Alzheimer's disease, light-chain amyloidosis and the spongiform encephalopathies, is assocd. with the deposition in tissue of proteinaceous aggregates known as amyloid fibrils or plaques.  It has been shown previously that fibrillar aggregates that are closely similar to those assocd. with clin. amyloidoses can be formed in vitro from proteins not connected with these diseases, including the SH3 domain from bovine phosphatidylinositol 3'-kinase and the amino-terminal domain of the Escherichia coli HypF protein.  Here we show that species formed early in the aggregation of these non-disease-assocd. proteins can be inherently highly cytotoxic.  This finding provides added evidence that avoidance of protein aggregation is crucial for the preservation of biol. function and suggests common features in the origins of this family of protein deposition diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXeFpX-dgu6bVg90H21EOLACvtfcHk0li94GiojBX76w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivVOgtbg%253D&md5=51b2c159259afa99b6985a1d2f006ffc</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2F416507a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F416507a%26sid%3Dliteratum%253Aachs%26aulast%3DBucciantini%26aufirst%3DM.%26aulast%3DGiannoni%26aufirst%3DE.%26aulast%3DChiti%26aufirst%3DF.%26aulast%3DBaroni%26aufirst%3DF.%26aulast%3DFormigli%26aufirst%3DL.%26aulast%3DZurdo%26aufirst%3DJ.%26aulast%3DTaddei%26aufirst%3DN.%26aulast%3DRamponi%26aufirst%3DG.%26aulast%3DDobson%26aufirst%3DC.%2BM.%26aulast%3DStefani%26aufirst%3DM.%26atitle%3DInherent%2520toxicity%2520of%2520aggregates%2520implies%2520a%2520common%2520mechanism%2520for%2520protein%2520misfolding%2520diseases%26jtitle%3DNature%26date%3D2002%26volume%3D416%26spage%3D507%26epage%3D511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Kagan, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimova, R.</span><span> </span><span class="NLM_article-title">Amyloid peptide channels</span> <span class="citation_source-journal">J. Membr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1007%2Fs00232-004-0709-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15702375" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivFygsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2004&pages=1-10&author=B.+L.+Kaganauthor=R.+Azimovauthor=R.+Azimova&title=Amyloid+peptide+channels"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid peptide channels</span></div><div class="casAuthors">Kagan, B. L.; Azimov, R.; Azimova, R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Membrane Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">JMBBBO</span>;
        ISSN:<span class="NLM_cas:issn">0022-2631</span>.
    
            (<span class="NLM_cas:orgname">Springer Science+Business Media, Inc.</span>)
        </div><div class="casAbstract">A review.  At least 16 distinct clin. syndromes including Alzheimer's disease (AD), Parkinson's disease (PD), rheumatoid arthritis, type II diabetes mellitus (DM), and spongiform encephalopathies (prion diseases), are characterized by the deposition of amorphous, Congo red-staining deposits known as amyloid.  These "misfolded" proteins adopt β-sheet structures and aggregate spontaneously into similar extended fibrils despite their widely divergent primary sequences.  Many, if not all, of these peptides are capable of forming ion-permeable channels in vitro and possibly in vivo.  Common channel properties include irreversible, spontaneous insertion into membranes, relatively large, heterogeneous single-channel conductances, inhibition of channel formation by Congo red, and blockade of inserted channels by Zn2+.  Physiol. effects of amyloid, including Ca2+ dysregulation, membrane depolarization, mitochondrial dysfunction, inhibition of long-term potentiation (LTP), and cytotoxicity, suggest that channel formation in plasma and intracellular membranes may play a key role in the pathophysiol. of the amyloidoses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9cqx5JL33HLVg90H21EOLACvtfcHk0li94GiojBX76w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivFygsw%253D%253D&md5=9d97f19b1bea9c648ee1103e72b1ea0f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs00232-004-0709-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00232-004-0709-4%26sid%3Dliteratum%253Aachs%26aulast%3DKagan%26aufirst%3DB.%2BL.%26aulast%3DAzimov%26aufirst%3DR.%26aulast%3DAzimova%26aufirst%3DR.%26atitle%3DAmyloid%2520peptide%2520channels%26jtitle%3DJ.%2520Membr.%2520Biol.%26date%3D2004%26volume%3D202%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Soto, C.</span><span> </span><span class="NLM_article-title">Unfolding the role of protein misfolding in neurodegenerative diseases</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnrn1007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=12511861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=49-60&author=C.+Soto&title=Unfolding+the+role+of+protein+misfolding+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Unfolding the role of protein misfolding in neurodegenerative diseases</span></div><div class="casAuthors">Soto, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-60</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recent evidence indicates that diverse neurodegenerative diseases might have a common cause and pathol. mechanism - the misfolding, aggregation and accumulation of proteins in the brain, resulting in neuronal apoptosis.  Studies from different disciplines strongly support this hypothesis and indicate that a common therapy for these devastating disorders might be possible.  The aim of this article is to review the literature on the mol. mechanism of protein misfolding and aggregation, its role in neurodegeneration and the potential targets for therapeutic intervention in neurodegenerative diseases.  Many questions still need to be answered and future research in this field will result in exciting new discoveries that might impact other areas of biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt-G4N2FMUNbVg90H21EOLACvtfcHk0li94GiojBX76w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlY%253D&md5=08a612ce6947fd846bb0d469fa747bef</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnrn1007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1007%26sid%3Dliteratum%253Aachs%26aulast%3DSoto%26aufirst%3DC.%26atitle%3DUnfolding%2520the%2520role%2520of%2520protein%2520misfolding%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2003%26volume%3D4%26spage%3D49%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Cohen, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, J. W.</span><span> </span><span class="NLM_article-title">Therapeutic approaches to protein-misfolding diseases</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">426</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnature02265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=14685252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVGmur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2003&pages=905-909&author=F.+E.+Cohenauthor=J.+W.+Kelly&title=Therapeutic+approaches+to+protein-misfolding+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic approaches to protein-misfolding diseases</span></div><div class="casAuthors">Cohen, Fred E.; Kelly, Jeffery W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">426</span>
        (<span class="NLM_cas:issue">6968</span>),
    <span class="NLM_cas:pages">905-909</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Several sporadic and genetic diseases are caused by protein misfolding.  These include cystic fibrosis and other devastating diseases of childhood as well as Alzheimer's, Parkinson's and other debilitating maladies of the elderly.  A unified view of the mol. and cellular pathogenesis of these conditions has led to the search for chem. chaperones that can slow, arrest or revert disease progression.  Mols. are now emerging that link our biophys. insights with our therapeutic aspirations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiCHoSl7MD-7Vg90H21EOLACvtfcHk0ljoyV2XnZRtlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVGmur8%253D&md5=0fbd2350d560f9db117e0f3c666bbcca</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnature02265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02265%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DF.%2BE.%26aulast%3DKelly%26aufirst%3DJ.%2BW.%26atitle%3DTherapeutic%2520approaches%2520to%2520protein-misfolding%2520diseases%26jtitle%3DNature%26date%3D2003%26volume%3D426%26spage%3D905%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Carrell, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lomas, D. A.</span><span> </span><span class="NLM_article-title">Conformational disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2FS0140-6736%2897%2902073-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=9228977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaK2sXkvFeis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=1997&pages=134-138&author=R.+W.+Carrellauthor=D.+A.+Lomas&title=Conformational+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational disease</span></div><div class="casAuthors">Carrell, Robin W.; Lomas, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">9071</span>),
    <span class="NLM_cas:pages">134-138</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Lancet</span>)
        </div><div class="casAbstract">A review with 40 refs.  Several diverse disorders, including the prevalent dementias and encephalopathies, are now believed to arise from the same general disease mechanism.  In each, there is abnormal unfolding and then aggregation of an underlying protein.  The gradual accumulation of these aggregates and the acceleration of their formation by stress explain the characteristic late or episodic onset of the clin. disease.  The understanding of these processes at the mol. level is opening prospects of more rational approaches to investigation and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh9shwoswSerVg90H21EOLACvtfcHk0ljoyV2XnZRtlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkvFeis7s%253D&md5=faff5df41f01cb42395ee0b3cb7402e1</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2897%2902073-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252897%252902073-4%26sid%3Dliteratum%253Aachs%26aulast%3DCarrell%26aufirst%3DR.%2BW.%26aulast%3DLomas%26aufirst%3DD.%2BA.%26atitle%3DConformational%2520disease%26jtitle%3DLancet%26date%3D1997%26volume%3D350%26spage%3D134%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Caughey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansbury, P. T.</span><span> </span><span class="NLM_article-title">Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1146%2Fannurev.neuro.26.010302.081142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=12704221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntFSisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2003&pages=267-298&author=B.+Caugheyauthor=P.+T.+Lansbury&title=Protofibrils%2C+pores%2C+fibrils%2C+and+neurodegeneration%3A+separating+the+responsible+protein+aggregates+from+the+innocent+bystanders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders</span></div><div class="casAuthors">Caughey, Byron; Lansbury, Peter T., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">267-298</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Many neurodegenerative diseases, including Alzheimer's and Parkinson's and the transmissible spongiform encephalopathies (prion diseases), are characterized at autopsy by neuronal loss and protein aggregates that are typically fibrillar.  A convergence of evidence strongly suggests that protein aggregation is neurotoxic and not a product of cell death.  However, the identity of the neurotoxic aggregate and the mechanism by which it disables and eventually kills a neuron are unknown.  Both biophys. studies aimed at elucidating the precise mechanism of in vitro aggregation and animal modeling studies support the emerging notion that an ordered prefibrillar oligomer, or protofibril, may be responsible for cell death and that the fibrillar form that is typically obsd. at autopsy may actually be neuroprotective.  A subpopulation of protofibrils may function as pathogenic amyloid pores.  An analogous mechanism may explain the neurotoxicity of the prion protein; recent data demonstrates that the disease-assocd., infectious form of the prion protein differs from the neurotoxic species.  This review focuses on recent exptl. studies aimed at identification and characterization of the neurotoxic protein aggregates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpa3a9FOppAYbVg90H21EOLACvtfcHk0ljoyV2XnZRtlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntFSisL0%253D&md5=d48fc232b660b43c22fabe69854d06f0</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.26.010302.081142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.26.010302.081142%26sid%3Dliteratum%253Aachs%26aulast%3DCaughey%26aufirst%3DB.%26aulast%3DLansbury%26aufirst%3DP.%2BT.%26atitle%3DProtofibrils%252C%2520pores%252C%2520fibrils%252C%2520and%2520neurodegeneration%253A%2520separating%2520the%2520responsible%2520protein%2520aggregates%2520from%2520the%2520innocent%2520bystanders%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D2003%26volume%3D26%26spage%3D267%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Kagan, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimova, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M. C.</span><span> </span><span class="NLM_article-title">The channel hypothesis of Alzheimerʼs disease: current status</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1311</span><span class="NLM_x">–</span> <span class="NLM_lpage">1315</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=1311-1315&author=B.+L.+Kaganauthor=Y.+Hirakuraauthor=R.+Azimovauthor=R.+Azimovaauthor=M.+C.+Lin&title=The+channel+hypothesis+of+Alzheimer%CA%BCs+disease%3A+current+status"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKagan%26aufirst%3DB.%2BL.%26aulast%3DHirakura%26aufirst%3DY.%26aulast%3DAzimov%26aufirst%3DR.%26aulast%3DAzimova%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DM.%2BC.%26atitle%3DThe%2520channel%2520hypothesis%2520of%2520Alzheimer%25CA%25BCs%2520disease%253A%2520current%2520status%26jtitle%3DPeptides%26date%3D2002%26volume%3D23%26spage%3D1311%26epage%3D1315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Lin, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, M. F.</span><span> </span><span class="NLM_article-title">Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">443</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnature05292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17051205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyktbbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=443&publication_year=2006&pages=787-795&author=M.+T.+Linauthor=M.+F.+Beal&title=Mitochondrial+dysfunction+and+oxidative+stress+in+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases</span></div><div class="casAuthors">Lin, Michael T.; Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">443</span>
        (<span class="NLM_cas:issue">7113</span>),
    <span class="NLM_cas:pages">787-795</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Many lines of evidence suggest that mitochondria have a central role in aging-related neurodegenerative diseases.  Mitochondria are crit. regulators of cell death, a key feature of neurodegeneration.  Mutations in mitochondrial DNA and oxidative stress both contribute to aging, which is the greatest risk factor for neurodegenerative diseases.  In all major examples of these diseases there is strong evidence that mitochondrial dysfunction occurs early and acts causally in disease pathogenesis.  Moreover, an impressive no. of disease-specific proteins interact with mitochondria.  Thus, therapies targeting basic mitochondrial processes, such as energy metab. or free-radical generation, or specific interactions of disease-related proteins with mitochondria, hold great promise.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ_a_kJVRRZbVg90H21EOLACvtfcHk0liy8FbuTiAEkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyktbbO&md5=f1f1e0773f62373232ff10156e630cae</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnature05292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05292%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DM.%2BT.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DMitochondrial%2520dysfunction%2520and%2520oxidative%2520stress%2520in%2520neurodegenerative%2520diseases%26jtitle%3DNature%26date%3D2006%26volume%3D443%26spage%3D787%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Bray, T. M.</span><span> </span><span class="NLM_article-title">Antioxidants and oxidative stress in health and disease: introduction</span> <span class="citation_source-journal">Proc. Soc. Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">222</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1046%2Fj.1525-1373.1999.d01-135.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=10601877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaK1MXnvVSjtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=222&publication_year=1999&pages=195&author=T.+M.+Bray&title=Antioxidants+and+oxidative+stress+in+health+and+disease%3A+introduction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidants and oxidative stress in health and disease: introduction</span></div><div class="casAuthors">Bray, Tammy M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Society for Experimental Biology and Medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">222</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">195</span>CODEN:
                <span class="NLM_cas:coden">PSEBAA</span>;
        ISSN:<span class="NLM_cas:issn">0037-9727</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science, Inc.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVQ_gu304CorVg90H21EOLACvtfcHk0liy8FbuTiAEkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnvVSjtbs%253D&md5=8d3b1a0c08cc4e2558ccd073796801b6</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1046%2Fj.1525-1373.1999.d01-135.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1525-1373.1999.d01-135.x%26sid%3Dliteratum%253Aachs%26aulast%3DBray%26aufirst%3DT.%2BM.%26atitle%3DAntioxidants%2520and%2520oxidative%2520stress%2520in%2520health%2520and%2520disease%253A%2520introduction%26jtitle%3DProc.%2520Soc.%2520Exp.%2520Biol.%2520Med.%26date%3D1999%26volume%3D222%26spage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Andersen, J. K.</span><span> </span><span class="NLM_article-title">Oxidative stress in neurodegeneration: cause or consequence</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">S18</span><span class="NLM_x">–</span> <span class="NLM_lpage">S25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=S18-S25&issue=Suppl.&author=J.+K.+Andersen&title=Oxidative+stress+in+neurodegeneration%3A+cause+or+consequence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndersen%26aufirst%3DJ.%2BK.%26atitle%3DOxidative%2520stress%2520in%2520neurodegeneration%253A%2520cause%2520or%2520consequence%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26issue%3DSuppl%26spage%3DS18%26epage%3DS25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Contestabile, A.</span><span> </span><span class="NLM_article-title">Oxidative stress in neurodegeneration: mechanisms and therapeutic perspectives</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">568</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.2174%2F1568026013394723" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=11895131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3MXos1ait7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=553-568&author=A.+Contestabile&title=Oxidative+stress+in+neurodegeneration%3A+mechanisms+and+therapeutic+perspectives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress in neurodegeneration: mechanisms and therapeutic perspectives</span></div><div class="casAuthors">Contestabile, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Hilversum, Netherlands)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">553-568</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  Neural tissue is esp. sensitive to oxidative stress, which is considered a prominent factor in both acute and chronic neurodegenerative diseases and traumatic brain insults.  On this basis, therapeutical strategies centered on antioxidants and on drugs able to scavenge excess free radicals and to re-establish the redox equil., have been proposed for treatment of several brain pathologies.  The present paper shortly summarizes the main sources of free radical prodn. in the brain and reviews some of the recent data on mechanisms of cellular transduction through which free radicals are believed to damage cells and, eventually, to bring them to death.  Some of the most promising therapeutical perspectives for treatment of oxidative stress in neurodegeneration, are then considered.  Their choice is the result of a selection, that is unavoidably due to the enormous amt. of the literature data, based on personal evaluation as well as on the personal exptl. experience of the author.  Four main categories of possible therapeuticals are considered: inhibitors of antioxidant enzymes, endogenous antioxidants and their precursors, vitamins and related compds., other natural antioxidants from fruits and vegetables.  Some theor. and practical issues relevant to the adoption of antioxidant therapies for neurodegeneration are highlighted, with particular ref. to the fact that a basal prodn. of free radicals must be maintained in the brain due to the host of essential cellular functions subserved by them.  In this connection, it seems advisable that future antioxidant strategies for neurodegeneration are based on mixts. of agents able to modulate multiple mechanisms of free radical prodn. and scavenging, without dangerously hampering essential physiol. defense based on free radical cellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp67qlqqP46orVg90H21EOLACvtfcHk0liy8FbuTiAEkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXos1ait7c%253D&md5=2c612d25cb8b3b34d4c96d24a5c8b473</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F1568026013394723&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026013394723%26sid%3Dliteratum%253Aachs%26aulast%3DContestabile%26aufirst%3DA.%26atitle%3DOxidative%2520stress%2520in%2520neurodegeneration%253A%2520mechanisms%2520and%2520therapeutic%2520perspectives%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2001%26volume%3D1%26spage%3D553%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Wang, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ku, M. C.</span><span> </span><span class="NLM_article-title">Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3521</span><span class="NLM_x">–</span> <span class="NLM_lpage">3533</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.2174%2F138161206778343109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17017945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVGlt7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=3521-3533&author=J.+Y.+Wangauthor=L.+L.+Wenauthor=Y.+N.+Huangauthor=Y.+T.+Chenauthor=M.+C.+Ku&title=Dual+effects+of+antioxidants+in+neurodegeneration%3A+direct+neuroprotection+against+oxidative+stress+and+indirect+protection+via+suppression+of+glia-mediated+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of gliamediated inflammation</span></div><div class="casAuthors">Wang, Jia-Yi; Wen, Li- Li; Huang, Ya-Ni; Chen, Yen-Tsun; Ku, Min-Chi</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">3521-3533</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress, in which prodn. of highly reactive oxygen species (ROS) and reactive nitrogen species (RNS) overwhelms antioxidant defenses, is a feature of many neurol. diseases and neurodegeneration.  ROS and RNS generated extracellularly and intracellularly by various processes initiate and promote neurodegeneration in CNS.  ROS and RNS can directly oxidize and damage macromols. such as DNA, proteins, and lipids, culminating in neurodegeneration in the CNS.  Neurons are most susceptible to direct oxidative injury by ROS and RNS.  ROS and RNS can also indirectly contribute to tissue damage by activating a no. of cellular pathways resulting in the expression of stress-sensitive genes and proteins to cause oxidative injury.  Moreover, oxidative stress also activates mechanisms that result in a glia-mediated inflammation that also causes secondary neuronal damage.  Assocd. with neuronal injuries caused by many CNS insults is an activation of glial cells (particularly astrocytes and microglia) at the sites of injury.  Activated glial cells are thus histopathol. hallmarks of neurodegenerative diseases.  Even though direct contact of activated glial with neurons per se may not necessarily be toxic, the immune mediators (e.g. nitric oxide and reactive oxygen species, pro-inflammatory cytokines and chemokines) released by activated glial cells are currently considered to be candidate neurotoxins.  Therefore, study of the protective role of antioxidant compds. on inhibition of the inflammatory response and correcting the fundamental oxidant/antioxidant imbalance in patients suffering from neurodegenerative diseases are important vistas for further research.  The purpose of this review is to summarize the current evidence in support of this crit. role played by oxidative stress of neuronal and glial origin in neurodegenerative diseases.  The mechanistic basis of the neuroprotective activity of antioxidants does not only rely on the general free radical trapping or antioxidant activity per se in neurons, but also the suppression of genes induced by pro-inflammatory cytokines and other mediators released by glial cells.  We propose that combinations of agents which act at sequential steps in the neurodegenerative process can produce additive neuroprotective effects.  A cocktail of multiple antioxidants with anti-inflammatory agents may be more beneficial in the prevention of neurodegenerative disease.  A clearer appreciation of the potential therapeutic utility of antioxidants would emerge only when the complexity of their effects on mechanisms that interact to det. the extent of oxidative damage in vivo are more fully defined and understood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqa4hpnzSYYJbVg90H21EOLACvtfcHk0lhq26MrYm1i0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVGlt7zO&md5=2cff0185e16bec5d6a249a77f3f0247a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F138161206778343109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206778343109%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BY.%26aulast%3DWen%26aufirst%3DL.%2BL.%26aulast%3DHuang%26aufirst%3DY.%2BN.%26aulast%3DChen%26aufirst%3DY.%2BT.%26aulast%3DKu%26aufirst%3DM.%2BC.%26atitle%3DDual%2520effects%2520of%2520antioxidants%2520in%2520neurodegeneration%253A%2520direct%2520neuroprotection%2520against%2520oxidative%2520stress%2520and%2520indirect%2520protection%2520via%2520suppression%2520of%2520glia-mediated%2520inflammation%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D3521%26epage%3D3533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Doraiswamy, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finefrock, A. E.</span><span> </span><span class="NLM_article-title">Metals in our minds: therapeutic implications for neurodegenerative disorders</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2FS1474-4422%2804%2900809-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15207800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVOmt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=431-434&author=P.+M.+Doraiswamyauthor=A.+E.+Finefrock&title=Metals+in+our+minds%3A+therapeutic+implications+for+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Metals in our minds: therapeutic implications for neurodegenerative disorders</span></div><div class="casAuthors">Doraiswamy, P. Murali; Finefrock, Anne E.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">431-434</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Lancet Neurology</span>)
        </div><div class="casAbstract">A review.  Abnormal interactions of copper or iron in the brain with metal-binding proteins (such as amyloid-β peptide [Aβ] or neuromelanin) that lead to oxidative stress have emerged as important potential mechanisms in brain ageing and neurodegenerative disorders.  Although a controlled study of desferrioxamine in Alzheimer's disease (AD) had some promising results, concerns about toxicity and brain delivery have limited trials of traditional chelators.  The therapeutic significance of metal dysregulation in neurodegenerative disorders has remained difficult to test.  Clioquinol was identified as a prototype metal-protein-attenuating compd. (MPAC).  In a blinded and controlled 9 wk study of a mouse model of AD, oral clioquinol decreased brain Aβ by 49% without systemic toxicity.  The concns. of copper and zinc in the brain rose by about 15% in mice treated with clioquinol.  Two other studies in mice showed that the raising of brain copper concns. through diet or genetics could lower amyloid load and increase survival.  A recent placebo-controlled trial in 36 patients with AD showed that clioquinol (250-750 mg daily) reduced plasma concns. of Aβ1-42, raised plasma concns. of zinc, and-in a subset with moderate dementia-slowed cognitive decline over 24 wk.  Two recent expts. also showed the neuroprotective effects of iron chelation in a mouse model of Parkinson's disease.  The exptl. and transgenic-animal studies of metal-protein interactions are convincing but do not provide conclusive answers either about causality or whether this strategy will protect against neurodegeneration in human beings.  The finding that clioquinol could modulate plasma concns. of amyloid and cognition in patients with AD needs to be interpreted cautiously, but is an important first step.  Clioquinol was withdrawn because of concerns of its assocn. with subacute myelo-optic neuropathy in Japan; therefore, any addnl. studies with this drug will likely be small and closely monitored proof-of-concept studies.  The development of optimal second-generation MPACs is a desirable goal and may permit greater insights into the significance of metal-protein interactions across several neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4nb8v83ZKXbVg90H21EOLACvtfcHk0lhq26MrYm1i0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVOmt7w%253D&md5=fbec7c10a8275304aba421710fbd3d83</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2804%2900809-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252804%252900809-9%26sid%3Dliteratum%253Aachs%26aulast%3DDoraiswamy%26aufirst%3DP.%2BM.%26aulast%3DFinefrock%26aufirst%3DA.%2BE.%26atitle%3DMetals%2520in%2520our%2520minds%253A%2520therapeutic%2520implications%2520for%2520neurodegenerative%2520disorders%26jtitle%3DLancet%2520Neurol.%26date%3D2004%26volume%3D3%26spage%3D431%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Gaeta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hider, R. C.</span><span> </span><span class="NLM_article-title">The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">146</span><span class="NLM_x">, </span> <span class="NLM_fpage">1041</span><span class="NLM_x">–</span> <span class="NLM_lpage">1059</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fsj.bjp.0706416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16205720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht12ltrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2005&pages=1041-1059&author=A.+Gaetaauthor=R.+C.+Hider&title=The+crucial+role+of+metal+ions+in+neurodegeneration%3A+the+basis+for+a+promising+therapeutic+strategy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy</span></div><div class="casAuthors">Gaeta, Alessandra; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1041-1059</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The variety of factors and events involved in neurodegeneration renders the subject a major challenge.  Neurodegenerative disorders include a no. of different pathol. conditions, which share similar crit. metabolic processes, such as protein aggregation and oxidative stress, both of which are assocd. with the involvement of metal ions.  In this review, Alzheimer's disease, Parkinson's disease and prion disease are discussed, with the aim of identifying common trends underlying these devastating neurol. conditions.  Chelation therapy could be a valuable therapeutic approach, since metals are considered to be a pharmacol. target for the rationale design of new therapeutic agents directed towards the treatment of neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAwJWM3yTd87Vg90H21EOLACvtfcHk0lhq26MrYm1i0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht12ltrvJ&md5=2a2e568a5940601f6a6f6f6aa5f5a1ac</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706416%26sid%3Dliteratum%253Aachs%26aulast%3DGaeta%26aufirst%3DA.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DThe%2520crucial%2520role%2520of%2520metal%2520ions%2520in%2520neurodegeneration%253A%2520the%2520basis%2520for%2520a%2520promising%2520therapeutic%2520strategy%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D146%26spage%3D1041%26epage%3D1059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Zeevalk, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gluck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrhart, J.</span><span> </span><span class="NLM_article-title">Mitochondrial inhibition and oxidative stress: reciprocating players in neurodegeneration</span> <span class="citation_source-journal">Antioxid. Redox Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1089%2Fars.2005.7.1117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16115016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXos1eqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=1117-1139&author=G.+D.+Zeevalkauthor=L.+P.+Bernardauthor=C.+Songauthor=M.+Gluckauthor=J.+Ehrhart&title=Mitochondrial+inhibition+and+oxidative+stress%3A+reciprocating+players+in+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial Inhibition and Oxidative Stress: Reciprocating Players in Neurodegeneration</span></div><div class="casAuthors">Zeevalk, G. D.; Bernard, L. P.; Song, C.; Gluck, M.; Ehrhart, J.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9 & 10</span>),
    <span class="NLM_cas:pages">1117-1139</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Although the etiol. for many neurodegenerative diseases is unknown, the common findings of mitochondrial defects and oxidative damage posit these events as contributing factors.  The temporal conundrum of whether mitochondrial defects lead to enhanced reactive oxygen species generation, or conversely, if oxidative stress is the underlying cause of the mitochondrial defects remains enigmatic.  This review focuses on evidence to show that either event can lead to the evolution of the other with subsequent neuronal cell loss.  Glutathione is a major antioxidant system used by cells and mitochondria for protection and is altered in a no. of neurodegenerative and neuropathol. conditions.  This review also addresses the multiple roles for glutathione during mitochondrial inhibition or oxidative stress.  Protein aggregation and inclusions are hallmarks of a no. of neurodegenerative diseases.  Recent evidence that links protein aggregation to oxidative stress and mitochondrial dysfunction will also be examd.  Lastly, current therapies that target mitochondrial dysfunction or oxidative stress are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnTR7Sks_ifrVg90H21EOLACvtfcHk0ljVTVjtKq28jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXos1eqsL8%253D&md5=9e2b9466bc8a663620a6fb45fcb17d40</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1089%2Fars.2005.7.1117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2005.7.1117%26sid%3Dliteratum%253Aachs%26aulast%3DZeevalk%26aufirst%3DG.%2BD.%26aulast%3DBernard%26aufirst%3DL.%2BP.%26aulast%3DSong%26aufirst%3DC.%26aulast%3DGluck%26aufirst%3DM.%26aulast%3DEhrhart%26aufirst%3DJ.%26atitle%3DMitochondrial%2520inhibition%2520and%2520oxidative%2520stress%253A%2520reciprocating%2520players%2520in%2520neurodegeneration%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2005%26volume%3D7%26spage%3D1117%26epage%3D1139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Coppede, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancuso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siciliano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliore, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murri, L.</span><span> </span><span class="NLM_article-title">Genes and the environment in neurodegeneration</span> <span class="citation_source-journal">Biosci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1007%2Fs10540-006-9028-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17029001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFyltLnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=341-367&author=F.+Coppedeauthor=M.+Mancusoauthor=G.+Sicilianoauthor=L.+Miglioreauthor=L.+Murri&title=Genes+and+the+environment+in+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Genes and the environment in neurodegeneration</span></div><div class="casAuthors">Coppede, Fabio; Mancuso, Michelangelo; Siciliano, Gabriele; Migliore, Lucia; Murri, Luigi</div><div class="citationInfo"><span class="NLM_cas:title">Bioscience Reports</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">341-367</span>CODEN:
                <span class="NLM_cas:coden">BRPTDT</span>;
        ISSN:<span class="NLM_cas:issn">0144-8463</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative diseases are a heterogeneous group of pathologies which includes complex multifactorial diseases, monogenic disorders and disorders for which inherited, sporadic and transmissible forms are known.  Factors assocd. with predisposition and vulnerability to neurodegenerative disorders may be described usefully within the context of gene-environment interplay.  There are many identified genetic determinants for neurodegeneration, and it is possible to duplicate many elements of recognized human neurodegenerative disorders in animal models of the disease.  However, there are similarly several identifiable environmental influences on outcomes of the genetic defects; and the course of a progressive neurodegenerative disorder can be greatly modified by environmental elements.  In this review we highlight some of the major neurodegenerative disorders (Alzheimer's disease, Parkinson's disease, Amyotrophic lateral sclerosis, Huntington's disease, and prion diseases.) and discuss possible links of gene-environment interplay including, where implicated, mitochondrial genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZBK_hkd2RNrVg90H21EOLACvtfcHk0ljVTVjtKq28jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFyltLnF&md5=8a67b663438ca4411264bfc5a7e4c971</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs10540-006-9028-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10540-006-9028-6%26sid%3Dliteratum%253Aachs%26aulast%3DCoppede%26aufirst%3DF.%26aulast%3DMancuso%26aufirst%3DM.%26aulast%3DSiciliano%26aufirst%3DG.%26aulast%3DMigliore%26aufirst%3DL.%26aulast%3DMurri%26aufirst%3DL.%26atitle%3DGenes%2520and%2520the%2520environment%2520in%2520neurodegeneration%26jtitle%3DBiosci.%2520Rep.%26date%3D2006%26volume%3D26%26spage%3D341%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Danial, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korsmeyer, S. J.</span><span> </span><span class="NLM_article-title">Cell death: critical control points</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2FS0092-8674%2804%2900046-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=14744432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtValsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2004&pages=205-219&author=N.+N.+Danialauthor=S.+J.+Korsmeyer&title=Cell+death%3A+critical+control+points"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Cell death: Critical control points</span></div><div class="casAuthors">Danial, Nika N.; Korsmeyer, Stanley J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-219</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review and discussion.  Programmed cell death (apoptosis) is a distinct genetic and biochem. pathway essential to metazoans.  An intact death pathway is required for successful embryonic development and the maintenance of normal tissue homeostasis.  Apoptosis has proven to be tightly interwoven with other essential cell pathways.  The identification of crit. control points in the cell death pathway has yielded fundamental insights for basic biol., as well as provided rational targets for new therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfuRt2EjV6WLVg90H21EOLACvtfcHk0ljVTVjtKq28jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtValsrY%253D&md5=de853177ac091305b7f237e58108f579</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2804%2900046-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252804%252900046-7%26sid%3Dliteratum%253Aachs%26aulast%3DDanial%26aufirst%3DN.%2BN.%26aulast%3DKorsmeyer%26aufirst%3DS.%2BJ.%26atitle%3DCell%2520death%253A%2520critical%2520control%2520points%26jtitle%3DCell%26date%3D2004%26volume%3D116%26spage%3D205%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Mi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, G. V.</span><span> </span><span class="NLM_article-title">The role of tau phosphorylation in the pathogenesis of Alzheimerʼs disease</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">449</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.2174%2F156720506779025279" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17168644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWksbrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=449-463&author=K.+Miauthor=G.+V.+Johnson&title=The+role+of+tau+phosphorylation+in+the+pathogenesis+of+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The role of tau phosphorylation in the pathogenesis of Alzheimer's disease</span></div><div class="casAuthors">Mi, Kaihong; Johnson, Gail V. W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">449-463</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The microtubule-assocd. protein tau, which is abundantly expressed in neurons, is deposited in cells in an abnormally phosphorylated state as fibrillar lesions in numerous neurodegenerative diseases, with the most notable being Alzheimer's disease.  Tau plays a crucial role in the neuron as it binds and stabilizes microtubules, and can regulate axonal transport; functions that are regulated by site-specific phosphorylation events.  In pathol. conditions such as Alzheimer's disease and other tauopathies, tau is abnormally phosphorylated, and that this contributes to its dysfunction.  Given the increasing evidence that a disruption in the normal phosphorylation state of tau followed by conformational changes plays a key role in the pathogenic events that occur in Alzheimer's disease and other tauopathies; it is crit. to elucidate the regulation of tau phosphorylation.  This review focuses on recent literature pertaining to the regulation of tau phosphorylation and function, and the role that a dysregulation of tau phosphorylation may play in the neuronal dysfunction in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_9dvtaMDpfbVg90H21EOLACvtfcHk0liZml3iO5pu5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWksbrM&md5=1e0ea8f6bceba1b430a44392ceb34181</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2174%2F156720506779025279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720506779025279%26sid%3Dliteratum%253Aachs%26aulast%3DMi%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DG.%2BV.%26atitle%3DThe%2520role%2520of%2520tau%2520phosphorylation%2520in%2520the%2520pathogenesis%2520of%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2006%26volume%3D3%26spage%3D449%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Saito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawashima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruberu, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawabe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanouchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murayama, S.</span><span> </span><span class="NLM_article-title">Accumulation of phosphorylated alpha-synuclein in aging human brain</span> <span class="citation_source-journal">J. Neuropathol. Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">644</span><span class="NLM_x">–</span> <span class="NLM_lpage">654</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=12834109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlt1yqu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2003&pages=644-654&author=Y.+Saitoauthor=A.+Kawashimaauthor=N.+N.+Ruberuauthor=H.+Fujiwaraauthor=S.+Koyamaauthor=M.+Sawabeauthor=T.+Araiauthor=H.+Naguraauthor=H.+Yamanouchiauthor=M.+Hasegawaauthor=T.+Iwatsuboauthor=S.+Murayama&title=Accumulation+of+phosphorylated+alpha-synuclein+in+aging+human+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Accumulation of phosphorylated α-synuclein in aging human brain</span></div><div class="casAuthors">Saito, Yuko; Kawashima, Akiko; Ruberu, Nyoka N.; Fujiwara, Hideo; Koyama, Shunichi; Sawabe, Motoji; Arai, Tomio; Nagura, Hiroshi; Yamanouchi, Hiroshi; Hasegawa, Masato; Iwatsubo, Takeshi; Murayama, Shigeo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuropathology and Experimental Neurology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">644-654</span>CODEN:
                <span class="NLM_cas:coden">JNENAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    
            (<span class="NLM_cas:orgname">American Association of Neuropathologists, Inc.</span>)
        </div><div class="casAbstract">α-Synuclein in Lewy bodies (LBs) is phosphorylated at Ser129.  The authors raised monoclonal and polyclonal antibodies to this phosphorylation site (psyn) and examd. 157 serial autopsy brains from a geriatric hospital.  Anti-psyn immunoreactivity was obsd. in 40 of these cases (25.5%).  Immunohistochem. revealed 4 novel types of pathol.: diffuse neuronal cytoplasmic staining (pre-LB); neuropil thread-like structures (Lewy threads); dot-like structures similar to argyrophilic grains (Lewy dots); and axons in the white matter (Lewy axons).  This novel pathol. was abundantly present around LBs and also involved the limbic subcortical white matter, the cerebral cortical mol. layer, and the spongiform changes of the medial temporal lobe assocd. with cases of dementia with LBs (DLB).  The phosphorylated α-synuclein was limited to the temporal lobe in cases of Parkinson disease, spread from the temporal lobe to the frontal lobe in cases of DLB transitional form and further spread to the parietal and occipital lobes in DLB neocortical form.  These findings suggest that LB-related pathol. initially involves the neuronal perikarya, dendrites and axons, causes impairment of axonal transport and synaptic transmission, and later leads to the formation of LBs, a hallmark of functional disturbance long before neuronal cell death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMmJmRmpThZbVg90H21EOLACvtfcHk0liZml3iO5pu5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlt1yqu78%253D&md5=54a0ac3adcda371512d36ae45629deec</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DY.%26aulast%3DKawashima%26aufirst%3DA.%26aulast%3DRuberu%26aufirst%3DN.%2BN.%26aulast%3DFujiwara%26aufirst%3DH.%26aulast%3DKoyama%26aufirst%3DS.%26aulast%3DSawabe%26aufirst%3DM.%26aulast%3DArai%26aufirst%3DT.%26aulast%3DNagura%26aufirst%3DH.%26aulast%3DYamanouchi%26aufirst%3DH.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DMurayama%26aufirst%3DS.%26atitle%3DAccumulation%2520of%2520phosphorylated%2520alpha-synuclein%2520in%2520aging%2520human%2520brain%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D2003%26volume%3D62%26spage%3D644%26epage%3D654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Strong, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesavapany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pant, H. C.</span><span> </span><span class="NLM_article-title">The pathobiology of amyotrophic lateral sclerosis: a proteinopathy</span> <span class="citation_source-journal">J. Neuropathol. Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">649</span><span class="NLM_x">–</span> <span class="NLM_lpage">664</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1097%2F01.jnen.0000173889.71434.ea" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16106213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVemsL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2005&pages=649-664&author=M.+J.+Strongauthor=S.+Kesavapanyauthor=H.+C.+Pant&title=The+pathobiology+of+amyotrophic+lateral+sclerosis%3A+a+proteinopathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The pathobiology of amyotrophic lateral sclerosis: a proteinopathy?</span></div><div class="casAuthors">Strong, Michael J.; Kesavapany, Sashi; Pant, Harish C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuropathology & Experimental Neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">649-664</span>CODEN:
                <span class="NLM_cas:coden">JNENAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Amyotrophic lateral sclerosis (ALS) is increasingly considered to be a disorder of multiple etiologies that have in common progressive degeneration of both upper and lower motor neurons, ultimately giving rise to a relentless loss of muscle function.  This progressive degeneration is assocd. with heightened levels of oxidative injury, excitotoxicity, and mitochondrial dysfunction-all occurring concurrently.  In this article, we review the evidence that suggests, in common with other age-dependent neurodegenerative disorders, that ALS can be considered a disorder of protein aggregation.  Morphol., this is evident as Bunina bodies, ubiquitin-immunoreactive fibrils or aggregates, neurofilamentous aggregates, mutant copper/zinc superoxide dismutase (SOD1) aggregates in familial ALS variants harboring mutations in SOD1, peripherin-immunoreactive aggregates within spinal motor neurons and as neuroaxonal spheroids, and in an increasingly greater population of patients with ALS with cognitive impairment, both intra- and extraneuronal tau aggregates.  We review the evidence that somatotopically specific patterns of altered kinase and phosphatase activity are assocd. with alterations in the phosphorylation state of these proteins, altering either soly. or assembly characteristics.  The role of nonneuronal cells in mediating motor neuronal injury is discussed in the context of alterations in tyrosine kinase activity and enhanced protein phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWAmzTh9eWX7Vg90H21EOLACvtfcHk0liKaXk5dJPo-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVemsL3K&md5=af483a63c7b9cadd240094ad93eea93e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1097%2F01.jnen.0000173889.71434.ea&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.jnen.0000173889.71434.ea%26sid%3Dliteratum%253Aachs%26aulast%3DStrong%26aufirst%3DM.%2BJ.%26aulast%3DKesavapany%26aufirst%3DS.%26aulast%3DPant%26aufirst%3DH.%2BC.%26atitle%3DThe%2520pathobiology%2520of%2520amyotrophic%2520lateral%2520sclerosis%253A%2520a%2520proteinopathy%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D2005%26volume%3D64%26spage%3D649%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Lievens, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, G. P.</span><span> </span><span class="NLM_article-title">Abnormal phosphorylation of synapsin I predicts a neuronal transmission impairment in the R6/2 Huntingtonʼs disease transgenic mice</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">638</span><span class="NLM_x">–</span> <span class="NLM_lpage">648</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1006%2Fmcne.2002.1152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=12213445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsV2lu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2002&pages=638-648&author=J.+C.+Lievensauthor=B.+Woodmanauthor=A.+Mahalauthor=G.+P.+Bates&title=Abnormal+phosphorylation+of+synapsin+I+predicts+a+neuronal+transmission+impairment+in+the+R6%2F2+Huntington%CA%BCs+disease+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Abnormal Phosphorylation of Synapsin I Predicts a Neuronal Transmission Impairment in the R6/2 Huntington's Disease Transgenic Mice</span></div><div class="casAuthors">Lievens, Jean-Charles; Woodman, Benjamin; Mahal, Amarbirpal; Bates, Gillian P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">638-648</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Motor and cognitive deficits in Huntington's disease (HD) are likely caused by progressive neuronal dysfunction preceding neuronal cell death.  Synapsin I is one of the major phosphoproteins regulating neurotransmitter release.  The authors report here an abnormal phosphorylation state of synapsin I in the striatum and the cerebral cortex of R6/2 transgenic mice expressing the HD mutation.  These changes are mostly characterized by an early overphosphorylation at sites 3-5, whereas phosphorylation at site 1 remains unchanged and at site 6 becomes reduced only close to the end stage of the disease.  Such changes do not result from modification in protein expression levels.  However, we show a decreased expression of the calcineurin regulatory subunit-B, which may contribute to an imbalance between kinase and phosphatase activities.  Together the results suggest that an early impairment in synapsin phosphorylation-dephosphorylation may alter synaptic vesicle trafficking and lead to defective neurotransmission in HD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO9WE5VDCzMrVg90H21EOLACvtfcHk0liKaXk5dJPo-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsV2lu7c%253D&md5=df6d35da491eff4cf40ec8611e3f55eb</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1006%2Fmcne.2002.1152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.2002.1152%26sid%3Dliteratum%253Aachs%26aulast%3DLievens%26aufirst%3DJ.%2BC.%26aulast%3DWoodman%26aufirst%3DB.%26aulast%3DMahal%26aufirst%3DA.%26aulast%3DBates%26aufirst%3DG.%2BP.%26atitle%3DAbnormal%2520phosphorylation%2520of%2520synapsin%2520I%2520predicts%2520a%2520neuronal%2520transmission%2520impairment%2520in%2520the%2520R6%252F2%2520Huntington%25CA%25BCs%2520disease%2520transgenic%2520mice%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2002%26volume%3D20%26spage%3D638%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overington, J. P.</span><span> </span><span class="NLM_article-title">Can we rationally design promiscuous drugs?</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.sbi.2006.01.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16442279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFOjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=127-136&author=A.+L.+Hopkinsauthor=J.+S.+Masonauthor=J.+P.+Overington&title=Can+we+rationally+design+promiscuous+drugs%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Can we rationally design promiscuous drugs?</span></div><div class="casAuthors">Hopkins, Andrew L.; Mason, Jonathan S.; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-136</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Structure-based drug design is now used widely in modern medicinal chem.  The application of structural biol. to medicinal chem. has heralded the 'rational drug design' vision of discovering exquisitely selective ligands.  However, recent advances in post-genomic biol. are indicating that polypharmacol. may be a necessary trait for the efficacy of many drugs, therefore questioning the 'one drug, one target' assumption of current rational drug design.  By combining advances in chemoinformatics and structural biol., it might be possible to rationally design the next generation of promiscuous drugs with polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQWdh60x9AHrVg90H21EOLACvtfcHk0liKaXk5dJPo-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFOjsrc%253D&md5=8f9e95a41976b8e3ac790f2fff2c406f</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2006.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2006.01.013%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DCan%2520we%2520rationally%2520design%2520promiscuous%2520drugs%253F%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2006%26volume%3D16%26spage%3D127%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Mount, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downton, C.</span><span> </span><span class="NLM_article-title">Alzheimer disease: progress or profit</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">780</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnm0706-780" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16829947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1eks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=780-784&author=C.+Mountauthor=C.+Downton&title=Alzheimer+disease%3A+progress+or+profit"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer disease: progress or profit?</span></div><div class="casAuthors">Mount, Claire; Downton, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">780-784</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp458aEz9g7-rVg90H21EOLACvtfcHk0lj0Io6JSdEmkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1eks7s%253D&md5=53e9af938ef93beee99bc9a7feb7eeea</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnm0706-780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0706-780%26sid%3Dliteratum%253Aachs%26aulast%3DMount%26aufirst%3DC.%26aulast%3DDownton%26aufirst%3DC.%26atitle%3DAlzheimer%2520disease%253A%2520progress%2520or%2520profit%26jtitle%3DNat.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D780%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Melnikova, I.</span><span> </span><span class="NLM_article-title">Therapies for Alzheimerʼs disease</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=341-342&author=I.+Melnikova&title=Therapies+for+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMelnikova%26aufirst%3DI.%26atitle%3DTherapies%2520for%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D341%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Alzheimer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stelzmann, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnitzlein, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murtagh, F. R.</span><span> </span><span class="NLM_article-title">An English translation of Alzheimerʼs 1907 paper, “Uber eine eigenartige Erkankung der Hirnrinde”</span> <span class="citation_source-journal">Clin. Anat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fca.980080612" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=8713166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADyaK28zkvVWktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1995&pages=429-431&author=A.+Alzheimerauthor=R.+A.+Stelzmannauthor=H.+N.+Schnitzleinauthor=F.+R.+Murtagh&title=An+English+translation+of+Alzheimer%CA%BCs+1907+paper%2C+%E2%80%9CUber+eine+eigenartige+Erkankung+der+Hirnrinde%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde"</span></div><div class="casAuthors">Alzheimer A; Stelzmann R A; Schnitzlein H N; Murtagh F R</div><div class="citationInfo"><span class="NLM_cas:title">Clinical anatomy (New York, N.Y.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">429-31</span>
        ISSN:<span class="NLM_cas:issn">0897-3806</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcScU3l9NPx0TrjnyZkbE8yXfW6udTcc2eaqr82KG5uisbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28zkvVWktg%253D%253D&md5=0bb8ce0dabc45d35e51a22636756708c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fca.980080612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fca.980080612%26sid%3Dliteratum%253Aachs%26aulast%3DAlzheimer%26aufirst%3DA.%26aulast%3DStelzmann%26aufirst%3DR.%2BA.%26aulast%3DSchnitzlein%26aufirst%3DH.%2BN.%26aulast%3DMurtagh%26aufirst%3DF.%2BR.%26atitle%3DAn%2520English%2520translation%2520of%2520Alzheimer%25CA%25BCs%25201907%2520paper%252C%2520%25E2%2580%259CUber%2520eine%2520eigenartige%2520Erkankung%2520der%2520Hirnrinde%25E2%2580%259D%26jtitle%3DClin.%2520Anat.%26date%3D1995%26volume%3D8%26spage%3D429%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Bartus, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. L.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippa, A. S.</span><span> </span><span class="NLM_article-title">The cholinergic hypothesis of geriatric memory dysfunction</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">217</span><span class="NLM_x">, </span> <span class="NLM_fpage">408</span><span class="NLM_x">–</span> <span class="NLM_lpage">414</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1126%2Fscience.7046051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=7046051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaL38XkslShur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=217&publication_year=1982&pages=408-414&author=R.+T.+Bartusauthor=R.+L.+Deanauthor=B.+Beerauthor=A.+S.+Lippa&title=The+cholinergic+hypothesis+of+geriatric+memory+dysfunction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The cholinergic hypothesis of geriatric memory dysfunction</span></div><div class="casAuthors">Bartus, Raymond T.; Dean, Reginald L., III; Beer, Bernard; Lippa, Arnold S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">217</span>
        (<span class="NLM_cas:issue">4558</span>),
    <span class="NLM_cas:pages">408-17</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 93 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC5hLTTFFYoLVg90H21EOLACvtfcHk0lj0Io6JSdEmkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XkslShur4%253D&md5=ff0661ed096b9cb45406dd159c88e15e</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1126%2Fscience.7046051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.7046051%26sid%3Dliteratum%253Aachs%26aulast%3DBartus%26aufirst%3DR.%2BT.%26aulast%3DDean%26aufirst%3DR.%2BL.%26aulast%3DBeer%26aufirst%3DB.%26aulast%3DLippa%26aufirst%3DA.%2BS.%26atitle%3DThe%2520cholinergic%2520hypothesis%2520of%2520geriatric%2520memory%2520dysfunction%26jtitle%3DScience%26date%3D1982%26volume%3D217%26spage%3D408%26epage%3D414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Sivaprakasam, K.</span><span> </span><span class="NLM_article-title">Towards a unifying hypothesis of Alzheimerʼs disease: cholinergic system linked to plaques, tangles and neuroinflammation</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2179</span><span class="NLM_x">–</span> <span class="NLM_lpage">2188</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.2174%2F092986706777935203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16918347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XnslOks7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=2179-2188&author=K.+Sivaprakasam&title=Towards+a+unifying+hypothesis+of+Alzheimer%CA%BCs+disease%3A+cholinergic+system+linked+to+plaques%2C+tangles+and+neuroinflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Towards a unifying hypothesis of Alzheimer's disease: cholinergic system linked to plaques, tangles and neuroinflammation</span></div><div class="casAuthors">Sivaprakasam, Kannan</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2179-2188</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The central role of cholinergic system in Alzheimer's disease (AD) pathway is becoming increasingly significant as reports linking the various components of cholinergic neurotransmission with the other pathol. hallmarks emerge.  This review, while addressing the mol. mechanisms assocd. with the pathol. hallmarks of the disease and their close interactions, also makes an attempt to address the crit. question that evades an answer: Given the significant role played by cholinergic system in AD pathway, why do the cholinergic-mechanism-based drugs are not successful in reversing or arresting the disease progress.  Further, as mols. of diverse structural features were shown to inhibit amyloid aggregation, an understanding of the generic pathway of amyloid aggregation slowly emerges.  For the first time, a coherent view of amyloid aggregation is presented in this review.  The possible role of neuroinflammatory response in the events leading to the degeneration of cholinergic neurons is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBXh8g6TaBN7Vg90H21EOLACvtfcHk0lhJIgcu9PXMrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnslOks7w%253D&md5=b56fac0776c02f3a8aa9c37a974f88dd</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.2174%2F092986706777935203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706777935203%26sid%3Dliteratum%253Aachs%26aulast%3DSivaprakasam%26aufirst%3DK.%26atitle%3DTowards%2520a%2520unifying%2520hypothesis%2520of%2520Alzheimer%25CA%25BCs%2520disease%253A%2520cholinergic%2520system%2520linked%2520to%2520plaques%252C%2520tangles%2520and%2520neuroinflammation%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D2179%26epage%3D2188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Kennedy, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tariot, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, J. L.</span><span> </span><span class="NLM_article-title">Amyloid-based interventions in Alzheimerʼs disease</span> <span class="citation_source-journal">CNS Spectrums</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=1-14&author=G.+J.+Kennedyauthor=T.+E.+Goldeauthor=P.+N.+Tariotauthor=J.+L.+Cummings&title=Amyloid-based+interventions+in+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DG.%2BJ.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DTariot%26aufirst%3DP.%2BN.%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26atitle%3DAmyloid-based%2520interventions%2520in%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DCNS%2520Spectrums%26date%3D2007%26volume%3D12%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Tang, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liou, Y. C.</span><span> </span><span class="NLM_article-title">Novel modulators of amyloid-beta precursor protein processing</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1111%2Fj.1471-4159.2006.04215.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17241154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFaksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2007&pages=314-323&author=B.+L.+Tangauthor=Y.+C.+Liou&title=Novel+modulators+of+amyloid-beta+precursor+protein+processing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Novel modulators of amyloid-β precursor protein processing</span></div><div class="casAuthors">Tang, Bor Luen; Liou, Yih Cherng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">314-323</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Proteolytic processing of the amyloid precursor protein (APP) is modulated by the action of enzymes α-, β- and γ-secretases, with the latter two mediating the amyloidogenic prodn. of amyloid-β (Aβ).  Cellular modulators of APP processing are well known from studies of genetic mutations (such as those found in APP and presenilins) or polymorphisms (such as the apolipoprotein E4 ε-allele) that predisposes an individual to early or late-onset Alzheimer's disease.  In recent years, several classes of mol. with modulating functions in APP processing and Aβ secretion have emerged.  These include the neuronal Munc-18 interacting proteins (Mints)/X11s, members of the reticulon family (RTN-3 and RTN-4/Nogo-B), the Nogo-66 receptor (NgR), the peptidylprolyl isomerase Pin1 and the Rho family GTPases and their effectors.  Mints and NgR bind to APP directly, while RTN3 and Nogo-B interact with the β-secretase BACE1.  Phosphorylated APP is a Pin1 substrate, which binds to its phosphor-Thr668-Pro motif.  These interactions by and large resulted in a redn. of Aβ generation both in vitro and in vivo.  Inhibition of Rho and Rho-kinase (ROCK) activity may underlie the ability of non-steroidal anti-inflammatory drugs and statins to reduce Aβ prodn., a feat which could also be achieved by Rac1 inhibition.  Detailed understanding of the underlying mechanisms of action of these novel modulators of APP processing, as well as insights into the mol. neurol. basis of how Aβ impairs learning and memory, will open up multiple avenues for the therapeutic intervention of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonb01iQcoPn7Vg90H21EOLACvtfcHk0lhJIgcu9PXMrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFaksrY%253D&md5=ea726b131480814b85cbfc9ddfa86cce</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04215.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04215.x%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DB.%2BL.%26aulast%3DLiou%26aufirst%3DY.%2BC.%26atitle%3DNovel%2520modulators%2520of%2520amyloid-beta%2520precursor%2520protein%2520processing%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D100%26spage%3D314%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Lundkvist, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naslund, J.</span><span> </span><span class="NLM_article-title">Gamma-secretase: a complex target for Alzheimerʼs disease</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">112</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.coph.2006.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17169612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntlGisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=112-118&author=J.+Lundkvistauthor=J.+Naslund&title=Gamma-secretase%3A+a+complex+target+for+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase: a complex target for Alzheimer's disease</span></div><div class="casAuthors">Lundkvist, Johan; Naeslund, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">112-118</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Data accumulated during the past two decades place amyloid β-peptide (Aβ) at center stage as the main perpetrator in initiating the pathol. cascade that eventually leads to Alzheimer's disease.  Consequently, significant resources have been allocated to identify and develop treatment strategies that alter the metab. of Aβ.  The γ-secretase protease has deservedly received attention as an attractive drug target, as it is directly involved in Aβ biogenesis and dets. the pathogenic potential of Aβ by its heterogeneous catalytic action, generating peptides of various lengths.  Despite the complexity of the multi-subunit γ-secretase and the lack of structural information, drug discovery research has identified small-mol. compds. that inhibit or modulate activity of this enzyme and some of these have already entered clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmYpXv1AqDXbVg90H21EOLACvtfcHk0lhJIgcu9PXMrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntlGisg%253D%253D&md5=98007a90520f378003e9fa904cd2c5f1</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2006.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2006.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DLundkvist%26aufirst%3DJ.%26aulast%3DNaslund%26aufirst%3DJ.%26atitle%3DGamma-secretase%253A%2520a%2520complex%2520target%2520for%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2007%26volume%3D7%26spage%3D112%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertram, L.</span><span> </span><span class="NLM_article-title">Twenty years of the Alzheimerʼs disease amyloid hypothesis: a genetic perspective</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">555</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2005&pages=545-555&author=R.+E.+Tanziauthor=L.+Bertram&title=Twenty+years+of+the+Alzheimer%CA%BCs+disease+amyloid+hypothesis%3A+a+genetic+perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DBertram%26aufirst%3DL.%26atitle%3DTwenty%2520years%2520of%2520the%2520Alzheimer%25CA%25BCs%2520disease%2520amyloid%2520hypothesis%253A%2520a%2520genetic%2520perspective%26jtitle%3DCell%26date%3D2005%26volume%3D120%26spage%3D545%26epage%3D555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Lustbader, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirilli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takuma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caspersen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinchese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn-Moore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lue, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuppusamy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zewier, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span> </span><span class="NLM_article-title">ABAD directly links Abeta to mitochondrial toxicity in Alzheimerʼs disease</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">448</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2004&pages=448-452&author=J.+W.+Lustbaderauthor=M.+Cirilliauthor=C.+Linauthor=H.+W.+Xuauthor=K.+Takumaauthor=N.+Wangauthor=C.+Caspersenauthor=X.+Chenauthor=S.+Pollakauthor=M.+Chaneyauthor=F.+Trincheseauthor=S.+Liuauthor=F.+Gunn-Mooreauthor=L.+F.+Lueauthor=D.+G.+Walkerauthor=P.+Kuppusamyauthor=Z.+L.+Zewierauthor=O.+Arancioauthor=D.+Sternauthor=S.+S.+Yanauthor=H.+Wu&title=ABAD+directly+links+Abeta+to+mitochondrial+toxicity+in+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLustbader%26aufirst%3DJ.%2BW.%26aulast%3DCirilli%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DH.%2BW.%26aulast%3DTakuma%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DCaspersen%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DPollak%26aufirst%3DS.%26aulast%3DChaney%26aufirst%3DM.%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DGunn-Moore%26aufirst%3DF.%26aulast%3DLue%26aufirst%3DL.%2BF.%26aulast%3DWalker%26aufirst%3DD.%2BG.%26aulast%3DKuppusamy%26aufirst%3DP.%26aulast%3DZewier%26aufirst%3DZ.%2BL.%26aulast%3DArancio%26aufirst%3DO.%26aulast%3DStern%26aufirst%3DD.%26aulast%3DYan%26aufirst%3DS.%2BS.%26aulast%3DWu%26aufirst%3DH.%26atitle%3DABAD%2520directly%2520links%2520Abeta%2520to%2520mitochondrial%2520toxicity%2520in%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DScience%26date%3D2004%26volume%3D304%26spage%3D448%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Caricasole, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caruso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caraci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iacovelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sortino, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terstappen, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, F.</span><span> </span><span class="NLM_article-title">The Wnt pathway, cell-cycle activation and beta-amyloid: novel therapeutic strategies in Alzheimerʼs disease</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=233-238&author=A.+Caricasoleauthor=A.+Copaniauthor=A.+Carusoauthor=F.+Caraciauthor=L.+Iacovelliauthor=M.+A.+Sortinoauthor=G.+C.+Terstappenauthor=F.+Nicoletti&title=The+Wnt+pathway%2C+cell-cycle+activation+and+beta-amyloid%3A+novel+therapeutic+strategies+in+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaricasole%26aufirst%3DA.%26aulast%3DCopani%26aufirst%3DA.%26aulast%3DCaruso%26aufirst%3DA.%26aulast%3DCaraci%26aufirst%3DF.%26aulast%3DIacovelli%26aufirst%3DL.%26aulast%3DSortino%26aufirst%3DM.%2BA.%26aulast%3DTerstappen%26aufirst%3DG.%2BC.%26aulast%3DNicoletti%26aufirst%3DF.%26atitle%3DThe%2520Wnt%2520pathway%252C%2520cell-cycle%2520activation%2520and%2520beta-amyloid%253A%2520novel%2520therapeutic%2520strategies%2520in%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2003%26volume%3D24%26spage%3D233%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helmerhorst, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taddei, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plewright, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Bronswijk, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, R.</span><span> </span><span class="NLM_article-title">Alzheimerʼs beta-amyloid peptides compete for insulin binding to the insulin receptor</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">RC221</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=RC221&author=L.+Xieauthor=E.+Helmerhorstauthor=K.+Taddeiauthor=B.+Plewrightauthor=W.+Van+Bronswijkauthor=R.+Martins&title=Alzheimer%CA%BCs+beta-amyloid+peptides+compete+for+insulin+binding+to+the+insulin+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DL.%26aulast%3DHelmerhorst%26aufirst%3DE.%26aulast%3DTaddei%26aufirst%3DK.%26aulast%3DPlewright%26aufirst%3DB.%26aulast%3DVan%2BBronswijk%26aufirst%3DW.%26aulast%3DMartins%26aufirst%3DR.%26atitle%3DAlzheimer%25CA%25BCs%2520beta-amyloid%2520peptides%2520compete%2520for%2520insulin%2520binding%2520to%2520the%2520insulin%2520receptor%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26spage%3DRC221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Tamagno, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parola, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglielmotto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marra, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabaton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danni, O.</span><span> </span><span class="NLM_article-title">Multiple signaling events in amyloid beta-induced, oxidative stress-dependent neuronal apoptosis</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2FS0891-5849%2803%2900244-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=12826255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvVKiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2003&pages=45-58&author=E.+Tamagnoauthor=M.+Parolaauthor=M.+Guglielmottoauthor=G.+Santoroauthor=P.+Bardiniauthor=L.+Marraauthor=M.+Tabatonauthor=O.+Danni&title=Multiple+signaling+events+in+amyloid+beta-induced%2C+oxidative+stress-dependent+neuronal+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple signaling events in amyloid β-induced, oxidative stress-dependent neuronal apoptosis</span></div><div class="casAuthors">Tamagno, Elena; Parola, Maurizio; Guglielmotto, Michela; Santoro, Gianni; Bardini, Paola; Marra, Laura; Tabaton, Massimo; Danni, Oliviero</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-58</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Current evidence suggests that amyloid β peptides (Aβ) may play a major role in the pathogenesis of Alzheimer's disease by eliciting oxidative stress and neuronal apoptosis.  The authors have used differentiated SK-N-BE neurons to investigate mol. mechanisms and regulatory pathways underlying apoptotic neuronal cell death elicited by Aβ1-40 and Aβ1-42 peptides as well as the relationships between apoptosis and oxidative stress.  Aβ peptides, used at concns. able to induce oxidative stress, elicit a classic type of neuronal apoptosis involving mitochondrial regulatory proteins and pathways (i.e. affecting Bax and Bcl-2 protein levels as well as release of cytochrome c in the cytosol), poly-ADP ribose polymerase cleavage and activation of caspase 3.  This pattern of neuronal apoptosis, that is significantly prevented by α-tocopherol and N-acetylcysteine and completely abolished by specific inhibitors of stress-activated protein kinases (SAPK) such as JNKs and p38MAPK, involved early elevation of p53 protein levels.  Pretreatment of neurons with α-pifithrin, a specific p53 inhibitor, resulted in a 50-60% prevention of Aβ induced apoptosis.  These results suggest that oxidative stress - mediated neuronal apoptosis induced by amyloid β operates by eliciting a SAPK-dependent multiple regulation of pro-apoptotic mitochondrial pathways involving both p53 and bcl-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEBIDmfzQuW7Vg90H21EOLACvtfcHk0li4OGBuIugy7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvVKiurY%253D&md5=623197c5ccc38f98dddc6a8761a14050</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2803%2900244-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252803%252900244-2%26sid%3Dliteratum%253Aachs%26aulast%3DTamagno%26aufirst%3DE.%26aulast%3DParola%26aufirst%3DM.%26aulast%3DGuglielmotto%26aufirst%3DM.%26aulast%3DSantoro%26aufirst%3DG.%26aulast%3DBardini%26aufirst%3DP.%26aulast%3DMarra%26aufirst%3DL.%26aulast%3DTabaton%26aufirst%3DM.%26aulast%3DDanni%26aufirst%3DO.%26atitle%3DMultiple%2520signaling%2520events%2520in%2520amyloid%2520beta-induced%252C%2520oxidative%2520stress-dependent%2520neuronal%2520apoptosis%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2003%26volume%3D35%26spage%3D45%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Bamberger, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landreth, G. E.</span><span> </span><span class="NLM_article-title">Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimerʼs disease</span> <span class="citation_source-journal">Microsc. Res. Tech.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fjemt.1121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=11455613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlslGrsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2001&pages=59-70&author=M.+E.+Bambergerauthor=G.+E.+Landreth&title=Microglial+interaction+with+beta-amyloid%3A+implications+for+the+pathogenesis+of+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Microglial interaction with β-amyloid: implications for the pathogenesis of Alzheimer's disease</span></div><div class="casAuthors">Bamberger, Maria E.; Landreth, Gary E.</div><div class="citationInfo"><span class="NLM_cas:title">Microscopy Research and Technique</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">59-70</span>CODEN:
                <span class="NLM_cas:coden">MRTEEO</span>;
        ISSN:<span class="NLM_cas:issn">1059-910X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  The etiol. of Alzheimer's disease (AD) involves a significant inflammatory component as evidenced by the presence of elevated levels of a diverse range of proinflammatory mols. in the AD brain.  These inflammatory mols. are produced principally by activated microglia, which are found to be clustered within and adjacent to the senile plaque.  Moreover, long-term treatment of patients with non-steroidal anti-inflammatory drugs was shown to reduce risk and incidence of AD and delay disease progression.  The microglia respond to beta-amyloid (Aβ) deposition in the brain through the interaction of fibrillar forms of amyloid with cell surface receptors, leading to the activation of intracellular signal transduction cascades.  The activation of multiple independent signaling pathways ultimately leads to the induction of proinflammatory gene expression and prodn. of reactive O and N species.  These microglial inflammatory products act in concert to produce neuronal toxicity and death.  Therapeutic approaches focused on inhibition of the microglial-mediated local inflammatory response in the AD brain offer new opportunities to intervene in the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzNuX6fXLMmrVg90H21EOLACvtfcHk0ljdX2a2ppKcyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlslGrsr8%253D&md5=2e5dc18d700d23c1602e53204727a198</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fjemt.1121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjemt.1121%26sid%3Dliteratum%253Aachs%26aulast%3DBamberger%26aufirst%3DM.%2BE.%26aulast%3DLandreth%26aufirst%3DG.%2BE.%26atitle%3DMicroglial%2520interaction%2520with%2520beta-amyloid%253A%2520implications%2520for%2520the%2520pathogenesis%2520of%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DMicrosc.%2520Res.%2520Tech.%26date%3D2001%26volume%3D54%26spage%3D59%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Devi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabhu, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galati, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avadhani, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anandatheerthavarada, H. K.</span><span> </span><span class="NLM_article-title">Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimerʼs disease brain is associated with mitochondrial dysfunction</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">9057</span><span class="NLM_x">–</span> <span class="NLM_lpage">9068</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1523%2FJNEUROSCI.1469-06.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16943564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1aqu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=9057-9068&author=L.+Deviauthor=B.+M.+Prabhuauthor=D.+F.+Galatiauthor=N.+G.+Avadhaniauthor=H.+K.+Anandatheerthavarada&title=Accumulation+of+amyloid+precursor+protein+in+the+mitochondrial+import+channels+of+human+Alzheimer%CA%BCs+disease+brain+is+associated+with+mitochondrial+dysfunction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction</span></div><div class="casAuthors">Devi, Latha; Prabhu, Badanavalu M.; Galati, Domenico F.; Avadhani, Narayan G.; Anandatheerthavarada, Hindupur K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">9057-9068</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Mitochondrial dysfunction is one of the major intracellular lesions of Alzheimer's disease (AD).  However, the causative factors involved in the mitochondrial dysfunction in human AD are not well understood.  Here we report that non-glycosylated full-length and C-terminal truncated amyloid precursor protein (APP) accumulates exclusively in the protein import channels of mitochondria of human AD brains but not in age-matched controls.  Furthermore, in AD brains, mitochondrially assocd. APP formed stable ∼480 kDa complexes with the translocase of the outer mitochondrial membrane 40 (TOM40) import channel and a super complex of ∼620 kDa with both mitochondrial TOM40 and the translocase of the inner mitochondrial membrane 23 (TIM23) import channel TIM23 in an "Nin mitochondria-Cout cytoplasm" orientation.  Accumulation of APP across mitochondrial import channels, which varied with the severity of AD, inhibited the entry of nuclear-encoded cytochrome c oxidase subunits IV and Vb proteins, which was assocd. with decreased cytochrome c oxidase activity and increased levels of H2O2.  Regional distribution of mitochondrial APP showed higher levels in AD-vulnerable brain regions, such as the frontal cortex, hippocampus, and amygdala.  Mitochondrial accumulation of APP was also obsd. in the cholinergic, dopaminergic, GABAergic, and glutamatergic neuronal types in the category III AD brains.  The levels of translocationally arrested mitochondrial APP directly correlated with mitochondrial dysfunction.  Moreover, apolipoprotein genotype anal. revealed that AD subjects with the E3/E4 alleles had the highest content of mitochondrial APP.  Collectively, these results suggest that abnormal accumulation of APP across mitochondrial import channels, causing mitochondrial dysfunction, is a hallmark of human AD pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq75HFO53TO0rVg90H21EOLACvtfcHk0ljdX2a2ppKcyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1aqu70%253D&md5=9fd32520cee814fb0b7b89df6176e179</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1469-06.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1469-06.2006%26sid%3Dliteratum%253Aachs%26aulast%3DDevi%26aufirst%3DL.%26aulast%3DPrabhu%26aufirst%3DB.%2BM.%26aulast%3DGalati%26aufirst%3DD.%2BF.%26aulast%3DAvadhani%26aufirst%3DN.%2BG.%26aulast%3DAnandatheerthavarada%26aufirst%3DH.%2BK.%26atitle%3DAccumulation%2520of%2520amyloid%2520precursor%2520protein%2520in%2520the%2520mitochondrial%2520import%2520channels%2520of%2520human%2520Alzheimer%25CA%25BCs%2520disease%2520brain%2520is%2520associated%2520with%2520mitochondrial%2520dysfunction%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26spage%3D9057%26epage%3D9068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Lin, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, M. F.</span><span> </span><span class="NLM_article-title">Alzheimerʼs APP mangles mitochondria</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1241</span><span class="NLM_x">–</span> <span class="NLM_lpage">1243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnm1106-1241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17088888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKlsLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=1241-1243&author=M.+T.+Linauthor=M.+F.+Beal&title=Alzheimer%CA%BCs+APP+mangles+mitochondria"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's APP mangles mitochondria</span></div><div class="casAuthors">Lin, Michael T.; Beal, M. Flint</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1241-1243</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">New findings in humans examine how mitochondrial function declines during Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX6yOgF6CRHLVg90H21EOLACvtfcHk0ljdX2a2ppKcyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKlsLjI&md5=307d5872ac596a493a6d912ee9ec5e5f</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fnm1106-1241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1106-1241%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DM.%2BT.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DAlzheimer%25CA%25BCs%2520APP%2520mangles%2520mitochondria%26jtitle%3DNat.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D1241%26epage%3D1243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Wang, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundke-Iqbal, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, K.</span><span> </span><span class="NLM_article-title">Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1111%2Fj.1460-9568.2006.05226.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17241267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252Fkt1Sktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=59-68&author=J.+Z.+Wangauthor=I.+Grundke-Iqbalauthor=K.+Iqbal&title=Kinases+and+phosphatases+and+tau+sites+involved+in+Alzheimer+neurofibrillary+degeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration</span></div><div class="casAuthors">Wang Jian-Zhi; Grundke-Iqbal Inge; Iqbal Khalid</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-68</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Microtubule associated protein (MAP) tau is abnormally hyperphosphorylated in Alzheimer's disease (AD) and related tauopathies; in this form it is the major protein subunit of paired helical filaments (PHF)/neurofibrillary tangles.  However, the nature of protein kinases and phosphatases and tau sites involved in this lesion has been elusive.  We investigated self-assembly and microtubule assembly promoting activities of hyperphosphorylated tau isolated from Alzheimer disease brain cytosol, the AD abnormally hyperphosphorylated tau (AD P-tau) before and after dephosphorylation by phosphoseryl/phosphothreonyl protein phosphatase-2A (PP-2A), and then rephosphorylation by cyclic AMP-dependent protein kinase (PKA), calcium, calmodulin-dependent protein kinase II (CaMKII), glycogen synthase kinase-3beta (GSK-3beta) and cyclin-dependent protein kinase 5 (cdk5) in different kinase combinations.  We found that (i) dephosphorylation of AD P-tau by PP-2A inhibits its polymerization into PHF/straight filaments (SF) and restores its binding and ability to promote assembly of tubulin into microtubules; (ii) rephosphorylation of PP-2A-dephosphorylated AD P-tau by sequential phosphorylation by PKA, CaMKII and GSK-3beta or cdk5, and as well as by cdk5 and GSK-3beta, promotes its self-assembly into tangles of PHF similar to those seen in Alzheimer brain, and (iii) phosphorylation of tau sites required for this pathology are Thr231 and Ser262, along with several sites flanking the microtubule binding repeat region.  Phosphorylation of recombinant human brain tau(441) yielded similar results as the PP-2A dephosphorylated AD P-tau, except that mostly SF were formed.  The conditions for the abnormal hyperphosphorylation of tau that promoted its self-assembly also induced the microtubule assembly inhibitory activity.  These findings suggest that activation of PP-2A or inhibition of either both GSK-3beta and cdk5 or one of these two kinases plus PKA or CaMKII might be required to inhibit Alzheimer neurofibrillary degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRI9DB-4K5ZmF1C8OJBvdfbfW6udTcc2eZlyAm6RNB_E7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252Fkt1Sktg%253D%253D&md5=b8f8ba0a76085995f6c652cc737c55b2</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.2006.05226.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.2006.05226.x%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BZ.%26aulast%3DGrundke-Iqbal%26aufirst%3DI.%26aulast%3DIqbal%26aufirst%3DK.%26atitle%3DKinases%2520and%2520phosphatases%2520and%2520tau%2520sites%2520involved%2520in%2520Alzheimer%2520neurofibrillary%2520degeneration%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2007%26volume%3D25%26spage%3D59%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Blennow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Leon, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zetterberg, H.</span><span> </span><span class="NLM_article-title">Alzheimerʼs disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2006&pages=387-403&author=K.+Blennowauthor=M.+J.+de+Leonauthor=H.+Zetterberg&title=Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3Dde%2BLeon%26aufirst%3DM.%2BJ.%26aulast%3DZetterberg%26aufirst%3DH.%26atitle%3DAlzheimer%25CA%25BCs%2520disease%26jtitle%3DLancet%26date%3D2006%26volume%3D368%26spage%3D387%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Sultana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perluigi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butterfield, D. A.</span><span> </span><span class="NLM_article-title">Protein oxidation and lipid peroxidation in brain of subjects with Alzheimerʼs disease: insights into mechanism of neurodegeneration from redox proteomics</span> <span class="citation_source-journal">Antioxid. Redox Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2021</span><span class="NLM_x">–</span> <span class="NLM_lpage">2037</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1089%2Fars.2006.8.2021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17034347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVKntb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=2021-2037&author=R.+Sultanaauthor=M.+Perluigiauthor=D.+A.+Butterfield&title=Protein+oxidation+and+lipid+peroxidation+in+brain+of+subjects+with+Alzheimer%CA%BCs+disease%3A+insights+into+mechanism+of+neurodegeneration+from+redox+proteomics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Oxidation and Lipid Peroxidation in Brain of Subjects with Alzheimer's Disease: Insights into Mechanism of Neurodegeneration from Redox Proteomics</span></div><div class="casAuthors">Sultana, Rukhsana; Perluigi, Marzia; Butterfield, D. Allan</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11 & 12</span>),
    <span class="NLM_cas:pages">2021-2037</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD), the leading cause of dementia, involves regionalized neuronal death, synaptic loss, and an accumulation of intraneuronal, neurofibrillary tangles and extracellular senile plaques.  Although the initiating causes leading to AD are unknown, a no. of previous studies reported the role of oxidative stress in AD brain.  Postmortem anal. of AD brain showed elevated markers of oxidative stress including protein nitrotyrosine, carbonyls in proteins, lipid oxidn. products, and oxidized DNA bases.  In this review, we focus our attention on the role of protein oxidn. and lipid peroxidn. in the pathogenesis of AD.  Particular attention is given to the current knowledge about the redox proteomics identification of oxidatively modified proteins in AD brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6VJc0AQ9nobVg90H21EOLACvtfcHk0lhHA-m1a-ornQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVKntb%252FO&md5=c8891e5a423e4392cbba68319bde7bd9</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1089%2Fars.2006.8.2021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2006.8.2021%26sid%3Dliteratum%253Aachs%26aulast%3DSultana%26aufirst%3DR.%26aulast%3DPerluigi%26aufirst%3DM.%26aulast%3DButterfield%26aufirst%3DD.%2BA.%26atitle%3DProtein%2520oxidation%2520and%2520lipid%2520peroxidation%2520in%2520brain%2520of%2520subjects%2520with%2520Alzheimer%25CA%25BCs%2520disease%253A%2520insights%2520into%2520mechanism%2520of%2520neurodegeneration%2520from%2520redox%2520proteomics%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2006%26volume%3D8%26spage%3D2021%26epage%3D2037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolston, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreira, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunomura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, G.</span><span> </span><span class="NLM_article-title">Prevention and treatment of Alzheimer disease and aging: antioxidants</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=171-180&author=Q.+Liuauthor=F.+Xieauthor=R.+Rolstonauthor=P.+I.+Moreiraauthor=A.+Nunomuraauthor=X.+Zhuauthor=M.+A.+Smithauthor=G.+Perry&title=Prevention+and+treatment+of+Alzheimer+disease+and+aging%3A+antioxidants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DF.%26aulast%3DRolston%26aufirst%3DR.%26aulast%3DMoreira%26aufirst%3DP.%2BI.%26aulast%3DNunomura%26aufirst%3DA.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26aulast%3DPerry%26aufirst%3DG.%26atitle%3DPrevention%2520and%2520treatment%2520of%2520Alzheimer%2520disease%2520and%2520aging%253A%2520antioxidants%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D171%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Brewer, G. J.</span><span> </span><span class="NLM_article-title">Iron and copper toxicity in diseases of aging, particularly atherosclerosis and Alzheimerʼs disease</span> <span class="citation_source-journal">Exp. Biol. Med. (Maywood)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">232</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17259340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=2007&pages=323-335&author=G.+J.+Brewer&title=Iron+and+copper+toxicity+in+diseases+of+aging%2C+particularly+atherosclerosis+and+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Iron and copper toxicity in diseases of aging, particularly atherosclerosis and Alzheimer's disease</span></div><div class="casAuthors">Brewer, George J.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Biology and Medicine (Maywood, NJ, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">232</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">323-335</span>CODEN:
                <span class="NLM_cas:coden">EBMMBE</span>;
        ISSN:<span class="NLM_cas:issn">1535-3702</span>.
    
            (<span class="NLM_cas:orgname">Society for Experimental Biology and Medicine</span>)
        </div><div class="casAbstract">A review.  In this review, we point out that natural selection does not act to lessen human diseases after the reproductive and caregiving period and that normal levels of iron and copper that may be healthy during the reproductive years appear to be contributing to diseases of aging and possibly the aging process itself.  It is clear that oxidant damage contributes to many of the diseases of aging, such as atherosclerosis, Alzheimer's disease, Parkinson's diseases, diabetes, diseases of inflammation, diseases of fibrosis, diseases of autoimmunity, and so on.  It is equally clear that both iron and copper can contribute to excess prodn. of damaging reactive oxygen species through Fenton chem.  Here, we examine the evidence that "normal" levels of iron and copper contribute to various diseases of aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr43INahQmh17Vg90H21EOLACvtfcHk0lhHA-m1a-ornQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWjtLg%253D&md5=06225f81609e1f71fcfb0c0366bac19b</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrewer%26aufirst%3DG.%2BJ.%26atitle%3DIron%2520and%2520copper%2520toxicity%2520in%2520diseases%2520of%2520aging%252C%2520particularly%2520atherosclerosis%2520and%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DExp.%2520Biol.%2520Med.%2520%2528Maywood%2529%26date%3D2007%26volume%3D232%26spage%3D323%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">El Khoury, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toft, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Means, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geula, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luster, A. D.</span><span> </span><span class="NLM_article-title">Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">432</span><span class="NLM_x">–</span> <span class="NLM_lpage">438</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnm1555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17351623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvVaqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=432-438&author=J.+El+Khouryauthor=M.+Toftauthor=S.+E.+Hickmanauthor=T.+K.+Meansauthor=K.+Teradaauthor=C.+Geulaauthor=A.+D.+Luster&title=Ccr2+deficiency+impairs+microglial+accumulation+and+accelerates+progression+of+Alzheimer-like+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease</span></div><div class="casAuthors">El Khoury, Joseph; Toft, Michelle; Hickman, Suzanne E.; Means, Terry K.; Terada, Kinya; Geula, Changiz; Luster, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">432-438</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Microglia are the principal immune cells of the brain.  In Alzheimer disease, these brain mononuclear phagocytes are recruited from the blood and accumulate in senile plaques.  However, the role of microglia in Alzheimer disease has not been resolved.  Microglia may be neuroprotective by phagocytosing amyloid-β (Aβ), but their activation and the secretion of neurotoxins may also cause neurodegeneration.  Ccr2 is a chemokine receptor expressed on microglia, which mediates the accumulation of mononuclear phagocytes at sites of inflammation.  Here we show that Ccr2 deficiency accelerates early disease progression and markedly impairs microglial accumulation in a transgenic mouse model of Alzheimer disease (Tg2576).  Alzheimer disease mice deficient in Ccr2 accumulated Aβ earlier and died prematurely, in a manner that correlated with Ccr2 gene dosage, indicating that absence of early microglial accumulation leads to decreased Aβ clearance and increased mortality.  Thus, Ccr2-dependent microglial accumulation plays a protective role in the early stages of Alzheimer disease by promoting Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMCV0o0yiwLbVg90H21EOLACvtfcHk0li80avkPjCY3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvVaqtbc%253D&md5=4a1f6f506d9573867fbfc12b035ce397</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Fnm1555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1555%26sid%3Dliteratum%253Aachs%26aulast%3DEl%2BKhoury%26aufirst%3DJ.%26aulast%3DToft%26aufirst%3DM.%26aulast%3DHickman%26aufirst%3DS.%2BE.%26aulast%3DMeans%26aufirst%3DT.%2BK.%26aulast%3DTerada%26aufirst%3DK.%26aulast%3DGeula%26aufirst%3DC.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26atitle%3DCcr2%2520deficiency%2520impairs%2520microglial%2520accumulation%2520and%2520accelerates%2520progression%2520of%2520Alzheimer-like%2520disease%26jtitle%3DNat.%2520Med.%26date%3D2007%26volume%3D13%26spage%3D432%26epage%3D438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Piehl, F.</span><span> </span><span class="NLM_article-title">Inflammation and neurodegeneration</span> <span class="citation_source-journal">Future Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.2217%2F14796708.1.1.97" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=95-105&author=F.+Piehl&title=Inflammation+and+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.2217%2F14796708.1.1.97&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252F14796708.1.1.97%26sid%3Dliteratum%253Aachs%26aulast%3DPiehl%26aufirst%3DF.%26atitle%3DInflammation%2520and%2520neurodegeneration%26jtitle%3DFuture%2520Neurol.%26date%3D2006%26volume%3D1%26spage%3D95%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Takeda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loveman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clegg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picot, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, C.</span><span> </span><span class="NLM_article-title">A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimerʼs disease</span> <span class="citation_source-journal">Int. J. Geriatr. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fgps.1402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16323253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADC%252BD2MnovVGmuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=17-28&author=A.+Takedaauthor=E.+Lovemanauthor=A.+Cleggauthor=J.+Kirbyauthor=J.+Picotauthor=E.+Payneauthor=C.+Green&title=A+systematic+review+of+the+clinical+effectiveness+of+donepezil%2C+rivastigmine+and+galantamine+on+cognition%2C+quality+of+life+and+adverse+events+in+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease</span></div><div class="casAuthors">Takeda A; Loveman E; Clegg A; Kirby J; Picot J; Payne E; Green C</div><div class="citationInfo"><span class="NLM_cas:title">International journal of geriatric psychiatry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-28</span>
        ISSN:<span class="NLM_cas:issn">0885-6230</span>.
    </div><div class="casAbstract">BACKGROUND:  The use of cholinesterase inhibitors for Alzheimer's disease (AD) is currently being appraised by the National Institute for Clinical Evidence (NICE).  This article provides the latest evidence that NICE will be using as part of this appraisal process.  OBJECTIVE:  To provide a systematic review of the best quality evidence of the effects of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in people with mild to moderately-severe AD.  DESIGN:  Electronic databases were searched, references of all retrieved articles were checked, and experts were contacted for advice, peer review and to identify additional references.  Randomised controlled trials (RCTs) were included if they fulfilled pre-specified criteria.  Data were synthesised through a narrative review.  RESULTS:  Twenty-six RCTs that compared any one of the cholinesterase inhibitors with either a control group or with another cholinesterase inhibitor were included.  The quality of reporting and methodology was varied.  Treatment with donepezil, rivastigmine or galantamine resulted in significantly better cognitive performance using the ADAS-cog scale when compared with placebo.  These findings were generally supported using the MMSE scale.  Results from head to head comparisons were limited by the low number of studies and the study quality; generally showing no robust support for any one drug.  Few studies evaluated quality of life.  Adverse events were generally related to the gastrointestinal system, with a tendency for these to be more common in the treatment arms.  CONCLUSIONS:  The cholinesterase inhibitors donepezil, rivastigmine, and galantamine can delay cognitive impairment in patients with mild to moderately-severe AD for at least 6 months duration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRuEPgp1XJWgr5XHngOXiV_fW6udTcc2ebS93aquqA-d7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MnovVGmuw%253D%253D&md5=64dc8b182e5f3c617c2a2a2a3aa24a6f</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1002%2Fgps.1402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fgps.1402%26sid%3Dliteratum%253Aachs%26aulast%3DTakeda%26aufirst%3DA.%26aulast%3DLoveman%26aufirst%3DE.%26aulast%3DClegg%26aufirst%3DA.%26aulast%3DKirby%26aufirst%3DJ.%26aulast%3DPicot%26aufirst%3DJ.%26aulast%3DPayne%26aufirst%3DE.%26aulast%3DGreen%26aufirst%3DC.%26atitle%3DA%2520systematic%2520review%2520of%2520the%2520clinical%2520effectiveness%2520of%2520donepezil%252C%2520rivastigmine%2520and%2520galantamine%2520on%2520cognition%252C%2520quality%2520of%2520life%2520and%2520adverse%2520events%2520in%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DInt.%2520J.%2520Geriatr.%2520Psychiatry%26date%3D2006%26volume%3D21%26spage%3D17%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Birks, J.</span><span> </span><span class="NLM_article-title">Cholinesterase inhibitors for Alzheimerʼs disease</span> <span class="citation_source-journal">Cochrane Database Syst. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">CD005593</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=CD005593&author=J.+Birks&title=Cholinesterase+inhibitors+for+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBirks%26aufirst%3DJ.%26atitle%3DCholinesterase%2520inhibitors%2520for%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DCochrane%2520Database%2520Syst.%2520Rev.%26date%3D2006%26spage%3DCD005593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Christensen, D. D.</span><span> </span><span class="NLM_article-title">Alzheimerʼs disease: progress in the development of anti-amyloid disease-modifying therapies</span> <span class="citation_source-journal">CNS Spectrums</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span><div class="note"><p class="first last">, 119–123</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=113-116&author=D.+D.+Christensen&title=Alzheimer%CA%BCs+disease%3A+progress+in+the+development+of+anti-amyloid+disease-modifying+therapies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DD.%2BD.%26atitle%3DAlzheimer%25CA%25BCs%2520disease%253A%2520progress%2520in%2520the%2520development%2520of%2520anti-amyloid%2520disease-modifying%2520therapies%26jtitle%3DCNS%2520Spectrums%26date%3D2007%26volume%3D12%26spage%3D113%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Silman, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, J. L.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase: “classical” and “non-classical” functions and pharmacology</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.coph.2005.01.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15907917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktlejtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=293-302&author=I.+Silmanauthor=J.+L.+Sussman&title=Acetylcholinesterase%3A+%E2%80%9Cclassical%E2%80%9D+and+%E2%80%9Cnon-classical%E2%80%9D+functions+and+pharmacology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase: "classical" and "non-classical" functions and pharmacology</span></div><div class="casAuthors">Silman, Israel; Sussman, Joel L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">293-302</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The synaptic enzyme acetylcholinesterase (AChE) terminates transmission at cholinergic synapses by rapidly hydrolyzing acetylcholine.  It is anchored within the synaptic cleft by a highly specialized anchoring device in which catalytic subunit tetramers assemble around a polyproline II helix.  AChE is the target of nerve agents, insecticides, and therapeutic drugs, in particular, the first generation of anti-Alzheimer drugs.  Both target-guided synthesis and structure-based drug design have been used effectively to obtain potent anticholinesterase agents.  In addn., AChE is believed to play non-classical roles in addn. to its classical role in terminating synaptic transmission (e.g. as an adhesion protein).  It also accelerates assembly of Aβ into amyloid fibrils.  Both of these actions involve the so-called peripheral anionic site at the entrance to the active-site gorge.  Novel anticholinesterases are targeted against this site, rather than against the active site at the bottom of the gorge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAM8PG1ZkG47Vg90H21EOLACvtfcHk0lh4TyZK2DZueg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktlejtbg%253D&md5=c7be6648c9f1239a016054f85dba1b44</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2005.01.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2005.01.014%26sid%3Dliteratum%253Aachs%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DAcetylcholinesterase%253A%2520%25E2%2580%259Cclassical%25E2%2580%259D%2520and%2520%25E2%2580%259Cnon-classical%25E2%2580%259D%2520functions%2520and%2520pharmacology%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2005%26volume%3D5%26spage%3D293%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Holzgrabe, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapkova, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alptuzun, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheiber, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugelmann, E.</span><span> </span><span class="NLM_article-title">Targeting acetylcholinesterase to treat neurodegeneration</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1517%2F14728222.11.2.161" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17227232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt12ruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=161-179&author=U.+Holzgrabeauthor=P.+Kapkovaauthor=V.+Alptuzunauthor=J.+Scheiberauthor=E.+Kugelmann&title=Targeting+acetylcholinesterase+to+treat+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting acetylcholinesterase to treat neurodegeneration</span></div><div class="casAuthors">Holzgrabe, Ulrike; Kapkova, Petra; Alptuezuen, Vildan; Scheiber, Josef; Kugelmann, Eva</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">161-179</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative disorders, such as Alzheimer's disease, are often characterized by the degeneration of the cholinergic system.  Thus, the aim of many treatment regimens is to support this system either by means of muscarinic agonists or by inhibitors of acetylcholinesterase (AChE), the latter being able to increase the concn. of acetylcholine.  However, both pharmacol. groups of drugs can only help in the beginning of the progressive disease.  The finding that the occupation of the peripheral anionic site of AChE is able to stop the formation of the amyloid plaque led to the development of bivalent ligands that occupy both the active and the peripheral site.  This dual action might be more beneficial for treatment of Alzheimer's disease than simple inhibition of the acetylcholine hydrolysis.  Thus, the new bivalent ligands are the focus of this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfJ1Ef8XjB3LVg90H21EOLACvtfcHk0lh4TyZK2DZueg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt12ruw%253D%253D&md5=e38fa01804094ae9ed273d68f0e74a50</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1517%2F14728222.11.2.161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.11.2.161%26sid%3Dliteratum%253Aachs%26aulast%3DHolzgrabe%26aufirst%3DU.%26aulast%3DKapkova%26aufirst%3DP.%26aulast%3DAlptuzun%26aufirst%3DV.%26aulast%3DScheiber%26aufirst%3DJ.%26aulast%3DKugelmann%26aufirst%3DE.%26atitle%3DTargeting%2520acetylcholinesterase%2520to%2520treat%2520neurodegeneration%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2007%26volume%3D11%26spage%3D161%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, P.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase inhibitors as a starting point towards improved Alzheimerʼs disease therapeutics</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">3157</span><span class="NLM_x">–</span> <span class="NLM_lpage">3166</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.2174%2F1381612043383313" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15544505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnslCktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=3157-3166&author=M.+Recanatiniauthor=P.+Valenti&title=Acetylcholinesterase+inhibitors+as+a+starting+point+towards+improved+Alzheimer%CA%BCs+disease+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase inhibitors as a starting point towards improved Alzheimer's disease therapeutics</span></div><div class="casAuthors">Recanatini, Maurizio; Valenti, Piero</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3157-3166</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The knowledge about the pathogenesis and the development of the neurodegeneration assocd. with Alzheimer's disease (AD) has been organized throughout the years into two theories, namely the cholinergic and the amyloid hypotheses.  The loss of cholinergic neurotransmission and the abnormal aggregation and deposition of the amyloid-β peptide (Aβ) in the brain are retained as the central events by the two theories, resp.  These phenomena and their pathol. consequences are the main targets of the drug discovery strategies based on each hypothesis.  However, the two paradigms share some common aspects as shown by several exptl. evidences, such that they might even fit into a unifying scenario of neuropathol. and neurodegeneration.  In this context, in a perspective of drug discovery, the enzyme acetylcholinesterase (AChE) holds a key position, as it is a main target for cholinomimetic AD drugs being responsible for the breakdown of the neurotransmitter, and it is also involved in the aggregation of Aβ and the formation of the neurotoxic fibrils.  Following this view, in recent years, a drug design strategy has emerged, directed to finding mols. able to inhibit both of these actions exerted by AChE.  In this review, we will briefly introduce the biol. basis of this strategy, and then will account for the early results obtained in this field in our and in other labs.  The main focus will be on potential lead compds. for which some exptl. evidence exists supporting the hypothesis of their dual action, as AChE inhibitors and blockers of the AChE-induced Aβ aggregation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCl-ZXkLB5YrVg90H21EOLACvtfcHk0lh4TyZK2DZueg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnslCktrk%253D&md5=d2b80fd0d6598b8cdb9526f24ecea86e</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.2174%2F1381612043383313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612043383313%26sid%3Dliteratum%253Aachs%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DValenti%26aufirst%3DP.%26atitle%3DAcetylcholinesterase%2520inhibitors%2520as%2520a%2520starting%2520point%2520towards%2520improved%2520Alzheimer%25CA%25BCs%2520disease%2520therapeutics%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2004%26volume%3D10%26spage%3D3157%26epage%3D3166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Castro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span> </span><span class="NLM_article-title">Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4377</span><span class="NLM_x">–</span> <span class="NLM_lpage">4387</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.2174%2F138161206778792985" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17105433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1GntrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=4377-4387&author=A.+Castroauthor=A.+Martinez&title=Targeting+beta-amyloid+pathogenesis+through+acetylcholinesterase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors</span></div><div class="casAuthors">Castro, Ana; Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">4377-4387</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Although the hallmarks of neurodegeneration in Alzheimer's brains are well known, one of the current difficulties is related to the lack of solid evidence about the ultimate factors that give rise to the pathogenesis of this disease, creating a great challenge for the definition of efficient treatments for Alzheimer's disease (AD).  Current therapeutic option for AD patients is the use of acetylcholinesterase (AChE) inhibitors, which gives only a symptomatic relief.  However, recent studies show a long-lasting effect in a certain percentage of patients.  In fact, there is accumulating evidence that an AChE has secondary non-cholinergic functions including the processing and deposition of β-amyloid (Aβ).  AChE could play a role in the Aβ metab. and during an early step in the development of the senile plaque, as revealed by the finding that AChE accelerates Aβ deposition.  Considering the non-classical AChE functions, their relationships with AD hallmarks, and the putative role of peripheral anionic site in all these functions, the dual binding site AChE inhibitors may acquire importance for AD treatment.  On the other hand, the interference of AChE inhibitors with Aβ processing is not a general rule for this class of compds. with the involvement of other features such as chem. structure and/or genetic regulation.  This review highlights the collection of several compds. with an outstanding profile against AChE-induced amyloid aggregation and potent AChE inhibitory activity, indicating the possibility of targeting Aβ through the inhibition of AChE and reveals the emergence of a new generation of AChE inhibitors aiming to be excellent candidate drugs for the future cure of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrisn7G_dIHxrVg90H21EOLACvtfcHk0lh4TyZK2DZueg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1GntrbI&md5=fd41eca56c6433d9ee6a3989908ff2c5</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.2174%2F138161206778792985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206778792985%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DTargeting%2520beta-amyloid%2520pathogenesis%2520through%2520acetylcholinesterase%2520inhibitors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D4377%26epage%3D4387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Alvarez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronfman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrido, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inestrosa, N. C.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase, a senile plaque component, affects the fibrillogenesis of amyloid-beta-peptides</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">201</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=201&publication_year=1995&pages=49-52&author=A.+Alvarezauthor=F.+Bronfmanauthor=C.+A.+Perezauthor=M.+Vicenteauthor=J.+Garridoauthor=N.+C.+Inestrosa&title=Acetylcholinesterase%2C+a+senile+plaque+component%2C+affects+the+fibrillogenesis+of+amyloid-beta-peptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarez%26aufirst%3DA.%26aulast%3DBronfman%26aufirst%3DF.%26aulast%3DPerez%26aufirst%3DC.%2BA.%26aulast%3DVicente%26aufirst%3DM.%26aulast%3DGarrido%26aufirst%3DJ.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26atitle%3DAcetylcholinesterase%252C%2520a%2520senile%2520plaque%2520component%252C%2520affects%2520the%2520fibrillogenesis%2520of%2520amyloid-beta-peptides%26jtitle%3DNeurosci.%2520Lett.%26date%3D1995%26volume%3D201%26spage%3D49%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Schmitt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernhardt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moeller, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuser, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frolich, L.</span><span> </span><span class="NLM_article-title">Combination therapy in Alzheimerʼs disease: a review of current evidence</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">827</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=827-844&author=B.+Schmittauthor=T.+Bernhardtauthor=H.+J.+Moellerauthor=I.+Heuserauthor=L.+Frolich&title=Combination+therapy+in+Alzheimer%CA%BCs+disease%3A+a+review+of+current+evidence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchmitt%26aufirst%3DB.%26aulast%3DBernhardt%26aufirst%3DT.%26aulast%3DMoeller%26aufirst%3DH.%2BJ.%26aulast%3DHeuser%26aufirst%3DI.%26aulast%3DFrolich%26aufirst%3DL.%26atitle%3DCombination%2520therapy%2520in%2520Alzheimer%25CA%25BCs%2520disease%253A%2520a%2520review%2520of%2520current%2520evidence%26jtitle%3DCNS%2520Drugs%26date%3D2004%26volume%3D18%26spage%3D827%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Progress in acetylcholinesterase inhibitors for Alzheimerʼs disease</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">811</span><span class="NLM_x">–</span> <span class="NLM_lpage">823</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1517%2F13543776.16.6.811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XltVOhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=811-823&author=M.+L.+Bolognesiauthor=A.+Minariniauthor=V.+Tumiattiauthor=C.+Melchiorre&title=Progress+in+acetylcholinesterase+inhibitors+for+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in acetylcholinesterase inhibitors for Alzheimer's disease</span></div><div class="casAuthors">Bolognesi, Maria Laura; Minarini, Anna; Tumiatti, Vincenzo; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">811-823</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Current pharmacotherapy of Alzheimer's disease (AD) involves drugs that are known as acetylcholinesterase inhibitors (AChEIs), which increase the acetylcholine concn. in the brain.  Although effective in improving cognitive, behavioral and functional impairments, these drugs are not able to alter disease progression.  In this review, the recent patent literature on AChEIs from 2002 to early 2005 will be discussed, focusing attention on the novel analogs of the approved drugs, as well as on the most important AD therapeutic advances.  The clin. efficacy of AChEIs will probably be enhanced by their combination with other drugs acting through different pharmacol. mechanisms.  As the neuronal loss comprises more than the forebrain cholinergic system, the weak effectiveness of AChEIs is not surprising.  Besides the cholinergic hypothesis' approaches, new treatments are emerging based on multipotent compds. able to target the underlying pathogenic mechanisms of AD; these treatments are summarized herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptSL4AfWXbaLVg90H21EOLACvtfcHk0lg4wAOI7vyzcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltVOhu7g%253D&md5=1094dc53e60353b61a4ac6fe0cbbfee8</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1517%2F13543776.16.6.811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.16.6.811%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DProgress%2520in%2520acetylcholinesterase%2520inhibitors%2520for%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2006%26volume%3D16%26spage%3D811%26epage%3D823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Grossberg, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Q.</span><span> </span><span class="NLM_article-title">Rationale for combination therapy with galantamine and memantine in Alzheimerʼs disease</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">17S</span><span class="NLM_x">–</span> <span class="NLM_lpage">26S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=17S-26S&author=G.+T.+Grossbergauthor=K.+R.+Edwardsauthor=Q.+Zhao&title=Rationale+for+combination+therapy+with+galantamine+and+memantine+in+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrossberg%26aufirst%3DG.%2BT.%26aulast%3DEdwards%26aufirst%3DK.%2BR.%26aulast%3DZhao%26aufirst%3DQ.%26atitle%3DRationale%2520for%2520combination%2520therapy%2520with%2520galantamine%2520and%2520memantine%2520in%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2006%26volume%3D46%26spage%3D17S%26epage%3D26S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Decker, M.</span><span> </span><span class="NLM_article-title">Recent advances in the development of hybrid molecules/designed multiple compounds with antiamnesic properties</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=221-229&author=M.+Decker&title=Recent+advances+in+the+development+of+hybrid+molecules%2Fdesigned+multiple+compounds+with+antiamnesic+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DRecent%2520advances%2520in%2520the%2520development%2520of%2520hybrid%2520molecules%252Fdesigned%2520multiple%2520compounds%2520with%2520antiamnesic%2520properties%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D221%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Van der Schyf, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geldenhuys, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Multifunctional drugs with different CNS targets for neuropsychiatric disorders</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">1033</span><span class="NLM_x">–</span> <span class="NLM_lpage">1048</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1111%2Fj.1471-4159.2006.04141.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17054441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yks7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2006&pages=1033-1048&author=C.+J.+Van+der+Schyfauthor=W.+J.+Geldenhuysauthor=M.+B.+Youdim&title=Multifunctional+drugs+with+different+CNS+targets+for+neuropsychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional drugs with different CNS targets for neuropsychiatric disorders</span></div><div class="casAuthors">Van der Schyf, Cornelis J.; Geldenhuys, Werner J.; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1033-1048</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The multiple disease etiologies that lead to neuropsychiatric disorders, such as Parkinson's and Alzheimer's disease, amyotrophic lateral sclerosis, Huntington disease, schizophrenia, depressive illness and stroke, offer significant challenges to drug discovery efforts aimed at preventing or even reversing the progression of these disorders.  Transcriptomic tools and proteomic profiling have clearly indicated that such diseases are multifactorial in origin.  Further, they are thought to be initiated by a cascade of mol. events that involve several neurotransmitter systems.  In response to this complexity, a new paradigm has recently emerged that challenges the widely held assumption that 'silver bullet' agents are superior to 'dirty drugs' in therapeutic approaches aimed at the prevention or treatment of neuropsychiatric diseases.  A similar pattern of drug development has occurred in strategies for the treatment of cancer, AIDS and cardiovascular diseases.  In this review, we offer an overview of therapeutic strategies and novel investigative drugs discovered or developed in our own and other labs., that address multiple CNS etiol. targets assocd. with an array of neuropsychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC-WgbIJvzwLVg90H21EOLACvtfcHk0lg4wAOI7vyzcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yks7rE&md5=bf77745eb16accd063b0ff8e988dc812</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04141.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04141.x%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26aulast%3DGeldenhuys%26aufirst%3DW.%2BJ.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DMultifunctional%2520drugs%2520with%2520different%2520CNS%2520targets%2520for%2520neuropsychiatric%2520disorders%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D99%26spage%3D1033%26epage%3D1048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J. J.</span><span> </span><span class="NLM_article-title">Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.tips.2004.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15629202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktV2m" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=27-35&author=M.+B.+Youdimauthor=J.+J.+Buccafusco&title=Multi-functional+drugs+for+various+CNS+targets+in+the+treatment+of+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders</span></div><div class="casAuthors">Youdim, Moussa B. H.; Buccafusco, Jerry J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-35</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Individuals with neurodegenerative diseases such as Parkinson's disease or Alzheimer's disease are benefiting from drugs developed to act on a single mol. target.  However, current pharmacol. approaches are limited in their ability to modify significantly the course of the disease, and offer incomplete and transient benefit to patients.  New therapeutic strategies comprise drug candidates designed specifically to act on multiple neural and biochem. targets for the treatment of cognition impairment, motor dysfunction, depression and neurodegeneration.  Examples include the development of single mol. entities that combine 2 or more of the following properties: (i) cholinesterase inhibition; (ii) activation or inhibition of specific subtypes of acetylcholine receptors or α-adrenoceptors; (iii) anti-inflammatory activity; (iv) monoamine oxidase inhibition; (v) catechol-O-Me transferase inhibition; (vi) nitric oxide prodn.; (vii) neuroprotection; (viii) anti-apoptotic activity; and (ix) activation of mitochondrial-dependent cell-survival genes and proteins.  These bi- or multi-functional compds. might provide greater symptomatic efficacy, and better utility as potential neuroprotective disease-modifying drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreBPSKLWPfGLVg90H21EOLACvtfcHk0lj3kP8U7v1Clw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktV2m&md5=0f2bd02614627d98b7e17a7a49905d1a</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2004.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2004.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DBuccafusco%26aufirst%3DJ.%2BJ.%26atitle%3DMulti-functional%2520drugs%2520for%2520various%2520CNS%2520targets%2520in%2520the%2520treatment%2520of%2520neurodegenerative%2520disorders%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D27%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Zhang, H. Y.</span><span> </span><span class="NLM_article-title">One-compound-multiple-targets strategy to combat Alzheimerʼs disease</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">579</span><span class="NLM_x">, </span> <span class="NLM_fpage">5260</span><span class="NLM_x">–</span> <span class="NLM_lpage">5264</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=579&publication_year=2005&pages=5260-5264&author=H.+Y.+Zhang&title=One-compound-multiple-targets+strategy+to+combat+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%2BY.%26atitle%3DOne-compound-multiple-targets%2520strategy%2520to%2520combat%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DFEBS%2520Lett.%26date%3D2005%26volume%3D579%26spage%3D5260%26epage%3D5264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">The path from anti Parkinson drug selegiline and rasagiline to multifunctional neuroprotective anti Alzheimer drugs ladostigil and m30</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.2174%2F156720506779025288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17168653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlWksbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=541-550&author=M.+B.+Youdim&title=The+path+from+anti+Parkinson+drug+selegiline+and+rasagiline+to+multifunctional+neuroprotective+anti+Alzheimer+drugs+ladostigil+and+m30"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">The path from anti Parkinson drug selegiline and rasagiline to multifunctional neuroprotective anti Alzheimer drugs ladostigil and M30</span></div><div class="casAuthors">Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">541-550</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The therapeutic use of enzyme inhibitors in treatment of neurodegenerative diseases has its origin in the anti Parkinson action of the selective monoamine oxidase (MAO) B inhibitor, 1-deprenyl (selegiline), a failed anti depressant in 1975.  This led to further development of MAO- A and B, catechol-O-methyltansferase and cholinestrerase inhibitors as anti Parkinson and Alzheimer drugs.  One of the main reasons for the cognitive deficit in dementia of the Alzheimer' type (AD) and in dementia with Lewy bodies (DLB) is degeneration of cholinergic cortical neurons and synaptic plasticity.  This led to a correlation that similar to Parkinson's Disease (PD), cholinesterase inhibitors (ChEI) may also have therapeutic activity in AD.  Significant percentage of AD and DLB subjects also nigrostriatal dopaminergic, locus ceruleous noradrenergic and raphe nucleus serotoninergic neurons.  The present ChEI anti AD drugs have limited symptomatic activity and devoid of neuroprotective property that is needed for disease modifying action.  It is becoming clear that there are no magic bullets for neurodegenerative disorders and shut gun approach is needed either as polypharmacol. or drugs with multiple activity at different target sites in the CNS.  The complex pathol. of AD as well as cascade of events that leads to the neurodegenerative process has led us to develop several multifunctional neuroprotective drugs with several CNS targets with possible disease modifying activity.  Employing the pharmacophore of our antiparkinson drug rasagiline (Azilect, Agilect, N-propagrgyl-1R-aminoindan) we have developed a novel multifunctional neuroprotective drug, ladostigil [TV-3326 (N-propargyl-3R-aminoindan-5yl)-Et methylcarbamate], with both cholinesterase-butyrylesterase (Ch-BuE) and brain selective monoamine-oxidase (MAO) AB inhibitory activities possessing the neuroprotective-neurescue propargyl moiety, as potential treatment of AD and DLB and PD with dementias.  Since brain MAO and iron increase in AD, PD and aging, that could lead to iron dependent oxidative stress neurodegeneration, we have developed another series of multifunctional drugs (M30 HLA-20 series) which are brain permeable iron chelators- brain selective MAO inhibitors and possess the propargyl neuroprotective moiety.  These series of drugs have the ability of regulating and processing APP (amyloid precursor protein) and reducing Aβ peptide, since APP is a metaloprotein, with an iron responsive element 5''UTR similar to transferring and ferritin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUf6C6njrCALVg90H21EOLACvtfcHk0lj3kP8U7v1Clw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlWksbrF&md5=33be9cc15d120660265a0927b176d0dd</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.2174%2F156720506779025288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720506779025288%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DThe%2520path%2520from%2520anti%2520Parkinson%2520drug%2520selegiline%2520and%2520rasagiline%2520to%2520multifunctional%2520neuroprotective%2520anti%2520Alzheimer%2520drugs%2520ladostigil%2520and%2520m30%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2006%26volume%3D3%26spage%3D541%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">van der Schyf, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geldenhuys, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Multifunctional neuroprotective drugs for the treatment of cognitive and movement impairment disorders, including Alzheimerʼs and Parkinsonʼs diseases</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">447</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1358%2Fdof.2006.031.05.985904" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsFyntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=447-460&author=C.+J.+van+der+Schyfauthor=W.+J.+Geldenhuysauthor=M.+B.+Youdim&title=Multifunctional+neuroprotective+drugs+for+the+treatment+of+cognitive+and+movement+impairment+disorders%2C+including+Alzheimer%CA%BCs+and+Parkinson%CA%BCs+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional neuroprotective drugs for the treatment of cognitive and movement impairment disorders, including Alzheimer's and Parkinson's diseases</span></div><div class="casAuthors">Van der Schyf, Cornelis J.; Geldenhuys, Werner J.; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">447-460</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  The concept of targeting multiple disease etiologies that lead to cognitive and movement impairment in neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease and stroke, is challenging the widely held assumption that "silver bullet" agents are superior to "dirty drugs" in the pharmacol. treatment of these diseases.  Accumulating evidence in the literature suggests that a drug with two or more mechanisms of action targeted at multiple etiologies of the same disease may offer greater therapeutic benefit in certain disorders than a drug that targets only one disease etiol.  In addn., the use of a single such multifunctional drug possessing several pharmacol. active moieties may yield a more favorable side effect profile than a combination of several drugs that individually target the same disease etiologies.  In this review, we offer a synopsis of therapeutic strategies and novel investigative drugs developed in our own and other labs. that modulate multiple disease targets assocd. with cognitive and movement impairment disorders, including cognitive decline assocd. with Alzheimer's disease, Parkinson's disease with dementia and movement deficits in Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXfldsPAa7krVg90H21EOLACvtfcHk0lj3kP8U7v1Clw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsFyntbk%253D&md5=4899ea8eef04811b55f1c4638898dc42</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1358%2Fdof.2006.031.05.985904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2006.031.05.985904%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26aulast%3DGeldenhuys%26aufirst%3DW.%2BJ.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DMultifunctional%2520neuroprotective%2520drugs%2520for%2520the%2520treatment%2520of%2520cognitive%2520and%2520movement%2520impairment%2520disorders%252C%2520including%2520Alzheimer%25CA%25BCs%2520and%2520Parkinson%25CA%25BCs%2520diseases%26jtitle%3DDrugs%2520Future%26date%3D2006%26volume%3D31%26spage%3D447%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Melchiorre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonello, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banzi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span> </span><span class="NLM_article-title">Polymethylene tetraamine backbone as template for the development of biologically active polyamines</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fmed.10029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=12500289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitVyksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=200-233&author=C.+Melchiorreauthor=A.+Antonelloauthor=R.+Banziauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiatti&title=Polymethylene+tetraamine+backbone+as+template+for+the+development+of+biologically+active+polyamines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Polymethylene tetraamine backbone as template for the development of biologically active polyamines</span></div><div class="casAuthors">Melchiorre, Carlo; Antonello, Alessandra; Banzi, Rita; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">200-233</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The concept that polyamines may represent a universal template in the receptor recognition process is embodied in the design of ligands for different biol. targets.  As a matter of fact, the insertion of different pharmacophores onto the polymethylene tetraamine backbone can tune both affinity and selectivity for any given receptor.  The application of this approach provided a prospect of modifying benextramine (1) structure to achieve specific recognition of muscarinic receptors that led to the discovery of methoctramine (2), which is widely used as a pharmacol. tool for muscarinic receptor characterization.  In turn, appropriate structural modifications performed on the structure of methoctramine led to the discovery of new polyamines endowed with high affinity and selectivity for (a) muscarinic receptor subtypes, (b) Gi proteins, and (c) muscle-type nicotinic receptors.  Thus, polyamines tripitramine (9) and spirotramine (33), among others, were designed, which were shown to be highly selective for muscarinic M2 and M1 receptors, resp.  Several polyamines have been discovered, which inhibit noncompetitively a closed state of the nicotinic receptor.  These ligands, such as 66, resulted in important tools for elucidating the mode and site of interaction of polyamines with the ion channel.  It was discovered that reducing the flexibility of the diaminohexane spacer of methoctramine led to polyamines, such as 70, which are endowed with a biol. profile significantly different from that of the prototype.  Most likely, tetraamine (70) is a potent activator of Gi proteins.  Finally, the universal template approach formed the basis for modifying benextramine (1) structure to the design of ligands, which display affinity for acetylcholinesterase and muscarinic M2 receptors.  Thus, these polyamines, such as caproctamine (78), could have potential in the investigation of Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6Nb4xLhb1F7Vg90H21EOLACvtfcHk0lhO5tSg_K3EZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitVyksro%253D&md5=71f7966a0f5ff169106de2d617e340b2</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1002%2Fmed.10029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.10029%26sid%3Dliteratum%253Aachs%26aulast%3DMelchiorre%26aufirst%3DC.%26aulast%3DAntonello%26aufirst%3DA.%26aulast%3DBanzi%26aufirst%3DR.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26atitle%3DPolymethylene%2520tetraamine%2520backbone%2520as%2520template%2520for%2520the%2520development%2520of%2520biologically%2520active%2520polyamines%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2003%26volume%3D23%26spage%3D200%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Melchiorre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budriesi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavrini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span> </span><span class="NLM_article-title">Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimerʼs disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">4186</span><span class="NLM_x">–</span> <span class="NLM_lpage">4189</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9810452" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=4186-4189&author=C.+Melchiorreauthor=V.+Andrisanoauthor=M.+L.+Bolognesiauthor=R.+Budriesiauthor=A.+Cavalliauthor=V.+Cavriniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatini&title=Acetylcholinesterase+noncovalent+inhibitors+based+on+a+polyamine+backbone+for+potential+use+against+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm9810452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9810452%26sid%3Dliteratum%253Aachs%26aulast%3DMelchiorre%26aufirst%3DC.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DBudriesi%26aufirst%3DR.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DCavrini%26aufirst%3DV.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26atitle%3DAcetylcholinesterase%2520noncovalent%2520inhibitors%2520based%2520on%2520a%2520polyamine%2520backbone%2520for%2520potential%2520use%2520against%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D4186%26epage%3D4189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span> </span><span class="NLM_article-title">3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2<i>H</i>-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimerʼs disease therapy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2279</span><span class="NLM_x">–</span> <span class="NLM_lpage">2282</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0340602" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2279-2282&author=L.+Piazziauthor=A.+Rampaauthor=A.+Bisiauthor=S.+Gobbiauthor=F.+Bellutiauthor=A.+Cavalliauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=P.+Valentiauthor=M.+Recanatini&title=3-%284-%5B%5BBenzyl%28methyl%29amino%5Dmethyl%5Dphenyl%29-6%2C7-dimethoxy-2H-2-chromenone+%28AP2238%29+inhibits+both+acetylcholinesterase+and+acetylcholinesterase-induced+beta-amyloid+aggregation%3A+a+dual+function+lead+for+Alzheimer%CA%BCs+disease+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm0340602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0340602%26sid%3Dliteratum%253Aachs%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DValenti%26aufirst%3DP.%26aulast%3DRecanatini%26aufirst%3DM.%26atitle%3D3-%25284-%255B%255BBenzyl%2528methyl%2529amino%255Dmethyl%255Dphenyl%2529-6%252C7-dimethoxy-2H-2-chromenone%2520%2528AP2238%2529%2520inhibits%2520both%2520acetylcholinesterase%2520and%2520acetylcholinesterase-induced%2520beta-amyloid%2520aggregation%253A%2520a%2520dual%2520function%2520lead%2520for%2520Alzheimer%25CA%25BCs%2520disease%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2279%26epage%3D2282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavrini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span> </span><span class="NLM_article-title">beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2FS0006-2952%2802%2901514-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=12527333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivVKitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2003&pages=407-416&author=M.+Bartoliniauthor=C.+Bertucciauthor=V.+Cavriniauthor=V.+Andrisano&title=beta-Amyloid+aggregation+induced+by+human+acetylcholinesterase%3A+inhibition+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">β-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies</span></div><div class="casAuthors">Bartolini, Manuela; Bertucci, Carlo; Cavrini, Vanni; Andrisano, Vincenza</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">407-416</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The aggregation of β-amyloid (1-40) (Aβ) induced by human recombinant acetylcholinesterase (HuAChE) was studied by means of CD (CD) and by thioflavin T fluorescence spectroscopy.  Aβ was incubated alone and with HuAChE.  The kinetic of fibrils formation was followed for 48 h.  The increasing β-conformation content induced by HuAChE, preliminary to the formation of Aβ fibrils, was detd. by CD.  This phenomenon was found to be related to the thioflavin T emission of fluorescence at 490 nm.  Incubation expts. were performed in the presence of known AChE inhibitors (physostigmine, edrophonium, decamethonium, propidium) and drugs used for Alzheimer's disease (AD) (tacrine, donepezil), to test their capability of preventing the HuAChE-induced Aβ aggregation.  The non-competitive or mixed mode of AChE inhibition was confirmed to be an essential feature.  At 100 μM propidium, decamethonium, donepezil and physostigmine were found to inhibit the HuAChE-induced Aβ aggregation by 82, 25, 22 and 30%, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2eDGIBesVCbVg90H21EOLACvtfcHk0lhO5tSg_K3EZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivVKitA%253D%253D&md5=51d1021e8be93014f0b15a61db241392</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2802%2901514-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252802%252901514-9%26sid%3Dliteratum%253Aachs%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DBertucci%26aufirst%3DC.%26aulast%3DCavrini%26aufirst%3DV.%26aulast%3DAndrisano%26aufirst%3DV.%26atitle%3Dbeta-Amyloid%2520aggregation%2520induced%2520by%2520human%2520acetylcholinesterase%253A%2520inhibition%2520studies%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2003%26volume%3D65%26spage%3D407%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banzi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Structure−activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 3. Effect of replacing the inner polymethylene chain with cyclic moieties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6490</span><span class="NLM_x">–</span> <span class="NLM_lpage">6498</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0494366" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6490-6498&author=V.+Tumiattiauthor=V.+Andrisanoauthor=R.+Banziauthor=M.+Bartoliniauthor=A.+Minariniauthor=M.+Rosiniauthor=C.+Melchiorre&title=Structure%E2%88%92activity+relationships+of+acetylcholinesterase+noncovalent+inhibitors+based+on+a+polyamine+backbone.+3.+Effect+of+replacing+the+inner+polymethylene+chain+with+cyclic+moieties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjm0494366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0494366%26sid%3Dliteratum%253Aachs%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBanzi%26aufirst%3DR.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520of%2520acetylcholinesterase%2520noncovalent%2520inhibitors%2520based%2520on%2520a%2520polyamine%2520backbone.%25203.%2520Effect%2520of%2520replacing%2520the%2520inner%2520polymethylene%2520chain%2520with%2520cyclic%2520moieties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6490%26epage%3D6498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Belluti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rampa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piazzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, P.</span><span> </span><span class="NLM_article-title">Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4444</span><span class="NLM_x">–</span> <span class="NLM_lpage">4456</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049515h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4444-4456&author=F.+Bellutiauthor=A.+Rampaauthor=L.+Piazziauthor=A.+Bisiauthor=S.+Gobbiauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=A.+Cavalliauthor=M.+Recanatiniauthor=P.+Valenti&title=Cholinesterase+inhibitors%3A+xanthostigmine+derivatives+blocking+the+acetylcholinesterase-induced+beta-amyloid+aggregation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fjm049515h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049515h%26sid%3Dliteratum%253Aachs%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DValenti%26aufirst%3DP.%26atitle%3DCholinesterase%2520inhibitors%253A%2520xanthostigmine%2520derivatives%2520blocking%2520the%2520acetylcholinesterase-induced%2520beta-amyloid%2520aggregation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4444%26epage%3D4456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budriesi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacciaguerra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spampinato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">4150</span><span class="NLM_x">–</span> <span class="NLM_lpage">4160</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm981038d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=4150-4160&author=M.+L.+Bolognesiauthor=A.+Minariniauthor=R.+Budriesiauthor=S.+Cacciaguerraauthor=A.+Chiariniauthor=S.+Spampinatoauthor=V.+Tumiattiauthor=C.+Melchiorre&title=Universal+template+approach+to+drug+design%3A+polyamines+as+selective+muscarinic+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjm981038d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm981038d%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DBudriesi%26aufirst%3DR.%26aulast%3DCacciaguerra%26aufirst%3DS.%26aulast%3DChiarini%26aufirst%3DA.%26aulast%3DSpampinato%26aufirst%3DS.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DUniversal%2520template%2520approach%2520to%2520drug%2520design%253A%2520polyamines%2520as%2520selective%2520muscarinic%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D4150%26epage%3D4160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banzi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-beta aggregation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049156q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=24-27&author=M.+L.+Bolognesiauthor=V.+Andrisanoauthor=M.+Bartoliniauthor=R.+Banziauthor=C.+Melchiorre&title=Propidium-based+polyamine+ligands+as+potent+inhibitors+of+acetylcholinesterase+and+acetylcholinesterase-induced+amyloid-beta+aggregation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fjm049156q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049156q%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DBanzi%26aufirst%3DR.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DPropidium-based%2520polyamine%2520ligands%2520as%2520potent%2520inhibitors%2520of%2520acetylcholinesterase%2520and%2520acetylcholinesterase-induced%2520amyloid-beta%2520aggregation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D24%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Munoz-Ruiz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Palomero, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorronsoro, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Monte-Millan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenzuela, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Austria, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bidon-Chanal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orozco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimerʼs disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7223</span><span class="NLM_x">–</span> <span class="NLM_lpage">7233</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0503289" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7223-7233&author=P.+Munoz-Ruizauthor=L.+Rubioauthor=E.+Garcia-Palomeroauthor=I.+Dorronsoroauthor=M.+del+Monte-Millanauthor=R.+Valenzuelaauthor=P.+Usanauthor=C.+de+Austriaauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=A.+Bidon-Chanalauthor=M.+Orozcoauthor=F.+J.+Luqueauthor=M.+Medinaauthor=A.+Martinez&title=Design%2C+synthesis%2C+and+biological+evaluation+of+dual+binding+site+acetylcholinesterase+inhibitors%3A+new+disease-modifying+agents+for+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fjm0503289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503289%26sid%3Dliteratum%253Aachs%26aulast%3DMunoz-Ruiz%26aufirst%3DP.%26aulast%3DRubio%26aufirst%3DL.%26aulast%3DGarcia-Palomero%26aufirst%3DE.%26aulast%3DDorronsoro%26aufirst%3DI.%26aulast%3Ddel%2BMonte-Millan%26aufirst%3DM.%26aulast%3DValenzuela%26aufirst%3DR.%26aulast%3DUsan%26aufirst%3DP.%26aulast%3Dde%2BAustria%26aufirst%3DC.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMedina%26aufirst%3DM.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520dual%2520binding%2520site%2520acetylcholinesterase%2520inhibitors%253A%2520new%2520disease-modifying%2520agents%2520for%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7223%26epage%3D7233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Kapkova, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alptuzun, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erciyas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holzgrabe, U.</span><span> </span><span class="NLM_article-title">Search for dual function inhibitors for Alzheimerʼs disease: synthesis and biological activity of acetylcholinesterase inhibitors of pyridinium-type and their Abeta fibril formation inhibition capacity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">472</span><span class="NLM_x">–</span> <span class="NLM_lpage">478</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=472-478&author=P.+Kapkovaauthor=V.+Alptuzunauthor=P.+Freyauthor=E.+Erciyasauthor=U.+Holzgrabe&title=Search+for+dual+function+inhibitors+for+Alzheimer%CA%BCs+disease%3A+synthesis+and+biological+activity+of+acetylcholinesterase+inhibitors+of+pyridinium-type+and+their+Abeta+fibril+formation+inhibition+capacity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKapkova%26aufirst%3DP.%26aulast%3DAlptuzun%26aufirst%3DV.%26aulast%3DFrey%26aufirst%3DP.%26aulast%3DErciyas%26aufirst%3DE.%26aulast%3DHolzgrabe%26aufirst%3DU.%26atitle%3DSearch%2520for%2520dual%2520function%2520inhibitors%2520for%2520Alzheimer%25CA%25BCs%2520disease%253A%2520synthesis%2520and%2520biological%2520activity%2520of%2520acetylcholinesterase%2520inhibitors%2520of%2520pyridinium-type%2520and%2520their%2520Abeta%2520fibril%2520formation%2520inhibition%2520capacity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D472%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Gottfries, C. G.</span><span> </span><span class="NLM_article-title">Neurochemical aspects on aging and diseases with cognitive impairment</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fjnr.490270415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=2079715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaK3MXnvFCjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1990&pages=541-547&author=C.+G.+Gottfries&title=Neurochemical+aspects+on+aging+and+diseases+with+cognitive+impairment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Neurochemical aspects on aging and diseases with cognitive impairment</span></div><div class="casAuthors">Gottfries, C. G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-7</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    </div><div class="casAbstract">A review with 61 refs. discussing neurochem. changes in normal aging, in idiopathic dementias, mainly Alzheimer's disease, and in vascular dementias.  Emphasis is placed on neurotransmitter disturbances, disturbed enzyme activities involved in neurotransmitter metab., and disturbed metab. of gangliosides and white matter components.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlFu_AlLpO7Vg90H21EOLACvtfcHk0ljgUizFl1hiwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXnvFCjuw%253D%253D&md5=f3744df7ad8b6c0a44ed3587451a3030</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1002%2Fjnr.490270415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.490270415%26sid%3Dliteratum%253Aachs%26aulast%3DGottfries%26aufirst%3DC.%2BG.%26atitle%3DNeurochemical%2520aspects%2520on%2520aging%2520and%2520diseases%2520with%2520cognitive%2520impairment%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D1990%26volume%3D27%26spage%3D541%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Meltzer, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeKosky, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kupfer, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. F.</span><span> </span><span class="NLM_article-title">3rd serotonin in aging, late-life depression, and Alzheimerʼs disease: the emerging role of functional imaging</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1998&pages=407-430&author=C.+C.+Meltzerauthor=G.+Smithauthor=S.+T.+DeKoskyauthor=B.+G.+Pollockauthor=C.+A.+Mathisauthor=R.+Y.+Mooreauthor=D.+J.+Kupferauthor=C.+F.+Reynolds&title=3rd+serotonin+in+aging%2C+late-life+depression%2C+and+Alzheimer%CA%BCs+disease%3A+the+emerging+role+of+functional+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeltzer%26aufirst%3DC.%2BC.%26aulast%3DSmith%26aufirst%3DG.%26aulast%3DDeKosky%26aufirst%3DS.%2BT.%26aulast%3DPollock%26aufirst%3DB.%2BG.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DMoore%26aufirst%3DR.%2BY.%26aulast%3DKupfer%26aufirst%3DD.%2BJ.%26aulast%3DReynolds%26aufirst%3DC.%2BF.%26atitle%3D3rd%2520serotonin%2520in%2520aging%252C%2520late-life%2520depression%252C%2520and%2520Alzheimer%25CA%25BCs%2520disease%253A%2520the%2520emerging%2520role%2520of%2520functional%2520imaging%26jtitle%3DNeuropsychopharmacology%26date%3D1998%26volume%3D18%26spage%3D407%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Schneider, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olin, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawluczyk, S.</span><span> </span><span class="NLM_article-title">A double-blind crossover pilot study of l-deprenyl (selegiline) combined with cholinesterase inhibitor in Alzheimerʼs disease</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">150</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=8422085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADyaK3s7jsFaktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=1993&pages=321-323&author=L.+S.+Schneiderauthor=J.+T.+Olinauthor=S.+Pawluczyk&title=A+double-blind+crossover+pilot+study+of+l-deprenyl+%28selegiline%29+combined+with+cholinesterase+inhibitor+in+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">A double-blind crossover pilot study of l-deprenyl (selegiline) combined with cholinesterase inhibitor in Alzheimer's disease</span></div><div class="casAuthors">Schneider L S; Olin J T; Pawluczyk S</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">321-3</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">The potential efficacy of oral l-deprenyl (5 mg b.i.d.) added to the regimen of 10 patients with Alzheimer's disease receiving either tacrine or physostigmine was assessed in a double-blind, placebo-controlled, 4-week, two-period crossover pilot study. l-Deprenyl was associated with significant improvement in scores on the cognitive subscale of the Alzheimer's Disease Assessment Scale, suggesting possible additive effects of l-deprenyl to the effects of cholinesterase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2cVuWGb1YXiO2kE7krGOBfW6udTcc2ebj58K6-9ddHrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s7jsFaktA%253D%253D&md5=f08c97c512557e001923687acf581e62</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DL.%2BS.%26aulast%3DOlin%26aufirst%3DJ.%2BT.%26aulast%3DPawluczyk%26aufirst%3DS.%26atitle%3DA%2520double-blind%2520crossover%2520pilot%2520study%2520of%2520l-deprenyl%2520%2528selegiline%2529%2520combined%2520with%2520cholinesterase%2520inhibitor%2520in%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D1993%26volume%3D150%26spage%3D321%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Marin, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bierer, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawlor, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmeidler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohs, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, K. L.</span><span> </span><span class="NLM_article-title"><span class="smallcaps smallerCapital">l</span>-Deprenyl and physostigmine for the treatment of Alzheimerʼs disease</span> <span class="citation_source-journal">Psychiatry Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2F0165-1781%2895%2902714-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=8570774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaK28Xhs1ynug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1995&pages=181-189&author=D.+B.+Marinauthor=L.+M.+Biererauthor=B.+A.+Lawlorauthor=T.+M.+Ryanauthor=R.+Jacobsonauthor=J.+Schmeidlerauthor=R.+C.+Mohsauthor=K.+L.+Davis&title=l-Deprenyl+and+physostigmine+for+the+treatment+of+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">L-Deprenyl and physostigmine for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Marin, Deborah B.; Bierer, Linda M.; Lawlor, Brian A.; Ryan, Theresa M.; Jacobson, Rachel; Schmeidler, James; Mohs, Richard C.; Davis, Kenneth L.</div><div class="citationInfo"><span class="NLM_cas:title">Psychiatry Research</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">181-9</span>CODEN:
                <span class="NLM_cas:coden">PSRSDR</span>;
        ISSN:<span class="NLM_cas:issn">0165-1781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The present study evaluated the safety of and obtained preliminary data on the cognitive effects of L-deprenyl and physostigmine in patients with Alzheimer's Disease.  Seventeen outpatients with Alzheimer's Disease participated in a double-blind crossover study in which they received 4 wk of L-deprenyl at a dose of 10 mg p.o., q.d., and 4 wk of placebo in random order.  During both the L-deprenyl and placebo periods, patients received cognitive assessments during physostigmine (0.5 mg) and placebo infusions sepd. by 2 days.  The cognitive effects of these agents alone and in combination were measured with digit span, verbal fluency, list learning, praxis, delayed recall, and delayed recognition tasks.  Fifteen patients completed the study.  The two drugs, used alone or in combination, were safe and well tolerated.  Analyses of variance demonstrated that neither physostigmine nor L-deprenyl, whether given alone or in combination, significantly improved cognition, when compared with the double placebo condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfpGtkFzVkw7Vg90H21EOLACvtfcHk0ljgUizFl1hiwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xhs1ynug%253D%253D&md5=ac35b0cee6b80e5f0eef5082cf4ee89f</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2F0165-1781%2895%2902714-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1781%252895%252902714-8%26sid%3Dliteratum%253Aachs%26aulast%3DMarin%26aufirst%3DD.%2BB.%26aulast%3DBierer%26aufirst%3DL.%2BM.%26aulast%3DLawlor%26aufirst%3DB.%2BA.%26aulast%3DRyan%26aufirst%3DT.%2BM.%26aulast%3DJacobson%26aufirst%3DR.%26aulast%3DSchmeidler%26aufirst%3DJ.%26aulast%3DMohs%26aufirst%3DR.%2BC.%26aulast%3DDavis%26aufirst%3DK.%2BL.%26atitle%3Dl-Deprenyl%2520and%2520physostigmine%2520for%2520the%2520treatment%2520of%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DPsychiatry%2520Res.%26date%3D1995%26volume%3D58%26spage%3D181%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Alper, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girgin, F. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozgonul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mentes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ersoz, B.</span><span> </span><span class="NLM_article-title">MAO inhibitors and oxidant stress in aging brain tissue</span> <span class="citation_source-journal">Eur. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2FS0924-977X%2898%2900035-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=10208295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaK1MXhsVWntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=247-252&author=G.+Alperauthor=F.+K.+Girginauthor=M.+Ozgonulauthor=G.+Mentesauthor=B.+Ersoz&title=MAO+inhibitors+and+oxidant+stress+in+aging+brain+tissue"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">MAO inhibitors and oxidant stress in aging brain tissue</span></div><div class="casAuthors">Alper, Gulinnaz; Girgin, Ferhan Kulahcioglu; Ozgonul, Mert; Mentes, Gulriz; Ersoz, Biltan</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">247-252</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">The process of aging presents itself with various alterations in physiol. events.  Among many theories, the free radical (FR) theory of aging which reflects the FR damage to cellular components is accepted as one of the most important theories.  Recently, the increases in catecholamine metab. in aging have also attracted attention, and monoamine oxidase (MAO), a key enzyme in this process has been extensively studied.  The aim of this study was to assess the role of FR species via MAO, a possible source of FRs, in physiol. aging by detg. the lipid peroxidn. products (LPP) (malondialdehyde, diene conjugates) and antioxidant enzyme levels (superoxide dismutase (SOD) and catalase (CAT)) in young (3 mo old, n=10) and aging (16-18 mo old, n=10) rat brain tissues of Swiss male albino rats.  In the second part of the study, the same parameters were detd. after the acute administration of MAO inhibitors (deprenyl and pargyline, 25 mg/kg i.p.) to investigate whether these agents have any beneficial effects in reducing oxidant stress via inhibition of MAO.  In old rat brains, MAO activities showed a significant increase (P=0.000) in addn. to an insignificant increase in LPP, while SOD (P=0.007) and CAT activities showed a decrease with advancing age.  After the acute administration of both deprenyl and pargyline, a significant decrease in the MAO activities of both young (P=0.0002 for each) and aging rats (P=0.0002 for deprenyl and P=0.0001 for pargyline) were obsd.  It was noted that deprenyl causes a significant increase in CAT activity (P<0.05) but a significant decrease in SOD activity (P<0.05) in young rats, while it causes only a significant increase in SOD activity in aging rats (P<0.05).  Both deprenyl and pargyline cause a significant decrease in conjugated diene levels of aging rats (P<0.05).  These results confirm the role of catecholamine oxidn. and MAO activity as one of the causative factors in increased oxidant stress during aging.  By reducing the oxidant stress obsd. in aging brain, MAO inhibitors, esp. deprenyl, may contribute to the control of the aging process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm6M1xBHX5l7Vg90H21EOLACvtfcHk0li4yHjcEyQT8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhsVWntLc%253D&md5=b575a7571b0de3b6f39e66c1dd2e7088</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2FS0924-977X%2898%2900035-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0924-977X%252898%252900035-2%26sid%3Dliteratum%253Aachs%26aulast%3DAlper%26aufirst%3DG.%26aulast%3DGirgin%26aufirst%3DF.%2BK.%26aulast%3DOzgonul%26aufirst%3DM.%26aulast%3DMentes%26aufirst%3DG.%26aulast%3DErsoz%26aufirst%3DB.%26atitle%3DMAO%2520inhibitors%2520and%2520oxidant%2520stress%2520in%2520aging%2520brain%2520tissue%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D1999%26volume%3D9%26spage%3D247%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Fink, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palermo, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bores, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huger, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurys, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merriman, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petko, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OʼMalley, G. J.</span><span> </span><span class="NLM_article-title">Imino 1,2,3,4-tetrahydrocyclopent[<i>b</i>]indole carbamates as dual inhibitors of acetylcholinesterase and monoamine oxidase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">625</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=625-630&author=D.+M.+Finkauthor=M.+G.+Palermoauthor=G.+M.+Boresauthor=F.+P.+Hugerauthor=B.+E.+Kurysauthor=M.+C.+Merrimanauthor=G.+E.+Olsenauthor=W.+Petkoauthor=G.+J.+O%CA%BCMalley&title=Imino+1%2C2%2C3%2C4-tetrahydrocyclopent%5Bb%5Dindole+carbamates+as+dual+inhibitors+of+acetylcholinesterase+and+monoamine+oxidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFink%26aufirst%3DD.%2BM.%26aulast%3DPalermo%26aufirst%3DM.%2BG.%26aulast%3DBores%26aufirst%3DG.%2BM.%26aulast%3DHuger%26aufirst%3DF.%2BP.%26aulast%3DKurys%26aufirst%3DB.%2BE.%26aulast%3DMerriman%26aufirst%3DM.%2BC.%26aulast%3DOlsen%26aufirst%3DG.%2BE.%26aulast%3DPetko%26aufirst%3DW.%26aulast%3DO%25CA%25BCMalley%26aufirst%3DG.%2BJ.%26atitle%3DImino%25201%252C2%252C3%252C4-tetrahydrocyclopent%255Bb%255Dindole%2520carbamates%2520as%2520dual%2520inhibitors%2520of%2520acetylcholinesterase%2520and%2520monoamine%2520oxidase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1996%26volume%3D6%26spage%3D625%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Gnerre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span> </span><span class="NLM_article-title">Inhibition of monoamine oxidases by functionalized coumarin derivatives: biological activities, QSARs, and 3D-QSARs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4747</span><span class="NLM_x">–</span> <span class="NLM_lpage">4758</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm001028o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4747-4758&author=C.+Gnerreauthor=M.+Cattoauthor=F.+Leonettiauthor=P.+Weberauthor=P.+A.+Carruptauthor=C.+Altomareauthor=A.+Carottiauthor=B.+Testa&title=Inhibition+of+monoamine+oxidases+by+functionalized+coumarin+derivatives%3A+biological+activities%2C+QSARs%2C+and+3D-QSARs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Fjm001028o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm001028o%26sid%3Dliteratum%253Aachs%26aulast%3DGnerre%26aufirst%3DC.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DWeber%26aufirst%3DP.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DAltomare%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidases%2520by%2520functionalized%2520coumarin%2520derivatives%253A%2520biological%2520activities%252C%2520QSARs%252C%2520and%25203D-QSARs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4747%26epage%3D4758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Bruhlmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ooms, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altomare, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carotti, A.</span><span> </span><span class="NLM_article-title">Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3195</span><span class="NLM_x">–</span> <span class="NLM_lpage">3198</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010894d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3195-3198&author=C.+Bruhlmannauthor=F.+Oomsauthor=P.+A.+Carruptauthor=B.+Testaauthor=M.+Cattoauthor=F.+Leonettiauthor=C.+Altomareauthor=A.+Carotti&title=Coumarins+derivatives+as+dual+inhibitors+of+acetylcholinesterase+and+monoamine+oxidase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1021%2Fjm010894d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010894d%26sid%3Dliteratum%253Aachs%26aulast%3DBruhlmann%26aufirst%3DC.%26aulast%3DOoms%26aufirst%3DF.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DTesta%26aufirst%3DB.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DAltomare%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DCoumarins%2520derivatives%2520as%2520dual%2520inhibitors%2520of%2520acetylcholinesterase%2520and%2520monoamine%2520oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3195%26epage%3D3198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Novaroli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertolini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Giovanni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reist, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P.-A.</span><span> </span><span class="NLM_article-title">Identification of novel multifunctional compounds for the treatment of some aging related neurodegenerative diseases</span> <span class="citation_source-journal">Chimia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">315</span><span class="NLM_x">–</span> <span class="NLM_lpage">320</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2005&pages=315-320&author=L.+Novaroliauthor=A.+Dainaauthor=F.+Bertoliniauthor=S.+Di+Giovanniauthor=J.+Bravoauthor=M.+Reistauthor=P.-A.+Carrupt&title=Identification+of+novel+multifunctional+compounds+for+the+treatment+of+some+aging+related+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNovaroli%26aufirst%3DL.%26aulast%3DDaina%26aufirst%3DA.%26aulast%3DBertolini%26aufirst%3DF.%26aulast%3DDi%2BGiovanni%26aufirst%3DS.%26aulast%3DBravo%26aufirst%3DJ.%26aulast%3DReist%26aufirst%3DM.%26aulast%3DCarrupt%26aufirst%3DP.-A.%26atitle%3DIdentification%2520of%2520novel%2520multifunctional%2520compounds%2520for%2520the%2520treatment%2520of%2520some%2520aging%2520related%2520neurodegenerative%2520diseases%26jtitle%3DChimia%26date%3D2005%26volume%3D59%26spage%3D315%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Bruhlmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hostettmann, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrupt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Testa, B.</span><span> </span><span class="NLM_article-title">Screening of non-alkaloidal natural compounds as acetylcholinesterase inhibitors</span> <span class="citation_source-journal">Chem. Biodiversity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">819</span><span class="NLM_x">–</span> <span class="NLM_lpage">829</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fcbdv.200490064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17191882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADC%252BD28jlsV2ltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=819-829&author=C.+Bruhlmannauthor=A.+Marstonauthor=K.+Hostettmannauthor=P.+A.+Carruptauthor=B.+Testa&title=Screening+of+non-alkaloidal+natural+compounds+as+acetylcholinesterase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Screening of non-alkaloidal natural compounds as acetylcholinesterase inhibitors</span></div><div class="casAuthors">Bruhlmann Corinne; Marston Andrew; Hostettmann Kurt; Carrupt Pierre-Alain; Testa Bernard</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & biodiversity</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">819-29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Acetylcholinesterase (AChE) inhibitors are currently the only approved therapy for the treatment of Alzheimer's disease, only a limited number of drugs are commercially available.  A library of non-alkaloidal natural compounds was investigated.  To this end, a convenient microtitre plate method for assaying AChE inhibition, which allows a complete kinetic analysis of AChE inhibitors, was developed.  Seven active compounds with Ki values in the micromolar range were identified, six of which were xanthones.  This is the first report that a promising potential for AChE inhibition exists in such non-nitrogenous natural compounds.  Furthermore, four xanthones among these xanthones had already been described as monoamine oxidase (MAO) inhibitors, making then dual AChE/MAO inhibitors of great interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSLoMMalrvgaRFwe7cAcrfPfW6udTcc2eYSuBkWj1QgpLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jlsV2ltw%253D%253D&md5=4fedc3c51f6e5a2ff6b9013b86f3da4e</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.200490064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.200490064%26sid%3Dliteratum%253Aachs%26aulast%3DBruhlmann%26aufirst%3DC.%26aulast%3DMarston%26aufirst%3DA.%26aulast%3DHostettmann%26aufirst%3DK.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DTesta%26aufirst%3DB.%26atitle%3DScreening%2520of%2520non-alkaloidal%2520natural%2520compounds%2520as%2520acetylcholinesterase%2520inhibitors%26jtitle%3DChem.%2520Biodiversity%26date%3D2004%26volume%3D1%26spage%3D819%26epage%3D829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Sterling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzig, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkelstein, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miskolczi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molnar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rantal, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zagyva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zekany, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavian, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Razin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krais, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chorev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstock, M.</span><span> </span><span class="NLM_article-title">Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimerʼs disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">5260</span><span class="NLM_x">–</span> <span class="NLM_lpage">5279</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020120c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5260-5279&author=J.+Sterlingauthor=Y.+Herzigauthor=T.+Gorenauthor=N.+Finkelsteinauthor=D.+Lernerauthor=W.+Goldenbergauthor=I.+Miskolcziauthor=S.+Molnarauthor=F.+Rantalauthor=T.+Tamasauthor=G.+Tothauthor=A.+Zagyvaauthor=A.+Zekanyauthor=J.+Finbergauthor=G.+Lavianauthor=A.+Grossauthor=R.+Friedmanauthor=M.+Razinauthor=W.+Huangauthor=B.+Kraisauthor=M.+Chorevauthor=M.+B.+Youdimauthor=M.+Weinstock&title=Novel+dual+inhibitors+of+AChE+and+MAO+derived+from+hydroxy+aminoindan+and+phenethylamine+as+potential+treatment+for+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fjm020120c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020120c%26sid%3Dliteratum%253Aachs%26aulast%3DSterling%26aufirst%3DJ.%26aulast%3DHerzig%26aufirst%3DY.%26aulast%3DGoren%26aufirst%3DT.%26aulast%3DFinkelstein%26aufirst%3DN.%26aulast%3DLerner%26aufirst%3DD.%26aulast%3DGoldenberg%26aufirst%3DW.%26aulast%3DMiskolczi%26aufirst%3DI.%26aulast%3DMolnar%26aufirst%3DS.%26aulast%3DRantal%26aufirst%3DF.%26aulast%3DTamas%26aufirst%3DT.%26aulast%3DToth%26aufirst%3DG.%26aulast%3DZagyva%26aufirst%3DA.%26aulast%3DZekany%26aufirst%3DA.%26aulast%3DFinberg%26aufirst%3DJ.%26aulast%3DLavian%26aufirst%3DG.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DFriedman%26aufirst%3DR.%26aulast%3DRazin%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DKrais%26aufirst%3DB.%26aulast%3DChorev%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DWeinstock%26aufirst%3DM.%26atitle%3DNovel%2520dual%2520inhibitors%2520of%2520AChE%2520and%2520MAO%2520derived%2520from%2520hydroxy%2520aminoindan%2520and%2520phenethylamine%2520as%2520potential%2520treatment%2520for%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5260%26epage%3D5279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Am, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yogev-Falach, M.</span><span> </span><span class="NLM_article-title">Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs; ladostigil</span> <span class="citation_source-journal">Neurotoxic. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1007%2FBF03033355" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17197368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsFekt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=181-192&author=M.+B.+Youdimauthor=T.+Amitauthor=O.+Bar-Amauthor=O.+Weinrebauthor=M.+Yogev-Falach&title=Implications+of+co-morbidity+for+etiology+and+treatment+of+neurodegenerative+diseases+with+multifunctional+neuroprotective-neurorescue+drugs%3B+ladostigil"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs; ladostigil</span></div><div class="casAuthors">Youdim, Moussa B. H.; Amit, Tamar; Bar-Am, Orit; Weinreb, Orly; Yogev-Falach, Mara</div><div class="citationInfo"><span class="NLM_cas:title">Neurotoxicity Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3,4</span>),
    <span class="NLM_cas:pages">181-192</span>CODEN:
                <span class="NLM_cas:coden">NURRFI</span>;
        ISSN:<span class="NLM_cas:issn">1029-8428</span>.
    
            (<span class="NLM_cas:orgname">F. P. Graham Publishing Co.</span>)
        </div><div class="casAbstract">A review.  The recent therapeutic approach in which drug candidates are designed to possess diverse pharmacol. properties and act on multiple targets has stimulated the development of several multifunction drugs.  These include ladostigil (TV3326) [(N-propargyl-(3R) aminoindan-5yl)-Et Me carbamate], which combines the pharmacophore-neuroprotective effects of rasagiline, a selective monoamine oxidase (MAO)-B inhibitor, with the cholinesterase (ChE) inhibitory activity of rivastigmine or iron chelating moiety such as M30.  In the case of M30 the pharmacophore of brain permeable iron chelator VK-28 plus the MAO inhibitor-neuroprotective propargylamine moiety of rasagiline are combined in a single mol. as a potential treatment for Alzheimer's disease, Lewy body disease, and Parkinson's disease with dementia.  Here, we discuss the activities of ladostigil in terms of its cholinesterase cognitive enhancing potential, antiParkinson, antidepressant, neuroprotection and APP (amyloid precursor protein) processing potential.  One major attribute of ladostigil is its neuroprotective activity in neuronal cell cultures and in vivo.  Employing an apoptotic model of neuroblastoma SK-N-SH cells, the mol. mechanism of its neuroprotective activity has been detd.  The current studies show that ladostigil significantly decreased apoptosis via inhibition of the cleavage and prevention of caspase-3 activation through a mechanism related to regulation of the Bcl-2 family proteins, resulting in reduced levels of Bad and Bax and induced levels of Bcl-2.  In addn., ladostigil elevated the levels of pPKC(pan).  We have also followed the regulation of APP processing and found that ladostigil markedly decreased apoptotic-induced levels of holo-APP, as well as stimulated the release of the non-amyloidogenic sol. APP (sAPPα) into the conditioned medium via a established protein kinsae c-MAPkinase dependent pathway.  Similar to ladostigil, its S-isomer, TV3279, which is a ChE inhibitor lacking MAO inhibitory activity, exerted similar neuroprotective properties and APP processing, suggesting that the mode of action is independent of MAO inhibition.  These effects were shown to reside in the propargylamine moiety.  These findings indicate that the dual actions of the anti-apoptotic-neuroprotective activity and the ability to modulate APP processing, could make ladostigil a potentially valuable drug for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpywM2IsMu1OLVg90H21EOLACvtfcHk0lgnXabZrqfukA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsFekt70%253D&md5=58ba89f08e3eb4afdb5d602265baf060</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1007%2FBF03033355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF03033355%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DBar-Am%26aufirst%3DO.%26aulast%3DWeinreb%26aufirst%3DO.%26aulast%3DYogev-Falach%26aufirst%3DM.%26atitle%3DImplications%2520of%2520co-morbidity%2520for%2520etiology%2520and%2520treatment%2520of%2520neurodegenerative%2520diseases%2520with%2520multifunctional%2520neuroprotective-neurorescue%2520drugs%253B%2520ladostigil%26jtitle%3DNeurotoxic.%2520Res.%26date%3D2006%26volume%3D10%26spage%3D181%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">McKenna, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proctor, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, A. L.</span><span> </span><span class="NLM_article-title">Novel tacrine analogues for potential use against Alzheimerʼs disease: potent and selective acetylcholinesterase inhibitors and 5-HT uptake inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">3516</span><span class="NLM_x">–</span> <span class="NLM_lpage">3523</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970150t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=3516-3523&author=M.+T.+McKennaauthor=G.+R.+Proctorauthor=L.+C.+Youngauthor=A.+L.+Harvey&title=Novel+tacrine+analogues+for+potential+use+against+Alzheimer%CA%BCs+disease%3A+potent+and+selective+acetylcholinesterase+inhibitors+and+5-HT+uptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Fjm970150t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970150t%26sid%3Dliteratum%253Aachs%26aulast%3DMcKenna%26aufirst%3DM.%2BT.%26aulast%3DProctor%26aufirst%3DG.%2BR.%26aulast%3DYoung%26aufirst%3DL.%2BC.%26aulast%3DHarvey%26aufirst%3DA.%2BL.%26atitle%3DNovel%2520tacrine%2520analogues%2520for%2520potential%2520use%2520against%2520Alzheimer%25CA%25BCs%2520disease%253A%2520potent%2520and%2520selective%2520acetylcholinesterase%2520inhibitors%2520and%25205-HT%2520uptake%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D3516%26epage%3D3523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Hirai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayako, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, M.</span><span> </span><span class="NLM_article-title">Neurochemical effects of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1<i>H</i>-1-b enzazepin-8-yl)-1-propanone fumarate (TAK-147), a novel acetylcholinesterase inhibitor, in rats</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">1261</span><span class="NLM_x">–</span> <span class="NLM_lpage">1269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=9067312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaK2sXhvF2mtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=1997&pages=1261-1269&author=K.+Hiraiauthor=K.+Katoauthor=T.+Nakayamaauthor=H.+Hayakoauthor=Y.+Ishiharaauthor=G.+Gotoauthor=M.+Miyamoto&title=Neurochemical+effects+of+3-%5B1-%28phenylmethyl%29-4-piperidinyl%5D-1-%282%2C3%2C4%2C5-tetrahydro-1H-1-b+enzazepin-8-yl%29-1-propanone+fumarate+%28TAK-147%29%2C+a+novel+acetylcholinesterase+inhibitor%2C+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Neurochemical effects of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1H-1-benzazepin -8-yl)-1-propanone fumarate (TAK-147), a novel acetylcholinesterase inhibitor, in rats</span></div><div class="casAuthors">Hirai, Keisuke; Kato, Koki; Nakayama, Takahiro; Hayako, Hitomi; Ishihara, Yuji; Goto, Giichi; Miyamoto, Masaomi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1261-1269</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The authors examd. the neurochem. effects of 3-[1-(phenylmethyl)-4-piperidinyl]-1-(2,3,4,5-tetrahydro-1H-1-benzazepin-8-yl)-1-propanone fumarate (TAK-147), a novel acetylcholinesterase (AChE) inhibitor in vitro and in vivo.  TAK-147 showed a potent and reversible inhibition of AChE activity in homogenates of the rat cerebral cortex (IC50 = 51.2 nM), and was 3.0- and 2.4-fold more potent than tacrine and physostigmine, resp.  By contrast, TAK-147 was the least potent inhibitor of butyrylcholinesterase activity in rat plasma (IC50 = 23,500 nM).  Tacrine and physostigmine inhibited butyrylcholinesterase activity potently and nonselectively.  TAK-147 showed a moderate inhibition of muscarinic M1 and M2 receptor binding with Ki values of 234 and 340 nM, resp.  TAK-147 showed very weak or no inhibition of high-affinity choline uptake, nicotinic receptor binding and choline acetyltransferase activity.  In ex vivo expts., oral administration of TAK-147 at doses ranging from 1 to 10 mg/kg induced a statistically significant and dose-dependent decrease in AChE activity in the cerebral cortex.  Of the monoaminergic systems, TAK-147 moderately inhibited uptake of noradrenaline and serotonin with IC50 values of 4020 and 1350 nM, resp.  TAK-147 also inhibited ligand binding at alpha-1, alpha-2 and serotonin 2 receptors with Ki values of 324, 2330 and 3510 nM, resp., whereas it showed only weak activities on D1, D2 and serotonin 1A receptor bindings.  Oral administration of TAK-147 (3 mg/kg) significantly accelerated the turnover rates of dopamine, noradrenaline and serotonin in the rat brain.  These results suggest that TAK-147 activates the central cholinergic system by specific inhibition of AChE activity without affecting peripheral butyrylcholinesterase activity, and that TAK-147 also moderately activates the monoaminergic systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4hUQDQN7Cu7Vg90H21EOLACvtfcHk0lgnXabZrqfukA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhvF2mtLs%253D&md5=d983c91ca6ea72acfb9322ff93a8a57c</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirai%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DHayako%26aufirst%3DH.%26aulast%3DIshihara%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DG.%26aulast%3DMiyamoto%26aufirst%3DM.%26atitle%3DNeurochemical%2520effects%2520of%25203-%255B1-%2528phenylmethyl%2529-4-piperidinyl%255D-1-%25282%252C3%252C4%252C5-tetrahydro-1H-1-b%2520enzazepin-8-yl%2529-1-propanone%2520fumarate%2520%2528TAK-147%2529%252C%2520a%2520novel%2520acetylcholinesterase%2520inhibitor%252C%2520in%2520rats%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D280%26spage%3D1261%26epage%3D1269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Kogen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naruto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyagi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, T.</span><span> </span><span class="NLM_article-title">Design and synthesis of dual inhibitors of acetylcholinesterase and serotonin transporter targeting potential agents for Alzheimerʼs disease</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">3359</span><span class="NLM_x">–</span> <span class="NLM_lpage">3362</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol026418e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=3359-3362&author=H.+Kogenauthor=N.+Todaauthor=K.+Tagoauthor=S.+Marumotoauthor=K.+Takamiauthor=M.+Oriauthor=N.+Yamadaauthor=K.+Koyamaauthor=S.+Narutoauthor=K.+Abeauthor=R.+Yamazakiauthor=T.+Haraauthor=A.+Aoyagiauthor=Y.+Abeauthor=T.+Kaneko&title=Design+and+synthesis+of+dual+inhibitors+of+acetylcholinesterase+and+serotonin+transporter+targeting+potential+agents+for+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fol026418e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol026418e%26sid%3Dliteratum%253Aachs%26aulast%3DKogen%26aufirst%3DH.%26aulast%3DToda%26aufirst%3DN.%26aulast%3DTago%26aufirst%3DK.%26aulast%3DMarumoto%26aufirst%3DS.%26aulast%3DTakami%26aufirst%3DK.%26aulast%3DOri%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DN.%26aulast%3DKoyama%26aufirst%3DK.%26aulast%3DNaruto%26aufirst%3DS.%26aulast%3DAbe%26aufirst%3DK.%26aulast%3DYamazaki%26aufirst%3DR.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DAoyagi%26aufirst%3DA.%26aulast%3DAbe%26aufirst%3DY.%26aulast%3DKaneko%26aufirst%3DT.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520dual%2520inhibitors%2520of%2520acetylcholinesterase%2520and%2520serotonin%2520transporter%2520targeting%2520potential%2520agents%2520for%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DOrg.%2520Lett.%26date%3D2002%26volume%3D4%26spage%3D3359%26epage%3D3362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Toda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naruto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyagi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogen, H.</span><span> </span><span class="NLM_article-title">Design, synthesis and structure−activity relationships of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimerʼs disease</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1935</span><span class="NLM_x">–</span> <span class="NLM_lpage">1955</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=1935-1955&author=N.+Todaauthor=K.+Tagoauthor=S.+Marumotoauthor=K.+Takamiauthor=M.+Oriauthor=N.+Yamadaauthor=K.+Koyamaauthor=S.+Narutoauthor=K.+Abeauthor=R.+Yamazakiauthor=T.+Haraauthor=A.+Aoyagiauthor=Y.+Abeauthor=T.+Kanekoauthor=H.+Kogen&title=Design%2C+synthesis+and+structure%E2%88%92activity+relationships+of+dual+inhibitors+of+acetylcholinesterase+and+serotonin+transporter+as+potential+agents+for+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToda%26aufirst%3DN.%26aulast%3DTago%26aufirst%3DK.%26aulast%3DMarumoto%26aufirst%3DS.%26aulast%3DTakami%26aufirst%3DK.%26aulast%3DOri%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DN.%26aulast%3DKoyama%26aufirst%3DK.%26aulast%3DNaruto%26aufirst%3DS.%26aulast%3DAbe%26aufirst%3DK.%26aulast%3DYamazaki%26aufirst%3DR.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DAoyagi%26aufirst%3DA.%26aulast%3DAbe%26aufirst%3DY.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DKogen%26aufirst%3DH.%26atitle%3DDesign%252C%2520synthesis%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%2520dual%2520inhibitors%2520of%2520acetylcholinesterase%2520and%2520serotonin%2520transporter%2520as%2520potential%2520agents%2520for%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D1935%26epage%3D1955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Toda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naruto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyagi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogen, H.</span><span> </span><span class="NLM_article-title">A conformational restriction approach to the development of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimerʼs disease</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">4389</span><span class="NLM_x">–</span> <span class="NLM_lpage">4415</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=4389-4415&author=N.+Todaauthor=K.+Tagoauthor=S.+Marumotoauthor=K.+Takamiauthor=M.+Oriauthor=N.+Yamadaauthor=K.+Koyamaauthor=S.+Narutoauthor=K.+Abeauthor=R.+Yamazakiauthor=T.+Haraauthor=A.+Aoyagiauthor=Y.+Abeauthor=T.+Kanekoauthor=H.+Kogen&title=A+conformational+restriction+approach+to+the+development+of+dual+inhibitors+of+acetylcholinesterase+and+serotonin+transporter+as+potential+agents+for+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToda%26aufirst%3DN.%26aulast%3DTago%26aufirst%3DK.%26aulast%3DMarumoto%26aufirst%3DS.%26aulast%3DTakami%26aufirst%3DK.%26aulast%3DOri%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DN.%26aulast%3DKoyama%26aufirst%3DK.%26aulast%3DNaruto%26aufirst%3DS.%26aulast%3DAbe%26aufirst%3DK.%26aulast%3DYamazaki%26aufirst%3DR.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DAoyagi%26aufirst%3DA.%26aulast%3DAbe%26aufirst%3DY.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DKogen%26aufirst%3DH.%26atitle%3DA%2520conformational%2520restriction%2520approach%2520to%2520the%2520development%2520of%2520dual%2520inhibitors%2520of%2520acetylcholinesterase%2520and%2520serotonin%2520transporter%2520as%2520potential%2520agents%2520for%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D4389%26epage%3D4415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Abe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyagi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumagae, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naruto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, T.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of RS-1259, an orally active dual inhibitor of acetylcholinesterase and serotonin transporter, in rodents: possible treatment of Alzheimerʼs disease</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1254%2Fjphs.93.95" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=14501158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvVWntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2003&pages=95-105&author=Y.+Abeauthor=A.+Aoyagiauthor=T.+Haraauthor=K.+Abeauthor=R.+Yamazakiauthor=Y.+Kumagaeauthor=S.+Narutoauthor=K.+Koyamaauthor=S.+Marumotoauthor=K.+Tagoauthor=N.+Todaauthor=K.+Takamiauthor=N.+Yamadaauthor=M.+Oriauthor=H.+Kogenauthor=T.+Kaneko&title=Pharmacological+characterization+of+RS-1259%2C+an+orally+active+dual+inhibitor+of+acetylcholinesterase+and+serotonin+transporter%2C+in+rodents%3A+possible+treatment+of+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of RS-1259, an orally active dual inhibitor of acetylcholinesterase and serotonin transporter, in rodents: Possible treatment of Alzheimer's disease</span></div><div class="casAuthors">Abe, Yasuyuki; Aoyagi, Atsushi; Hara, Takao; Abe, Kazumi; Yamazaki, Reina; Kumagae, Yoshihiro; Naruto, Shunji; Koyama, Kazuo; Marumoto, Shinji; Tago, Keiko; Toda, Narihiro; Takami, Kazuko; Yamada, Naho; Ori, Mayuko; Kogen, Hiroshi; Kaneko, Tsugio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-105</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">A dual inhibitor of acetylcholinesterase (AChE) and serotonin transporter (SERT), RS-1259 , was newly synthesized.  RS-1259 simultaneously inhibited AChE and SERT in the brain following an oral administration in mice and rats.  Actual simultaneous elevation of extra-cellular levels of 5-HT and ACh in the rat hippocampus was confirmed by microdialysis.  The compd. was as effective as SERT inhibitors such as fluoxetine and fluvoxamine in a 5-hydroxytryptophan-enhancing test in mice.  Spatial memory deficits in the two-platform task of a water maze in aged rats were ameliorated by RS-1259 as well as donepezil.  Both RS-1259 and donepezil increased the awake episodes in the daytime EEG of rats.  Although RS-1259 was weaker than donepezil in enhancing central cholinergic transmission, as obsd. by ACh elevation in the hippocampus and memory enhancement in aged rats, the efficacy of RS-1259 on the consciousness level, which reflects the whole activity in the brain, was almost the same as that of donepezil.  These results suggest that both cholinergic and serotonergic systems are involved in maintaining brain arousal and that a dual inhibitor of AChE and SERT may be useful for the treatment of cognitive disorders assocd. with reduced brain activity such as in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBPLc4E5ZapLVg90H21EOLACvtfcHk0ljr8WO4_gc68A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvVWntro%253D&md5=a06b84e5e5f12f2405a05860f10a5515</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1254%2Fjphs.93.95&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.93.95%26sid%3Dliteratum%253Aachs%26aulast%3DAbe%26aufirst%3DY.%26aulast%3DAoyagi%26aufirst%3DA.%26aulast%3DHara%26aufirst%3DT.%26aulast%3DAbe%26aufirst%3DK.%26aulast%3DYamazaki%26aufirst%3DR.%26aulast%3DKumagae%26aufirst%3DY.%26aulast%3DNaruto%26aufirst%3DS.%26aulast%3DKoyama%26aufirst%3DK.%26aulast%3DMarumoto%26aufirst%3DS.%26aulast%3DTago%26aufirst%3DK.%26aulast%3DToda%26aufirst%3DN.%26aulast%3DTakami%26aufirst%3DK.%26aulast%3DYamada%26aufirst%3DN.%26aulast%3DOri%26aufirst%3DM.%26aulast%3DKogen%26aufirst%3DH.%26aulast%3DKaneko%26aufirst%3DT.%26atitle%3DPharmacological%2520characterization%2520of%2520RS-1259%252C%2520an%2520orally%2520active%2520dual%2520inhibitor%2520of%2520acetylcholinesterase%2520and%2520serotonin%2520transporter%252C%2520in%2520rodents%253A%2520possible%2520treatment%2520of%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2003%26volume%3D93%26spage%3D95%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Barnes, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costall, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wischik, C. M.</span><span> </span><span class="NLM_article-title">Normal densities of 5-HT3 receptor recognition sites in Alzheimerʼs disease</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">253</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1990&pages=253-254&author=N.+M.+Barnesauthor=B.+Costallauthor=R.+J.+Naylorauthor=T.+J.+Williamsauthor=C.+M.+Wischik&title=Normal+densities+of+5-HT3+receptor+recognition+sites+in+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DN.%2BM.%26aulast%3DCostall%26aufirst%3DB.%26aulast%3DNaylor%26aufirst%3DR.%2BJ.%26aulast%3DWilliams%26aufirst%3DT.%2BJ.%26aulast%3DWischik%26aufirst%3DC.%2BM.%26atitle%3DNormal%2520densities%2520of%25205-HT3%2520receptor%2520recognition%2520sites%2520in%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DNeuroReport%26date%3D1990%26volume%3D1%26spage%3D253%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Cappelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennuni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makovec, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menziani, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortuso, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vomero, S.</span><span> </span><span class="NLM_article-title">Further studies on the interaction of the 5-hydroxytryptamine3 (5-HT3) receptor with arylpiperazine ligands. Development of a new 5-HT3 receptor ligand showing potent acetylcholinesterase inhibitory properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3564</span><span class="NLM_x">–</span> <span class="NLM_lpage">3575</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0493461" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3564-3575&author=A.+Cappelliauthor=A.+Gallelliauthor=M.+Maniniauthor=M.+Anziniauthor=L.+Mennuniauthor=F.+Makovecauthor=M.+C.+Menzianiauthor=S.+Alcaroauthor=F.+Ortusoauthor=S.+Vomero&title=Further+studies+on+the+interaction+of+the+5-hydroxytryptamine3+%285-HT3%29+receptor+with+arylpiperazine+ligands.+Development+of+a+new+5-HT3+receptor+ligand+showing+potent+acetylcholinesterase+inhibitory+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1021%2Fjm0493461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0493461%26sid%3Dliteratum%253Aachs%26aulast%3DCappelli%26aufirst%3DA.%26aulast%3DGallelli%26aufirst%3DA.%26aulast%3DManini%26aufirst%3DM.%26aulast%3DAnzini%26aufirst%3DM.%26aulast%3DMennuni%26aufirst%3DL.%26aulast%3DMakovec%26aufirst%3DF.%26aulast%3DMenziani%26aufirst%3DM.%2BC.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DOrtuso%26aufirst%3DF.%26aulast%3DVomero%26aufirst%3DS.%26atitle%3DFurther%2520studies%2520on%2520the%2520interaction%2520of%2520the%25205-hydroxytryptamine3%2520%25285-HT3%2529%2520receptor%2520with%2520arylpiperazine%2520ligands.%2520Development%2520of%2520a%2520new%25205-HT3%2520receptor%2520ligand%2520showing%2520potent%2520acetylcholinesterase%2520inhibitory%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3564%26epage%3D3575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Witkin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. L.</span><span> </span><span class="NLM_article-title">Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.pharmthera.2004.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15251226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsFylu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2004&pages=1-20&author=J.+M.+Witkinauthor=D.+L.+Nelson&title=Selective+histamine+H3+receptor+antagonists+for+treatment+of+cognitive+deficiencies+and+other+disorders+of+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system</span></div><div class="casAuthors">Witkin, J. M.; Nelson, D. L.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-20</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Evidence exists to implicate the monoamine histamine in the control of arousal and cognitive functions.  Antagonists of H3 receptors are postsynaptic and presynaptic modulators of neural transmission in a variety of neuronal circuits relevant to cognition.  Accumulating neuroanatomical, neurochem., pharmacol., and behavioral data support the idea that H3 receptor antagonists may function to improve cognitive performances in disease states (e.g., Alzheimer's disease and mild cognitive impairment states).  Thus, H3 receptor antagonists have been shown to increase performance in attention and memory tests in nonhuman expts. and prevent the degrdn. in performances produced by scopolamine, MK-801, or age.  In contrast, agonists of the H3 receptor generally produce cognitive impairing effects in animal models.  The role of H3 receptors in these behavioral effects is substantiated by data indicating a central origin for their effects, the selectivity of some of the H3 receptor antagonists studied, and the pharmacol. modification of effects of H3 receptor antagonists by selective H3 receptor agonists.  Data and issues that challenge the potential role for H3 receptor antagonists in cognitive processes are also critically reviewed.  H3 receptor antagonists may also have therapeutic value in the management of obesity, pain, sleep disorders, schizophrenia, and attention deficit hyperactivity disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYt2x3LVstu7Vg90H21EOLACvtfcHk0lgo5ZRJX3p8dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsFylu7c%253D&md5=617ca9544608401f2d0789872e7a8323</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2004.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2004.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DWitkin%26aufirst%3DJ.%2BM.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26atitle%3DSelective%2520histamine%2520H3%2520receptor%2520antagonists%2520for%2520treatment%2520of%2520cognitive%2520deficiencies%2520and%2520other%2520disorders%2520of%2520the%2520central%2520nervous%2520system%26jtitle%3DPharmacol.%2520Ther.%26date%3D2004%26volume%3D103%26spage%3D1%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Petroianu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arafat, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasse, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, H.</span><span> </span><span class="NLM_article-title">Multiple enzyme inhibitions by histamine H3 receptor antagonists as potential procognitive agents</span> <span class="citation_source-journal">Pharmazie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2006&pages=179-182&author=G.+Petroianuauthor=K.+Arafatauthor=B.+C.+Sasseauthor=H.+Stark&title=Multiple+enzyme+inhibitions+by+histamine+H3+receptor+antagonists+as+potential+procognitive+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetroianu%26aufirst%3DG.%26aulast%3DArafat%26aufirst%3DK.%26aulast%3DSasse%26aufirst%3DB.%2BC.%26aulast%3DStark%26aufirst%3DH.%26atitle%3DMultiple%2520enzyme%2520inhibitions%2520by%2520histamine%2520H3%2520receptor%2520antagonists%2520as%2520potential%2520procognitive%2520agents%26jtitle%3DPharmazie%26date%3D2006%26volume%3D61%26spage%3D179%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Holmquist, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuchbury, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berbaum, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muscat, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hager, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munch, G.</span><span> </span><span class="NLM_article-title">Lipoic acid as a novel treatment for Alzheimerʼs disease and related dementias</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.pharmthera.2006.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16989905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsFCkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2007&pages=154-164&author=L.+Holmquistauthor=G.+Stuchburyauthor=K.+Berbaumauthor=S.+Muscatauthor=S.+Youngauthor=K.+Hagerauthor=J.+Engelauthor=G.+Munch&title=Lipoic+acid+as+a+novel+treatment+for+Alzheimer%CA%BCs+disease+and+related+dementias"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Lipoic acid as a novel treatment for Alzheimer's disease and related dementias</span></div><div class="casAuthors">Holmquist, Lina; Stuchbury, Grant; Berbaum, Katrin; Muscat, Sonja; Young, Simon; Hager, Klaus; Engel, Juergen; Muench, Gerald</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">154-164</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a progressive neurodegenerative disorder that destroys patient memory and cognition, communication ability with the social environment and the ability to carry out daily activities.  Despite extensive research into the pathogenesis of AD, a neuroprotective treatment - particularly for the early stages of disease - remains unavailable for clin. use.  In this review, we advance the suggestion that lipoic acid (LA) may fulfil this therapeutic need.  A naturally occurring precursor of an essential cofactor for mitochondrial enzymes, including pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase (KGDH), LA has been shown to have a variety of properties which can interfere with pathogenic principles of AD.  For example, LA increases acetylcholine (ACh) prodn. by activation of choline acetyltransferase and increases glucose uptake, thus supplying more acetyl-CoA for the prodn. of ACh.  LA chelates redox-active transition metals, thus inhibiting the formation of hydroxyl radicals and also scavenges reactive oxygen species (ROS), thereby increasing the levels of reduced glutathione.  Via the same mechanisms, downregulation redox-sensitive inflammatory processes is also achieved.  Furthermore, LA can scavenge lipid peroxidn. products such as hydroxynonenal and acrolein.  The reduced form of LA, dihydrolipoic acid (DHLA), is the active compd. responsible for most of these beneficial effects.  R-α-LA can be applied instead of DHLA, as it is reduced by mitochondrial lipoamide dehydrogenase, a part of the PDH complex.  In this review, the properties of LA are explored with particular emphasis on how this agent, particularly the R-α-enantiomer, may be effective to treat AD and related dementias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcoiEDmF4ru7Vg90H21EOLACvtfcHk0lgo5ZRJX3p8dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsFCkug%253D%253D&md5=9de980ce1a7f7c2b1c13ed92e36d9b5f</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2006.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2006.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DHolmquist%26aufirst%3DL.%26aulast%3DStuchbury%26aufirst%3DG.%26aulast%3DBerbaum%26aufirst%3DK.%26aulast%3DMuscat%26aufirst%3DS.%26aulast%3DYoung%26aufirst%3DS.%26aulast%3DHager%26aufirst%3DK.%26aulast%3DEngel%26aufirst%3DJ.%26aulast%3DMunch%26aufirst%3DG.%26atitle%3DLipoic%2520acid%2520as%2520a%2520novel%2520treatment%2520for%2520Alzheimer%25CA%25BCs%2520disease%2520and%2520related%2520dementias%26jtitle%3DPharmacol.%2520Ther.%26date%3D2007%26volume%3D113%26spage%3D154%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrelia, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarozzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Rational approach to discover multipotent anti-Alzheimer drugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">360</span><span class="NLM_x">–</span> <span class="NLM_lpage">363</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049112h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslSk" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=360-363&author=M.+Rosiniauthor=V.+Andrisanoauthor=M.+Bartoliniauthor=M.+L.+Bolognesiauthor=P.+Hreliaauthor=A.+Minariniauthor=A.+Tarozziauthor=C.+Melchiorre&title=Rational+approach+to+discover+multipotent+anti-Alzheimer+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Approach To Discover Multipotent Anti-Alzheimer Drugs</span></div><div class="casAuthors">Rosini, Michela; Andrisano, Vincenza; Bartolini, Manuela; Bolognesi, Maria L.; Hrelia, Patrizia; Minarini, Anna; Tarozzi, Andrea; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">360-363</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The coupling of two different pharmacophores, each endowed with different biol. properties, afforded the hybrid compd. lipocrine (7), whose biol. profile was markedly improved relative to those of prototypes tacrine and lipoic acid.  Lipocrine is the first compd. that inhibits the catalytic activity of AChE and AChE-induced amyloid-β aggregation and protects against reactive oxygen species.  Thus, it emerged as a valuable pharmacol. tool to investigate Alzheimer's disease and as a promising lead compd. for new anti-Alzheimer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcNiocyuiJWLVg90H21EOLACvtfcHk0lg0emGwwp2XPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslSk&md5=e632c934e744d35d5acf7047827fc91f</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1021%2Fjm049112h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049112h%26sid%3Dliteratum%253Aachs%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DHrelia%26aufirst%3DP.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DTarozzi%26aufirst%3DA.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DRational%2520approach%2520to%2520discover%2520multipotent%2520anti-Alzheimer%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D360%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Lipoic acid, a lead structure for multi-target-directed drugs for neurodegeneration</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1269</span><span class="NLM_x">–</span> <span class="NLM_lpage">1274</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1269-1274&author=M.+L.+Bolognesiauthor=A.+Minariniauthor=V.+Tumiattiauthor=C.+Melchiorre&title=Lipoic+acid%2C+a+lead+structure+for+multi-target-directed+drugs+for+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DLipoic%2520acid%252C%2520a%2520lead%2520structure%2520for%2520multi-target-directed%2520drugs%2520for%2520neurodegeneration%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1269%26epage%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J. T.</span><span> </span><span class="NLM_article-title">Beneficial effects of melatonin in experimental models of Alzheimer disease</span> <span class="citation_source-journal">Acta Pharmacol. Sin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1111%2Fj.1745-7254.2006.00267.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16412260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Witrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=129-139&author=Y.+Chengauthor=Z.+Fengauthor=Q.+Z.+Zhangauthor=J.+T.+Zhang&title=Beneficial+effects+of+melatonin+in+experimental+models+of+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Beneficial effects of melatonin in experimental models of Alzheimer disease</span></div><div class="casAuthors">Cheng, Yong; Feng, Zheng; Zhang, Qing-zhu; Zhang, Jun-tian</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica Sinica</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">129-139</span>CODEN:
                <span class="NLM_cas:coden">APSCG5</span>;
        ISSN:<span class="NLM_cas:issn">1671-4083</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD), a progressive degenerative disorder, is characterized by the presence of amyloid deposits, neurofibrillary tangles and neuron loss.  Emerging evidence indicates that antioxidants could be useful either for the prevention or treatment of AD.  It has been shown that melatonin is a potent antioxidant and free radical scavenger.  Addnl., melatonin stimulates several antioxidative enzymes and improves mitochondrial energy metab.  These findings led us to study amyloid precursor protein transgenic mice, ovariectomized rats, and pheochromocytoma and astroglioma cell lines, to observe whether melatonin had any effect on Alzheimer's symptoms or pathol. changes.  We found that melatonin had many beneficial effects in exptl. models of AD, including improvement of cognitive function, anti-oxidative injury, anti-apoptosis, inhibition of β-amyloid (Aβ) deposition and Aβ fiber formation.  Several groups have shown that melatonin has an inhibitory effect on tau protein hyperphosphorylation.  These actions may potentially slow down or stop the progression of dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonU5s8mdLRubVg90H21EOLACvtfcHk0lg0emGwwp2XPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Witrk%253D&md5=8105a133d67224e0fa493f695ee6a00f</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1111%2Fj.1745-7254.2006.00267.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1745-7254.2006.00267.x%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DQ.%2BZ.%26aulast%3DZhang%26aufirst%3DJ.%2BT.%26atitle%3DBeneficial%2520effects%2520of%2520melatonin%2520in%2520experimental%2520models%2520of%2520Alzheimer%2520disease%26jtitle%3DActa%2520Pharmacol.%2520Sin.%26date%3D2006%26volume%3D27%26spage%3D129%26epage%3D139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Rodriguez-Franco, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Bachiller, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez-Ledesma, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolome, B.</span><span> </span><span class="NLM_article-title">Novel tacrine-melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">462</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050746d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=459-462&author=M.+I.+Rodriguez-Francoauthor=M.+I.+Fernandez-Bachillerauthor=C.+Perezauthor=B.+Hernandez-Ledesmaauthor=B.+Bartolome&title=Novel+tacrine-melatonin+hybrids+as+dual-acting+drugs+for+Alzheimer+disease%2C+with+improved+acetylcholinesterase+inhibitory+and+antioxidant+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Fjm050746d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050746d%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DFernandez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DHernandez-Ledesma%26aufirst%3DB.%26aulast%3DBartolome%26aufirst%3DB.%26atitle%3DNovel%2520tacrine-melatonin%2520hybrids%2520as%2520dual-acting%2520drugs%2520for%2520Alzheimer%2520disease%252C%2520with%2520improved%2520acetylcholinesterase%2520inhibitory%2520and%2520antioxidant%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D459%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Mattson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, S. L.</span><span> </span><span class="NLM_article-title">Dysregulation of cellular calcium homeostasis in Alzheimerʼs disease: bad genes and bad habits</span> <span class="citation_source-journal">J. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1385%2FJMN%3A17%3A2%3A205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=11816794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosVKit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2001&pages=205-224&author=M.+P.+Mattsonauthor=S.+L.+Chan&title=Dysregulation+of+cellular+calcium+homeostasis+in+Alzheimer%CA%BCs+disease%3A+bad+genes+and+bad+habits"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Dysregulation of cellular calcium homeostasis in Alzheimer's disease. Bad genes and bad habits</span></div><div class="casAuthors">Mattson, Mark P.; Chan, Sic L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-224</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Calcium is one of the most important intracellular messengers in the brain, being essential for neuronal development, synaptic transmission and plasticity, and the regulation of various metabolic pathways.  The findings reviewed in the present article suggest that calcium also plays a prominent role in the pathogenesis of Alzheimer's disease (AD).  Assocns. between the pathol. hallmarks of AD (neurofibrillary tangles [NFT] and amyloid plaques) and perturbed cellular calcium homeostasis have been established in studies of patients, and in animal and cell culture models of AD.  Studies of the effects of mutations in the β-amyloid precursor protein (APP) and presenilins on neuronal plasticity and survival have provided insight into the mol. cascades that result in synaptic dysfunction and neuronal degeneration in AD.  Central to the neurodegenerative process is the inability of neurons to properly regulate intracellular calcium levels.  Increased levels of amyloid β-peptide (Aβ) induce oxidative stress, which impairs cellular ion homeostasis and energy metab. and renders neurons vulnerable to apoptosis and excitotoxicity.  Subtoxic levels of Aβ may induce synaptic dysfunction by impairing multiple signal transduction pathways.  Presenilin mutations perturb calcium homeostasis in the endoplasmic reticulum in a way that sensitizes neurons to apoptosis and excitotoxicity; links between aberrant calcium regulation and altered APP processing are emerging.  Environmental risk factors for AD are being identified and may include high calorie diets, folic acid insufficiency, and a low level of intellectual activity (bad habits); in each case, the environmental factor impacts on neuronal calcium homeostasis.  Low calorie diets and intellectual activity may guard against AD by stimulating prodn. of neurotrophic factors and chaperone proteins.  The emerging picture of the cell and mol. biol. of AD is revealing novel preventative and therapeutic strategies for eradicating this growing epidemic of the elderly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZX54N8EP-37Vg90H21EOLACvtfcHk0liT1qpDqwuTtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosVKit7g%253D&md5=cca6641a88729abc25b101b0cf03eb30</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1385%2FJMN%3A17%3A2%3A205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FJMN%253A17%253A2%253A205%26sid%3Dliteratum%253Aachs%26aulast%3DMattson%26aufirst%3DM.%2BP.%26aulast%3DChan%26aufirst%3DS.%2BL.%26atitle%3DDysregulation%2520of%2520cellular%2520calcium%2520homeostasis%2520in%2520Alzheimer%25CA%25BCs%2520disease%253A%2520bad%2520genes%2520and%2520bad%2520habits%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2001%26volume%3D17%26spage%3D205%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Villarroya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, J. L.</span><span> </span><span class="NLM_article-title">New classes of AChE inhibitors with additional pharmacological effects of interest for the treatment of Alzheimerʼs disease</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">3177</span><span class="NLM_x">–</span> <span class="NLM_lpage">3184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.2174%2F1381612043383368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15544507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnslCktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=3177-3184&author=M.+Villarroyaauthor=A.+G.+Garciaauthor=J.+L.+Marco&title=New+classes+of+AChE+inhibitors+with+additional+pharmacological+effects+of+interest+for+the+treatment+of+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">New classes of AChE inhibitors with additional pharmacological effects of interest for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Villarroya, M.; Garcia, A. G.; Marco, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3177-3184</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is assocd. to a gradual loss of attention and memory that have been assocd. to impairment of brain cholinergic neurotransmission, particularly a deficit of cholinergic neurons in the nucleus basalis of Meynert.  Thus, it is not surprising that the first therapeutic target that has demonstrated therapeutic efficacy on cognition, behavior and functional daily activities has been the inhibitors of acetylcholinesterase (AChE), i.e. tacrine, donepezil, rivastigmine and galanthamine.  But not all inhibitors of AChE have the same potency to block the enzyme and have a different pharmacol. profile.  For instance, rivastigmine is a dual inhibitor of AChE and butyrylcholinesterase (BuChE), and galanthamine is a mild inhibitor of AChE and an allosteric potentiating ligand of neuronal nicotinic receptors for acetylcholine (nAChRs).  In addn., we have recently found that galanthamine has neuroprotective effects by inducing calcium signals and the induction of the antiapoptotic protein Bcl-2.  In this frame, we have been synthesizing new tacrine derivs. that keep their ability to inhibit AChE but that interfere with neuronal calcium overloading and prevent apoptosis.  Some of these compds. exhibit neuroprotecting properties and thus, could be useful in the treatment of neurodegenerative and ischemic brain diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjQD-w50ztubVg90H21EOLACvtfcHk0liT1qpDqwuTtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnslCktrc%253D&md5=40b4e7aa0b7fb3c31c85c4058a0e9961</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.2174%2F1381612043383368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612043383368%26sid%3Dliteratum%253Aachs%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DMarco%26aufirst%3DJ.%2BL.%26atitle%3DNew%2520classes%2520of%2520AChE%2520inhibitors%2520with%2520additional%2520pharmacological%2520effects%2520of%2520interest%2520for%2520the%2520treatment%2520of%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2004%26volume%3D10%26spage%3D3177%26epage%3D3184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Kelly, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, R. L.</span><span> </span><span class="NLM_article-title">Tetrahydroaminoacridine (THA) reduces voltage-dependent calcium currents in rat sensory neurons</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=1991&pages=247-250&author=K.+M.+Kellyauthor=R.+A.+Grossauthor=R.+L.+Macdonald&title=Tetrahydroaminoacridine+%28THA%29+reduces+voltage-dependent+calcium+currents+in+rat+sensory+neurons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DK.%2BM.%26aulast%3DGross%26aufirst%3DR.%2BA.%26aulast%3DMacdonald%26aufirst%3DR.%2BL.%26atitle%3DTetrahydroaminoacridine%2520%2528THA%2529%2520reduces%2520voltage-dependent%2520calcium%2520currents%2520in%2520rat%2520sensory%2520neurons%26jtitle%3DNeurosci.%2520Lett.%26date%3D1991%26volume%3D132%26spage%3D247%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">de los Rios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreiras, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinchon, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span> </span><span class="NLM_article-title">Novel tacrine derivatives that block neuronal calcium channels</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2077</span><span class="NLM_x">–</span> <span class="NLM_lpage">2088</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=2077-2088&author=C.+de+los+Riosauthor=J.+L.+Marcoauthor=M.+D.+Carreirasauthor=P.+M.+Chinchonauthor=A.+G.+Garciaauthor=M.+Villarroya&title=Novel+tacrine+derivatives+that+block+neuronal+calcium+channels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2Blos%2BRios%26aufirst%3DC.%26aulast%3DMarco%26aufirst%3DJ.%2BL.%26aulast%3DCarreiras%26aufirst%3DM.%2BD.%26aulast%3DChinchon%26aufirst%3DP.%2BM.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26atitle%3DNovel%2520tacrine%2520derivatives%2520that%2520block%2520neuronal%2520calcium%2520channels%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D2077%26epage%3D2088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Leon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span> </span><span class="NLM_article-title">Synthesis, acetylcholinesterase inhibition and neuroprotective activity of new tacrine analogues</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1167</span><span class="NLM_x">–</span> <span class="NLM_lpage">1175</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=1167-1175&author=R.+Leonauthor=J.+Marco-Contellesauthor=A.+G.+Garciaauthor=M.+Villarroya&title=Synthesis%2C+acetylcholinesterase+inhibition+and+neuroprotective+activity+of+new+tacrine+analogues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeon%26aufirst%3DR.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520acetylcholinesterase%2520inhibition%2520and%2520neuroprotective%2520activity%2520of%2520new%2520tacrine%2520analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D1167%26epage%3D1175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de los Rios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span> </span><span class="NLM_article-title">New multipotent tetracyclic tacrines with neuroprotective activity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">8176</span><span class="NLM_x">–</span> <span class="NLM_lpage">8185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=8176-8185&author=J.+Marco-Contellesauthor=R.+Leonauthor=C.+de+los+Riosauthor=A.+G.+Garciaauthor=M.+G.+Lopezauthor=M.+Villarroya&title=New+multipotent+tetracyclic+tacrines+with+neuroprotective+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DLeon%26aufirst%3DR.%26aulast%3Dde%2Blos%2BRios%26aufirst%3DC.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26atitle%3DNew%2520multipotent%2520tetracyclic%2520tacrines%2520with%2520neuroprotective%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D8176%26epage%3D8185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of new 4<i>H</i>-pyrano[2,3-<i>b</i>]quinoline derivatives that block acetylcholinesterase and cell calcium signals, and cause neuroprotection against calcium overload and free radicals</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1464</span><span class="NLM_x">–</span> <span class="NLM_lpage">1469</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2006&pages=1464-1469&author=J.+Marco-Contellesauthor=R.+Leonauthor=M.+G.+Lopezauthor=A.+G.+Garciaauthor=M.+Villarroya&title=Synthesis+and+biological+evaluation+of+new+4H-pyrano%5B2%2C3-b%5Dquinoline+derivatives+that+block+acetylcholinesterase+and+cell+calcium+signals%2C+and+cause+neuroprotection+against+calcium+overload+and+free+radicals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DLeon%26aufirst%3DR.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520new%25204H-pyrano%255B2%252C3-b%255Dquinoline%2520derivatives%2520that%2520block%2520acetylcholinesterase%2520and%2520cell%2520calcium%2520signals%252C%2520and%2520cause%2520neuroprotection%2520against%2520calcium%2520overload%2520and%2520free%2520radicals%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2006%26volume%3D41%26spage%3D1464%26epage%3D1469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Marco, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de los Rios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreiras, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eleuterio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morreale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orozco, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luque, F. J.</span><span> </span><span class="NLM_article-title">Synthesis, biological evaluation and molecular modelling of diversely functionalized heterocyclic derivatives as inhibitors of acetylcholinesterase/butyrylcholinesterase and modulators of Ca<sup>2+</sup> channels and nicotinic receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2199</span><span class="NLM_x">–</span> <span class="NLM_lpage">2218</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=2199-2218&author=J.+L.+Marcoauthor=C.+de+los+Riosauthor=A.+G.+Garciaauthor=M.+Villarroyaauthor=M.+C.+Carreirasauthor=C.+Martinsauthor=A.+Eleuterioauthor=A.+Morrealeauthor=M.+Orozcoauthor=F.+J.+Luque&title=Synthesis%2C+biological+evaluation+and+molecular+modelling+of+diversely+functionalized+heterocyclic+derivatives+as+inhibitors+of+acetylcholinesterase%2Fbutyrylcholinesterase+and+modulators+of+Ca2%2B+channels+and+nicotinic+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarco%26aufirst%3DJ.%2BL.%26aulast%3Dde%2Blos%2BRios%26aufirst%3DC.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DCarreiras%26aufirst%3DM.%2BC.%26aulast%3DMartins%26aufirst%3DC.%26aulast%3DEleuterio%26aufirst%3DA.%26aulast%3DMorreale%26aufirst%3DA.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%2520and%2520molecular%2520modelling%2520of%2520diversely%2520functionalized%2520heterocyclic%2520derivatives%2520as%2520inhibitors%2520of%2520acetylcholinesterase%252Fbutyrylcholinesterase%2520and%2520modulators%2520of%2520Ca2%252B%2520channels%2520and%2520nicotinic%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D2199%26epage%3D2218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Marco-Contelles, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Los Rios, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglietta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terencio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villarroya, M.</span><span> </span><span class="NLM_article-title">Novel multipotent tacrine−dihydropyridine hybrids with improved acetylcholinesterase inhibitory and neuroprotective activities as potential drugs for the treatment of Alzheimerʼs disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7607</span><span class="NLM_x">–</span> <span class="NLM_lpage">7610</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061047j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7607-7610&author=J.+Marco-Contellesauthor=R.+Leonauthor=C.+de+Los+Riosauthor=A.+Gugliettaauthor=J.+Terencioauthor=M.+G.+Lopezauthor=A.+G.+Garciaauthor=M.+Villarroya&title=Novel+multipotent+tacrine%E2%88%92dihydropyridine+hybrids+with+improved+acetylcholinesterase+inhibitory+and+neuroprotective+activities+as+potential+drugs+for+the+treatment+of+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Fjm061047j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061047j%26sid%3Dliteratum%253Aachs%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DLeon%26aufirst%3DR.%26aulast%3Dde%2BLos%2BRios%26aufirst%3DC.%26aulast%3DGuglietta%26aufirst%3DA.%26aulast%3DTerencio%26aufirst%3DJ.%26aulast%3DLopez%26aufirst%3DM.%2BG.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26atitle%3DNovel%2520multipotent%2520tacrine%25E2%2588%2592dihydropyridine%2520hybrids%2520with%2520improved%2520acetylcholinesterase%2520inhibitory%2520and%2520neuroprotective%2520activities%2520as%2520potential%2520drugs%2520for%2520the%2520treatment%2520of%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7607%26epage%3D7610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">White, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnham, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, A. I.</span><span> </span><span class="NLM_article-title">Metal homeostasis in Alzheimerʼs disease</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">722</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1586%2F14737175.6.5.711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16734519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtlKntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=711-722&author=A.+R.+Whiteauthor=K.+J.+Barnhamauthor=A.+I.+Bush&title=Metal+homeostasis+in+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Metal homeostasis in Alzheimer's disease</span></div><div class="casAuthors">White, Anthony R.; Barnham, Kevin J.; Bush, Ashley I.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">711-722</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by neuronal dysfunction and the formation of amyloid plaques in the brain.  Although the pathol. processes resulting in the onset and progression of AD are not well understood, there is a growing body of evidence to support a central role for biometals in many crit. aspects of the illness.  Recent reports have described the exciting development of potential therapeutic agents based on the modulation of metal bioavailability.  The metal ligand, clioquinol has demonstrated promising results in animal models and small clin. trials and a new generation of metal ligand-based therapeutics are currently under development.  However, further research is necessary to fully understand the complex and interdependent pathways of biometal homeostasis and amyloid metab. in AD.  This information will be vital for the development of safe and effective metal-based pharmaceuticals for the treatment of AD and, potentially, other neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI6vkJs17_AbVg90H21EOLACvtfcHk0lg3VVICNys0sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtlKntL0%253D&md5=ee25c253448f39464fcf62bc1e49e6e5</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1586%2F14737175.6.5.711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.6.5.711%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DA.%2BR.%26aulast%3DBarnham%26aufirst%3DK.%2BJ.%26aulast%3DBush%26aufirst%3DA.%2BI.%26atitle%3DMetal%2520homeostasis%2520in%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2006%26volume%3D6%26spage%3D711%26epage%3D722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Dedeoglu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cormier, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseitlin, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremsky, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moir, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowall, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span> </span><span class="NLM_article-title">Preliminary studies of a novel bifunctional metal chelator targeting Alzheimerʼs amyloidogenesis</span> <span class="citation_source-journal">Exp. Gerontol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1641</span><span class="NLM_x">–</span> <span class="NLM_lpage">1649</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.exger.2004.08.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15582280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVCltLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2004&pages=1641-1649&author=A.+Dedeogluauthor=K.+Cormierauthor=S.+Paytonauthor=K.+A.+Tseitlinauthor=J.+N.+Kremskyauthor=L.+Laiauthor=X.+Liauthor=R.+D.+Moirauthor=R.+E.+Tanziauthor=A.+I.+Bushauthor=N.+W.+Kowallauthor=J.+T.+Rogersauthor=X.+Huang&title=Preliminary+studies+of+a+novel+bifunctional+metal+chelator+targeting+Alzheimer%CA%BCs+amyloidogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis</span></div><div class="casAuthors">Dedeoglu, Alpaslan; Cormier, Kerry; Payton, Sandra; Tseitlin, Katya A.; Kremsky, Jonathan N.; Lai, Li; Li, Xiaohua; Moir, Robert D.; Tanzi, Rudolph E.; Bush, Ashley I.; Kowall, Neil W.; Rogers, Jack T.; Huang, Xudong</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Gerontology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">11-12</span>),
    <span class="NLM_cas:pages">1641-1649</span>CODEN:
                <span class="NLM_cas:coden">EXGEAB</span>;
        ISSN:<span class="NLM_cas:issn">0531-5565</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A growing body of evidence indicates that dysregulation of cerebral biometals (Fe, Cu, Zn) and their interactions with APP and Aβ amyloid may contribute to the Alzheimer's amyloid pathol., and thus metal chelation could be a rational therapeutic approach for interdicting AD pathogenesis.  However, poor target specificity and consequential clin. safety of current metal-complexing agents have limited their widespread clin. use.  To develop the next generation of metal chelators, we have designed and synthesized a new bifunctional mol.-XH1, based on a novel 'pharmacophore conjugation' concept.  This lipophilic mol. has both amyloid-binding and metal-chelating moieties covalently connected by amide bonds.  It achieved a putative binding geometry with Aβ1-40 peptide by the computational chem. modeling and reduced Zn(II)-induced Aβ1-40 aggregation in vitro as detd. by turbidometry.  Moreover, our pilot data indicated that XH1 has no significant neurotoxicity at low micromolar concns. and acute animal toxicity.  XH1 specifically reduced APP protein expression in human SH-SY5Y neuroblastoma cells and attenuated cerebral Aβ amyloid pathol. in PS1/APP transgenic mice without inducing apparent toxicity and behavior disturbances.  Collectively, these preliminary findings carry implication for XH1 being a BBB-permeable lead compd. for AD therapeutics targeting Alzheimer's amyloidogenesis, although further studies are needed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ_WW34UJTebVg90H21EOLACvtfcHk0li2LRX9ChssPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVCltLbJ&md5=2811096bf475d1370d099d9e751230c6</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.exger.2004.08.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exger.2004.08.016%26sid%3Dliteratum%253Aachs%26aulast%3DDedeoglu%26aufirst%3DA.%26aulast%3DCormier%26aufirst%3DK.%26aulast%3DPayton%26aufirst%3DS.%26aulast%3DTseitlin%26aufirst%3DK.%2BA.%26aulast%3DKremsky%26aufirst%3DJ.%2BN.%26aulast%3DLai%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DMoir%26aufirst%3DR.%2BD.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DBush%26aufirst%3DA.%2BI.%26aulast%3DKowall%26aufirst%3DN.%2BW.%26aulast%3DRogers%26aufirst%3DJ.%2BT.%26aulast%3DHuang%26aufirst%3DX.%26atitle%3DPreliminary%2520studies%2520of%2520a%2520novel%2520bifunctional%2520metal%2520chelator%2520targeting%2520Alzheimer%25CA%25BCs%2520amyloidogenesis%26jtitle%3DExp.%2520Gerontol.%26date%3D2004%26volume%3D39%26spage%3D1641%26epage%3D1649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Bebbington, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monck, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benwell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, R. H.</span><span> </span><span class="NLM_article-title">3,5-Disubstituted-4-hydroxyphenyls linked to 3-hydroxy-2-methyl-4(1<i>H</i>)-pyridinone: potent inhibitors of lipid peroxidation and cell toxicity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2779</span><span class="NLM_x">–</span> <span class="NLM_lpage">2782</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990945v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2779-2782&author=D.+Bebbingtonauthor=N.+J.+Monckauthor=S.+Gaurauthor=A.+M.+Palmerauthor=K.+Benwellauthor=V.+Harveyauthor=C.+S.+Malcolmauthor=R.+H.+Porter&title=3%2C5-Disubstituted-4-hydroxyphenyls+linked+to+3-hydroxy-2-methyl-4%281H%29-pyridinone%3A+potent+inhibitors+of+lipid+peroxidation+and+cell+toxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1021%2Fjm990945v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990945v%26sid%3Dliteratum%253Aachs%26aulast%3DBebbington%26aufirst%3DD.%26aulast%3DMonck%26aufirst%3DN.%2BJ.%26aulast%3DGaur%26aufirst%3DS.%26aulast%3DPalmer%26aufirst%3DA.%2BM.%26aulast%3DBenwell%26aufirst%3DK.%26aulast%3DHarvey%26aufirst%3DV.%26aulast%3DMalcolm%26aufirst%3DC.%2BS.%26aulast%3DPorter%26aufirst%3DR.%2BH.%26atitle%3D3%252C5-Disubstituted-4-hydroxyphenyls%2520linked%2520to%25203-hydroxy-2-methyl-4%25281H%2529-pyridinone%253A%2520potent%2520inhibitors%2520of%2520lipid%2520peroxidation%2520and%2520cell%2520toxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2779%26epage%3D2782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Ji, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. Y.</span><span> </span><span class="NLM_article-title">A new strategy to combat Alzheimerʼs disease. Combining radical-scavenging potential with metal-protein-attenuating ability in one molecule</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=21-24&author=H.+F.+Jiauthor=H.+Y.+Zhang&title=A+new+strategy+to+combat+Alzheimer%CA%BCs+disease.+Combining+radical-scavenging+potential+with+metal-protein-attenuating+ability+in+one+molecule"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DH.%2BF.%26aulast%3DZhang%26aufirst%3DH.%2BY.%26atitle%3DA%2520new%2520strategy%2520to%2520combat%2520Alzheimer%25CA%25BCs%2520disease.%2520Combining%2520radical-scavenging%2520potential%2520with%2520metal-protein-attenuating%2520ability%2520in%2520one%2520molecule%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D21%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Schugar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storr, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohmerle, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockman, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merkel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orvig, C.</span><span> </span><span class="NLM_article-title">Combating Alzheimerʼs disease with multifunctional molecules designed for metal passivation</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1716</span><span class="NLM_x">–</span> <span class="NLM_lpage">1718</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=1716-1718&author=H.+Schugarauthor=D.+E.+Greenauthor=M.+L.+Bowenauthor=L.+E.+Scottauthor=T.+Storrauthor=K.+Bohmerleauthor=F.+Thomasauthor=D.+D.+Allenauthor=P.+R.+Lockmanauthor=M.+Merkelauthor=K.+H.+Thompsonauthor=C.+Orvig&title=Combating+Alzheimer%CA%BCs+disease+with+multifunctional+molecules+designed+for+metal+passivation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchugar%26aufirst%3DH.%26aulast%3DGreen%26aufirst%3DD.%2BE.%26aulast%3DBowen%26aufirst%3DM.%2BL.%26aulast%3DScott%26aufirst%3DL.%2BE.%26aulast%3DStorr%26aufirst%3DT.%26aulast%3DBohmerle%26aufirst%3DK.%26aulast%3DThomas%26aufirst%3DF.%26aulast%3DAllen%26aufirst%3DD.%2BD.%26aulast%3DLockman%26aufirst%3DP.%2BR.%26aulast%3DMerkel%26aufirst%3DM.%26aulast%3DThompson%26aufirst%3DK.%2BH.%26aulast%3DOrvig%26aufirst%3DC.%26atitle%3DCombating%2520Alzheimer%25CA%25BCs%2520disease%2520with%2520multifunctional%2520molecules%2520designed%2520for%2520metal%2520passivation%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26spage%3D1716%26epage%3D1718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Storr, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merkel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song-Zhao, G. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowen, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, B. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schugar, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orvig, C.</span><span> </span><span class="NLM_article-title">Synthesis, Characterization, and Metal Coordinating Ability of Multifunctional Carbohydrate-Containing Compounds for Alzheimerʼs Therapy</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">7453</span><span class="NLM_x">–</span> <span class="NLM_lpage">7463</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja068965r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=7453-7463&author=T.+Storrauthor=M.+Merkelauthor=G.+X.+Song-Zhaoauthor=L.+E.+Scottauthor=D.+E.+Greenauthor=M.+L.+Bowenauthor=K.+H.+Thompsonauthor=B.+O.+Patrickauthor=H.+J.+Schugarauthor=C.+Orvig&title=Synthesis%2C+Characterization%2C+and+Metal+Coordinating+Ability+of+Multifunctional+Carbohydrate-Containing+Compounds+for+Alzheimer%CA%BCs+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fja068965r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja068965r%26sid%3Dliteratum%253Aachs%26aulast%3DStorr%26aufirst%3DT.%26aulast%3DMerkel%26aufirst%3DM.%26aulast%3DSong-Zhao%26aufirst%3DG.%2BX.%26aulast%3DScott%26aufirst%3DL.%2BE.%26aulast%3DGreen%26aufirst%3DD.%2BE.%26aulast%3DBowen%26aufirst%3DM.%2BL.%26aulast%3DThompson%26aufirst%3DK.%2BH.%26aulast%3DPatrick%26aufirst%3DB.%2BO.%26aulast%3DSchugar%26aufirst%3DH.%2BJ.%26aulast%3DOrvig%26aufirst%3DC.%26atitle%3DSynthesis%252C%2520Characterization%252C%2520and%2520Metal%2520Coordinating%2520Ability%2520of%2520Multifunctional%2520Carbohydrate-Containing%2520Compounds%2520for%2520Alzheimer%25CA%25BCs%2520Therapy%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D7453%26epage%3D7463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capsoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrisano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margotti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattaneo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">A Small Molecule Targeting the Multifactorial Nature of Alzheimerʼs Disease</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3689</span><span class="NLM_x">–</span> <span class="NLM_lpage">3692</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=3689-3692&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=S.+Capsoniauthor=V.+Andrisanoauthor=M.+Bartoliniauthor=E.+Margottiauthor=A.+Cattaneoauthor=M.+Recanatiniauthor=C.+Melchiorre&title=A+Small+Molecule+Targeting+the+Multifactorial+Nature+of+Alzheimer%CA%BCs+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DCapsoni%26aufirst%3DS.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMargotti%26aufirst%3DE.%26aulast%3DCattaneo%26aufirst%3DA.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DA%2520Small%2520Molecule%2520Targeting%2520the%2520Multifactorial%2520Nature%2520of%2520Alzheimer%25CA%25BCs%2520Disease%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26spage%3D3689%26epage%3D3692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Beal, M. F.</span><span> </span><span class="NLM_article-title">Mitochondrial dysfunction and oxidative damage in Alzheimerʼs and Parkinsonʼs diseases and coenzyme Q10 as a potential treatment</span> <span class="citation_source-journal">J. Bioenerg. Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2004&pages=381-386&author=M.+F.+Beal&title=Mitochondrial+dysfunction+and+oxidative+damage+in+Alzheimer%CA%BCs+and+Parkinson%CA%BCs+diseases+and+coenzyme+Q10+as+a+potential+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeal%26aufirst%3DM.%2BF.%26atitle%3DMitochondrial%2520dysfunction%2520and%2520oxidative%2520damage%2520in%2520Alzheimer%25CA%25BCs%2520and%2520Parkinson%25CA%25BCs%2520diseases%2520and%2520coenzyme%2520Q10%2520as%2520a%2520potential%2520treatment%26jtitle%3DJ.%2520Bioenerg.%2520Biomembr.%26date%3D2004%26volume%3D36%26spage%3D381%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Bragin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chemodanova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dzhafarova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bragin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czerniawski, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aliev, G.</span><span> </span><span class="NLM_article-title">Integrated treatment approach improves cognitive function in demented and clinically depressed patients</span> <span class="citation_source-journal">Am. J. Alzheimers Dis. Other Dementias</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1177%2F153331750502000103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15751450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADC%252BD2M7itV2ksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2005&pages=21-26&author=V.+Braginauthor=M.+Chemodanovaauthor=N.+Dzhafarovaauthor=I.+Braginauthor=J.+L.+Czerniawskiauthor=G.+Aliev&title=Integrated+treatment+approach+improves+cognitive+function+in+demented+and+clinically+depressed+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated treatment approach improves cognitive function in demented and clinically depressed patients</span></div><div class="casAuthors">Bragin Valentin; Chemodanova Marina; Dzhafarova Narmina; Bragin Ilya; Czerniawski Jennifer L; Aliev Gjumrakch</div><div class="citationInfo"><span class="NLM_cas:title">American journal of Alzheimer's disease and other dementias</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-6</span>
        ISSN:<span class="NLM_cas:issn">1533-3175</span>.
    </div><div class="casAbstract">The purpose of this study was to evaluate the efficacy of an integrative treatment approach on cognitive performance.  The study sample comprised 35 medically ill patients (20 male, 15 female) with an average age of 71.05, who were diagnosed with mild dementia and depression.  These patients were evaluated at baseline and at six, 12, and 24 months of treatment, which included antidepressants (sertraline, citalopram, or venlafaxine XR, alone or in combination with bupropion XR), cholinesterase inhibitors (donepezil, rivastigmine or galantamine), as well as vitamins and supplements (multivitamins, vitamin E, alpha-lipoic acid, omega-3 and coenzyme Q-10).  Patients were encouraged to modify their diet and lifestyle and perform mild physical exercises.  Results show that the integrative treatment not only protracted cognitive decline for 24 months but even improved cognition, especially memory and frontal lobe functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT0vW8RSBBoPWLFM_lbR1VmfW6udTcc2eYtkWwDzgN2a7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7itV2ksw%253D%253D&md5=7eee4011eb7bc5c7ae91312b1c0cd808</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1177%2F153331750502000103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F153331750502000103%26sid%3Dliteratum%253Aachs%26aulast%3DBragin%26aufirst%3DV.%26aulast%3DChemodanova%26aufirst%3DM.%26aulast%3DDzhafarova%26aufirst%3DN.%26aulast%3DBragin%26aufirst%3DI.%26aulast%3DCzerniawski%26aufirst%3DJ.%2BL.%26aulast%3DAliev%26aufirst%3DG.%26atitle%3DIntegrated%2520treatment%2520approach%2520improves%2520cognitive%2520function%2520in%2520demented%2520and%2520clinically%2520depressed%2520patients%26jtitle%3DAm.%2520J.%2520Alzheimers%2520Dis.%2520Other%2520Dementias%26date%3D2005%26volume%3D20%26spage%3D21%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Ono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naiki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, M.</span><span> </span><span class="NLM_article-title">Preformed beta-amyloid fibrils are destabilized by coenzyme Q10 in vitro</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2005&pages=111-116&author=K.+Onoauthor=K.+Hasegawaauthor=H.+Naikiauthor=M.+Yamada&title=Preformed+beta-amyloid+fibrils+are+destabilized+by+coenzyme+Q10+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOno%26aufirst%3DK.%26aulast%3DHasegawa%26aufirst%3DK.%26aulast%3DNaiki%26aufirst%3DH.%26aulast%3DYamada%26aufirst%3DM.%26atitle%3DPreformed%2520beta-amyloid%2520fibrils%2520are%2520destabilized%2520by%2520coenzyme%2520Q10%2520in%2520vitro%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D330%26spage%3D111%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Tomiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoji, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataoka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suwa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endo, N.</span><span> </span><span class="NLM_article-title">Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">6839</span><span class="NLM_x">–</span> <span class="NLM_lpage">6844</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=6839-6844&author=T.+Tomiyamaauthor=A.+Shojiauthor=K.+Kataokaauthor=Y.+Suwaauthor=S.+Asanoauthor=H.+Kanekoauthor=N.+Endo&title=Inhibition+of+amyloid+beta+protein+aggregation+and+neurotoxicity+by+rifampicin.+Its+possible+function+as+a+hydroxyl+radical+scavenger"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTomiyama%26aufirst%3DT.%26aulast%3DShoji%26aufirst%3DA.%26aulast%3DKataoka%26aufirst%3DK.%26aulast%3DSuwa%26aufirst%3DY.%26aulast%3DAsano%26aufirst%3DS.%26aulast%3DKaneko%26aufirst%3DH.%26aulast%3DEndo%26aufirst%3DN.%26atitle%3DInhibition%2520of%2520amyloid%2520beta%2520protein%2520aggregation%2520and%2520neurotoxicity%2520by%2520rifampicin.%2520Its%2520possible%2520function%2520as%2520a%2520hydroxyl%2520radical%2520scavenger%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D6839%26epage%3D6844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Nesterov, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skoch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacskai, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swager, T. M.</span><span> </span><span class="NLM_article-title">In vivo optical imaging of amyloid aggregates in brain: design of fluorescent markers</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">5452</span><span class="NLM_x">–</span> <span class="NLM_lpage">5456</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fanie.200500845" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16059955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvF2ksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=5452-5456&author=E.+E.+Nesterovauthor=J.+Skochauthor=B.+T.+Hymanauthor=W.+E.+Klunkauthor=B.+J.+Bacskaiauthor=T.+M.+Swager&title=In+vivo+optical+imaging+of+amyloid+aggregates+in+brain%3A+design+of+fluorescent+markers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo optical imaging of amyloid aggregates in brain: Design of fluorescent markers</span></div><div class="casAuthors">Nesterov, Evgueni E.; Skoch, Jesse; Hyman, Bradley T.; Klunk, William E.; Bacskai, Brian J.; Swager, Timothy M.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">5452-5456</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Routine diagnostics and studies of Alzheimer's disease might benefit form the noninvasive optical imaging of amyloid-β plaques in the brain.  A rational design strategy for in vivo amyloid-imaging agents that enter the brain and selectively stain amyloid plaques is presented (see picture), and properties of a promising lead biomarker candidate are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5E9TYWs6pyLVg90H21EOLACvtfcHk0ligmF5vEDUCjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvF2ksLs%253D&md5=784428c9422af2b31caf739625afc87a</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1002%2Fanie.200500845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200500845%26sid%3Dliteratum%253Aachs%26aulast%3DNesterov%26aufirst%3DE.%2BE.%26aulast%3DSkoch%26aufirst%3DJ.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DBacskai%26aufirst%3DB.%2BJ.%26aulast%3DSwager%26aufirst%3DT.%2BM.%26atitle%3DIn%2520vivo%2520optical%2520imaging%2520of%2520amyloid%2520aggregates%2520in%2520brain%253A%2520design%2520of%2520fluorescent%2520markers%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2005%26volume%3D44%26spage%3D5452%26epage%3D5456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Rice-Evans, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, N. J.</span><span> </span><span class="NLM_article-title">Total antioxidant status in plasma and body fluids</span> <span class="citation_source-journal">Methods Enzymol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">234</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=234&publication_year=1994&pages=279-293&author=C.+Rice-Evansauthor=N.+J.+Miller&title=Total+antioxidant+status+in+plasma+and+body+fluids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRice-Evans%26aufirst%3DC.%26aulast%3DMiller%26aufirst%3DN.%2BJ.%26atitle%3DTotal%2520antioxidant%2520status%2520in%2520plasma%2520and%2520body%2520fluids%26jtitle%3DMethods%2520Enzymol.%26date%3D1994%26volume%3D234%26spage%3D279%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Mordente, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martorana, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minotti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giardina, B.</span><span> </span><span class="NLM_article-title">Antioxidant properties of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone (idebenone)</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx970136j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1998&pages=54-63&author=A.+Mordenteauthor=G.+E.+Martoranaauthor=G.+Minottiauthor=B.+Giardina&title=Antioxidant+properties+of+2%2C3-dimethoxy-5-methyl-6-%2810-hydroxydecyl%29-1%2C4-benzoquinone+%28idebenone%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1021%2Ftx970136j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx970136j%26sid%3Dliteratum%253Aachs%26aulast%3DMordente%26aufirst%3DA.%26aulast%3DMartorana%26aufirst%3DG.%2BE.%26aulast%3DMinotti%26aufirst%3DG.%26aulast%3DGiardina%26aufirst%3DB.%26atitle%3DAntioxidant%2520properties%2520of%25202%252C3-dimethoxy-5-methyl-6-%252810-hydroxydecyl%2529-1%252C4-benzoquinone%2520%2528idebenone%2529%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D1998%26volume%3D11%26spage%3D54%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">SantaCruz, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yazlovitskaya, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCarli, C.</span><span> </span><span class="NLM_article-title">Regional NAD(P)H:quinone oxidoreductase activity in Alzheimerʼs disease</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2FS0197-4580%2803%2900117-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=14675732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVait7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=63-69&author=K.+S.+SantaCruzauthor=E.+Yazlovitskayaauthor=J.+Collinsauthor=J.+Johnsonauthor=C.+DeCarli&title=Regional+NAD%28P%29H%3Aquinone+oxidoreductase+activity+in+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Regional NAD(P)H:quinone oxidoreductase activity in Alzheimer's disease</span></div><div class="casAuthors">SantaCruz, Karen S.; Yazlovitskaya, Eugenia; Collins, Julie; Johnson, Jeff; DeCarli, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-69</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Converging evidence supports the role of oxidative stress in the pathol. of Alzheimer's disease (AD).  This notion is further supported by recent findings of increased NAD(P)H:quinone oxidoreductase (NQO1) activity, a potent antioxidant system, in assocn. with hippocampal AD pathol.  If increased NQO1 activity is truly related to the AD process, however, one would expect to see regional co-localization of NQO1 activity with AD pathol. throughout affected brain regions and the absence of NQO1 activity in regions unaffected by AD.  The authors examd. this hypothesis by measuring NQO1 enzymic activity and NQO1 immunohistochem. staining in regions commonly affected by the AD process such as frontal cortex and compared this to regions generally unaffected by the AD process such as occipital cortex, cerebellum, and substantia nigra for a group of AD patients and controls.  The ratio of frontal to cerebellar NQO1 enzymic activity was significantly increased in patients with AD (2.07±1.90) vs. controls (0.60±0.31; P<0.03).  Moreover, regional immunohistochem. staining revealed specific localization of NQO1 staining to astrocytes and neurites surrounding senile plaques.  The extent of immunohistochem. staining also closely correlated with the extent of local AD pathol. across the various brain regions examd.  Neuronal NQO1 staining seen in frontal cortex of AD patients was absent in frontal cortex of controls, but was found to the same extent in neurons of the substantia nigra of both AD patients and controls.  We conclude that NQO1 activity co-localizes closely with AD pathol. supporting a presumed role as an antioxidant system upregulated in response to the oxidative stress of the AD process.  The antioxidant role for NQO1 is further supported by finding increased neuronal NQO1 activity in substantia nigra neurons of both AD patients and controls as this neuronal population is known to be under const. oxidative stress.  While requiring further study, these findings, in conjunction with previous work, suggest that increased NQO1 activity may be neuroprotective, may offer novel insights into the pathophysiol. of AD and may also provide possible avenues for future treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2fZpmY5FUCrVg90H21EOLACvtfcHk0lj8j8JDqz0gKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVait7c%253D&md5=c003379838446fd2a51ab6d6364cf8c4</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2FS0197-4580%2803%2900117-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-4580%252803%252900117-9%26sid%3Dliteratum%253Aachs%26aulast%3DSantaCruz%26aufirst%3DK.%2BS.%26aulast%3DYazlovitskaya%26aufirst%3DE.%26aulast%3DCollins%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DDeCarli%26aufirst%3DC.%26atitle%3DRegional%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520activity%2520in%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2004%26volume%3D25%26spage%3D63%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santa-Cruz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCarli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J. A.</span><span> </span><span class="NLM_article-title">NAD(P)H:quinone oxidoreductase activity is increased in hippocampal pyramidal neurons of patients with Aalzheimerʼs disease</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2FS0197-4580%2800%2900114-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=10924765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltlersb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=525-531&author=Y.+Wangauthor=K.+Santa-Cruzauthor=C.+DeCarliauthor=J.+A.+Johnson&title=NAD%28P%29H%3Aquinone+oxidoreductase+activity+is+increased+in+hippocampal+pyramidal+neurons+of+patients+with+Aalzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">NAD(P)H:quinone oxidoreductase activity is increased in hippocampal pyramidal neurons of patients with Alzheimer's disease</span></div><div class="casAuthors">Wang, Y.; Santa-Cruz, K.; DeCarli, C.; Johnson, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">525-531</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">NAD(P)H:quinone oxidoreductase (QR) catalyzes the two-electron redn. of quinones, preventing their participation in redox cycling and subsequent generation of reactive oxygen species.  Pretreatment of neuroblastoma cells with compds., such as tert-butylhydroquinone and di-Me fumarate, that increase QR expression protect cells from oxidative stress-induced cell death by glutamate, H2O2, and dopamine.  The potential neuroprotective role of QR as well as the evidence for oxidative stress-induced neuronal cell death in Alzheimer's disease (AD) led us to examine the expression pattern of QR from AD and control patients.  Histochem. staining of hippocampal sections from AD patients revealed QR activity in pyramidal neurons.  The presence of QR protein in these neurons also was confirmed by immunoreactivity.  In control patients, hippocampal pyramidal neurons were neg. for both QR enzymic activity and QR immunoreactivity.  In addn., the QR pos. neurons of AD patients were selectively located in areas where neuronal populations exhibited tau immunostaining.  Our data demonstrate that QR is up-regulated in hippocampal pyramidal neurons of AD patients.  We hypothesize that this is part of a neuroprotective system up-regulated in response to the AD process.  Understanding this system may lead to further insights into the pathogenesis and potential new avenues of treatment for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoS_EfRfekd7Vg90H21EOLACvtfcHk0lgdV6Dt_e7tbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltlersb8%253D&md5=4b0eb4ff412fc157b063f094627ec126</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1016%2FS0197-4580%2800%2900114-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-4580%252800%252900114-7%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSanta-Cruz%26aufirst%3DK.%26aulast%3DDeCarli%26aufirst%3DC.%26aulast%3DJohnson%26aufirst%3DJ.%2BA.%26atitle%3DNAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520activity%2520is%2520increased%2520in%2520hippocampal%2520pyramidal%2520neurons%2520of%2520patients%2520with%2520Aalzheimer%25CA%25BCs%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2000%26volume%3D21%26spage%3D525%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Capsoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugolini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comparini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruberti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattaneo, A.</span><span> </span><span class="NLM_article-title">Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">6826</span><span class="NLM_x">–</span> <span class="NLM_lpage">6831</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=6826-6831&author=S.+Capsoniauthor=G.+Ugoliniauthor=A.+Compariniauthor=F.+Rubertiauthor=N.+Berardiauthor=A.+Cattaneo&title=Alzheimer-like+neurodegeneration+in+aged+antinerve+growth+factor+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCapsoni%26aufirst%3DS.%26aulast%3DUgolini%26aufirst%3DG.%26aulast%3DComparini%26aufirst%3DA.%26aulast%3DRuberti%26aufirst%3DF.%26aulast%3DBerardi%26aufirst%3DN.%26aulast%3DCattaneo%26aufirst%3DA.%26atitle%3DAlzheimer-like%2520neurodegeneration%2520in%2520aged%2520antinerve%2520growth%2520factor%2520transgenic%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D6826%26epage%3D6831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Capsoni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattaneo, A.</span><span> </span><span class="NLM_article-title">On the molecular basis linking nerve growth factor (NGF) to Alzheimerʼs disease</span> <span class="citation_source-journal">Cell. Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">619</span><span class="NLM_x">–</span> <span class="NLM_lpage">633</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1007%2Fs10571-006-9112-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16944323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtleksbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=619-633&author=S.+Capsoniauthor=A.+Cattaneo&title=On+the+molecular+basis+linking+nerve+growth+factor+%28NGF%29+to+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">On the Molecular Basis Linking Nerve Growth Factor (NGF) to Alzheimer's Disease</span></div><div class="casAuthors">Capsoni, Simona; Cattaneo, Antonino</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4-6</span>),
    <span class="NLM_cas:pages">619-633</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  1. Alzheimer's disease (AD) is pathol. defined by the deposition of amyloid peptide and neurofibrillary tangles and is characterized by a progressive loss of cognition and memory function, due to marked cortical cholinergic depletion. 2.  Cholinergic cortical innervation is provided by basal forebrain cholinergic neurons.  The neurotrophin Nerve Growth Factor (NGF) promotes survival and differentiation of basal forebrain cholinergic neurons. 3.  This assertion has been at the basis of the hypothesis developed in the last 20 years, whereby NGF deprivation would be one of the factor involved in the etiol. of sporadic forms of AD. 4.  In this review, we shall summarize data that lead to the prodn. and characterization of a mouse model for AD (AD11 anti-NGF mice), based on the expression of transgenic antibodies neutralizing NGF.  The AD-like phenotype of AD11 mice will be discussed on the basis of recent studies that have posed NGF and its precursor pro-NGF back to the stage of AD-like neurodegeneration, showing the involvement of the precursor pro-NGF in one of the cascades leading to AD neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1JwAZLpPpxbVg90H21EOLACvtfcHk0ljdQJFAq2pEPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtleksbrL&md5=50ed72a8c0dd983594959edee6e4d787</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1007%2Fs10571-006-9112-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10571-006-9112-2%26sid%3Dliteratum%253Aachs%26aulast%3DCapsoni%26aufirst%3DS.%26aulast%3DCattaneo%26aufirst%3DA.%26atitle%3DOn%2520the%2520molecular%2520basis%2520linking%2520nerve%2520growth%2520factor%2520%2528NGF%2529%2520to%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D2006%26volume%3D26%26spage%3D619%26epage%3D633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Wood-Kaczmar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, N. W.</span><span> </span><span class="NLM_article-title">Understanding the molecular causes of Parkinsonʼs disease</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">521</span><span class="NLM_x">–</span> <span class="NLM_lpage">528</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=521-528&author=A.+Wood-Kaczmarauthor=S.+Gandhiauthor=N.+W.+Wood&title=Understanding+the+molecular+causes+of+Parkinson%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood-Kaczmar%26aufirst%3DA.%26aulast%3DGandhi%26aufirst%3DS.%26aulast%3DWood%26aufirst%3DN.%2BW.%26atitle%3DUnderstanding%2520the%2520molecular%2520causes%2520of%2520Parkinson%25CA%25BCs%2520disease%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D521%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span> </span><span class="NLM_article-title">Mechanisms of Parkinsonʼs disease linked to pathological alpha-synuclein: new targets for drug discovery</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2006&pages=33-38&author=V.+M.+Leeauthor=J.+Q.+Trojanowski&title=Mechanisms+of+Parkinson%CA%BCs+disease+linked+to+pathological+alpha-synuclein%3A+new+targets+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DMechanisms%2520of%2520Parkinson%25CA%25BCs%2520disease%2520linked%2520to%2520pathological%2520alpha-synuclein%253A%2520new%2520targets%2520for%2520drug%2520discovery%26jtitle%3DNeuron%26date%3D2006%26volume%3D52%26spage%3D33%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Volles, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rochet, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shtilerman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansbury, P. T.,  Jr.</span><span> </span><span class="NLM_article-title">Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinsonʼs disease</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">7812</span><span class="NLM_x">–</span> <span class="NLM_lpage">7819</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi0102398" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=7812-7819&author=M.+J.+Vollesauthor=S.+J.+Leeauthor=J.+C.+Rochetauthor=M.+D.+Shtilermanauthor=T.+T.+Dingauthor=J.+C.+Kesslerauthor=P.+T.+Lansbury&title=Vesicle+permeabilization+by+protofibrillar+alpha-synuclein%3A+implications+for+the+pathogenesis+and+treatment+of+Parkinson%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1021%2Fbi0102398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0102398%26sid%3Dliteratum%253Aachs%26aulast%3DVolles%26aufirst%3DM.%2BJ.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DRochet%26aufirst%3DJ.%2BC.%26aulast%3DShtilerman%26aufirst%3DM.%2BD.%26aulast%3DDing%26aufirst%3DT.%2BT.%26aulast%3DKessler%26aufirst%3DJ.%2BC.%26aulast%3DLansbury%26aufirst%3DP.%2BT.%26atitle%3DVesicle%2520permeabilization%2520by%2520protofibrillar%2520alpha-synuclein%253A%2520implications%2520for%2520the%2520pathogenesis%2520and%2520treatment%2520of%2520Parkinson%25CA%25BCs%2520disease%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D7812%26epage%3D7819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Bilen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonini, N. M.</span><span> </span><span class="NLM_article-title">Drosophila as a model for human neurodegenerative disease</span> <span class="citation_source-journal">Annu. Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2005&pages=153-171&author=J.+Bilenauthor=N.+M.+Bonini&title=Drosophila+as+a+model+for+human+neurodegenerative+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBilen%26aufirst%3DJ.%26aulast%3DBonini%26aufirst%3DN.%2BM.%26atitle%3DDrosophila%2520as%2520a%2520model%2520for%2520human%2520neurodegenerative%2520disease%26jtitle%3DAnnu.%2520Rev.%2520Genet.%26date%3D2005%26volume%3D39%26spage%3D153%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Cuervo, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefanis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredenburg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansbury, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulzer, D.</span><span> </span><span class="NLM_article-title">Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">1292</span><span class="NLM_x">–</span> <span class="NLM_lpage">1295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1126%2Fscience.1101738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15333840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvFCit7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=1292-1295&author=A.+M.+Cuervoauthor=L.+Stefanisauthor=R.+Fredenburgauthor=P.+T.+Lansburyauthor=D.+Sulzer&title=Impaired+degradation+of+mutant+alpha-synuclein+by+chaperone-mediated+autophagy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy</span></div><div class="casAuthors">Cuervo, Ana Maria; Stefanis, Leonidas; Fredenburg, Ross; Lansbury, Peter T.; Sulzer, David</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">305</span>
        (<span class="NLM_cas:issue">5688</span>),
    <span class="NLM_cas:pages">1292-1295</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Aberrant α-synuclein degrdn. is implicated in Parkinson's disease pathogenesis because the protein accumulates in the Lewy inclusion bodies assocd. with the disease.  Little is known, however, about the pathways by which wild-type α-synuclein is normally degraded.  We found that wild-type α-synuclein was selectively translocated into lysosomes for degrdn. by the chaperone-mediated autophagy pathway.  The pathogenic A53T and A30P α-synuclein mutants bound to the receptor for this pathway on the lysosomal membrane, but appeared to act as uptake blockers, inhibiting both their own degrdn. and that of other substrates.  These findings may underlie the toxic gain-of-function by the mutants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCVMt6d-3aVbVg90H21EOLACvtfcHk0ljxUBi98d5kSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvFCit7w%253D&md5=9185e1003c9cdd1a63c4ca45e4671614</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1126%2Fscience.1101738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1101738%26sid%3Dliteratum%253Aachs%26aulast%3DCuervo%26aufirst%3DA.%2BM.%26aulast%3DStefanis%26aufirst%3DL.%26aulast%3DFredenburg%26aufirst%3DR.%26aulast%3DLansbury%26aufirst%3DP.%2BT.%26aulast%3DSulzer%26aufirst%3DD.%26atitle%3DImpaired%2520degradation%2520of%2520mutant%2520alpha-synuclein%2520by%2520chaperone-mediated%2520autophagy%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D1292%26epage%3D1295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Okochi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahle, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Constitutive phosphorylation of the Parkinsonʼs disease associated alpha-synuclein</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">390</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=390-397&author=M.+Okochiauthor=J.+Walterauthor=A.+Koyamaauthor=S.+Nakajoauthor=M.+Babaauthor=T.+Iwatsuboauthor=L.+Meijerauthor=P.+J.+Kahleauthor=C.+Haass&title=Constitutive+phosphorylation+of+the+Parkinson%CA%BCs+disease+associated+alpha-synuclein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkochi%26aufirst%3DM.%26aulast%3DWalter%26aufirst%3DJ.%26aulast%3DKoyama%26aufirst%3DA.%26aulast%3DNakajo%26aufirst%3DS.%26aulast%3DBaba%26aufirst%3DM.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DKahle%26aufirst%3DP.%2BJ.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DConstitutive%2520phosphorylation%2520of%2520the%2520Parkinson%25CA%25BCs%2520disease%2520associated%2520alpha-synuclein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D390%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Taylor, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mata, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, M. J.</span><span> </span><span class="NLM_article-title">LRRK2: a common pathway for parkinsonism, pathogenesis and prevention</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">76</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=76-82&author=J.+P.+Taylorauthor=I.+F.+Mataauthor=M.+J.+Farrer&title=LRRK2%3A+a+common+pathway+for+parkinsonism%2C+pathogenesis+and+prevention"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DJ.%2BP.%26aulast%3DMata%26aufirst%3DI.%2BF.%26aulast%3DFarrer%26aufirst%3DM.%2BJ.%26atitle%3DLRRK2%253A%2520a%2520common%2520pathway%2520for%2520parkinsonism%252C%2520pathogenesis%2520and%2520prevention%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2006%26volume%3D12%26spage%3D76%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Savitt, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span> </span><span class="NLM_article-title">Diagnosis and treatment of Parkinson disease: molecules to medicine</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">1744</span><span class="NLM_x">–</span> <span class="NLM_lpage">1754</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2006&pages=1744-1754&author=J.+M.+Savittauthor=V.+L.+Dawsonauthor=T.+M.+Dawson&title=Diagnosis+and+treatment+of+Parkinson+disease%3A+molecules+to+medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSavitt%26aufirst%3DJ.%2BM.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26atitle%3DDiagnosis%2520and%2520treatment%2520of%2520Parkinson%2520disease%253A%2520molecules%2520to%2520medicine%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2006%26volume%3D116%26spage%3D1744%26epage%3D1754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Zecca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connor, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crichton, R. R.</span><span> </span><span class="NLM_article-title">Iron, brain ageing and neurodegenerative disorders</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">863</span><span class="NLM_x">–</span> <span class="NLM_lpage">873</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnrn1537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15496864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXos1Ojtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=863-873&author=L.+Zeccaauthor=M.+B.+Youdimauthor=P.+Riedererauthor=J.+R.+Connorauthor=R.+R.+Crichton&title=Iron%2C+brain+ageing+and+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Iron, brain aging and neurodegenerative disorders</span></div><div class="casAuthors">Zecca, Luigi; Youdim, Moussa B. H.; Riederer, Peter; Connor, James R.; Crichton, Robert R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">863-873</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is increasing evidence that iron is involved in the mechanisms that underlie many neurodegenerative diseases.  Conditions such as neuro-ferritinopathy and Friedreich ataxia are assocd. with mutations in genes that encode proteins that are involved in iron metab., and as the brain ages, iron accumulates in regions that are affected by Alzheimer's disease and Parkinson's disease.  High concns. of reactive iron can increase oxidative-stress induced neuronal vulnerability, and iron accumulation might increase the toxicity of environmental or endogenous toxins.  By studying the accumulation and cellular distribution of iron during aging, we should be able to increase our understanding of these neurodegenerative disorders and develop new therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNNc8epL4ObbVg90H21EOLACvtfcHk0ljFfGj2P9nMEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXos1Ojtrc%253D&md5=e4d3e1b563faffd919138ab1abc0e5b6</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1038%2Fnrn1537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1537%26sid%3Dliteratum%253Aachs%26aulast%3DZecca%26aufirst%3DL.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DConnor%26aufirst%3DJ.%2BR.%26aulast%3DCrichton%26aufirst%3DR.%2BR.%26atitle%3DIron%252C%2520brain%2520ageing%2520and%2520neurodegenerative%2520disorders%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2004%26volume%3D5%26spage%3D863%26epage%3D873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Shachar, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahana, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kampel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warshawsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2004&pages=254-263&author=D.+B.+Shacharauthor=N.+Kahanaauthor=V.+Kampelauthor=A.+Warshawskyauthor=M.+B.+Youdim&title=Neuroprotection+by+a+novel+brain+permeable+iron+chelator%2C+VK-28%2C+against+6-hydroxydopamine+lession+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShachar%26aufirst%3DD.%2BB.%26aulast%3DKahana%26aufirst%3DN.%26aulast%3DKampel%26aufirst%3DV.%26aulast%3DWarshawsky%26aufirst%3DA.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DNeuroprotection%2520by%2520a%2520novel%2520brain%2520permeable%2520iron%2520chelator%252C%2520VK-28%252C%2520against%25206-hydroxydopamine%2520lession%2520in%2520rats%26jtitle%3DNeuropharmacology%26date%3D2004%26volume%3D46%26spage%3D254%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Fernandez, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. J.</span><span> </span><span class="NLM_article-title">Monamine oxidase inhibitors: current and emerging agents for Parkinson disease</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=150-168&author=H.+H.+Fernandezauthor=J.+J.+Chen&title=Monamine+oxidase+inhibitors%3A+current+and+emerging+agents+for+Parkinson+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez%26aufirst%3DH.%2BH.%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26atitle%3DMonamine%2520oxidase%2520inhibitors%253A%2520current%2520and%2520emerging%2520agents%2520for%2520Parkinson%2520disease%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2007%26volume%3D30%26spage%3D150%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Singh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillay, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choonara, Y. E.</span><span> </span><span class="NLM_article-title">Advances in the treatment of Parkinsonʼs disease</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.pneurobio.2006.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17258379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitFOrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2007&pages=29-44&author=N.+Singhauthor=V.+Pillayauthor=Y.+E.+Choonara&title=Advances+in+the+treatment+of+Parkinson%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the treatment of Parkinson's disease</span></div><div class="casAuthors">Singh, Neha; Pillay, Viness; Choonara, Yahya E.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-44</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Parkinson's disease (PD) affects one in every 100 persons above the age of 65 years, making it the second most common neurodegenerative disease after Alzheimer's disease.  PD is a disease of the central nervous system that leads to severe difficulties with body motions.  The currently available therapies aim to improve the functional capacity of the patient for as long as possible; however they do not modify the progression of the neurodegenerative process.  The need for newer and more effective agents is consequently receiving a great deal of attention and consequently being subjected to extensive research.  This review concisely compiles the limitations of currently available therapies and the most recent research regarding neuroprotective agents, antioxidants, stem cell research, vaccines and various surgical techniques available and being developed for the management of PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopehFcHUWiALVg90H21EOLACvtfcHk0lj-5fH8yc9hHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitFOrsLg%253D&md5=bfb1aa5f822c802507c43fa1156be14b</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2006.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2006.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DN.%26aulast%3DPillay%26aufirst%3DV.%26aulast%3DChoonara%26aufirst%3DY.%2BE.%26atitle%3DAdvances%2520in%2520the%2520treatment%2520of%2520Parkinson%25CA%25BCs%2520disease%26jtitle%3DProg.%2520Neurobiol.%26date%3D2007%26volume%3D81%26spage%3D29%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Schrag, A.</span><span> </span><span class="NLM_article-title">Entacapone in the treatment of Parkinsonʼs disease</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2FS1474-4422%2805%2970098-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15907741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXls1eis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=366-370&author=A.+Schrag&title=Entacapone+in+the+treatment+of+Parkinson%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Entacapone in the treatment of Parkinson's disease</span></div><div class="casAuthors">Schrag, Anette</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">366-370</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Lancet Neurology</span>)
        </div><div class="casAbstract">A review.  Background: The development of fluctuations in motor response and involuntary movements commonly complicate the treatment of Parkinson's disease (PD).  Catechol-O-methyltransferase (COMT) inhibitors delay the breakdown of levodopa, which leads to an increase in levodopa bioavailability and more stable concns. of plasma levodopa.  The addn. of a COMT inhibitor therefore combines the rapid onset of levodopa with prolonged efficacy, and theor. provides a more continuous stimulation of dopamine receptors with reduced risk of motor complications.  Randomised, controlled trials have shown that in patients with PD who have motor fluctuations, the addn. of the COMT-inhibitor entacapone results in an improvement in motor fluctuations, particularly of the "wearing-off" type, with about 1.0-1.7 h more on-time and less off-time per day, reduced required levodopa dose, modest improvement in motor and disability scores (mean total unified PD rating scale [UPDRS] scores of about 4.5), and in some but not all studies improvement of health-related quality of life [HRQOL] scores.  Recent developments: Patients with stable PD, without motor fluctuations, also have improved HRQOL scores on treatment with entacapone in addn. to levodopa with a dopa-decarboxylase inhibitor.  However, in a recent large multicenter study, UPDRS motor and disability scores were not improved despite significant improvements in HRQOL scores.  The disparity between results on clin. rating scales and HRQOL scores suggests that these scales give different and potentially complementary information on health status changes in PD, and that entacapone provides benefit that may not be captured with std. clin. rating scales.  Whether entacapone combined with levodopa can delay dyskinesia or motor fluctuations in patients with untreated PD is unknown; however, in animal studies, a decrease in motor complications has been reported in drug-naive animals given frequent doses of levodopa combined with entacapone.  Where next: Clin. studies are underway to address the hypothesis that motor complications in PD can be delayed if entacapone is given from the start of treatment.  Until the results of these trials are available, entacapone is indicated as a useful adjunct to levodopa in the symptomatic treatment of patients with PD with and without motor fluctuations.  In addn., future trials should specifically assess the effect of entacapone on HRQOL in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR3O2q8wka4LVg90H21EOLACvtfcHk0lh9PfQZ0__l7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXls1eis7c%253D&md5=f12147171ff96ab71f05c02e4ca83ace</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2805%2970098-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252805%252970098-3%26sid%3Dliteratum%253Aachs%26aulast%3DSchrag%26aufirst%3DA.%26atitle%3DEntacapone%2520in%2520the%2520treatment%2520of%2520Parkinson%25CA%25BCs%2520disease%26jtitle%3DLancet%2520Neurol.%26date%3D2005%26volume%3D4%26spage%3D366%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Schapira, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collingridge, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hengerer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Novere, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obeso, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spampinato, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidai, G.</span><span> </span><span class="NLM_article-title">Novel pharmacological targets for the treatment of Parkinsonʼs disease</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">845</span><span class="NLM_x">–</span> <span class="NLM_lpage">854</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=845-854&author=A.+H.+Schapiraauthor=E.+Bezardauthor=J.+Brotchieauthor=F.+Calonauthor=G.+L.+Collingridgeauthor=B.+Fergerauthor=B.+Hengererauthor=E.+Hirschauthor=P.+Jennerauthor=N.+Le+Novereauthor=J.+A.+Obesoauthor=M.+A.+Schwarzschildauthor=U.+Spampinatoauthor=G.+Davidai&title=Novel+pharmacological+targets+for+the+treatment+of+Parkinson%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchapira%26aufirst%3DA.%2BH.%26aulast%3DBezard%26aufirst%3DE.%26aulast%3DBrotchie%26aufirst%3DJ.%26aulast%3DCalon%26aufirst%3DF.%26aulast%3DCollingridge%26aufirst%3DG.%2BL.%26aulast%3DFerger%26aufirst%3DB.%26aulast%3DHengerer%26aufirst%3DB.%26aulast%3DHirsch%26aufirst%3DE.%26aulast%3DJenner%26aufirst%3DP.%26aulast%3DLe%2BNovere%26aufirst%3DN.%26aulast%3DObeso%26aufirst%3DJ.%2BA.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26aulast%3DSpampinato%26aufirst%3DU.%26aulast%3DDavidai%26aufirst%3DG.%26atitle%3DNovel%2520pharmacological%2520targets%2520for%2520the%2520treatment%2520of%2520Parkinson%25CA%25BCs%2520disease%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D845%26epage%3D854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Mandel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives</span> <span class="citation_source-journal">Brain Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.brainresrev.2004.12.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15850677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjs1Clsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=379-387&author=S.+Mandelauthor=O.+Weinrebauthor=T.+Amitauthor=M.+B.+Youdim&title=Mechanism+of+neuroprotective+action+of+the+anti-Parkinson+drug+rasagiline+and+its+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives</span></div><div class="casAuthors">Mandel, Silvia; Weinreb, Orly; Amit, Tamar; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Reviews</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">379-387</span>CODEN:
                <span class="NLM_cas:coden">BRERD2</span>;
        ISSN:<span class="NLM_cas:issn">0165-0173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The mitochondria are directly involved in cell survival and death.  Drugs that protect mitochondria viability and prevent apoptotic cascade mechanisms involved in mitochondrial permeability transition pore (MPTp) will be cytoprotective.  Rasagiline (N-propargyl-1R-aminoindan) is a novel, highly potent irreversible monoamine oxidase (MAO) B inhibitor, anti-Parkinson drug.  Unlike selegiline, rasagiline is not derived from amphetamine, is not metabolized to neurotoxic l-methamphetamine deriv., nor does it have sympathomimetic activity.  Rasagiline is effective as monotherapy or adjunct to L-dopa for patients with early and late Parkinson's disease (PD), and adverse events do not occur with greater frequency in subjects receiving rasagiline than those on placebo.  Controlled studies indicate that it might have a disease-modifying effect in PD that may be related to neuroprotection.  Its S-isomer, TVP1022, is a relatively inactive MAO inhibitor.  However, both drugs have similar neuroprotective activities in neuronal cell cultures in response to various neurotoxins and in vivo (global ischemia, neurotrauma, head injury, anoxia, etc.), indicating that MAO inhibition is not a pre-requisite for neuroprotection.  Structure activity studies have shown that the neuroprotective activity is assocd. with the propargyl moiety of rasagiline which protects mitochondrial viability and MPTp by activating Bcl-2 and protein kinase C (PKC), and down regulating pro-apoptotic FAS and Bax.  Rasagiline and its derivs. also process amyloid precursor protein (APP) to the neuroprotective-neurotrophic sol. APP alpha (sAPPα) by PKC and MAP kinase-dependent activation of α-secretase.  The neuroprotective activity of propargylamine has led us to develop novel bifunctional neuroprotective iron-chelating MAO-inhibiting drugs possessing propargyl moiety for the treatment of other neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqo-jzsUjjFfbVg90H21EOLACvtfcHk0lgRTro_faOB9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjs1Clsr0%253D&md5=7defa497360ae91d0d8bea6f1e1ee6b0</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresrev.2004.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresrev.2004.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DMandel%26aufirst%3DS.%26aulast%3DWeinreb%26aufirst%3DO.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DMechanism%2520of%2520neuroprotective%2520action%2520of%2520the%2520anti-Parkinson%2520drug%2520rasagiline%2520and%2520its%2520derivatives%26jtitle%3DBrain%2520Res.%2520Rev.%26date%3D2005%26volume%3D48%26spage%3D379%26epage%3D387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falach-Yogev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Am, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naoi, M.</span><span> </span><span class="NLM_article-title">The essentiality of Bcl-2, PKC and proteasome−ubiquitin complex activations in the neuroprotective−antiapoptotic action of the anti-Parkinson drug, rasagiline</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1635</span><span class="NLM_x">–</span> <span class="NLM_lpage">1641</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2003&pages=1635-1641&author=M.+B.+Youdimauthor=T.+Amitauthor=M.+Falach-Yogevauthor=O.+B.+Amauthor=W.+Maruyamaauthor=M.+Naoi&title=The+essentiality+of+Bcl-2%2C+PKC+and+proteasome%E2%88%92ubiquitin+complex+activations+in+the+neuroprotective%E2%88%92antiapoptotic+action+of+the+anti-Parkinson+drug%2C+rasagiline"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DFalach-Yogev%26aufirst%3DM.%26aulast%3DAm%26aufirst%3DO.%2BB.%26aulast%3DMaruyama%26aufirst%3DW.%26aulast%3DNaoi%26aufirst%3DM.%26atitle%3DThe%2520essentiality%2520of%2520Bcl-2%252C%2520PKC%2520and%2520proteasome%25E2%2588%2592ubiquitin%2520complex%2520activations%2520in%2520the%2520neuroprotective%25E2%2588%2592antiapoptotic%2520action%2520of%2520the%2520anti-Parkinson%2520drug%252C%2520rasagiline%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2003%26volume%3D66%26spage%3D1635%26epage%3D1641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Yogev-Falach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Am, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">The importance of propargylamine moiety in the anti-Parkinson drug rasagiline and its derivatives in MAPK-dependent amyloid precursor protein processing</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2325</span><span class="NLM_x">–</span> <span class="NLM_lpage">2327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=2325-2327&author=M.+Yogev-Falachauthor=T.+Amitauthor=O.+Bar-Amauthor=M.+B.+Youdim&title=The+importance+of+propargylamine+moiety+in+the+anti-Parkinson+drug+rasagiline+and+its+derivatives+in+MAPK-dependent+amyloid+precursor+protein+processing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYogev-Falach%26aufirst%3DM.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DBar-Am%26aufirst%3DO.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DThe%2520importance%2520of%2520propargylamine%2520moiety%2520in%2520the%2520anti-Parkinson%2520drug%2520rasagiline%2520and%2520its%2520derivatives%2520in%2520MAPK-dependent%2520amyloid%2520precursor%2520protein%2520processing%26jtitle%3DFASEB%2520J.%26date%3D2003%26volume%3D17%26spage%3D2325%26epage%3D2327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Am, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Contrasting neuroprotective and neurotoxic actions of respective metabolites of anti-Parkinson drugs rasagiline and selegiline</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2004&pages=169-172&author=O.+B.+Amauthor=T.+Amitauthor=M.+B.+Youdim&title=Contrasting+neuroprotective+and+neurotoxic+actions+of+respective+metabolites+of+anti-Parkinson+drugs+rasagiline+and+selegiline"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAm%26aufirst%3DO.%2BB.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DContrasting%2520neuroprotective%2520and%2520neurotoxic%2520actions%2520of%2520respective%2520metabolites%2520of%2520anti-Parkinson%2520drugs%2520rasagiline%2520and%2520selegiline%26jtitle%3DNeurosci.%2520Lett.%26date%3D2004%26volume%3D355%26spage%3D169%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Maruyama, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naoi, M.</span><span> </span><span class="NLM_article-title">Neurotoxins induce apoptosis in dopamine neurons: protection by <i>N</i>-propargylamine-1(<i>R</i>)- and (<i>S</i>)-aminoindan, rasagiline and TV1022</span> <span class="citation_source-journal">J. Neural Transm., Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=11205138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADC%252BD3M3gt1Ojuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=171-186&author=W.+Maruyamaauthor=Y.+Akaoauthor=M.+B.+Youdimauthor=M.+Naoi&title=Neurotoxins+induce+apoptosis+in+dopamine+neurons%3A+protection+by+N-propargylamine-1%28R%29-+and+%28S%29-aminoindan%2C+rasagiline+and+TV1022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotoxins induce apoptosis in dopamine neurons: protection by N-propargylamine-1(R)- and (S)-aminoindan, rasagiline and TV1022</span></div><div class="casAuthors">Maruyama W; Akao Y; Youdim M B; Naoi M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neural transmission. Supplementum</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">60</span>),
    <span class="NLM_cas:pages">171-86</span>
        ISSN:<span class="NLM_cas:issn">0303-6995</span>.
    </div><div class="casAbstract">In Parkinson's disease, apoptosis was proposed to cause cell death in nigral dopamine neurons.  An endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, stereo-selectively induced apoptosis in human neuroblastoma SH-SY5Y cells.  In this paper the intracellular mechanism of apoptosis was studied using N-methyl(R)salsolinol, 6-hydroxydopamine and peroxynitrite as inducers of apoptosis.  Apoptotic cascade was initiated by opening of mitochondrial permeability transition pore, as shown by collapse of mitochondrial membrane potential, deltapsim.  Apoptosis was executed by caspase 3 activation, followed by DNA fragmentation, which was antagonized by overexpressed Bcl-2.  Propargylamines were found to protect the cells from apoptosis, and rasagiline, a selective irreversible inhibitor of type B monoamine oxidase was the most potent to prevent the cell death.  Rasagiline preserved deltapsim, which was proved also in isolated mitochondria, and rasagiline completely suppressed the activation of caspases and DNA fragmentation.  These results suggest that mitochondria regulate apoptotic process, which may be a target of neuroprotection by rasagiline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRj2Aw68nvLXdTiMd2aNQVUfW6udTcc2eZY_9am1aFgGbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M3gt1Ojuw%253D%253D&md5=92ae001e5921b0d176173c04faf53c88</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaruyama%26aufirst%3DW.%26aulast%3DAkao%26aufirst%3DY.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DNaoi%26aufirst%3DM.%26atitle%3DNeurotoxins%2520induce%2520apoptosis%2520in%2520dopamine%2520neurons%253A%2520protection%2520by%2520N-propargylamine-1%2528R%2529-%2520and%2520%2528S%2529-aminoindan%252C%2520rasagiline%2520and%2520TV1022%26jtitle%3DJ.%2520Neural%2520Transm.%252C%2520Suppl.%26date%3D2000%26spage%3D171%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Petty, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elands, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linnik, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moskowitz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarty, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, B. M.</span><span> </span><span class="NLM_article-title">The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraine</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2FS0014-2999%2897%2901218-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=9384224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaK2sXmsVKmur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=1997&pages=127-136&author=M.+A.+Pettyauthor=J.+Elandsauthor=M.+P.+Johnsonauthor=M.+D.+Linnikauthor=E.+Hamelauthor=M.+A.+Moskowitzauthor=W.+S.+Leeauthor=D.+R.+McCartyauthor=M.+Hibertauthor=B.+M.+Baron&title=The+selectivity+of+MDL+74%2C721+in+models+of+neurogenic+versus+vascular+components+of+migraine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraine</span></div><div class="casAuthors">Petty, Margaret A.; Elands, Jack; Johnson, Michael P.; Linnik, Matthew D.; Hamel, Edith; Moskowitz, Michael A.; Lee, Won Suk; McCarty, Deborah R.; Hibert, Marcel; Baron, Bruce M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">127-136</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">MDL 74,721 (R)-2-(N1,N1-dipropylamino)-8-methylaminosulfonylmethyl-1,2,3,4-tetrahydronaphthalene, a sulfonamidotetralin, has been found to exhibit a 10000-fold greater potency in neurogenic vs. vascular models of migraine.  Sumatriptan, a relatively pure 5-HT1D/5-HT1B receptor agonist, also showed higher potency vs. neurogenic inflammation.  However, for sumatriptan, the potency difference (100-fold) in the two pathophysiol. models was less pronounced than seen for MDL 74,721.  The affinity profile of MDL 74,721 at 5-HT1 receptor subtypes may in part explain its ability to differentiate these two physiol. responses.  MDL 74,721 demonstrated nanomolar affinity for 5-HT1A (12.7 nM) and 5-HT1D (41.3 nM) but considerably lower affinity for 5-HT1B receptors (>1000 nM).  Serotonin-like activity was seen in in vitro functional assays including inhibition of forskolin-stimulated cAMP accumulation in human 5-HT1D receptor-transfected fibroblasts or eliciting vasoconstriction in isolated human pial arteries.  The intrinsic activity (relative to 5-HTEAmax) and affinity (pD2) for the human cerebrovascular 5-HT receptors were: 5-HT (100%, 7.51), sumatriptan (94%, 6.85) and MDL 74,721 (66%, 5.70).  In anesthetized cats, treatment with MDL 74,721 resulted in a dose-related redn. in the percentage of carotid flow going through the arteriovenous anastomoses to the lungs, with an ED50 of 0.3 mg/kg i.v., the same as sumatriptan.  However, in the guinea-pig neurogenic model, MDL 74,721 inhibited plasma protein extravasation with an ED50 of 0.023 μg/kg compared to 2.5 μg/kg for sumatriptan.  MDL 74,721 was also effective in this model (in rats) after oral administration.  In conclusion, MDL 74,721 demonstrates a preclin. profile consistent with anti-migraine efficacy.  Its marked preference for inhibiting neurogenic inflammation makes this compd. a useful tool for assessing the relative contribution of this pathophysiol. mechanism to the human disease state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0OvQvGRQarLVg90H21EOLACvtfcHk0lgab9Ygl-URSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmsVKmur8%253D&md5=04ef49479225cf0dea8a4b8e14fbcc35</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2897%2901218-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252897%252901218-1%26sid%3Dliteratum%253Aachs%26aulast%3DPetty%26aufirst%3DM.%2BA.%26aulast%3DElands%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DM.%2BP.%26aulast%3DLinnik%26aufirst%3DM.%2BD.%26aulast%3DHamel%26aufirst%3DE.%26aulast%3DMoskowitz%26aufirst%3DM.%2BA.%26aulast%3DLee%26aufirst%3DW.%2BS.%26aulast%3DMcCarty%26aufirst%3DD.%2BR.%26aulast%3DHibert%26aufirst%3DM.%26aulast%3DBaron%26aufirst%3DB.%2BM.%26atitle%3DThe%2520selectivity%2520of%2520MDL%252074%252C721%2520in%2520models%2520of%2520neurogenic%2520versus%2520vascular%2520components%2520of%2520migraine%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D336%26spage%3D127%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatton, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstock, M.</span><span> </span><span class="NLM_article-title">The anti-Parkinson drug rasagiline and its cholinesterase inhibitor derivatives exert neuroprotection unrelated to MAO inhibition in cell culture and in vivo</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">939</span><span class="NLM_x">, </span> <span class="NLM_fpage">450</span><span class="NLM_x">–</span> <span class="NLM_lpage">458</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=939&publication_year=2001&pages=450-458&author=M.+B.+Youdimauthor=A.+Wadiaauthor=W.+Tattonauthor=M.+Weinstock&title=The+anti-Parkinson+drug+rasagiline+and+its+cholinesterase+inhibitor+derivatives+exert+neuroprotection+unrelated+to+MAO+inhibition+in+cell+culture+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DWadia%26aufirst%3DA.%26aulast%3DTatton%26aufirst%3DW.%26aulast%3DWeinstock%26aufirst%3DM.%26atitle%3DThe%2520anti-Parkinson%2520drug%2520rasagiline%2520and%2520its%2520cholinesterase%2520inhibitor%2520derivatives%2520exert%2520neuroprotection%2520unrelated%2520to%2520MAO%2520inhibition%2520in%2520cell%2520culture%2520and%2520in%2520vivo%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2001%26volume%3D939%26spage%3D450%26epage%3D458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">Maruyama, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naoi, M.</span><span> </span><span class="NLM_article-title">Anti-apoptotic action of anti-Alzheimer drug, TV3326 [(<i>N</i>-propargyl)-(3<i>R</i>)-aminoindan-5-yl]-ethyl methyl carbamate, a novel cholinesterase-monoamine oxidase inhibitor</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2003&pages=233-236&author=W.+Maruyamaauthor=M.+Weinstockauthor=M.+B.+Youdimauthor=M.+Nagaiauthor=M.+Naoi&title=Anti-apoptotic+action+of+anti-Alzheimer+drug%2C+TV3326+%5B%28N-propargyl%29-%283R%29-aminoindan-5-yl%5D-ethyl+methyl+carbamate%2C+a+novel+cholinesterase-monoamine+oxidase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaruyama%26aufirst%3DW.%26aulast%3DWeinstock%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DNagai%26aufirst%3DM.%26aulast%3DNaoi%26aufirst%3DM.%26atitle%3DAnti-apoptotic%2520action%2520of%2520anti-Alzheimer%2520drug%252C%2520TV3326%2520%255B%2528N-propargyl%2529-%25283R%2529-aminoindan-5-yl%255D-ethyl%2520methyl%2520carbamate%252C%2520a%2520novel%2520cholinesterase-monoamine%2520oxidase%2520inhibitor%26jtitle%3DNeurosci.%2520Lett.%26date%3D2003%26volume%3D341%26spage%3D233%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">Roach, E. S.</span><span> </span><span class="NLM_article-title">Initial Parkinson disease therapy: levodopa, dopamine agonists, or both</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1972</span><span class="NLM_x">–</span> <span class="NLM_lpage">1973</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1001%2Farchneur.61.12.1972" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15596625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADC%252BD2cnitVyntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2004&pages=1972-1973&author=E.+S.+Roach&title=Initial+Parkinson+disease+therapy%3A+levodopa%2C+dopamine+agonists%2C+or+both"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Initial Parkinson disease therapy: levodopa, dopamine agonists, or both?</span></div><div class="casAuthors">Roach E S</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1972-3</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSDMltEW9VQzPxQvRxYU81tfW6udTcc2eaw9N-4FQEaL7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cnitVyntw%253D%253D&md5=ee996ce0bc9cbf47bb2ad7db0426d5bf</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1001%2Farchneur.61.12.1972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.61.12.1972%26sid%3Dliteratum%253Aachs%26aulast%3DRoach%26aufirst%3DE.%2BS.%26atitle%3DInitial%2520Parkinson%2520disease%2520therapy%253A%2520levodopa%252C%2520dopamine%2520agonists%252C%2520or%2520both%26jtitle%3DArch.%2520Neurol.%26date%3D2004%26volume%3D61%26spage%3D1972%26epage%3D1973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Silver, D. E.</span><span> </span><span class="NLM_article-title">Clinical experience with the novel levodopa formulation entacapone + levodopa + carbidopa (Stalevo)</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="NLM_x">–</span> <span class="NLM_lpage">599</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1586%2F14737175.4.4.589" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15853578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtlSmsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=589-599&author=D.+E.+Silver&title=Clinical+experience+with+the+novel+levodopa+formulation+entacapone+%2B+levodopa+%2B+carbidopa+%28Stalevo%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical experience with the novel levodopa formulation entacapone + levodopa + carbidopa (Stalevo)</span></div><div class="casAuthors">Silver, Dee E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">589-599</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Levodopa is the main pharmacol. treatment for Parkinson's disease.  However, the long-term administration of levodopa is assocd. with the development of motor complications which can seriously compromise patient function.  Increasing evidence indicates that such problems are related to abnormal pulsatile stimulation of striatal dopamine receptors and that treatments providing more continuous stimulation reduce the risk of motor complications.  It is possible that administering levodopa with a reversible catechol-O-Me transferase inhibitor at frequent intervals might reduce the risk of these complications.  Stalevo (Orion) combines levodopa, the dopa-decarboxylase inhibitor carbidopa and the catechol-O-Me transferase inhibitor entacapone in a single tablet.  This review provides an overview of the initial clin. experience gained with Stalevo during clin. trials, including several case studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSrW0p8jctGbVg90H21EOLACvtfcHk0liVWa9AFCF8SQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtlSmsL4%253D&md5=911ebf6414e5a186f0d2d0ccca5cfac4</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1586%2F14737175.4.4.589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.4.4.589%26sid%3Dliteratum%253Aachs%26aulast%3DSilver%26aufirst%3DD.%2BE.%26atitle%3DClinical%2520experience%2520with%2520the%2520novel%2520levodopa%2520formulation%2520entacapone%2520%252B%2520levodopa%2520%252B%2520carbidopa%2520%2528Stalevo%2529%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2004%26volume%3D4%26spage%3D589%26epage%3D599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group">Jost, W. H.</span><span> </span><span class="NLM_article-title">Ropinirole: current status of the studies</span> <span class="citation_source-journal">J. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">VI/13</span><span class="NLM_x">–</span> <span class="NLM_lpage">VI/18</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=2004&pages=VI%2F13-VI%2F18&issue=6&author=W.+H.+Jost&title=Ropinirole%3A+current+status+of+the+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJost%26aufirst%3DW.%2BH.%26atitle%3DRopinirole%253A%2520current%2520status%2520of%2520the%2520studies%26jtitle%3DJ.%2520Neurol.%26date%3D2004%26volume%3D251%26issue%3D6%26spage%3DVI%252F13%26epage%3DVI%252F18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group">Mattson, M. P.</span><span> </span><span class="NLM_article-title">Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1012</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1012&publication_year=2004&pages=37-50&author=M.+P.+Mattson&title=Metal-catalyzed+disruption+of+membrane+protein+and+lipid+signaling+in+the+pathogenesis+of+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMattson%26aufirst%3DM.%2BP.%26atitle%3DMetal-catalyzed%2520disruption%2520of%2520membrane%2520protein%2520and%2520lipid%2520signaling%2520in%2520the%2520pathogenesis%2520of%2520neurodegenerative%2520disorders%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2004%26volume%3D1012%26spage%3D37%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group">Kaur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yantiri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mo, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boonplueang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viswanath, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beal, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMonte, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volitaskis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellerby, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherny, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bush, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, J. K.</span><span> </span><span class="NLM_article-title">Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinsonʼs disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2003&pages=899-909&author=D.+Kaurauthor=F.+Yantiriauthor=S.+Rajagopalanauthor=J.+Kumarauthor=J.+Q.+Moauthor=R.+Boonplueangauthor=V.+Viswanathauthor=R.+Jacobsauthor=L.+Yangauthor=M.+F.+Bealauthor=D.+DiMonteauthor=I.+Volitaskisauthor=L.+Ellerbyauthor=R.+A.+Chernyauthor=A.+I.+Bushauthor=J.+K.+Andersen&title=Genetic+or+pharmacological+iron+chelation+prevents+MPTP-induced+neurotoxicity+in+vivo%3A+a+novel+therapy+for+Parkinson%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKaur%26aufirst%3DD.%26aulast%3DYantiri%26aufirst%3DF.%26aulast%3DRajagopalan%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DJ.%26aulast%3DMo%26aufirst%3DJ.%2BQ.%26aulast%3DBoonplueang%26aufirst%3DR.%26aulast%3DViswanath%26aufirst%3DV.%26aulast%3DJacobs%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26aulast%3DDiMonte%26aufirst%3DD.%26aulast%3DVolitaskis%26aufirst%3DI.%26aulast%3DEllerby%26aufirst%3DL.%26aulast%3DCherny%26aufirst%3DR.%2BA.%26aulast%3DBush%26aufirst%3DA.%2BI.%26aulast%3DAndersen%26aufirst%3DJ.%2BK.%26atitle%3DGenetic%2520or%2520pharmacological%2520iron%2520chelation%2520prevents%2520MPTP-induced%2520neurotoxicity%2520in%2520vivo%253A%2520a%2520novel%2520therapy%2520for%2520Parkinson%25CA%25BCs%2520disease%26jtitle%3DNeuron%26date%3D2003%26volume%3D37%26spage%3D899%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group">Shoham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Iron involvement in neural damage and microgliosis in models of neurodegenerative diseases</span> <span class="citation_source-journal">Cell. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">760</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=10875437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkt1agsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2000&pages=743-760&author=S.+Shohamauthor=M.+B.+Youdim&title=Iron+involvement+in+neural+damage+and+microgliosis+in+models+of+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Iron involvement in neural damage and microgliosis in models of neurodegenerative diseases</span></div><div class="casAuthors">Shoham, S.; Youdim, M. B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Biology (Paris)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">743-760</span>CODEN:
                <span class="NLM_cas:coden">CMOBEF</span>;
        ISSN:<span class="NLM_cas:issn">0145-5680</span>.
    
            (<span class="NLM_cas:orgname">C.M.B. Association</span>)
        </div><div class="casAbstract">A review, with 134 refs.  In several neurodegenerative diseases, iron accumulates at sites of brain pathol.  Since post-mortem examn. cannot distinguish whether iron accumulation caused the damage or resulted from damage, it is necessary to manipulate iron in animal and tissue culture models to assess its causal role(s).  However, only in models of Parkinson's disease and of global ischemia, iron deprivation (ID) or iron-chelators have been used to protect from damage.  In these studies, documentation of microgliosis was not performed even though several lines of evidence converge to suggest that activation of microglia is an important source of oxidative stress.  In the kainate model of epilepsy, we found that ID protected the olfactory cortex, thalamus and hippocampus and attenuated microgliosis, whereas iron supplementation to ID rats increased damage and microgliosis in the above regions.  In the hilus of the hippocampal dentate gyrus, even though no cell loss was obsd., ID attenuated microgliosis and iron-supplementation increased it.  Thus there is a tight relationship between iron and microgliosis.  In addn., iron+zinc supplementation dramatically increased damage to hippocampal CA1 whereas zinc supplementation alone had no effect.  This study demonstrates an anatomically unique interaction of iron and zinc, which may lead to new insights to neurodegeneration in epilepsy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIPeEZz1azsLVg90H21EOLACvtfcHk0lgH1-NXbuQLGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkt1agsLg%253D&md5=4d5e22d9f8f0c95e06e3b132dffce06c</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShoham%26aufirst%3DS.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DIron%2520involvement%2520in%2520neural%2520damage%2520and%2520microgliosis%2520in%2520models%2520of%2520neurodegenerative%2520diseases%26jtitle%3DCell.%2520Mol.%2520Biol.%26date%3D2000%26volume%3D46%26spage%3D743%26epage%3D760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridkin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span> </span><span class="NLM_article-title">Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinsonʼs disease and other neurodegenerative diseases</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">1455</span><span class="NLM_x">–</span> <span class="NLM_lpage">1471</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2004&pages=1455-1471&author=M.+B.+Youdimauthor=M.+Fridkinauthor=H.+Zheng&title=Novel+bifunctional+drugs+targeting+monoamine+oxidase+inhibition+and+iron+chelation+as+an+approach+to+neuroprotection+in+Parkinson%CA%BCs+disease+and+other+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DFridkin%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DH.%26atitle%3DNovel%2520bifunctional%2520drugs%2520targeting%2520monoamine%2520oxidase%2520inhibition%2520and%2520iron%2520chelation%2520as%2520an%2520approach%2520to%2520neuroprotection%2520in%2520Parkinson%25CA%25BCs%2520disease%2520and%2520other%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2004%26volume%3D111%26spage%3D1455%26epage%3D1471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group">Youdim, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finberg, J. P.</span><span> </span><span class="NLM_article-title">Rasagiline [<i>N</i>-propargyl-1<i>R</i>(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">500</span><span class="NLM_x">–</span> <span class="NLM_lpage">506</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fsj.bjp.0703826" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=11159700" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3MXht1Sgu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2001&pages=500-506&author=M.+B.+Youdimauthor=A.+Grossauthor=J.+P.+Finberg&title=Rasagiline+%5BN-propargyl-1R%28%2B%29-aminoindan%5D%2C+a+selective+and+potent+inhibitor+of+mitochondrial+monoamine+oxidase+B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B</span></div><div class="casAuthors">Youdim, Moussa B. H.; Gross, Aviva; Finberg, John P. M.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">500-506</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Rasagiline [N-propargyl-1R(+)-aminoindan], was examd. for its monoamine oxidase (MAO) A and B inhibitor activities in rats together with its S(-)-enantiomer (TVP 1022) and the racemic compd. (AGN-1135) and compared to selegiline (1-deprenyl).  The tissues that were studied for MAO inhibition were the brain, liver and small intestine.  While rasagiline and AGN1135 are highly potent selective irreversible inhibitors of MAO in vitro and in vivo, the S(-) enantiomer is relatively inactive in the tissues examd.  The in vitro IC50 values for inhibition of rat brain MAO activity by rasagiline are 4.43±0.92 nM (type B), and 412±123 nM (type A).  The ED50 values for ex vivo inhibition of MAO in the brain and liver by a single dose of rasagiline are 0.1±0.01, 0.042±0.0045 mg kg-1 resp. for MAO-B, and 6.48±0.81, 2.38±0.35 mg kg-1 resp. for MAO-A.  Selective MAO-B inhibition in the liver and brain was maintained on chronic (21 days) oral dosage with ED50 values of 0.014±0.002 and 0.013±0.001 mg kg-1 resp.  The degree of selectivity of rasagiline for inhibition of MAO-B as opposed to MAO-A was similar to that of selegiline.  Rasagiline was three to 15 times more potent than selegiline for inhibition of MAO-B in rat brain and liver in vivo on acute and chronic administration, but had similar potency in vitro.  These data together with lack of tyramine sympathomimetic potentiation by rasagiline, at selective MAO-B inhibitory dosage, indicate that this inhibitor like selegiline may be a useful agent in the treatment of Parkinson's disease in either symptomatic or L-DOPA adjunct therapy, but lack of amphetamine-like metabolites could present a therapeutic advantage for rasagiline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq020sdG8LiPbVg90H21EOLACvtfcHk0lhEHFKeOpdOfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXht1Sgu7o%253D&md5=692cfb1e7f679e073f6cbdb2c8650ba9</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703826%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DGross%26aufirst%3DA.%26aulast%3DFinberg%26aufirst%3DJ.%2BP.%26atitle%3DRasagiline%2520%255BN-propargyl-1R%2528%252B%2529-aminoindan%255D%252C%2520a%2520selective%2520and%2520potent%2520inhibitor%2520of%2520mitochondrial%2520monoamine%2520oxidase%2520B%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D132%26spage%3D500%26epage%3D506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bar-Am, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warshawsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridkin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Novel multifunctional neuroprotective iron chelator−monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1111%2Fj.1471-4159.2005.03340.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16181413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVygs7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2005&pages=68-78&author=H.+Zhengauthor=S.+Galauthor=L.+M.+Weinerauthor=O.+Bar-Amauthor=A.+Warshawskyauthor=M.+Fridkinauthor=M.+B.+Youdim&title=Novel+multifunctional+neuroprotective+iron+chelator%E2%88%92monoamine+oxidase+inhibitor+drugs+for+neurodegenerative+diseases%3A+in+vitro+studies+on+antioxidant+activity%2C+prevention+of+lipid+peroxide+formation+and+monoamine+oxidase+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition</span></div><div class="casAuthors">Zheng, Hailin; Gal, Shunit; Weiner, Lev M.; Bar-Am, Orit; Warshawsky, Abraham; Fridkin, Mati; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">68-78</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Iron-dependent oxidative stress, elevated levels of iron and of monoamine oxidase (MAO)-B activity, and depletion of antioxidants in the brain may be major pathogenic factors in Parkinson's disease, Alzheimer's disease and related neurodegenerative diseases.  Accordingly, iron chelators, antioxidants and MAO-B inhibitors have shown efficacy in a variety of cellular and animal models of CNS injury.  In searching for novel antioxidant iron chelators with potential MAO-B inhibitory activity, a series of new iron chelators has been designed, synthesized and investigated.  In this study, the novel chelators were further examd. for their activity as antioxidants, MAO-B inhibitors and neuroprotective agents in vitro.  Three of the selected chelators (M30, HLA20 and M32) were the most effective in inhibiting iron-dependent lipid peroxidn. in rat brain homogenates with IC50 values (12-16 μM), which is comparable with that of desferal, a prototype iron chelator that is not has orally active.  Their antioxidant activities were further confirmed using ESR spectroscopy.  In PC12 cell culture, the three novel chelators at 0.1 μM were able to attenuate cell death induced by serum deprivation and by 6-hydroxydopamine.  M30 possessing propargyl, the MAO inhibitory moiety of the anti-Parkinson drug rasagiline, displayed greater neuroprotective potency than that of rasagiline.  In addn., in vitro, M30 was a highly potent non-selective MAO-A and MAO-B inhibitor (IC50 < 0.1 μM).  However, HLA20 was more selective for MAO-B but had poor MAO inhibition, with an IC50 value of 64.2 μM.  The data suggest that M30 and HLA20 might serve as leads in developing drugs with multifunctional activities for the treatment of various neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaog8Swg2o4rVg90H21EOLACvtfcHk0ljfh1oFhYKZhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVygs7bE&md5=4d75e3046fe79c9f86fc015fa5796529</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2005.03340.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2005.03340.x%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DGal%26aufirst%3DS.%26aulast%3DWeiner%26aufirst%3DL.%2BM.%26aulast%3DBar-Am%26aufirst%3DO.%26aulast%3DWarshawsky%26aufirst%3DA.%26aulast%3DFridkin%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DNovel%2520multifunctional%2520neuroprotective%2520iron%2520chelator%25E2%2588%2592monoamine%2520oxidase%2520inhibitor%2520drugs%2520for%2520neurodegenerative%2520diseases%253A%2520in%2520vitro%2520studies%2520on%2520antioxidant%2520activity%252C%2520prevention%2520of%2520lipid%2520peroxide%2520formation%2520and%2520monoamine%2520oxidase%2520inhibition%26jtitle%3DJ.%2520Neurochem.%26date%3D2005%26volume%3D95%26spage%3D68%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group">Gal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridkin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Novel multifunctional neuroprotective iron chelator−monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1111%2Fj.1471-4159.2005.03341.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16181414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVygs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2005&pages=79-88&author=S.+Galauthor=H.+Zhengauthor=M.+Fridkinauthor=M.+B.+Youdim&title=Novel+multifunctional+neuroprotective+iron+chelator%E2%88%92monoamine+oxidase+inhibitor+drugs+for+neurodegenerative+diseases.+In+vivo+selective+brain+monoamine+oxidase+inhibition+and+prevention+of+MPTP-induced+striatal+dopamine+depletion"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion</span></div><div class="casAuthors">Gal, Shunit; Zheng, Hailin; Fridkin, Mati; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-88</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Several multifunctional iron chelators have been synthesized from hydroxyquinoline pharmacophore of the iron chelator, VK-28, possessing the monoamine oxidase (MAO) and neuroprotective N-propargylamine moiety.  They have iron chelating potency similar to desferal.  M30 is a potent irreversible rat brain mitochondrial MAO-A and -B inhibitor in vitro (IC50, MAO-A, 0.037±0.02; MAO-B, 0.057±0.01).  Acute (1-5 mg/kg) and chronic [5-10 mg/kg i.p., or orally (p.o.) once daily for 14 days] in vivo studies have shown M30 to be a potent brain selective (striatum, hippocampus and cerebellum) MAO-A and -B inhibitor.  It has little effects on the enzyme activities of the liver and small intestine.  Its N-des-methylated deriv., M30A is significantly less active.  Acute and chronic treatment with M30 results in increased levels of dopamine (DA), serotonin(5-HT), noradrenaline (NA) and decreases in DOPAC (dihydroxyphenylacetic acid), HVA (homovanillic acid) and 5-HIAA (5-hydroxyindole acetic acid) as detd. in striatum and hypothalamus.  In the mouse MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) model of Parkinson's disease (PD) it attenuates the DA depleting action of the neurotoxin and increases striatal levels of DA, 5-HT and NA, while decreasing their metabolites.  As DA is equally well metabolized by MAO-A and -B, it is expected that M30 would have a greater DA neurotransmission potentiation in PD than selective MAO-B inhibitors, for which it is being developed, as MAO-B inhibitors do not alter brain dopamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphycb87iHT6rVg90H21EOLACvtfcHk0ljh1kyWbdLdmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVygs7bF&md5=2797ec27ec14297aca6733b910ce2aa5</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2005.03341.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2005.03341.x%26sid%3Dliteratum%253Aachs%26aulast%3DGal%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DFridkin%26aufirst%3DM.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DNovel%2520multifunctional%2520neuroprotective%2520iron%2520chelator%25E2%2588%2592monoamine%2520oxidase%2520inhibitor%2520drugs%2520for%2520neurodegenerative%2520diseases.%2520In%2520vivo%2520selective%2520brain%2520monoamine%2520oxidase%2520inhibition%2520and%2520prevention%2520of%2520MPTP-induced%2520striatal%2520dopamine%2520depletion%26jtitle%3DJ.%2520Neurochem.%26date%3D2005%26volume%3D95%26spage%3D79%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group">Kalir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabbagh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Selective acetylenic “suicide” and reversible inhibitors of monoamine oxidase types A and B</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=7284698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaL3MXltFSku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1981&pages=55-64&author=A.+Kalirauthor=A.+Sabbaghauthor=M.+B.+Youdim&title=Selective+acetylenic+%E2%80%9Csuicide%E2%80%9D+and+reversible+inhibitors+of+monoamine+oxidase+types+A+and+B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Selective acetylenic 'suicide' and reversible inhibitors of monoamine oxidase types A and B</span></div><div class="casAuthors">Kalir, A.; Sabbagh, A.; Youdim, M. B. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-64</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">Structure-activity studies with arom. N-propargyl (acetylenic) derivs. indicated that brain monoamine oxidase (MAO) inhibitory potency was least dependent on the arom. portion of the compds.  N-Methylated propargyl derivs. were most active; higher alkyl or arom. group replacement of the Me group resulted in a significant redn. of activity.  A triple bond β to the N atom in the propargyl group was essential for irreversible activity; the acetylenic group gave these compds. their irreversible MAO inhibitory properties.  The distance between the arom. ring and N-propargyl terminus of the substrate analogs detd. the specificity for type A or B MAO.  AGN-1133 and AGN-1135 may be useful as antidepressants or in Parkinson's disease treatment as they were specific for MAO type B.  A no. of indoleamine derivs. were found to be reversible selective type A inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsHr_ORRp6z7Vg90H21EOLACvtfcHk0ljh1kyWbdLdmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXltFSku7g%253D&md5=bfc69e02bdb7bffdfbea26aafd9946e3</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKalir%26aufirst%3DA.%26aulast%3DSabbagh%26aufirst%3DA.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DSelective%2520acetylenic%2520%25E2%2580%259Csuicide%25E2%2580%259D%2520and%2520reversible%2520inhibitors%2520of%2520monoamine%2520oxidase%2520types%2520A%2520and%2520B%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1981%26volume%3D73%26spage%3D55%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group">OʼCarrol, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobbia, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipton, K. F.</span><span> </span><span class="NLM_article-title">The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions</span> <span class="citation_source-journal">Naunyn Schmiedebergʼs Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=1983&pages=198-202&author=A.+M.+O%CA%BCCarrolauthor=C.+J.+Fowlerauthor=J.+P.+Phillipsauthor=I.+Tobbiaauthor=K.+F.+Tipton&title=The+deamination+of+dopamine+by+human+brain+monoamine+oxidase.+Specificity+for+the+two+enzyme+forms+in+seven+brain+regions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25CA%25BCCarrol%26aufirst%3DA.%2BM.%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DPhillips%26aufirst%3DJ.%2BP.%26aulast%3DTobbia%26aufirst%3DI.%26aulast%3DTipton%26aufirst%3DK.%2BF.%26atitle%3DThe%2520deamination%2520of%2520dopamine%2520by%2520human%2520brain%2520monoamine%2520oxidase.%2520Specificity%2520for%2520the%2520two%2520enzyme%2520forms%2520in%2520seven%2520brain%2520regions%26jtitle%3DNaunyn%2520Schmiedeberg%25CA%25BCs%2520Arch.%2520Pharmacol.%26date%3D1983%26volume%3D322%26spage%3D198%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group">Green, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tordoff, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1111%2Fj.1476-5381.1977.tb07506.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=890205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaE2sXlslyju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1977&pages=343-349&author=A.+R.+Greenauthor=B.+D.+Mitchellauthor=A.+F.+Tordoffauthor=M.+B.+Youdim&title=Evidence+for+dopamine+deamination+by+both+type+A+and+type+B+monoamine+oxidase+in+rat+brain+in+vivo+and+for+the+degree+of+inhibition+of+enzyme+necessary+for+increased+functional+activity+of+dopamine+and+5-hydroxytryptamine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine</span></div><div class="casAuthors">Green, A. R.; Mitchell, B. D.; Tordoff, Ann F. C.; Youdim, M. B. H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">343-9</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">Tranylcypromine (I) (20 mg/kg, i.p.) administration to rats inhibited brain monoamine oxidase (II) [9001-66-5] oxidn. of 5-hydroxytryptamine (III) [50-67-9], phenylethylamine (IV) [64-04-0], and dopamine (V) [51-61-6]; when L-DOPA (50 mg/kg, i.p.) was given 30 min after I, brain V and noradrenaline (VI) [51-41-2] levels increased and the rats displayed hyperactivity syndromes.  Clorgyline (5 mg/kg, i.p.) administration inhibited III and IV oxidn. by 100 and 29% resp. while deprenil (5 mg/kg, i.p.) inhibited III and IV oxidn. by 31 and <100% resp.  Administration of clorgyline + deprenil inhibited oxidn. of III and IV <100%, increased brain V and VI levels and resulted in a behavior pattern similar to that obsd. after I or L-DOPA administration.  Brain III levels were elevated 18 h after I (20 mg/kg, i.p.) and then declined, whereas V and VI increased levels remained steady for 48 h.  Administration of L-tryptophan (50 mg/kg, i.p.) to I-pretreated rats resulted in the hyperactivity syndrome at 12 h but not at 18 h and III levels increased at 12 h.  When L-DOPA (50 mg/kg, i.p.) was given after I a further rise in brain V and VI occurred at 12 h but not at 18 h, and behavioral changes occurred at 12 h.  After I treatment the half-life of II with III, IV, and V as substrates was 4.5, 8.5, and 4.5 days, resp.  Thus V was metabolized by Type A and Type B II in vivo and only when both forms were totally inhibited was III and V functional activity increased.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0gK6LwoWUrbVg90H21EOLACvtfcHk0lgdtm17c05W5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXlslyju7g%253D&md5=b9d0533dd87d8e87c32d7581df2b8d8f</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1977.tb07506.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1977.tb07506.x%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DA.%2BR.%26aulast%3DMitchell%26aufirst%3DB.%2BD.%26aulast%3DTordoff%26aufirst%3DA.%2BF.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DEvidence%2520for%2520dopamine%2520deamination%2520by%2520both%2520type%2520A%2520and%2520type%2520B%2520monoamine%2520oxidase%2520in%2520rat%2520brain%2520in%2520vivo%2520and%2520for%2520the%2520degree%2520of%2520inhibition%2520of%2520enzyme%2520necessary%2520for%2520increased%2520functional%2520activity%2520of%2520dopamine%2520and%25205-hydroxytryptamine%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1977%26volume%3D60%26spage%3D343%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group">Ross, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrovitch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morens, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandinetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanner, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masaki, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchette, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curb, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popper, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, L. R.</span><span> </span><span class="NLM_article-title">Association of coffee and caffeine intake with the risk of Parkinson disease</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">2674</span><span class="NLM_x">–</span> <span class="NLM_lpage">2679</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2000&pages=2674-2679&author=G.+W.+Rossauthor=R.+D.+Abbottauthor=H.+Petrovitchauthor=D.+M.+Morensauthor=A.+Grandinettiauthor=K.+H.+Tungauthor=C.+M.+Tannerauthor=K.+H.+Masakiauthor=P.+L.+Blanchetteauthor=J.+D.+Curbauthor=J.+S.+Popperauthor=L.+R.+White&title=Association+of+coffee+and+caffeine+intake+with+the+risk+of+Parkinson+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DG.%2BW.%26aulast%3DAbbott%26aufirst%3DR.%2BD.%26aulast%3DPetrovitch%26aufirst%3DH.%26aulast%3DMorens%26aufirst%3DD.%2BM.%26aulast%3DGrandinetti%26aufirst%3DA.%26aulast%3DTung%26aufirst%3DK.%2BH.%26aulast%3DTanner%26aufirst%3DC.%2BM.%26aulast%3DMasaki%26aufirst%3DK.%2BH.%26aulast%3DBlanchette%26aufirst%3DP.%2BL.%26aulast%3DCurb%26aufirst%3DJ.%2BD.%26aulast%3DPopper%26aufirst%3DJ.%2BS.%26aulast%3DWhite%26aufirst%3DL.%2BR.%26atitle%3DAssociation%2520of%2520coffee%2520and%2520caffeine%2520intake%2520with%2520the%2520risk%2520of%2520Parkinson%2520disease%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2000%26volume%3D283%26spage%3D2674%26epage%3D2679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group">Ascherio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawachi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colditz, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speizer, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, W. C.</span><span> </span><span class="NLM_article-title">Prospective study of caffeine consumption and risk of Parkinsonʼs disease in men and women</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fana.1052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=11456310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlt12gurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2001&pages=56-63&author=A.+Ascherioauthor=S.+M.+Zhangauthor=M.+A.+Hernanauthor=I.+Kawachiauthor=G.+A.+Colditzauthor=F.+E.+Speizerauthor=W.+C.+Willett&title=Prospective+study+of+caffeine+consumption+and+risk+of+Parkinson%CA%BCs+disease+in+men+and+women"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Prospective study of caffeine consumption and risk of Parkinson's disease in men and women</span></div><div class="casAuthors">Ascherio, Alberto; Zhang, Shumin M.; Hernan, Miguel A.; Kawachi, Ichiro; Colditz, Graham A.; Speizer, Frank E.; Willett, Walter C.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-63</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Results of case-control studies and of a prospective investigation in men suggest that consumption of coffee could protect against the risk of Parkinson's disease, but the active constituent is not clear.  To address the hypothesis that caffeine is protective against Parkinson's disease, we examd. the relationship of coffee and caffeine consumption to the risk of this disease among participants in two ongoing cohorts, the Health Professionals' Follow-Up Study (HPFS) and the Nurses' Health Study (NHS).  The study population comprised 47,351 men and 88,565 women who were free of Parkinson's disease, stroke, or cancer at baseline.  A comprehensive life style and dietary questionnaire was completed by the participants at baseline and updated every two to four years.  During the follow-up (10 yr in men, 16 yr in women), we documented a total of 288 incident cases of Parkinson's disease.  Among men, after adjustment for age and smoking, the relative risk of Parkinson's disease was 0.42 (95% CI: 0.23-0.78; p for trend < 0.001) for men in the top one-fifth of caffeine intake compared to those in the bottom one-fifth.  An inverse assocn. was also obsd. with consumption of coffee (p for trend = 0.004), caffeine from non-coffee sources (p for trend < 0.001), and tea (p for trend = 0.02) but not decaffeinated coffee.  Among women, the relationship between caffeine or coffee intake and risk of Parkinson's disease was U-shaped, with the lowest risk obsd. at moderate intakes (1-3 cups of coffee/day, or the third quintile of caffeine consumption).  These results support a possible protective effect of moderate doses of caffeine on risk of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIgS7GGPMwGrVg90H21EOLACvtfcHk0lj9nil-vjTv-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlt12gurg%253D&md5=6ed856feee3eb746e8149ce9c7c6a5a6</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1002%2Fana.1052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.1052%26sid%3Dliteratum%253Aachs%26aulast%3DAscherio%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DS.%2BM.%26aulast%3DHernan%26aufirst%3DM.%2BA.%26aulast%3DKawachi%26aufirst%3DI.%26aulast%3DColditz%26aufirst%3DG.%2BA.%26aulast%3DSpeizer%26aufirst%3DF.%2BE.%26aulast%3DWillett%26aufirst%3DW.%2BC.%26atitle%3DProspective%2520study%2520of%2520caffeine%2520consumption%2520and%2520risk%2520of%2520Parkinson%25CA%25BCs%2520disease%2520in%2520men%2520and%2520women%26jtitle%3DAnn.%2520Neurol.%26date%3D2001%26volume%3D50%26spage%3D56%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group">Carboni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spielewoy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nosten-Bertrand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giros, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Chiara, G.</span><span> </span><span class="NLM_article-title">Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">RC141:1</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=RC141%3A1-4&author=E.+Carboniauthor=C.+Spielewoyauthor=C.+Vaccaauthor=M.+Nosten-Bertrandauthor=B.+Girosauthor=G.+Di+Chiara&title=Cocaine+and+amphetamine+increase+extracellular+dopamine+in+the+nucleus+accumbens+of+mice+lacking+the+dopamine+transporter+gene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarboni%26aufirst%3DE.%26aulast%3DSpielewoy%26aufirst%3DC.%26aulast%3DVacca%26aufirst%3DC.%26aulast%3DNosten-Bertrand%26aufirst%3DM.%26aulast%3DGiros%26aufirst%3DB.%26aulast%3DDi%2BChiara%26aufirst%3DG.%26atitle%3DCocaine%2520and%2520amphetamine%2520increase%2520extracellular%2520dopamine%2520in%2520the%2520nucleus%2520accumbens%2520of%2520mice%2520lacking%2520the%2520dopamine%2520transporter%2520gene%26jtitle%3DJ.%2520Neurosci.%26date%3D2001%26volume%3D21%26spage%3DRC141%253A1%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group">Chen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzer, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beilstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonsalla, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, N.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span> </span><span class="NLM_article-title">Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinsonʼs disease</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">RC143</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=RC143&author=J.+F.+Chenauthor=K.+Xuauthor=J.+P.+Petzerauthor=R.+Staalauthor=Y.+H.+Xuauthor=M.+Beilsteinauthor=P.+K.+Sonsallaauthor=K.+Castagnoliauthor=N.+Castagnoliauthor=M.+A.+Schwarzschild&title=Neuroprotection+by+caffeine+and+A%282A%29+adenosine+receptor+inactivation+in+a+model+of+Parkinson%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BF.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26aulast%3DStaal%26aufirst%3DR.%26aulast%3DXu%26aufirst%3DY.%2BH.%26aulast%3DBeilstein%26aufirst%3DM.%26aulast%3DSonsalla%26aufirst%3DP.%2BK.%26aulast%3DCastagnoli%26aufirst%3DK.%26aulast%3DCastagnoli%26aufirst%3DN.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26atitle%3DNeuroprotection%2520by%2520caffeine%2520and%2520A%25282A%2529%2520adenosine%2520receptor%2520inactivation%2520in%2520a%2520model%2520of%2520Parkinson%25CA%25BCs%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D2001%26volume%3D21%26spage%3DRC143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group">Ikeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurokawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwana, Y.</span><span> </span><span class="NLM_article-title">Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinsonʼs disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1046%2Fj.0022-3042.2001.00694.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=11902116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD38XptV2jsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2002&pages=262-270&author=K.+Ikedaauthor=M.+Kurokawaauthor=S.+Aoyamaauthor=Y.+Kuwana&title=Neuroprotection+by+adenosine+A2A+receptor+blockade+in+experimental+models+of+Parkinson%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease</span></div><div class="casAuthors">Ikeda, Ken; Kurokawa, Masako; Aoyama, Shiro; Kuwana, Yoshihisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">262-270</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Adenosine A2A receptors are abundant in the caudate-putamen and involved in the motor control in several species.  In MPTP-treated monkeys, A2A receptor-blockade with an antagonist alleviates parkinsonian symptoms without provoking dyskinesia, suggesting this receptor may offer a new target for the antisymptomatic therapy of Parkinson's disease.  In the present study, a significant neuroprotective effect of A2A receptor antagonists is shown in exptl. models of Parkinson's disease.  Oral administration of A2A receptor antagonists protected against the loss of nigral dopaminergic neuronal cells induced by 6-hydroxydopamine in rats.  A2A antagonists also prevented the functional loss of dopaminergic nerve terminals in the striatum and the ensuing gliosis caused by MPTP in mice.  The neuroprotective property of A2A receptor antagonists may be exerted by altering the packaging of these neurotoxins into vesicles, thus reducing their effective intracellular concn.  We therefore conclude that the adenosine A2A receptor may provide a novel target for the long-term medication of Parkinson's disease, because blockade of this receptor exerts both acutely antisymptomatic and chronically neuroprotective activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqb8toXJpqCzLVg90H21EOLACvtfcHk0lj1bCwNY5zoOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptV2jsQ%253D%253D&md5=68ddb10b0be184393df31567d2acc7ca</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1046%2Fj.0022-3042.2001.00694.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0022-3042.2001.00694.x%26sid%3Dliteratum%253Aachs%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DKurokawa%26aufirst%3DM.%26aulast%3DAoyama%26aufirst%3DS.%26aulast%3DKuwana%26aufirst%3DY.%26atitle%3DNeuroprotection%2520by%2520adenosine%2520A2A%2520receptor%2520blockade%2520in%2520experimental%2520models%2520of%2520Parkinson%25CA%25BCs%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D80%26spage%3D262%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group">Xu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzschild, M.</span><span> </span><span class="NLM_article-title">Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinsonʼs disease</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.pharmthera.2004.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15737407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvVCjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=267-310&author=K.+Xuauthor=E.+Bastiaauthor=M.+Schwarzschild&title=Therapeutic+potential+of+adenosine+A%282A%29+receptor+antagonists+in+Parkinson%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease</span></div><div class="casAuthors">Xu, Kui; Bastia, Elena; Schwarzschild, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">267-310</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In the pursuit of improved treatments for Parkinson's disease (PD), the adenosine A2A receptor has emerged as an attractive nondopaminergic target.  Based on the compelling behavioral pharmacol. and selective basal ganglia expression of this G-protein-coupled receptor, its antagonists are now crossing the threshold of clin. development as adjunctive symptomatic treatment for relatively advanced PD.  The antiparkinsonian potential of A2A antagonism has been boosted further by recent preclin. evidence that A2A antagonists might favorably alter the course as well as the symptoms of the disease.  Convergent epidemiol. and lab. data have suggested that A2A blockade may confer neuroprotection against the underlying dopaminergic neuron degeneration.  In addn., rodent and nonhuman primate studies have raised the possibility that A2A receptor activation contributes to the pathophysiol. of dyskinesias-problematic motor complications of std. PD therapy-and that A2A antagonism might help prevent them.  Realistically, despite being targeted to basal ganglia pathophysiol., A2A antagonists may be expected to have other beneficial and adverse effects elsewhere in the central nervous system (e.g., on mood and sleep) and in the periphery (e.g., on immune and inflammatory processes).  The thoughtful design of new clin. trials of A2A antagonists should take into consideration these counterbalancing hopes and concerns and may do well to shift toward a broader set of disease-modifying as well as symptomatic indications in early PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3HbF9ZxHP3bVg90H21EOLACvtfcHk0lj43TrerZ98Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvVCjt7s%253D&md5=ca493d29bdda09382108c0566a3a0877</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2004.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2004.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DK.%26aulast%3DBastia%26aufirst%3DE.%26aulast%3DSchwarzschild%26aufirst%3DM.%26atitle%3DTherapeutic%2520potential%2520of%2520adenosine%2520A%25282A%2529%2520receptor%2520antagonists%2520in%2520Parkinson%25CA%25BCs%2520disease%26jtitle%3DPharmacol.%2520Ther.%26date%3D2005%26volume%3D105%26spage%3D267%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group">Bara-Jimenez, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherzai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitrova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibbiani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouradian, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, T. N.</span><span> </span><span class="NLM_article-title">Adenosine A(2A) receptor antagonist treatment of Parkinsonʼs disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2003&pages=293-296&author=W.+Bara-Jimenezauthor=A.+Sherzaiauthor=T.+Dimitrovaauthor=A.+Favitauthor=F.+Bibbianiauthor=M.+Gillespieauthor=M.+J.+Morrisauthor=M.+M.+Mouradianauthor=T.+N.+Chase&title=Adenosine+A%282A%29+receptor+antagonist+treatment+of+Parkinson%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBara-Jimenez%26aufirst%3DW.%26aulast%3DSherzai%26aufirst%3DA.%26aulast%3DDimitrova%26aufirst%3DT.%26aulast%3DFavit%26aufirst%3DA.%26aulast%3DBibbiani%26aufirst%3DF.%26aulast%3DGillespie%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DM.%2BJ.%26aulast%3DMouradian%26aufirst%3DM.%2BM.%26aulast%3DChase%26aufirst%3DT.%2BN.%26atitle%3DAdenosine%2520A%25282A%2529%2520receptor%2520antagonist%2520treatment%2520of%2520Parkinson%25CA%25BCs%2520disease%26jtitle%3DNeurology%26date%3D2003%26volume%3D61%26spage%3D293%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikodijevic, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padgett, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo-Rodriguez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maillard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, J. W.</span><span> </span><span class="NLM_article-title">8-(3-Chlorostyryl)caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">323</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=1993&pages=141-144&author=K.+A.+Jacobsonauthor=O.+Nikodijevicauthor=W.+L.+Padgettauthor=C.+Gallo-Rodriguezauthor=M.+Maillardauthor=J.+W.+Daly&title=8-%283-Chlorostyryl%29caffeine+%28CSC%29+is+a+selective+A2-adenosine+antagonist+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DNikodijevic%26aufirst%3DO.%26aulast%3DPadgett%26aufirst%3DW.%2BL.%26aulast%3DGallo-Rodriguez%26aufirst%3DC.%26aulast%3DMaillard%26aufirst%3DM.%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3D8-%25283-Chlorostyryl%2529caffeine%2520%2528CSC%2529%2520is%2520a%2520selective%2520A2-adenosine%2520antagonist%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DFEBS%2520Lett.%26date%3D1993%26volume%3D323%26spage%3D141%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group">Chen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzer, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Der Schyf, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonsalla, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, N.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span> </span><span class="NLM_article-title">8-(3-Chlorostyryl)caffeine may attenuate MPTP neurotoxicity through dual actions of monoamine oxidase inhibition and A2A receptor antagonism</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">36040</span><span class="NLM_x">–</span> <span class="NLM_lpage">36044</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=36040-36044&author=J.+F.+Chenauthor=S.+Steynauthor=R.+Staalauthor=J.+P.+Petzerauthor=K.+Xuauthor=C.+J.+Van+Der+Schyfauthor=K.+Castagnoliauthor=P.+K.+Sonsallaauthor=N.+Castagnoliauthor=M.+A.+Schwarzschild&title=8-%283-Chlorostyryl%29caffeine+may+attenuate+MPTP+neurotoxicity+through+dual+actions+of+monoamine+oxidase+inhibition+and+A2A+receptor+antagonism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BF.%26aulast%3DSteyn%26aufirst%3DS.%26aulast%3DStaal%26aufirst%3DR.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DVan%2BDer%2BSchyf%26aufirst%3DC.%2BJ.%26aulast%3DCastagnoli%26aufirst%3DK.%26aulast%3DSonsalla%26aufirst%3DP.%2BK.%26aulast%3DCastagnoli%26aufirst%3DN.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26atitle%3D8-%25283-Chlorostyryl%2529caffeine%2520may%2520attenuate%2520MPTP%2520neurotoxicity%2520through%2520dual%2520actions%2520of%2520monoamine%2520oxidase%2520inhibition%2520and%2520A2A%2520receptor%2520antagonism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D36040%26epage%3D36044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group">Gerlach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riederer, P.</span><span> </span><span class="NLM_article-title">Animal models of Parkinsonʼs disease: an empirical comparison with the phenomenology of the disease in man</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">1041</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1996&pages=987-1041&author=M.+Gerlachauthor=P.+Riederer&title=Animal+models+of+Parkinson%CA%BCs+disease%3A+an+empirical+comparison+with+the+phenomenology+of+the+disease+in+man"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGerlach%26aufirst%3DM.%26aulast%3DRiederer%26aufirst%3DP.%26atitle%3DAnimal%2520models%2520of%2520Parkinson%25CA%25BCs%2520disease%253A%2520an%2520empirical%2520comparison%2520with%2520the%2520phenomenology%2520of%2520the%2520disease%2520in%2520man%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D1996%26volume%3D103%26spage%3D987%26epage%3D1041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group">Petzer, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van der Schyf, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, N.</span><span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase B by selective adenosine A2A receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1299</span><span class="NLM_x">–</span> <span class="NLM_lpage">1310</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=1299-1310&author=J.+P.+Petzerauthor=S.+Steynauthor=K.+P.+Castagnoliauthor=J.+F.+Chenauthor=M.+A.+Schwarzschildauthor=C.+J.+Van+der+Schyfauthor=N.+Castagnoli&title=Inhibition+of+monoamine+oxidase+B+by+selective+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26aulast%3DSteyn%26aufirst%3DS.%26aulast%3DCastagnoli%26aufirst%3DK.%2BP.%26aulast%3DChen%26aufirst%3DJ.%2BF.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26aulast%3DCastagnoli%26aufirst%3DN.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520B%2520by%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D1299%26epage%3D1310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group">Vlok, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malan, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castagnoli, N.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petzer, J. P.</span><span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase B by analogues of the adenosine A2A receptor antagonist (<i>E</i>)-8-(3-chlorostyryl)caffeine (CSC)</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3512</span><span class="NLM_x">–</span> <span class="NLM_lpage">3521</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=3512-3521&author=N.+Vlokauthor=S.+F.+Malanauthor=N.+Castagnoliauthor=J.+J.+Berghauthor=J.+P.+Petzer&title=Inhibition+of+monoamine+oxidase+B+by+analogues+of+the+adenosine+A2A+receptor+antagonist+%28E%29-8-%283-chlorostyryl%29caffeine+%28CSC%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVlok%26aufirst%3DN.%26aulast%3DMalan%26aufirst%3DS.%2BF.%26aulast%3DCastagnoli%26aufirst%3DN.%26aulast%3DBergh%26aufirst%3DJ.%2BJ.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520B%2520by%2520analogues%2520of%2520the%2520adenosine%2520A2A%2520receptor%2520antagonist%2520%2528E%2529-8-%25283-chlorostyryl%2529caffeine%2520%2528CSC%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D3512%26epage%3D3521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group">Di Stefano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sozio, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iannitelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santucci, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasuti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantalamessa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinnen, F.</span><span> </span><span class="NLM_article-title"><span class="smallcaps smallerCapital">l</span>-dopa- and dopamine-(<i>R</i>)-alpha-lipoic acid conjugates as multifunctional codrugs with antioxidant properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1486</span><span class="NLM_x">–</span> <span class="NLM_lpage">1493</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051145p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1486-1493&author=A.+Di+Stefanoauthor=P.+Sozioauthor=A.+Coccoauthor=A.+Iannitelliauthor=E.+Santucciauthor=M.+Costaauthor=L.+Pecciauthor=C.+Nasutiauthor=F.+Cantalamessaauthor=F.+Pinnen&title=l-dopa-+and+dopamine-%28R%29-alpha-lipoic+acid+conjugates+as+multifunctional+codrugs+with+antioxidant+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1021%2Fjm051145p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051145p%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BStefano%26aufirst%3DA.%26aulast%3DSozio%26aufirst%3DP.%26aulast%3DCocco%26aufirst%3DA.%26aulast%3DIannitelli%26aufirst%3DA.%26aulast%3DSantucci%26aufirst%3DE.%26aulast%3DCosta%26aufirst%3DM.%26aulast%3DPecci%26aufirst%3DL.%26aulast%3DNasuti%26aufirst%3DC.%26aulast%3DCantalamessa%26aufirst%3DF.%26aulast%3DPinnen%26aufirst%3DF.%26atitle%3Dl-dopa-%2520and%2520dopamine-%2528R%2529-alpha-lipoic%2520acid%2520conjugates%2520as%2520multifunctional%2520codrugs%2520with%2520antioxidant%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1486%26epage%3D1493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group">Packer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tritschler, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wessel, K.</span><span> </span><span class="NLM_article-title">Neuroprotection by the metabolic antioxidant alpha-lipoic acid</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">378</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2FS0891-5849%2896%2900269-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=8958163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaK28XnsVGisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1997&pages=359-378&author=L.+Packerauthor=H.+J.+Tritschlerauthor=K.+Wessel&title=Neuroprotection+by+the+metabolic+antioxidant+alpha-lipoic+acid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotection by the metabolic antioxidant α-lipoic acid</span></div><div class="casAuthors">Packer, Lester; Tritschler, Hans J.; Wessel, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">359-378</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Reactive oxygen species are thought to be involved in a no. of types of acute and chronic pathol. conditions in the brain and neural tissue.  The metabolic antioxidant α-lipoate (thioctic acid, 1, 2-dithiolane-3-pentanoic acid; 1, 2-dithiolane-3 valeric acid; and 6,8-dithiooctanoic acid) is a low mol. wt. substance that is absorbed from the diet and crosses the blood-brain barrier.  α-Lipoate is taken up and reduced in cells and tissues to dihydrolipoate, which is also exported to the extracellular medium; hence, protection is afforded to both intracellular and extracellular environments.  Both α-lipoate and esp. dihydrolipoate have been shown to be potent antioxidants, to regenerate through redox cycling other antioxidants like vitamin C and vitamin E, and to raise intracellular glutathione levels.  Thus, it would seem an ideal substance in the treatment of oxidative brain and neural disorders involving free radical processes.  Examn. of current research reveals protective effects of these compds. in cerebral ischemia-reperfusion, excitotoxic amino acid brain injury, mitochondrial dysfunction, diabetes and diabetic neuropathy, inborn errors of metab., and other causes of acute or chronic damage to brain or neural tissue.  Very few neuropharmacol. intervention strategies are currently available for the treatment of stroke and numerous other brain disorders involving free radical injury.  We propose that the various metabolic antioxidant properties of α-lipoate relate to its possible therapeutic roles in a variety of brain and neuronal tissue pathologies: thiols are central to antioxidant defense in brain and other tissues.  The most important thiol antioxidant, glutathione, cannot be directly administered, whereas α-lipoic acid can.  In vitro, animal, and preliminary human studies indicate that α-lipoate may be effective in numerous neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ_kYauAICg7Vg90H21EOLACvtfcHk0lj0k1aa6B8rFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XnsVGisr0%253D&md5=57e70add85f7f074e28936031085be69</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2896%2900269-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252896%252900269-9%26sid%3Dliteratum%253Aachs%26aulast%3DPacker%26aufirst%3DL.%26aulast%3DTritschler%26aufirst%3DH.%2BJ.%26aulast%3DWessel%26aufirst%3DK.%26atitle%3DNeuroprotection%2520by%2520the%2520metabolic%2520antioxidant%2520alpha-lipoic%2520acid%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D1997%26volume%3D22%26spage%3D359%26epage%3D378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group">Suh, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, B. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">deSzoeke, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frei, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagen, T. M.</span><span> </span><span class="NLM_article-title">Dihydrolipoic acid lowers the redox activity of transition metal ions but does not remove them from the active site of enzymes</span> <span class="citation_source-journal">Redox Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1179%2F135100004225003923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15035828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtlajs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=57-61&author=J.+H.+Suhauthor=B.+Z.+Zhuauthor=E.+deSzoekeauthor=B.+Freiauthor=T.+M.+Hagen&title=Dihydrolipoic+acid+lowers+the+redox+activity+of+transition+metal+ions+but+does+not+remove+them+from+the+active+site+of+enzymes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Dihydrolipoic acid lowers the redox activity of transition metal ions but does not remove them from the active site of enzymes</span></div><div class="casAuthors">Suh, Jung H.; Zhu, Ben-Zhan; DeSzoeke, Evan; Frei, Balz; Hagen, Tory M.</div><div class="citationInfo"><span class="NLM_cas:title">Redox Report</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-61</span>CODEN:
                <span class="NLM_cas:coden">RDRPE4</span>;
        ISSN:<span class="NLM_cas:issn">1351-0002</span>.
    
            (<span class="NLM_cas:orgname">Maney Publishing</span>)
        </div><div class="casAbstract">α-Lipoic acid (LA) and its reduced form, dihydrolipoic acid (DHLA), have been suggested to chelate transition metal ions and, hence, mitigate iron- and copper-mediated oxidative stress in biol. systems.  However, it remains unclear whether LA and DHLA chelate transition metal ions in a redox-inactive form, and whether they remove metal ions from the active site of enzymes.  Therefore, we investigated the effects of LA and DHLA on iron- or copper-catalyzed oxidn. of ascorbate, a sensitive assay for the redox activity of these metal ions.  We found that DHLA, but not LA, significantly inhibited ascorbate oxidn. mediated by Fe(III)-citrate, suggesting that reduced thiols are required for iron binding.  DHLA also strongly inhibited Cu(II)(histidine)2-mediated ascorbate oxidn. in a concn.-dependent manner, with complete inhibition at a DHLA:Cu(II) molar ratio of 3:1.  In contrast, no inhibition of copper-catalyzed ascorbate oxidn. was obsd. with LA.  To investigate whether LA and DHLA remove copper or iron from the active site of enzymes, Cu,Zn superoxide dismutase and the iron-contg. enzyme aconitase were used.  We found that neither LA nor DHLA, even at high, millimolar concns., altered the activity of these enzymes.  Our results suggest that DHLA chelates and inactivates redox-active transition metal ions in small-mol., biol. complexes without affecting iron- or copper-dependent enzyme activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxxfH-XQwivLVg90H21EOLACvtfcHk0liS-AHW3K6k9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtlajs70%253D&md5=1aabfe4bb0be8ff80f82fbfc487c9ae5</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1179%2F135100004225003923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1179%252F135100004225003923%26sid%3Dliteratum%253Aachs%26aulast%3DSuh%26aufirst%3DJ.%2BH.%26aulast%3DZhu%26aufirst%3DB.%2BZ.%26aulast%3DdeSzoeke%26aufirst%3DE.%26aulast%3DFrei%26aufirst%3DB.%26aulast%3DHagen%26aufirst%3DT.%2BM.%26atitle%3DDihydrolipoic%2520acid%2520lowers%2520the%2520redox%2520activity%2520of%2520transition%2520metal%2520ions%2520but%2520does%2520not%2520remove%2520them%2520from%2520the%2520active%2520site%2520of%2520enzymes%26jtitle%3DRedox%2520Rep.%26date%3D2004%26volume%3D9%26spage%3D57%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group">Michiels, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toussaint, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remacle, J.</span><span> </span><span class="NLM_article-title">Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress</span> <span class="citation_source-journal">Free Radical Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2F0891-5849%2894%2990079-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=7982629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaK2cXmslOitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1994&pages=235-248&author=C.+Michielsauthor=M.+Raesauthor=O.+Toussaintauthor=J.+Remacle&title=Importance+of+Se-glutathione+peroxidase%2C+catalase%2C+and+Cu%2FZn-SOD+for+cell+survival+against+oxidative+stress"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress</span></div><div class="casAuthors">Michiels, Carine; Raes, Martine; Toussaint, Olivier; Remacle, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">235-48</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    </div><div class="casAbstract">A review, with 110 refs., on: O-derived free radicals; antioxidant systems; protecting effects of the antioxidant enzymes; threshold of free radical attacks and modulation by antioxidant enzymes; effects of inhibition of the different antioxidant enzymes; and transfection of antioxidant enzyme cDNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7pT0pnOa9b7Vg90H21EOLACvtfcHk0lhYWjw4yfYZ_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmslOitLg%253D&md5=ae2b9a2e754a6618ac7932e62ee84457</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1016%2F0891-5849%2894%2990079-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0891-5849%252894%252990079-5%26sid%3Dliteratum%253Aachs%26aulast%3DMichiels%26aufirst%3DC.%26aulast%3DRaes%26aufirst%3DM.%26aulast%3DToussaint%26aufirst%3DO.%26aulast%3DRemacle%26aufirst%3DJ.%26atitle%3DImportance%2520of%2520Se-glutathione%2520peroxidase%252C%2520catalase%252C%2520and%2520Cu%252FZn-SOD%2520for%2520cell%2520survival%2520against%2520oxidative%2520stress%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D1994%26volume%3D17%26spage%3D235%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group">Nappi, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vass, E.</span><span> </span><span class="NLM_article-title">Comparative studies of enhanced iron-mediated production of hydroxyl radical by glutathione, cysteine, ascorbic acid, and selected catechols</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">1336</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1336&publication_year=1997&pages=295-302&author=A.+J.+Nappiauthor=E.+Vass&title=Comparative+studies+of+enhanced+iron-mediated+production+of+hydroxyl+radical+by+glutathione%2C+cysteine%2C+ascorbic+acid%2C+and+selected+catechols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNappi%26aufirst%3DA.%2BJ.%26aulast%3DVass%26aufirst%3DE.%26atitle%3DComparative%2520studies%2520of%2520enhanced%2520iron-mediated%2520production%2520of%2520hydroxyl%2520radical%2520by%2520glutathione%252C%2520cysteine%252C%2520ascorbic%2520acid%252C%2520and%2520selected%2520catechols%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1997%26volume%3D1336%26spage%3D295%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group">McIntyre, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayes, M.</span><span> </span><span class="NLM_article-title">Sarizotan hydrochloride</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">314</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1358%2Fdof.2006.031.04.982108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVylsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=314-319&author=J.+A.+McIntyreauthor=J.+Castanerauthor=M.+Bayes&title=Sarizotan+hydrochloride"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Sarizotan hydrochloride: antidyskinetic drug 5-HT1A receptor agonist dopamine D2 receptor ligand</span></div><div class="casAuthors">McIntyre, J. A.; Castaner, J.; Bayes, M.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">314-319</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  The treatment of Parkinson's disease with levodopa is assocd. with the development of dyskinesias, or involuntary movements.  The risk increases with increasing duration of treatment.  Sarizotan exhibits dual 5-HT1A receptor agonism and dopamine D2 receptor ligand activity and is in development for the treatment of dyskinesia assocd. with Parkinson's disease.  In an animal model of Parkinson's disease, sarizotan reduced levodopa-induced choreiform dyskinesias in monkeys by up to 90% without diminishing the antiparkinsonian efficacy of levodopa.  In hemiparkinsonian rats, sarizotan effectively reduced the abnormal involuntary movements, dystonia and contralateral rotations assocd. with chronic levodopa therapy.  In an initial proof-of-concept study in patients with moderate to advanced Parkinson's disease, sarizotan significantly reduced levodopa-induced dyskinesias in a within-patient comparison.  The efficacy of sarizotan was further demonstrated in an open-label study in which there was a significant increase between baseline and the final treatment visit in the percent "on" time without dyskinesia.  This benefit was maintained in a 1-yr follow-up.  Sarizotan has been well tolerated in clin. studies to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr21CO_hP5UnrVg90H21EOLACvtfcHk0lgMki_XtXHqwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVylsbo%253D&md5=fad99882b586e823c0da83b02af56340</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1358%2Fdof.2006.031.04.982108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2006.031.04.982108%26sid%3Dliteratum%253Aachs%26aulast%3DMcIntyre%26aufirst%3DJ.%2BA.%26aulast%3DCastaner%26aufirst%3DJ.%26aulast%3DBayes%26aufirst%3DM.%26atitle%3DSarizotan%2520hydrochloride%26jtitle%3DDrugs%2520Future%26date%3D2006%26volume%3D31%26spage%3D314%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group">Nicholson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchie, J. M.</span><span> </span><span class="NLM_article-title">5-Hydroxytryptamine (5-HT, serotonin) and Parkinsonʼs disease. Opportunities for novel therapeutics to reduce the problems of levodopa therapy</span> <span class="citation_source-journal">Eur. J. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1046%2Fj.1468-1331.9.s3.1.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=12464115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADC%252BD38jgt1yktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=1-6&issue=Suppl.+3&author=S.+L.+Nicholsonauthor=J.+M.+Brotchie&title=5-Hydroxytryptamine+%285-HT%2C+serotonin%29+and+Parkinson%CA%BCs+disease.+Opportunities+for+novel+therapeutics+to+reduce+the+problems+of+levodopa+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">5-hydroxytryptamine (5-HT, serotonin) and Parkinson's disease - opportunities for novel therapeutics to reduce the problems of levodopa therapy</span></div><div class="casAuthors">Nicholson S L; Brotchie J M</div><div class="citationInfo"><span class="NLM_cas:title">European journal of neurology : the official journal of the European Federation of Neurological Societies</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9 Suppl 3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-6</span>
        ISSN:<span class="NLM_cas:issn">1351-5101</span>.
    </div><div class="casAbstract">While Parkinson's disease is undoubtedly a disorder with a primary pathology of dopamine neuronal loss, that loss of dopamine and subsequent dopamine replacement therapy leads to imbalances in many non-dopaminergic transmitter systems, including 5-hydroxytryptamine (5-HT).  Recent advances in understanding the role of 5-HT in parkinsonism and the generation of side-effects of dopamine replacement therapy (e.g. wearing-off and levodopa-induced dyskinesia) have identified 5-HT1A, 5-HT1B and 5-HT2C receptors as potential therapeutic targets in Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDFVC73stjdnWEEzDrymxmfW6udTcc2eZNkhdrZ_SSv7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38jgt1yktQ%253D%253D&md5=190f721c9c5e3a5cdd645a323ff3131a</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1046%2Fj.1468-1331.9.s3.1.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1468-1331.9.s3.1.x%26sid%3Dliteratum%253Aachs%26aulast%3DNicholson%26aufirst%3DS.%2BL.%26aulast%3DBrotchie%26aufirst%3DJ.%2BM.%26atitle%3D5-Hydroxytryptamine%2520%25285-HT%252C%2520serotonin%2529%2520and%2520Parkinson%25CA%25BCs%2520disease.%2520Opportunities%2520for%2520novel%2520therapeutics%2520to%2520reduce%2520the%2520problems%2520of%2520levodopa%2520therapy%26jtitle%3DEur.%2520J.%2520Neurol.%26date%3D2002%26volume%3D9%26issue%3DSuppl.%25203%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group">Spires, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannan, A. J.</span><span> </span><span class="NLM_article-title">Molecular mechanisms mediating pathological plasticity in Huntingtonʼs disease and Alzheimerʼs disease</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">874</span><span class="NLM_x">–</span> <span class="NLM_lpage">882</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1111%2Fj.1471-4159.2006.04275.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17217424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisFGnurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2007&pages=874-882&author=T.+L.+Spiresauthor=A.+J.+Hannan&title=Molecular+mechanisms+mediating+pathological+plasticity+in+Huntington%CA%BCs+disease+and+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms mediating pathological plasticity in Huntington's disease and Alzheimer's disease</span></div><div class="casAuthors">Spires, Tara L.; Hannan, Anthony J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">874-882</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative diseases such as Huntington's disease and Alzheimer's disease, although very different in etiol., share common degenerative processes.  These include neuronal dysfunction, decreased neural connectivity, and disruption of cellular plasticity.  Understanding the mol. mechanisms underlying the neural plasticity deficits in these devastating conditions may lead the way toward new therapeutic targets, both disease-specific and more generalized, which can ameliorate degenerative cognitive deficits.  Furthermore, investigations of 'pathol. plasticity' in these diseases lend insight into normal brain function.  This review will present evidence for altered plasticity in Huntington's and Alzheimer's diseases, relate these findings to symptomatol., and review possible causes and commonalities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXDMEh_U7kELVg90H21EOLACvtfcHk0ljxD7YKXqd--g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisFGnurw%253D&md5=7a34d44e348aeb29be06e15070343cf3</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04275.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04275.x%26sid%3Dliteratum%253Aachs%26aulast%3DSpires%26aufirst%3DT.%2BL.%26aulast%3DHannan%26aufirst%3DA.%2BJ.%26atitle%3DMolecular%2520mechanisms%2520mediating%2520pathological%2520plasticity%2520in%2520Huntington%25CA%25BCs%2520disease%2520and%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D100%26spage%3D874%26epage%3D882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group">Bates, G.; Harper, P.; Jones, L.</span> <span class="citation_source-book">Huntingtonʼs Disease</span>, <span class="NLM_edition">3</span>rd ed.; <span class="NLM_publisher-name">Oxford University Press</span>: <span class="NLM_publisher-loc">Oxford, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=G.+Bates&author=P.+Harper&author=L.+Jones&title=Huntington%CA%BCs+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBates%26aufirst%3DG.%26btitle%3DHuntington%25CA%25BCs%2520Disease%26pub%3DOxford%2520University%2520Press%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group">van Dellen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grote, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannan, A. J.</span><span> </span><span class="NLM_article-title">Gene−environment interactions, neuronal dysfunction and pathological plasticity in Huntingtonʼs disease</span> <span class="citation_source-journal">Clin. Exp. Pharmacol. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1019</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1111%2Fj.1440-1681.2005.04313.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16445565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtFaitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2005&pages=1007-1019&author=A.+van+Dellenauthor=H.+E.+Groteauthor=A.+J.+Hannan&title=Gene%E2%88%92environment+interactions%2C+neuronal+dysfunction+and+pathological+plasticity+in+Huntington%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Gene-environment interactions, neuronal dysfunction and pathological plasticity in Huntington's disease</span></div><div class="casAuthors">van Dellen, Anton; Grote, Helen E.; Hannan, Anthony J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Pharmacology and Physiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1007-1019</span>CODEN:
                <span class="NLM_cas:coden">CEXPB9</span>;
        ISSN:<span class="NLM_cas:issn">0305-1870</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">A review.  Huntington's disease (HD) is a fatal autosomal dominant disorder in which there is progressive neurodegeneration producing motor, cognitive and psychiatric symptoms.  The dynamic mutation that causes the disease is common to numerous other brain disorders, which may share similar pathogenic mechanisms.  Much progress has been made in the past decade in understanding how a trinucleotide (CAG) repeat expansion, encoding an expanded polyglutamine tract in the huntingtin protein, induces dysfunction at mol. and cellular levels.  The present review integrates various lines of exptl. evidence in an attempt to move towards a unifying mechanistic framework, which may explain the pathogenesis of HD, from mol. through to neuronal network and behavioral levels.  Recent evidence, using transgenic mouse models, also suggests that environmental factors can modify the onset and progression of HD.  The effects of specific environmental manipulations are discussed in the context of gene-environment interactions and experience-dependent plasticity in the healthy and diseased brain, particularly the cerebral cortex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpadwVYKG-KYbVg90H21EOLACvtfcHk0liJDe6eyXISdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtFaitw%253D%253D&md5=4c5229e1d1698b630d5766cd1abdf68f</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1111%2Fj.1440-1681.2005.04313.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1440-1681.2005.04313.x%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BDellen%26aufirst%3DA.%26aulast%3DGrote%26aufirst%3DH.%2BE.%26aulast%3DHannan%26aufirst%3DA.%2BJ.%26atitle%3DGene%25E2%2588%2592environment%2520interactions%252C%2520neuronal%2520dysfunction%2520and%2520pathological%2520plasticity%2520in%2520Huntington%25CA%25BCs%2520disease%26jtitle%3DClin.%2520Exp.%2520Pharmacol.%2520Physiol.%26date%3D2005%26volume%3D32%26spage%3D1007%26epage%3D1019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group">Tarlac, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storey, E.</span><span> </span><span class="NLM_article-title">Role of proteolysis in polyglutamine disorders</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">406</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fjnr.10746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=14598317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptFWnt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2003&pages=406-416&author=V.+Tarlacauthor=E.+Storey&title=Role+of+proteolysis+in+polyglutamine+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Role of proteolysis in polyglutamine disorders</span></div><div class="casAuthors">Tarlac, V.; Storey, E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">406-416</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  To date, nine polyglutamine disorders have been characterized, including Huntington's disease (HD), spinobulbar muscular atrophy (SBMA), dentatorubralpallidoluysian atrophy (DRPLA), and spinocerebellar ataxias 1, 2, 3, 6, 7 and 17 (SCAs).  Although knockout and transgenic mouse expts. suggest that a toxic gain of function is central to neuronal death in these diseases (with the probable exception of SCA6), the exact mechanisms of neurotoxicity remain contentious.  A further conundrum is the characteristic distribution of neuronal damage in each disease, despite ubiquitous expression of the abnormal proteins.  One mechanism that could possibly underlie the specific distribution of neuronal toxicity is proteolytic cleavage of the full-length expanded polyglutamine tract-contg. proteins.  There is evidence found in vitro or in vivo (or both) of proteolytic cleavage in HD, SBMA, DRPLA, and SCAs 2, 3, and 7.  In HD, cleavage has been demonstrated to be regionally specific, occurring as a result of caspase activation.  These diseases are also characterized by development of intra-neuronal aggregates of the abnormal protein that co-localize with components of the ubiquitin-proteasome pathway.  It remains unclear whether these aggregates are pathogenic or merely disease markers; however, at least in the case of ataxin-3, cleavage promotes aggregation.  Inhibition of specific proteases constitutes a potential therapeutic approach in these diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkz1EUfPsR3LVg90H21EOLACvtfcHk0ljYK4AzcrThsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptFWnt74%253D&md5=891e0cb99c1b6cf056478668508b5089</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1002%2Fjnr.10746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.10746%26sid%3Dliteratum%253Aachs%26aulast%3DTarlac%26aufirst%3DV.%26aulast%3DStorey%26aufirst%3DE.%26atitle%3DRole%2520of%2520proteolysis%2520in%2520polyglutamine%2520disorders%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2003%26volume%3D74%26spage%3D406%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group">Arrasate, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweitzer, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segal, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finkbeiner, S.</span><span> </span><span class="NLM_article-title">Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">431</span><span class="NLM_x">, </span> <span class="NLM_fpage">805</span><span class="NLM_x">–</span> <span class="NLM_lpage">810</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnature02998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15483602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotl2ktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=431&publication_year=2004&pages=805-810&author=M.+Arrasateauthor=S.+Mitraauthor=E.+S.+Schweitzerauthor=M.+R.+Segalauthor=S.+Finkbeiner&title=Inclusion+body+formation+reduces+levels+of+mutant+huntingtin+and+the+risk+of+neuronal+death"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death</span></div><div class="casAuthors">Arrasate, Montserrat; Mitra, Siddhartha; Schweitzer, Erik S.; Segal, Mark R.; Finkbeiner, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">431</span>
        (<span class="NLM_cas:issue">7010</span>),
    <span class="NLM_cas:pages">805-810</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Huntington's disease is caused by an abnormal poly-glutamine expansion within the protein huntingtin and is characterized by microscopic inclusion bodies of aggregated huntingtin and by the death of selected types of neuron.  Whether inclusion bodies are pathogenic, incidental or a beneficial coping response is controversial.  To resolve this issue we have developed an automated microscope that returns to precisely the same neuron after arbitrary intervals, even after cells have been removed from the microscope stage.  Here we show, by survival anal., that neurons die in a time-independent fashion but one that is dependent on mutant huntingtin dose and poly-glutamine expansion; many neurons die without forming an inclusion body.  Rather, the amt. of diffuse intracellular huntingtin predicts whether and when inclusion body formation or death will occur.  Surprisingly, inclusion body formation predicts improved survival and leads to decreased levels of mutant huntingtin elsewhere in a neuron.  Thus, inclusion body formation can function as a coping response to toxic mutant huntingtin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4cEVA-oqxdLVg90H21EOLACvtfcHk0liZZCovu_4zCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotl2ktrc%253D&md5=6c5f5ffc582e0015fa0a3c3ca0051e64</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1038%2Fnature02998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02998%26sid%3Dliteratum%253Aachs%26aulast%3DArrasate%26aufirst%3DM.%26aulast%3DMitra%26aufirst%3DS.%26aulast%3DSchweitzer%26aufirst%3DE.%2BS.%26aulast%3DSegal%26aufirst%3DM.%2BR.%26aulast%3DFinkbeiner%26aufirst%3DS.%26atitle%3DInclusion%2520body%2520formation%2520reduces%2520levels%2520of%2520mutant%2520huntingtin%2520and%2520the%2520risk%2520of%2520neuronal%2520death%26jtitle%3DNature%26date%3D2004%26volume%3D431%26spage%3D805%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group">Panov, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutekunst, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leavitt, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayden, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strittmatter, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenamyre, J. T.</span><span> </span><span class="NLM_article-title">Early mitochondrial calcium defects in Huntingtonʼs disease are a direct effect of polyglutamines</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">731</span><span class="NLM_x">–</span> <span class="NLM_lpage">736</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=12089530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFaqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2002&pages=731-736&author=A.+V.+Panovauthor=C.+A.+Gutekunstauthor=B.+R.+Leavittauthor=M.+R.+Haydenauthor=J.+R.+Burkeauthor=W.+J.+Strittmatterauthor=J.+T.+Greenamyre&title=Early+mitochondrial+calcium+defects+in+Huntington%CA%BCs+disease+are+a+direct+effect+of+polyglutamines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines</span></div><div class="casAuthors">Panov, Alexander V.; Gutekunst, Claire-Anne; Leavitt, Blair R.; Hayden, Michael R.; Burke, James R.; Strittmatter, Warren J.; Greenamyre, J. Timothy</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">731-736</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Huntington's disease (HD) is caused by an expansion of exonic CAG triplet repeats in the gene encoding huntingtin protein (Htt), but the mechanisms by which this mutant protein causes neurodegeneration remain unknown.  Here we show that lymphoblast mitochondria from patients with HD have a lower membrane potential and depolarize at lower calcium loads than do mitochondria from controls.  We found a similar defect in brain mitochondria from transgenic mice expressing full-length mutant huntingtin, and this defect preceded the onset of pathol. or behavioral abnormalities by months.  By electron microscopy, we identified N-terminal mutant huntingtin on neuronal mitochondrial membranes, and by incubating normal mitochondria with a fusion protein contg. an abnormally long polyglutamine repeat, we reproduced the mitochondrial calcium defect seen in human patients and transgenic animals.  Thus, mitochondrial calcium abnormalities occur early in HD pathogenesis and may be a direct effect of mutant huntingtin on the organelle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqpe87fhbCK7Vg90H21EOLACvtfcHk0liZZCovu_4zCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFaqu7g%253D&md5=59fd63b141c8f7205c791fa36ad9d33d</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPanov%26aufirst%3DA.%2BV.%26aulast%3DGutekunst%26aufirst%3DC.%2BA.%26aulast%3DLeavitt%26aufirst%3DB.%2BR.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26aulast%3DBurke%26aufirst%3DJ.%2BR.%26aulast%3DStrittmatter%26aufirst%3DW.%2BJ.%26aulast%3DGreenamyre%26aufirst%3DJ.%2BT.%26atitle%3DEarly%2520mitochondrial%2520calcium%2520defects%2520in%2520Huntington%25CA%25BCs%2520disease%2520are%2520a%2520direct%2520effect%2520of%2520polyglutamines%26jtitle%3DNat.%2520Neurosci.%26date%3D2002%26volume%3D5%26spage%3D731%26epage%3D736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group">Firdaus, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyttenbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Latoud, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currie, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrigo, A. P.</span><span> </span><span class="NLM_article-title">Analysis of oxidative events induced by expanded polyglutamine huntingtin exon 1 that are differentially restored by expression of heat shock proteins or treatment with an antioxidant</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">3076</span><span class="NLM_x">–</span> <span class="NLM_lpage">3093</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=2006&pages=3076-3093&author=W.+J.+Firdausauthor=A.+Wyttenbachauthor=C.+Diaz-Latoudauthor=R.+W.+Currieauthor=A.+P.+Arrigo&title=Analysis+of+oxidative+events+induced+by+expanded+polyglutamine+huntingtin+exon+1+that+are+differentially+restored+by+expression+of+heat+shock+proteins+or+treatment+with+an+antioxidant"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFirdaus%26aufirst%3DW.%2BJ.%26aulast%3DWyttenbach%26aufirst%3DA.%26aulast%3DDiaz-Latoud%26aufirst%3DC.%26aulast%3DCurrie%26aufirst%3DR.%2BW.%26aulast%3DArrigo%26aufirst%3DA.%2BP.%26atitle%3DAnalysis%2520of%2520oxidative%2520events%2520induced%2520by%2520expanded%2520polyglutamine%2520huntingtin%2520exon%25201%2520that%2520are%2520differentially%2520restored%2520by%2520expression%2520of%2520heat%2520shock%2520proteins%2520or%2520treatment%2520with%2520an%2520antioxidant%26jtitle%3DFEBS%2520J.%26date%3D2006%26volume%3D273%26spage%3D3076%26epage%3D3093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group">Firdaus, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyttenbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kretz-Remy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currie, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrigo, A. P.</span><span> </span><span class="NLM_article-title">Huntingtin inclusion bodies are iron-dependent centers of oxidative events</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">5428</span><span class="NLM_x">–</span> <span class="NLM_lpage">5441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=2006&pages=5428-5441&author=W.+J.+Firdausauthor=A.+Wyttenbachauthor=P.+Giulianoauthor=C.+Kretz-Remyauthor=R.+W.+Currieauthor=A.+P.+Arrigo&title=Huntingtin+inclusion+bodies+are+iron-dependent+centers+of+oxidative+events"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFirdaus%26aufirst%3DW.%2BJ.%26aulast%3DWyttenbach%26aufirst%3DA.%26aulast%3DGiuliano%26aufirst%3DP.%26aulast%3DKretz-Remy%26aufirst%3DC.%26aulast%3DCurrie%26aufirst%3DR.%2BW.%26aulast%3DArrigo%26aufirst%3DA.%2BP.%26atitle%3DHuntingtin%2520inclusion%2520bodies%2520are%2520iron-dependent%2520centers%2520of%2520oxidative%2520events%26jtitle%3DFEBS%2520J.%26date%3D2006%26volume%3D273%26spage%3D5428%26epage%3D5441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group">Mulder, D. W.</span><span> </span><span class="NLM_article-title">Clinical limits of amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Adv. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=7180681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADyaL3s%252Fps1yqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1982&pages=15-22&author=D.+W.+Mulder&title=Clinical+limits+of+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical limits of amyotrophic lateral sclerosis</span></div><div class="casAuthors">Mulder D W</div><div class="citationInfo"><span class="NLM_cas:title">Advances in neurology</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15-22</span>
        ISSN:<span class="NLM_cas:issn">0091-3952</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAAieAWmRWDEBuFdjgVNKSfW6udTcc2eanBe3q4AMnrrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3s%252Fps1yqsA%253D%253D&md5=845d754b50ccadc1e9c00d71658947b5</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMulder%26aufirst%3DD.%2BW.%26atitle%3DClinical%2520limits%2520of%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DAdv.%2520Neurol.%26date%3D1982%26volume%3D36%26spage%3D15%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group">Ince, P. G.</span> In  <span class="citation_source-book">Amyotrophic Lateral Sclerosis</span>; <span class="NLM_contrib-group">Brown, R. H.,  Jr.; Meininger, V.; Swash, M.</span>, Eds.; <span class="NLM_publisher-name">Martin Dunitz</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=83-112&author=P.+G.+Ince&title=Amyotrophic+Lateral+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DInce%26aufirst%3DP.%2BG.%26btitle%3DAmyotrophic%2520Lateral%2520Sclerosis%26aulast%3DBrown%26aufirst%3DR.%2BH.%26pub%3DMartin%2520Dunitz%26date%3D2000%26spage%3D83%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group">Gurney, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Canto, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polchow, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caliendo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hentati, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, H. X.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">264</span><span class="NLM_x">, </span> <span class="NLM_fpage">1772</span><span class="NLM_x">–</span> <span class="NLM_lpage">1775</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=264&publication_year=1994&pages=1772-1775&author=M.+E.+Gurneyauthor=H.+Puauthor=A.+Y.+Chiuauthor=M.+C.+Dal+Cantoauthor=C.+Y.+Polchowauthor=D.+D.+Alexanderauthor=J.+Caliendoauthor=A.+Hentatiauthor=Y.+W.+Kwonauthor=H.+X.+Deng&title=Motor+neuron+degeneration+in+mice+that+express+a+human+Cu%2CZn+superoxide+dismutase+mutation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGurney%26aufirst%3DM.%2BE.%26aulast%3DPu%26aufirst%3DH.%26aulast%3DChiu%26aufirst%3DA.%2BY.%26aulast%3DDal%2BCanto%26aufirst%3DM.%2BC.%26aulast%3DPolchow%26aufirst%3DC.%2BY.%26aulast%3DAlexander%26aufirst%3DD.%2BD.%26aulast%3DCaliendo%26aufirst%3DJ.%26aulast%3DHentati%26aufirst%3DA.%26aulast%3DKwon%26aufirst%3DY.%2BW.%26aulast%3DDeng%26aufirst%3DH.%2BX.%26atitle%3DMotor%2520neuron%2520degeneration%2520in%2520mice%2520that%2520express%2520a%2520human%2520Cu%252CZn%2520superoxide%2520dismutase%2520mutation%26jtitle%3DScience%26date%3D1994%26volume%3D264%26spage%3D1772%26epage%3D1775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group">Rakhit, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakrabartty, A.</span><span> </span><span class="NLM_article-title">Structure, folding, and misfolding of Cu,Zn superoxide dismutase in amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1762</span><span class="NLM_x">, </span> <span class="NLM_fpage">1025</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1762&publication_year=2006&pages=1025-1037&author=R.+Rakhitauthor=A.+Chakrabartty&title=Structure%2C+folding%2C+and+misfolding+of+Cu%2CZn+superoxide+dismutase+in+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRakhit%26aufirst%3DR.%26aulast%3DChakrabartty%26aufirst%3DA.%26atitle%3DStructure%252C%2520folding%252C%2520and%2520misfolding%2520of%2520Cu%252CZn%2520superoxide%2520dismutase%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2006%26volume%3D1762%26spage%3D1025%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group">Deng, H. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorrie, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigio, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Canto, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OʼHalloran, T. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddique, T.</span><span> </span><span class="NLM_article-title">Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria</span> <span class="citation_source-journal">Proc. Natl. Acad. Sc.i U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">7142</span><span class="NLM_x">–</span> <span class="NLM_lpage">7147</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1073%2Fpnas.0602046103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16636275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslCktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=7142-7147&author=H.+X.+Dengauthor=Y.+Shiauthor=Y.+Furukawaauthor=H.+Zhaiauthor=R.+Fuauthor=E.+Liuauthor=G.+H.+Gorrieauthor=M.+S.+Khanauthor=W.+Y.+Hungauthor=E.+H.+Bigioauthor=T.+Lukasauthor=M.+C.+Dal+Cantoauthor=T.+V.+O%CA%BCHalloranauthor=T.+Siddique&title=Conversion+to+the+amyotrophic+lateral+sclerosis+phenotype+is+associated+with+intermolecular+linked+insoluble+aggregates+of+SOD1+in+mitochondria"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria</span></div><div class="casAuthors">Deng, Han-Xiang; Shi, Yong; Furukawa, Yoshiaki; Zhai, Hong; Fu, Ronggen; Liu, Erdong; Gorrie, George H.; Khan, Mohammad S.; Hung, Wu-Yen; Bigio, Eileen H.; Lukas, Thomas; Dal Canto, Mauro C.; O'Halloran, Thomas V.; Siddique, Teepu</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7142-7147</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Twenty percent of the familial form of amyotrophic lateral sclerosis (ALS) is caused by mutations in the Cu, Zn-superoxide dismutase gene (SOD1) through the gain of a toxic function.  The nature of this toxic function of mutant SOD1 has remained largely unknown.  Here we show that WT SOD1 not only hastens onset of the ALS phenotype but can also convert an unaffected phenotype to an ALS phenotype in mutant SOD1 transgenic mouse models.  Further analyses of the single- and double-transgenic mice revealed that conversion of mutant SOD1 from a sol. form to an aggregated and detergent-insol. form was assocd. with development of the ALS phenotype in transgenic mice.  Conversion of WT SOD1 from a sol. form to an aggregated and insol. form also correlates with exacerbation of the disease or conversion to a disease phenotype in double-transgenic mice.  This conversion, obsd. in the mitochondrial fraction of the spinal cord, involved formation of insol. SOD1 dimers and multimers that are crosslinked through intermol. disulfide bonds via oxidn. of cysteine residues in SOD1.  Our data thus show a mol. mechanism by which SOD1, an important protein in cellular defense against free radicals, is converted to aggregated and apparently ALS-assocd. toxic dimers and multimers by redox processes.  These findings provide evidence of direct links among oxidn., protein aggregation, mitochondrial damage, and SOD1-mediated ALS, with possible applications to the aging process and other late-onset neurodegenerative disorders.  Importantly, rational therapy based on these observations can now be developed and tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7JwV_hQLzRrVg90H21EOLACvtfcHk0ljujyErVMlv0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslCktLg%253D&md5=c3a2c3ef835a417ab5072963db77ccfd</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0602046103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0602046103%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DH.%2BX.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DFurukawa%26aufirst%3DY.%26aulast%3DZhai%26aufirst%3DH.%26aulast%3DFu%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DE.%26aulast%3DGorrie%26aufirst%3DG.%2BH.%26aulast%3DKhan%26aufirst%3DM.%2BS.%26aulast%3DHung%26aufirst%3DW.%2BY.%26aulast%3DBigio%26aufirst%3DE.%2BH.%26aulast%3DLukas%26aufirst%3DT.%26aulast%3DDal%2BCanto%26aufirst%3DM.%2BC.%26aulast%3DO%25CA%25BCHalloran%26aufirst%3DT.%2BV.%26aulast%3DSiddique%26aufirst%3DT.%26atitle%3DConversion%2520to%2520the%2520amyotrophic%2520lateral%2520sclerosis%2520phenotype%2520is%2520associated%2520with%2520intermolecular%2520linked%2520insoluble%2520aggregates%2520of%2520SOD1%2520in%2520mitochondria%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sc.i%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D7142%26epage%3D7147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group">Pasinelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. H.</span><span> </span><span class="NLM_article-title">Molecular biology of amyotrophic lateral sclerosis: insights from genetics</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnrn1971" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16924260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlCgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=710-723&author=P.+Pasinelliauthor=R.+H.+Brown&title=Molecular+biology+of+amyotrophic+lateral+sclerosis%3A+insights+from+genetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular biology of amyotrophic lateral sclerosis: insights from genetics</span></div><div class="casAuthors">Pasinelli, Piera; Brown, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">710-723</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Amyotrophic lateral sclerosis (ALS) is a paralytic disorder caused by motor neuron degeneration.  Mutations in more than 50 human genes cause diverse types of motor neuron pathol.  Moreover, defects in five Mendelian genes lead to motor neuron disease, with two mutations reproducing the ALS phenotype.  Analyses of these genetic effects have generated new insights into the diverse mol. pathways involved in ALS pathogenesis.  Here, we present an overview of the mechanisms for motor neuron death and of the role of non-neuronal cells in ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGeL8ButRoa7Vg90H21EOLACvtfcHk0lhuAm4fC6Q8EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlCgtro%253D&md5=0c023f607f81378751f0b2c3cd8310f7</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1038%2Fnrn1971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1971%26sid%3Dliteratum%253Aachs%26aulast%3DPasinelli%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DR.%2BH.%26atitle%3DMolecular%2520biology%2520of%2520amyotrophic%2520lateral%2520sclerosis%253A%2520insights%2520from%2520genetics%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2006%26volume%3D7%26spage%3D710%26epage%3D723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borchelt, D. R.</span><span> </span><span class="NLM_article-title">High molecular weight complexes of mutant superoxide dismutase 1: age-dependent and tissue-specific accumulation</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1006%2Fnbdi.2001.0471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=11895367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvVSksrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=139-148&author=J.+Wangauthor=G.+Xuauthor=D.+R.+Borchelt&title=High+molecular+weight+complexes+of+mutant+superoxide+dismutase+1%3A+age-dependent+and+tissue-specific+accumulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">High Molecular Weight Complexes of Mutant Superoxide Dismutase 1: Age-Dependent and Tissue-Specific Accumulation</span></div><div class="casAuthors">Wang, Jiou; Xu, Guilian; Borchelt, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-148</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Mutations in the cytosolic enzyme, superoxide dismutase 1, have been identified as the cause of motor neuron disease in a subset of cases of familial amyotrophic lateral sclerosis.  It has been postulated that the injurious property of mutant enzyme resides in its propensity to aggregate or its propensity to catalyze deleterious, copper-mediated, chemistries.  Aggregates of SOD1 have been identified, histol., in neurons and astroglia of the spinal cords of SOD1-linked FALS patients and in transgenic mice that express these mutant proteins.  In the present study, we have employed a technique used in detecting and quantifying aggregates of mutant huntingtin (cellulose acetate filtration) to examine the mol. characteristics of mutant SOD1 in three previously characterized transgenic mouse models of FALS.  The brains and spinal cords of these mice accumulate mutant SOD1 complexes that can be trapped by cellulose acetate filtration.  The relative abundance of these structures increases dramatically with age.  Although expressed to the same level in nonnervous tissues, mutant SOD1 was not found in high mol. wt. structures.  We conclude that some aspect of the biol. of neural tissues (in a setting of declining motor neuron function) predisposes to the accumulation of high mol. wt. complexes of mutant SOD1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1LrTI2-qYQrVg90H21EOLACvtfcHk0lhuAm4fC6Q8EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvVSksrw%253D&md5=effd7d4c1cd5c379b8fd68429313586f</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1006%2Fnbdi.2001.0471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fnbdi.2001.0471%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DBorchelt%26aufirst%3DD.%2BR.%26atitle%3DHigh%2520molecular%2520weight%2520complexes%2520of%2520mutant%2520superoxide%2520dismutase%25201%253A%2520age-dependent%2520and%2520tissue-specific%2520accumulation%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2002%26volume%3D9%26spage%3D139%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group">Johnston, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalton, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurney, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopito, R. R.</span><span> </span><span class="NLM_article-title">Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">12571</span><span class="NLM_x">–</span> <span class="NLM_lpage">12576</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1073%2Fpnas.220417997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=11050163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotFygt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=12571-12576&author=J.+A.+Johnstonauthor=M.+J.+Daltonauthor=M.+E.+Gurneyauthor=R.+R.+Kopito&title=Formation+of+high+molecular+weight+complexes+of+mutant+Cu%2C+Zn-superoxide+dismutase+in+a+mouse+model+for+familial+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Formation of high molecular weight complexes of mutant Cu,Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis</span></div><div class="casAuthors">Johnston, Jennifer A.; Dalton, Muffie J.; Gurney, Mark E.; Kopito, Ron R.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">12571-12576</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Deposition of aggregated protein into neurofilament-rich cytoplasmic inclusion bodies is a common cytopathol. feature of neurodegenerative disease.  How-or indeed whether-protein aggregation and inclusion body formation cause neurotoxicity are presently unknown.  Here, we show that the capacity of superoxide dismutase (SOD) to aggregate into biochem. distinct, high mol. wt., insol. protein complexes (IPCs) is a gain of function assocd. with mutations linked to autosomal dominant familial amyotrophic lateral sclerosis.  SOD IPCs are detectable in spinal cord exts. from transgenic mice expressing mutant SOD several months before inclusion bodies and motor neuron pathol. are apparent.  Sequestration of mutant SOD into cytoplasmic inclusion bodies resembling aggresomes requires retrograde transport on microtubules.  These data indicate that aggregation and inclusion body formation are mechanistically and temporally distinct processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-ZLh_Cnv-67Vg90H21EOLACvtfcHk0lg2jfKiGgHyuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotFygt7c%253D&md5=85abbf2d15a35bc59273345093f58f87</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1073%2Fpnas.220417997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.220417997%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DJ.%2BA.%26aulast%3DDalton%26aufirst%3DM.%2BJ.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26aulast%3DKopito%26aufirst%3DR.%2BR.%26atitle%3DFormation%2520of%2520high%2520molecular%2520weight%2520complexes%2520of%2520mutant%2520Cu%252C%2520Zn-superoxide%2520dismutase%2520in%2520a%2520mouse%2520model%2520for%2520familial%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D12571%26epage%3D12576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref208"><div class="reference"><strong class="refLabel"><a href="#ref208" class="rightTabRefNumLink">208</a></strong><div class="NLM_citation" id="rightTab-cit208"><span><span class="NLM_contrib-group">Bruijn, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houseweart, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohama, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reaume, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleveland, D. W.</span><span> </span><span class="NLM_article-title">Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">1851</span><span class="NLM_x">–</span> <span class="NLM_lpage">1854</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=1998&pages=1851-1854&author=L.+I.+Bruijnauthor=M.+K.+Houseweartauthor=S.+Katoauthor=K.+L.+Andersonauthor=S.+D.+Andersonauthor=E.+Ohamaauthor=A.+G.+Reaumeauthor=R.+W.+Scottauthor=D.+W.+Cleveland&title=Aggregation+and+motor+neuron+toxicity+of+an+ALS-linked+SOD1+mutant+independent+from+wild-type+SOD1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBruijn%26aufirst%3DL.%2BI.%26aulast%3DHouseweart%26aufirst%3DM.%2BK.%26aulast%3DKato%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DK.%2BL.%26aulast%3DAnderson%26aufirst%3DS.%2BD.%26aulast%3DOhama%26aufirst%3DE.%26aulast%3DReaume%26aufirst%3DA.%2BG.%26aulast%3DScott%26aufirst%3DR.%2BW.%26aulast%3DCleveland%26aufirst%3DD.%2BW.%26atitle%3DAggregation%2520and%2520motor%2520neuron%2520toxicity%2520of%2520an%2520ALS-linked%2520SOD1%2520mutant%2520independent%2520from%2520wild-type%2520SOD1%26jtitle%3DScience%26date%3D1998%26volume%3D281%26spage%3D1851%26epage%3D1854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref209"><div class="reference"><strong class="refLabel"><a href="#ref209" class="rightTabRefNumLink">209</a></strong><div class="NLM_citation" id="rightTab-cit209"><span><span class="NLM_contrib-group">Ray, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strokovich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. H.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lansbury, P. T.,  Jr</span><span> </span><span class="NLM_article-title">An intersubunit disulfide bond prevents in vitro aggregation of a superoxide dismutase-1 mutant linked to familial amytrophic lateral sclerosis</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4899</span><span class="NLM_x">–</span> <span class="NLM_lpage">4905</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi030246r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=4899-4905&author=S.+S.+Rayauthor=R.+J.+Nowakauthor=K.+Strokovichauthor=R.+H.+Brownauthor=T.+Walzauthor=P.+T.+Lansbury&title=An+intersubunit+disulfide+bond+prevents+in+vitro+aggregation+of+a+superoxide+dismutase-1+mutant+linked+to+familial+amytrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1021%2Fbi030246r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi030246r%26sid%3Dliteratum%253Aachs%26aulast%3DRay%26aufirst%3DS.%2BS.%26aulast%3DNowak%26aufirst%3DR.%2BJ.%26aulast%3DStrokovich%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DR.%2BH.%26aulast%3DWalz%26aufirst%3DT.%26aulast%3DLansbury%26aufirst%3DP.%2BT.%26atitle%3DAn%2520intersubunit%2520disulfide%2520bond%2520prevents%2520in%2520vitro%2520aggregation%2520of%2520a%2520superoxide%2520dismutase-1%2520mutant%2520linked%2520to%2520familial%2520amytrophic%2520lateral%2520sclerosis%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D4899%26epage%3D4905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref210"><div class="reference"><strong class="refLabel"><a href="#ref210" class="rightTabRefNumLink">210</a></strong><div class="NLM_citation" id="rightTab-cit210"><span><span class="NLM_contrib-group">Matsumoto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morimoto, R. I.</span><span> </span><span class="NLM_article-title">Huntingtin and mutant SOD1 form aggregate structures with distinct molecular properties in human cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">4477</span><span class="NLM_x">–</span> <span class="NLM_lpage">4485</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=4477-4485&author=G.+Matsumotoauthor=S.+Kimauthor=R.+I.+Morimoto&title=Huntingtin+and+mutant+SOD1+form+aggregate+structures+with+distinct+molecular+properties+in+human+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumoto%26aufirst%3DG.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DMorimoto%26aufirst%3DR.%2BI.%26atitle%3DHuntingtin%2520and%2520mutant%2520SOD1%2520form%2520aggregate%2520structures%2520with%2520distinct%2520molecular%2520properties%2520in%2520human%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D4477%26epage%3D4485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref211"><div class="reference"><strong class="refLabel"><a href="#ref211" class="rightTabRefNumLink">211</a></strong><div class="NLM_citation" id="rightTab-cit211"><span><span class="NLM_contrib-group">Bacman, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moraes, C. T.</span><span> </span><span class="NLM_article-title">Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target</span> <span class="citation_source-journal">Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1385%2FMN%3A33%3A2%3A113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16603792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFOmtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=113-131&author=S.+R.+Bacmanauthor=W.+G.+Bradleyauthor=C.+T.+Moraes&title=Mitochondrial+involvement+in+amyotrophic+lateral+sclerosis%3A+trigger+or+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondrial involvement in amyotrophic lateral sclerosis. Trigger or target?</span></div><div class="casAuthors">Bacman, Sandra R.; Bradley, Walter G.; Moraes, Carlos T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">113-131</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Despite numerous reports demonstrating mitochondrial abnormalities assocd. with amyotrophic lateral sclerosis (ALS), the role of mitochondrial dysfunction in the disease onset and progression remains unknown.  The intrinsic mitochondrial apoptotic program is activated in the central nervous system of mouse models of ALS harboring mutant superoxide dismutase 1 protein.  This is assocd. with the release of cytochrome-c from the mitochondrial intermembrane space and mitochondrial swelling.  However, it is unclear if the obsd. mitochondrial changes are caused by the decreasing cellular viability or if these changes precede and actually trigger apoptosis.  This article discusses the current evidence for mitochondrial involvement in familial and sporadic ALS and concludes that mitochondria is likely to be both a trigger and a target in ALS and that their demise is a crit. step in the motor neuron death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_zr-rp7GijbVg90H21EOLACvtfcHk0lifPeENql_Hqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFOmtbo%253D&md5=614f8c9b4330ea7f12c46c72f924aaa1</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1385%2FMN%3A33%3A2%3A113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FMN%253A33%253A2%253A113%26sid%3Dliteratum%253Aachs%26aulast%3DBacman%26aufirst%3DS.%2BR.%26aulast%3DBradley%26aufirst%3DW.%2BG.%26aulast%3DMoraes%26aufirst%3DC.%2BT.%26atitle%3DMitochondrial%2520involvement%2520in%2520amyotrophic%2520lateral%2520sclerosis%253A%2520trigger%2520or%2520target%26jtitle%3DMol.%2520Neurobiol.%26date%3D2006%26volume%3D33%26spage%3D113%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref212"><div class="reference"><strong class="refLabel"><a href="#ref212" class="rightTabRefNumLink">212</a></strong><div class="NLM_citation" id="rightTab-cit212"><span><span class="NLM_contrib-group">Okado-Matsumoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridovich, I.</span><span> </span><span class="NLM_article-title">Amyotrophic lateral sclerosis: a proposed mechanism</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">9010</span><span class="NLM_x">–</span> <span class="NLM_lpage">9014</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=9010-9014&author=A.+Okado-Matsumotoauthor=I.+Fridovich&title=Amyotrophic+lateral+sclerosis%3A+a+proposed+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkado-Matsumoto%26aufirst%3DA.%26aulast%3DFridovich%26aufirst%3DI.%26atitle%3DAmyotrophic%2520lateral%2520sclerosis%253A%2520a%2520proposed%2520mechanism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D9010%26epage%3D9014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref213"><div class="reference"><strong class="refLabel"><a href="#ref213" class="rightTabRefNumLink">213</a></strong><div class="NLM_citation" id="rightTab-cit213"><span><span class="NLM_contrib-group">Pasinelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belford, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lennon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacskai, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trotti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, R. H.,  Jr</span><span> </span><span class="NLM_article-title">Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=19-30&author=P.+Pasinelliauthor=M.+E.+Belfordauthor=N.+Lennonauthor=B.+J.+Bacskaiauthor=B.+T.+Hymanauthor=D.+Trottiauthor=R.+H.+Brown&title=Amyotrophic+lateral+sclerosis-associated+SOD1+mutant+proteins+bind+and+aggregate+with+Bcl-2+in+spinal+cord+mitochondria"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPasinelli%26aufirst%3DP.%26aulast%3DBelford%26aufirst%3DM.%2BE.%26aulast%3DLennon%26aufirst%3DN.%26aulast%3DBacskai%26aufirst%3DB.%2BJ.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DTrotti%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DR.%2BH.%26atitle%3DAmyotrophic%2520lateral%2520sclerosis-associated%2520SOD1%2520mutant%2520proteins%2520bind%2520and%2520aggregate%2520with%2520Bcl-2%2520in%2520spinal%2520cord%2520mitochondria%26jtitle%3DNeuron%26date%3D2004%26volume%3D43%26spage%3D19%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref214"><div class="reference"><strong class="refLabel"><a href="#ref214" class="rightTabRefNumLink">214</a></strong><div class="NLM_citation" id="rightTab-cit214"><span><span class="NLM_contrib-group">Rothstein, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuncl, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clawson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornblath, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drachman, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pestronk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauch, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyle, J. T.</span><span> </span><span class="NLM_article-title">Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fana.410280106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=2375630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaK3MXksVOitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1990&pages=18-25&author=J.+D.+Rothsteinauthor=G.+Tsaiauthor=R.+W.+Kunclauthor=L.+Clawsonauthor=D.+R.+Cornblathauthor=D.+B.+Drachmanauthor=A.+Pestronkauthor=B.+L.+Stauchauthor=J.+T.+Coyle&title=Abnormal+excitatory+amino+acid+metabolism+in+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis</span></div><div class="casAuthors">Rothstein, Jeffrey D.; Tsai, Guochuan; Kuncl, Ralph W.; Clawson, Lora; Cornblath, David R.; Drachman, Daniel B.; Pestronk, Alan; Stauch, Barbara L.; Coyle, Joseph T.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-25</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">Recently, the excitatory amino acid neurotransmitter glutamate was implicated in the pathogenesis of a variety of chronic degenerative neurol. diseases in humans and animals.  This report described abnormalities in excitatory amino acids in the central nervous system of 18 patients with amyotrophic lateral sclerosis (ALS).  The concn. of the excitatory amino acids glutamate and aspartate in the cerebrospinal fluid were increased by 100-200% in patients with ALS.  Similarly, the concns. of the excitatory neuropeptide N-acetyl-aspartyl glutamate and its metabolite, N-acetyl-aspartate, were elevated 2-3-fold in the cerebrospinal fluid from the patients.  There was no relationship between amino acid concns. and duration of disease, clin. impairment, or patient age.  In the ventral horns of the cervical region of the spinal cord, levels of N-acetyl-aspartyl glutamate and N-acetyl-aspartate were decreased by 60% and 40%, resp., in 8 patients with ALS.  Choline acetyltransferase activity was also diminished by 35% in the ventral horn consistent with motor neuron loss.  It is concluded that excitatory amino acid metab. is altered in patients with ALS.  Based on neurodegenerative disease models, these changes may play a role in motor neuron loss in ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRX8VxT6HRubVg90H21EOLACvtfcHk0lhpuDnpa_zDUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXksVOitL8%253D&md5=b4e78be9359965fbf623e86df98248bd</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1002%2Fana.410280106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410280106%26sid%3Dliteratum%253Aachs%26aulast%3DRothstein%26aufirst%3DJ.%2BD.%26aulast%3DTsai%26aufirst%3DG.%26aulast%3DKuncl%26aufirst%3DR.%2BW.%26aulast%3DClawson%26aufirst%3DL.%26aulast%3DCornblath%26aufirst%3DD.%2BR.%26aulast%3DDrachman%26aufirst%3DD.%2BB.%26aulast%3DPestronk%26aufirst%3DA.%26aulast%3DStauch%26aufirst%3DB.%2BL.%26aulast%3DCoyle%26aufirst%3DJ.%2BT.%26atitle%3DAbnormal%2520excitatory%2520amino%2520acid%2520metabolism%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DAnn.%2520Neurol.%26date%3D1990%26volume%3D28%26spage%3D18%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref215"><div class="reference"><strong class="refLabel"><a href="#ref215" class="rightTabRefNumLink">215</a></strong><div class="NLM_citation" id="rightTab-cit215"><span><span class="NLM_contrib-group">Rothstein, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Kammen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levey, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuncl, R. W.</span><span> </span><span class="NLM_article-title">Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fana.410380114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=7611729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaK2MXnt12lsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=73-84&author=J.+D.+Rothsteinauthor=M.+Van+Kammenauthor=A.+I.+Leveyauthor=L.+J.+Martinauthor=R.+W.+Kuncl&title=Selective+loss+of+glial+glutamate+transporter+GLT-1+in+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis</span></div><div class="casAuthors">Rothstein, Jeffrey D.; Van Kammen, Marleen; Levey, Allan I.; Martin, Lee J.; Kuncl, Ralph W.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-84</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Little, Brown</span>)
        </div><div class="casAbstract">The pathogenesis of sporadic amyotrophic lateral sclerosis (ALS) is unknown, but defects in synaptosomal high-affinity glutamate transport have been obsd.  In exptl. models, chronic loss of glutamate transport can produce a loss of motor neurons and, therefore, could contribute to the disease.  With the recent cloning of three glutamate transporters, i.e., EAAC1, GLT-1, and GLAST, it has become possible to det. if the loss of glutamate transport in ALS is subtype specific.  We developed C-terminal, antioligopeptide antibodies that were specific for each glutamate transporter.  EAAC1 is selective for neurons, while GLT-1 and GLAST are selective for astroglia.  Tissue from various brain regions of ALS patients and controls were examd. by immunoblot or immunocytochem. methods for each transporter subtype.  All tissue was matched for age and postmortem delay.  GLT-1 immunoreactive protein was severely decreased in ALS, both in motor cortex (71% decrease compared with control) and in spinal cord.  In approx. a quarter of the ALS motor cortex specimens, the loss of GLT-1 protein (90% decrease from control) was dramatic.  By contrast, there was only a modest loss (20% decrease from control) of immunoreactive protein EAAC1 in ALS motor cortex, and there was no appreciable change in GLAST.  The minor loss of EAAC1 could be secondary to loss of cortical motor neurons.  As a comparison, glial fibrillary acidic protein, which is selectively localized to astroglia, was not changed in ALS motor cortex.  Because there is no loss of astroglia in ALS, the dramatic abnormalities in GLT-1 could reflect a primary defect in GLT-1 protein, a secondary loss due to down regulation, or other toxic processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8oaNq-rMF6rVg90H21EOLACvtfcHk0ljw9RLeMOWMUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnt12lsbw%253D&md5=f3d58fa817c3adb6e9204b68419d29d5</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1002%2Fana.410380114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410380114%26sid%3Dliteratum%253Aachs%26aulast%3DRothstein%26aufirst%3DJ.%2BD.%26aulast%3DVan%2BKammen%26aufirst%3DM.%26aulast%3DLevey%26aufirst%3DA.%2BI.%26aulast%3DMartin%26aufirst%3DL.%2BJ.%26aulast%3DKuncl%26aufirst%3DR.%2BW.%26atitle%3DSelective%2520loss%2520of%2520glial%2520glutamate%2520transporter%2520GLT-1%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DAnn.%2520Neurol.%26date%3D1995%26volume%3D38%26spage%3D73%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref216"><div class="reference"><strong class="refLabel"><a href="#ref216" class="rightTabRefNumLink">216</a></strong><div class="NLM_citation" id="rightTab-cit216"><span><span class="NLM_contrib-group">Rothstein, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuncl, R. W.</span><span> </span><span class="NLM_article-title">Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">1464</span><span class="NLM_x">–</span> <span class="NLM_lpage">1468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1056%2FNEJM199205283262204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=1349424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADyaK383ksVejug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=1992&pages=1464-1468&author=J.+D.+Rothsteinauthor=L.+J.+Martinauthor=R.+W.+Kuncl&title=Decreased+glutamate+transport+by+the+brain+and+spinal+cord+in+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis</span></div><div class="casAuthors">Rothstein J D; Martin L J; Kuncl R W</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">1464-8</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">BACKGROUND:  Amyotrophic lateral sclerosis (ALS) is a chronic degenerative neurologic disorder characterized by the death of motor neurons in the cerebral cortex and spinal cord.  Recent studies have suggested that the metabolism of glutamate, a potentially neurotoxic amino acid, is abnormal in patients with ALS.  We hypothesized that the high-affinity glutamate transporter is the site of the defect.  METHODS:  We measured high-affinity, sodium-dependent glutamate transport in synaptosomes from neural tissue obtained from 13 patients with ALS, 17 patients with no neurologic disease, and 27 patients with other neuro-degenerative diseases (Alzheimer's disease in 15 patients and Huntington's disease in 12 patients).  The groups were comparable with respect to age and the interval between death and autopsy.  Synaptosomes were prepared from spinal cord, motor cortex, sensory cortex, visual cortex, striatum, and hippocampus.  We also measured sodium-dependent transport of gamma-aminobutyric acid and phenylalanine in the synaptosomal preparations.  RESULTS:  In patients with ALS, there was a marked decrease in the maximal velocity of transport for high-affinity glutamate uptake in synaptosomes from spinal cord (-59 percent, P less than 0.001), motor cortex (-70 percent, P less than 0.001), and somatosensory cortex (-39 percent, P less than 0.05), but not in those from visual cortex, striatum, or hippocampus.  The affinity of the transporter for glutamate was not altered.  No abnormalities in glutamate transport were found in synaptosomes from patients with other chronic neurodegenerative disorders.  The transport of gamma-aminobutyric acid and phenylalanine was normal in patients with ALS.  CONCLUSIONS:  ALS is associated with a defect in high-affinity glutamate transport that has disease, region, and chemical specificity.  Defects in the clearance of extracellular glutamate because of a faulty transporter could lead to neurotoxic levels of extracellular glutamate and thus be pathogenic in ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSb-TqizNGf3TQLBVDQn4bCfW6udTcc2eY4Qz34eaZO3Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK383ksVejug%253D%253D&md5=ef942d464aa496ae655355af27de2e3a</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1056%2FNEJM199205283262204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199205283262204%26sid%3Dliteratum%253Aachs%26aulast%3DRothstein%26aufirst%3DJ.%2BD.%26aulast%3DMartin%26aufirst%3DL.%2BJ.%26aulast%3DKuncl%26aufirst%3DR.%2BW.%26atitle%3DDecreased%2520glutamate%2520transport%2520by%2520the%2520brain%2520and%2520spinal%2520cord%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1992%26volume%3D326%26spage%3D1464%26epage%3D1468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref217"><div class="reference"><strong class="refLabel"><a href="#ref217" class="rightTabRefNumLink">217</a></strong><div class="NLM_citation" id="rightTab-cit217"><span><span class="NLM_contrib-group">Alexianu, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohamed, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Bella, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appel, S. H.</span><span> </span><span class="NLM_article-title">The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">846</span><span class="NLM_x">–</span> <span class="NLM_lpage">858</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fana.410360608" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=7998770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADyaK2MXjsVehsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1994&pages=846-858&author=M.+E.+Alexianuauthor=B.+K.+Hoauthor=A.+H.+Mohamedauthor=V.+La+Bellaauthor=R.+G.+Smithauthor=S.+H.+Appel&title=The+role+of+calcium-binding+proteins+in+selective+motoneuron+vulnerability+in+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit217R"><div class="casContent"><span class="casTitleNuber">217</span><div class="casTitle"><span class="NLM_cas:atitle">The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis</span></div><div class="casAuthors">Alexianu, Maria E.; Ho, Bao-Kuang; Mohamed, A. Habib; La Bella, Vincenzo; Smith, R. Glenn; Appel, Stanley H.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">846-58</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">The factors contributing to selective motoneuron loss in amyotrophic lateral sclerosis (ALS) remain undefined.  To investigate whether calcium-binding proteins contribute to selective motoneuron vulnerability in ALS, the authors compared calbindin-D28K and parvalbumin immunoreactivity in motoneuron populations in human ALS, and in a ventral spinal cord hybrid cell line selectively vulnerable to the cytotoxic effects of ALS IgG.  In human autopsy specimens, immunoreactive calbindin-D28K and parvalbumin were absent in motoneuron populations lost early in ALS (i.e., cortical and spinal motoneurons, lower cranial nerve motoneurons), while motoneurons damaged late or infrequently in the disease (i.e., Onuf's nucleus motoneurons, oculomotor, trochlear, and abducens nerve neurons) expressed markedly higher levels of immunoreactive calbindin-D28K and/or parvalbumin.  Motoneuron-neuroblastoma VSC 4.1 hybrid cells lost immunoreactive calbindin-D28K and parvalbumin following dibutyryl-cAMP-induced differentiation and were killed by IgG from ALS patients.  Undifferentiated calbindin/parvalbumin-reactive VSC 4.1 cells were not killed, nor were other cell lines expressing high levels of calbindin-D28K and parvalbumin immunoreactivity (substantia nigra-neuroblastoma hybrid cells and N18TG2 neuroblastoma parent cells).  These studies suggest that decreased calbindin-D28K and parvalbumin immunoreactivity may help explain the selective vulnerability of motoneurons in ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5FDzYpk22RrVg90H21EOLACvtfcHk0ljw9RLeMOWMUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjsVehsrw%253D&md5=d89e6445c9c145a75151772471eb2796</span></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1002%2Fana.410360608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410360608%26sid%3Dliteratum%253Aachs%26aulast%3DAlexianu%26aufirst%3DM.%2BE.%26aulast%3DHo%26aufirst%3DB.%2BK.%26aulast%3DMohamed%26aufirst%3DA.%2BH.%26aulast%3DLa%2BBella%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DR.%2BG.%26aulast%3DAppel%26aufirst%3DS.%2BH.%26atitle%3DThe%2520role%2520of%2520calcium-binding%2520proteins%2520in%2520selective%2520motoneuron%2520vulnerability%2520in%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DAnn.%2520Neurol.%26date%3D1994%26volume%3D36%26spage%3D846%26epage%3D858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref218"><div class="reference"><strong class="refLabel"><a href="#ref218" class="rightTabRefNumLink">218</a></strong><div class="NLM_citation" id="rightTab-cit218"><span><span class="NLM_contrib-group">Bruijn, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cudkowicz, M.</span><span> </span><span class="NLM_article-title">Therapeutic targets for amyotrophic lateral sclerosis: current treatments and prospects for more effective therapies</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1586%2F14737175.6.3.417" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16533145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjs1yjt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=417-428&author=L.+I.+Bruijnauthor=M.+Cudkowicz&title=Therapeutic+targets+for+amyotrophic+lateral+sclerosis%3A+current+treatments+and+prospects+for+more+effective+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targets for amyotrophic lateral sclerosis: current treatments and prospects for more effective therapies</span></div><div class="casAuthors">Bruijn, Lucie I.; Cudkowicz, Merit</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">417-428</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Although amyotrophic lateral sclerosis (ALS) was described more than 130 years ago, the cause(s) of most cases of this adult motor neuron disease remains a mystery.  With the discovery of mutations in one gene (Cu/Zn superoxide dismutase) as a primary cause of some forms of ALS, model systems have been developed that have helped us begin to understand mechanisms involved in motor neuron death and enabled testing of potential new therapies.  Several other genes have been implicated as risk factors in motor neuron diseases, including neurofilaments, cytoplasmic dynein and dynactin, vascular endothelial growth factor, and angiogenin.  With advances in the basic research of the disease, many hypotheses accounting for motor neuron death are being explored, including loss of trophic support, protein mishandling, mitochondrial dysfunction, excitotoxicity, axonal abnormalities and inflammation.  Many of these mechanisms are the focus of research in other neurodegenerative disorders, such as Parkinson's, Alzheimer's and Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1He-j3O0w1LVg90H21EOLACvtfcHk0lj746393mf-XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjs1yjt7o%253D&md5=916d3cef60e529d8da7a5bc4c3bebaff</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.1586%2F14737175.6.3.417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.6.3.417%26sid%3Dliteratum%253Aachs%26aulast%3DBruijn%26aufirst%3DL.%2BI.%26aulast%3DCudkowicz%26aufirst%3DM.%26atitle%3DTherapeutic%2520targets%2520for%2520amyotrophic%2520lateral%2520sclerosis%253A%2520current%2520treatments%2520and%2520prospects%2520for%2520more%2520effective%2520therapies%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2006%26volume%3D6%26spage%3D417%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref219"><div class="reference"><strong class="refLabel"><a href="#ref219" class="rightTabRefNumLink">219</a></strong><div class="NLM_citation" id="rightTab-cit219"><span><span class="NLM_contrib-group">Turner, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parton, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leigh, P. N.</span><span> </span><span class="NLM_article-title">Clinical trials in ALS: an overview</span> <span class="citation_source-journal">Semin. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1055%2Fs-2001-15262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=11442325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A280%3ADC%252BD38%252FhvVymtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=167-175&author=M.+R.+Turnerauthor=M.+J.+Partonauthor=P.+N.+Leigh&title=Clinical+trials+in+ALS%3A+an+overview"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit219R"><div class="casContent"><span class="casTitleNuber">219</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical trials in ALS: an overview</span></div><div class="casAuthors">Turner M R; Parton M J; Leigh P N</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in neurology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">167-75</span>
        ISSN:<span class="NLM_cas:issn">0271-8235</span>.
    </div><div class="casAbstract">Clinical trials in amyotrophic lateral sclerosis (ALS) have been conducted for over half a century now and have incorporated a wide variety of drugs.  Most of these trials have had negative results and a cure remains elusive.  The explosion in our understanding of molecular biology and parallel developments in clinical epidemiology have opened up a vast number of novel therapeutic strategies.  However, advances in statistical analysis, computing, and global communications have also put greater pressure on scientific investigators to improve the design and implementation of clinical trials so that they permit rigorous testing of hypotheses within a solid ethical framework.  This article documents the first published trial for all drugs tried clinically in the treatment of ALS, focusing in more detail on the large, multicenter trials of recent years, namely those involving riluzole, ciliary neurotrophic factor, insulin-like growth factor-I, brain-derived neurotrophic factor, and SR57746A.  The problems in the design of trials in ALS are discussed, including the selection of end points and surrogate markers of disease progression, and the major parameters in ALS assessment are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSrRzVfxY9I0DdblLE_E9PWfW6udTcc2eaT47o2QXrIobntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38%252FhvVymtQ%253D%253D&md5=48b77e678bcbdc0179a38d8047d001fa</span></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.1055%2Fs-2001-15262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2001-15262%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DM.%2BR.%26aulast%3DParton%26aufirst%3DM.%2BJ.%26aulast%3DLeigh%26aufirst%3DP.%2BN.%26atitle%3DClinical%2520trials%2520in%2520ALS%253A%2520an%2520overview%26jtitle%3DSemin.%2520Neurol.%26date%3D2001%26volume%3D21%26spage%3D167%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref220"><div class="reference"><strong class="refLabel"><a href="#ref220" class="rightTabRefNumLink">220</a></strong><div class="NLM_citation" id="rightTab-cit220"><span><span class="NLM_contrib-group">Carri, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grignaschi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bendotti, C.</span><span> </span><span class="NLM_article-title">Targets in ALS: designing multidrug therapies</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=267-273&author=M.+T.+Carriauthor=G.+Grignaschiauthor=C.+Bendotti&title=Targets+in+ALS%3A+designing+multidrug+therapies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarri%26aufirst%3DM.%2BT.%26aulast%3DGrignaschi%26aufirst%3DG.%26aulast%3DBendotti%26aufirst%3DC.%26atitle%3DTargets%2520in%2520ALS%253A%2520designing%2520multidrug%2520therapies%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2006%26volume%3D27%26spage%3D267%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref221"><div class="reference"><strong class="refLabel"><a href="#ref221" class="rightTabRefNumLink">221</a></strong><div class="NLM_citation" id="rightTab-cit221"><span><span class="NLM_contrib-group">Kriz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowing, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julien, J. P.</span><span> </span><span class="NLM_article-title">Efficient three-drug cocktail for disease induced by mutant superoxide dismutase</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">436</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1002%2Fana.10500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=12666110" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtFGitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2003&pages=429-436&author=J.+Krizauthor=G.+Gowingauthor=J.+P.+Julien&title=Efficient+three-drug+cocktail+for+disease+induced+by+mutant+superoxide+dismutase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit221R"><div class="casContent"><span class="casTitleNuber">221</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient three-drug cocktail for disease induced by mutant superoxide dismutase</span></div><div class="casAuthors">Kriz, Jasna; Gowing, Genevieve; Julien, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">429-436</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">There is currently no effective pharmacol. treatment for amyotrophic lateral sclerosis (ALS).  Because evidence suggests that multiple pathways may contribute to ALS pathogenesis, we tested in a mouse model of ALS (SOD1G37R mice) a combination approach consisting of three drugs for distinct targets in the complex pathway to neuronal death: minocycline, an antimicrobial agent that inhibits microglial activation, riluzole, a glutamate antagonist, and nimodipine, a voltage-gated calcium channel blocker.  The efficacy of this three-drug cocktail was remarkable when administered in the diet from late presymptomatic stage (8-9 mo).  It delayed the onset of disease, slowed the loss of muscle strength, and increased the av. longevity of SOD1G37R mice by 6 wk.  The protective effect of the treatment was corroborated by the reduced immunodetection signals for markers of gliosis and neurodegeneration in the spinal cord of SOD1G37R mice.  These results indicate that such three-drug combination may represent an effective strategy for ALS treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0XMOUSREXlbVg90H21EOLACvtfcHk0lhU8IHnuVL8Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtFGitbg%253D&md5=9ee13296465b5f87a8c3024c10fa787b</span></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=10.1002%2Fana.10500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.10500%26sid%3Dliteratum%253Aachs%26aulast%3DKriz%26aufirst%3DJ.%26aulast%3DGowing%26aufirst%3DG.%26aulast%3DJulien%26aufirst%3DJ.%2BP.%26atitle%3DEfficient%2520three-drug%2520cocktail%2520for%2520disease%2520induced%2520by%2520mutant%2520superoxide%2520dismutase%26jtitle%3DAnn.%2520Neurol.%26date%3D2003%26volume%3D53%26spage%3D429%26epage%3D436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref222"><div class="reference"><strong class="refLabel"><a href="#ref222" class="rightTabRefNumLink">222</a></strong><div class="NLM_citation" id="rightTab-cit222"><span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, W.</span><span> </span><span class="NLM_article-title">Neuroprotective effects of (−)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1263</span><span class="NLM_x">–</span> <span class="NLM_lpage">1269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1007%2Fs11064-006-9166-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=17021948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKmtr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=1263-1269&author=Z.+Xuauthor=S.+Chenauthor=X.+Liauthor=G.+Luoauthor=L.+Liauthor=W.+Le&title=Neuroprotective+effects+of+%28%E2%88%92%29-epigallocatechin-3-gallate+in+a+transgenic+mouse+model+of+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit222R"><div class="casContent"><span class="casTitleNuber">222</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective Effects of (-)-Epigallocatechin-3-gallate in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis</span></div><div class="casAuthors">Xu, Zhihao; Chen, Sheng; Li, Xuping; Luo, Guangrui; Li, Liang; Le, Weidong</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1263-1269</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The purpose of this study is to evaluate neuroprotective effects of (-)-Epigallocatechin-3-gallate (EGCG) in a transgenic mouse model of Amyotrophic lateral sclerosis (ALS).  SOD1-G93A transgenic mice and wild-type mice were randomly divided into EGCG-treated groups (10 mg/kg, p.o) and vehicle-treated control groups.  Rotarod measurement was performed to assess the motor function of mice starting at the age of 70 days.  Nissl staining to examine the no. of motor neurons and CD11b immunohistochem. staining to evaluate activation of microglia in the lumbar spinal cords were conducted at the age of 120 days.  In addn., for further observation of regulation of cell signaling pathways by EGCG, we used immunohistochem. anal. for nuclear factor kappa B (NF-κB) and cleaved caspase-3 as well as western blot anal. to det. the expression of nitric oxide synthase (iNOS) and NF-κB in the spinal cord.  This study demonstrated that oral administration of EGCG beginning from a pre-symptomatic stage significantly delayed the onset of disease, and extended life span.  Furthermore, EGCG-treated transgenic mice showed increased no. of motor neurons, diminished microglial activation, reduced immunohistochem. reaction of NF-κB and cleaved caspase-3 as well as reduced protein level of iNOS and NF-κB in the spinal cords.  In conclusion, this study provides further evidences that EGCG has multifunctional therapeutic effects in the mouse model of ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhxjL14Q6Bo7Vg90H21EOLACvtfcHk0li2KhbAhXc84Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKmtr7L&md5=4fba17c226be1fdda5f22d02b227daa3</span></div><a href="/servlet/linkout?suffix=cit222&amp;dbid=16384&amp;doi=10.1007%2Fs11064-006-9166-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-006-9166-z%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLuo%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLe%26aufirst%3DW.%26atitle%3DNeuroprotective%2520effects%2520of%2520%2528%25E2%2588%2592%2529-epigallocatechin-3-gallate%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DNeurochem.%2520Res.%26date%3D2006%26volume%3D31%26spage%3D1263%26epage%3D1269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref223"><div class="reference"><strong class="refLabel"><a href="#ref223" class="rightTabRefNumLink">223</a></strong><div class="NLM_citation" id="rightTab-cit223"><span><span class="NLM_contrib-group">Nagle, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y. D.</span><span> </span><span class="NLM_article-title">Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives</span> <span class="citation_source-journal">Phytochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1849</span><span class="NLM_x">–</span> <span class="NLM_lpage">1855</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.phytochem.2006.06.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16876833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XovVSisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=1849-1855&author=D.+G.+Nagleauthor=D.+Ferreiraauthor=Y.+D.+Zhou&title=Epigallocatechin-3-gallate+%28EGCG%29%3A+chemical+and+biomedical+perspectives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit223R"><div class="casContent"><span class="casTitleNuber">223</span><div class="casTitle"><span class="NLM_cas:atitle">Epigallocatechin-3-gallate (EGCG): Chemical and biomedical perspectives</span></div><div class="casAuthors">Nagle, Dale G.; Ferreira, Daneel; Zhou, Yu-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry (Elsevier)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1849-1855</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The compd. (-)-epigallocatechin-3-gallate (EGCG) is the major catechin found in green tea [Camellia sinensis L. Ktze. (Theaceae)].  This polyphenolic compd. and several related catechins are believed to be responsible for the health benefits assocd. with the consumption of green tea.  The potential health benefits ascribed to green tea and EGCG include antioxidant effects, cancer chemoprevention, improving cardiovascular health, enhancing wt. loss, protecting the skin from the damage caused by ionizing radiation, and others.  The compd. EGCG has been shown to regulate dozens of disease-specific mol. targets.  Many of these mol. targets are only affected by concns. of EGCG that are far above the levels achieved by either drinking green tea or consuming moderate doses of green tea ext.-based dietary supplements.  In spite of this, well-designed double-blinded controlled clin. studies have recently demonstrated the efficacy of green tea exts. and purified EGCG products in patients.  Therefore, this review highlights results from what the authors believe to be some of the most clin. significant recent studies and describes current developments in the stereoselective total synthesis of EGCG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoURj2mtMid77Vg90H21EOLACvtfcHk0li2KhbAhXc84Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovVSisL4%253D&md5=88777ac2cfe6a65f09a74db2cffe0386</span></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=10.1016%2Fj.phytochem.2006.06.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytochem.2006.06.020%26sid%3Dliteratum%253Aachs%26aulast%3DNagle%26aufirst%3DD.%2BG.%26aulast%3DFerreira%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DY.%2BD.%26atitle%3DEpigallocatechin-3-gallate%2520%2528EGCG%2529%253A%2520chemical%2520and%2520biomedical%2520perspectives%26jtitle%3DPhytochemistry%26date%3D2006%26volume%3D67%26spage%3D1849%26epage%3D1855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref224"><div class="reference"><strong class="refLabel"><a href="#ref224" class="rightTabRefNumLink">224</a></strong><div class="NLM_citation" id="rightTab-cit224"><span><span class="NLM_contrib-group">Streit, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conde, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fendrick, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flanary, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mariani, C. L.</span><span> </span><span class="NLM_article-title">Role of microglia in the central nervous systemʼs immune response</span> <span class="citation_source-journal">Neurol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16197805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Wkt7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2005&pages=685-691&author=W.+J.+Streitauthor=J.+R.+Condeauthor=S.+E.+Fendrickauthor=B.+E.+Flanaryauthor=C.+L.+Mariani&title=Role+of+microglia+in+the+central+nervous+system%CA%BCs+immune+response"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit224R"><div class="casContent"><span class="casTitleNuber">224</span><div class="casTitle"><span class="NLM_cas:atitle">Role of microglia in the central nervous system's immune response</span></div><div class="casAuthors">Streit, Wolfgang J.; Conde, Jessica R.; Fendrick, Sarah E.; Flanary, Barry E.; Mariani, Christopher L.</div><div class="citationInfo"><span class="NLM_cas:title">Neurological Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">685-691</span>CODEN:
                <span class="NLM_cas:coden">NRESDZ</span>;
        ISSN:<span class="NLM_cas:issn">0161-6412</span>.
    
            (<span class="NLM_cas:orgname">Maney Publishing</span>)
        </div><div class="casAbstract">Microglial cells comprise a network of endogenous immunocompetent cells that pervade the brain and spinal cord.  The primary function of this system is to provide continuous surveillance of the parenchyma and protect the central nervous system (CNS) during injury and disease.  Here we discuss the involvement of microglia during brain aging and aging-related neurodegenerative disease, i.e. Alzheimer's disease, and briefly summarize their possible roles in amyotrophic lateral sclerosis (ALS).  In addn., we provide an overview of the neuroinflammation assocd. with primary brain tumors and how microglial tumor cytotoxicity could be targeted for immunotherapeutic approaches designed to treat these lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5CYtfyJhGhLVg90H21EOLACvtfcHk0li2KhbAhXc84Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Wkt7bI&md5=e168e449e1fe19229ef3f19c89ec8cea</span></div><a href="/servlet/linkout?suffix=cit224&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStreit%26aufirst%3DW.%2BJ.%26aulast%3DConde%26aufirst%3DJ.%2BR.%26aulast%3DFendrick%26aufirst%3DS.%2BE.%26aulast%3DFlanary%26aufirst%3DB.%2BE.%26aulast%3DMariani%26aufirst%3DC.%2BL.%26atitle%3DRole%2520of%2520microglia%2520in%2520the%2520central%2520nervous%2520system%25CA%25BCs%2520immune%2520response%26jtitle%3DNeurol.%2520Res.%26date%3D2005%26volume%3D27%26spage%3D685%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref225"><div class="reference"><strong class="refLabel"><a href="#ref225" class="rightTabRefNumLink">225</a></strong><div class="NLM_citation" id="rightTab-cit225"><span><span class="NLM_contrib-group">Weydt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moller, T.</span><span> </span><span class="NLM_article-title">Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosis</span> <span class="citation_source-journal">NeuroReport</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2005&pages=527-531&author=P.+Weydtauthor=T.+Moller&title=Neuroinflammation+in+the+pathogenesis+of+amyotrophic+lateral+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit225&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeydt%26aufirst%3DP.%26aulast%3DMoller%26aufirst%3DT.%26atitle%3DNeuroinflammation%2520in%2520the%2520pathogenesis%2520of%2520amyotrophic%2520lateral%2520sclerosis%26jtitle%3DNeuroReport%26date%3D2005%26volume%3D16%26spage%3D527%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref226"><div class="reference"><strong class="refLabel"><a href="#ref226" class="rightTabRefNumLink">226</a></strong><div class="NLM_citation" id="rightTab-cit226"><span><span class="NLM_contrib-group">Ji, H.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-Y.</span><span> </span><span class="NLM_article-title">Theoretical evaluation of flavonoids as multipotent agents to combat Alzheimerʼs disease</span> <span class="citation_source-journal">J. Mol. Struct.: THEOCHEM</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">767</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.theochem.2006.04.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVGnt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=767&publication_year=2006&pages=3-9&author=H.-F.+Jiauthor=H.-Y.+Zhang&title=Theoretical+evaluation+of+flavonoids+as+multipotent+agents+to+combat+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit226R"><div class="casContent"><span class="casTitleNuber">226</span><div class="casTitle"><span class="NLM_cas:atitle">Theoretical evaluation of flavonoids as multipotent agents to combat Alzheimer's disease</span></div><div class="casAuthors">Ji, Hong-Fang; Zhang, Hong-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Structure: THEOCHEM</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">767</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-9</span>CODEN:
                <span class="NLM_cas:coden">THEODJ</span>;
        ISSN:<span class="NLM_cas:issn">0166-1280</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">As multiple pathogenetic factors, including aggregated amyloid-β peptide and tau protein, excessive transition metals, oxidative stress and reduced acetylcholine level, have been implicated in Alzheimer's disease (AD), multipotent agents aiming at diverse targets are expected to act better than the single-target-aiming counterparts in the fight against AD.  Among the potential multipotent agents, natural products, esp. flavonoids (including xanthones), have been given much attention.  To explore to what extent the desired multiple pharmacol. effects can be combined into one flavonoid mol., we examd. the structural requirements of flavonoids (including xanthones) as inhibitors of monoamine oxidase (including isoenzymes A and B), acetylcholinesterase and/or butyrylcholinesterase.  In combination with the known structure-activity relationships of flavonoids as reactive oxygen species scavengers and metal chelators, we provide a theor. evaluation of flavonoids (including xanthones) as multipotent agents to combat AD, which is of great significance to directing the screening of novel AD-modifying drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqLJDStXLf27Vg90H21EOLACvtfcHk0lh3g-ji2e4sng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVGnt74%253D&md5=9c2f716c5b94ad2e307c95ffa0c11ffa</span></div><a href="/servlet/linkout?suffix=cit226&amp;dbid=16384&amp;doi=10.1016%2Fj.theochem.2006.04.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.theochem.2006.04.041%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DH.-F.%26aulast%3DZhang%26aufirst%3DH.-Y.%26atitle%3DTheoretical%2520evaluation%2520of%2520flavonoids%2520as%2520multipotent%2520agents%2520to%2520combat%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DJ.%2520Mol.%2520Struct.%253A%2520THEOCHEM%26date%3D2006%26volume%3D767%26spage%3D3%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref227"><div class="reference"><strong class="refLabel"><a href="#ref227" class="rightTabRefNumLink">227</a></strong><div class="NLM_citation" id="rightTab-cit227"><span><span class="NLM_contrib-group">Mandel, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avramovich-Tirosh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reznichenko, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amit, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youdim, M. B.</span><span> </span><span class="NLM_article-title">Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway</span> <span class="citation_source-journal">Neurosignals</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1159%2F000085385" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15956814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref227/cit227&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlt1Smsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=46-60&author=S.+A.+Mandelauthor=Y.+Avramovich-Tiroshauthor=L.+Reznichenkoauthor=H.+Zhengauthor=O.+Weinrebauthor=T.+Amitauthor=M.+B.+Youdim&title=Multifunctional+activities+of+green+tea+catechins+in+neuroprotection.+Modulation+of+cell+survival+genes%2C+iron-dependent+oxidative+stress+and+PKC+signaling+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit227R"><div class="casContent"><span class="casTitleNuber">227</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional Activities of Green Tea Catechins in Neuroprotection</span></div><div class="casAuthors">Mandel, Silvia A.; Avramovich-Tirosh, Yael; Reznichenko, Lydia; Zheng, Hailin; Weinreb, Orly; Amit, Tamar; Youdim, Moussa B. H.</div><div class="citationInfo"><span class="NLM_cas:title">Neurosignals</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">46-60</span>CODEN:
                <span class="NLM_cas:coden">NEURIQ</span>;
        ISSN:<span class="NLM_cas:issn">1424-862X</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  Many lines of evidence suggest that oxidative stress resulting in reactive oxygen species (ROS) generation and inflammation play a pivotal role in the age-assocd. cognitive decline and neuronal loss in neurodegenerative diseases including Alzheimer's (AD), Parkinson's (PD) and Huntington's diseases.  One cardinal chem. pathol. obsd. in these disorders is the accumulation of iron at sites where the neurons die.  The buildup of an iron gradient in conjunction with ROS (superoxide, hydroxyl radical and nitric oxide) are thought to constitute a major trigger in neuronal toxicity and demise in all these diseases.  Thus, promising future treatment of neurodegenerative diseases and aging depends on availability of effective brain permeable, iron-chelatable/radical scavenger neuroprotective drugs that would prevent the progression of neurodegeneration.  Tea flavonoids (catechins) have been reported to possess potent iron-chelating, radical-scavenging and anti-inflammatory activities and to protect neuronal death in a wide array of cellular and animal models of neurol. diseases.  Recent studies have indicated that in addn. to the known antioxidant activity of catechins, other mechanisms such as modulation of signal transduction pathways, cell survival/death genes and mitochondrial function, contribute significantly to the induction of cell viability.  This review will focus on the multifunctional properties of green tea and its major component (-)-epigallocatechin-3-gallate (EGCG) and their ability to induce neuroprotection and neurorescue in vitro and in vivo.  In particular, their transitional metal (iron and copper) chelating property and inhibition of oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPpE1q4N9CerVg90H21EOLACvtfcHk0lh3g-ji2e4sng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlt1Smsr0%253D&md5=98fc92ac5ece333afa15e5197364b2df</span></div><a href="/servlet/linkout?suffix=cit227&amp;dbid=16384&amp;doi=10.1159%2F000085385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000085385%26sid%3Dliteratum%253Aachs%26aulast%3DMandel%26aufirst%3DS.%2BA.%26aulast%3DAvramovich-Tirosh%26aufirst%3DY.%26aulast%3DReznichenko%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DWeinreb%26aufirst%3DO.%26aulast%3DAmit%26aufirst%3DT.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26atitle%3DMultifunctional%2520activities%2520of%2520green%2520tea%2520catechins%2520in%2520neuroprotection.%2520Modulation%2520of%2520cell%2520survival%2520genes%252C%2520iron-dependent%2520oxidative%2520stress%2520and%2520PKC%2520signaling%2520pathway%26jtitle%3DNeurosignals%26date%3D2005%26volume%3D14%26spage%3D46%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref228"><div class="reference"><strong class="refLabel"><a href="#ref228" class="rightTabRefNumLink">228</a></strong><div class="NLM_citation" id="rightTab-cit228"><span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span> </span><span class="NLM_article-title">Estrogen, beta-amyloid metabolism/trafficking, and Alzheimerʼs disease</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1089</span><span class="NLM_x">, </span> <span class="NLM_fpage">324</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1089&publication_year=2006&pages=324-342&author=H.+Xuauthor=R.+Wangauthor=Y.+W.+Zhangauthor=X.+Zhang&title=Estrogen%2C+beta-amyloid+metabolism%2Ftrafficking%2C+and+Alzheimer%CA%BCs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit228&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DY.%2BW.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DEstrogen%252C%2520beta-amyloid%2520metabolism%252Ftrafficking%252C%2520and%2520Alzheimer%25CA%25BCs%2520disease%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2006%26volume%3D1089%26spage%3D324%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref229"><div class="reference"><strong class="refLabel"><a href="#ref229" class="rightTabRefNumLink">229</a></strong><div class="NLM_citation" id="rightTab-cit229"><span><span class="NLM_contrib-group">Schmeer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kretz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isenmann, S.</span><span> </span><span class="NLM_article-title">Statin-mediated protective effects in the central nervous system: general mechanisms and putative role of stress proteins</span> <span class="citation_source-journal">Restor. Neurol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16720944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref229/cit229&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28Xks1Cgtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=79-95&author=C.+Schmeerauthor=A.+Kretzauthor=S.+Isenmann&title=Statin-mediated+protective+effects+in+the+central+nervous+system%3A+general+mechanisms+and+putative+role+of+stress+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit229R"><div class="casContent"><span class="casTitleNuber">229</span><div class="casTitle"><span class="NLM_cas:atitle">Statin-mediated protective effects in the central nervous system: General mechanisms and putative role of stress proteins</span></div><div class="casAuthors">Schmeer, Christian; Kretz, Alexandra; Isenmann, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Restorative Neurology and Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">79-95</span>CODEN:
                <span class="NLM_cas:coden">RNNEEL</span>;
        ISSN:<span class="NLM_cas:issn">0922-6028</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  Purpose: The 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase inhibitors, or "statins", are used as cholesterol-lowering agents worldwide.  This review, focused on recent exptl. and clin. data, summarizes general mechanisms of statin actions underlying neuroprotective effects in the central nervous system (CNS) and presents evidence for putative mechanisms involving heat shock proteins and the survival-related PI-3K/Akt pathway that may be beneficial for the treatment of neurol. disorders.  Methods: We carried out a med-line search on statin actions, with respect to biochem. pathways and signal transduction on the one hand, and clin. studies in neurol. and retinal diseases on the other hand.  Novel exptl. data obtained in a rat model of axonal CNS injury were also included.  Results: Statins exert multiple effects on endothelial function, cell proliferation, inflammatory response, immunol. reactions, platelet function, and lipid oxidn.  These "pleiotropic actions" are independent of cholesterol lowering and appear to be beneficial in the context of brain injury.  Several mechanisms of statin actions underlying neuroprotective effects may also involve heat shock proteins and the survival-related PI-3K/Akt pathway.  Conclusions: Available data suggest that statins may be of potential therapeutic use in a variety of diseases of the CNS including ischemic stroke, Alzheimer's disease, multiple sclerosis and some forms of retinal and eye diseases.  Before general recommendations can be made and specific therapeutic approaches can be developed, more reliable clin. data and studies are required, and possible side effects must be carefully evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6Jk3l14yr2rVg90H21EOLACvtfcHk0lgcaPQ5viPEjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xks1Cgtb8%253D&md5=92827c63de07d1c12025f9329e86aabe</span></div><a href="/servlet/linkout?suffix=cit229&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchmeer%26aufirst%3DC.%26aulast%3DKretz%26aufirst%3DA.%26aulast%3DIsenmann%26aufirst%3DS.%26atitle%3DStatin-mediated%2520protective%2520effects%2520in%2520the%2520central%2520nervous%2520system%253A%2520general%2520mechanisms%2520and%2520putative%2520role%2520of%2520stress%2520proteins%26jtitle%3DRestor.%2520Neurol.%2520Neurosci.%26date%3D2006%26volume%3D24%26spage%3D79%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref230"><div class="reference"><strong class="refLabel"><a href="#ref230" class="rightTabRefNumLink">230</a></strong><div class="NLM_citation" id="rightTab-cit230"><span><span class="NLM_contrib-group">Barger, S. W.</span><span> </span><span class="NLM_article-title">Cooperative ideas about cooperative strategies</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1035</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1035&publication_year=2004&pages=350-353&author=S.+W.+Barger&title=Cooperative+ideas+about+cooperative+strategies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit230&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarger%26aufirst%3DS.%2BW.%26atitle%3DCooperative%2520ideas%2520about%2520cooperative%2520strategies%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2004%26volume%3D1035%26spage%3D350%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref231"><div class="reference"><strong class="refLabel"><a href="#ref231" class="rightTabRefNumLink">231</a></strong><div class="NLM_citation" id="rightTab-cit231"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">The physicochemical challenges of designing multiple ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4961</span><span class="NLM_x">–</span> <span class="NLM_lpage">4970</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref231/cit231&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFejtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4961-4970&author=R.+Morphyauthor=Z.+Rankovic&title=The+physicochemical+challenges+of+designing+multiple+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit231R"><div class="casContent"><span class="casTitleNuber">231</span><div class="casTitle"><span class="NLM_cas:atitle">The Physicochemical Challenges of Designing Multiple Ligands</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4961-4970</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compds. designed to bind more than one target can provide a therapeutic benefit relative to highly target-selective ligands.  The physicochem. properties of designed multiple ligands were found to be less druglike than those for preclin. compds. in general.  These properties are controlled by the superfamily to which the targets belong and the lead discovery strategy that was followed.  The properties for peptide G-protein-coupled receptor (GPCR) ligands were the least favorable for oral delivery, whereas transporter, monoamine GPCR, and oxidase ligands were the most druglike.  The lead discovery strategy, framework combination or screening, exerts a profound influence on the property values.  Combining the frameworks from two selective ligands often results in large, complex dual ligands, but druglike ligands can be achieved if the degree of framework overlap is maximized and the size of the selective ligands minimized.  For some target combinations, a screening approach may provide a route to smaller, less complex leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonGHbXyxgv4LVg90H21EOLACvtfcHk0lhSxRW0GpL3-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFejtL4%253D&md5=c7a227848516d0aa58ed037a582943fe</span></div><a href="/servlet/linkout?suffix=cit231&amp;dbid=16384&amp;doi=10.1021%2Fjm0603015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603015%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DThe%2520physicochemical%2520challenges%2520of%2520designing%2520multiple%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4961%26epage%3D4970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref232"><div class="reference"><strong class="refLabel"><a href="#ref232" class="rightTabRefNumLink">232</a></strong><div class="NLM_citation" id="rightTab-cit232"><span><span class="NLM_contrib-group">Stark, H.</span><span> </span><span class="NLM_article-title">Turning from monogamy to strategic promiscuity</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">736</span><span class="NLM_x">–</span> <span class="NLM_lpage">737</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=736-737&author=H.+Stark&title=Turning+from+monogamy+to+strategic+promiscuity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit232&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStark%26aufirst%3DH.%26atitle%3DTurning%2520from%2520monogamy%2520to%2520strategic%2520promiscuity%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D736%26epage%3D737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref233"><div class="reference"><strong class="refLabel"><a href="#ref233" class="rightTabRefNumLink">233</a></strong><div class="NLM_citation" id="rightTab-cit233"><span><span class="NLM_contrib-group">Barabasi, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oltvai, Z. N.</span><span> </span><span class="NLM_article-title">Network biology: understanding the cellʼs functional organization</span> <span class="citation_source-journal">Nat. Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnrg1272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=14735121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref233/cit233&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovV2mtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=101-113&author=A.+L.+Barabasiauthor=Z.+N.+Oltvai&title=Network+biology%3A+understanding+the+cell%CA%BCs+functional+organization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit233R"><div class="casContent"><span class="casTitleNuber">233</span><div class="casTitle"><span class="NLM_cas:atitle">Network biology: Understanding the cell's functional organization</span></div><div class="casAuthors">Barabasi, Albert-Laszlo; Oltvai, Zoltan N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">101-113</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A key aim of postgenomic biomedical research is to systematically catalog all mols. and their interactions within a living cell.  There is a clear need to understand how these mols. and the interactions between them det. the function of this enormously complex machinery, both in isolation and when surrounded by other cells.  Rapid advances in network biol. indicate that cellular networks are governed by universal laws and offer a new conceptual framework that could potentially revolutionize our view of biol. and disease pathologies in the twenty-first century.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov1DuovBZth7Vg90H21EOLACvtfcHk0lhrP6mKYTApPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovV2mtg%253D%253D&md5=2ac9082dfaf88d56da1fdd75b9edddb4</span></div><a href="/servlet/linkout?suffix=cit233&amp;dbid=16384&amp;doi=10.1038%2Fnrg1272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg1272%26sid%3Dliteratum%253Aachs%26aulast%3DBarabasi%26aufirst%3DA.%2BL.%26aulast%3DOltvai%26aufirst%3DZ.%2BN.%26atitle%3DNetwork%2520biology%253A%2520understanding%2520the%2520cell%25CA%25BCs%2520functional%2520organization%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2004%26volume%3D5%26spage%3D101%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref234"><div class="reference"><strong class="refLabel"><a href="#ref234" class="rightTabRefNumLink">234</a></strong><div class="NLM_citation" id="rightTab-cit234"><span><span class="NLM_contrib-group">van der Greef, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBurney, R. N.</span><span> </span><span class="NLM_article-title">Innovation: rescuing drug discovery: in vivo systems pathology and systems pharmacology</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">961</span><span class="NLM_x">–</span> <span class="NLM_lpage">967</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=961-967&author=J.+van+der+Greefauthor=R.+N.+McBurney&title=Innovation%3A+rescuing+drug+discovery%3A+in+vivo+systems+pathology+and+systems+pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit234&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BGreef%26aufirst%3DJ.%26aulast%3DMcBurney%26aufirst%3DR.%2BN.%26atitle%3DInnovation%253A%2520rescuing%2520drug%2520discovery%253A%2520in%2520vivo%2520systems%2520pathology%2520and%2520systems%2520pharmacology%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D961%26epage%3D967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref235"><div class="reference"><strong class="refLabel"><a href="#ref235" class="rightTabRefNumLink">235</a></strong><div class="NLM_citation" id="rightTab-cit235"><span><span class="NLM_contrib-group">Butcher, E. C.</span><span> </span><span class="NLM_article-title">Can cell systems biology rescue drug discovery?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=461-467&author=E.+C.+Butcher&title=Can+cell+systems+biology+rescue+drug+discovery%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit235&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DButcher%26aufirst%3DE.%2BC.%26atitle%3DCan%2520cell%2520systems%2520biology%2520rescue%2520drug%2520discovery%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D461%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref236"><div class="reference"><strong class="refLabel"><a href="#ref236" class="rightTabRefNumLink">236</a></strong><div class="NLM_citation" id="rightTab-cit236"><span><span class="NLM_contrib-group">Keith, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borisy, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockwell, B. R.</span><span> </span><span class="NLM_article-title">Multicomponent therapeutics for networked systems</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=71-78&author=C.+T.+Keithauthor=A.+A.+Borisyauthor=B.+R.+Stockwell&title=Multicomponent+therapeutics+for+networked+systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit236&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeith%26aufirst%3DC.%2BT.%26aulast%3DBorisy%26aufirst%3DA.%2BA.%26aulast%3DStockwell%26aufirst%3DB.%2BR.%26atitle%3DMulticomponent%2520therapeutics%2520for%2520networked%2520systems%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D71%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref237"><div class="reference"><strong class="refLabel"><a href="#ref237" class="rightTabRefNumLink">237</a></strong><div class="NLM_citation" id="rightTab-cit237"><span><span class="NLM_contrib-group">Fitzgerald, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoeberl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, U. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorger, P. K.</span><span> </span><span class="NLM_article-title">Systems biology and combination therapy in the quest for clinical efficacy</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnchembio817" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16921358" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref237/cit237&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1Gns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=458-466&author=J.+B.+Fitzgeraldauthor=B.+Schoeberlauthor=U.+B.+Nielsenauthor=P.+K.+Sorger&title=Systems+biology+and+combination+therapy+in+the+quest+for+clinical+efficacy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit237R"><div class="casContent"><span class="casTitleNuber">237</span><div class="casTitle"><span class="NLM_cas:atitle">Systems biology and combination therapy in the quest for clinical efficacy</span></div><div class="casAuthors">Fitzgerald, Jonathan B.; Schoeberl, Birgit; Nielsen, Ulrik B.; Sorger, Peter K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">458-466</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Combinatorial control of biol. processes, in which redundancy and multifunctionality are the norm, fundamentally limits the therapeutic index that can be achieved by even the most potent and highly selective drugs.  Thus, it will almost certainly be necessary to use new 'targeted' pharmaceuticals in combinations.  Multicomponent drugs are std. in cytotoxic chemotherapy, but their development has required arduous empirical testing.  However, exptl. validated numerical models should greatly aid in the formulation of new combination therapies, particularly those tailored to the needs of specific patients.  This perspective focuses on opportunities and challenges inherent in the application of math. modeling and systems approached to pharmacol., specifically with respect to the idea of achieving combinatorial selectivity through use of multicomponent drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8p9-4JKdU17Vg90H21EOLACvtfcHk0lhmioDLrHwa9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1Gns7k%253D&md5=223e075af6f4df42ea1be560accfaf31</span></div><a href="/servlet/linkout?suffix=cit237&amp;dbid=16384&amp;doi=10.1038%2Fnchembio817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio817%26sid%3Dliteratum%253Aachs%26aulast%3DFitzgerald%26aufirst%3DJ.%2BB.%26aulast%3DSchoeberl%26aufirst%3DB.%26aulast%3DNielsen%26aufirst%3DU.%2BB.%26aulast%3DSorger%26aufirst%3DP.%2BK.%26atitle%3DSystems%2520biology%2520and%2520combination%2520therapy%2520in%2520the%2520quest%2520for%2520clinical%2520efficacy%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D458%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref238"><div class="reference"><strong class="refLabel"><a href="#ref238" class="rightTabRefNumLink">238</a></strong><div class="NLM_citation" id="rightTab-cit238"><span><span class="NLM_contrib-group">Csermely, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agoston, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pongor, S.</span><span> </span><span class="NLM_article-title">The efficiency of multi-target drugs: the network approach might help drug design</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">178</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.tips.2005.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15808341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref238/cit238&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivV2ht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=178-182&author=P.+Csermelyauthor=V.+Agostonauthor=S.+Pongor&title=The+efficiency+of+multi-target+drugs%3A+the+network+approach+might+help+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit238R"><div class="casContent"><span class="casTitleNuber">238</span><div class="casTitle"><span class="NLM_cas:atitle">The efficiency of multi-target drugs: the network approach might help drug design</span></div><div class="casAuthors">Csermely, Peter; Agoston, Vilmos; Pongor, Sandor</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">178-182</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Despite considerable progress in genome- and proteome-based high-throughput screening methods and rational drug design, the no. of successful single-target drugs did not increase appreciably during the past decade.  Network models suggest that partial inhibition of a surprisingly small no. of targets can be more efficient than the complete inhibition of a single target.  This and the success stories of multi-target drugs and combinatorial therapies led us to suggest that systematic drug-design strategies should be directed against multiple targets.  The authors propose that the final effect of partial, but multiple, drug actions might often surpass that of complete drug action at a single target.  The future success of this novel drug-design paradigm will depend not only on a new generation of computer models to identify the correct multiple targets and their multi-fitting, low-affinity drug candidates but also on more-efficient in vivo testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQRoFMVKb5m7Vg90H21EOLACvtfcHk0lhmioDLrHwa9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivV2ht70%253D&md5=4f1383f4699221ef99041dffafe03e8c</span></div><a href="/servlet/linkout?suffix=cit238&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2005.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2005.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DCsermely%26aufirst%3DP.%26aulast%3DAgoston%26aufirst%3DV.%26aulast%3DPongor%26aufirst%3DS.%26atitle%3DThe%2520efficiency%2520of%2520multi-target%2520drugs%253A%2520the%2520network%2520approach%2520might%2520help%2520drug%2520design%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D178%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref239"><div class="reference"><strong class="refLabel"><a href="#ref239" class="rightTabRefNumLink">239</a></strong><div class="NLM_citation" id="rightTab-cit239"><span><span class="NLM_contrib-group">Millan, M. J.</span><span> </span><span class="NLM_article-title">Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1016%2Fj.pharmthera.2005.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=16522330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref239/cit239&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtFCqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2006&pages=135-370&author=M.+J.+Millan&title=Multi-target+strategies+for+the+improved+treatment+of+depressive+states%3A+conceptual+foundations+and+neuronal+substrates%2C+drug+discovery+and+therapeutic+application"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit239R"><div class="casContent"><span class="casTitleNuber">239</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application</span></div><div class="casAuthors">Millan, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-370</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Major depression is a debilitating and recurrent disorder with a substantial lifetime risk and a high social cost.  Depressed patients generally display co-morbid symptoms, and depression frequently accompanies other serious disorders.  Currently available drugs display limited efficacy and a pronounced delay to onset of action, and all provoke distressing side effects.  Cloning of the human genome has fuelled expectations that symptomatic treatment may soon become more rapid and effective, and that depressive states may ultimately be "prevented" or "cured".  In pursuing these objectives, in particular for genome-derived, non-monoaminergic targets, "specificity" of drug actions is often emphasized.  That is, priority is afforded to agents that interact exclusively with a single site hypothesized as critically involved in the pathogenesis and/or control of depression.  Certain highly selective drugs may prove effective, and they remain indispensable in the exptl. (and clin.) evaluation of the significance of novel mechanisms.  However, by analogy to other multifactorial disorders, "multi-target" agents may be better adapted to the improved treatment of depressive states.  Support for this contention is garnered from a broad palette of observations, ranging from mechanisms of action of adjunctive drug combinations and electroconvulsive therapy to "network theory" anal. of the etiol. and management of depressive states.  The review also outlines opportunities to be exploited, and challenges to be addressed, in the discovery and characterization of drugs recognizing multiple targets.  Finally, a diversity of multi-target strategies is proposed for the more efficacious and rapid control of core and co-morbid symptoms of depression, together with improved tolerance relative to currently available agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxf3nCB4E-O7Vg90H21EOLACvtfcHk0lhmioDLrHwa9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtFCqtr4%253D&md5=dbca7f1b7bba52c69d9c6b95eea01d69</span></div><a href="/servlet/linkout?suffix=cit239&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2005.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2005.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26atitle%3DMulti-target%2520strategies%2520for%2520the%2520improved%2520treatment%2520of%2520depressive%2520states%253A%2520conceptual%2520foundations%2520and%2520neuronal%2520substrates%252C%2520drug%2520discovery%2520and%2520therapeutic%2520application%26jtitle%3DPharmacol.%2520Ther.%26date%3D2006%26volume%3D110%26spage%3D135%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref240"><div class="reference"><strong class="refLabel"><a href="#ref240" class="rightTabRefNumLink">240</a></strong><div class="NLM_citation" id="rightTab-cit240"><span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheffler, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroeze, W. K.</span><span> </span><span class="NLM_article-title">Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=16&amp;doi=10.1021%2Fjm7009364&amp;key=10.1038%2Fnrd1346" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=8&amp;doi=10.1021%2Fjm7009364&amp;key=15060530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref240/cit240&amp;dbid=32&amp;doi=10.1021%2Fjm7009364&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1Gkt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=353-359&author=B.+L.+Rothauthor=D.+J.+Shefflerauthor=W.+K.+Kroeze&title=Magic+shotguns+versus+magic+bullets%3A+selectively+non-selective+drugs+for+mood+disorders+and+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit240R"><div class="casContent"><span class="casTitleNuber">240</span><div class="casTitle"><span class="NLM_cas:atitle">Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia</span></div><div class="casAuthors">Roth, Bryan L.; Sheffler, Douglas J.; Kroeze, Wesley K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">353-359</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Most common central nervous system disorders - such as depression, bipolar disorder, and schizophrenia - seem to be polygenic in origin, and the most effective medications have exceedingly complex pharmacologies.  Attempts to develop more effective treatments for diseases such as schizophrenia and depression by discovering drugs selective for single mol. targets (i.e., 'magic bullets') have, not surprisingly, been largely unsuccessful.  Here the authors propose that designing selectively non-selective drugs (i.e., 'magic shotguns') that interact with several mol. targets will lead to new and more effective medications for a variety of central nervous system disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnSsuUXzmbirVg90H21EOLACvtfcHk0lgicxCohb1cew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1Gkt78%253D&md5=77196583acccca65457fec7a67218463</span></div><a href="/servlet/linkout?suffix=cit240&amp;dbid=16384&amp;doi=10.1038%2Fnrd1346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1346%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DSheffler%26aufirst%3DD.%2BJ.%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26atitle%3DMagic%2520shotguns%2520versus%2520magic%2520bullets%253A%2520selectively%2520non-selective%2520drugs%2520for%2520mood%2520disorders%2520and%2520schizophrenia%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D353%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm7009364&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Fjm7009364%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-3%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm7009364" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991dd2e93f329d","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
